




Analysis Type:	PANTHER Overrepresentation Test (Released 20240807)
Annotation Version and Release Date:	GO Ontology database DOI:  10.5281/zenodo.14083199 Released 2024-11-03
Analyzed List:	upload_1 (Mus musculus)
Reference List:	Mus musculus (all genes in database)
Test Type:	FISHER
Correction:	FDR
GO biological process complete	Mus musculus - REFLIST (21836)	upload_1 (364)	upload_1 (expected)	upload_1 (over/under)	upload_1 (fold Enrichment)	upload_1 (raw P-value)	upload_1 (FDR)
negative regulation of prolactin secretion (GO:1902721)	1	1	.02	+	59.99	1.67E-02	4.78E-01
negative regulation of erythrocyte aggregation (GO:0034119)	1	1	.02	+	59.99	1.67E-02	4.78E-01
symbiont-mediated suppression of host apoptosis (GO:0033668)	1	1	.02	+	59.99	1.67E-02	4.77E-01
chemokine receptor transport within lipid bilayer (GO:0033606)	1	1	.02	+	59.99	1.67E-02	4.76E-01
adenosine biosynthetic process (GO:0046086)	1	1	.02	+	59.99	1.67E-02	4.75E-01
negative regulation of axon guidance (GO:1902668)	1	1	.02	+	59.99	1.67E-02	4.74E-01
negative regulation of T cell homeostatic proliferation (GO:0046014)	1	1	.02	+	59.99	1.67E-02	4.73E-01
midbrain-hindbrain boundary initiation (GO:0021547)	1	1	.02	+	59.99	1.67E-02	4.72E-01
prechordal plate formation (GO:0021501)	1	1	.02	+	59.99	1.67E-02	4.71E-01
positive regulation of N-terminal peptidyl-lysine acetylation (GO:2000761)	1	1	.02	+	59.99	1.67E-02	4.71E-01
regulation of N-terminal peptidyl-lysine acetylation (GO:2000759)	1	1	.02	+	59.99	1.67E-02	4.70E-01
negative regulation of retinal cone cell fate commitment (GO:0060226)	1	1	.02	+	59.99	1.67E-02	4.69E-01
retinal rod cell fate commitment (GO:0060223)	1	1	.02	+	59.99	1.67E-02	4.68E-01
regulation of retinal cone cell fate commitment (GO:0060222)	1	1	.02	+	59.99	1.67E-02	4.67E-01
polyphosphate catabolic process (GO:0006798)	1	1	.02	+	59.99	1.67E-02	4.66E-01
polyphosphate metabolic process (GO:0006797)	1	1	.02	+	59.99	1.67E-02	4.65E-01
positive regulation of angiotensin-activated signaling pathway (GO:0110063)	1	1	.02	+	59.99	1.67E-02	4.65E-01
response to cyclophosphamide (GO:1902518)	1	1	.02	+	59.99	1.67E-02	4.64E-01
transitional two stage B cell differentiation (GO:0002334)	1	1	.02	+	59.99	1.67E-02	4.63E-01
negative regulation of transforming growth factor beta3 production (GO:0032913)	1	1	.02	+	59.99	1.67E-02	4.62E-01
positive regulation of cellular glucuronidation (GO:2001031)	1	1	.02	+	59.99	1.67E-02	4.61E-01
positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902220)	1	1	.02	+	59.99	1.67E-02	4.60E-01
small intestine smooth muscle contraction (GO:1990770)	1	1	.02	+	59.99	1.67E-02	4.60E-01
negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902163)	1	1	.02	+	59.99	1.67E-02	4.59E-01
chemokine receptor transport out of membrane raft (GO:0032600)	1	1	.02	+	59.99	1.67E-02	4.58E-01
protein transport out of membrane raft (GO:0032599)	1	1	.02	+	59.99	1.67E-02	4.57E-01
B cell receptor transport into membrane raft (GO:0032597)	1	1	.02	+	59.99	1.67E-02	4.56E-01
B cell receptor transport within lipid bilayer (GO:0032595)	1	1	.02	+	59.99	1.67E-02	4.55E-01
symbiont-mediated suppression of host programmed cell death (GO:0052041)	1	1	.02	+	59.99	1.67E-02	4.55E-01
positive regulation of protein homooligomerization (GO:0032464)	1	1	.02	+	59.99	1.67E-02	4.54E-01
post-embryonic body morphogenesis (GO:0040032)	1	1	.02	+	59.99	1.67E-02	4.53E-01
regulation of excitatory synapse pruning (GO:1905810)	1	1	.02	+	59.99	1.67E-02	4.52E-01
negative regulation of retinal ganglion cell axon guidance (GO:0090260)	1	1	.02	+	59.99	1.67E-02	4.51E-01
negative regulation of lipid kinase activity (GO:0090219)	1	1	.02	+	59.99	1.67E-02	4.51E-01
induction of negative chemotaxis (GO:0050929)	1	1	.02	+	59.99	1.67E-02	4.50E-01
positive regulation of negative chemotaxis (GO:0050924)	1	1	.02	+	59.99	1.67E-02	4.49E-01
proprioception involved in equilibrioception (GO:0051355)	1	1	.02	+	59.99	1.67E-02	4.48E-01
positive regulation of intracellular transport of viral material (GO:1901254)	1	1	.02	+	59.99	1.67E-02	4.48E-01
detection of cold stimulus involved in thermoception (GO:0120169)	1	1	.02	+	59.99	1.67E-02	4.47E-01
cell-cell signaling via exosome (GO:0099156)	1	1	.02	+	59.99	1.67E-02	4.46E-01
synaptic transmission, serotonergic (GO:0099153)	1	1	.02	+	59.99	1.67E-02	4.45E-01
negative regulation of clathrin coat assembly (GO:1905444)	1	1	.02	+	59.99	1.67E-02	4.44E-01
negative regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905433)	1	1	.02	+	59.99	1.67E-02	4.44E-01
regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905432)	1	1	.02	+	59.99	1.67E-02	4.43E-01
positive regulation of dense core granule exocytosis (GO:1905415)	1	1	.02	+	59.99	1.67E-02	4.42E-01
negative regulation of dense core granule exocytosis (GO:1905414)	1	1	.02	+	59.99	1.67E-02	4.41E-01
large intestinal transit (GO:0120056)	1	1	.02	+	59.99	1.67E-02	4.41E-01
intestinal motility (GO:0120054)	1	1	.02	+	59.99	1.67E-02	4.40E-01
negative regulation of natural killer cell degranulation (GO:0043322)	1	1	.02	+	59.99	1.67E-02	4.39E-01
negative regulation of shelterin complex assembly (GO:1904791)	1	1	.02	+	59.99	1.67E-02	4.38E-01
negative regulation of short-term neuronal synaptic plasticity (GO:0048174)	1	1	.02	+	59.99	1.67E-02	4.38E-01
positive regulation of granulosa cell apoptotic process (GO:1904710)	1	1	.02	+	59.99	1.67E-02	4.37E-01
negative regulation of synaptic vesicle endocytosis (GO:1900243)	1	1	.02	+	59.99	1.67E-02	4.36E-01
menarche (GO:0042696)	1	1	.02	+	59.99	1.67E-02	4.35E-01
vesicle fusion with vesicle (GO:0061782)	1	1	.02	+	59.99	1.67E-02	4.35E-01
sensory perception of cold stimulus (GO:0062035)	1	1	.02	+	59.99	1.67E-02	4.34E-01
positive regulation of transcription by transcription factor localization (GO:0061586)	1	1	.02	+	59.99	1.67E-02	4.33E-01
colon epithelial cell migration (GO:0061580)	1	1	.02	+	59.99	1.67E-02	4.32E-01
actin filament bundle retrograde transport (GO:0061573)	1	1	.02	+	59.99	1.67E-02	4.32E-01
regulation of postsynaptic dense core vesicle exocytosis (GO:0150044)	1	1	.02	+	59.99	1.67E-02	4.31E-01
postsynaptic dense core vesicle exocytosis (GO:0150038)	1	1	.02	+	59.99	1.67E-02	4.30E-01
negative regulation of transformation of host cell by virus (GO:1904188)	1	1	.02	+	59.99	1.67E-02	4.30E-01
positive regulation of T cell homeostatic proliferation (GO:0042103)	1	1	.02	+	59.99	1.67E-02	4.29E-01
positive regulation of mitotic recombination (GO:0045951)	1	1	.02	+	59.99	1.67E-02	4.28E-01
endoplasmic reticulum polarization (GO:0061163)	1	1	.02	+	59.99	1.67E-02	4.27E-01
alveolar primary septum development (GO:0061143)	1	1	.02	+	59.99	1.67E-02	4.27E-01
corticospinal neuron axon guidance through spinal cord (GO:0021972)	1	1	.02	+	59.99	1.67E-02	4.26E-01
actin filament bundle distribution (GO:0070650)	3	2	.05	+	39.99	8.22E-04	6.96E-02
positive regulation of cardiac muscle hypertrophy in response to stress (GO:1903244)	2	1	.03	+	29.99	3.31E-02	6.52E-01
glycerol-3-phosphate catabolic process (GO:0046168)	2	1	.03	+	29.99	3.31E-02	6.51E-01
positive regulation of growth factor dependent skeletal muscle satellite cell proliferation (GO:1902728)	2	1	.03	+	29.99	3.31E-02	6.50E-01
positive regulation of skeletal muscle satellite cell proliferation (GO:1902724)	2	1	.03	+	29.99	3.31E-02	6.49E-01
regulation of erythrocyte aggregation (GO:0034118)	2	1	.03	+	29.99	3.31E-02	6.48E-01
negative regulation of erythrocyte clearance (GO:0034107)	2	1	.03	+	29.99	3.31E-02	6.47E-01
regulation of erythrocyte clearance (GO:0034106)	2	1	.03	+	29.99	3.31E-02	6.47E-01
fourth ventricle development (GO:0021592)	2	1	.03	+	29.99	3.31E-02	6.46E-01
symbiont-mediated killing of host cell (GO:0001907)	2	1	.03	+	29.99	3.31E-02	6.45E-01
positive regulation of respiratory burst involved in inflammatory response (GO:0060265)	2	1	.03	+	29.99	3.31E-02	6.44E-01
positive regulation of anterior head development (GO:2000744)	2	1	.03	+	29.99	3.31E-02	6.43E-01
regulation of anterior head development (GO:2000742)	2	1	.03	+	29.99	3.31E-02	6.43E-01
camera-type eye photoreceptor cell fate commitment (GO:0060220)	2	1	.03	+	29.99	3.31E-02	6.42E-01
positive regulation of dense core granule biogenesis (GO:2000707)	2	1	.03	+	29.99	3.31E-02	6.41E-01
regulation of cellular glucuronidation (GO:2001029)	2	1	.03	+	29.99	3.31E-02	6.40E-01
negative regulation of phospholipase C/protein kinase C signal transduction (GO:0160195)	2	1	.03	+	29.99	3.31E-02	6.39E-01
T cell homeostatic proliferation (GO:0001777)	2	1	.03	+	29.99	3.31E-02	6.39E-01
positive regulation of T-helper 2 cell activation (GO:2000570)	2	1	.03	+	29.99	3.31E-02	6.38E-01
regulation of T-helper 2 cell activation (GO:2000569)	2	1	.03	+	29.99	3.31E-02	6.37E-01
oncostatin-M-mediated signaling pathway (GO:0038165)	4	2	.07	+	29.99	1.63E-03	1.07E-01
response to chloroquine (GO:1902349)	2	1	.03	+	29.99	3.31E-02	6.36E-01
sensory perception of itch (GO:0160025)	2	1	.03	+	29.99	3.31E-02	6.35E-01
symbiont-mediated activation of host apoptosis (GO:0052151)	2	1	.03	+	29.99	3.31E-02	6.35E-01
symbiont-mediated perturbation of host apoptosis (GO:0052150)	2	1	.03	+	29.99	3.31E-02	6.34E-01
cellular response to carbon dioxide (GO:0071244)	2	1	.03	+	29.99	3.31E-02	6.33E-01
positive regulation of peptidyl-cysteine S-nitrosylation (GO:2000170)	2	1	.03	+	29.99	3.31E-02	6.32E-01
symbiont-mediated activation of host programmed cell death (GO:0052042)	2	1	.03	+	29.99	3.31E-02	6.31E-01
symbiont-mediated perturbation of host programmed cell death (GO:0052040)	2	1	.03	+	29.99	3.31E-02	6.31E-01
thermosensory behavior (GO:0040040)	2	1	.03	+	29.99	3.31E-02	6.30E-01
peptidyl-threonine autophosphorylation (GO:1990443)	2	1	.03	+	29.99	3.31E-02	6.29E-01
positive regulation of type B pancreatic cell development (GO:2000078)	2	1	.03	+	29.99	3.31E-02	6.28E-01
negative regulation of axon extension involved in regeneration (GO:0048692)	2	1	.03	+	29.99	3.31E-02	6.27E-01
negative regulation of sprouting of injured axon (GO:0048688)	2	1	.03	+	29.99	3.31E-02	6.27E-01
evoked excitatory postsynaptic potential (GO:0098817)	2	1	.03	+	29.99	3.31E-02	6.26E-01
chemorepulsion of dopaminergic neuron axon (GO:0036518)	2	1	.03	+	29.99	3.31E-02	6.25E-01
symbiont-mediated perturbation of host cellular process (GO:0044068)	2	1	.03	+	29.99	3.31E-02	6.24E-01
negative regulation of ERBB4 signaling pathway (GO:0120154)	2	1	.03	+	29.99	3.31E-02	6.24E-01
regulation of synaptic vesicle docking (GO:0099148)	2	1	.03	+	29.99	3.31E-02	6.23E-01
symbiont-mediated perturbation of host process (GO:0044003)	2	1	.03	+	29.99	3.31E-02	6.22E-01
nose morphogenesis (GO:0043585)	2	1	.03	+	29.99	3.31E-02	6.21E-01
positive regulation of activation-induced cell death of T cells (GO:0070237)	2	1	.03	+	29.99	3.31E-02	6.21E-01
opsin transport (GO:0036372)	2	1	.03	+	29.99	3.31E-02	6.20E-01
positive regulation of cell proliferation in midbrain (GO:1904935)	2	1	.03	+	29.99	3.31E-02	6.19E-01
vesicle targeting, trans-Golgi to endosome (GO:0048203)	2	1	.03	+	29.99	3.31E-02	6.18E-01
regulation of shelterin complex assembly (GO:1904790)	2	1	.03	+	29.99	3.31E-02	6.18E-01
negative regulation of protein K48-linked ubiquitination (GO:0061944)	2	1	.03	+	29.99	3.31E-02	6.17E-01
positive regulation of metalloendopeptidase activity (GO:1904685)	2	1	.03	+	29.99	3.31E-02	6.16E-01
negative regulation of Kit signaling pathway (GO:1900235)	2	1	.03	+	29.99	3.31E-02	6.15E-01
regulation of Kit signaling pathway (GO:1900234)	2	1	.03	+	29.99	3.31E-02	6.15E-01
argininosuccinate metabolic process (GO:0000053)	2	1	.03	+	29.99	3.31E-02	6.14E-01
lipopolysaccharide transport (GO:0015920)	2	1	.03	+	29.99	3.31E-02	6.13E-01
positive regulation of hair cycle (GO:0042635)	2	1	.03	+	29.99	3.31E-02	6.12E-01
cellular detoxification of hydrogen peroxide (GO:0061692)	2	1	.03	+	29.99	3.31E-02	6.12E-01
peptidyl-lysine modification to peptidyl-hypusine (GO:0008612)	2	1	.03	+	29.99	3.31E-02	6.11E-01
negative regulation of odontogenesis of dentin-containing tooth (GO:0042489)	2	1	.03	+	29.99	3.31E-02	6.10E-01
regulation of trans-synaptic signaling by BDNF, modulating synaptic transmission (GO:0150035)	2	1	.03	+	29.99	3.31E-02	6.09E-01
polyprenol catabolic process (GO:0016095)	2	1	.03	+	29.99	3.31E-02	6.09E-01
cuticle development (GO:0042335)	2	1	.03	+	29.99	3.31E-02	6.08E-01
regulation of transformation of host cell by virus (GO:1904187)	2	1	.03	+	29.99	3.31E-02	6.07E-01
menstrual cycle phase (GO:0022601)	2	1	.03	+	29.99	3.31E-02	6.07E-01
positive regulation of cardiac muscle adaptation (GO:0010615)	2	1	.03	+	29.99	3.31E-02	6.06E-01
behavioral response to acetic acid induced pain (GO:0061367)	2	1	.03	+	29.99	3.31E-02	6.05E-01
creatinine metabolic process (GO:0046449)	2	1	.03	+	29.99	3.31E-02	6.04E-01
esophagus smooth muscle contraction (GO:0014846)	2	1	.03	+	29.99	3.31E-02	6.04E-01
corticospinal neuron axon guidance (GO:0021966)	2	1	.03	+	29.99	3.31E-02	6.03E-01
chemorepulsion involved in postnatal olfactory bulb interneuron migration (GO:0021836)	2	1	.03	+	29.99	3.31E-02	6.02E-01
macrophage fusion (GO:0034238)	2	1	.03	+	29.99	3.31E-02	6.02E-01
adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198)	9	4	.15	+	26.66	8.96E-06	1.70E-03
heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)	5	2	.08	+	24.00	2.68E-03	1.55E-01
negative regulation of synaptic vesicle exocytosis (GO:2000301)	5	2	.08	+	24.00	2.68E-03	1.54E-01
lipid phosphorylation (GO:0046834)	10	4	.17	+	24.00	1.47E-05	2.58E-03
behavioral response to formalin induced pain (GO:0061368)	5	2	.08	+	24.00	2.68E-03	1.54E-01
behavioral response to chemical pain (GO:0061366)	5	2	.08	+	24.00	2.68E-03	1.53E-01
opsonization (GO:0008228)	5	2	.08	+	24.00	2.68E-03	1.52E-01
positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049)	9	3	.15	+	20.00	3.58E-04	3.54E-02
heparan sulfate proteoglycan metabolic process (GO:0030201)	9	3	.15	+	20.00	3.58E-04	3.52E-02
vestibular nucleus development (GO:0021750)	3	1	.05	+	20.00	4.92E-02	7.87E-01
dolichol biosynthetic process (GO:0019408)	3	1	.05	+	20.00	4.92E-02	7.86E-01
lung induction (GO:0060492)	3	1	.05	+	20.00	4.92E-02	7.85E-01
vitamin A import into cell (GO:0071939)	3	1	.05	+	20.00	4.92E-02	7.85E-01
vitamin A transport (GO:0071938)	3	1	.05	+	20.00	4.92E-02	7.84E-01
cerebellar molecular layer development (GO:0021679)	3	1	.05	+	20.00	4.92E-02	7.83E-01
lactam metabolic process (GO:0072338)	3	1	.05	+	20.00	4.92E-02	7.82E-01
positive regulation of metanephric glomerulus development (GO:0072300)	3	1	.05	+	20.00	4.92E-02	7.81E-01
positive regulation of axon guidance (GO:1902669)	3	1	.05	+	20.00	4.92E-02	7.81E-01
cytoplasmic actin-based contraction involved in cell motility (GO:0060327)	3	1	.05	+	20.00	4.92E-02	7.80E-01
negative regulation of blood vessel remodeling (GO:0060313)	3	1	.05	+	20.00	4.92E-02	7.79E-01
elastin catabolic process (GO:0060309)	3	1	.05	+	20.00	4.92E-02	7.78E-01
negative regulation of animal organ morphogenesis (GO:0110111)	3	1	.05	+	20.00	4.92E-02	7.77E-01
regulation of metanephric glomerulus development (GO:0072298)	3	1	.05	+	20.00	4.92E-02	7.77E-01
epithalamus development (GO:0021538)	3	1	.05	+	20.00	4.92E-02	7.76E-01
visceral motor neuron differentiation (GO:0021524)	3	1	.05	+	20.00	4.92E-02	7.75E-01
positive regulation of nephron tubule epithelial cell differentiation (GO:2000768)	3	1	.05	+	20.00	4.92E-02	7.74E-01
positive regulation of metanephros development (GO:0072216)	3	1	.05	+	20.00	4.92E-02	7.73E-01
regulation of dense core granule biogenesis (GO:2000705)	3	1	.05	+	20.00	4.92E-02	7.73E-01
protein localization to P-body (GO:0110012)	3	1	.05	+	20.00	4.92E-02	7.72E-01
B cell affinity maturation (GO:0002344)	3	1	.05	+	20.00	4.92E-02	7.71E-01
peripheral B cell selection (GO:0002343)	3	1	.05	+	20.00	4.92E-02	7.70E-01
transitional stage B cell differentiation (GO:0002332)	3	1	.05	+	20.00	4.92E-02	7.69E-01
adenylate cyclase-activating serotonin receptor signaling pathway (GO:0007192)	3	1	.05	+	20.00	4.92E-02	7.69E-01
glomerular parietal epithelial cell differentiation (GO:0072139)	3	1	.05	+	20.00	4.92E-02	7.68E-01
regulation of transforming growth factor beta3 production (GO:0032910)	3	1	.05	+	20.00	4.92E-02	7.67E-01
ribosomal protein import into nucleus (GO:0006610)	3	1	.05	+	20.00	4.92E-02	7.66E-01
eosinophil homeostasis (GO:1990959)	3	1	.05	+	20.00	4.92E-02	7.66E-01
endothelial cell-cell adhesion (GO:0071603)	3	1	.05	+	20.00	4.92E-02	7.65E-01
calcium ion regulated lysosome exocytosis (GO:1990927)	3	1	.05	+	20.00	4.92E-02	7.64E-01
mitotic chromosome movement towards spindle pole (GO:0007079)	3	1	.05	+	20.00	4.92E-02	7.63E-01
ureteric bud invasion (GO:0072092)	3	1	.05	+	20.00	4.92E-02	7.63E-01
GDF15-GFRAL signaling pathway (GO:0160144)	3	1	.05	+	20.00	4.92E-02	7.62E-01
interleukin-23-mediated signaling pathway (GO:0038155)	3	1	.05	+	20.00	4.92E-02	7.61E-01
interleukin-11-mediated signaling pathway (GO:0038154)	6	2	.10	+	20.00	3.98E-03	2.01E-01
octopamine biosynthetic process (GO:0006589)	3	1	.05	+	20.00	4.92E-02	7.60E-01
dsRNA transport (GO:0033227)	3	1	.05	+	20.00	4.92E-02	7.59E-01
sequestering of BMP from receptor via BMP binding (GO:0038098)	3	1	.05	+	20.00	4.92E-02	7.59E-01
negative regulation of mast cell cytokine production (GO:0032764)	3	1	.05	+	20.00	4.92E-02	7.58E-01
mast cell cytokine production (GO:0032762)	6	2	.10	+	20.00	3.98E-03	2.00E-01
cellular response to alkaline pH (GO:0071469)	3	1	.05	+	20.00	4.92E-02	7.57E-01
cellular response to oleic acid (GO:0071400)	3	1	.05	+	20.00	4.92E-02	7.56E-01
regulation of renal output by angiotensin (GO:0002019)	3	1	.05	+	20.00	4.92E-02	7.56E-01
regulation of translation at presynapse (GO:0140244)	3	1	.05	+	20.00	4.92E-02	7.55E-01
regulation of translation at presynapse, modulating synaptic transmission (GO:0099577)	3	1	.05	+	20.00	4.92E-02	7.54E-01
interleukin-10-mediated signaling pathway (GO:0140105)	6	2	.10	+	20.00	3.98E-03	2.00E-01
regulation of protein homooligomerization (GO:0032462)	3	1	.05	+	20.00	4.92E-02	7.53E-01
regulation of endocannabinoid signaling pathway (GO:2000124)	3	1	.05	+	20.00	4.92E-02	7.53E-01
peptidyl-cysteine methylation (GO:0018125)	3	1	.05	+	20.00	4.92E-02	7.52E-01
calcitonin gene-related peptide receptor signaling pathway (GO:1990408)	3	1	.05	+	20.00	4.92E-02	7.51E-01
regulation of retinal ganglion cell axon guidance (GO:0090259)	3	1	.05	+	20.00	4.92E-02	7.50E-01
protein localization to nuclear pore (GO:0090204)	3	1	.05	+	20.00	4.92E-02	7.50E-01
response to magnetism (GO:0071000)	3	1	.05	+	20.00	4.92E-02	7.49E-01
sprouting of injured axon (GO:0048682)	3	1	.05	+	20.00	4.92E-02	7.48E-01
axon extension involved in regeneration (GO:0048677)	3	1	.05	+	20.00	4.92E-02	7.47E-01
collateral sprouting in absence of injury (GO:0048669)	3	1	.05	+	20.00	4.92E-02	7.47E-01
detection of chemical stimulus involved in sensory perception of pain (GO:0050968)	3	1	.05	+	20.00	4.92E-02	7.46E-01
positive regulation of inflammatory response to wounding (GO:0106016)	3	1	.05	+	20.00	4.92E-02	7.45E-01
regulation of intracellular transport of viral material (GO:1901252)	3	1	.05	+	20.00	4.92E-02	7.45E-01
monocyte aggregation (GO:0070487)	6	2	.10	+	20.00	3.98E-03	1.99E-01
musculoskeletal movement, spinal reflex action (GO:0050883)	3	1	.05	+	20.00	4.92E-02	7.44E-01
negative regulation of protein kinase C signaling (GO:0090038)	3	1	.05	+	20.00	4.92E-02	7.43E-01
negative regulation of monocyte chemotaxis (GO:0090027)	6	2	.10	+	20.00	3.98E-03	1.98E-01
postsynaptic intermediate filament cytoskeleton organization (GO:0099185)	3	1	.05	+	20.00	4.92E-02	7.42E-01
positive regulation of monocyte aggregation (GO:1900625)	3	1	.05	+	20.00	4.92E-02	7.42E-01
regulation of monocyte aggregation (GO:1900623)	3	1	.05	+	20.00	4.92E-02	7.41E-01
cornification (GO:0070268)	3	1	.05	+	20.00	4.92E-02	7.40E-01
regulation of cell proliferation in midbrain (GO:1904933)	3	1	.05	+	20.00	4.92E-02	7.39E-01
innate vocalization behavior (GO:0098582)	3	1	.05	+	20.00	4.92E-02	7.39E-01
peptidyl-glutamic acid carboxylation (GO:0017187)	3	1	.05	+	20.00	4.92E-02	7.38E-01
positive regulation of excitatory synapse assembly (GO:1904891)	3	1	.05	+	20.00	4.92E-02	7.37E-01
negative regulation of long-term synaptic depression (GO:1900453)	3	1	.05	+	20.00	4.92E-02	7.37E-01
negative regulation of neutrophil degranulation (GO:0043314)	3	1	.05	+	20.00	4.92E-02	7.36E-01
regulation of sulfur amino acid metabolic process (GO:0031335)	3	1	.05	+	20.00	4.92E-02	7.35E-01
toxin catabolic process (GO:0009407)	3	1	.05	+	20.00	4.92E-02	7.34E-01
TRAM-dependent toll-like receptor 4 signaling pathway (GO:0035669)	3	1	.05	+	20.00	4.92E-02	7.34E-01
TRAM-dependent toll-like receptor signaling pathway (GO:0035668)	3	1	.05	+	20.00	4.92E-02	7.33E-01
positive regulation of protein localization to phagocytic vesicle (GO:1905171)	3	1	.05	+	20.00	4.92E-02	7.32E-01
regulation of protein localization to phagocytic vesicle (GO:1905169)	3	1	.05	+	20.00	4.92E-02	7.32E-01
regulation of phagosome maturation (GO:1905162)	3	1	.05	+	20.00	4.92E-02	7.31E-01
negative regulation of membrane invagination (GO:1905154)	3	1	.05	+	20.00	4.92E-02	7.30E-01
response to resveratrol (GO:1904638)	3	1	.05	+	20.00	4.92E-02	7.29E-01
eye photoreceptor cell fate commitment (GO:0042706)	3	1	.05	+	20.00	4.92E-02	7.29E-01
secretory granule maturation (GO:0061792)	3	1	.05	+	20.00	4.92E-02	7.28E-01
positive regulation of endothelin production (GO:1904472)	3	1	.05	+	20.00	4.92E-02	7.27E-01
detoxification of hydrogen peroxide (GO:0061691)	3	1	.05	+	20.00	4.92E-02	7.27E-01
oligosaccharide transport (GO:0015772)	3	1	.05	+	20.00	4.92E-02	7.26E-01
sucrose transport (GO:0015770)	3	1	.05	+	20.00	4.92E-02	7.25E-01
disaccharide transport (GO:0015766)	3	1	.05	+	20.00	4.92E-02	7.25E-01
negative regulation of odontogenesis (GO:0042483)	3	1	.05	+	20.00	4.92E-02	7.24E-01
intestinal epithelial cell migration (GO:0061582)	3	1	.05	+	20.00	4.92E-02	7.23E-01
positive regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904237)	3	1	.05	+	20.00	4.92E-02	7.23E-01
regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904235)	3	1	.05	+	20.00	4.92E-02	7.22E-01
retinol transport (GO:0034633)	3	1	.05	+	20.00	4.92E-02	7.21E-01
photoreceptor cell fate commitment (GO:0046552)	3	1	.05	+	20.00	4.92E-02	7.20E-01
satellite cell activation involved in skeletal muscle regeneration (GO:0014901)	3	1	.05	+	20.00	4.92E-02	7.20E-01
Peyer's patch morphogenesis (GO:0061146)	3	1	.05	+	20.00	4.92E-02	7.19E-01
habenula development (GO:0021986)	3	1	.05	+	20.00	4.92E-02	7.18E-01
positive regulation of translational termination (GO:0045905)	3	1	.05	+	20.00	4.92E-02	7.18E-01
negative regulation of synaptic vesicle recycling (GO:1903422)	3	1	.05	+	20.00	4.92E-02	7.17E-01
octopamine metabolic process (GO:0046333)	3	1	.05	+	20.00	4.92E-02	7.16E-01
endocardial cushion to mesenchymal transition involved in heart valve formation (GO:0003199)	3	1	.05	+	20.00	4.92E-02	7.16E-01
postnatal olfactory bulb interneuron migration (GO:0021827)	3	1	.05	+	20.00	4.92E-02	7.15E-01
substrate-dependent cerebral cortex tangential migration (GO:0021825)	3	1	.05	+	20.00	4.92E-02	7.14E-01
cerebral cortex tangential migration using cell-cell interactions (GO:0021823)	3	1	.05	+	20.00	4.92E-02	7.14E-01
enkephalin processing (GO:0034230)	3	1	.05	+	20.00	4.92E-02	7.13E-01
G protein-coupled serotonin receptor signaling pathway (GO:0098664)	16	5	.27	+	18.75	4.70E-06	1.02E-03
positive regulation of peptidyl-lysine acetylation (GO:2000758)	7	2	.12	+	17.14	5.51E-03	2.53E-01
oncogene-induced cell senescence (GO:0090402)	7	2	.12	+	17.14	5.51E-03	2.52E-01
Cdc42 protein signal transduction (GO:0032488)	7	2	.12	+	17.14	5.51E-03	2.51E-01
gastro-intestinal system smooth muscle contraction (GO:0014831)	7	2	.12	+	17.14	5.51E-03	2.50E-01
negative regulation of transforming growth factor beta production (GO:0071635)	11	3	.18	+	16.36	6.86E-04	5.94E-02
globus pallidus development (GO:0021759)	4	1	.07	+	15.00	6.50E-02	8.46E-01
club cell differentiation (GO:0060486)	4	1	.07	+	15.00	6.50E-02	8.45E-01
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141)	8	2	.13	+	15.00	7.26E-03	2.98E-01
substrate-dependent cell migration, cell extension (GO:0006930)	8	2	.13	+	15.00	7.26E-03	2.97E-01
lncRNA processing (GO:0180035)	4	1	.07	+	15.00	6.50E-02	8.44E-01
regulation of T cell homeostatic proliferation (GO:0046013)	4	1	.07	+	15.00	6.50E-02	8.44E-01
positive regulation of caveolin-mediated endocytosis (GO:2001288)	4	1	.07	+	15.00	6.50E-02	8.43E-01
response to mycotoxin (GO:0010046)	4	1	.07	+	15.00	6.50E-02	8.42E-01
dorsal/ventral axon guidance (GO:0033563)	4	1	.07	+	15.00	6.50E-02	8.42E-01
cerebellum maturation (GO:0021590)	4	1	.07	+	15.00	6.50E-02	8.41E-01
corpus callosum morphogenesis (GO:0021540)	8	2	.13	+	15.00	7.26E-03	2.96E-01
thigmotaxis (GO:0001966)	4	1	.07	+	15.00	6.50E-02	8.40E-01
regulation of angiotensin-activated signaling pathway (GO:0110061)	4	1	.07	+	15.00	6.50E-02	8.39E-01
cellular response to prostaglandin D stimulus (GO:0071799)	4	1	.07	+	15.00	6.50E-02	8.39E-01
response to prostaglandin D (GO:0071798)	4	1	.07	+	15.00	6.50E-02	8.38E-01
negative regulation of primary miRNA processing (GO:2000635)	4	1	.07	+	15.00	6.50E-02	8.37E-01
nuclear protein quality control by the ubiquitin-proteasome system (GO:0071630)	4	1	.07	+	15.00	6.50E-02	8.37E-01
negative regulation of granulocyte chemotaxis (GO:0071623)	4	1	.07	+	15.00	6.50E-02	8.36E-01
protein localization to secretory granule (GO:0033366)	4	1	.07	+	15.00	6.50E-02	8.35E-01
metanephric renal vesicle formation (GO:0072093)	4	1	.07	+	15.00	6.50E-02	8.35E-01
positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)	12	3	.20	+	15.00	9.04E-04	7.29E-02
interleukin-9-mediated signaling pathway (GO:0038113)	8	2	.13	+	15.00	7.26E-03	2.95E-01
interleukin-2-mediated signaling pathway (GO:0038110)	8	2	.13	+	15.00	7.26E-03	2.94E-01
L-arginine biosynthetic process (GO:0006526)	4	1	.07	+	15.00	6.50E-02	8.34E-01
cellular response to heparin (GO:0071504)	4	1	.07	+	15.00	6.50E-02	8.33E-01
RNA import into nucleus (GO:0006404)	4	1	.07	+	15.00	6.50E-02	8.32E-01
cellular response to amine stimulus (GO:0071418)	4	1	.07	+	15.00	6.50E-02	8.32E-01
renin-angiotensin regulation of aldosterone production (GO:0002018)	4	1	.07	+	15.00	6.50E-02	8.31E-01
renin secretion into blood stream (GO:0002001)	4	1	.07	+	15.00	6.50E-02	8.30E-01
endocardial cushion to mesenchymal transition (GO:0090500)	4	1	.07	+	15.00	6.50E-02	8.30E-01
termination of RNA polymerase I transcription (GO:0006363)	4	1	.07	+	15.00	6.50E-02	8.29E-01
cellular response to interleukin-9 (GO:0071355)	8	2	.13	+	15.00	7.26E-03	2.94E-01
cellular response to interleukin-2 (GO:0071352)	8	2	.13	+	15.00	7.26E-03	2.93E-01
negative regulation of neutrophil apoptotic process (GO:0033030)	4	1	.07	+	15.00	6.50E-02	8.28E-01
protein carboxylation (GO:0018214)	4	1	.07	+	15.00	6.50E-02	8.28E-01
regulation of peptidyl-cysteine S-nitrosylation (GO:2000169)	8	2	.13	+	15.00	7.26E-03	2.92E-01
positive regulation of protein oligomerization (GO:0032461)	4	1	.07	+	15.00	6.50E-02	8.27E-01
response to methylmercury (GO:0051597)	4	1	.07	+	15.00	6.50E-02	8.26E-01
negative regulation of lymphangiogenesis (GO:1901491)	4	1	.07	+	15.00	6.50E-02	8.26E-01
regulation of synapse pruning (GO:1905806)	12	3	.20	+	15.00	9.04E-04	7.25E-02
negative regulation of cortisol biosynthetic process (GO:2000065)	4	1	.07	+	15.00	6.50E-02	8.25E-01
negative regulation of aldosterone biosynthetic process (GO:0032348)	4	1	.07	+	15.00	6.50E-02	8.24E-01
negative regulation of aldosterone metabolic process (GO:0032345)	4	1	.07	+	15.00	6.50E-02	8.24E-01
regulation of axon extension involved in regeneration (GO:0048690)	4	1	.07	+	15.00	6.50E-02	8.23E-01
regulation of negative chemotaxis (GO:0050923)	4	1	.07	+	15.00	6.50E-02	8.22E-01
positive regulation of synaptic transmission, dopaminergic (GO:0032226)	4	1	.07	+	15.00	6.50E-02	8.22E-01
unidimensional cell growth (GO:0009826)	4	1	.07	+	15.00	6.50E-02	8.21E-01
negative regulation of neutrophil chemotaxis (GO:0090024)	4	1	.07	+	15.00	6.50E-02	8.20E-01
protein localization to lipid droplet (GO:1990044)	4	1	.07	+	15.00	6.50E-02	8.19E-01
ascending aorta morphogenesis (GO:0035910)	4	1	.07	+	15.00	6.50E-02	8.19E-01
response to high light intensity (GO:0009644)	4	1	.07	+	15.00	6.50E-02	8.18E-01
imitative learning (GO:0098596)	8	2	.13	+	15.00	7.26E-03	2.91E-01
positive regulation of hepatic stellate cell proliferation (GO:1904899)	4	1	.07	+	15.00	6.50E-02	8.17E-01
ureter maturation (GO:0035799)	4	1	.07	+	15.00	6.50E-02	8.17E-01
regulation of natural killer cell degranulation (GO:0043321)	4	1	.07	+	15.00	6.50E-02	8.16E-01
negative regulation of myofibroblast differentiation (GO:1904761)	4	1	.07	+	15.00	6.50E-02	8.15E-01
phosphatidylinositol acyl-chain remodeling (GO:0036149)	4	1	.07	+	15.00	6.50E-02	8.15E-01
regulation of granulosa cell apoptotic process (GO:1904708)	4	1	.07	+	15.00	6.50E-02	8.14E-01
sequestering of BMP in extracellular matrix (GO:0035582)	4	1	.07	+	15.00	6.50E-02	8.14E-01
phosphatidylinositol catabolic process (GO:0031161)	4	1	.07	+	15.00	6.50E-02	8.13E-01
dense core granule priming (GO:0061789)	4	1	.07	+	15.00	6.50E-02	8.12E-01
creatine transmembrane transport (GO:0015881)	4	1	.07	+	15.00	6.50E-02	8.12E-01
regulation of endothelin production (GO:1904470)	4	1	.07	+	15.00	6.50E-02	8.11E-01
phospholipase C-activating angiotensin-activated signaling pathway (GO:0086097)	4	1	.07	+	15.00	6.50E-02	8.10E-01
terpenoid transport (GO:0046865)	4	1	.07	+	15.00	6.50E-02	8.10E-01
isoprenoid transport (GO:0046864)	4	1	.07	+	15.00	6.50E-02	8.09E-01
taurine biosynthetic process (GO:0042412)	4	1	.07	+	15.00	6.50E-02	8.08E-01
polyprenol biosynthetic process (GO:0016094)	4	1	.07	+	15.00	6.50E-02	8.08E-01
negative regulation of hydrogen peroxide biosynthetic process (GO:0010730)	4	1	.07	+	15.00	6.50E-02	8.07E-01
vocal learning (GO:0042297)	8	2	.13	+	15.00	7.26E-03	2.91E-01
regulation of locomotor rhythm (GO:1904059)	4	1	.07	+	15.00	6.50E-02	8.06E-01
positive regulation of membrane tubulation (GO:1903527)	4	1	.07	+	15.00	6.50E-02	8.06E-01
neuroligin clustering involved in postsynaptic membrane assembly (GO:0097118)	4	1	.07	+	15.00	6.50E-02	8.05E-01
response to alkaline pH (GO:0010446)	4	1	.07	+	15.00	6.50E-02	8.04E-01
neural plate anterior/posterior regionalization (GO:0021999)	4	1	.07	+	15.00	6.50E-02	8.04E-01
positive regulation of phospholipid efflux (GO:1902995)	4	1	.07	+	15.00	6.50E-02	8.03E-01
regulation of phospholipid efflux (GO:1902994)	4	1	.07	+	15.00	6.50E-02	8.02E-01
alkanesulfonate biosynthetic process (GO:0046305)	4	1	.07	+	15.00	6.50E-02	8.02E-01
negative regulation of amacrine cell differentiation (GO:1902870)	4	1	.07	+	15.00	6.50E-02	8.01E-01
trachea cartilage morphogenesis (GO:0060535)	4	1	.07	+	15.00	6.50E-02	8.01E-01
glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860)	13	3	.22	+	13.84	1.16E-03	8.48E-02
negative regulation of leukocyte degranulation (GO:0043301)	13	3	.22	+	13.84	1.16E-03	8.44E-02
chemosensory behavior (GO:0007635)	26	6	.43	+	13.84	3.58E-06	8.48E-04
negative regulation of regulated secretory pathway (GO:1903306)	26	6	.43	+	13.84	3.58E-06	8.35E-04
growth hormone receptor signaling pathway via JAK-STAT (GO:0060397)	9	2	.15	+	13.33	9.23E-03	3.41E-01
neuron cell-cell adhesion (GO:0007158)	9	2	.15	+	13.33	9.23E-03	3.40E-01
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158)	9	2	.15	+	13.33	9.23E-03	3.40E-01
gamma-aminobutyric acid secretion (GO:0014051)	9	2	.15	+	13.33	9.23E-03	3.39E-01
response to interleukin-9 (GO:0071104)	9	2	.15	+	13.33	9.23E-03	3.38E-01
positive regulation of synaptic vesicle membrane organization (GO:1901634)	14	3	.23	+	12.85	1.46E-03	9.99E-02
calcium-dependent activation of synaptic vesicle fusion (GO:0099502)	14	3	.23	+	12.85	1.46E-03	9.95E-02
positive regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031632)	14	3	.23	+	12.85	1.46E-03	9.90E-02
cellular response to prostaglandin stimulus (GO:0071379)	19	4	.32	+	12.63	2.41E-04	2.60E-02
positive regulation of Ras protein signal transduction (GO:0046579)	24	5	.40	+	12.50	4.10E-05	6.19E-03
cellular response to prostaglandin E stimulus (GO:0071380)	15	3	.25	+	12.00	1.80E-03	1.14E-01
response to oleic acid (GO:0034201)	5	1	.08	+	12.00	8.06E-02	9.33E-01
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure (GO:0003072)	10	2	.17	+	12.00	1.14E-02	3.82E-01
acrosomal vesicle exocytosis (GO:0060478)	5	1	.08	+	12.00	8.06E-02	9.32E-01
third ventricle development (GO:0021678)	5	1	.08	+	12.00	8.06E-02	9.31E-01
regulation of parathyroid hormone secretion (GO:2000828)	5	1	.08	+	12.00	8.06E-02	9.31E-01
protein localization to adherens junction (GO:0071896)	5	1	.08	+	12.00	8.06E-02	9.30E-01
negative regulation of neutrophil migration (GO:1902623)	5	1	.08	+	12.00	8.06E-02	9.29E-01
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure (GO:0001999)	5	1	.08	+	12.00	8.06E-02	9.29E-01
medulla oblongata development (GO:0021550)	5	1	.08	+	12.00	8.06E-02	9.28E-01
negative regulation of receptor recycling (GO:0001920)	5	1	.08	+	12.00	8.06E-02	9.27E-01
serotonin receptor signaling pathway (GO:0007210)	10	2	.17	+	12.00	1.14E-02	3.82E-01
phospholipase C-activating serotonin receptor signaling pathway (GO:0007208)	5	1	.08	+	12.00	8.06E-02	9.27E-01
regulation of metanephros development (GO:0072215)	5	1	.08	+	12.00	8.06E-02	9.26E-01
negative regulation of dendritic cell differentiation (GO:2001199)	5	1	.08	+	12.00	8.06E-02	9.25E-01
B cell selection (GO:0002339)	5	1	.08	+	12.00	8.06E-02	9.24E-01
pro-B cell differentiation (GO:0002328)	5	1	.08	+	12.00	8.06E-02	9.24E-01
negative regulation of smooth muscle cell chemotaxis (GO:0071672)	5	1	.08	+	12.00	8.06E-02	9.23E-01
somite specification (GO:0001757)	5	1	.08	+	12.00	8.06E-02	9.22E-01
positive regulation of monocyte extravasation (GO:2000439)	5	1	.08	+	12.00	8.06E-02	9.22E-01
notochord formation (GO:0014028)	5	1	.08	+	12.00	8.06E-02	9.21E-01
maintenance of blood vessel diameter homeostasis by renin-angiotensin (GO:0002034)	10	2	.17	+	12.00	1.14E-02	3.81E-01
angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002033)	5	1	.08	+	12.00	8.06E-02	9.20E-01
positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141)	5	1	.08	+	12.00	8.06E-02	9.20E-01
transcription initiation at mitochondrial promoter (GO:0006391)	5	1	.08	+	12.00	8.06E-02	9.19E-01
cellular response to interleukin-15 (GO:0071350)	10	2	.17	+	12.00	1.14E-02	3.80E-01
cellular response to nicotine (GO:0071316)	10	2	.17	+	12.00	1.14E-02	3.79E-01
protein targeting to chloroplast (GO:0045036)	5	1	.08	+	12.00	8.06E-02	9.18E-01
positive regulation of neutrophil apoptotic process (GO:0033031)	5	1	.08	+	12.00	8.06E-02	9.18E-01
regulation of neutrophil apoptotic process (GO:0033029)	10	2	.17	+	12.00	1.14E-02	3.78E-01
action potential initiation (GO:0099610)	5	1	.08	+	12.00	8.06E-02	9.17E-01
protein O-linked glycosylation via threonine (GO:0018243)	10	2	.17	+	12.00	1.14E-02	3.77E-01
protein O-linked glycosylation via serine (GO:0018242)	10	2	.17	+	12.00	1.14E-02	3.77E-01
leukemia inhibitory factor signaling pathway (GO:0048861)	5	1	.08	+	12.00	8.06E-02	9.16E-01
negative regulation of glucocorticoid biosynthetic process (GO:0031947)	5	1	.08	+	12.00	8.06E-02	9.16E-01
negative regulation of glucocorticoid metabolic process (GO:0031944)	5	1	.08	+	12.00	8.06E-02	9.15E-01
response to interleukin-2 (GO:0070669)	10	2	.17	+	12.00	1.14E-02	3.76E-01
negative regulation of voltage-gated calcium channel activity (GO:1901386)	10	2	.17	+	12.00	1.14E-02	3.75E-01
retrograde trans-synaptic signaling by trans-synaptic protein complex (GO:0098942)	5	1	.08	+	12.00	8.06E-02	9.14E-01
positive regulation of glomerulus development (GO:0090193)	5	1	.08	+	12.00	8.06E-02	9.14E-01
regulation of sprouting of injured axon (GO:0048686)	5	1	.08	+	12.00	8.06E-02	9.13E-01
detection of temperature stimulus involved in thermoception (GO:0050960)	5	1	.08	+	12.00	8.06E-02	9.12E-01
thermoception (GO:0050955)	10	2	.17	+	12.00	1.14E-02	3.74E-01
regulation of vesicle docking (GO:0106020)	5	1	.08	+	12.00	8.06E-02	9.12E-01
positive regulation of blood-brain barrier permeability (GO:1905605)	5	1	.08	+	12.00	8.06E-02	9.11E-01
ascending aorta development (GO:0035905)	5	1	.08	+	12.00	8.06E-02	9.10E-01
regulation of dense core granule exocytosis (GO:1905413)	5	1	.08	+	12.00	8.06E-02	9.10E-01
DNA ligation involved in DNA repair (GO:0051103)	5	1	.08	+	12.00	8.06E-02	9.09E-01
observational learning (GO:0098597)	10	2	.17	+	12.00	1.14E-02	3.73E-01
detection of virus (GO:0009597)	5	1	.08	+	12.00	8.06E-02	9.08E-01
negative regulation of Golgi to plasma membrane protein transport (GO:0042997)	5	1	.08	+	12.00	8.06E-02	9.08E-01
negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904878)	5	1	.08	+	12.00	8.06E-02	9.07E-01
ciliary neurotrophic factor-mediated signaling pathway (GO:0070120)	5	1	.08	+	12.00	8.06E-02	9.06E-01
interleukin-15-mediated signaling pathway (GO:0035723)	10	2	.17	+	12.00	1.14E-02	3.73E-01
regulation of metalloendopeptidase activity (GO:1904683)	5	1	.08	+	12.00	8.06E-02	9.06E-01
negative regulation of clathrin-dependent endocytosis (GO:1900186)	5	1	.08	+	12.00	8.06E-02	9.05E-01
catagen (GO:0042637)	5	1	.08	+	12.00	8.06E-02	9.04E-01
leukotriene signaling pathway (GO:0061737)	5	1	.08	+	12.00	8.06E-02	9.04E-01
chemorepulsion of axon (GO:0061643)	5	1	.08	+	12.00	8.06E-02	9.03E-01
Roundabout signaling pathway (GO:0035385)	5	1	.08	+	12.00	8.06E-02	9.02E-01
glucose-6-phosphate transport (GO:0015760)	5	1	.08	+	12.00	8.06E-02	9.02E-01
bundle of His cell action potential (GO:0086043)	5	1	.08	+	12.00	8.06E-02	9.01E-01
hexose phosphate transport (GO:0015712)	5	1	.08	+	12.00	8.06E-02	9.00E-01
bundle of His cell to Purkinje myocyte signaling (GO:0086028)	5	1	.08	+	12.00	8.06E-02	9.00E-01
neuron-glial cell signaling (GO:0150099)	5	1	.08	+	12.00	8.06E-02	8.99E-01
positive regulation of monoatomic anion transport (GO:1903793)	5	1	.08	+	12.00	8.06E-02	8.98E-01
susceptibility to natural killer cell mediated cytotoxicity (GO:0042271)	5	1	.08	+	12.00	8.06E-02	8.98E-01
dermatan sulfate catabolic process (GO:0030209)	5	1	.08	+	12.00	8.06E-02	8.97E-01
neural plate regionalization (GO:0060897)	5	1	.08	+	12.00	8.06E-02	8.96E-01
negative regulation of lamellipodium assembly (GO:0010593)	5	1	.08	+	12.00	8.06E-02	8.96E-01
myotube differentiation involved in skeletal muscle regeneration (GO:0014908)	10	2	.17	+	12.00	1.14E-02	3.72E-01
negative regulation of mature B cell apoptotic process (GO:0002906)	5	1	.08	+	12.00	8.06E-02	8.95E-01
regulation of mature B cell apoptotic process (GO:0002905)	5	1	.08	+	12.00	8.06E-02	8.95E-01
positive regulation of B cell apoptotic process (GO:0002904)	5	1	.08	+	12.00	8.06E-02	8.94E-01
paramesonephric duct development (GO:0061205)	5	1	.08	+	12.00	8.06E-02	8.93E-01
hair follicle placode formation (GO:0060789)	5	1	.08	+	12.00	8.06E-02	8.93E-01
noradrenergic neuron development (GO:0003358)	5	1	.08	+	12.00	8.06E-02	8.92E-01
noradrenergic neuron differentiation (GO:0003357)	10	2	.17	+	12.00	1.14E-02	3.71E-01
positive regulation of skeletal muscle cell proliferation (GO:0014858)	5	1	.08	+	12.00	8.06E-02	8.91E-01
intestine smooth muscle contraction (GO:0014827)	5	1	.08	+	12.00	8.06E-02	8.91E-01
gephyrin clustering involved in postsynaptic density assembly (GO:0097116)	5	1	.08	+	12.00	8.06E-02	8.90E-01
negative regulation of calcium ion-dependent exocytosis (GO:0045955)	10	2	.17	+	12.00	1.14E-02	3.70E-01
positive regulation of translational elongation (GO:0045901)	5	1	.08	+	12.00	8.06E-02	8.89E-01
corticospinal tract morphogenesis (GO:0021957)	10	2	.17	+	12.00	1.14E-02	3.70E-01
atrial septum primum morphogenesis (GO:0003289)	5	1	.08	+	12.00	8.06E-02	8.89E-01
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961)	5	1	.08	+	12.00	8.06E-02	8.88E-01
ciliary body morphogenesis (GO:0061073)	5	1	.08	+	12.00	8.06E-02	8.87E-01
protein localization to chloroplast (GO:0072598)	5	1	.08	+	12.00	8.06E-02	8.87E-01
establishment of protein localization to chloroplast (GO:0072596)	5	1	.08	+	12.00	8.06E-02	8.86E-01
regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)	26	5	.43	+	11.54	6.17E-05	8.89E-03
behavioral response to pain (GO:0048266)	32	6	.53	+	11.25	1.29E-05	2.32E-03
neuron-neuron synaptic transmission (GO:0007270)	11	2	.18	+	10.91	1.38E-02	4.28E-01
inositol trisphosphate metabolic process (GO:0032957)	11	2	.18	+	10.91	1.38E-02	4.27E-01
phosphatidic acid biosynthetic process (GO:0006654)	22	4	.37	+	10.91	4.38E-04	4.12E-02
neurofilament cytoskeleton organization (GO:0060052)	11	2	.18	+	10.91	1.38E-02	4.26E-01
glomerular basement membrane development (GO:0032836)	11	2	.18	+	10.91	1.38E-02	4.25E-01
regulation of blood volume by renin-angiotensin (GO:0002016)	11	2	.18	+	10.91	1.38E-02	4.24E-01
response to interleukin-15 (GO:0070672)	11	2	.18	+	10.91	1.38E-02	4.24E-01
negative regulation of hormone biosynthetic process (GO:0032353)	11	2	.18	+	10.91	1.38E-02	4.23E-01
negative regulation of inflammatory response to wounding (GO:0106015)	11	2	.18	+	10.91	1.38E-02	4.22E-01
positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666)	11	2	.18	+	10.91	1.38E-02	4.21E-01
neuronal dense core vesicle exocytosis (GO:0099011)	11	2	.18	+	10.91	1.38E-02	4.20E-01
learned vocalization behavior or vocal learning (GO:0098598)	11	2	.18	+	10.91	1.38E-02	4.19E-01
negative regulation of myeloid leukocyte mediated immunity (GO:0002887)	11	2	.18	+	10.91	1.38E-02	4.19E-01
diaphragm development (GO:0060539)	11	2	.18	+	10.91	1.38E-02	4.18E-01
glomerular filtration (GO:0003094)	18	3	.30	+	10.00	3.11E-03	1.68E-01
mucus secretion (GO:0070254)	18	3	.30	+	10.00	3.11E-03	1.68E-01
U2-type prespliceosome assembly (GO:1903241)	6	1	.10	+	10.00	9.60E-02	9.86E-01
negative regulation of protein targeting to mitochondrion (GO:1903215)	6	1	.10	+	10.00	9.60E-02	9.85E-01
regulation of axon guidance (GO:1902667)	12	2	.20	+	10.00	1.64E-02	4.79E-01
eosinophil mediated immunity (GO:0002447)	6	1	.10	+	10.00	9.60E-02	9.84E-01
response to carbon dioxide (GO:0010037)	6	1	.10	+	10.00	9.60E-02	9.84E-01
proprioception (GO:0019230)	6	1	.10	+	10.00	9.60E-02	9.83E-01
regulation of peptidyl-lysine acetylation (GO:2000756)	12	2	.20	+	10.00	1.64E-02	4.78E-01
regulation of primary miRNA processing (GO:2000634)	6	1	.10	+	10.00	9.60E-02	9.83E-01
negative regulation of transforming growth factor beta1 production (GO:0032911)	6	1	.10	+	10.00	9.60E-02	9.82E-01
renal vesicle formation (GO:0072033)	6	1	.10	+	10.00	9.60E-02	9.81E-01
interleukin-17A-mediated signaling pathway (GO:0038173)	6	1	.10	+	10.00	9.60E-02	9.81E-01
somatostatin signaling pathway (GO:0038170)	6	1	.10	+	10.00	9.60E-02	9.80E-01
modulation by host of viral RNA genome replication (GO:0044830)	6	1	.10	+	10.00	9.60E-02	9.79E-01
somatostatin receptor signaling pathway (GO:0038169)	6	1	.10	+	10.00	9.60E-02	9.79E-01
rhythmic synaptic transmission (GO:0060024)	6	1	.10	+	10.00	9.60E-02	9.78E-01
desmosome assembly (GO:0002159)	6	1	.10	+	10.00	9.60E-02	9.77E-01
response to heparin (GO:0071503)	6	1	.10	+	10.00	9.60E-02	9.77E-01
neuron projection extension involved in neuron projection guidance (GO:1902284)	12	2	.20	+	10.00	1.64E-02	4.77E-01
regulation of monocyte extravasation (GO:2000437)	6	1	.10	+	10.00	9.60E-02	9.76E-01
cellular response to laminar fluid shear stress (GO:0071499)	6	1	.10	+	10.00	9.60E-02	9.75E-01
negative regulation of gamma-aminobutyric acid secretion (GO:0014053)	6	1	.10	+	10.00	9.60E-02	9.75E-01
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139)	6	1	.10	+	10.00	9.60E-02	9.74E-01
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902162)	6	1	.10	+	10.00	9.60E-02	9.73E-01
cellular response to glucagon stimulus (GO:0071377)	12	2	.20	+	10.00	1.64E-02	4.76E-01
protein transport into membrane raft (GO:0032596)	6	1	.10	+	10.00	9.60E-02	9.73E-01
negative regulation of peptidyl-cysteine S-nitrosylation (GO:1902083)	6	1	.10	+	10.00	9.60E-02	9.72E-01
cellular response to ammonium ion (GO:0071242)	6	1	.10	+	10.00	9.60E-02	9.72E-01
axon extension involved in axon guidance (GO:0048846)	12	2	.20	+	10.00	1.64E-02	4.75E-01
regulation of translation at postsynapse, modulating synaptic transmission (GO:0099578)	6	1	.10	+	10.00	9.60E-02	9.71E-01
regulation of protein oligomerization (GO:0032459)	6	1	.10	+	10.00	9.60E-02	9.70E-01
negative regulation of mitochondrial calcium ion concentration (GO:0051562)	6	1	.10	+	10.00	9.60E-02	9.70E-01
elastin metabolic process (GO:0051541)	6	1	.10	+	10.00	9.60E-02	9.69E-01
negative regulation of synaptic plasticity (GO:0031914)	6	1	.10	+	10.00	9.60E-02	9.68E-01
regulation of type B pancreatic cell development (GO:2000074)	6	1	.10	+	10.00	9.60E-02	9.68E-01
regulation of glomerulus development (GO:0090192)	6	1	.10	+	10.00	9.60E-02	9.67E-01
chromosome movement towards spindle pole (GO:0051305)	6	1	.10	+	10.00	9.60E-02	9.66E-01
negative regulation of steroid hormone biosynthetic process (GO:0090032)	6	1	.10	+	10.00	9.60E-02	9.66E-01
transcription by RNA polymerase V (GO:0001060)	6	1	.10	+	10.00	9.60E-02	9.65E-01
transcription by RNA polymerase IV (GO:0001059)	6	1	.10	+	10.00	9.60E-02	9.65E-01
dopaminergic neuron axon guidance (GO:0036514)	6	1	.10	+	10.00	9.60E-02	9.64E-01
ciliary basal body organization (GO:0032053)	6	1	.10	+	10.00	9.60E-02	9.63E-01
cardiolipin acyl-chain remodeling (GO:0035965)	6	1	.10	+	10.00	9.60E-02	9.63E-01
regulation of hepatic stellate cell proliferation (GO:1904897)	6	1	.10	+	10.00	9.60E-02	9.62E-01
determination of dorsal identity (GO:0048263)	6	1	.10	+	10.00	9.60E-02	9.61E-01
interleukin-4-mediated signaling pathway (GO:0035771)	6	1	.10	+	10.00	9.60E-02	9.61E-01
T-helper 2 cell cytokine production (GO:0035745)	6	1	.10	+	10.00	9.60E-02	9.60E-01
CD4-positive, alpha-beta T cell proliferation (GO:0035739)	12	2	.20	+	10.00	1.64E-02	4.74E-01
positive regulation of aspartic-type peptidase activity (GO:1905247)	6	1	.10	+	10.00	9.60E-02	9.60E-01
negative regulation of mast cell degranulation (GO:0043305)	6	1	.10	+	10.00	9.60E-02	9.59E-01
negative regulation of vesicle fusion (GO:0031339)	6	1	.10	+	10.00	9.60E-02	9.58E-01
regulation of myofibroblast differentiation (GO:1904760)	6	1	.10	+	10.00	9.60E-02	9.58E-01
regulation of protein K48-linked ubiquitination (GO:0061945)	6	1	.10	+	10.00	9.60E-02	9.57E-01
plastid transcription (GO:0042793)	6	1	.10	+	10.00	9.60E-02	9.56E-01
cellular response to interleukin-3 (GO:0036016)	6	1	.10	+	10.00	9.60E-02	9.56E-01
response to interleukin-3 (GO:0036015)	6	1	.10	+	10.00	9.60E-02	9.55E-01
citrulline metabolic process (GO:0000052)	6	1	.10	+	10.00	9.60E-02	9.55E-01
endoplasmic reticulum-plasma membrane tethering (GO:0061817)	6	1	.10	+	10.00	9.60E-02	9.54E-01
positive regulation of microtubule depolymerization (GO:0031117)	6	1	.10	+	10.00	9.60E-02	9.53E-01
AV node cell to bundle of His cell signaling (GO:0086027)	6	1	.10	+	10.00	9.60E-02	9.53E-01
AV node cell action potential (GO:0086016)	6	1	.10	+	10.00	9.60E-02	9.52E-01
regulation of Toll signaling pathway (GO:0008592)	6	1	.10	+	10.00	9.60E-02	9.52E-01
negative regulation of sequestering of triglyceride (GO:0010891)	6	1	.10	+	10.00	9.60E-02	9.51E-01
negative regulation of hydrogen peroxide metabolic process (GO:0010727)	6	1	.10	+	10.00	9.60E-02	9.50E-01
ganglioside biosynthetic process via lactosylceramide (GO:0010706)	6	1	.10	+	10.00	9.60E-02	9.50E-01
olfactory learning (GO:0008355)	6	1	.10	+	10.00	9.60E-02	9.49E-01
chondroitin sulfate catabolic process (GO:0030207)	6	1	.10	+	10.00	9.60E-02	9.49E-01
myoblast fusion involved in skeletal muscle regeneration (GO:0014905)	6	1	.10	+	10.00	9.60E-02	9.48E-01
regulation of membrane tubulation (GO:1903525)	6	1	.10	+	10.00	9.60E-02	9.47E-01
urinary bladder smooth muscle contraction (GO:0014832)	12	2	.20	+	10.00	1.64E-02	4.74E-01
NMDA glutamate receptor clustering (GO:0097114)	6	1	.10	+	10.00	9.60E-02	9.47E-01
pulmonary artery morphogenesis (GO:0061156)	6	1	.10	+	10.00	9.60E-02	9.46E-01
septum primum development (GO:0003284)	6	1	.10	+	10.00	9.60E-02	9.45E-01
ureteric bud elongation (GO:0060677)	6	1	.10	+	10.00	9.60E-02	9.45E-01
ductus arteriosus closure (GO:0097070)	6	1	.10	+	10.00	9.60E-02	9.44E-01
anterior head development (GO:0097065)	6	1	.10	+	10.00	9.60E-02	9.44E-01
skeletal muscle satellite cell activation (GO:0014719)	6	1	.10	+	10.00	9.60E-02	9.43E-01
uterus morphogenesis (GO:0061038)	6	1	.10	+	10.00	9.60E-02	9.42E-01
central nervous system neuron axonogenesis (GO:0021955)	43	7	.72	+	9.77	6.49E-06	1.28E-03
regulation of cell-cell adhesion mediated by cadherin (GO:2000047)	19	3	.32	+	9.47	3.65E-03	1.88E-01
negative regulation of exocytosis (GO:0045920)	38	6	.63	+	9.47	3.62E-05	5.53E-03
response to pain (GO:0048265)	51	8	.85	+	9.41	1.88E-06	5.09E-04
lung saccule development (GO:0060430)	13	2	.22	+	9.23	1.91E-02	4.73E-01
regulation of toll-like receptor 3 signaling pathway (GO:0034139)	13	2	.22	+	9.23	1.91E-02	4.72E-01
positive regulation of heterotypic cell-cell adhesion (GO:0034116)	13	2	.22	+	9.23	1.91E-02	4.71E-01
negative regulation of neuron migration (GO:2001223)	13	2	.22	+	9.23	1.91E-02	4.71E-01
negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)	13	2	.22	+	9.23	1.91E-02	4.70E-01
negative regulation of synaptic transmission, glutamatergic (GO:0051967)	13	2	.22	+	9.23	1.91E-02	4.69E-01
dense core granule exocytosis (GO:1990504)	13	2	.22	+	9.23	1.91E-02	4.68E-01
negative regulation of hormone metabolic process (GO:0032351)	13	2	.22	+	9.23	1.91E-02	4.68E-01
positive regulation of collateral sprouting (GO:0048672)	13	2	.22	+	9.23	1.91E-02	4.67E-01
protein kinase C signaling (GO:0070528)	13	2	.22	+	9.23	1.91E-02	4.66E-01
regulation of inflammatory response to wounding (GO:0106014)	13	2	.22	+	9.23	1.91E-02	4.65E-01
CDP-diacylglycerol biosynthetic process (GO:0016024)	13	2	.22	+	9.23	1.91E-02	4.65E-01
desmosome organization (GO:0002934)	13	2	.22	+	9.23	1.91E-02	4.64E-01
G protein-coupled dopamine receptor signaling pathway (GO:0007212)	27	4	.45	+	8.89	9.84E-04	7.70E-02
forebrain dorsal/ventral pattern formation (GO:0021798)	7	1	.12	+	8.57	1.11E-01	1.00E00
lung growth (GO:0060437)	7	1	.12	+	8.57	1.11E-01	1.00E00
positive regulation of toll-like receptor 4 signaling pathway (GO:0034145)	14	2	.23	+	8.57	2.21E-02	5.12E-01
regulation of melanocyte differentiation (GO:0045634)	7	1	.12	+	8.57	1.11E-01	1.00E00
lateral ventricle development (GO:0021670)	14	2	.23	+	8.57	2.21E-02	5.11E-01
positive regulation of cell-cell adhesion mediated by integrin (GO:0033634)	7	1	.12	+	8.57	1.11E-01	1.00E00
dolichol metabolic process (GO:0019348)	7	1	.12	+	8.57	1.11E-01	1.00E00
negative regulation of dopamine secretion (GO:0033602)	7	1	.12	+	8.57	1.11E-01	1.00E00
regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373)	7	1	.12	+	8.57	1.11E-01	1.00E00
regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060368)	14	2	.23	+	8.57	2.21E-02	5.10E-01
response to ammonium ion (GO:0060359)	7	1	.12	+	8.57	1.11E-01	1.00E00
negative regulation of regulatory T cell differentiation (GO:0045590)	7	1	.12	+	8.57	1.11E-01	1.00E00
regulation of caveolin-mediated endocytosis (GO:2001286)	7	1	.12	+	8.57	1.11E-01	1.00E00
hindbrain maturation (GO:0021578)	7	1	.12	+	8.57	1.11E-01	1.00E00
lymphoid progenitor cell differentiation (GO:0002320)	14	2	.23	+	8.57	2.21E-02	5.10E-01
positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698)	7	1	.12	+	8.57	1.11E-01	1.00E00
maintenance of protein location in extracellular region (GO:0071694)	7	1	.12	+	8.57	1.11E-01	1.00E00
protein localization to bicellular tight junction (GO:1902396)	7	1	.12	+	8.57	1.11E-01	1.00E00
thyroid hormone generation (GO:0006590)	14	2	.23	+	8.57	2.21E-02	5.09E-01
response to endothelin (GO:1990839)	7	1	.12	+	8.57	1.11E-01	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902218)	7	1	.12	+	8.57	1.11E-01	1.00E00
regulation of acetylcholine secretion, neurotransmission (GO:0014056)	7	1	.12	+	8.57	1.11E-01	1.00E00
positive regulation of neuron maturation (GO:0014042)	7	1	.12	+	8.57	1.11E-01	1.00E00
cellular response to histamine (GO:0071420)	7	1	.12	+	8.57	1.11E-01	1.00E00
brain renin-angiotensin system (GO:0002035)	7	1	.12	+	8.57	1.11E-01	1.00E00
regulation of neutrophil mediated cytotoxicity (GO:0070948)	7	1	.12	+	8.57	1.11E-01	1.00E00
cyclic-GMP-AMP transmembrane import across plasma membrane (GO:0140361)	7	1	.12	+	8.57	1.11E-01	1.00E00
intracellular glutamate homeostasis (GO:0090461)	7	1	.12	+	8.57	1.11E-01	1.00E00
DNA replication, synthesis of primer (GO:0006269)	7	1	.12	+	8.57	1.11E-01	1.00E00
formation of anatomical boundary (GO:0048859)	7	1	.12	+	8.57	1.11E-01	1.00E00
postsynapse to nucleus signaling pathway (GO:0099527)	14	2	.23	+	8.57	2.21E-02	5.08E-01
regulation of lymphangiogenesis (GO:1901490)	7	1	.12	+	8.57	1.11E-01	1.00E00
regulation of cortisol biosynthetic process (GO:2000064)	7	1	.12	+	8.57	1.11E-01	1.00E00
inhibitory chemical synaptic transmission (GO:0098977)	7	1	.12	+	8.57	1.11E-01	1.00E00
regulation of neuronal action potential (GO:0098908)	14	2	.23	+	8.57	2.21E-02	5.07E-01
sensory perception of umami taste (GO:0050917)	7	1	.12	+	8.57	1.11E-01	1.00E00
sensory perception of sweet taste (GO:0050916)	7	1	.12	+	8.57	1.11E-01	1.00E00
secretory granule localization (GO:0032252)	28	4	.47	+	8.57	1.13E-03	8.48E-02
lipid droplet disassembly (GO:1905691)	7	1	.12	+	8.57	1.11E-01	1.00E00
leukocyte aggregation (GO:0070486)	14	2	.23	+	8.57	2.21E-02	5.07E-01
regulation of clathrin coat assembly (GO:1905443)	7	1	.12	+	8.57	1.11E-01	1.00E00
determination of dorsal/ventral asymmetry (GO:0048262)	7	1	.12	+	8.57	1.11E-01	1.00E00
paranodal junction assembly (GO:0030913)	7	1	.12	+	8.57	1.11E-01	1.00E00
neutrophil degranulation (GO:0043312)	7	1	.12	+	8.57	1.11E-01	1.00E00
auditory behavior (GO:0031223)	14	2	.23	+	8.57	2.21E-02	5.06E-01
regulation of mitotic recombination (GO:0000019)	7	1	.12	+	8.57	1.11E-01	1.00E00
positive regulation of metallopeptidase activity (GO:1905050)	7	1	.12	+	8.57	1.11E-01	1.00E00
PML body organization (GO:0030578)	7	1	.12	+	8.57	1.11E-01	1.00E00
negative regulation of tubulin deacetylation (GO:1904428)	7	1	.12	+	8.57	1.11E-01	1.00E00
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025)	14	2	.23	+	8.57	2.21E-02	5.05E-01
dopamine catabolic process (GO:0042420)	7	1	.12	+	8.57	1.11E-01	1.00E00
post-embryonic hemopoiesis (GO:0035166)	7	1	.12	+	8.57	1.11E-01	1.00E00
response to prostaglandin E (GO:0034695)	28	4	.47	+	8.57	1.13E-03	8.44E-02
neural plate pattern specification (GO:0060896)	7	1	.12	+	8.57	1.11E-01	1.00E00
negative regulation of photoreceptor cell differentiation (GO:0046533)	7	1	.12	+	8.57	1.11E-01	1.00E00
vascular endothelial growth factor production (GO:0010573)	7	1	.12	+	8.57	1.11E-01	1.00E00
cellular response to gonadotropin-releasing hormone (GO:0097211)	7	1	.12	+	8.57	1.11E-01	1.00E00
renal filtration (GO:0097205)	21	3	.35	+	8.57	4.89E-03	2.32E-01
mammary duct terminal end bud growth (GO:0060763)	7	1	.12	+	8.57	1.11E-01	1.00E00
phosphatidic acid metabolic process (GO:0046473)	28	4	.47	+	8.57	1.13E-03	8.40E-02
postsynaptic density protein 95 clustering (GO:0097119)	7	1	.12	+	8.57	1.11E-01	1.00E00
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959)	7	1	.12	+	8.57	1.11E-01	1.00E00
CDP-diacylglycerol metabolic process (GO:0046341)	14	2	.23	+	8.57	2.21E-02	5.04E-01
regulation of branching involved in lung morphogenesis (GO:0061046)	7	1	.12	+	8.57	1.11E-01	1.00E00
cellular response to dopamine (GO:1903351)	42	6	.70	+	8.57	6.51E-05	9.20E-03
cerebral cortex tangential migration (GO:0021800)	7	1	.12	+	8.57	1.11E-01	1.00E00
response to prostaglandin (GO:0034694)	35	5	.58	+	8.57	2.69E-04	2.79E-02
dense core granule localization (GO:0032253)	22	3	.37	+	8.18	5.59E-03	2.53E-01
presynaptic modulation of chemical synaptic transmission (GO:0099171)	66	9	1.10	+	8.18	1.44E-06	4.04E-04
locomotory exploration behavior (GO:0035641)	22	3	.37	+	8.18	5.59E-03	2.52E-01
response to dopamine (GO:1903350)	44	6	.73	+	8.18	8.51E-05	1.12E-02
blood coagulation, fibrin clot formation (GO:0072378)	15	2	.25	+	8.00	2.52E-02	5.52E-01
growth hormone receptor signaling pathway (GO:0060396)	15	2	.25	+	8.00	2.52E-02	5.51E-01
neutrophil activation involved in immune response (GO:0002283)	15	2	.25	+	8.00	2.52E-02	5.50E-01
actin crosslink formation (GO:0051764)	15	2	.25	+	8.00	2.52E-02	5.50E-01
negative regulation of cAMP-mediated signaling (GO:0043951)	15	2	.25	+	8.00	2.52E-02	5.49E-01
negative regulation of axon regeneration (GO:0048681)	15	2	.25	+	8.00	2.52E-02	5.48E-01
detection of temperature stimulus involved in sensory perception (GO:0050961)	30	4	.50	+	8.00	1.48E-03	9.90E-02
interleukin-6-mediated signaling pathway (GO:0070102)	15	2	.25	+	8.00	2.52E-02	5.47E-01
positive regulation of ruffle assembly (GO:1900029)	15	2	.25	+	8.00	2.52E-02	5.47E-01
urinary tract smooth muscle contraction (GO:0014848)	15	2	.25	+	8.00	2.52E-02	5.46E-01
mitral valve morphogenesis (GO:0003183)	15	2	.25	+	8.00	2.52E-02	5.45E-01
cellular response to catecholamine stimulus (GO:0071870)	46	6	.77	+	7.82	1.10E-04	1.40E-02
cellular response to monoamine stimulus (GO:0071868)	46	6	.77	+	7.82	1.10E-04	1.39E-02
vocalization behavior (GO:0071625)	23	3	.38	+	7.82	6.35E-03	2.77E-01
positive regulation of vesicle fusion (GO:0031340)	23	3	.38	+	7.82	6.35E-03	2.76E-01
neuromuscular synaptic transmission (GO:0007274)	31	4	.52	+	7.74	1.67E-03	1.10E-01
regulation of dopamine secretion (GO:0014059)	31	4	.52	+	7.74	1.67E-03	1.09E-01
regulation of homotypic cell-cell adhesion (GO:0034110)	39	5	.65	+	7.69	4.52E-04	4.23E-02
sensory perception of temperature stimulus (GO:0050951)	39	5	.65	+	7.69	4.52E-04	4.20E-02
negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903298)	8	1	.13	+	7.50	1.26E-01	1.00E00
regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903297)	8	1	.13	+	7.50	1.26E-01	1.00E00
negative regulation of lamellipodium organization (GO:1902744)	8	1	.13	+	7.50	1.26E-01	1.00E00
negative regulation of homotypic cell-cell adhesion (GO:0034111)	16	2	.27	+	7.50	2.85E-02	5.99E-01
inflammatory cell apoptotic process (GO:0006925)	8	1	.13	+	7.50	1.26E-01	1.00E00
cytokine production involved in inflammatory response (GO:0002534)	8	1	.13	+	7.50	1.26E-01	1.00E00
acrosome reaction (GO:0007340)	24	3	.40	+	7.50	7.17E-03	2.96E-01
regulation of aldosterone secretion (GO:2000858)	8	1	.13	+	7.50	1.26E-01	1.00E00
regulation of mineralocorticoid secretion (GO:2000855)	8	1	.13	+	7.50	1.26E-01	1.00E00
adenosine metabolic process (GO:0046085)	16	2	.27	+	7.50	2.85E-02	5.98E-01
positive regulation of respiratory burst (GO:0060267)	8	1	.13	+	7.50	1.26E-01	1.00E00
cAMP/PKA signal transduction (GO:0141156)	8	1	.13	+	7.50	1.26E-01	1.00E00
pre-B cell differentiation (GO:0002329)	8	1	.13	+	7.50	1.26E-01	1.00E00
positive regulation of ATP biosynthetic process (GO:2001171)	16	2	.27	+	7.50	2.85E-02	5.98E-01
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:0002291)	8	1	.13	+	7.50	1.26E-01	1.00E00
leukocyte chemotaxis involved in inflammatory response (GO:0002232)	8	1	.13	+	7.50	1.26E-01	1.00E00
regulation of mast cell cytokine production (GO:0032763)	8	1	.13	+	7.50	1.26E-01	1.00E00
netrin-activated signaling pathway (GO:0038007)	8	1	.13	+	7.50	1.26E-01	1.00E00
regulation of translational termination (GO:0006449)	8	1	.13	+	7.50	1.26E-01	1.00E00
regulation of microvillus assembly (GO:0032534)	8	1	.13	+	7.50	1.26E-01	1.00E00
DNA ligation (GO:0006266)	8	1	.13	+	7.50	1.26E-01	1.00E00
cAMP catabolic process (GO:0006198)	8	1	.13	+	7.50	1.26E-01	1.00E00
NADH oxidation (GO:0006116)	8	1	.13	+	7.50	1.26E-01	1.00E00
calcium ion-regulated exocytosis of neurotransmitter (GO:0048791)	16	2	.27	+	7.50	2.85E-02	5.97E-01
positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)	8	1	.13	+	7.50	1.26E-01	1.00E00
regulation of aldosterone biosynthetic process (GO:0032347)	8	1	.13	+	7.50	1.26E-01	1.00E00
NMDA selective glutamate receptor signaling pathway (GO:0098989)	8	1	.13	+	7.50	1.26E-01	1.00E00
anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971)	8	1	.13	+	7.50	1.26E-01	1.00E00
induction of positive chemotaxis (GO:0050930)	16	2	.27	+	7.50	2.85E-02	5.96E-01
negative regulation of hydrogen peroxide-mediated programmed cell death (GO:1901299)	8	1	.13	+	7.50	1.26E-01	1.00E00
positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748)	8	1	.13	+	7.50	1.26E-01	1.00E00
regulation of lipid kinase activity (GO:0043550)	8	1	.13	+	7.50	1.26E-01	1.00E00
negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)	16	2	.27	+	7.50	2.85E-02	5.95E-01
regulation of activation-induced cell death of T cells (GO:0070235)	8	1	.13	+	7.50	1.26E-01	1.00E00
establishment of protein localization to telomere (GO:0070200)	8	1	.13	+	7.50	1.26E-01	1.00E00
peptidyl-serine autophosphorylation (GO:0036289)	8	1	.13	+	7.50	1.26E-01	1.00E00
negative regulation of chemokine-mediated signaling pathway (GO:0070100)	8	1	.13	+	7.50	1.26E-01	1.00E00
alkanesulfonate transmembrane transport (GO:0042918)	8	1	.13	+	7.50	1.26E-01	1.00E00
regulation of aspartic-type peptidase activity (GO:1905245)	8	1	.13	+	7.50	1.26E-01	1.00E00
toxin metabolic process (GO:0009404)	16	2	.27	+	7.50	2.85E-02	5.94E-01
autophagic cell death (GO:0048102)	8	1	.13	+	7.50	1.26E-01	1.00E00
CAMKK-AMPK signaling cascade (GO:0061762)	8	1	.13	+	7.50	1.26E-01	1.00E00
negative regulation of macrophage activation (GO:0043031)	16	2	.27	+	7.50	2.85E-02	5.94E-01
habituation (GO:0046959)	8	1	.13	+	7.50	1.26E-01	1.00E00
negative regulation of neurotransmitter secretion (GO:0046929)	8	1	.13	+	7.50	1.26E-01	1.00E00
calcitonin family receptor signaling pathway (GO:0097646)	8	1	.13	+	7.50	1.26E-01	1.00E00
negative regulation of microglial cell activation (GO:1903979)	8	1	.13	+	7.50	1.26E-01	1.00E00
negative regulation of hepatocyte apoptotic process (GO:1903944)	8	1	.13	+	7.50	1.26E-01	1.00E00
taurine transmembrane transport (GO:0015734)	8	1	.13	+	7.50	1.26E-01	1.00E00
negative regulation of protein export from nucleus (GO:0046826)	8	1	.13	+	7.50	1.26E-01	1.00E00
catecholamine catabolic process (GO:0042424)	8	1	.13	+	7.50	1.26E-01	1.00E00
mast cell migration (GO:0097531)	8	1	.13	+	7.50	1.26E-01	1.00E00
regulation of complement activation, classical pathway (GO:0030450)	8	1	.13	+	7.50	1.26E-01	1.00E00
positive regulation of plasminogen activation (GO:0010756)	8	1	.13	+	7.50	1.26E-01	1.00E00
neuroblast migration (GO:0097402)	8	1	.13	+	7.50	1.26E-01	1.00E00
poly-N-acetyllactosamine biosynthetic process (GO:0030311)	8	1	.13	+	7.50	1.26E-01	1.00E00
poly-N-acetyllactosamine metabolic process (GO:0030309)	8	1	.13	+	7.50	1.26E-01	1.00E00
negative regulation of establishment of protein localization to mitochondrion (GO:1903748)	8	1	.13	+	7.50	1.26E-01	1.00E00
response to interleukin-17 (GO:0097396)	24	3	.40	+	7.50	7.17E-03	2.95E-01
male sex determination (GO:0030238)	16	2	.27	+	7.50	2.85E-02	5.93E-01
regulation of photoreceptor cell differentiation (GO:0046532)	8	1	.13	+	7.50	1.26E-01	1.00E00
skeletal muscle satellite cell differentiation (GO:0014816)	8	1	.13	+	7.50	1.26E-01	1.00E00
positive regulation of T cell mediated immune response to tumor cell (GO:0002842)	8	1	.13	+	7.50	1.26E-01	1.00E00
anterior commissure morphogenesis (GO:0021960)	8	1	.13	+	7.50	1.26E-01	1.00E00
central nervous system projection neuron axonogenesis (GO:0021952)	32	4	.53	+	7.50	1.89E-03	1.19E-01
catechol-containing compound catabolic process (GO:0019614)	8	1	.13	+	7.50	1.26E-01	1.00E00
diacylglycerol metabolic process (GO:0046339)	32	4	.53	+	7.50	1.89E-03	1.18E-01
negative regulation of protein polyubiquitination (GO:1902915)	8	1	.13	+	7.50	1.26E-01	1.00E00
positive regulation of muscle adaptation (GO:0014744)	8	1	.13	+	7.50	1.26E-01	1.00E00
negative regulation of dendritic spine morphogenesis (GO:0061002)	8	1	.13	+	7.50	1.26E-01	1.00E00
mitral valve development (GO:0003174)	16	2	.27	+	7.50	2.85E-02	5.92E-01
regulation of amacrine cell differentiation (GO:1902869)	8	1	.13	+	7.50	1.26E-01	1.00E00
trachea cartilage development (GO:0060534)	8	1	.13	+	7.50	1.26E-01	1.00E00
type II pneumocyte differentiation (GO:0060510)	8	1	.13	+	7.50	1.26E-01	1.00E00
corpus callosum development (GO:0022038)	33	4	.55	+	7.27	2.12E-03	1.31E-01
mast cell activation involved in immune response (GO:0002279)	33	4	.55	+	7.27	2.12E-03	1.31E-01
mast cell degranulation (GO:0043303)	33	4	.55	+	7.27	2.12E-03	1.30E-01
detection of temperature stimulus (GO:0016048)	33	4	.55	+	7.27	2.12E-03	1.30E-01
regulation of Ras protein signal transduction (GO:0046578)	58	7	.97	+	7.24	4.89E-05	7.31E-03
response to glucagon (GO:0033762)	25	3	.42	+	7.20	8.05E-03	3.15E-01
regulation of calcium ion-dependent exocytosis (GO:0017158)	50	6	.83	+	7.20	1.76E-04	2.01E-02
gamma-aminobutyric acid signaling pathway (GO:0007214)	34	4	.57	+	7.06	2.37E-03	1.41E-01
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	34	4	.57	+	7.06	2.37E-03	1.40E-01
positive regulation of protein acetylation (GO:1901985)	17	2	.28	+	7.06	3.20E-02	6.46E-01
B cell apoptotic process (GO:0001783)	17	2	.28	+	7.06	3.20E-02	6.45E-01
response to ATP (GO:0033198)	34	4	.57	+	7.06	2.37E-03	1.40E-01
ganglioside biosynthetic process (GO:0001574)	17	2	.28	+	7.06	3.20E-02	6.45E-01
cellular response to growth hormone stimulus (GO:0071378)	17	2	.28	+	7.06	3.20E-02	6.44E-01
CD4-positive, alpha-beta T cell lineage commitment (GO:0043373)	17	2	.28	+	7.06	3.20E-02	6.43E-01
gamma-aminobutyric acid transport (GO:0015812)	17	2	.28	+	7.06	3.20E-02	6.42E-01
negative regulation of miRNA-mediated gene silencing (GO:0060965)	17	2	.28	+	7.06	3.20E-02	6.41E-01
negative regulation of alpha-beta T cell proliferation (GO:0046642)	17	2	.28	+	7.06	3.20E-02	6.40E-01
mechanosensory behavior (GO:0007638)	17	2	.28	+	7.06	3.20E-02	6.40E-01
negative regulation of dendritic spine development (GO:0061000)	17	2	.28	+	7.06	3.20E-02	6.39E-01
layer formation in cerebral cortex (GO:0021819)	17	2	.28	+	7.06	3.20E-02	6.38E-01
T-helper 17 type immune response (GO:0072538)	17	2	.28	+	7.06	3.20E-02	6.37E-01
substrate-dependent cell migration (GO:0006929)	26	3	.43	+	6.92	8.99E-03	3.40E-01
response to catecholamine (GO:0071869)	52	6	.87	+	6.92	2.20E-04	2.43E-02
axon extension (GO:0048675)	52	6	.87	+	6.92	2.20E-04	2.42E-02
detection of temperature stimulus involved in sensory perception of pain (GO:0050965)	26	3	.43	+	6.92	8.99E-03	3.39E-01
positive regulation of cardiac muscle cell apoptotic process (GO:0010666)	26	3	.43	+	6.92	8.99E-03	3.38E-01
mast cell mediated immunity (GO:0002448)	35	4	.58	+	6.86	2.64E-03	1.53E-01
Ras protein signal transduction (GO:0007265)	70	8	1.17	+	6.86	2.12E-05	3.51E-03
response to monoamine (GO:0071867)	53	6	.88	+	6.79	2.44E-04	2.61E-02
cerebral cortex regionalization (GO:0021796)	9	1	.15	+	6.67	1.40E-01	1.00E00
regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081)	36	4	.60	+	6.67	2.94E-03	1.62E-01
central nervous system maturation (GO:0021626)	9	1	.15	+	6.67	1.40E-01	1.00E00
regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371)	9	1	.15	+	6.67	1.40E-01	1.00E00
type II interferon-mediated signaling pathway (GO:0060333)	9	1	.15	+	6.67	1.40E-01	1.00E00
positive regulation of circadian sleep/wake cycle, non-REM sleep (GO:0046010)	9	1	.15	+	6.67	1.40E-01	1.00E00
tangential migration from the subventricular zone to the olfactory bulb (GO:0022028)	9	1	.15	+	6.67	1.40E-01	1.00E00
suckling behavior (GO:0001967)	18	2	.30	+	6.67	3.56E-02	6.35E-01
regulation of respiratory burst involved in inflammatory response (GO:0060264)	9	1	.15	+	6.67	1.40E-01	1.00E00
regulation of dendritic cell differentiation (GO:2001198)	9	1	.15	+	6.67	1.40E-01	1.00E00
immature B cell differentiation (GO:0002327)	18	2	.30	+	6.67	3.56E-02	6.34E-01
negative regulation of sodium ion transmembrane transporter activity (GO:2000650)	9	1	.15	+	6.67	1.40E-01	1.00E00
negative regulation of post-transcriptional gene silencing (GO:0060149)	18	2	.30	+	6.67	3.56E-02	6.34E-01
regulation of smooth muscle cell chemotaxis (GO:0071671)	9	1	.15	+	6.67	1.40E-01	1.00E00
negative regulation of monocyte chemotactic protein-1 production (GO:0071638)	9	1	.15	+	6.67	1.40E-01	1.00E00
dense core granule transport (GO:1901950)	9	1	.15	+	6.67	1.40E-01	1.00E00
plasma membrane raft assembly (GO:0044854)	9	1	.15	+	6.67	1.40E-01	1.00E00
aspartate metabolic process (GO:0006531)	9	1	.15	+	6.67	1.40E-01	1.00E00
dolichol-linked oligosaccharide biosynthetic process (GO:0006488)	18	2	.30	+	6.67	3.56E-02	6.33E-01
NADPH oxidation (GO:0070995)	9	1	.15	+	6.67	1.40E-01	1.00E00
transcription elongation by RNA polymerase I (GO:0006362)	9	1	.15	+	6.67	1.40E-01	1.00E00
anterograde axonal protein transport (GO:0099641)	9	1	.15	+	6.67	1.40E-01	1.00E00
cellular response to manganese ion (GO:0071287)	9	1	.15	+	6.67	1.40E-01	1.00E00
positive regulation of CoA-transferase activity (GO:1905920)	9	1	.15	+	6.67	1.40E-01	1.00E00
regulation of CoA-transferase activity (GO:1905918)	9	1	.15	+	6.67	1.40E-01	1.00E00
dense core granule cytoskeletal transport (GO:0099519)	9	1	.15	+	6.67	1.40E-01	1.00E00
embryonic cleavage (GO:0040016)	9	1	.15	+	6.67	1.40E-01	1.00E00
regulation of glucocorticoid biosynthetic process (GO:0031946)	9	1	.15	+	6.67	1.40E-01	1.00E00
regulation of aldosterone metabolic process (GO:0032344)	9	1	.15	+	6.67	1.40E-01	1.00E00
retrograde trans-synaptic signaling (GO:0098917)	9	1	.15	+	6.67	1.40E-01	1.00E00
equilibrioception (GO:0050957)	9	1	.15	+	6.67	1.40E-01	1.00E00
regulation of pigment cell differentiation (GO:0050932)	9	1	.15	+	6.67	1.40E-01	1.00E00
central nervous system myelin formation (GO:0032289)	9	1	.15	+	6.67	1.40E-01	1.00E00
maintenance of postsynaptic specialization structure (GO:0098880)	18	2	.30	+	6.67	3.56E-02	6.32E-01
post-embryonic animal morphogenesis (GO:0009886)	9	1	.15	+	6.67	1.40E-01	1.00E00
cellular response to cold (GO:0070417)	18	2	.30	+	6.67	3.56E-02	6.31E-01
negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569)	9	1	.15	+	6.67	1.40E-01	1.00E00
protein localization to presynapse (GO:1905383)	9	1	.15	+	6.67	1.40E-01	1.00E00
midbrain-hindbrain boundary development (GO:0030917)	9	1	.15	+	6.67	1.40E-01	1.00E00
positive regulation of purine nucleotide biosynthetic process (GO:1900373)	18	2	.30	+	6.67	3.56E-02	6.31E-01
negative regulation of post-transcriptional gene silencing by regulatory ncRNA (GO:1900369)	18	2	.30	+	6.67	3.56E-02	6.30E-01
positive regulation of nucleotide biosynthetic process (GO:0030810)	18	2	.30	+	6.67	3.56E-02	6.29E-01
proline transmembrane transport (GO:0035524)	9	1	.15	+	6.67	1.40E-01	1.00E00
polyprenol metabolic process (GO:0016093)	9	1	.15	+	6.67	1.40E-01	1.00E00
guanine nucleotide transmembrane transport (GO:1903790)	9	1	.15	+	6.67	1.40E-01	1.00E00
negative regulation of gene silencing by regulatory ncRNA (GO:0060967)	18	2	.30	+	6.67	3.56E-02	6.28E-01
intestinal cholesterol absorption (GO:0030299)	9	1	.15	+	6.67	1.40E-01	1.00E00
dermatan sulfate metabolic process (GO:0030205)	9	1	.15	+	6.67	1.40E-01	1.00E00
regulation of complement-dependent cytotoxicity (GO:1903659)	9	1	.15	+	6.67	1.40E-01	1.00E00
response to gonadotropin-releasing hormone (GO:0097210)	9	1	.15	+	6.67	1.40E-01	1.00E00
postsynaptic membrane assembly (GO:0097104)	9	1	.15	+	6.67	1.40E-01	1.00E00
ventricular compact myocardium morphogenesis (GO:0003223)	9	1	.15	+	6.67	1.40E-01	1.00E00
adherens junction maintenance (GO:0034334)	9	1	.15	+	6.67	1.40E-01	1.00E00
lymphocyte migration into lymphoid organs (GO:0097021)	9	1	.15	+	6.67	1.40E-01	1.00E00
olfactory bulb interneuron development (GO:0021891)	9	1	.15	+	6.67	1.40E-01	1.00E00
T-helper 17 cell lineage commitment (GO:0072540)	9	1	.15	+	6.67	1.40E-01	1.00E00
regulation of transmission of nerve impulse (GO:0051969)	27	3	.45	+	6.67	9.99E-03	3.58E-01
mRNA splice site recognition (GO:0006376)	27	3	.45	+	6.67	9.99E-03	3.57E-01
positive regulation of striated muscle cell apoptotic process (GO:0010663)	27	3	.45	+	6.67	9.99E-03	3.56E-01
forebrain regionalization (GO:0021871)	27	3	.45	+	6.67	9.99E-03	3.56E-01
myeloid cell activation involved in immune response (GO:0002275)	73	8	1.22	+	6.57	2.89E-05	4.64E-03
response to growth hormone (GO:0060416)	28	3	.47	+	6.43	1.11E-02	3.75E-01
regulation of synaptic vesicle membrane organization (GO:1901632)	28	3	.47	+	6.43	1.11E-02	3.74E-01
regulation of platelet aggregation (GO:0090330)	28	3	.47	+	6.43	1.11E-02	3.74E-01
regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031630)	28	3	.47	+	6.43	1.11E-02	3.73E-01
positive regulation of alpha-beta T cell proliferation (GO:0046641)	28	3	.47	+	6.43	1.11E-02	3.72E-01
semaphorin-plexin signaling pathway (GO:0071526)	47	5	.78	+	6.38	1.08E-03	8.25E-02
multicellular organismal response to stress (GO:0033555)	113	12	1.88	+	6.37	4.19E-07	1.50E-04
negative regulation of catecholamine secretion (GO:0033604)	19	2	.32	+	6.31	3.93E-02	6.81E-01
protein activation cascade (GO:0072376)	19	2	.32	+	6.31	3.93E-02	6.80E-01
alpha-beta T cell lineage commitment (GO:0002363)	19	2	.32	+	6.31	3.93E-02	6.79E-01
angiotensin-activated signaling pathway (GO:0038166)	19	2	.32	+	6.31	3.93E-02	6.78E-01
radial glial cell differentiation (GO:0060019)	19	2	.32	+	6.31	3.93E-02	6.78E-01
regulation of natural killer cell differentiation (GO:0032823)	19	2	.32	+	6.31	3.93E-02	6.77E-01
receptor catabolic process (GO:0032801)	19	2	.32	+	6.31	3.93E-02	6.76E-01
regulation of long-term synaptic depression (GO:1900452)	19	2	.32	+	6.31	3.93E-02	6.75E-01
negative regulation of axon extension (GO:0030517)	38	4	.63	+	6.31	3.58E-03	1.87E-01
alpha-beta T cell proliferation (GO:0046633)	19	2	.32	+	6.31	3.93E-02	6.75E-01
negative regulation of leukocyte chemotaxis (GO:0002689)	19	2	.32	+	6.31	3.93E-02	6.74E-01
leukocyte degranulation (GO:0043299)	48	5	.80	+	6.25	1.19E-03	8.61E-02
positive regulation of dendrite extension (GO:1903861)	29	3	.48	+	6.21	1.22E-02	3.90E-01
regulation of vascular permeability (GO:0043114)	49	5	.82	+	6.12	1.31E-03	9.16E-02
regulation of alpha-beta T cell proliferation (GO:0046640)	49	5	.82	+	6.12	1.31E-03	9.12E-02
intermembrane lipid transfer (GO:0120009)	30	3	.50	+	6.00	1.34E-02	4.18E-01
negative regulation of receptor-mediated endocytosis (GO:0048261)	30	3	.50	+	6.00	1.34E-02	4.17E-01
neutrophil activation (GO:0042119)	30	3	.50	+	6.00	1.34E-02	4.16E-01
positive regulation of sodium ion export across plasma membrane (GO:1903278)	10	1	.17	+	6.00	1.55E-01	1.00E00
inhibition of non-skeletal tissue mineralization (GO:0140928)	10	1	.17	+	6.00	1.55E-01	1.00E00
purine ribonucleoside biosynthetic process (GO:0046129)	10	1	.17	+	6.00	1.55E-01	1.00E00
positive regulation of dopamine secretion (GO:0033603)	10	1	.17	+	6.00	1.55E-01	1.00E00
regulation of blood vessel remodeling (GO:0060312)	10	1	.17	+	6.00	1.55E-01	1.00E00
positive regulation of cell proliferation in bone marrow (GO:0071864)	10	1	.17	+	6.00	1.55E-01	1.00E00
floor plate development (GO:0033504)	10	1	.17	+	6.00	1.55E-01	1.00E00
metanephric renal vesicle morphogenesis (GO:0072283)	10	1	.17	+	6.00	1.55E-01	1.00E00
negative regulation of cytoplasmic translation (GO:2000766)	10	1	.17	+	6.00	1.55E-01	1.00E00
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway (GO:0007207)	10	1	.17	+	6.00	1.55E-01	1.00E00
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191)	10	1	.17	+	6.00	1.55E-01	1.00E00
phosphatidylserine metabolic process (GO:0006658)	20	2	.33	+	6.00	4.32E-02	7.25E-01
wound healing involved in inflammatory response (GO:0002246)	10	1	.17	+	6.00	1.55E-01	1.00E00
establishment of T cell polarity (GO:0001768)	10	1	.17	+	6.00	1.55E-01	1.00E00
establishment of lymphocyte polarity (GO:0001767)	10	1	.17	+	6.00	1.55E-01	1.00E00
micturition (GO:0060073)	10	1	.17	+	6.00	1.55E-01	1.00E00
hard palate development (GO:0060022)	10	1	.17	+	6.00	1.55E-01	1.00E00
negative regulation of sodium ion transmembrane transport (GO:1902306)	10	1	.17	+	6.00	1.55E-01	1.00E00
positive regulation of hepatic stellate cell activation (GO:2000491)	10	1	.17	+	6.00	1.55E-01	1.00E00
immunoglobulin V(D)J recombination (GO:0033152)	10	1	.17	+	6.00	1.55E-01	1.00E00
regulation of lamellipodium morphogenesis (GO:2000392)	10	1	.17	+	6.00	1.55E-01	1.00E00
cellular response to interleukin-12 (GO:0071349)	10	1	.17	+	6.00	1.55E-01	1.00E00
apoptotic DNA fragmentation (GO:0006309)	10	1	.17	+	6.00	1.55E-01	1.00E00
regulation protein catabolic process at postsynapse (GO:0140252)	10	1	.17	+	6.00	1.55E-01	1.00E00
regulation of translation at postsynapse (GO:0140245)	10	1	.17	+	6.00	1.55E-01	1.00E00
protein transport within lipid bilayer (GO:0032594)	10	1	.17	+	6.00	1.55E-01	1.00E00
guanine nucleotide transport (GO:0001408)	10	1	.17	+	6.00	1.55E-01	1.00E00
axo-dendritic protein transport (GO:0099640)	10	1	.17	+	6.00	1.55E-01	1.00E00
positive regulation of rRNA processing (GO:2000234)	10	1	.17	+	6.00	1.55E-01	1.00E00
transcription-coupled nucleotide-excision repair (GO:0006283)	10	1	.17	+	6.00	1.55E-01	1.00E00
cellular response to lipoteichoic acid (GO:0071223)	10	1	.17	+	6.00	1.55E-01	1.00E00
endoplasmic reticulum localization (GO:0051643)	10	1	.17	+	6.00	1.55E-01	1.00E00
cyclic nucleotide transport (GO:0070729)	10	1	.17	+	6.00	1.55E-01	1.00E00
maintenance of postsynaptic density structure (GO:0099562)	10	1	.17	+	6.00	1.55E-01	1.00E00
trans-synaptic signaling by trans-synaptic complex (GO:0099545)	10	1	.17	+	6.00	1.55E-01	1.00E00
presynaptic dense core vesicle exocytosis (GO:0099525)	10	1	.17	+	6.00	1.55E-01	1.00E00
AMP catabolic process (GO:0006196)	10	1	.17	+	6.00	1.55E-01	1.00E00
positive regulation of phospholipase A2 activity (GO:0032430)	10	1	.17	+	6.00	1.55E-01	1.00E00
glycerol-3-phosphate metabolic process (GO:0006072)	10	1	.17	+	6.00	1.55E-01	1.00E00
dendritic transport (GO:0098935)	20	2	.33	+	6.00	4.32E-02	7.25E-01
negative regulation of neuron projection regeneration (GO:0070571)	20	2	.33	+	6.00	4.32E-02	7.24E-01
collateral sprouting (GO:0048668)	20	2	.33	+	6.00	4.32E-02	7.23E-01
positive regulation of extracellular matrix disassembly (GO:0090091)	10	1	.17	+	6.00	1.55E-01	1.00E00
regulation of blood-brain barrier permeability (GO:1905603)	10	1	.17	+	6.00	1.55E-01	1.00E00
thrombin-activated receptor signaling pathway (GO:0070493)	10	1	.17	+	6.00	1.55E-01	1.00E00
response to lipoteichoic acid (GO:0070391)	10	1	.17	+	6.00	1.55E-01	1.00E00
UV protection (GO:0009650)	10	1	.17	+	6.00	1.55E-01	1.00E00
positive regulation of long-term synaptic depression (GO:1900454)	10	1	.17	+	6.00	1.55E-01	1.00E00
regulation of defense response to bacterium (GO:1900424)	20	2	.33	+	6.00	4.32E-02	7.22E-01
negative regulation of cellular response to oxidative stress (GO:1900408)	10	1	.17	+	6.00	1.55E-01	1.00E00
spliceosomal complex assembly (GO:0000245)	50	5	.83	+	6.00	1.43E-03	9.87E-02
CD4-positive, alpha-beta T cell cytokine production (GO:0035743)	10	1	.17	+	6.00	1.55E-01	1.00E00
ATP export (GO:1904669)	10	1	.17	+	6.00	1.55E-01	1.00E00
sequestering of extracellular ligand from receptor (GO:0035581)	10	1	.17	+	6.00	1.55E-01	1.00E00
rRNA 3'-end processing (GO:0031125)	10	1	.17	+	6.00	1.55E-01	1.00E00
regulation of hepatocyte apoptotic process (GO:1903943)	10	1	.17	+	6.00	1.55E-01	1.00E00
AV node cell to bundle of His cell communication (GO:0086067)	10	1	.17	+	6.00	1.55E-01	1.00E00
regulation of phosphatidylcholine metabolic process (GO:0150172)	10	1	.17	+	6.00	1.55E-01	1.00E00
ribonucleoside biosynthetic process (GO:0042455)	10	1	.17	+	6.00	1.55E-01	1.00E00
purine nucleoside biosynthetic process (GO:0042451)	10	1	.17	+	6.00	1.55E-01	1.00E00
ethanolamine-containing compound metabolic process (GO:0042439)	10	1	.17	+	6.00	1.55E-01	1.00E00
norepinephrine biosynthetic process (GO:0042421)	10	1	.17	+	6.00	1.55E-01	1.00E00
sleep (GO:0030431)	10	1	.17	+	6.00	1.55E-01	1.00E00
vitamin K metabolic process (GO:0042373)	10	1	.17	+	6.00	1.55E-01	1.00E00
regulation of hydrogen peroxide biosynthetic process (GO:0010728)	10	1	.17	+	6.00	1.55E-01	1.00E00
negative regulation of miRNA processing (GO:1903799)	10	1	.17	+	6.00	1.55E-01	1.00E00
isoprenoid catabolic process (GO:0008300)	10	1	.17	+	6.00	1.55E-01	1.00E00
CD40 signaling pathway (GO:0023035)	10	1	.17	+	6.00	1.55E-01	1.00E00
development of secondary female sexual characteristics (GO:0046543)	10	1	.17	+	6.00	1.55E-01	1.00E00
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589)	10	1	.17	+	6.00	1.55E-01	1.00E00
alkanesulfonate metabolic process (GO:0019694)	10	1	.17	+	6.00	1.55E-01	1.00E00
forebrain neuron fate commitment (GO:0021877)	10	1	.17	+	6.00	1.55E-01	1.00E00
taurine metabolic process (GO:0019530)	10	1	.17	+	6.00	1.55E-01	1.00E00
pulmonary valve morphogenesis (GO:0003184)	20	2	.33	+	6.00	4.32E-02	7.21E-01
negative regulation of cellular extravasation (GO:0002692)	10	1	.17	+	6.00	1.55E-01	1.00E00
neuronal action potential (GO:0019228)	51	5	.85	+	5.88	1.57E-03	1.04E-01
mast cell activation (GO:0045576)	41	4	.68	+	5.85	4.73E-03	2.26E-01
negative chemotaxis (GO:0050919)	41	4	.68	+	5.85	4.73E-03	2.26E-01
detection of stimulus involved in sensory perception of pain (GO:0062149)	41	4	.68	+	5.85	4.73E-03	2.25E-01
glycosphingolipid biosynthetic process (GO:0006688)	31	3	.52	+	5.81	1.46E-02	4.37E-01
reflex (GO:0060004)	31	3	.52	+	5.81	1.46E-02	4.36E-01
acute-phase response (GO:0006953)	42	4	.70	+	5.71	5.16E-03	2.41E-01
macrophage activation involved in immune response (GO:0002281)	21	2	.35	+	5.71	4.72E-02	7.75E-01
cellular response to interleukin-7 (GO:0098761)	21	2	.35	+	5.71	4.72E-02	7.74E-01
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369)	21	2	.35	+	5.71	4.72E-02	7.73E-01
regulation of short-term neuronal synaptic plasticity (GO:0048172)	21	2	.35	+	5.71	4.72E-02	7.72E-01
regulation of membrane invagination (GO:1905153)	21	2	.35	+	5.71	4.72E-02	7.71E-01
positive regulation of vascular permeability (GO:0043117)	21	2	.35	+	5.71	4.72E-02	7.70E-01
ventricular cardiac muscle cell action potential (GO:0086005)	21	2	.35	+	5.71	4.72E-02	7.70E-01
positive regulation of protein export from nucleus (GO:0046827)	21	2	.35	+	5.71	4.72E-02	7.69E-01
cellular response to interleukin-17 (GO:0097398)	21	2	.35	+	5.71	4.72E-02	7.68E-01
extracellular matrix disassembly (GO:0022617)	21	2	.35	+	5.71	4.72E-02	7.67E-01
negative regulation of mononuclear cell migration (GO:0071676)	32	3	.53	+	5.62	1.59E-02	4.69E-01
regulation of synaptic vesicle exocytosis (GO:2000300)	64	6	1.07	+	5.62	6.84E-04	5.95E-02
response to auditory stimulus (GO:0010996)	32	3	.53	+	5.62	1.59E-02	4.68E-01
calcium-ion regulated exocytosis (GO:0017156)	43	4	.72	+	5.58	5.62E-03	2.52E-01
positive regulation of small GTPase mediated signal transduction (GO:0051057)	76	7	1.27	+	5.53	2.75E-04	2.83E-02
action potential (GO:0001508)	132	12	2.20	+	5.45	2.23E-06	5.83E-04
regulation of presynaptic membrane potential (GO:0099505)	33	3	.55	+	5.45	1.73E-02	4.40E-01
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)	33	3	.55	+	5.45	1.73E-02	4.40E-01
positive regulation of cholesterol efflux (GO:0010875)	33	3	.55	+	5.45	1.73E-02	4.39E-01
regulation of dendrite extension (GO:1903859)	33	3	.55	+	5.45	1.73E-02	4.38E-01
establishment or maintenance of transmembrane electrochemical gradient (GO:0010248)	11	1	.18	+	5.45	1.69E-01	1.00E00
regulation of sodium ion export across plasma membrane (GO:1903276)	11	1	.18	+	5.45	1.69E-01	1.00E00
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242)	11	1	.18	+	5.45	1.69E-01	1.00E00
integrin activation (GO:0033622)	11	1	.18	+	5.45	1.69E-01	1.00E00
phenol-containing compound catabolic process (GO:0019336)	11	1	.18	+	5.45	1.69E-01	1.00E00
cAMP metabolic process (GO:0046058)	22	2	.37	+	5.45	5.14E-02	7.34E-01
regulation of systemic arterial blood pressure by circulatory renin-angiotensin (GO:0001991)	22	2	.37	+	5.45	5.14E-02	7.34E-01
trigeminal nerve development (GO:0021559)	11	1	.18	+	5.45	1.69E-01	1.00E00
spinal cord motor neuron cell fate specification (GO:0021520)	11	1	.18	+	5.45	1.69E-01	1.00E00
transcription elongation-coupled chromatin remodeling (GO:0140673)	11	1	.18	+	5.45	1.69E-01	1.00E00
regulation of transforming growth factor beta1 production (GO:0032908)	11	1	.18	+	5.45	1.69E-01	1.00E00
NLS-bearing protein import into nucleus (GO:0006607)	11	1	.18	+	5.45	1.69E-01	1.00E00
regulation of resting membrane potential (GO:0060075)	11	1	.18	+	5.45	1.69E-01	1.00E00
mammary gland involution (GO:0060056)	11	1	.18	+	5.45	1.69E-01	1.00E00
vascular associated smooth muscle cell proliferation (GO:1990874)	11	1	.18	+	5.45	1.69E-01	1.00E00
regulation of serotonin secretion (GO:0014062)	11	1	.18	+	5.45	1.69E-01	1.00E00
angiotensin maturation (GO:0002003)	11	1	.18	+	5.45	1.69E-01	1.00E00
transcription initiation at RNA polymerase I promoter (GO:0006361)	11	1	.18	+	5.45	1.69E-01	1.00E00
positive regulation of myeloid cell apoptotic process (GO:0033034)	11	1	.18	+	5.45	1.69E-01	1.00E00
negative regulation of mast cell activation (GO:0033004)	11	1	.18	+	5.45	1.69E-01	1.00E00
neurotransmitter receptor diffusion trapping (GO:0099628)	11	1	.18	+	5.45	1.69E-01	1.00E00
actin filament network formation (GO:0051639)	11	1	.18	+	5.45	1.69E-01	1.00E00
negative regulation of platelet aggregation (GO:0090331)	11	1	.18	+	5.45	1.69E-01	1.00E00
negative regulation of axon extension involved in axon guidance (GO:0048843)	11	1	.18	+	5.45	1.69E-01	1.00E00
hair follicle maturation (GO:0048820)	22	2	.37	+	5.45	5.14E-02	7.33E-01
regulation of translation at synapse, modulating synaptic transmission (GO:0099547)	11	1	.18	+	5.45	1.69E-01	1.00E00
cAMP biosynthetic process (GO:0006171)	11	1	.18	+	5.45	1.69E-01	1.00E00
negative regulation of protein autophosphorylation (GO:0031953)	11	1	.18	+	5.45	1.69E-01	1.00E00
regulation of glucocorticoid metabolic process (GO:0031943)	11	1	.18	+	5.45	1.69E-01	1.00E00
excitatory chemical synaptic transmission (GO:0098976)	11	1	.18	+	5.45	1.69E-01	1.00E00
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970)	11	1	.18	+	5.45	1.69E-01	1.00E00
positive regulation of kidney development (GO:0090184)	11	1	.18	+	5.45	1.69E-01	1.00E00
regulation of synaptic transmission, dopaminergic (GO:0032225)	11	1	.18	+	5.45	1.69E-01	1.00E00
response to interleukin-7 (GO:0098760)	22	2	.37	+	5.45	5.14E-02	7.32E-01
regulation of fever generation (GO:0031620)	11	1	.18	+	5.45	1.69E-01	1.00E00
bleb assembly (GO:0032060)	11	1	.18	+	5.45	1.69E-01	1.00E00
ion channel modulating, G protein-coupled receptor signaling pathway (GO:0099105)	11	1	.18	+	5.45	1.69E-01	1.00E00
positive regulation of mucus secretion (GO:0070257)	11	1	.18	+	5.45	1.69E-01	1.00E00
dermatan sulfate proteoglycan metabolic process (GO:0050655)	11	1	.18	+	5.45	1.69E-01	1.00E00
midbrain dopaminergic neuron differentiation (GO:1904948)	11	1	.18	+	5.45	1.69E-01	1.00E00
regulation of Golgi to plasma membrane protein transport (GO:0042996)	11	1	.18	+	5.45	1.69E-01	1.00E00
spliceosomal tri-snRNP complex assembly (GO:0000244)	11	1	.18	+	5.45	1.69E-01	1.00E00
common myeloid progenitor cell proliferation (GO:0035726)	11	1	.18	+	5.45	1.69E-01	1.00E00
regulation of chemokine-mediated signaling pathway (GO:0070099)	11	1	.18	+	5.45	1.69E-01	1.00E00
positive regulation of long-term neuronal synaptic plasticity (GO:0048170)	11	1	.18	+	5.45	1.69E-01	1.00E00
retinal ganglion cell axon guidance (GO:0031290)	22	2	.37	+	5.45	5.14E-02	7.32E-01
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790)	11	1	.18	+	5.45	1.69E-01	1.00E00
urea cycle (GO:0000050)	11	1	.18	+	5.45	1.69E-01	1.00E00
negative regulation of vascular permeability (GO:0043116)	22	2	.37	+	5.45	5.14E-02	7.31E-01
extracellular negative regulation of signal transduction (GO:1900116)	11	1	.18	+	5.45	1.69E-01	1.00E00
extracellular regulation of signal transduction (GO:1900115)	11	1	.18	+	5.45	1.69E-01	1.00E00
L-alanine transport (GO:0015808)	11	1	.18	+	5.45	1.69E-01	1.00E00
positive regulation of dendrite development (GO:1900006)	22	2	.37	+	5.45	5.14E-02	7.30E-01
peroxisome proliferator activated receptor signaling pathway (GO:0035357)	11	1	.18	+	5.45	1.69E-01	1.00E00
dendrite extension (GO:0097484)	11	1	.18	+	5.45	1.69E-01	1.00E00
interleukin-17-mediated signaling pathway (GO:0097400)	11	1	.18	+	5.45	1.69E-01	1.00E00
embryonic camera-type eye formation (GO:0060900)	11	1	.18	+	5.45	1.69E-01	1.00E00
response to laminar fluid shear stress (GO:0034616)	11	1	.18	+	5.45	1.69E-01	1.00E00
urea metabolic process (GO:0019627)	11	1	.18	+	5.45	1.69E-01	1.00E00
mesenchymal-epithelial cell signaling (GO:0060638)	11	1	.18	+	5.45	1.69E-01	1.00E00
negative regulation of glial cell apoptotic process (GO:0034351)	11	1	.18	+	5.45	1.69E-01	1.00E00
MyD88-independent toll-like receptor signaling pathway (GO:0002756)	11	1	.18	+	5.45	1.69E-01	1.00E00
intracellular amino acid homeostasis (GO:0080144)	11	1	.18	+	5.45	1.69E-01	1.00E00
ligand-gated ion channel signaling pathway (GO:1990806)	45	4	.75	+	5.33	6.61E-03	2.83E-01
behavioral fear response (GO:0001662)	45	4	.75	+	5.33	6.61E-03	2.82E-01
response to angiotensin (GO:1990776)	45	4	.75	+	5.33	6.61E-03	2.81E-01
postsynaptic modulation of chemical synaptic transmission (GO:0099170)	45	4	.75	+	5.33	6.61E-03	2.80E-01
innervation (GO:0060384)	34	3	.57	+	5.29	1.88E-02	4.67E-01
regulation of transforming growth factor beta production (GO:0071634)	34	3	.57	+	5.29	1.88E-02	4.66E-01
transcription by RNA polymerase I (GO:0006360)	34	3	.57	+	5.29	1.88E-02	4.66E-01
cellular response to angiotensin (GO:1904385)	34	3	.57	+	5.29	1.88E-02	4.65E-01
regulation of regulated secretory pathway (GO:1903305)	161	14	2.68	+	5.22	5.50E-07	1.84E-04
positive regulation of cell adhesion mediated by integrin (GO:0033630)	23	2	.38	+	5.22	5.57E-02	7.75E-01
regulation of ATP biosynthetic process (GO:2001169)	23	2	.38	+	5.22	5.57E-02	7.74E-01
podocyte differentiation (GO:0072112)	23	2	.38	+	5.22	5.57E-02	7.73E-01
excitatory postsynaptic potential (GO:0060079)	69	6	1.15	+	5.22	1.02E-03	7.90E-02
ERBB2 signaling pathway (GO:0038128)	23	2	.38	+	5.22	5.57E-02	7.73E-01
negative regulation of purine nucleotide catabolic process (GO:0033122)	23	2	.38	+	5.22	5.57E-02	7.72E-01
negative regulation of cilium assembly (GO:1902018)	23	2	.38	+	5.22	5.57E-02	7.71E-01
regulation of voltage-gated calcium channel activity (GO:1901385)	23	2	.38	+	5.22	5.57E-02	7.71E-01
positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190)	23	2	.38	+	5.22	5.57E-02	7.70E-01
regulation of collateral sprouting (GO:0048670)	23	2	.38	+	5.22	5.57E-02	7.69E-01
detection of mechanical stimulus involved in sensory perception of pain (GO:0050966)	23	2	.38	+	5.22	5.57E-02	7.68E-01
negative regulation of calcium ion transmembrane transporter activity (GO:1901020)	23	2	.38	+	5.22	5.57E-02	7.68E-01
positive regulation of lymphocyte apoptotic process (GO:0070230)	23	2	.38	+	5.22	5.57E-02	7.67E-01
notochord development (GO:0030903)	23	2	.38	+	5.22	5.57E-02	7.66E-01
outer dynein arm assembly (GO:0036158)	23	2	.38	+	5.22	5.57E-02	7.66E-01
negative regulation of nucleotide catabolic process (GO:0030812)	23	2	.38	+	5.22	5.57E-02	7.65E-01
protein localization to cell-cell junction (GO:0150105)	23	2	.38	+	5.22	5.57E-02	7.64E-01
positive regulation of sodium ion transport (GO:0010765)	46	4	.77	+	5.22	7.14E-03	2.96E-01
apoptotic nuclear changes (GO:0030262)	23	2	.38	+	5.22	5.57E-02	7.64E-01
renal filtration cell differentiation (GO:0061318)	23	2	.38	+	5.22	5.57E-02	7.63E-01
phasic smooth muscle contraction (GO:0014821)	23	2	.38	+	5.22	5.57E-02	7.62E-01
negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179)	23	2	.38	+	5.22	5.57E-02	7.62E-01
negative regulation of glycolytic process (GO:0045820)	23	2	.38	+	5.22	5.57E-02	7.61E-01
insulin-like growth factor receptor signaling pathway (GO:0048009)	81	7	1.35	+	5.18	4.08E-04	3.90E-02
vesicle docking involved in exocytosis (GO:0006904)	35	3	.58	+	5.14	2.03E-02	4.85E-01
behavioral defense response (GO:0002209)	47	4	.78	+	5.11	7.71E-03	3.04E-01
myeloid leukocyte mediated immunity (GO:0002444)	72	6	1.20	+	5.00	1.28E-03	9.01E-02
secretion by tissue (GO:0032941)	36	3	.60	+	5.00	2.19E-02	5.12E-01
positive regulation of leukocyte apoptotic process (GO:2000108)	36	3	.60	+	5.00	2.19E-02	5.11E-01
collagen catabolic process (GO:0030574)	36	3	.60	+	5.00	2.19E-02	5.10E-01
postsynaptic density organization (GO:0097106)	36	3	.60	+	5.00	2.19E-02	5.09E-01
midgut development (GO:0007494)	12	1	.20	+	5.00	1.83E-01	1.00E00
glyceraldehyde-3-phosphate biosynthetic process (GO:0046166)	12	1	.20	+	5.00	1.83E-01	1.00E00
trachea morphogenesis (GO:0060439)	12	1	.20	+	5.00	1.83E-01	1.00E00
lung vasculature development (GO:0060426)	12	1	.20	+	5.00	1.83E-01	1.00E00
regulation of heterotypic cell-cell adhesion (GO:0034114)	24	2	.40	+	5.00	6.01E-02	8.06E-01
cellular component disassembly involved in execution phase of apoptosis (GO:0006921)	24	2	.40	+	5.00	6.01E-02	8.05E-01
regulation of cell-cell adhesion mediated by integrin (GO:0033632)	12	1	.20	+	5.00	1.83E-01	1.00E00
glomerular epithelial cell differentiation (GO:0072311)	24	2	.40	+	5.00	6.01E-02	8.04E-01
regulation of cell proliferation in bone marrow (GO:0071863)	12	1	.20	+	5.00	1.83E-01	1.00E00
positive regulation of gamma-delta T cell differentiation (GO:0045588)	12	1	.20	+	5.00	1.83E-01	1.00E00
protein localization to membrane raft (GO:1903044)	12	1	.20	+	5.00	1.83E-01	1.00E00
alditol phosphate metabolic process (GO:0052646)	12	1	.20	+	5.00	1.83E-01	1.00E00
response to nitric oxide (GO:0071731)	24	2	.40	+	5.00	6.01E-02	8.03E-01
activation of adenylate cyclase activity (GO:0007190)	12	1	.20	+	5.00	1.83E-01	1.00E00
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	48	4	.80	+	5.00	8.30E-03	3.23E-01
positive regulation of miRNA-mediated gene silencing (GO:2000637)	12	1	.20	+	5.00	1.83E-01	1.00E00
sphingomyelin biosynthetic process (GO:0006686)	12	1	.20	+	5.00	1.83E-01	1.00E00
renal vesicle morphogenesis (GO:0072077)	12	1	.20	+	5.00	1.83E-01	1.00E00
podocyte development (GO:0072015)	12	1	.20	+	5.00	1.83E-01	1.00E00
righting reflex (GO:0060013)	12	1	.20	+	5.00	1.83E-01	1.00E00
positive regulation of natural killer cell differentiation (GO:0032825)	12	1	.20	+	5.00	1.83E-01	1.00E00
positive regulation of transmission of nerve impulse (GO:0051971)	12	1	.20	+	5.00	1.83E-01	1.00E00
leptin-mediated signaling pathway (GO:0033210)	12	1	.20	+	5.00	1.83E-01	1.00E00
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725)	12	1	.20	+	5.00	1.83E-01	1.00E00
manganese ion transmembrane transport (GO:0071421)	12	1	.20	+	5.00	1.83E-01	1.00E00
establishment of endothelial intestinal barrier (GO:0090557)	12	1	.20	+	5.00	1.83E-01	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166)	12	1	.20	+	5.00	1.83E-01	1.00E00
positive regulation of T cell differentiation in thymus (GO:0033089)	12	1	.20	+	5.00	1.83E-01	1.00E00
peripheral nervous system neuron development (GO:0048935)	12	1	.20	+	5.00	1.83E-01	1.00E00
peripheral nervous system neuron differentiation (GO:0048934)	12	1	.20	+	5.00	1.83E-01	1.00E00
response to interleukin-12 (GO:0070671)	12	1	.20	+	5.00	1.83E-01	1.00E00
negative regulation of protein localization to cell surface (GO:2000009)	12	1	.20	+	5.00	1.83E-01	1.00E00
positive regulation of phospholipid biosynthetic process (GO:0071073)	12	1	.20	+	5.00	1.83E-01	1.00E00
mannose metabolic process (GO:0006013)	12	1	.20	+	5.00	1.83E-01	1.00E00
receptor diffusion trapping (GO:0098953)	12	1	.20	+	5.00	1.83E-01	1.00E00
anterograde dendritic transport (GO:0098937)	12	1	.20	+	5.00	1.83E-01	1.00E00
regulation of cellular response to osmotic stress (GO:0106049)	12	1	.20	+	5.00	1.83E-01	1.00E00
intestinal lipid absorption (GO:0098856)	12	1	.20	+	5.00	1.83E-01	1.00E00
cellular response to leucine starvation (GO:1990253)	12	1	.20	+	5.00	1.83E-01	1.00E00
negative regulation of macrophage migration (GO:1905522)	12	1	.20	+	5.00	1.83E-01	1.00E00
catechol-containing compound biosynthetic process (GO:0009713)	24	2	.40	+	5.00	6.01E-02	8.03E-01
negative regulation of dendrite morphogenesis (GO:0050774)	12	1	.20	+	5.00	1.83E-01	1.00E00
mesendoderm development (GO:0048382)	12	1	.20	+	5.00	1.83E-01	1.00E00
negative regulation of thymocyte apoptotic process (GO:0070244)	12	1	.20	+	5.00	1.83E-01	1.00E00
ameloblast differentiation (GO:0036305)	12	1	.20	+	5.00	1.83E-01	1.00E00
cellular response to increased oxygen levels (GO:0036295)	12	1	.20	+	5.00	1.83E-01	1.00E00
regulation of neutrophil degranulation (GO:0043313)	12	1	.20	+	5.00	1.83E-01	1.00E00
coenzyme A biosynthetic process (GO:0015937)	12	1	.20	+	5.00	1.83E-01	1.00E00
ventricular cardiac muscle cell development (GO:0055015)	12	1	.20	+	5.00	1.83E-01	1.00E00
proline transport (GO:0015824)	12	1	.20	+	5.00	1.83E-01	1.00E00
membrane depolarization during action potential (GO:0086010)	24	2	.40	+	5.00	6.01E-02	8.02E-01
regulation of stress granule assembly (GO:0062028)	12	1	.20	+	5.00	1.83E-01	1.00E00
catecholamine biosynthetic process (GO:0042423)	24	2	.40	+	5.00	6.01E-02	8.01E-01
dopamine biosynthetic process (GO:0042416)	12	1	.20	+	5.00	1.83E-01	1.00E00
response to histamine (GO:0034776)	12	1	.20	+	5.00	1.83E-01	1.00E00
positive regulation of gamma-delta T cell activation (GO:0046645)	12	1	.20	+	5.00	1.83E-01	1.00E00
regulation of cardiac muscle adaptation (GO:0010612)	12	1	.20	+	5.00	1.83E-01	1.00E00
regulation of B cell apoptotic process (GO:0002902)	24	2	.40	+	5.00	6.01E-02	8.01E-01
microvillus assembly (GO:0030033)	12	1	.20	+	5.00	1.83E-01	1.00E00
cellular response to thyroid hormone stimulus (GO:0097067)	12	1	.20	+	5.00	1.83E-01	1.00E00
cerebral cortex GABAergic interneuron differentiation (GO:0021892)	12	1	.20	+	5.00	1.83E-01	1.00E00
pulmonary valve development (GO:0003177)	24	2	.40	+	5.00	6.01E-02	8.00E-01
cartilage morphogenesis (GO:0060536)	12	1	.20	+	5.00	1.83E-01	1.00E00
receptor clustering (GO:0043113)	61	5	1.02	+	4.92	3.47E-03	1.82E-01
protein monoubiquitination (GO:0006513)	49	4	.82	+	4.90	8.92E-03	3.41E-01
regulation of platelet activation (GO:0010543)	49	4	.82	+	4.90	8.92E-03	3.40E-01
ventricular system development (GO:0021591)	37	3	.62	+	4.86	2.35E-02	5.29E-01
cellular response to dexamethasone stimulus (GO:0071549)	37	3	.62	+	4.86	2.35E-02	5.28E-01
positive regulation of filopodium assembly (GO:0051491)	37	3	.62	+	4.86	2.35E-02	5.27E-01
neuromuscular process controlling balance (GO:0050885)	74	6	1.23	+	4.86	1.47E-03	9.90E-02
positive T cell selection (GO:0043368)	37	3	.62	+	4.86	2.35E-02	5.26E-01
regulation of systemic arterial blood pressure by hormone (GO:0001990)	50	4	.83	+	4.80	9.57E-03	3.48E-01
retinal rod cell differentiation (GO:0060221)	25	2	.42	+	4.80	6.46E-02	8.50E-01
regulation of protein acetylation (GO:1901983)	25	2	.42	+	4.80	6.46E-02	8.49E-01
glucose catabolic process (GO:0006007)	25	2	.42	+	4.80	6.46E-02	8.48E-01
regulation of branching involved in ureteric bud morphogenesis (GO:0090189)	25	2	.42	+	4.80	6.46E-02	8.48E-01
negative regulation of phagocytosis (GO:0050765)	25	2	.42	+	4.80	6.46E-02	8.47E-01
regulation of modification of postsynaptic structure (GO:0099159)	25	2	.42	+	4.80	6.46E-02	8.46E-01
regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0098696)	25	2	.42	+	4.80	6.46E-02	8.46E-01
response to salt stress (GO:0009651)	25	2	.42	+	4.80	6.46E-02	8.45E-01
exploration behavior (GO:0035640)	50	4	.83	+	4.80	9.57E-03	3.47E-01
regulation of cellular response to hypoxia (GO:1900037)	25	2	.42	+	4.80	6.46E-02	8.44E-01
positive regulation of fibroblast migration (GO:0010763)	25	2	.42	+	4.80	6.46E-02	8.43E-01
type 2 immune response (GO:0042092)	25	2	.42	+	4.80	6.46E-02	8.43E-01
regulated exocytosis (GO:0045055)	152	12	2.53	+	4.74	9.65E-06	1.81E-03
regulation of neutrophil chemotaxis (GO:0090022)	38	3	.63	+	4.74	2.52E-02	5.55E-01
lipopolysaccharide-mediated signaling pathway (GO:0031663)	38	3	.63	+	4.74	2.52E-02	5.54E-01
regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)	38	3	.63	+	4.74	2.52E-02	5.53E-01
granulocyte activation (GO:0036230)	38	3	.63	+	4.74	2.52E-02	5.52E-01
glutamate receptor signaling pathway (GO:0007215)	51	4	.85	+	4.71	1.03E-02	3.62E-01
Kit signaling pathway (GO:0038109)	51	4	.85	+	4.71	1.03E-02	3.62E-01
cellular response to stem cell factor stimulus (GO:0036216)	51	4	.85	+	4.71	1.03E-02	3.61E-01
response to stem cell factor (GO:0036215)	51	4	.85	+	4.71	1.03E-02	3.60E-01
fear response (GO:0042596)	51	4	.85	+	4.71	1.03E-02	3.59E-01
negative regulation of leukocyte migration (GO:0002686)	51	4	.85	+	4.71	1.03E-02	3.58E-01
membrane depolarization (GO:0051899)	64	5	1.07	+	4.69	4.27E-03	2.09E-01
branching involved in prostate gland morphogenesis (GO:0060442)	13	1	.22	+	4.61	1.96E-01	1.00E00
negative regulation of calcium ion transmembrane transport (GO:1903170)	52	4	.87	+	4.61	1.10E-02	3.75E-01
positive regulation of integrin activation (GO:0033625)	13	1	.22	+	4.61	1.96E-01	1.00E00
glomerular epithelial cell development (GO:0072310)	13	1	.22	+	4.61	1.96E-01	1.00E00
xenobiotic transmembrane transport (GO:0006855)	13	1	.22	+	4.61	1.96E-01	1.00E00
tyrosine phosphorylation of STAT protein (GO:0007260)	13	1	.22	+	4.61	1.96E-01	1.00E00
transmission of nerve impulse (GO:0019226)	91	7	1.52	+	4.61	8.23E-04	6.93E-02
regulation of nephron tubule epithelial cell differentiation (GO:0072182)	13	1	.22	+	4.61	1.96E-01	1.00E00
positive regulation of post-transcriptional gene silencing (GO:0060148)	13	1	.22	+	4.61	1.96E-01	1.00E00
Leydig cell differentiation (GO:0033327)	13	1	.22	+	4.61	1.96E-01	1.00E00
plasma membrane raft organization (GO:0044857)	13	1	.22	+	4.61	1.96E-01	1.00E00
ERBB2-ERBB3 signaling pathway (GO:0038133)	13	1	.22	+	4.61	1.96E-01	1.00E00
ERBB3 signaling pathway (GO:0038129)	13	1	.22	+	4.61	1.96E-01	1.00E00
negative regulation of amine transport (GO:0051953)	39	3	.65	+	4.61	2.70E-02	5.77E-01
regulation of hepatic stellate cell activation (GO:2000489)	13	1	.22	+	4.61	1.96E-01	1.00E00
positive regulation of CREB transcription factor activity (GO:0032793)	13	1	.22	+	4.61	1.96E-01	1.00E00
cellular response to UV-B (GO:0071493)	13	1	.22	+	4.61	1.96E-01	1.00E00
regulation of gamma-aminobutyric acid secretion (GO:0014052)	13	1	.22	+	4.61	1.96E-01	1.00E00
development of secondary sexual characteristics (GO:0045136)	13	1	.22	+	4.61	1.96E-01	1.00E00
regulation of killing of cells of another organism (GO:0051709)	13	1	.22	+	4.61	1.96E-01	1.00E00
cellular response to L-leucine (GO:0071233)	13	1	.22	+	4.61	1.96E-01	1.00E00
negative regulation of neurotransmitter transport (GO:0051589)	13	1	.22	+	4.61	1.96E-01	1.00E00
response to parathyroid hormone (GO:0071107)	13	1	.22	+	4.61	1.96E-01	1.00E00
regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)	13	1	.22	+	4.61	1.96E-01	1.00E00
regulation of kidney development (GO:0090183)	39	3	.65	+	4.61	2.70E-02	5.76E-01
endoplasmic reticulum membrane organization (GO:0090158)	13	1	.22	+	4.61	1.96E-01	1.00E00
lipid digestion (GO:0044241)	13	1	.22	+	4.61	1.96E-01	1.00E00
positive regulation of calcium ion import across plasma membrane (GO:1905665)	13	1	.22	+	4.61	1.96E-01	1.00E00
notochord morphogenesis (GO:0048570)	13	1	.22	+	4.61	1.96E-01	1.00E00
Peyer's patch development (GO:0048541)	13	1	.22	+	4.61	1.96E-01	1.00E00
mucosa-associated lymphoid tissue development (GO:0048537)	13	1	.22	+	4.61	1.96E-01	1.00E00
mucociliary clearance (GO:0120197)	13	1	.22	+	4.61	1.96E-01	1.00E00
regulation of postsynaptic neurotransmitter receptor internalization (GO:0099149)	39	3	.65	+	4.61	2.70E-02	5.75E-01
astral microtubule organization (GO:0030953)	13	1	.22	+	4.61	1.96E-01	1.00E00
regulation of long-term neuronal synaptic plasticity (GO:0048169)	39	3	.65	+	4.61	2.70E-02	5.74E-01
positive regulation of post-transcriptional gene silencing by RNA (GO:1900370)	13	1	.22	+	4.61	1.96E-01	1.00E00
regulation of metallopeptidase activity (GO:1905048)	13	1	.22	+	4.61	1.96E-01	1.00E00
cyclic nucleotide catabolic process (GO:0009214)	13	1	.22	+	4.61	1.96E-01	1.00E00
phosphate ion transmembrane transport (GO:0035435)	13	1	.22	+	4.61	1.96E-01	1.00E00
nonassociative learning (GO:0046958)	13	1	.22	+	4.61	1.96E-01	1.00E00
endothelin receptor signaling pathway (GO:0086100)	13	1	.22	+	4.61	1.96E-01	1.00E00
pharyngeal arch artery morphogenesis (GO:0061626)	13	1	.22	+	4.61	1.96E-01	1.00E00
cardiac muscle cell action potential (GO:0086001)	39	3	.65	+	4.61	2.70E-02	5.73E-01
negative regulation of steroid biosynthetic process (GO:0010894)	26	2	.43	+	4.61	6.93E-02	8.45E-01
serotonin metabolic process (GO:0042428)	13	1	.22	+	4.61	1.96E-01	1.00E00
synaptic vesicle docking (GO:0016081)	13	1	.22	+	4.61	1.96E-01	1.00E00
xenobiotic export from cell (GO:0046618)	13	1	.22	+	4.61	1.96E-01	1.00E00
regulation of skeletal muscle satellite cell proliferation (GO:0014842)	13	1	.22	+	4.61	1.96E-01	1.00E00
positive regulation of circadian sleep/wake cycle, sleep (GO:0045938)	13	1	.22	+	4.61	1.96E-01	1.00E00
pyramidal neuron development (GO:0021860)	13	1	.22	+	4.61	1.96E-01	1.00E00
T-helper 17 cell differentiation (GO:0072539)	13	1	.22	+	4.61	1.96E-01	1.00E00
chemical synaptic transmission, postsynaptic (GO:0099565)	79	6	1.32	+	4.56	2.06E-03	1.28E-01
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	133	10	2.22	+	4.51	8.04E-05	1.09E-02
regulation of sodium ion transmembrane transporter activity (GO:2000649)	40	3	.67	+	4.50	2.88E-02	5.97E-01
regulation of protein export from nucleus (GO:0046825)	40	3	.67	+	4.50	2.88E-02	5.96E-01
negative regulation of epithelial to mesenchymal transition (GO:0010719)	40	3	.67	+	4.50	2.88E-02	5.95E-01
glomerular epithelium development (GO:0072010)	27	2	.45	+	4.44	7.40E-02	8.87E-01
membrane protein ectodomain proteolysis (GO:0006509)	27	2	.45	+	4.44	7.40E-02	8.86E-01
positive regulation of positive chemotaxis (GO:0050927)	27	2	.45	+	4.44	7.40E-02	8.86E-01
myelin assembly (GO:0032288)	27	2	.45	+	4.44	7.40E-02	8.85E-01
positive regulation of sprouting angiogenesis (GO:1903672)	27	2	.45	+	4.44	7.40E-02	8.84E-01
negative regulation of Ras protein signal transduction (GO:0046580)	27	2	.45	+	4.44	7.40E-02	8.84E-01
labyrinthine layer blood vessel development (GO:0060716)	27	2	.45	+	4.44	7.40E-02	8.83E-01
acute inflammatory response (GO:0002526)	81	6	1.35	+	4.44	2.34E-03	1.41E-01
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	81	6	1.35	+	4.44	2.34E-03	1.41E-01
Rho protein signal transduction (GO:0007266)	68	5	1.13	+	4.41	5.53E-03	2.51E-01
membrane protein proteolysis (GO:0033619)	41	3	.68	+	4.39	3.07E-02	6.23E-01
neurotransmitter secretion (GO:0007269)	96	7	1.60	+	4.37	1.13E-03	8.53E-02
signal release from synapse (GO:0099643)	96	7	1.60	+	4.37	1.13E-03	8.49E-02
cerebral cortex cell migration (GO:0021795)	55	4	.92	+	4.36	1.33E-02	4.17E-01
regulation of postsynapse assembly (GO:0150052)	55	4	.92	+	4.36	1.33E-02	4.16E-01
central nervous system neuron development (GO:0021954)	110	8	1.83	+	4.36	5.17E-04	4.74E-02
exocytosis (GO:0006887)	250	18	4.17	+	4.32	2.36E-07	1.01E-04
respiratory burst (GO:0045730)	14	1	.23	+	4.28	2.10E-01	1.00E00
leukocyte migration involved in inflammatory response (GO:0002523)	28	2	.47	+	4.28	7.89E-02	9.28E-01
regulation of bicellular tight junction assembly (GO:2000810)	28	2	.47	+	4.28	7.89E-02	9.28E-01
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)	14	1	.23	+	4.28	2.10E-01	1.00E00
manganese ion transport (GO:0006828)	14	1	.23	+	4.28	2.10E-01	1.00E00
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)	14	1	.23	+	4.28	2.10E-01	1.00E00
T cell cytokine production (GO:0002369)	14	1	.23	+	4.28	2.10E-01	1.00E00
positive regulation of phospholipid transport (GO:2001140)	14	1	.23	+	4.28	2.10E-01	1.00E00
T-helper cell lineage commitment (GO:0002295)	14	1	.23	+	4.28	2.10E-01	1.00E00
plasma membrane repair (GO:0001778)	28	2	.47	+	4.28	7.89E-02	9.27E-01
membrane raft assembly (GO:0001765)	14	1	.23	+	4.28	2.10E-01	1.00E00
renal vesicle development (GO:0072087)	14	1	.23	+	4.28	2.10E-01	1.00E00
inhibitory postsynaptic potential (GO:0060080)	14	1	.23	+	4.28	2.10E-01	1.00E00
negative regulation of natural killer cell activation (GO:0032815)	14	1	.23	+	4.28	2.10E-01	1.00E00
hematopoietic stem cell proliferation (GO:0071425)	28	2	.47	+	4.28	7.89E-02	9.26E-01
regulation of angiotensin levels in blood (GO:0002002)	14	1	.23	+	4.28	2.10E-01	1.00E00
protein localization to nuclear envelope (GO:0090435)	14	1	.23	+	4.28	2.10E-01	1.00E00
regulation protein catabolic process at synapse (GO:0140250)	14	1	.23	+	4.28	2.10E-01	1.00E00
microvillus organization (GO:0032528)	14	1	.23	+	4.28	2.10E-01	1.00E00
detection of molecule of bacterial origin (GO:0032490)	14	1	.23	+	4.28	2.10E-01	1.00E00
regulation of phospholipase A2 activity (GO:0032429)	14	1	.23	+	4.28	2.10E-01	1.00E00
positive regulation of cholesterol transport (GO:0032376)	42	3	.70	+	4.28	3.27E-02	6.50E-01
positive regulation of sterol transport (GO:0032373)	42	3	.70	+	4.28	3.27E-02	6.49E-01
regulation of hydrogen peroxide-mediated programmed cell death (GO:1901298)	14	1	.23	+	4.28	2.10E-01	1.00E00
regulation of protein kinase C signaling (GO:0090036)	14	1	.23	+	4.28	2.10E-01	1.00E00
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280)	14	1	.23	+	4.28	2.10E-01	1.00E00
inositol phosphate metabolic process (GO:0043647)	28	2	.47	+	4.28	7.89E-02	9.26E-01
enteric nervous system development (GO:0048484)	14	1	.23	+	4.28	2.10E-01	1.00E00
cardiolipin metabolic process (GO:0032048)	14	1	.23	+	4.28	2.10E-01	1.00E00
regulation of mucus secretion (GO:0070255)	14	1	.23	+	4.28	2.10E-01	1.00E00
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033)	42	3	.70	+	4.28	3.27E-02	6.48E-01
semi-lunar valve development (GO:1905314)	42	3	.70	+	4.28	3.27E-02	6.47E-01
regulation of modification of postsynaptic actin cytoskeleton (GO:1905274)	14	1	.23	+	4.28	2.10E-01	1.00E00
regulation of purine nucleotide biosynthetic process (GO:1900371)	28	2	.47	+	4.28	7.89E-02	9.25E-01
regulation of nucleotide biosynthetic process (GO:0030808)	28	2	.47	+	4.28	7.89E-02	9.24E-01
positive regulation of circadian rhythm (GO:0042753)	28	2	.47	+	4.28	7.89E-02	9.23E-01
regulation of neurotransmitter secretion (GO:0046928)	112	8	1.87	+	4.28	5.83E-04	5.19E-02
negative regulation of mitochondrial membrane potential (GO:0010917)	14	1	.23	+	4.28	2.10E-01	1.00E00
bundle of His cell to Purkinje myocyte communication (GO:0086069)	14	1	.23	+	4.28	2.10E-01	1.00E00
regulation of odontogenesis of dentin-containing tooth (GO:0042487)	14	1	.23	+	4.28	2.10E-01	1.00E00
peristalsis (GO:0030432)	14	1	.23	+	4.28	2.10E-01	1.00E00
plasma membrane tubulation (GO:0097320)	14	1	.23	+	4.28	2.10E-01	1.00E00
postsynaptic density assembly (GO:0097107)	14	1	.23	+	4.28	2.10E-01	1.00E00
negative regulation of steroid metabolic process (GO:0045939)	28	2	.47	+	4.28	7.89E-02	9.23E-01
lung secretory cell differentiation (GO:0061140)	14	1	.23	+	4.28	2.10E-01	1.00E00
negative regulation of complement activation (GO:0045916)	14	1	.23	+	4.28	2.10E-01	1.00E00
positive regulation of cell maturation (GO:1903431)	14	1	.23	+	4.28	2.10E-01	1.00E00
rostrocaudal neural tube patterning (GO:0021903)	14	1	.23	+	4.28	2.10E-01	1.00E00
atrioventricular valve morphogenesis (GO:0003181)	28	2	.47	+	4.28	7.89E-02	9.22E-01
sex determination (GO:0007530)	28	2	.47	+	4.28	7.89E-02	9.21E-01
telencephalon cell migration (GO:0022029)	70	5	1.17	+	4.28	6.25E-03	2.75E-01
synaptic vesicle exocytosis (GO:0016079)	70	5	1.17	+	4.28	6.25E-03	2.75E-01
lung alveolus development (GO:0048286)	71	5	1.18	+	4.22	6.64E-03	2.80E-01
regulation of catecholamine secretion (GO:0050433)	57	4	.95	+	4.21	1.50E-02	4.45E-01
heart valve morphogenesis (GO:0003179)	57	4	.95	+	4.21	1.50E-02	4.44E-01
potassium ion import across plasma membrane (GO:1990573)	43	3	.72	+	4.19	3.47E-02	6.25E-01
negative regulation of calcium ion transport (GO:0051926)	72	5	1.20	+	4.17	7.04E-03	2.93E-01
negative regulation of endocytosis (GO:0045806)	72	5	1.20	+	4.17	7.04E-03	2.92E-01
heparan sulfate proteoglycan biosynthetic process (GO:0015012)	29	2	.48	+	4.14	8.38E-02	9.16E-01
purine ribonucleoside metabolic process (GO:0046128)	29	2	.48	+	4.14	8.38E-02	9.15E-01
regulation of toll-like receptor 4 signaling pathway (GO:0034143)	29	2	.48	+	4.14	8.38E-02	9.15E-01
negative regulation of tissue remodeling (GO:0034104)	29	2	.48	+	4.14	8.38E-02	9.14E-01
telencephalon glial cell migration (GO:0022030)	29	2	.48	+	4.14	8.38E-02	9.13E-01
T cell lineage commitment (GO:0002360)	29	2	.48	+	4.14	8.38E-02	9.13E-01
ganglioside metabolic process (GO:0001573)	29	2	.48	+	4.14	8.38E-02	9.12E-01
neural nucleus development (GO:0048857)	29	2	.48	+	4.14	8.38E-02	9.11E-01
regulation of positive chemotaxis (GO:0050926)	29	2	.48	+	4.14	8.38E-02	9.11E-01
postsynaptic cytoskeleton organization (GO:0099188)	29	2	.48	+	4.14	8.38E-02	9.10E-01
positive regulation of vascular endothelial growth factor production (GO:0010575)	29	2	.48	+	4.14	8.38E-02	9.09E-01
negative regulation of ATP metabolic process (GO:1903579)	29	2	.48	+	4.14	8.38E-02	9.09E-01
phosphatidylglycerol metabolic process (GO:0046471)	29	2	.48	+	4.14	8.38E-02	9.08E-01
cerebral cortex radial glia-guided migration (GO:0021801)	29	2	.48	+	4.14	8.38E-02	9.08E-01
negative regulation of neuron projection development (GO:0010977)	160	11	2.67	+	4.12	8.06E-05	1.08E-02
forebrain cell migration (GO:0021885)	73	5	1.22	+	4.11	7.45E-03	2.97E-01
postsynaptic specialization organization (GO:0099084)	44	3	.73	+	4.09	3.68E-02	6.47E-01
synaptic transmission, glutamatergic (GO:0035249)	59	4	.98	+	4.07	1.68E-02	4.30E-01
regulation of neurotransmitter transport (GO:0051588)	133	9	2.22	+	4.06	4.00E-04	3.85E-02
potassium ion transmembrane transport (GO:0071805)	164	11	2.73	+	4.02	1.01E-04	1.29E-02
regulation of exocytosis (GO:0017157)	224	15	3.73	+	4.02	5.83E-06	1.23E-03
positive regulation of Notch signaling pathway (GO:0045747)	45	3	.75	+	4.00	3.90E-02	6.80E-01
positive regulation of leukocyte tethering or rolling (GO:1903238)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044)	60	4	1.00	+	4.00	1.78E-02	4.49E-01
nitrogen cycle metabolic process (GO:0071941)	15	1	.25	+	4.00	2.23E-01	1.00E00
chronic inflammatory response (GO:0002544)	15	1	.25	+	4.00	2.23E-01	1.00E00
positive regulation of macrophage differentiation (GO:0045651)	15	1	.25	+	4.00	2.23E-01	1.00E00
Golgi to endosome transport (GO:0006895)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of gamma-delta T cell differentiation (GO:0045586)	15	1	.25	+	4.00	2.23E-01	1.00E00
pons development (GO:0021548)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of receptor recycling (GO:0001919)	30	2	.50	+	4.00	8.88E-02	9.47E-01
regulation of feeding behavior (GO:0060259)	45	3	.75	+	4.00	3.90E-02	6.79E-01
regulation of phospholipid transport (GO:2001138)	15	1	.25	+	4.00	2.23E-01	1.00E00
inositol phosphate biosynthetic process (GO:0032958)	15	1	.25	+	4.00	2.23E-01	1.00E00
glycosylceramide metabolic process (GO:0006677)	15	1	.25	+	4.00	2.23E-01	1.00E00
ectodermal placode morphogenesis (GO:0071697)	15	1	.25	+	4.00	2.23E-01	1.00E00
commissural neuron axon guidance (GO:0071679)	15	1	.25	+	4.00	2.23E-01	1.00E00
neural crest cell migration (GO:0001755)	60	4	1.00	+	4.00	1.78E-02	4.48E-01
retinal bipolar neuron differentiation (GO:0060040)	15	1	.25	+	4.00	2.23E-01	1.00E00
arginine metabolic process (GO:0006525)	15	1	.25	+	4.00	2.23E-01	1.00E00
positive regulation of glutamate secretion (GO:0014049)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of neuron maturation (GO:0014041)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of circadian sleep/wake cycle, non-REM sleep (GO:0045188)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645)	15	1	.25	+	4.00	2.23E-01	1.00E00
cellular response to ATP (GO:0071318)	15	1	.25	+	4.00	2.23E-01	1.00E00
positive thymic T cell selection (GO:0045059)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of translation at synapse (GO:0140243)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of microvillus organization (GO:0032530)	15	1	.25	+	4.00	2.23E-01	1.00E00
negative regulation of excitatory postsynaptic potential (GO:0090394)	15	1	.25	+	4.00	2.23E-01	1.00E00
lipid droplet formation (GO:0140042)	15	1	.25	+	4.00	2.23E-01	1.00E00
positive regulation of prostaglandin secretion (GO:0032308)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of postsynaptic neurotransmitter receptor activity (GO:0098962)	15	1	.25	+	4.00	2.23E-01	1.00E00
myoblast migration (GO:0051451)	15	1	.25	+	4.00	2.23E-01	1.00E00
smooth muscle cell proliferation (GO:0048659)	15	1	.25	+	4.00	2.23E-01	1.00E00
negative regulation of chemotaxis (GO:0050922)	45	3	.75	+	4.00	3.90E-02	6.78E-01
modification of postsynaptic actin cytoskeleton (GO:0098885)	15	1	.25	+	4.00	2.23E-01	1.00E00
protein transport along microtubule (GO:0098840)	15	1	.25	+	4.00	2.23E-01	1.00E00
positive regulation of neutrophil chemotaxis (GO:0090023)	30	2	.50	+	4.00	8.88E-02	9.47E-01
negative regulation of axonogenesis (GO:0050771)	60	4	1.00	+	4.00	1.78E-02	4.47E-01
microtubule-based protein transport (GO:0099118)	15	1	.25	+	4.00	2.23E-01	1.00E00
sodium ion export across plasma membrane (GO:0036376)	15	1	.25	+	4.00	2.23E-01	1.00E00
enamel mineralization (GO:0070166)	15	1	.25	+	4.00	2.23E-01	1.00E00
positive regulation of defense response to bacterium (GO:1900426)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of vesicle fusion (GO:0031338)	45	3	.75	+	4.00	3.90E-02	6.78E-01
oligosaccharide catabolic process (GO:0009313)	15	1	.25	+	4.00	2.23E-01	1.00E00
amine catabolic process (GO:0009310)	15	1	.25	+	4.00	2.23E-01	1.00E00
somatic hypermutation of immunoglobulin genes (GO:0016446)	15	1	.25	+	4.00	2.23E-01	1.00E00
purine ribonucleoside monophosphate catabolic process (GO:0009169)	15	1	.25	+	4.00	2.23E-01	1.00E00
nucleoside biosynthetic process (GO:0009163)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of ruffle assembly (GO:1900027)	30	2	.50	+	4.00	8.88E-02	9.46E-01
positive regulation of mitochondrial membrane potential (GO:0010918)	15	1	.25	+	4.00	2.23E-01	1.00E00
glutamine family amino acid biosynthetic process (GO:0009084)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of hormone biosynthetic process (GO:0046885)	30	2	.50	+	4.00	8.88E-02	9.45E-01
regulation of sequestering of triglyceride (GO:0010889)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of cholesterol efflux (GO:0010874)	45	3	.75	+	4.00	3.90E-02	6.77E-01
biogenic amine catabolic process (GO:0042402)	15	1	.25	+	4.00	2.23E-01	1.00E00
ionotropic glutamate receptor signaling pathway (GO:0035235)	30	2	.50	+	4.00	8.88E-02	9.45E-01
negative regulation of sodium ion transport (GO:0010766)	15	1	.25	+	4.00	2.23E-01	1.00E00
positive regulation of macrophage derived foam cell differentiation (GO:0010744)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of gamma-delta T cell activation (GO:0046643)	15	1	.25	+	4.00	2.23E-01	1.00E00
negative regulation of insulin receptor signaling pathway (GO:0046627)	45	3	.75	+	4.00	3.90E-02	6.76E-01
lipid glycosylation (GO:0030259)	15	1	.25	+	4.00	2.23E-01	1.00E00
positive regulation of muscle cell apoptotic process (GO:0010661)	45	3	.75	+	4.00	3.90E-02	6.75E-01
self proteolysis (GO:0097264)	15	1	.25	+	4.00	2.23E-01	1.00E00
ectodermal placode formation (GO:0060788)	15	1	.25	+	4.00	2.23E-01	1.00E00
nucleobase-containing small molecule biosynthetic process (GO:0034404)	15	1	.25	+	4.00	2.23E-01	1.00E00
regulation of T cell mediated immune response to tumor cell (GO:0002840)	15	1	.25	+	4.00	2.23E-01	1.00E00
olfactory bulb interneuron differentiation (GO:0021889)	15	1	.25	+	4.00	2.23E-01	1.00E00
forebrain neuron development (GO:0021884)	30	2	.50	+	4.00	8.88E-02	9.44E-01
positive regulation of protein maturation (GO:1903319)	30	2	.50	+	4.00	8.88E-02	9.43E-01
neurotransmitter-gated ion channel clustering (GO:0072578)	15	1	.25	+	4.00	2.23E-01	1.00E00
heart valve formation (GO:0003188)	15	1	.25	+	4.00	2.23E-01	1.00E00
aortic valve morphogenesis (GO:0003180)	30	2	.50	+	4.00	8.88E-02	9.43E-01
chemical synaptic transmission (GO:0007268)	379	25	6.32	+	3.96	6.16E-09	4.74E-06
anterograde trans-synaptic signaling (GO:0098916)	379	25	6.32	+	3.96	6.16E-09	4.52E-06
negative regulation of response to wounding (GO:1903035)	91	6	1.52	+	3.96	4.18E-03	2.06E-01
regulation of lymphocyte apoptotic process (GO:0070228)	76	5	1.27	+	3.95	8.81E-03	3.38E-01
positive regulation of DNA binding (GO:0043388)	46	3	.77	+	3.91	4.12E-02	7.00E-01
regulation of cellular extravasation (GO:0002691)	46	3	.77	+	3.91	4.12E-02	6.99E-01
negative regulation of peptide hormone secretion (GO:0090278)	77	5	1.28	+	3.90	9.29E-03	3.39E-01
myeloid leukocyte activation (GO:0002274)	170	11	2.83	+	3.88	1.38E-04	1.69E-02
renal system process involved in regulation of systemic arterial blood pressure (GO:0003071)	31	2	.52	+	3.87	9.39E-02	9.80E-01
negative regulation of protein localization to plasma membrane (GO:1903077)	31	2	.52	+	3.87	9.39E-02	9.79E-01
synaptic transmission, GABAergic (GO:0051932)	31	2	.52	+	3.87	9.39E-02	9.78E-01
cellular response to interleukin-6 (GO:0071354)	31	2	.52	+	3.87	9.39E-02	9.78E-01
mesenchymal cell migration (GO:0090497)	62	4	1.03	+	3.87	1.99E-02	4.78E-01
peptidyl-cysteine modification (GO:0018198)	31	2	.52	+	3.87	9.39E-02	9.77E-01
trans-synaptic signaling (GO:0099537)	403	26	6.72	+	3.87	4.82E-09	4.12E-06
negative regulation of T cell apoptotic process (GO:0070233)	31	2	.52	+	3.87	9.39E-02	9.76E-01
regulation of modification of synaptic structure (GO:1905244)	31	2	.52	+	3.87	9.39E-02	9.76E-01
positive regulation of macrophage activation (GO:0043032)	31	2	.52	+	3.87	9.39E-02	9.75E-01
adrenal gland development (GO:0030325)	31	2	.52	+	3.87	9.39E-02	9.74E-01
hematopoietic stem cell homeostasis (GO:0061484)	31	2	.52	+	3.87	9.39E-02	9.74E-01
regulation of miRNA-mediated gene silencing (GO:0060964)	31	2	.52	+	3.87	9.39E-02	9.73E-01
excretion (GO:0007588)	31	2	.52	+	3.87	9.39E-02	9.72E-01
negative regulation of cell projection organization (GO:0031345)	219	14	3.65	+	3.83	2.01E-05	3.40E-03
positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)	47	3	.78	+	3.83	4.35E-02	7.22E-01
negative regulation of lymphocyte apoptotic process (GO:0070229)	47	3	.78	+	3.83	4.35E-02	7.21E-01
positive regulation of ATP metabolic process (GO:1903580)	47	3	.78	+	3.83	4.35E-02	7.20E-01
smooth muscle contraction (GO:0006939)	63	4	1.05	+	3.81	2.09E-02	4.97E-01
regulation of neuron migration (GO:2001222)	63	4	1.05	+	3.81	2.09E-02	4.96E-01
leukocyte cell-cell adhesion (GO:0007159)	63	4	1.05	+	3.81	2.09E-02	4.96E-01
regulation of macrophage activation (GO:0043030)	63	4	1.05	+	3.81	2.09E-02	4.95E-01
axonogenesis (GO:0007409)	394	25	6.57	+	3.81	1.34E-08	7.92E-06
negative regulation of secretion (GO:0051048)	221	14	3.68	+	3.80	2.22E-05	3.64E-03
regulation of neuronal synaptic plasticity (GO:0048168)	79	5	1.32	+	3.80	1.03E-02	3.59E-01
negative regulation of peptide secretion (GO:0002792)	79	5	1.32	+	3.80	1.03E-02	3.58E-01
neuron projection extension (GO:1990138)	95	6	1.58	+	3.79	5.16E-03	2.42E-01
cellular response to ketone (GO:1901655)	127	8	2.12	+	3.78	1.32E-03	9.20E-02
negative regulation of neuroblast proliferation (GO:0007406)	16	1	.27	+	3.75	2.36E-01	1.00E00
somatic diversification of immune receptors via somatic mutation (GO:0002566)	16	1	.27	+	3.75	2.36E-01	1.00E00
negative regulation of cation channel activity (GO:2001258)	32	2	.53	+	3.75	9.92E-02	9.64E-01
postsynaptic membrane organization (GO:0001941)	32	2	.53	+	3.75	9.92E-02	9.63E-01
collagen metabolic process (GO:0032963)	64	4	1.07	+	3.75	2.20E-02	5.12E-01
cholesterol efflux (GO:0033344)	32	2	.53	+	3.75	9.92E-02	9.63E-01
hair cycle phase (GO:0044851)	16	1	.27	+	3.75	2.36E-01	1.00E00
negative regulation of cardiac muscle cell proliferation (GO:0060044)	16	1	.27	+	3.75	2.36E-01	1.00E00
positive regulation of protein sumoylation (GO:0033235)	16	1	.27	+	3.75	2.36E-01	1.00E00
regulation of translational elongation (GO:0006448)	16	1	.27	+	3.75	2.36E-01	1.00E00
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147)	16	1	.27	+	3.75	2.36E-01	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)	16	1	.27	+	3.75	2.36E-01	1.00E00
cellular response to peptide (GO:1901653)	16	1	.27	+	3.75	2.36E-01	1.00E00
regulation of rRNA processing (GO:2000232)	16	1	.27	+	3.75	2.36E-01	1.00E00
negative regulation of multicellular organism growth (GO:0040015)	16	1	.27	+	3.75	2.36E-01	1.00E00
positive regulation of non-canonical Wnt signaling pathway (GO:2000052)	16	1	.27	+	3.75	2.36E-01	1.00E00
glycosaminoglycan catabolic process (GO:0006027)	32	2	.53	+	3.75	9.92E-02	9.62E-01
regulation of synaptic transmission, cholinergic (GO:0032222)	16	1	.27	+	3.75	2.36E-01	1.00E00
endocrine process (GO:0050886)	64	4	1.07	+	3.75	2.20E-02	5.12E-01
positive regulation of sequestering of calcium ion (GO:0051284)	16	1	.27	+	3.75	2.36E-01	1.00E00
primary amino compound metabolic process (GO:1901160)	16	1	.27	+	3.75	2.36E-01	1.00E00
regulation of monoatomic anion transport (GO:0044070)	16	1	.27	+	3.75	2.36E-01	1.00E00
nose development (GO:0043584)	16	1	.27	+	3.75	2.36E-01	1.00E00
protein homotrimerization (GO:0070207)	16	1	.27	+	3.75	2.36E-01	1.00E00
negative regulation of purine nucleotide metabolic process (GO:1900543)	32	2	.53	+	3.75	9.92E-02	9.62E-01
establishment of protein localization to chromosome (GO:0070199)	16	1	.27	+	3.75	2.36E-01	1.00E00
response to L-leucine (GO:0043201)	16	1	.27	+	3.75	2.36E-01	1.00E00
neurotrophin TRK receptor signaling pathway (GO:0048011)	16	1	.27	+	3.75	2.36E-01	1.00E00
intracellular chloride ion homeostasis (GO:0030644)	16	1	.27	+	3.75	2.36E-01	1.00E00
glycine transport (GO:0015816)	16	1	.27	+	3.75	2.36E-01	1.00E00
purine nucleoside monophosphate catabolic process (GO:0009128)	16	1	.27	+	3.75	2.36E-01	1.00E00
detoxification of inorganic compound (GO:0061687)	16	1	.27	+	3.75	2.36E-01	1.00E00
negative regulation of neuroinflammatory response (GO:0150079)	16	1	.27	+	3.75	2.36E-01	1.00E00
regulation of extracellular matrix disassembly (GO:0010715)	16	1	.27	+	3.75	2.36E-01	1.00E00
regulation of miRNA processing (GO:1903798)	16	1	.27	+	3.75	2.36E-01	1.00E00
positive regulation of phospholipid metabolic process (GO:1903727)	16	1	.27	+	3.75	2.36E-01	1.00E00
positive regulation of Rac protein signal transduction (GO:0035022)	16	1	.27	+	3.75	2.36E-01	1.00E00
negative regulation of platelet activation (GO:0010544)	16	1	.27	+	3.75	2.36E-01	1.00E00
olfactory behavior (GO:0042048)	16	1	.27	+	3.75	2.36E-01	1.00E00
response to muscle activity (GO:0014850)	32	2	.53	+	3.75	9.92E-02	9.61E-01
intracellular potassium ion homeostasis (GO:0030007)	16	1	.27	+	3.75	2.36E-01	1.00E00
telencephalon regionalization (GO:0021978)	16	1	.27	+	3.75	2.36E-01	1.00E00
negative regulation of alcohol biosynthetic process (GO:1902931)	16	1	.27	+	3.75	2.36E-01	1.00E00
negative regulation of fatty acid oxidation (GO:0046322)	16	1	.27	+	3.75	2.36E-01	1.00E00
regulation of glial cell apoptotic process (GO:0034350)	16	1	.27	+	3.75	2.36E-01	1.00E00
Arp2/3 complex-mediated actin nucleation (GO:0034314)	16	1	.27	+	3.75	2.36E-01	1.00E00
eyelid development in camera-type eye (GO:0061029)	16	1	.27	+	3.75	2.36E-01	1.00E00
atrioventricular valve development (GO:0003171)	32	2	.53	+	3.75	9.92E-02	9.60E-01
regulation of axonogenesis (GO:0050770)	176	11	2.93	+	3.75	1.88E-04	2.13E-02
regulation of small GTPase mediated signal transduction (GO:0051056)	242	15	4.03	+	3.72	1.47E-05	2.60E-03
regulation of postsynaptic membrane potential (GO:0060078)	113	7	1.88	+	3.72	2.88E-03	1.60E-01
symbiont entry into host (GO:0044409)	65	4	1.08	+	3.69	2.32E-02	5.25E-01
symbiont entry into host cell (GO:0046718)	65	4	1.08	+	3.69	2.32E-02	5.24E-01
regulation of cell adhesion mediated by integrin (GO:0033628)	49	3	.82	+	3.67	4.82E-02	7.78E-01
vascular endothelial growth factor receptor-1 signaling pathway (GO:0036323)	49	3	.82	+	3.67	4.82E-02	7.77E-01
forebrain neuron differentiation (GO:0021879)	49	3	.82	+	3.67	4.82E-02	7.76E-01
cell growth (GO:0016049)	148	9	2.47	+	3.65	8.66E-04	7.13E-02
synaptic signaling (GO:0099536)	461	28	7.68	+	3.64	4.59E-09	4.16E-06
negative regulation of myoblast differentiation (GO:0045662)	33	2	.55	+	3.64	1.04E-01	1.00E00
central nervous system myelination (GO:0022010)	33	2	.55	+	3.64	1.04E-01	1.00E00
cytokine production involved in immune response (GO:0002367)	66	4	1.10	+	3.64	2.44E-02	5.43E-01
positive regulation of granulocyte chemotaxis (GO:0071624)	33	2	.55	+	3.64	1.04E-01	1.00E00
positive regulation of defense response to virus by host (GO:0002230)	33	2	.55	+	3.64	1.04E-01	1.00E00
vacuolar localization (GO:1990849)	66	4	1.10	+	3.64	2.44E-02	5.42E-01
lysosome localization (GO:0032418)	66	4	1.10	+	3.64	2.44E-02	5.41E-01
axon ensheathment in central nervous system (GO:0032291)	33	2	.55	+	3.64	1.04E-01	1.00E00
negative regulation of protein secretion (GO:0050709)	99	6	1.65	+	3.64	6.30E-03	2.75E-01
regulation of post-transcriptional gene silencing by regulatory ncRNA (GO:1900368)	33	2	.55	+	3.64	1.04E-01	1.00E00
surfactant homeostasis (GO:0043129)	33	2	.55	+	3.64	1.04E-01	1.00E00
cardiac muscle cell action potential involved in contraction (GO:0086002)	33	2	.55	+	3.64	1.04E-01	1.00E00
negative regulation of protein localization to cell periphery (GO:1904376)	33	2	.55	+	3.64	1.04E-01	9.99E-01
dopamine metabolic process (GO:0042417)	33	2	.55	+	3.64	1.04E-01	9.98E-01
thyroid hormone metabolic process (GO:0042403)	33	2	.55	+	3.64	1.04E-01	9.98E-01
negative regulation of insulin secretion (GO:0046676)	66	4	1.10	+	3.64	2.44E-02	5.40E-01
negative regulation of nucleotide metabolic process (GO:0045980)	33	2	.55	+	3.64	1.04E-01	9.97E-01
potassium ion transport (GO:0006813)	182	11	3.03	+	3.63	2.51E-04	2.67E-02
negative regulation of secretion by cell (GO:1903531)	199	12	3.32	+	3.62	1.36E-04	1.69E-02
ventral spinal cord development (GO:0021517)	50	3	.83	+	3.60	5.07E-02	7.29E-01
positive regulation of purine nucleotide metabolic process (GO:1900544)	50	3	.83	+	3.60	5.07E-02	7.28E-01
platelet-derived growth factor receptor-alpha signaling pathway (GO:0035790)	50	3	.83	+	3.60	5.07E-02	7.28E-01
response to cold (GO:0009409)	50	3	.83	+	3.60	5.07E-02	7.27E-01
negative regulation of cellular response to insulin stimulus (GO:1900077)	50	3	.83	+	3.60	5.07E-02	7.26E-01
phospholipid biosynthetic process (GO:0008654)	200	12	3.33	+	3.60	1.42E-04	1.73E-02
positive regulation of nucleotide metabolic process (GO:0045981)	50	3	.83	+	3.60	5.07E-02	7.26E-01
developmental growth involved in morphogenesis (GO:0060560)	169	10	2.82	+	3.55	5.62E-04	5.09E-02
macrophage colony-stimulating factor signaling pathway (GO:0038145)	51	3	.85	+	3.53	5.32E-02	7.47E-01
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)	119	7	1.98	+	3.53	3.84E-03	1.97E-01
response to pH (GO:0009268)	51	3	.85	+	3.53	5.32E-02	7.46E-01
negative regulation of systemic arterial blood pressure (GO:0003085)	34	2	.57	+	3.53	1.10E-01	1.00E00
atrial septum morphogenesis (GO:0060413)	17	1	.28	+	3.53	2.49E-01	1.00E00
positive regulation of homotypic cell-cell adhesion (GO:0034112)	17	1	.28	+	3.53	2.49E-01	1.00E00
response to manganese ion (GO:0010042)	17	1	.28	+	3.53	2.49E-01	1.00E00
sensory perception of pain (GO:0019233)	85	5	1.42	+	3.53	1.39E-02	4.19E-01
spinal cord motor neuron differentiation (GO:0021522)	34	2	.57	+	3.53	1.10E-01	1.00E00
positive regulation of receptor recycling (GO:0001921)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514)	17	1	.28	+	3.53	2.49E-01	1.00E00
NADH regeneration (GO:0006735)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of epidermal growth factor-activated receptor activity (GO:0007176)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of post-transcriptional gene silencing (GO:0060147)	34	2	.57	+	3.53	1.10E-01	1.00E00
regulation of protein localization to synapse (GO:1902473)	34	2	.57	+	3.53	1.10E-01	1.00E00
positive regulation of phagocytosis, engulfment (GO:0060100)	17	1	.28	+	3.53	2.49E-01	1.00E00
ectodermal placode development (GO:0071696)	17	1	.28	+	3.53	2.49E-01	1.00E00
cardiac muscle cell proliferation (GO:0060038)	34	2	.57	+	3.53	1.10E-01	1.00E00
negative regulation of cGAS/STING signaling pathway (GO:0160049)	17	1	.28	+	3.53	2.49E-01	1.00E00
negative regulation of receptor internalization (GO:0002091)	17	1	.28	+	3.53	2.49E-01	1.00E00
glutamate secretion (GO:0014047)	17	1	.28	+	3.53	2.49E-01	1.00E00
lipid import into cell (GO:0140354)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of regulatory ncRNA processing (GO:0070920)	17	1	.28	+	3.53	2.49E-01	1.00E00
positive regulation of T-helper 17 type immune response (GO:2000318)	17	1	.28	+	3.53	2.49E-01	1.00E00
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231)	17	1	.28	+	3.53	2.49E-01	1.00E00
peptidyl-L-cysteine S-palmitoylation (GO:0018230)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of axon extension involved in axon guidance (GO:0048841)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of prostaglandin secretion (GO:0032306)	17	1	.28	+	3.53	2.49E-01	1.00E00
epithelial cell-cell adhesion (GO:0090136)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of calcium ion import across plasma membrane (GO:1905664)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of heat generation (GO:0031650)	17	1	.28	+	3.53	2.49E-01	1.00E00
chondrocyte proliferation (GO:0035988)	17	1	.28	+	3.53	2.49E-01	1.00E00
interneuron migration (GO:1904936)	17	1	.28	+	3.53	2.49E-01	1.00E00
modulation of process of another organism (GO:0035821)	17	1	.28	+	3.53	2.49E-01	1.00E00
amyloid precursor protein catabolic process (GO:0042987)	17	1	.28	+	3.53	2.49E-01	1.00E00
thyroid gland development (GO:0030878)	34	2	.57	+	3.53	1.10E-01	1.00E00
positive regulation of membrane invagination (GO:1905155)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of sulfur metabolic process (GO:0042762)	17	1	.28	+	3.53	2.49E-01	1.00E00
drinking behavior (GO:0042756)	17	1	.28	+	3.53	2.49E-01	1.00E00
ribosomal large subunit assembly (GO:0000027)	17	1	.28	+	3.53	2.49E-01	1.00E00
phospholipid homeostasis (GO:0055091)	17	1	.28	+	3.53	2.49E-01	1.00E00
fatty acid homeostasis (GO:0055089)	17	1	.28	+	3.53	2.49E-01	1.00E00
glucose catabolic process to pyruvate (GO:0061718)	17	1	.28	+	3.53	2.49E-01	1.00E00
negative regulation of cellular response to hypoxia (GO:1900038)	17	1	.28	+	3.53	2.49E-01	1.00E00
canonical glycolysis (GO:0061621)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of plasminogen activation (GO:0010755)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of plasma membrane organization (GO:1903729)	17	1	.28	+	3.53	2.49E-01	1.00E00
decidualization (GO:0046697)	34	2	.57	+	3.53	1.10E-01	1.00E00
epithelial structure maintenance (GO:0010669)	34	2	.57	+	3.53	1.10E-01	1.00E00
negative regulation of humoral immune response (GO:0002921)	17	1	.28	+	3.53	2.49E-01	1.00E00
positive regulation of calcium ion transport into cytosol (GO:0010524)	17	1	.28	+	3.53	2.49E-01	1.00E00
positive regulation of phospholipase activity (GO:0010518)	17	1	.28	+	3.53	2.49E-01	1.00E00
negative regulation of B cell apoptotic process (GO:0002903)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of skeletal muscle cell proliferation (GO:0014857)	17	1	.28	+	3.53	2.49E-01	1.00E00
negative regulation of cell fate commitment (GO:0010454)	17	1	.28	+	3.53	2.49E-01	1.00E00
intracellular monoatomic anion homeostasis (GO:0030002)	17	1	.28	+	3.53	2.49E-01	1.00E00
adult heart development (GO:0007512)	17	1	.28	+	3.53	2.49E-01	1.00E00
negative regulation of response to oxidative stress (GO:1902883)	17	1	.28	+	3.53	2.49E-01	1.00E00
negative regulation of necroptotic process (GO:0060546)	17	1	.28	+	3.53	2.49E-01	1.00E00
regulation of extent of cell growth (GO:0061387)	120	7	2.00	+	3.50	4.02E-03	1.99E-01
regulation of tissue remodeling (GO:0034103)	86	5	1.43	+	3.49	1.45E-02	4.35E-01
regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)	86	5	1.43	+	3.49	1.45E-02	4.35E-01
negative regulation of leukocyte apoptotic process (GO:2000107)	69	4	1.15	+	3.48	2.81E-02	5.95E-01
developmental cell growth (GO:0048588)	138	8	2.30	+	3.48	2.24E-03	1.36E-01
glycolipid biosynthetic process (GO:0009247)	69	4	1.15	+	3.48	2.81E-02	5.94E-01
receptor localization to synapse (GO:0097120)	69	4	1.15	+	3.48	2.81E-02	5.93E-01
heart valve development (GO:0003170)	69	4	1.15	+	3.48	2.81E-02	5.92E-01
glycerophospholipid biosynthetic process (GO:0046474)	156	9	2.60	+	3.46	1.25E-03	8.91E-02
regulation of lamellipodium organization (GO:1902743)	52	3	.87	+	3.46	5.58E-02	7.61E-01
regulation of T cell apoptotic process (GO:0070232)	52	3	.87	+	3.46	5.58E-02	7.61E-01
positive regulation of insulin secretion (GO:0032024)	122	7	2.03	+	3.44	4.40E-03	2.13E-01
epithelial tube branching involved in lung morphogenesis (GO:0060441)	35	2	.58	+	3.43	1.15E-01	1.00E00
protein N-linked glycosylation via asparagine (GO:0018279)	35	2	.58	+	3.43	1.15E-01	1.00E00
regulation of axon regeneration (GO:0048679)	35	2	.58	+	3.43	1.15E-01	1.00E00
regulation of monocyte chemotaxis (GO:0090025)	35	2	.58	+	3.43	1.15E-01	1.00E00
peptide hormone processing (GO:0016486)	35	2	.58	+	3.43	1.15E-01	1.00E00
actin filament bundle organization (GO:0061572)	70	4	1.17	+	3.43	2.95E-02	6.04E-01
acid secretion (GO:0046717)	35	2	.58	+	3.43	1.15E-01	1.00E00
embryonic hindlimb morphogenesis (GO:0035116)	35	2	.58	+	3.43	1.15E-01	1.00E00
regulation of gene silencing by regulatory ncRNA (GO:0060966)	35	2	.58	+	3.43	1.15E-01	1.00E00
purine nucleoside metabolic process (GO:0042278)	35	2	.58	+	3.43	1.15E-01	1.00E00
positive regulation of cartilage development (GO:0061036)	35	2	.58	+	3.43	1.15E-01	1.00E00
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	246	14	4.10	+	3.41	7.15E-05	9.93E-03
neuron projection morphogenesis (GO:0048812)	545	31	9.08	+	3.41	3.19E-09	3.27E-06
regulation of sodium ion transport (GO:0002028)	88	5	1.47	+	3.41	1.59E-02	4.70E-01
negative regulation of cation transmembrane transport (GO:1904063)	88	5	1.47	+	3.41	1.59E-02	4.69E-01
T cell selection (GO:0045058)	53	3	.88	+	3.40	5.84E-02	7.90E-01
negative regulation of ion transmembrane transporter activity (GO:0032413)	53	3	.88	+	3.40	5.84E-02	7.89E-01
cellular response to virus (GO:0098586)	53	3	.88	+	3.40	5.84E-02	7.88E-01
central nervous system neuron differentiation (GO:0021953)	230	13	3.83	+	3.39	1.38E-04	1.70E-02
cell morphogenesis involved in neuron differentiation (GO:0048667)	497	28	8.28	+	3.38	2.33E-08	1.33E-05
plasma membrane bounded cell projection morphogenesis (GO:0120039)	551	31	9.19	+	3.38	4.13E-09	3.97E-06
ERBB signaling pathway (GO:0038127)	107	6	1.78	+	3.36	9.10E-03	3.39E-01
regulation of potassium ion transport (GO:0043266)	107	6	1.78	+	3.36	9.10E-03	3.39E-01
regulation of receptor-mediated endocytosis (GO:0048259)	143	8	2.38	+	3.36	2.79E-03	1.57E-01
positive regulation of adenylate cyclase activity (GO:0045762)	18	1	.30	+	3.33	2.61E-01	1.00E00
cerebellar Purkinje cell differentiation (GO:0021702)	18	1	.30	+	3.33	2.61E-01	1.00E00
positive regulation of catecholamine secretion (GO:0033605)	18	1	.30	+	3.33	2.61E-01	1.00E00
tricarboxylic acid metabolic process (GO:0072350)	18	1	.30	+	3.33	2.61E-01	1.00E00
intracellular copper ion homeostasis (GO:0006878)	18	1	.30	+	3.33	2.61E-01	1.00E00
regulation of respiratory burst (GO:0060263)	18	1	.30	+	3.33	2.61E-01	1.00E00
NADH metabolic process (GO:0006734)	36	2	.60	+	3.33	1.21E-01	1.00E00
negative regulation of signal transduction by p53 class mediator (GO:1901797)	36	2	.60	+	3.33	1.21E-01	1.00E00
inflammatory response to wounding (GO:0090594)	18	1	.30	+	3.33	2.61E-01	1.00E00
cellular response to misfolded protein (GO:0071218)	18	1	.30	+	3.33	2.61E-01	1.00E00
regulation of superoxide metabolic process (GO:0090322)	36	2	.60	+	3.33	1.21E-01	1.00E00
response to interleukin-6 (GO:0070741)	36	2	.60	+	3.33	1.21E-01	1.00E00
alanine transport (GO:0032328)	18	1	.30	+	3.33	2.61E-01	1.00E00
embryonic digestive tract development (GO:0048566)	36	2	.60	+	3.33	1.21E-01	1.00E00
regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459)	18	1	.30	+	3.33	2.61E-01	1.00E00
response to light intensity (GO:0009642)	18	1	.30	+	3.33	2.61E-01	1.00E00
positive regulation of T cell apoptotic process (GO:0070234)	18	1	.30	+	3.33	2.61E-01	1.00E00
response to morphine (GO:0043278)	18	1	.30	+	3.33	2.61E-01	1.00E00
negative regulation of potassium ion transport (GO:0043267)	36	2	.60	+	3.33	1.21E-01	1.00E00
neuron remodeling (GO:0016322)	18	1	.30	+	3.33	2.61E-01	1.00E00
regulation of response to osmotic stress (GO:0047484)	18	1	.30	+	3.33	2.61E-01	1.00E00
ribonucleoside metabolic process (GO:0009119)	36	2	.60	+	3.33	1.21E-01	1.00E00
nuclear body organization (GO:0030575)	18	1	.30	+	3.33	2.61E-01	1.00E00
cellular response to forskolin (GO:1904322)	18	1	.30	+	3.33	2.61E-01	1.00E00
magnesium ion transmembrane transport (GO:1903830)	18	1	.30	+	3.33	2.61E-01	1.00E00
regulation of vascular endothelial growth factor production (GO:0010574)	36	2	.60	+	3.33	1.21E-01	1.00E00
regulation of hydrogen peroxide metabolic process (GO:0010310)	18	1	.30	+	3.33	2.61E-01	1.00E00
negative regulation of membrane potential (GO:0045837)	18	1	.30	+	3.33	2.61E-01	1.00E00
aortic valve development (GO:0003176)	36	2	.60	+	3.33	1.21E-01	1.00E00
glycosphingolipid metabolic process (GO:0006687)	54	3	.90	+	3.33	6.11E-02	8.13E-01
negative regulation of interleukin-6 production (GO:0032715)	54	3	.90	+	3.33	6.11E-02	8.12E-01
detection of mechanical stimulus involved in sensory perception (GO:0050974)	54	3	.90	+	3.33	6.11E-02	8.11E-01
vesicle docking (GO:0048278)	54	3	.90	+	3.33	6.11E-02	8.11E-01
glial cell migration (GO:0008347)	54	3	.90	+	3.33	6.11E-02	8.10E-01
axon development (GO:0061564)	452	25	7.53	+	3.32	1.90E-07	8.38E-05
cell projection morphogenesis (GO:0048858)	561	31	9.35	+	3.31	6.29E-09	4.22E-06
negative regulation of neurogenesis (GO:0050768)	163	9	2.72	+	3.31	1.70E-03	1.11E-01
neurotransmitter transport (GO:0006836)	145	8	2.42	+	3.31	3.04E-03	1.66E-01
biological process involved in interaction with host (GO:0051701)	109	6	1.82	+	3.30	9.92E-03	3.56E-01
negative regulation of establishment of protein localization (GO:1904950)	164	9	2.73	+	3.29	1.77E-03	1.14E-01
regulation of membrane permeability (GO:0090559)	73	4	1.22	+	3.29	3.37E-02	6.11E-01
organelle localization by membrane tethering (GO:0140056)	73	4	1.22	+	3.29	3.37E-02	6.10E-01
postsynaptic signal transduction (GO:0098926)	73	4	1.22	+	3.29	3.37E-02	6.10E-01
regulation of neutrophil migration (GO:1902622)	55	3	.92	+	3.27	6.39E-02	8.43E-01
regulation of leukocyte apoptotic process (GO:2000106)	110	6	1.83	+	3.27	1.03E-02	3.58E-01
brain-derived neurotrophic factor receptor signaling pathway (GO:0031547)	55	3	.92	+	3.27	6.39E-02	8.42E-01
platelet-derived growth factor receptor-beta signaling pathway (GO:0035791)	55	3	.92	+	3.27	6.39E-02	8.42E-01
neuron maturation (GO:0042551)	55	3	.92	+	3.27	6.39E-02	8.41E-01
feeding behavior (GO:0007631)	110	6	1.83	+	3.27	1.03E-02	3.58E-01
negative regulation of protein transport (GO:0051224)	147	8	2.45	+	3.26	3.31E-03	1.76E-01
ephrin receptor signaling pathway (GO:0048013)	74	4	1.23	+	3.24	3.51E-02	6.29E-01
purine ribonucleotide transport (GO:0015868)	37	2	.62	+	3.24	1.26E-01	1.00E00
muscle cell migration (GO:0014812)	37	2	.62	+	3.24	1.26E-01	1.00E00
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)	37	2	.62	+	3.24	1.26E-01	1.00E00
response to dexamethasone (GO:0071548)	56	3	.93	+	3.21	6.67E-02	8.19E-01
regulation of leukocyte degranulation (GO:0043300)	56	3	.93	+	3.21	6.67E-02	8.18E-01
hepatocyte growth factor receptor signaling pathway (GO:0048012)	56	3	.93	+	3.21	6.67E-02	8.18E-01
cellular response to macrophage colony-stimulating factor stimulus (GO:0036006)	56	3	.93	+	3.21	6.67E-02	8.17E-01
regulation of mitochondrial membrane permeability (GO:0046902)	56	3	.93	+	3.21	6.67E-02	8.17E-01
response to nicotine (GO:0035094)	56	3	.93	+	3.21	6.67E-02	8.16E-01
negative regulation of monoatomic ion transmembrane transport (GO:0034766)	94	5	1.57	+	3.19	2.06E-02	4.90E-01
neuron projection development (GO:0031175)	809	43	13.49	+	3.19	2.07E-11	5.31E-08
regulation of amine transport (GO:0051952)	113	6	1.88	+	3.19	1.17E-02	3.78E-01
small GTPase-mediated signal transduction (GO:0007264)	247	13	4.12	+	3.16	2.77E-04	2.83E-02
positive regulation of cell size (GO:0045793)	19	1	.32	+	3.16	2.74E-01	1.00E00
aldehyde biosynthetic process (GO:0046184)	19	1	.32	+	3.16	2.74E-01	1.00E00
regulation of integrin activation (GO:0033623)	19	1	.32	+	3.16	2.74E-01	1.00E00
phosphate ion transport (GO:0006817)	19	1	.32	+	3.16	2.74E-01	1.00E00
regulation of B cell differentiation (GO:0045577)	38	2	.63	+	3.16	1.32E-01	1.00E00
regulation of mammary gland epithelial cell proliferation (GO:0033599)	19	1	.32	+	3.16	2.74E-01	1.00E00
metanephric nephron morphogenesis (GO:0072273)	19	1	.32	+	3.16	2.74E-01	1.00E00
ureter development (GO:0072189)	19	1	.32	+	3.16	2.74E-01	1.00E00
regulation of epithelial cell differentiation involved in kidney development (GO:2000696)	19	1	.32	+	3.16	2.74E-01	1.00E00
positive regulation of transcription regulatory region DNA binding (GO:2000679)	19	1	.32	+	3.16	2.74E-01	1.00E00
regulation of receptor internalization (GO:0002090)	95	5	1.58	+	3.16	2.14E-02	5.06E-01
positive regulation of myoblast fusion (GO:1901741)	19	1	.32	+	3.16	2.74E-01	1.00E00
regulation of clathrin-dependent endocytosis (GO:2000369)	19	1	.32	+	3.16	2.74E-01	1.00E00
cellular response to exogenous dsRNA (GO:0071360)	19	1	.32	+	3.16	2.74E-01	1.00E00
negative regulation of feeding behavior (GO:2000252)	19	1	.32	+	3.16	2.74E-01	1.00E00
synaptic vesicle cycle (GO:0099504)	171	9	2.85	+	3.16	2.36E-03	1.41E-01
adenine nucleotide transport (GO:0051503)	38	2	.63	+	3.16	1.32E-01	1.00E00
regulation of synaptic vesicle cycle (GO:0098693)	19	1	.32	+	3.16	2.74E-01	1.00E00
negative regulation of potassium ion transmembrane transporter activity (GO:1901017)	19	1	.32	+	3.16	2.74E-01	1.00E00
regulation of thymocyte apoptotic process (GO:0070243)	19	1	.32	+	3.16	2.74E-01	1.00E00
epithelial cell differentiation involved in kidney development (GO:0035850)	38	2	.63	+	3.16	1.32E-01	1.00E00
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092)	19	1	.32	+	3.16	2.74E-01	1.00E00
maternal behavior (GO:0042711)	19	1	.32	+	3.16	2.74E-01	1.00E00
copper ion homeostasis (GO:0055070)	19	1	.32	+	3.16	2.74E-01	1.00E00
ventricular cardiac muscle cell differentiation (GO:0055012)	19	1	.32	+	3.16	2.74E-01	1.00E00
cardiac myofibril assembly (GO:0055003)	19	1	.32	+	3.16	2.74E-01	1.00E00
response to caffeine (GO:0031000)	19	1	.32	+	3.16	2.74E-01	1.00E00
female genitalia development (GO:0030540)	19	1	.32	+	3.16	2.74E-01	1.00E00
regulation of microglial cell activation (GO:1903978)	19	1	.32	+	3.16	2.74E-01	1.00E00
negative regulation of programmed necrotic cell death (GO:0062099)	19	1	.32	+	3.16	2.74E-01	1.00E00
response to forskolin (GO:1904321)	19	1	.32	+	3.16	2.74E-01	1.00E00
hyaluronan catabolic process (GO:0030214)	19	1	.32	+	3.16	2.74E-01	1.00E00
negative regulation of epithelial cell migration (GO:0010633)	19	1	.32	+	3.16	2.74E-01	1.00E00
negative regulation of smooth muscle cell migration (GO:0014912)	38	2	.63	+	3.16	1.32E-01	1.00E00
regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923)	19	1	.32	+	3.16	2.74E-01	1.00E00
negative regulation of translational initiation (GO:0045947)	19	1	.32	+	3.16	2.74E-01	1.00E00
glyceraldehyde-3-phosphate metabolic process (GO:0019682)	19	1	.32	+	3.16	2.74E-01	1.00E00
cardiac right ventricle morphogenesis (GO:0003215)	19	1	.32	+	3.16	2.74E-01	1.00E00
lipid droplet organization (GO:0034389)	38	2	.63	+	3.16	1.32E-01	1.00E00
pyramidal neuron differentiation (GO:0021859)	19	1	.32	+	3.16	2.74E-01	1.00E00
intestinal epithelial cell development (GO:0060576)	19	1	.32	+	3.16	2.74E-01	1.00E00
secretion by cell (GO:0032940)	456	24	7.60	+	3.16	8.17E-07	2.52E-04
regulation of sodium ion transmembrane transport (GO:1902305)	57	3	.95	+	3.16	6.96E-02	8.48E-01
oligodendrocyte development (GO:0014003)	57	3	.95	+	3.16	6.96E-02	8.47E-01
regulation of filopodium assembly (GO:0051489)	57	3	.95	+	3.16	6.96E-02	8.46E-01
negative regulation of synaptic transmission (GO:0050805)	57	3	.95	+	3.16	6.96E-02	8.46E-01
regulation of membrane depolarization (GO:0003254)	57	3	.95	+	3.16	6.96E-02	8.45E-01
protein localization to cell junction (GO:1902414)	115	6	1.92	+	3.13	1.27E-02	4.04E-01
negative regulation of developmental growth (GO:0048640)	115	6	1.92	+	3.13	1.27E-02	4.03E-01
negative regulation of nervous system development (GO:0051961)	173	9	2.88	+	3.12	2.55E-03	1.49E-01
synaptic vesicle endocytosis (GO:0048488)	58	3	.97	+	3.10	7.25E-02	8.70E-01
response to macrophage colony-stimulating factor (GO:0036005)	58	3	.97	+	3.10	7.25E-02	8.70E-01
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178)	97	5	1.62	+	3.09	2.32E-02	5.24E-01
negative regulation of inflammatory response (GO:0050728)	175	9	2.92	+	3.09	2.75E-03	1.55E-01
respiratory system process (GO:0003016)	39	2	.65	+	3.08	1.38E-01	1.00E00
cerebellar Purkinje cell layer development (GO:0021680)	39	2	.65	+	3.08	1.38E-01	1.00E00
regulation of receptor localization to synapse (GO:1902683)	39	2	.65	+	3.08	1.38E-01	1.00E00
regulation of myeloid cell apoptotic process (GO:0033032)	39	2	.65	+	3.08	1.38E-01	1.00E00
CD4-positive, alpha-beta T cell activation (GO:0035710)	78	4	1.30	+	3.08	4.14E-02	7.00E-01
amine biosynthetic process (GO:0009309)	39	2	.65	+	3.08	1.38E-01	1.00E00
purine nucleotide transport (GO:0015865)	39	2	.65	+	3.08	1.38E-01	1.00E00
hair follicle morphogenesis (GO:0031069)	39	2	.65	+	3.08	1.38E-01	1.00E00
biogenic amine biosynthetic process (GO:0042401)	39	2	.65	+	3.08	1.38E-01	1.00E00
regulation of phospholipid metabolic process (GO:1903725)	39	2	.65	+	3.08	1.38E-01	1.00E00
positive regulation of alpha-beta T cell activation (GO:0046635)	78	4	1.30	+	3.08	4.14E-02	6.99E-01
negative regulation of monoatomic ion transport (GO:0043271)	137	7	2.28	+	3.07	8.19E-03	3.20E-01
vesicle-mediated transport in synapse (GO:0099003)	196	10	3.27	+	3.06	1.73E-03	1.12E-01
body morphogenesis (GO:0010171)	59	3	.98	+	3.05	7.55E-02	8.98E-01
collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063)	59	3	.98	+	3.05	7.55E-02	8.97E-01
regulation of response to wounding (GO:1903034)	177	9	2.95	+	3.05	2.97E-03	1.63E-01
positive regulation of cytosolic calcium ion concentration (GO:0007204)	197	10	3.28	+	3.05	1.80E-03	1.15E-01
postsynapse organization (GO:0099173)	138	7	2.30	+	3.04	8.51E-03	3.30E-01
cellular response to hydrogen peroxide (GO:0070301)	79	4	1.32	+	3.04	4.30E-02	7.23E-01
muscle cell proliferation (GO:0033002)	60	3	1.00	+	3.00	7.85E-02	9.27E-01
peptidyl-threonine modification (GO:0018210)	60	3	1.00	+	3.00	7.85E-02	9.27E-01
negative regulation of transporter activity (GO:0032410)	60	3	1.00	+	3.00	7.85E-02	9.26E-01
positive regulation of osteoclast differentiation (GO:0045672)	40	2	.67	+	3.00	1.43E-01	1.00E00
cerebellar Purkinje cell layer formation (GO:0021694)	20	1	.33	+	3.00	2.86E-01	1.00E00
acute inflammatory response to antigenic stimulus (GO:0002438)	20	1	.33	+	3.00	2.86E-01	1.00E00
positive regulation of B cell differentiation (GO:0045579)	20	1	.33	+	3.00	2.86E-01	1.00E00
sphingomyelin metabolic process (GO:0006684)	20	1	.33	+	3.00	2.86E-01	1.00E00
regulation of phagocytosis, engulfment (GO:0060099)	20	1	.33	+	3.00	2.86E-01	1.00E00
Wnt signaling pathway, planar cell polarity pathway (GO:0060071)	20	1	.33	+	3.00	2.86E-01	1.00E00
negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)	40	2	.67	+	3.00	1.43E-01	1.00E00
positive regulation of protein depolymerization (GO:1901881)	20	1	.33	+	3.00	2.86E-01	1.00E00
negative regulation of DNA-templated transcription, elongation (GO:0032785)	20	1	.33	+	3.00	2.86E-01	1.00E00
p38MAPK cascade (GO:0038066)	20	1	.33	+	3.00	2.86E-01	1.00E00
cellular response to fluid shear stress (GO:0071498)	20	1	.33	+	3.00	2.86E-01	1.00E00
response to isoquinoline alkaloid (GO:0014072)	20	1	.33	+	3.00	2.86E-01	1.00E00
cell migration involved in sprouting angiogenesis (GO:0002042)	20	1	.33	+	3.00	2.86E-01	1.00E00
V(D)J recombination (GO:0033151)	20	1	.33	+	3.00	2.86E-01	1.00E00
mitochondrial transcription (GO:0006390)	20	1	.33	+	3.00	2.86E-01	1.00E00
cellular response to ethanol (GO:0071361)	20	1	.33	+	3.00	2.86E-01	1.00E00
response to misfolded protein (GO:0051788)	20	1	.33	+	3.00	2.86E-01	1.00E00
glycosyl compound biosynthetic process (GO:1901659)	20	1	.33	+	3.00	2.86E-01	1.00E00
positive regulation of amyloid-beta formation (GO:1902004)	20	1	.33	+	3.00	2.86E-01	1.00E00
inorganic ion import across plasma membrane (GO:0099587)	100	5	1.67	+	3.00	2.61E-02	5.61E-01
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037)	20	1	.33	+	3.00	2.86E-01	1.00E00
regulation of cAMP-mediated signaling (GO:0043949)	40	2	.67	+	3.00	1.43E-01	1.00E00
cellular response to leptin stimulus (GO:0044320)	20	1	.33	+	3.00	2.86E-01	1.00E00
regulation of phospholipid biosynthetic process (GO:0071071)	20	1	.33	+	3.00	2.86E-01	1.00E00
neuron fate specification (GO:0048665)	40	2	.67	+	3.00	1.43E-01	1.00E00
calcium ion import (GO:0070509)	40	2	.67	+	3.00	1.43E-01	1.00E00
positive regulation of synaptic transmission, GABAergic (GO:0032230)	20	1	.33	+	3.00	2.86E-01	1.00E00
regulation of steroid hormone biosynthetic process (GO:0090030)	20	1	.33	+	3.00	2.86E-01	1.00E00
positive regulation of T cell receptor signaling pathway (GO:0050862)	20	1	.33	+	3.00	2.86E-01	1.00E00
postsynaptic specialization assembly (GO:0098698)	20	1	.33	+	3.00	2.86E-01	1.00E00
inorganic cation import across plasma membrane (GO:0098659)	100	5	1.67	+	3.00	2.61E-02	5.60E-01
protein trimerization (GO:0070206)	20	1	.33	+	3.00	2.86E-01	1.00E00
clathrin coat assembly (GO:0048268)	20	1	.33	+	3.00	2.86E-01	1.00E00
negative regulation of B cell proliferation (GO:0030889)	20	1	.33	+	3.00	2.86E-01	1.00E00
positive regulation of protein-containing complex disassembly (GO:0043243)	40	2	.67	+	3.00	1.43E-01	1.00E00
peptide catabolic process (GO:0043171)	20	1	.33	+	3.00	2.86E-01	1.00E00
superoxide anion generation (GO:0042554)	20	1	.33	+	3.00	2.86E-01	1.00E00
glycolytic process through glucose-6-phosphate (GO:0061620)	20	1	.33	+	3.00	2.86E-01	1.00E00
cardiac muscle cell contraction (GO:0086003)	40	2	.67	+	3.00	1.43E-01	1.00E00
positive regulation of telomere capping (GO:1904355)	20	1	.33	+	3.00	2.86E-01	1.00E00
positive regulation of ERAD pathway (GO:1904294)	20	1	.33	+	3.00	2.86E-01	1.00E00
regulation of bile acid metabolic process (GO:1904251)	20	1	.33	+	3.00	2.86E-01	1.00E00
synaptic vesicle lumen acidification (GO:0097401)	20	1	.33	+	3.00	2.86E-01	1.00E00
smooth muscle cell migration (GO:0014909)	20	1	.33	+	3.00	2.86E-01	1.00E00
positive regulation of inflammatory response to antigenic stimulus (GO:0002863)	20	1	.33	+	3.00	2.86E-01	1.00E00
placenta blood vessel development (GO:0060674)	40	2	.67	+	3.00	1.43E-01	1.00E00
energy homeostasis (GO:0097009)	100	5	1.67	+	3.00	2.61E-02	5.59E-01
positive regulation of natural killer cell mediated immunity (GO:0002717)	40	2	.67	+	3.00	1.43E-01	1.00E00
positive regulation of cell adhesion (GO:0045785)	521	26	8.68	+	2.99	7.74E-07	2.43E-04
positive regulation of peptide secretion (GO:0002793)	161	8	2.68	+	2.98	5.71E-03	2.56E-01
regulation of secretion by cell (GO:1903530)	706	35	11.77	+	2.97	1.04E-08	6.39E-06
export from cell (GO:0140352)	526	26	8.77	+	2.97	9.25E-07	2.80E-04
axon guidance (GO:0007411)	243	12	4.05	+	2.96	8.28E-04	6.90E-02
positive regulation of response to wounding (GO:1903036)	81	4	1.35	+	2.96	4.65E-02	7.64E-01
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	162	8	2.70	+	2.96	5.93E-03	2.64E-01
response to estrogen (GO:0043627)	81	4	1.35	+	2.96	4.65E-02	7.64E-01
negative regulation of T cell proliferation (GO:0042130)	81	4	1.35	+	2.96	4.65E-02	7.63E-01
glycerophospholipid metabolic process (GO:0006650)	264	13	4.40	+	2.95	5.23E-04	4.77E-02
regulation of granulocyte chemotaxis (GO:0071622)	61	3	1.02	+	2.95	8.16E-02	8.95E-01
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	61	3	1.02	+	2.95	8.16E-02	8.94E-01
neuron projection guidance (GO:0097485)	244	12	4.07	+	2.95	8.58E-04	7.11E-02
cerebral cortex radially oriented cell migration (GO:0021799)	41	2	.68	+	2.93	1.49E-01	1.00E00
phenol-containing compound biosynthetic process (GO:0046189)	41	2	.68	+	2.93	1.49E-01	1.00E00
cyclic purine nucleotide metabolic process (GO:0052652)	41	2	.68	+	2.93	1.49E-01	1.00E00
regulation of transcription regulatory region DNA binding (GO:2000677)	41	2	.68	+	2.93	1.49E-01	1.00E00
signaling receptor ligand precursor processing (GO:0140448)	41	2	.68	+	2.93	1.49E-01	1.00E00
response to purine-containing compound (GO:0014074)	164	8	2.73	+	2.93	6.37E-03	2.75E-01
cell-cell fusion (GO:0140253)	41	2	.68	+	2.93	1.49E-01	1.00E00
syncytium formation by plasma membrane fusion (GO:0000768)	41	2	.68	+	2.93	1.49E-01	1.00E00
aminoglycan catabolic process (GO:0006026)	41	2	.68	+	2.93	1.49E-01	1.00E00
negative regulation of protein localization to membrane (GO:1905476)	41	2	.68	+	2.93	1.49E-01	1.00E00
developmental induction (GO:0031128)	41	2	.68	+	2.93	1.49E-01	1.00E00
dendritic spine development (GO:0060996)	41	2	.68	+	2.93	1.49E-01	1.00E00
regulation of insulin receptor signaling pathway (GO:0046626)	82	4	1.37	+	2.93	4.82E-02	7.76E-01
regulation of lamellipodium assembly (GO:0010591)	41	2	.68	+	2.93	1.49E-01	1.00E00
membrane docking (GO:0022406)	82	4	1.37	+	2.93	4.82E-02	7.75E-01
detection of abiotic stimulus (GO:0009582)	144	7	2.40	+	2.92	1.06E-02	3.65E-01
response to organophosphorus (GO:0046683)	144	7	2.40	+	2.92	1.06E-02	3.64E-01
regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072)	103	5	1.72	+	2.91	2.91E-02	6.00E-01
regulation of axon extension (GO:0030516)	103	5	1.72	+	2.91	2.91E-02	5.99E-01
ADP metabolic process (GO:0046031)	62	3	1.03	+	2.90	8.48E-02	9.14E-01
cell surface receptor signaling pathway via JAK-STAT (GO:0007259)	62	3	1.03	+	2.90	8.48E-02	9.13E-01
calcium ion transmembrane transport (GO:0070588)	207	10	3.45	+	2.90	2.58E-03	1.51E-01
hematopoietic progenitor cell differentiation (GO:0002244)	145	7	2.42	+	2.90	1.10E-02	3.75E-01
detection of external stimulus (GO:0009581)	145	7	2.42	+	2.90	1.10E-02	3.74E-01
neuron development (GO:0048666)	995	48	16.59	+	2.89	3.76E-11	7.25E-08
negative regulation of protein ubiquitination (GO:0031397)	83	4	1.38	+	2.89	5.00E-02	7.23E-01
glycerolipid biosynthetic process (GO:0045017)	187	9	3.12	+	2.89	4.27E-03	2.09E-01
positive regulation of endothelial cell proliferation (GO:0001938)	104	5	1.73	+	2.88	3.02E-02	6.15E-01
regulation of alpha-beta T cell activation (GO:0046634)	125	6	2.08	+	2.88	1.85E-02	4.61E-01
regulation of membrane potential (GO:0042391)	521	25	8.68	+	2.88	2.55E-06	6.35E-04
modulation of chemical synaptic transmission (GO:0050804)	627	30	10.45	+	2.87	2.63E-07	1.07E-04
regulation of trans-synaptic signaling (GO:0099177)	628	30	10.47	+	2.87	2.72E-07	1.08E-04
positive regulation of cell-cell adhesion (GO:0022409)	335	16	5.58	+	2.87	1.74E-04	2.01E-02
regulation of insulin secretion (GO:0050796)	231	11	3.85	+	2.86	1.80E-03	1.15E-01
regulation of leukocyte tethering or rolling (GO:1903236)	21	1	.35	+	2.86	2.98E-01	1.00E00
regulation of protein targeting to mitochondrion (GO:1903214)	21	1	.35	+	2.86	2.98E-01	1.00E00
segment specification (GO:0007379)	21	1	.35	+	2.86	2.98E-01	1.00E00
regulation of corticosteroid hormone secretion (GO:2000846)	21	1	.35	+	2.86	2.98E-01	1.00E00
regulation of regulatory T cell differentiation (GO:0045589)	42	2	.70	+	2.86	1.55E-01	1.00E00
synaptic transmission, cholinergic (GO:0007271)	21	1	.35	+	2.86	2.98E-01	1.00E00
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213)	21	1	.35	+	2.86	2.98E-01	1.00E00
camera-type eye photoreceptor cell differentiation (GO:0060219)	42	2	.70	+	2.86	1.55E-01	1.00E00
unsaturated fatty acid biosynthetic process (GO:0006636)	42	2	.70	+	2.86	1.55E-01	1.00E00
dopaminergic neuron differentiation (GO:0071542)	42	2	.70	+	2.86	1.55E-01	1.00E00
negative regulation of amino acid transport (GO:0051956)	21	1	.35	+	2.86	2.98E-01	1.00E00
interleukin-2 production (GO:0032623)	21	1	.35	+	2.86	2.98E-01	1.00E00
regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108)	21	1	.35	+	2.86	2.98E-01	1.00E00
DNA catabolic process (GO:0006308)	21	1	.35	+	2.86	2.98E-01	1.00E00
maintenance of synapse structure (GO:0099558)	42	2	.70	+	2.86	1.55E-01	1.00E00
regulation of neurotransmitter uptake (GO:0051580)	21	1	.35	+	2.86	2.98E-01	1.00E00
regulation of potassium ion transmembrane transport (GO:1901379)	84	4	1.40	+	2.86	5.19E-02	7.36E-01
response to corticosterone (GO:0051412)	21	1	.35	+	2.86	2.98E-01	1.00E00
regulation of neuron projection regeneration (GO:0070570)	42	2	.70	+	2.86	1.55E-01	1.00E00
neuromuscular process controlling posture (GO:0050884)	21	1	.35	+	2.86	2.98E-01	1.00E00
positive regulation of vascular endothelial cell proliferation (GO:1905564)	21	1	.35	+	2.86	2.98E-01	1.00E00
axonemal dynein complex assembly (GO:0070286)	42	2	.70	+	2.86	1.55E-01	1.00E00
presynapse assembly (GO:0099054)	21	1	.35	+	2.86	2.98E-01	1.00E00
protein localization to chromosome, telomeric region (GO:0070198)	21	1	.35	+	2.86	2.98E-01	1.00E00
eosinophil chemotaxis (GO:0048245)	21	1	.35	+	2.86	2.98E-01	1.00E00
coenzyme A metabolic process (GO:0015936)	21	1	.35	+	2.86	2.98E-01	1.00E00
cyclic nucleotide metabolic process (GO:0009187)	42	2	.70	+	2.86	1.55E-01	1.00E00
cell-cell signaling involved in cardiac conduction (GO:0086019)	21	1	.35	+	2.86	2.98E-01	1.00E00
norepinephrine metabolic process (GO:0042415)	21	1	.35	+	2.86	2.98E-01	1.00E00
magnesium ion transport (GO:0015693)	21	1	.35	+	2.86	2.98E-01	1.00E00
cAMP-mediated signaling (GO:0019933)	42	2	.70	+	2.86	1.55E-01	1.00E00
maintenance of gastrointestinal epithelium (GO:0030277)	21	1	.35	+	2.86	2.98E-01	1.00E00
insulin receptor signaling pathway (GO:0008286)	126	6	2.10	+	2.86	1.91E-02	4.73E-01
activation of cysteine-type endopeptidase activity (GO:0097202)	21	1	.35	+	2.86	2.98E-01	1.00E00
regulation of calcium ion transport into cytosol (GO:0010522)	21	1	.35	+	2.86	2.98E-01	1.00E00
parental behavior (GO:0060746)	21	1	.35	+	2.86	2.98E-01	1.00E00
snRNA 3'-end processing (GO:0034472)	21	1	.35	+	2.86	2.98E-01	1.00E00
negative regulation of DNA replication (GO:0008156)	21	1	.35	+	2.86	2.98E-01	1.00E00
negative regulation of smooth muscle cell apoptotic process (GO:0034392)	21	1	.35	+	2.86	2.98E-01	1.00E00
negative regulation of D-glucose import (GO:0046325)	21	1	.35	+	2.86	2.98E-01	1.00E00
dendritic cell differentiation (GO:0097028)	42	2	.70	+	2.86	1.55E-01	1.00E00
myeloid leukocyte cytokine production (GO:0061082)	42	2	.70	+	2.86	1.55E-01	1.00E00
forebrain generation of neurons (GO:0021872)	63	3	1.05	+	2.86	8.79E-02	9.42E-01
behavior (GO:0007610)	800	38	13.34	+	2.85	7.41E-09	4.76E-06
negative regulation of locomotion (GO:0040013)	358	17	5.97	+	2.85	1.18E-04	1.48E-02
neuron migration (GO:0001764)	169	8	2.82	+	2.84	7.58E-03	3.01E-01
phospholipid metabolic process (GO:0006644)	339	16	5.65	+	2.83	2.00E-04	2.25E-02
neural crest cell development (GO:0014032)	85	4	1.42	+	2.82	5.38E-02	7.53E-01
negative regulation of cell motility (GO:2000146)	340	16	5.67	+	2.82	2.06E-04	2.30E-02
carbohydrate derivative transport (GO:1901264)	85	4	1.42	+	2.82	5.38E-02	7.52E-01
calcium-mediated signaling (GO:0019722)	170	8	2.83	+	2.82	7.85E-03	3.09E-01
response to calcium ion (GO:0051592)	149	7	2.48	+	2.82	1.26E-02	4.03E-01
vascular endothelial growth factor signaling pathway (GO:0038084)	64	3	1.07	+	2.81	9.12E-02	9.62E-01
collagen-activated signaling pathway (GO:0038065)	64	3	1.07	+	2.81	9.12E-02	9.62E-01
regulation of purine nucleotide catabolic process (GO:0033121)	64	3	1.07	+	2.81	9.12E-02	9.61E-01
regulation of interleukin-10 production (GO:0032653)	64	3	1.07	+	2.81	9.12E-02	9.61E-01
presynaptic endocytosis (GO:0140238)	64	3	1.07	+	2.81	9.12E-02	9.60E-01
positive regulation of wound healing (GO:0090303)	64	3	1.07	+	2.81	9.12E-02	9.59E-01
regulation of glycolytic process (GO:0006110)	64	3	1.07	+	2.81	9.12E-02	9.59E-01
actin-mediated cell contraction (GO:0070252)	64	3	1.07	+	2.81	9.12E-02	9.58E-01
regulation of nucleotide catabolic process (GO:0030811)	64	3	1.07	+	2.81	9.12E-02	9.57E-01
regulation of natural killer cell mediated cytotoxicity (GO:0042269)	64	3	1.07	+	2.81	9.12E-02	9.57E-01
response to ischemia (GO:0002931)	64	3	1.07	+	2.81	9.12E-02	9.56E-01
regulation of plasma membrane bounded cell projection assembly (GO:0120032)	214	10	3.57	+	2.80	3.28E-03	1.75E-01
negative regulation of hormone secretion (GO:0046888)	107	5	1.78	+	2.80	3.35E-02	6.10E-01
syncytium formation (GO:0006949)	43	2	.72	+	2.79	1.61E-01	1.00E00
hexose catabolic process (GO:0019320)	43	2	.72	+	2.79	1.61E-01	1.00E00
neural tube patterning (GO:0021532)	43	2	.72	+	2.79	1.61E-01	1.00E00
activation of GTPase activity (GO:0090630)	43	2	.72	+	2.79	1.61E-01	1.00E00
cellular response to calcium ion (GO:0071277)	86	4	1.43	+	2.79	5.57E-02	7.76E-01
positive regulation of behavior (GO:0048520)	43	2	.72	+	2.79	1.61E-01	1.00E00
positive regulation of morphogenesis of an epithelium (GO:1905332)	43	2	.72	+	2.79	1.61E-01	1.00E00
regulation of Rho protein signal transduction (GO:0035023)	86	4	1.43	+	2.79	5.57E-02	7.75E-01
negative regulation of blood coagulation (GO:0030195)	43	2	.72	+	2.79	1.61E-01	1.00E00
regulation of peptide secretion (GO:0002791)	280	13	4.67	+	2.79	9.02E-04	7.32E-02
positive regulation of protein secretion (GO:0050714)	194	9	3.23	+	2.78	5.41E-03	2.49E-01
hair follicle development (GO:0001942)	108	5	1.80	+	2.78	3.47E-02	6.24E-01
cellular response to carbohydrate stimulus (GO:0071322)	108	5	1.80	+	2.78	3.47E-02	6.23E-01
cell-cell signaling (GO:0007267)	713	33	11.89	+	2.78	1.39E-07	7.17E-05
positive regulation of miRNA metabolic process (GO:2000630)	65	3	1.08	+	2.77	9.45E-02	9.76E-01
glomerulus development (GO:0032835)	65	3	1.08	+	2.77	9.45E-02	9.76E-01
regulation of cholesterol transport (GO:0032374)	65	3	1.08	+	2.77	9.45E-02	9.75E-01
regulation of sterol transport (GO:0032371)	65	3	1.08	+	2.77	9.45E-02	9.75E-01
regulation of monoatomic ion transport (GO:0043269)	520	24	8.67	+	2.77	7.83E-06	1.53E-03
regulation of peptide transport (GO:0090087)	282	13	4.70	+	2.77	9.63E-04	7.65E-02
regulation of cell projection assembly (GO:0060491)	217	10	3.62	+	2.76	3.62E-03	1.88E-01
negative regulation of transport (GO:0051051)	500	23	8.33	+	2.76	1.28E-05	2.32E-03
neuron fate commitment (GO:0048663)	87	4	1.45	+	2.76	5.76E-02	7.83E-01
negative regulation of transmembrane transport (GO:0034763)	131	6	2.18	+	2.75	2.27E-02	5.17E-01
regulation of neuron projection development (GO:0010975)	569	26	9.49	+	2.74	3.90E-06	8.85E-04
secretion (GO:0046903)	591	27	9.85	+	2.74	2.54E-06	6.43E-04
regulation of cardiac muscle cell apoptotic process (GO:0010665)	66	3	1.10	+	2.73	9.78E-02	9.53E-01
macrophage activation (GO:0042116)	66	3	1.10	+	2.73	9.78E-02	9.52E-01
response to UV-B (GO:0010224)	22	1	.37	+	2.73	3.09E-01	1.00E00
trachea development (GO:0060438)	22	1	.37	+	2.73	3.09E-01	1.00E00
regulation of macrophage differentiation (GO:0045649)	22	1	.37	+	2.73	3.09E-01	1.00E00
positive regulation of neutrophil migration (GO:1902624)	44	2	.73	+	2.73	1.67E-01	1.00E00
nucleotide transport (GO:0006862)	44	2	.73	+	2.73	1.67E-01	1.00E00
nervous system process involved in regulation of systemic arterial blood pressure (GO:0001976)	22	1	.37	+	2.73	3.09E-01	1.00E00
hematopoietic stem cell differentiation (GO:0060218)	22	1	.37	+	2.73	3.09E-01	1.00E00
regulation of synaptic transmission, glutamatergic (GO:0051966)	88	4	1.47	+	2.73	5.96E-02	8.02E-01
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)	22	1	.37	+	2.73	3.09E-01	1.00E00
positive regulation of interleukin-10 production (GO:0032733)	44	2	.73	+	2.73	1.67E-01	1.00E00
DNA-templated transcription termination (GO:0006353)	22	1	.37	+	2.73	3.09E-01	1.00E00
regulation of establishment of cell polarity (GO:2000114)	22	1	.37	+	2.73	3.09E-01	1.00E00
proteoglycan metabolic process (GO:0006029)	88	4	1.47	+	2.73	5.96E-02	8.02E-01
positive regulation of skeletal muscle tissue development (GO:0048643)	22	1	.37	+	2.73	3.09E-01	1.00E00
regulation of tubulin deacetylation (GO:0090043)	22	1	.37	+	2.73	3.09E-01	1.00E00
excitatory synapse assembly (GO:1904861)	22	1	.37	+	2.73	3.09E-01	1.00E00
xenobiotic transport (GO:0042908)	44	2	.73	+	2.73	1.67E-01	1.00E00
phosphatidylinositol-mediated signaling (GO:0048015)	22	1	.37	+	2.73	3.09E-01	1.00E00
vitamin transmembrane transport (GO:0035461)	22	1	.37	+	2.73	3.09E-01	1.00E00
ribonucleoside monophosphate catabolic process (GO:0009158)	22	1	.37	+	2.73	3.09E-01	1.00E00
aspartate transmembrane transport (GO:0015810)	22	1	.37	+	2.73	3.09E-01	1.00E00
endocrine pancreas development (GO:0031018)	44	2	.73	+	2.73	1.67E-01	1.00E00
pore complex assembly (GO:0046931)	22	1	.37	+	2.73	3.09E-01	1.00E00
negative regulation of hemostasis (GO:1900047)	44	2	.73	+	2.73	1.67E-01	1.00E00
glycolytic process through fructose-6-phosphate (GO:0061615)	22	1	.37	+	2.73	3.09E-01	1.00E00
signal release (GO:0023061)	220	10	3.67	+	2.73	3.99E-03	1.98E-01
regulation of ATP metabolic process (GO:1903578)	88	4	1.47	+	2.73	5.96E-02	8.01E-01
regulation of dopamine metabolic process (GO:0042053)	22	1	.37	+	2.73	3.09E-01	1.00E00
actin filament-based movement (GO:0030048)	88	4	1.47	+	2.73	5.96E-02	8.00E-01
positive regulation of immune response to tumor cell (GO:0002839)	22	1	.37	+	2.73	3.09E-01	1.00E00
positive regulation of response to tumor cell (GO:0002836)	22	1	.37	+	2.73	3.09E-01	1.00E00
NAD catabolic process (GO:0019677)	22	1	.37	+	2.73	3.09E-01	1.00E00
eosinophil migration (GO:0072677)	22	1	.37	+	2.73	3.09E-01	1.00E00
regulation of metal ion transport (GO:0010959)	441	20	7.35	+	2.72	5.72E-05	8.31E-03
neuron differentiation (GO:0030182)	1242	56	20.70	+	2.70	1.03E-11	3.16E-08
phenol-containing compound metabolic process (GO:0018958)	111	5	1.85	+	2.70	3.84E-02	6.71E-01
spinal cord development (GO:0021510)	111	5	1.85	+	2.70	3.84E-02	6.70E-01
platelet-derived growth factor receptor signaling pathway (GO:0048008)	89	4	1.48	+	2.70	6.16E-02	8.16E-01
lung morphogenesis (GO:0060425)	67	3	1.12	+	2.69	1.01E-01	9.77E-01
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	67	3	1.12	+	2.69	1.01E-01	9.76E-01
actin filament bundle assembly (GO:0051017)	67	3	1.12	+	2.69	1.01E-01	9.75E-01
leukocyte activation involved in immune response (GO:0002366)	224	10	3.73	+	2.68	4.52E-03	2.18E-01
hair cycle process (GO:0022405)	112	5	1.87	+	2.68	3.96E-02	6.78E-01
molting cycle process (GO:0022404)	112	5	1.87	+	2.68	3.96E-02	6.77E-01
positive regulation of peptide hormone secretion (GO:0090277)	157	7	2.62	+	2.67	1.64E-02	4.74E-01
generation of neurons (GO:0048699)	1326	59	22.10	+	2.67	4.51E-12	2.31E-08
inflammatory response to antigenic stimulus (GO:0002437)	45	2	.75	+	2.67	1.73E-01	1.00E00
epidermis morphogenesis (GO:0048730)	45	2	.75	+	2.67	1.73E-01	1.00E00
regulation of protein localization to cell surface (GO:2000008)	45	2	.75	+	2.67	1.73E-01	1.00E00
negative regulation of coagulation (GO:0050819)	45	2	.75	+	2.67	1.73E-01	1.00E00
skeletal muscle tissue regeneration (GO:0043403)	45	2	.75	+	2.67	1.73E-01	1.00E00
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	45	2	.75	+	2.67	1.73E-01	1.00E00
positive regulation of cardiac muscle hypertrophy (GO:0010613)	45	2	.75	+	2.67	1.73E-01	1.00E00
striated muscle cell proliferation (GO:0014855)	45	2	.75	+	2.67	1.73E-01	1.00E00
renal system process (GO:0003014)	135	6	2.25	+	2.67	2.58E-02	5.56E-01
cellular response to peptide hormone stimulus (GO:0071375)	316	14	5.27	+	2.66	9.14E-04	7.30E-02
regulation of secretion (GO:0051046)	791	35	13.19	+	2.65	1.69E-07	7.65E-05
regulation of behavior (GO:0050795)	113	5	1.88	+	2.65	4.09E-02	6.96E-01
regulation of protein secretion (GO:0050708)	339	15	5.65	+	2.65	6.15E-04	5.41E-02
regulation of plasma membrane bounded cell projection organization (GO:0120035)	769	34	12.82	+	2.65	2.61E-07	1.09E-04
positive regulation of monoatomic ion transport (GO:0043270)	249	11	4.15	+	2.65	3.22E-03	1.72E-01
negative regulation of small GTPase mediated signal transduction (GO:0051058)	68	3	1.13	+	2.65	1.05E-01	9.98E-01
purine ribonucleoside diphosphate metabolic process (GO:0009179)	68	3	1.13	+	2.65	1.05E-01	9.97E-01
purine nucleoside diphosphate metabolic process (GO:0009135)	68	3	1.13	+	2.65	1.05E-01	9.97E-01
regulation of striated muscle cell apoptotic process (GO:0010662)	68	3	1.13	+	2.65	1.05E-01	9.96E-01
cellular response to glucose stimulus (GO:0071333)	91	4	1.52	+	2.64	6.58E-02	8.09E-01
cell activation involved in immune response (GO:0002263)	228	10	3.80	+	2.63	5.11E-03	2.41E-01
coagulation (GO:0050817)	137	6	2.28	+	2.63	2.75E-02	5.82E-01
blood coagulation (GO:0007596)	137	6	2.28	+	2.63	2.75E-02	5.82E-01
import across plasma membrane (GO:0098739)	160	7	2.67	+	2.62	1.80E-02	4.51E-01
learning (GO:0007612)	206	9	3.43	+	2.62	7.91E-03	3.10E-01
regulation of peptide hormone secretion (GO:0090276)	275	12	4.58	+	2.62	2.36E-03	1.40E-01
regulation of adenylate cyclase activity (GO:0045761)	23	1	.38	+	2.61	3.21E-01	1.00E00
hyperosmotic response (GO:0006972)	23	1	.38	+	2.61	3.21E-01	1.00E00
adrenergic receptor signaling pathway (GO:0071875)	23	1	.38	+	2.61	3.21E-01	1.00E00
cell migration in hindbrain (GO:0021535)	23	1	.38	+	2.61	3.21E-01	1.00E00
negative regulation of glial cell proliferation (GO:0060253)	23	1	.38	+	2.61	3.21E-01	1.00E00
maternal placenta development (GO:0001893)	46	2	.77	+	2.61	1.79E-01	1.00E00
biological phase (GO:0044848)	46	2	.77	+	2.61	1.79E-01	1.00E00
modulation by host of viral genome replication (GO:0044827)	23	1	.38	+	2.61	3.21E-01	1.00E00
prostaglandin biosynthetic process (GO:0001516)	23	1	.38	+	2.61	3.21E-01	1.00E00
positive regulation of cytokinesis (GO:0032467)	46	2	.77	+	2.61	1.79E-01	1.00E00
embryonic brain development (GO:1990403)	23	1	.38	+	2.61	3.21E-01	1.00E00
positive regulation of chondrocyte differentiation (GO:0032332)	23	1	.38	+	2.61	3.21E-01	1.00E00
stress-activated MAPK cascade (GO:0051403)	23	1	.38	+	2.61	3.21E-01	1.00E00
detection of mechanical stimulus (GO:0050982)	69	3	1.15	+	2.61	1.08E-01	1.00E00
sodium ion import across plasma membrane (GO:0098719)	23	1	.38	+	2.61	3.21E-01	1.00E00
calcium ion import across plasma membrane (GO:0098703)	23	1	.38	+	2.61	3.21E-01	1.00E00
synaptic vesicle recycling (GO:0036465)	69	3	1.15	+	2.61	1.08E-01	1.00E00
regulation of ARF protein signal transduction (GO:0032012)	23	1	.38	+	2.61	3.21E-01	1.00E00
regulation of defense response to virus by host (GO:0050691)	46	2	.77	+	2.61	1.79E-01	1.00E00
lymphocyte apoptotic process (GO:0070227)	46	2	.77	+	2.61	1.79E-01	1.00E00
amyloid precursor protein metabolic process (GO:0042982)	23	1	.38	+	2.61	3.21E-01	1.00E00
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707)	46	2	.77	+	2.61	1.79E-01	1.00E00
positive regulation of cyclase activity (GO:0031281)	23	1	.38	+	2.61	3.21E-01	1.00E00
maintenance of blood-brain barrier (GO:0035633)	23	1	.38	+	2.61	3.21E-01	1.00E00
biomineral tissue development (GO:0031214)	115	5	1.92	+	2.61	4.36E-02	7.21E-01
receptor metabolic process (GO:0043112)	46	2	.77	+	2.61	1.79E-01	1.00E00
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338)	23	1	.38	+	2.61	3.21E-01	1.00E00
cyclic nucleotide biosynthetic process (GO:0009190)	23	1	.38	+	2.61	3.21E-01	1.00E00
negative regulation of hippo signaling (GO:0035331)	23	1	.38	+	2.61	3.21E-01	1.00E00
regulation of odontogenesis (GO:0042481)	23	1	.38	+	2.61	3.21E-01	1.00E00
regulation of complement activation (GO:0030449)	23	1	.38	+	2.61	3.21E-01	1.00E00
negative regulation of TORC1 signaling (GO:1904262)	46	2	.77	+	2.61	1.79E-01	1.00E00
synaptic vesicle priming (GO:0016082)	23	1	.38	+	2.61	3.21E-01	1.00E00
hindlimb morphogenesis (GO:0035137)	46	2	.77	+	2.61	1.79E-01	1.00E00
regulation of ketone biosynthetic process (GO:0010566)	23	1	.38	+	2.61	3.21E-01	1.00E00
prostanoid biosynthetic process (GO:0046457)	23	1	.38	+	2.61	3.21E-01	1.00E00
positive regulation of calcium ion-dependent exocytosis (GO:0045956)	23	1	.38	+	2.61	3.21E-01	1.00E00
negative regulation of reactive oxygen species biosynthetic process (GO:1903427)	23	1	.38	+	2.61	3.21E-01	1.00E00
monosaccharide catabolic process (GO:0046365)	46	2	.77	+	2.61	1.79E-01	1.00E00
cardiac left ventricle morphogenesis (GO:0003214)	23	1	.38	+	2.61	3.21E-01	1.00E00
cell junction maintenance (GO:0034331)	69	3	1.15	+	2.61	1.08E-01	1.00E00
positive regulation of muscle hypertrophy (GO:0014742)	46	2	.77	+	2.61	1.79E-01	1.00E00
regulation of natural killer cell mediated immunity (GO:0002715)	69	3	1.15	+	2.61	1.08E-01	1.00E00
negative regulation of GTPase activity (GO:0034260)	23	1	.38	+	2.61	3.21E-01	1.00E00
positive regulation of cellular extravasation (GO:0002693)	23	1	.38	+	2.61	3.21E-01	1.00E00
regulation of cell projection organization (GO:0031344)	785	34	13.09	+	2.60	4.19E-07	1.54E-04
negative regulation of cell migration (GO:0030336)	324	14	5.40	+	2.59	1.16E-03	8.52E-02
regulation of systemic arterial blood pressure (GO:0003073)	139	6	2.32	+	2.59	2.92E-02	5.99E-01
negative regulation of protein localization (GO:1903828)	255	11	4.25	+	2.59	3.85E-03	1.96E-01
negative regulation of lipid metabolic process (GO:0045833)	116	5	1.93	+	2.59	4.49E-02	7.42E-01
negative regulation of neuron differentiation (GO:0045665)	93	4	1.55	+	2.58	7.01E-02	8.51E-01
regulation of vasoconstriction (GO:0019229)	93	4	1.55	+	2.58	7.01E-02	8.50E-01
stem cell development (GO:0048864)	93	4	1.55	+	2.58	7.01E-02	8.49E-01
regulation of cellular response to insulin stimulus (GO:1900076)	93	4	1.55	+	2.58	7.01E-02	8.49E-01
cell surface receptor protein tyrosine kinase signaling pathway (GO:0007169)	419	18	6.98	+	2.58	2.59E-04	2.72E-02
negative regulation of blood pressure (GO:0045776)	70	3	1.17	+	2.57	1.12E-01	1.00E00
cerebellar cortex development (GO:0021695)	70	3	1.17	+	2.57	1.12E-01	1.00E00
negative regulation of tumor necrosis factor production (GO:0032720)	70	3	1.17	+	2.57	1.12E-01	1.00E00
cellular response to glucocorticoid stimulus (GO:0071385)	70	3	1.17	+	2.57	1.12E-01	1.00E00
negative regulation of TOR signaling (GO:0032007)	70	3	1.17	+	2.57	1.12E-01	1.00E00
hemostasis (GO:0007599)	140	6	2.33	+	2.57	3.01E-02	6.14E-01
artery development (GO:0060840)	117	5	1.95	+	2.56	4.63E-02	7.64E-01
ventricular septum morphogenesis (GO:0060412)	47	2	.78	+	2.55	1.85E-01	1.00E00
epidermal growth factor receptor signaling pathway (GO:0007173)	94	4	1.57	+	2.55	7.23E-02	8.70E-01
cellular response to hexose stimulus (GO:0071331)	94	4	1.57	+	2.55	7.23E-02	8.70E-01
oligosaccharide metabolic process (GO:0009311)	47	2	.78	+	2.55	1.85E-01	1.00E00
myelination (GO:0042552)	141	6	2.35	+	2.55	3.10E-02	6.28E-01
sphingolipid biosynthetic process (GO:0030148)	94	4	1.57	+	2.55	7.23E-02	8.69E-01
negative regulation of protein modification by small protein conjugation or removal (GO:1903321)	94	4	1.57	+	2.55	7.23E-02	8.68E-01
regulation of synaptic plasticity (GO:0048167)	259	11	4.32	+	2.55	4.32E-03	2.11E-01
regulation of neuron differentiation (GO:0045664)	236	10	3.93	+	2.54	6.47E-03	2.79E-01
regulation of muscle cell apoptotic process (GO:0010660)	118	5	1.97	+	2.54	4.78E-02	7.73E-01
cell surface receptor signaling pathway via STAT (GO:0097696)	71	3	1.18	+	2.53	1.15E-01	1.00E00
bone mineralization (GO:0030282)	71	3	1.18	+	2.53	1.15E-01	1.00E00
viral life cycle (GO:0019058)	119	5	1.98	+	2.52	4.92E-02	7.13E-01
ensheathment of neurons (GO:0007272)	144	6	2.40	+	2.50	3.39E-02	6.13E-01
positive regulation of neural precursor cell proliferation (GO:2000179)	72	3	1.20	+	2.50	1.19E-01	1.00E00
endocrine system development (GO:0035270)	144	6	2.40	+	2.50	3.39E-02	6.12E-01
axon ensheathment (GO:0008366)	144	6	2.40	+	2.50	3.39E-02	6.11E-01
extracellular matrix organization (GO:0030198)	288	12	4.80	+	2.50	3.43E-03	1.80E-01
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)	72	3	1.20	+	2.50	1.19E-01	1.00E00
regulation of protein maturation (GO:1903317)	72	3	1.20	+	2.50	1.19E-01	1.00E00
cerebellar cortex morphogenesis (GO:0021696)	48	2	.80	+	2.50	1.91E-01	1.00E00
calcium ion import into cytosol (GO:1902656)	24	1	.40	+	2.50	3.32E-01	1.00E00
head morphogenesis (GO:0060323)	48	2	.80	+	2.50	1.91E-01	1.00E00
positive regulation of neuron migration (GO:2001224)	24	1	.40	+	2.50	3.32E-01	1.00E00
nitric oxide mediated signal transduction (GO:0007263)	24	1	.40	+	2.50	3.32E-01	1.00E00
glycolipid metabolic process (GO:0006664)	96	4	1.60	+	2.50	7.68E-02	9.10E-01
centriole replication (GO:0007099)	24	1	.40	+	2.50	3.32E-01	1.00E00
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	24	1	.40	+	2.50	3.32E-01	1.00E00
suppression of viral release by host (GO:0044790)	24	1	.40	+	2.50	3.32E-01	1.00E00
cellular response to monosaccharide stimulus (GO:0071326)	96	4	1.60	+	2.50	7.68E-02	9.10E-01
nucleotide transmembrane transport (GO:1901679)	24	1	.40	+	2.50	3.32E-01	1.00E00
negative regulation of myeloid cell apoptotic process (GO:0033033)	24	1	.40	+	2.50	3.32E-01	1.00E00
peptidyl-glutamic acid modification (GO:0018200)	24	1	.40	+	2.50	3.32E-01	1.00E00
positive regulation of icosanoid secretion (GO:0032305)	24	1	.40	+	2.50	3.32E-01	1.00E00
postsynaptic actin cytoskeleton organization (GO:0098974)	24	1	.40	+	2.50	3.32E-01	1.00E00
neurotransmitter receptor transport to plasma membrane (GO:0098877)	24	1	.40	+	2.50	3.32E-01	1.00E00
positive regulation of lyase activity (GO:0051349)	24	1	.40	+	2.50	3.32E-01	1.00E00
poly(A)+ mRNA export from nucleus (GO:0016973)	24	1	.40	+	2.50	3.32E-01	1.00E00
sympathetic nervous system development (GO:0048485)	24	1	.40	+	2.50	3.32E-01	1.00E00
response to muscle stretch (GO:0035994)	24	1	.40	+	2.50	3.32E-01	1.00E00
negative regulation of mRNA processing (GO:0050686)	24	1	.40	+	2.50	3.32E-01	1.00E00
negative regulation of lymphocyte proliferation (GO:0050672)	96	4	1.60	+	2.50	7.68E-02	9.09E-01
postsynapse assembly (GO:0099068)	24	1	.40	+	2.50	3.32E-01	1.00E00
modification of postsynaptic structure (GO:0099010)	24	1	.40	+	2.50	3.32E-01	1.00E00
midbrain development (GO:0030901)	48	2	.80	+	2.50	1.91E-01	1.00E00
erythrocyte maturation (GO:0043249)	24	1	.40	+	2.50	3.32E-01	1.00E00
negative regulation of mRNA splicing, via spliceosome (GO:0048025)	24	1	.40	+	2.50	3.32E-01	1.00E00
purinergic nucleotide receptor signaling pathway (GO:0035590)	24	1	.40	+	2.50	3.32E-01	1.00E00
myeloid dendritic cell differentiation (GO:0043011)	24	1	.40	+	2.50	3.32E-01	1.00E00
phosphatidylinositol phosphate biosynthetic process (GO:0046854)	48	2	.80	+	2.50	1.91E-01	1.00E00
regulation of sprouting angiogenesis (GO:1903670)	48	2	.80	+	2.50	1.91E-01	1.00E00
tooth mineralization (GO:0034505)	24	1	.40	+	2.50	3.32E-01	1.00E00
regulation of phospholipase activity (GO:0010517)	24	1	.40	+	2.50	3.32E-01	1.00E00
execution phase of apoptosis (GO:0097194)	48	2	.80	+	2.50	1.91E-01	1.00E00
regulation of catecholamine metabolic process (GO:0042069)	24	1	.40	+	2.50	3.32E-01	1.00E00
ammonium ion metabolic process (GO:0097164)	24	1	.40	+	2.50	3.32E-01	1.00E00
GABAergic neuron differentiation (GO:0097154)	24	1	.40	+	2.50	3.32E-01	1.00E00
atrial septum development (GO:0003283)	24	1	.40	+	2.50	3.32E-01	1.00E00
dorsal/ventral neural tube patterning (GO:0021904)	24	1	.40	+	2.50	3.32E-01	1.00E00
response to thyroid hormone (GO:0097066)	24	1	.40	+	2.50	3.32E-01	1.00E00
positive regulation of membrane potential (GO:0045838)	24	1	.40	+	2.50	3.32E-01	1.00E00
seminiferous tubule development (GO:0072520)	24	1	.40	+	2.50	3.32E-01	1.00E00
regulation of necroptotic process (GO:0060544)	24	1	.40	+	2.50	3.32E-01	1.00E00
external encapsulating structure organization (GO:0045229)	289	12	4.82	+	2.49	3.53E-03	1.84E-01
plasma membrane bounded cell projection organization (GO:0120036)	1280	53	21.34	+	2.48	1.09E-09	1.29E-06
neuron apoptotic process (GO:0051402)	145	6	2.42	+	2.48	3.49E-02	6.26E-01
extracellular structure organization (GO:0043062)	290	12	4.83	+	2.48	3.62E-03	1.87E-01
cerebral cortex development (GO:0021987)	145	6	2.42	+	2.48	3.49E-02	6.25E-01
calcium ion transport (GO:0006816)	266	11	4.43	+	2.48	5.27E-03	2.44E-01
hair cycle (GO:0042633)	121	5	2.02	+	2.48	5.22E-02	7.38E-01
molting cycle (GO:0042303)	121	5	2.02	+	2.48	5.22E-02	7.37E-01
cellular response to alcohol (GO:0097306)	121	5	2.02	+	2.48	5.22E-02	7.36E-01
protein dephosphorylation (GO:0006470)	97	4	1.62	+	2.47	7.91E-02	9.23E-01
protein K48-linked ubiquitination (GO:0070936)	97	4	1.62	+	2.47	7.91E-02	9.22E-01
dorsal/ventral pattern formation (GO:0009953)	97	4	1.62	+	2.47	7.91E-02	9.21E-01
positive regulation of axonogenesis (GO:0050772)	97	4	1.62	+	2.47	7.91E-02	9.21E-01
calcium ion transmembrane import into cytosol (GO:0097553)	97	4	1.62	+	2.47	7.91E-02	9.20E-01
liposaccharide metabolic process (GO:1903509)	97	4	1.62	+	2.47	7.91E-02	9.19E-01
biological process involved in intraspecies interaction between organisms (GO:0051703)	73	3	1.22	+	2.47	1.22E-01	1.00E00
exocytic process (GO:0140029)	73	3	1.22	+	2.47	1.22E-01	1.00E00
social behavior (GO:0035176)	73	3	1.22	+	2.47	1.22E-01	1.00E00
regulation of myeloid leukocyte mediated immunity (GO:0002886)	73	3	1.22	+	2.47	1.22E-01	1.00E00
developmental growth (GO:0048589)	560	23	9.34	+	2.46	7.38E-05	1.02E-02
regulation of cell adhesion (GO:0030155)	829	34	13.82	+	2.46	2.10E-06	5.59E-04
positive regulation of smooth muscle cell proliferation (GO:0048661)	122	5	2.03	+	2.46	5.37E-02	7.52E-01
regulation of monoatomic ion transmembrane transport (GO:0034765)	366	15	6.10	+	2.46	1.33E-03	9.18E-02
cell morphogenesis (GO:0000902)	806	33	13.44	+	2.46	3.14E-06	7.68E-04
regulation of interleukin-6 production (GO:0032675)	171	7	2.85	+	2.46	2.49E-02	5.50E-01
regulation of nervous system process (GO:0031644)	171	7	2.85	+	2.46	2.49E-02	5.49E-01
production of molecular mediator of immune response (GO:0002440)	147	6	2.45	+	2.45	3.69E-02	6.48E-01
negative regulation of mononuclear cell proliferation (GO:0032945)	98	4	1.63	+	2.45	8.14E-02	8.94E-01
regulation of natural killer cell activation (GO:0032814)	49	2	.82	+	2.45	1.97E-01	1.00E00
regulation of synapse organization (GO:0050807)	392	16	6.53	+	2.45	9.69E-04	7.66E-02
regulation of macrophage migration (GO:1905521)	49	2	.82	+	2.45	1.97E-01	1.00E00
response to carbohydrate (GO:0009743)	196	8	3.27	+	2.45	1.74E-02	4.38E-01
substrate adhesion-dependent cell spreading (GO:0034446)	49	2	.82	+	2.45	1.97E-01	1.00E00
cell differentiation involved in kidney development (GO:0061005)	49	2	.82	+	2.45	1.97E-01	1.00E00
regulation of cell-cell adhesion (GO:0022407)	515	21	8.58	+	2.45	1.67E-04	1.96E-02
neurogenesis (GO:0022008)	1546	63	25.77	+	2.44	3.41E-11	7.50E-08
regulation of protein localization to plasma membrane (GO:1903076)	123	5	2.05	+	2.44	5.52E-02	7.70E-01
growth (GO:0040007)	566	23	9.44	+	2.44	8.66E-05	1.13E-02
positive regulation of receptor signaling pathway via STAT (GO:1904894)	74	3	1.23	+	2.43	1.26E-01	1.00E00
vascular endothelial growth factor receptor signaling pathway (GO:0048010)	74	3	1.23	+	2.43	1.26E-01	1.00E00
cellular response to nitrogen compound (GO:1901699)	668	27	11.14	+	2.42	3.43E-05	5.45E-03
negative regulation of post-translational protein modification (GO:1901874)	99	4	1.65	+	2.42	8.38E-02	9.07E-01
neural crest cell differentiation (GO:0014033)	99	4	1.65	+	2.42	8.38E-02	9.06E-01
peptidyl-tyrosine phosphorylation (GO:0018108)	99	4	1.65	+	2.42	8.38E-02	9.06E-01
regulation of hormone secretion (GO:0046883)	347	14	5.78	+	2.42	2.20E-03	1.34E-01
peptidyl-serine modification (GO:0018209)	124	5	2.07	+	2.42	5.68E-02	7.72E-01
regulation of leukocyte migration (GO:0002685)	248	10	4.13	+	2.42	9.03E-03	3.38E-01
actin filament organization (GO:0007015)	273	11	4.55	+	2.42	6.36E-03	2.75E-01
negative regulation of response to external stimulus (GO:0032102)	422	17	7.03	+	2.42	7.86E-04	6.73E-02
inorganic cation transmembrane transport (GO:0098662)	623	25	10.39	+	2.41	7.67E-05	1.05E-02
cerebellar Purkinje cell layer morphogenesis (GO:0021692)	25	1	.42	+	2.40	3.43E-01	1.00E00
positive regulation of regulatory T cell differentiation (GO:0045591)	25	1	.42	+	2.40	3.43E-01	1.00E00
negative regulation of stem cell population maintenance (GO:1902455)	25	1	.42	+	2.40	3.43E-01	1.00E00
regulation of skeletal muscle cell differentiation (GO:2001014)	25	1	.42	+	2.40	3.43E-01	1.00E00
auditory receptor cell stereocilium organization (GO:0060088)	25	1	.42	+	2.40	3.43E-01	1.00E00
genomic imprinting (GO:0071514)	25	1	.42	+	2.40	3.43E-01	1.00E00
regulation of sensory perception of pain (GO:0051930)	25	1	.42	+	2.40	3.43E-01	1.00E00
cell-cell junction maintenance (GO:0045217)	25	1	.42	+	2.40	3.43E-01	1.00E00
regulation of myoblast fusion (GO:1901739)	25	1	.42	+	2.40	3.43E-01	1.00E00
regulation of hepatocyte proliferation (GO:2000345)	25	1	.42	+	2.40	3.43E-01	1.00E00
negative regulation of organelle assembly (GO:1902116)	50	2	.83	+	2.40	2.03E-01	1.00E00
positive regulation of embryonic development (GO:0040019)	25	1	.42	+	2.40	3.43E-01	1.00E00
type B pancreatic cell proliferation (GO:0044342)	25	1	.42	+	2.40	3.43E-01	1.00E00
negative regulation of double-strand break repair via homologous recombination (GO:2000042)	25	1	.42	+	2.40	3.43E-01	1.00E00
response to leptin (GO:0044321)	25	1	.42	+	2.40	3.43E-01	1.00E00
positive regulation of protein localization to cell surface (GO:2000010)	25	1	.42	+	2.40	3.43E-01	1.00E00
negative regulation of potassium ion transmembrane transport (GO:1901380)	25	1	.42	+	2.40	3.43E-01	1.00E00
detection of light stimulus involved in sensory perception (GO:0050962)	25	1	.42	+	2.40	3.43E-01	1.00E00
detection of light stimulus involved in visual perception (GO:0050908)	25	1	.42	+	2.40	3.43E-01	1.00E00
regulation of vascular endothelial growth factor signaling pathway (GO:1900746)	25	1	.42	+	2.40	3.43E-01	1.00E00
regulation of synapse structure or activity (GO:0050803)	400	16	6.67	+	2.40	1.20E-03	8.61E-02
negative regulation of nervous system process (GO:0031645)	25	1	.42	+	2.40	3.43E-01	1.00E00
autonomic nervous system development (GO:0048483)	50	2	.83	+	2.40	2.03E-01	1.00E00
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567)	25	1	.42	+	2.40	3.43E-01	1.00E00
mitotic G1 DNA damage checkpoint signaling (GO:0031571)	25	1	.42	+	2.40	3.43E-01	1.00E00
regulation of purine nucleotide metabolic process (GO:1900542)	100	4	1.67	+	2.40	8.62E-02	9.28E-01
vesicle targeting, to, from or within Golgi (GO:0048199)	25	1	.42	+	2.40	3.43E-01	1.00E00
response to stilbenoid (GO:0035634)	25	1	.42	+	2.40	3.43E-01	1.00E00
somatic diversification of immunoglobulins (GO:0016445)	50	2	.83	+	2.40	2.03E-01	1.00E00
chloride ion homeostasis (GO:0055064)	25	1	.42	+	2.40	3.43E-01	1.00E00
ATP transport (GO:0015867)	25	1	.42	+	2.40	3.43E-01	1.00E00
nucleoside monophosphate catabolic process (GO:0009125)	25	1	.42	+	2.40	3.43E-01	1.00E00
positive regulation of viral life cycle (GO:1903902)	25	1	.42	+	2.40	3.43E-01	1.00E00
maturation of SSU-rRNA (GO:0030490)	50	2	.83	+	2.40	2.03E-01	1.00E00
indole-containing compound metabolic process (GO:0042430)	25	1	.42	+	2.40	3.43E-01	1.00E00
regulation of macrophage derived foam cell differentiation (GO:0010743)	25	1	.42	+	2.40	3.43E-01	1.00E00
determination of adult lifespan (GO:0008340)	50	2	.83	+	2.40	2.03E-01	1.00E00
positive regulation of epithelial cell apoptotic process (GO:1904037)	25	1	.42	+	2.40	3.43E-01	1.00E00
cell surface pattern recognition receptor signaling pathway (GO:0002752)	50	2	.83	+	2.40	2.03E-01	1.00E00
response to estradiol (GO:0032355)	125	5	2.08	+	2.40	5.84E-02	7.90E-01
metal ion transport (GO:0030001)	653	26	10.89	+	2.39	5.67E-05	8.33E-03
protein-RNA complex assembly (GO:0022618)	176	7	2.93	+	2.39	2.85E-02	5.91E-01
regulation of mononuclear cell migration (GO:0071675)	151	6	2.52	+	2.38	4.12E-02	6.98E-01
cell projection organization (GO:0030030)	1334	53	22.24	+	2.38	5.83E-09	4.72E-06
response to ketone (GO:1901654)	252	10	4.20	+	2.38	1.00E-02	3.56E-01
alcohol biosynthetic process (GO:0046165)	101	4	1.68	+	2.38	8.87E-02	9.48E-01
ureteric bud development (GO:0001657)	101	4	1.68	+	2.38	8.87E-02	9.48E-01
regulation of nucleotide metabolic process (GO:0006140)	101	4	1.68	+	2.38	8.87E-02	9.47E-01
glucose homeostasis (GO:0042593)	253	10	4.22	+	2.37	1.03E-02	3.59E-01
monoatomic cation transmembrane transport (GO:0098655)	633	25	10.55	+	2.37	8.80E-05	1.14E-02
regulation of nitric oxide biosynthetic process (GO:0045428)	76	3	1.27	+	2.37	1.34E-01	1.00E00
multicellular organism growth (GO:0035264)	152	6	2.53	+	2.37	4.23E-02	7.13E-01
somatic stem cell population maintenance (GO:0035019)	76	3	1.27	+	2.37	1.34E-01	1.00E00
positive regulation of cell projection organization (GO:0031346)	456	18	7.60	+	2.37	1.14E-03	8.37E-02
positive regulation of T cell differentiation (GO:0045582)	127	5	2.12	+	2.36	6.17E-02	8.16E-01
carbohydrate homeostasis (GO:0033500)	254	10	4.23	+	2.36	1.06E-02	3.64E-01
regulation of circadian rhythm (GO:0042752)	127	5	2.12	+	2.36	6.17E-02	8.15E-01
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	280	11	4.67	+	2.36	7.63E-03	3.02E-01
lung epithelium development (GO:0060428)	51	2	.85	+	2.35	2.09E-01	1.00E00
positive regulation of myoblast differentiation (GO:0045663)	51	2	.85	+	2.35	2.09E-01	1.00E00
regulation of endothelial cell proliferation (GO:0001936)	153	6	2.55	+	2.35	4.34E-02	7.23E-01
mesonephric tubule development (GO:0072164)	102	4	1.70	+	2.35	9.11E-02	9.63E-01
mesonephric epithelium development (GO:0072163)	102	4	1.70	+	2.35	9.11E-02	9.63E-01
catecholamine metabolic process (GO:0006584)	51	2	.85	+	2.35	2.09E-01	1.00E00
DNA-templated transcription elongation (GO:0006354)	51	2	.85	+	2.35	2.09E-01	1.00E00
catechol-containing compound metabolic process (GO:0009712)	51	2	.85	+	2.35	2.09E-01	1.00E00
regulation of cell killing (GO:0031341)	153	6	2.55	+	2.35	4.34E-02	7.22E-01
regulation of fibroblast migration (GO:0010762)	51	2	.85	+	2.35	2.09E-01	1.00E00
negative regulation of alpha-beta T cell activation (GO:0046636)	51	2	.85	+	2.35	2.09E-01	1.00E00
artery morphogenesis (GO:0048844)	77	3	1.28	+	2.34	1.37E-01	1.00E00
positive regulation of nucleocytoplasmic transport (GO:0046824)	77	3	1.28	+	2.34	1.37E-01	1.00E00
positive regulation of myeloid leukocyte differentiation (GO:0002763)	77	3	1.28	+	2.34	1.37E-01	1.00E00
cellular response to type II interferon (GO:0071346)	103	4	1.72	+	2.33	9.36E-02	9.78E-01
peptidyl-tyrosine modification (GO:0018212)	103	4	1.72	+	2.33	9.36E-02	9.78E-01
oligodendrocyte differentiation (GO:0048709)	103	4	1.72	+	2.33	9.36E-02	9.77E-01
positive regulation of neuron projection development (GO:0010976)	233	9	3.88	+	2.32	1.66E-02	4.79E-01
epoxygenase P450 pathway (GO:0019373)	26	1	.43	+	2.31	3.54E-01	1.00E00
positive regulation of nitric oxide biosynthetic process (GO:0045429)	52	2	.87	+	2.31	2.15E-01	1.00E00
inner ear receptor cell stereocilium organization (GO:0060122)	52	2	.87	+	2.31	2.15E-01	1.00E00
viral release from host cell (GO:0019076)	26	1	.43	+	2.31	3.54E-01	1.00E00
organ induction (GO:0001759)	26	1	.43	+	2.31	3.54E-01	1.00E00
mitotic G1/S transition checkpoint signaling (GO:0044819)	26	1	.43	+	2.31	3.54E-01	1.00E00
positive regulation of sodium ion transmembrane transport (GO:1902307)	26	1	.43	+	2.31	3.54E-01	1.00E00
regulation of sensory perception (GO:0051931)	26	1	.43	+	2.31	3.54E-01	1.00E00
positive regulation of muscle tissue development (GO:1901863)	26	1	.43	+	2.31	3.54E-01	1.00E00
regulation of protein sumoylation (GO:0033233)	26	1	.43	+	2.31	3.54E-01	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)	26	1	.43	+	2.31	3.54E-01	1.00E00
negative regulation of peptidyl-serine phosphorylation (GO:0033137)	26	1	.43	+	2.31	3.54E-01	1.00E00
protein palmitoylation (GO:0018345)	26	1	.43	+	2.31	3.54E-01	1.00E00
cellular response to dsRNA (GO:0071359)	26	1	.43	+	2.31	3.54E-01	1.00E00
thymic T cell selection (GO:0045061)	26	1	.43	+	2.31	3.54E-01	1.00E00
mitotic spindle assembly (GO:0090307)	52	2	.87	+	2.31	2.15E-01	1.00E00
negative regulation of leukocyte proliferation (GO:0070664)	104	4	1.73	+	2.31	9.62E-02	9.44E-01
positive regulation of lipid transport (GO:0032370)	104	4	1.73	+	2.31	9.62E-02	9.43E-01
maintenance of protein location in nucleus (GO:0051457)	26	1	.43	+	2.31	3.54E-01	1.00E00
positive regulation of muscle organ development (GO:0048636)	26	1	.43	+	2.31	3.54E-01	1.00E00
macrophage migration (GO:1905517)	26	1	.43	+	2.31	3.54E-01	1.00E00
exit from host cell (GO:0035891)	26	1	.43	+	2.31	3.54E-01	1.00E00
regulation of membrane protein ectodomain proteolysis (GO:0051043)	26	1	.43	+	2.31	3.54E-01	1.00E00
response to increased oxygen levels (GO:0036296)	26	1	.43	+	2.31	3.54E-01	1.00E00
positive regulation of vascular associated smooth muscle cell migration (GO:1904754)	26	1	.43	+	2.31	3.54E-01	1.00E00
positive regulation of fibroblast proliferation (GO:0048146)	78	3	1.30	+	2.31	1.41E-01	1.00E00
protein autoprocessing (GO:0016540)	26	1	.43	+	2.31	3.54E-01	1.00E00
cardiac muscle tissue growth (GO:0055017)	52	2	.87	+	2.31	2.15E-01	1.00E00
nucleoside metabolic process (GO:0009116)	52	2	.87	+	2.31	2.15E-01	1.00E00
negative regulation of protein processing (GO:0010955)	26	1	.43	+	2.31	3.54E-01	1.00E00
apoptotic mitochondrial changes (GO:0008637)	78	3	1.30	+	2.31	1.41E-01	1.00E00
visual learning (GO:0008542)	78	3	1.30	+	2.31	1.41E-01	1.00E00
negative regulation of D-glucose transmembrane transport (GO:0010829)	26	1	.43	+	2.31	3.54E-01	1.00E00
regulation of establishment of protein localization to mitochondrion (GO:1903747)	26	1	.43	+	2.31	3.54E-01	1.00E00
monocyte differentiation (GO:0030224)	26	1	.43	+	2.31	3.54E-01	1.00E00
associative learning (GO:0008306)	130	5	2.17	+	2.31	6.68E-02	8.16E-01
metanephros morphogenesis (GO:0003338)	26	1	.43	+	2.31	3.54E-01	1.00E00
T cell proliferation (GO:0042098)	104	4	1.73	+	2.31	9.62E-02	9.43E-01
T-helper 1 type immune response (GO:0042088)	26	1	.43	+	2.31	3.54E-01	1.00E00
positive regulation of amyloid precursor protein catabolic process (GO:1902993)	26	1	.43	+	2.31	3.54E-01	1.00E00
positive regulation of protein tyrosine kinase activity (GO:0061098)	26	1	.43	+	2.31	3.54E-01	1.00E00
positive regulation of T cell cytokine production (GO:0002726)	26	1	.43	+	2.31	3.54E-01	1.00E00
positive regulation of striated muscle tissue development (GO:0045844)	26	1	.43	+	2.31	3.54E-01	1.00E00
negative regulation of protein maturation (GO:1903318)	26	1	.43	+	2.31	3.54E-01	1.00E00
regulation of vesicle-mediated transport (GO:0060627)	625	24	10.42	+	2.30	1.68E-04	1.96E-02
regulation of synapse assembly (GO:0051963)	209	8	3.48	+	2.30	2.44E-02	5.40E-01
single fertilization (GO:0007338)	183	7	3.05	+	2.29	3.42E-02	6.16E-01
kidney epithelium development (GO:0072073)	157	6	2.62	+	2.29	4.82E-02	7.79E-01
response to glucose (GO:0009749)	157	6	2.62	+	2.29	4.82E-02	7.78E-01
glycosylation (GO:0070085)	236	9	3.93	+	2.29	1.79E-02	4.49E-01
telencephalon development (GO:0021537)	315	12	5.25	+	2.29	6.91E-03	2.90E-01
mesonephros development (GO:0001823)	105	4	1.75	+	2.29	9.87E-02	9.61E-01
response to wounding (GO:0009611)	421	16	7.02	+	2.28	2.80E-03	1.56E-01
immunoglobulin production (GO:0002377)	79	3	1.32	+	2.28	1.45E-01	1.00E00
cellular response to corticosteroid stimulus (GO:0071384)	79	3	1.32	+	2.28	1.45E-01	1.00E00
regulation of epithelial cell migration (GO:0010632)	79	3	1.32	+	2.28	1.45E-01	1.00E00
regulation of nitric oxide metabolic process (GO:0080164)	79	3	1.32	+	2.28	1.45E-01	1.00E00
wound healing (GO:0042060)	290	11	4.83	+	2.28	9.78E-03	3.52E-01
membrane lipid biosynthetic process (GO:0046467)	132	5	2.20	+	2.27	7.03E-02	8.50E-01
regulation of wound healing (GO:0061041)	132	5	2.20	+	2.27	7.03E-02	8.49E-01
protein-RNA complex organization (GO:0071826)	185	7	3.08	+	2.27	3.59E-02	6.34E-01
protein methylation (GO:0006479)	53	2	.88	+	2.26	2.21E-01	1.00E00
cellular senescence (GO:0090398)	53	2	.88	+	2.26	2.21E-01	1.00E00
erythrocyte development (GO:0048821)	53	2	.88	+	2.26	2.21E-01	1.00E00
regulation of hormone metabolic process (GO:0032350)	53	2	.88	+	2.26	2.21E-01	1.00E00
camera-type eye morphogenesis (GO:0048593)	159	6	2.65	+	2.26	5.07E-02	7.30E-01
regulation of T cell receptor signaling pathway (GO:0050856)	53	2	.88	+	2.26	2.21E-01	1.00E00
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774)	53	2	.88	+	2.26	2.21E-01	1.00E00
MAPK cascade (GO:0000165)	212	8	3.53	+	2.26	2.63E-02	5.62E-01
organophosphate ester transport (GO:0015748)	159	6	2.65	+	2.26	5.07E-02	7.30E-01
protein alkylation (GO:0008213)	53	2	.88	+	2.26	2.21E-01	1.00E00
positive regulation of vasoconstriction (GO:0045907)	53	2	.88	+	2.26	2.21E-01	1.00E00
regulation of protein tyrosine kinase activity (GO:0061097)	53	2	.88	+	2.26	2.21E-01	1.00E00
positive regulation of secretion by cell (GO:1903532)	398	15	6.63	+	2.26	4.14E-03	2.04E-01
glycerolipid metabolic process (GO:0046486)	345	13	5.75	+	2.26	8.40E-03	3.26E-01
intracellular signaling cassette (GO:0141124)	824	31	13.74	+	2.26	3.46E-05	5.38E-03
ribonucleoside diphosphate metabolic process (GO:0009185)	80	3	1.33	+	2.25	1.49E-01	1.00E00
negative regulation of leukocyte mediated immunity (GO:0002704)	80	3	1.33	+	2.25	1.49E-01	1.00E00
regulation of locomotion (GO:0040012)	1149	43	19.15	+	2.25	6.89E-07	2.26E-04
positive regulation of exocytosis (GO:0045921)	107	4	1.78	+	2.24	1.04E-01	1.00E00
response to mechanical stimulus (GO:0009612)	241	9	4.02	+	2.24	2.02E-02	4.85E-01
cellular response to hormone stimulus (GO:0032870)	563	21	9.39	+	2.24	6.13E-04	5.43E-02
regulation of endocytosis (GO:0030100)	350	13	5.83	+	2.23	8.84E-03	3.39E-01
positive regulation of bone resorption (GO:0045780)	27	1	.45	+	2.22	3.65E-01	1.00E00
positive regulation of fatty acid biosynthetic process (GO:0045723)	27	1	.45	+	2.22	3.65E-01	1.00E00
nerve development (GO:0021675)	108	4	1.80	+	2.22	1.07E-01	1.00E00
fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342)	27	1	.45	+	2.22	3.65E-01	1.00E00
cardiac epithelial to mesenchymal transition (GO:0060317)	27	1	.45	+	2.22	3.65E-01	1.00E00
neutrophil mediated immunity (GO:0002446)	27	1	.45	+	2.22	3.65E-01	1.00E00
regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547)	27	1	.45	+	2.22	3.65E-01	1.00E00
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143)	27	1	.45	+	2.22	3.65E-01	1.00E00
positive regulation of superoxide anion generation (GO:0032930)	27	1	.45	+	2.22	3.65E-01	1.00E00
regulation of establishment or maintenance of cell polarity (GO:0032878)	27	1	.45	+	2.22	3.65E-01	1.00E00
positive regulation of interleukin-4 production (GO:0032753)	27	1	.45	+	2.22	3.65E-01	1.00E00
cellular response to pH (GO:0071467)	27	1	.45	+	2.22	3.65E-01	1.00E00
regulation of glutamate secretion (GO:0014048)	27	1	.45	+	2.22	3.65E-01	1.00E00
neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0099645)	27	1	.45	+	2.22	3.65E-01	1.00E00
protein localization to postsynaptic specialization membrane (GO:0099633)	27	1	.45	+	2.22	3.65E-01	1.00E00
regulation of presynaptic cytosolic calcium ion concentration (GO:0099509)	27	1	.45	+	2.22	3.65E-01	1.00E00
peptide cross-linking (GO:0018149)	27	1	.45	+	2.22	3.65E-01	1.00E00
mitochondrial calcium ion homeostasis (GO:0051560)	27	1	.45	+	2.22	3.65E-01	1.00E00
positive regulation of release of cytochrome c from mitochondria (GO:0090200)	27	1	.45	+	2.22	3.65E-01	1.00E00
negative regulation of T cell receptor signaling pathway (GO:0050860)	27	1	.45	+	2.22	3.65E-01	1.00E00
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857)	27	1	.45	+	2.22	3.65E-01	1.00E00
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996)	27	1	.45	+	2.22	3.65E-01	1.00E00
detection of light stimulus (GO:0009583)	54	2	.90	+	2.22	2.27E-01	1.00E00
regulation of excitatory synapse assembly (GO:1904889)	27	1	.45	+	2.22	3.65E-01	1.00E00
Rac protein signal transduction (GO:0016601)	27	1	.45	+	2.22	3.65E-01	1.00E00
positive regulation of nitric oxide metabolic process (GO:1904407)	54	2	.90	+	2.22	2.27E-01	1.00E00
C4-dicarboxylate transport (GO:0015740)	27	1	.45	+	2.22	3.65E-01	1.00E00
filopodium assembly (GO:0046847)	27	1	.45	+	2.22	3.65E-01	1.00E00
secondary palate development (GO:0062009)	27	1	.45	+	2.22	3.65E-01	1.00E00
negative regulation of keratinocyte proliferation (GO:0010839)	27	1	.45	+	2.22	3.65E-01	1.00E00
regulation of ERAD pathway (GO:1904292)	27	1	.45	+	2.22	3.65E-01	1.00E00
muscle cell cellular homeostasis (GO:0046716)	27	1	.45	+	2.22	3.65E-01	1.00E00
programmed cell death involved in cell development (GO:0010623)	27	1	.45	+	2.22	3.65E-01	1.00E00
positive regulation of Rho protein signal transduction (GO:0035025)	27	1	.45	+	2.22	3.65E-01	1.00E00
signal transduction involved in regulation of gene expression (GO:0023019)	27	1	.45	+	2.22	3.65E-01	1.00E00
positive regulation of activated T cell proliferation (GO:0042104)	27	1	.45	+	2.22	3.65E-01	1.00E00
B cell proliferation (GO:0042100)	54	2	.90	+	2.22	2.27E-01	1.00E00
amelogenesis (GO:0097186)	27	1	.45	+	2.22	3.65E-01	1.00E00
intestinal epithelial cell differentiation (GO:0060575)	27	1	.45	+	2.22	3.65E-01	1.00E00
granulocyte chemotaxis (GO:0071621)	81	3	1.35	+	2.22	1.53E-01	1.00E00
positive regulation of peptidyl-serine phosphorylation (GO:0033138)	81	3	1.35	+	2.22	1.53E-01	1.00E00
dendrite morphogenesis (GO:0048813)	81	3	1.35	+	2.22	1.53E-01	1.00E00
regulation of cytosolic calcium ion concentration (GO:0051480)	81	3	1.35	+	2.22	1.53E-01	1.00E00
positive regulation of pattern recognition receptor signaling pathway (GO:0062208)	81	3	1.35	+	2.22	1.53E-01	1.00E00
body fluid secretion (GO:0007589)	81	3	1.35	+	2.22	1.53E-01	1.00E00
regulation of cell size (GO:0008361)	217	8	3.62	+	2.21	2.96E-02	6.04E-01
response to hexose (GO:0009746)	163	6	2.72	+	2.21	5.59E-02	7.61E-01
monoatomic cation transport (GO:0006812)	789	29	13.15	+	2.20	8.47E-05	1.13E-02
kidney development (GO:0001822)	354	13	5.90	+	2.20	9.26E-03	3.38E-01
positive regulation of leukocyte differentiation (GO:1902107)	218	8	3.63	+	2.20	3.03E-02	6.16E-01
negative regulation of cellular response to growth factor stimulus (GO:0090288)	109	4	1.82	+	2.20	1.09E-01	1.00E00
positive regulation of hemopoiesis (GO:1903708)	218	8	3.63	+	2.20	3.03E-02	6.15E-01
regulation of cell migration (GO:0030334)	1037	38	17.29	+	2.20	5.24E-06	1.12E-03
nervous system development (GO:0007399)	2239	82	37.32	+	2.20	5.50E-12	2.12E-08
protein O-linked glycosylation (GO:0006493)	82	3	1.37	+	2.19	1.57E-01	1.00E00
regulation of carbohydrate catabolic process (GO:0043470)	82	3	1.37	+	2.19	1.57E-01	1.00E00
regulation of neurogenesis (GO:0050767)	466	17	7.77	+	2.19	2.63E-03	1.53E-01
angiogenesis (GO:0001525)	357	13	5.95	+	2.18	9.61E-03	3.48E-01
learning or memory (GO:0007611)	357	13	5.95	+	2.18	9.61E-03	3.47E-01
regulation of acute inflammatory response (GO:0002673)	55	2	.92	+	2.18	2.33E-01	1.00E00
cell differentiation in spinal cord (GO:0021515)	55	2	.92	+	2.18	2.33E-01	1.00E00
regulation of DNA binding (GO:0051101)	110	4	1.83	+	2.18	1.12E-01	1.00E00
secondary metabolic process (GO:0019748)	55	2	.92	+	2.18	2.33E-01	1.00E00
regulation of cell motility (GO:2000145)	1101	40	18.35	+	2.18	4.54E-06	9.99E-04
inorganic ion transmembrane transport (GO:0098660)	719	26	11.99	+	2.17	2.62E-04	2.73E-02
protein localization to synapse (GO:0035418)	83	3	1.38	+	2.17	1.61E-01	1.00E00
regulation of protein localization to cell periphery (GO:1904375)	166	6	2.77	+	2.17	6.00E-02	8.04E-01
ventricular septum development (GO:0003281)	83	3	1.38	+	2.17	1.61E-01	1.00E00
cardiac ventricle morphogenesis (GO:0003208)	83	3	1.38	+	2.17	1.61E-01	1.00E00
acylglycerol metabolic process (GO:0006639)	111	4	1.85	+	2.16	1.15E-01	1.00E00
regulation of peptidyl-serine phosphorylation (GO:0033135)	111	4	1.85	+	2.16	1.15E-01	1.00E00
amide biosynthetic process (GO:0043604)	139	5	2.32	+	2.16	8.34E-02	9.13E-01
monoatomic ion transmembrane transport (GO:0034220)	779	28	12.99	+	2.16	1.49E-04	1.80E-02
blood vessel morphogenesis (GO:0048514)	473	17	7.88	+	2.16	2.96E-03	1.63E-01
glycoprotein metabolic process (GO:0009100)	334	12	5.57	+	2.16	1.42E-02	4.27E-01
regulation of monoatomic cation transmembrane transport (GO:1904062)	334	12	5.57	+	2.16	1.42E-02	4.26E-01
heart growth (GO:0060419)	56	2	.93	+	2.14	2.40E-01	1.00E00
intracellular sodium ion homeostasis (GO:0006883)	28	1	.47	+	2.14	3.76E-01	1.00E00
stress granule assembly (GO:0034063)	28	1	.47	+	2.14	3.76E-01	1.00E00
positive regulation of lipase activity (GO:0060193)	28	1	.47	+	2.14	3.76E-01	1.00E00
negative regulation of stem cell proliferation (GO:2000647)	28	1	.47	+	2.14	3.76E-01	1.00E00
positive regulation of natural killer cell activation (GO:0032816)	28	1	.47	+	2.14	3.76E-01	1.00E00
positive regulation of synapse assembly (GO:0051965)	84	3	1.40	+	2.14	1.65E-01	1.00E00
positive regulation of amine transport (GO:0051954)	56	2	.93	+	2.14	2.40E-01	1.00E00
response to vitamin D (GO:0033280)	28	1	.47	+	2.14	3.76E-01	1.00E00
regulation of amine metabolic process (GO:0033238)	28	1	.47	+	2.14	3.76E-01	1.00E00
positive regulation of interleukin-17 production (GO:0032740)	28	1	.47	+	2.14	3.76E-01	1.00E00
lens morphogenesis in camera-type eye (GO:0002089)	28	1	.47	+	2.14	3.76E-01	1.00E00
cellular response to cAMP (GO:0071320)	56	2	.93	+	2.14	2.40E-01	1.00E00
actin nucleation (GO:0045010)	28	1	.47	+	2.14	3.76E-01	1.00E00
regulation of mast cell activation (GO:0033003)	28	1	.47	+	2.14	3.76E-01	1.00E00
glutamatergic neuron differentiation (GO:1905962)	28	1	.47	+	2.14	3.76E-01	1.00E00
modification of synaptic structure (GO:0099563)	28	1	.47	+	2.14	3.76E-01	1.00E00
animal organ maturation (GO:0048799)	28	1	.47	+	2.14	3.76E-01	1.00E00
regulation of non-canonical Wnt signaling pathway (GO:2000050)	28	1	.47	+	2.14	3.76E-01	1.00E00
regulation of flagellated sperm motility (GO:1901317)	28	1	.47	+	2.14	3.76E-01	1.00E00
negative regulation of non-canonical NF-kappaB signal transduction (GO:1901223)	28	1	.47	+	2.14	3.76E-01	1.00E00
regulation of postsynaptic specialization assembly (GO:0099150)	28	1	.47	+	2.14	3.76E-01	1.00E00
membrane raft organization (GO:0031579)	28	1	.47	+	2.14	3.76E-01	1.00E00
cellular response to vascular endothelial growth factor stimulus (GO:0035924)	84	3	1.40	+	2.14	1.65E-01	1.00E00
ruffle organization (GO:0031529)	28	1	.47	+	2.14	3.76E-01	1.00E00
alternative mRNA splicing, via spliceosome (GO:0000380)	28	1	.47	+	2.14	3.76E-01	1.00E00
positive regulation of transport (GO:0051050)	1064	38	17.74	+	2.14	1.10E-05	2.04E-03
cellular response to platelet-derived growth factor stimulus (GO:0036120)	28	1	.47	+	2.14	3.76E-01	1.00E00
T cell costimulation (GO:0031295)	28	1	.47	+	2.14	3.76E-01	1.00E00
monoatomic anion homeostasis (GO:0055081)	28	1	.47	+	2.14	3.76E-01	1.00E00
positive regulation of protein processing (GO:0010954)	28	1	.47	+	2.14	3.76E-01	1.00E00
positive regulation of cytokine production involved in inflammatory response (GO:1900017)	28	1	.47	+	2.14	3.76E-01	1.00E00
peptidyl-tyrosine dephosphorylation (GO:0035335)	28	1	.47	+	2.14	3.76E-01	1.00E00
miRNA-mediated post-transcriptional gene silencing (GO:0035195)	28	1	.47	+	2.14	3.76E-01	1.00E00
response to acidic pH (GO:0010447)	28	1	.47	+	2.14	3.76E-01	1.00E00
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953)	28	1	.47	+	2.14	3.76E-01	1.00E00
visual behavior (GO:0007632)	84	3	1.40	+	2.14	1.65E-01	1.00E00
negative regulation of cell development (GO:0010721)	309	11	5.15	+	2.14	2.05E-02	4.89E-01
negative regulation of cell activation (GO:0050866)	225	8	3.75	+	2.13	3.55E-02	6.35E-01
regulation of cell junction assembly (GO:1901888)	310	11	5.17	+	2.13	2.07E-02	4.92E-01
positive regulation of calcium ion transport (GO:0051928)	141	5	2.35	+	2.13	8.74E-02	9.39E-01
myeloid leukocyte migration (GO:0097529)	141	5	2.35	+	2.13	8.74E-02	9.38E-01
positive regulation of cell-substrate adhesion (GO:0010811)	141	5	2.35	+	2.13	8.74E-02	9.38E-01
phosphatidylinositol metabolic process (GO:0046488)	141	5	2.35	+	2.13	8.74E-02	9.37E-01
positive regulation of T cell activation (GO:0050870)	254	9	4.23	+	2.13	4.09E-02	6.96E-01
neutral lipid metabolic process (GO:0006638)	113	4	1.88	+	2.12	1.20E-01	1.00E00
regulation of tumor necrosis factor production (GO:0032680)	198	7	3.30	+	2.12	4.87E-02	7.81E-01
positive regulation of endocytosis (GO:0045807)	198	7	3.30	+	2.12	4.87E-02	7.80E-01
energy reserve metabolic process (GO:0006112)	85	3	1.42	+	2.12	1.69E-01	1.00E00
nucleoside diphosphate metabolic process (GO:0009132)	85	3	1.42	+	2.12	1.69E-01	1.00E00
regulation of chemotaxis (GO:0050920)	227	8	3.78	+	2.11	5.87E-02	7.92E-01
renal system development (GO:0072001)	369	13	6.15	+	2.11	1.13E-02	3.81E-01
regulation of calcium ion transport (GO:0051924)	284	10	4.73	+	2.11	2.96E-02	6.04E-01
regulation of angiogenesis (GO:0045765)	313	11	5.22	+	2.11	2.15E-02	5.06E-01
cellular response to oxygen-containing compound (GO:1901701)	1196	42	19.94	+	2.11	6.32E-06	1.28E-03
response to monosaccharide (GO:0034284)	171	6	2.85	+	2.10	6.72E-02	8.21E-01
homotypic cell-cell adhesion (GO:0034109)	57	2	.95	+	2.10	2.46E-01	1.00E00
ADP catabolic process (GO:0046032)	57	2	.95	+	2.10	2.46E-01	1.00E00
regulation of glial cell proliferation (GO:0060251)	57	2	.95	+	2.10	2.46E-01	1.00E00
acetylcholine receptor signaling pathway (GO:0095500)	57	2	.95	+	2.10	2.46E-01	1.00E00
vesicle cytoskeletal trafficking (GO:0099518)	57	2	.95	+	2.10	2.46E-01	1.00E00
negative regulation of endothelial cell migration (GO:0010596)	57	2	.95	+	2.10	2.46E-01	1.00E00
positive regulation of muscle contraction (GO:0045933)	57	2	.95	+	2.10	2.46E-01	1.00E00
regulation of protein transport (GO:0051223)	542	19	9.03	+	2.10	3.04E-03	1.66E-01
proton transmembrane transport (GO:1902600)	143	5	2.38	+	2.10	9.15E-02	9.59E-01
positive regulation of protein transport (GO:0051222)	315	11	5.25	+	2.09	2.20E-02	5.12E-01
protein targeting to membrane (GO:0006612)	86	3	1.43	+	2.09	1.73E-01	1.00E00
cellular component maintenance (GO:0043954)	86	3	1.43	+	2.09	1.73E-01	1.00E00
positive regulation of phagocytosis (GO:0050766)	86	3	1.43	+	2.09	1.73E-01	1.00E00
myotube differentiation (GO:0014902)	86	3	1.43	+	2.09	1.73E-01	1.00E00
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555)	201	7	3.35	+	2.09	5.20E-02	7.36E-01
positive regulation of canonical Wnt signaling pathway (GO:0090263)	115	4	1.92	+	2.09	1.26E-01	1.00E00
vascular process in circulatory system (GO:0003018)	259	9	4.32	+	2.08	4.28E-02	7.21E-01
cognition (GO:0050890)	403	14	6.72	+	2.08	9.17E-03	3.40E-01
regulation of inflammatory response (GO:0050727)	403	14	6.72	+	2.08	9.17E-03	3.40E-01
positive regulation of lymphocyte differentiation (GO:0045621)	144	5	2.40	+	2.08	9.36E-02	9.79E-01
regulation of dendrite development (GO:0050773)	144	5	2.40	+	2.08	9.36E-02	9.78E-01
positive regulation of hormone secretion (GO:0046887)	202	7	3.37	+	2.08	5.32E-02	7.47E-01
nucleocytoplasmic transport (GO:0006913)	260	9	4.33	+	2.08	4.33E-02	7.22E-01
calcium ion homeostasis (GO:0055074)	260	9	4.33	+	2.08	4.33E-02	7.21E-01
positive regulation of epidermis development (GO:0045684)	29	1	.48	+	2.07	3.86E-01	1.00E00
positive regulation of erythrocyte differentiation (GO:0045648)	29	1	.48	+	2.07	3.86E-01	1.00E00
AMP metabolic process (GO:0046033)	29	1	.48	+	2.07	3.86E-01	1.00E00
leukocyte apoptotic process (GO:0071887)	58	2	.97	+	2.07	2.52E-01	1.00E00
negative regulation of cell adhesion (GO:0007162)	319	11	5.32	+	2.07	2.32E-02	5.26E-01
auditory receptor cell morphogenesis (GO:0002093)	29	1	.48	+	2.07	3.86E-01	1.00E00
epithelial cell maturation (GO:0002070)	29	1	.48	+	2.07	3.86E-01	1.00E00
regulation of circadian sleep/wake cycle, sleep (GO:0045187)	29	1	.48	+	2.07	3.86E-01	1.00E00
cellular response to organic cyclic compound (GO:0071407)	493	17	8.22	+	2.07	6.19E-03	2.74E-01
negative regulation of RNA splicing (GO:0033119)	29	1	.48	+	2.07	3.86E-01	1.00E00
establishment of vesicle localization (GO:0051650)	174	6	2.90	+	2.07	7.18E-02	8.66E-01
positive regulation of fatty acid transport (GO:2000193)	29	1	.48	+	2.07	3.86E-01	1.00E00
regulation of icosanoid secretion (GO:0032303)	29	1	.48	+	2.07	3.86E-01	1.00E00
positive regulation of stress fiber assembly (GO:0051496)	58	2	.97	+	2.07	2.52E-01	1.00E00
nuclear transport (GO:0051169)	261	9	4.35	+	2.07	4.37E-02	7.23E-01
positive regulation of GTPase activity (GO:0043547)	145	5	2.42	+	2.07	9.57E-02	9.85E-01
detection of external biotic stimulus (GO:0098581)	29	1	.48	+	2.07	3.86E-01	1.00E00
regulation of cellular response to oxidative stress (GO:1900407)	29	1	.48	+	2.07	3.86E-01	1.00E00
response to temperature stimulus (GO:0009266)	174	6	2.90	+	2.07	7.18E-02	8.65E-01
axon regeneration (GO:0031103)	29	1	.48	+	2.07	3.86E-01	1.00E00
positive regulation of endopeptidase activity (GO:0010950)	145	5	2.42	+	2.07	9.57E-02	9.85E-01
regulation of programmed necrotic cell death (GO:0062098)	29	1	.48	+	2.07	3.86E-01	1.00E00
negative regulation of nucleocytoplasmic transport (GO:0046823)	29	1	.48	+	2.07	3.86E-01	1.00E00
regulation of telomere capping (GO:1904353)	29	1	.48	+	2.07	3.86E-01	1.00E00
synaptic vesicle maturation (GO:0016188)	29	1	.48	+	2.07	3.86E-01	1.00E00
sperm-egg recognition (GO:0035036)	58	2	.97	+	2.07	2.52E-01	1.00E00
prostate gland epithelium morphogenesis (GO:0060740)	29	1	.48	+	2.07	3.86E-01	1.00E00
gliogenesis (GO:0042063)	319	11	5.32	+	2.07	2.32E-02	5.25E-01
response to activity (GO:0014823)	87	3	1.45	+	2.07	1.77E-01	1.00E00
negative regulation of natural killer cell mediated immunity (GO:0002716)	29	1	.48	+	2.07	3.86E-01	1.00E00
hypothalamus development (GO:0021854)	29	1	.48	+	2.07	3.86E-01	1.00E00
positive regulation of miRNA transcription (GO:1902895)	58	2	.97	+	2.07	2.52E-01	1.00E00
lipid biosynthetic process (GO:0008610)	552	19	9.20	+	2.06	3.34E-03	1.76E-01
regulation of vasculature development (GO:1901342)	320	11	5.33	+	2.06	2.35E-02	5.29E-01
neuromuscular process (GO:0050905)	204	7	3.40	+	2.06	8.74E-02	9.39E-01
response to nitrogen compound (GO:1901698)	1167	40	19.45	+	2.06	1.62E-05	2.81E-03
glial cell development (GO:0021782)	146	5	2.43	+	2.05	9.78E-02	9.55E-01
sphingolipid metabolic process (GO:0006665)	146	5	2.43	+	2.05	9.78E-02	9.54E-01
digestive tract development (GO:0048565)	146	5	2.43	+	2.05	9.78E-02	9.54E-01
negative regulation of defense response (GO:0031348)	292	10	4.87	+	2.05	3.24E-02	6.46E-01
cellular response to reactive oxygen species (GO:0034614)	146	5	2.43	+	2.05	9.78E-02	9.53E-01
protein import into nucleus (GO:0006606)	117	4	1.95	+	2.05	1.32E-01	1.00E00
intracellular glucose homeostasis (GO:0001678)	117	4	1.95	+	2.05	1.32E-01	1.00E00
negative regulation of angiogenesis (GO:0016525)	117	4	1.95	+	2.05	1.32E-01	1.00E00
response to osmotic stress (GO:0006970)	88	3	1.47	+	2.05	1.81E-01	1.00E00
enzyme-linked receptor protein signaling pathway (GO:0007167)	616	21	10.27	+	2.05	2.00E-03	1.25E-01
regulation of signal transduction by p53 class mediator (GO:1901796)	88	3	1.47	+	2.05	1.81E-01	1.00E00
positive regulation of monoatomic ion transmembrane transport (GO:0034767)	176	6	2.93	+	2.05	7.49E-02	8.92E-01
regulation of dendritic spine development (GO:0060998)	88	3	1.47	+	2.05	1.81E-01	1.00E00
regulation of transport (GO:0051049)	1880	64	31.34	+	2.04	4.18E-08	2.30E-05
regulation of blood pressure (GO:0008217)	235	8	3.92	+	2.04	6.28E-02	8.30E-01
blood circulation (GO:0008015)	470	16	7.83	+	2.04	8.93E-03	3.40E-01
amino acid transport (GO:0006865)	147	5	2.45	+	2.04	9.99E-02	9.67E-01
negative regulation of leukocyte activation (GO:0002695)	206	7	3.43	+	2.04	8.87E-02	9.46E-01
forebrain development (GO:0030900)	471	16	7.85	+	2.04	9.00E-03	3.37E-01
blood vessel development (GO:0001568)	589	20	9.82	+	2.04	2.73E-03	1.55E-01
protein localization to membrane (GO:0072657)	501	17	8.35	+	2.04	6.63E-03	2.81E-01
positive regulation of myeloid cell differentiation (GO:0045639)	118	4	1.97	+	2.03	1.35E-01	1.00E00
cerebellum morphogenesis (GO:0021587)	59	2	.98	+	2.03	2.58E-01	1.00E00
regulation of amino acid transport (GO:0051955)	59	2	.98	+	2.03	2.58E-01	1.00E00
negative regulation of gliogenesis (GO:0014014)	59	2	.98	+	2.03	2.58E-01	1.00E00
regulation of phagocytosis (GO:0050764)	118	4	1.97	+	2.03	1.35E-01	1.00E00
negative regulation of protein modification process (GO:0031400)	413	14	6.88	+	2.03	1.08E-02	3.70E-01
fibroblast proliferation (GO:0048144)	59	2	.98	+	2.03	2.58E-01	1.00E00
cellular response to acetylcholine (GO:1905145)	59	2	.98	+	2.03	2.58E-01	1.00E00
neutrophil chemotaxis (GO:0030593)	59	2	.98	+	2.03	2.58E-01	1.00E00
regulation of substrate adhesion-dependent cell spreading (GO:1900024)	59	2	.98	+	2.03	2.58E-01	1.00E00
NAD metabolic process (GO:0019674)	59	2	.98	+	2.03	2.58E-01	1.00E00
respiratory gaseous exchange by respiratory system (GO:0007585)	59	2	.98	+	2.03	2.58E-01	1.00E00
memory (GO:0007613)	177	6	2.95	+	2.03	7.65E-02	9.08E-01
cytokine production (GO:0001816)	207	7	3.45	+	2.03	8.94E-02	9.48E-01
positive regulation of binding (GO:0051099)	148	5	2.47	+	2.03	1.02E-01	9.83E-01
regulation of leukocyte cell-cell adhesion (GO:1903037)	386	13	6.43	+	2.02	1.48E-02	4.39E-01
carbohydrate derivative catabolic process (GO:1901136)	208	7	3.47	+	2.02	9.01E-02	9.54E-01
nephron epithelium development (GO:0072009)	119	4	1.98	+	2.02	1.38E-01	1.00E00
negative regulation of blood vessel morphogenesis (GO:2000181)	119	4	1.98	+	2.02	1.38E-01	1.00E00
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	238	8	3.97	+	2.02	6.47E-02	8.43E-01
response to hydrogen peroxide (GO:0042542)	119	4	1.98	+	2.02	1.38E-01	1.00E00
cardiac ventricle development (GO:0003231)	149	5	2.48	+	2.01	1.04E-01	1.00E00
positive regulation of angiogenesis (GO:0045766)	179	6	2.98	+	2.01	1.29E-01	1.00E00
protein homooligomerization (GO:0051260)	209	7	3.48	+	2.01	9.08E-02	9.61E-01
regulation of establishment of protein localization (GO:0070201)	627	21	10.45	+	2.01	2.34E-03	1.40E-01
phosphorylation (GO:0016310)	538	18	8.97	+	2.01	5.35E-03	2.47E-01
cell migration (GO:0016477)	988	33	16.47	+	2.00	1.71E-04	1.98E-02
mammary gland morphogenesis (GO:0060443)	60	2	1.00	+	2.00	2.64E-01	1.00E00
regulation of steroid hormone secretion (GO:2000831)	30	1	.50	+	2.00	3.96E-01	1.00E00
negative regulation of stem cell differentiation (GO:2000737)	30	1	.50	+	2.00	3.96E-01	1.00E00
fat-soluble vitamin metabolic process (GO:0006775)	30	1	.50	+	2.00	3.96E-01	1.00E00
membrane assembly (GO:0071709)	60	2	1.00	+	2.00	2.64E-01	1.00E00
regulation of superoxide anion generation (GO:0032928)	30	1	.50	+	2.00	3.96E-01	1.00E00
phosphatidylinositol biosynthetic process (GO:0006661)	90	3	1.50	+	2.00	1.90E-01	1.00E00
reproductive behavior (GO:0019098)	60	2	1.00	+	2.00	2.64E-01	1.00E00
negative regulation of organic acid transport (GO:0032891)	30	1	.50	+	2.00	3.96E-01	1.00E00
uterus development (GO:0060065)	30	1	.50	+	2.00	3.96E-01	1.00E00
neurotrophin signaling pathway (GO:0038179)	30	1	.50	+	2.00	3.96E-01	1.00E00
zinc ion transmembrane transport (GO:0071577)	30	1	.50	+	2.00	3.96E-01	1.00E00
glycoprotein catabolic process (GO:0006516)	30	1	.50	+	2.00	3.96E-01	1.00E00
cellular response to gamma radiation (GO:0071480)	30	1	.50	+	2.00	3.96E-01	1.00E00
regulation of T cell differentiation in thymus (GO:0033081)	30	1	.50	+	2.00	3.96E-01	1.00E00
plasma membrane fusion (GO:0045026)	30	1	.50	+	2.00	3.96E-01	1.00E00
regulation of cytokinesis (GO:0032465)	90	3	1.50	+	2.00	1.90E-01	1.00E00
smooth muscle tissue development (GO:0048745)	30	1	.50	+	2.00	3.96E-01	1.00E00
negative regulation of vasculature development (GO:1901343)	120	4	2.00	+	2.00	1.41E-01	1.00E00
regulation of skeletal muscle tissue development (GO:0048641)	30	1	.50	+	2.00	3.96E-01	1.00E00
cochlea morphogenesis (GO:0090103)	30	1	.50	+	2.00	3.96E-01	1.00E00
embryonic camera-type eye morphogenesis (GO:0048596)	30	1	.50	+	2.00	3.96E-01	1.00E00
linoleic acid metabolic process (GO:0043651)	30	1	.50	+	2.00	3.96E-01	1.00E00
regulation of appetite (GO:0032098)	30	1	.50	+	2.00	3.96E-01	1.00E00
regulation of calcium ion transmembrane transporter activity (GO:1901019)	60	2	1.00	+	2.00	2.64E-01	1.00E00
CD4-positive, alpha-beta T cell differentiation (GO:0043367)	60	2	1.00	+	2.00	2.64E-01	1.00E00
lymphocyte costimulation (GO:0031294)	30	1	.50	+	2.00	3.96E-01	1.00E00
rRNA transcription (GO:0009303)	30	1	.50	+	2.00	3.96E-01	1.00E00
stress-activated protein kinase signaling cascade (GO:0031098)	30	1	.50	+	2.00	3.96E-01	1.00E00
purine ribonucleoside diphosphate catabolic process (GO:0009181)	60	2	1.00	+	2.00	2.64E-01	1.00E00
purine ribonucleotide catabolic process (GO:0009154)	90	3	1.50	+	2.00	1.90E-01	1.00E00
purine nucleoside diphosphate catabolic process (GO:0009137)	60	2	1.00	+	2.00	2.64E-01	1.00E00
negative regulation of BMP signaling pathway (GO:0030514)	60	2	1.00	+	2.00	2.64E-01	1.00E00
positive regulation of peptidyl-threonine phosphorylation (GO:0010800)	30	1	.50	+	2.00	3.96E-01	1.00E00
lung development (GO:0030324)	240	8	4.00	+	2.00	6.60E-02	8.11E-01
viral process (GO:0016032)	150	5	2.50	+	2.00	1.06E-01	1.00E00
chondroitin sulfate metabolic process (GO:0030204)	30	1	.50	+	2.00	3.96E-01	1.00E00
endochondral bone growth (GO:0003416)	30	1	.50	+	2.00	3.96E-01	1.00E00
ceramide biosynthetic process (GO:0046513)	60	2	1.00	+	2.00	2.64E-01	1.00E00
positive regulation of Wnt signaling pathway (GO:0030177)	150	5	2.50	+	2.00	1.06E-01	1.00E00
positive regulation of lamellipodium assembly (GO:0010592)	30	1	.50	+	2.00	3.96E-01	1.00E00
axo-dendritic transport (GO:0008088)	90	3	1.50	+	2.00	1.90E-01	1.00E00
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315)	30	1	.50	+	2.00	3.96E-01	1.00E00
myoblast fusion (GO:0007520)	30	1	.50	+	2.00	3.96E-01	1.00E00
prostate gland morphogenesis (GO:0060512)	30	1	.50	+	2.00	3.96E-01	1.00E00
positive regulation of secretion (GO:0051047)	450	15	7.50	+	2.00	1.32E-02	4.15E-01
monoatomic ion transport (GO:0006811)	961	32	16.02	+	2.00	2.35E-04	2.55E-02
regulation of transmembrane transport (GO:0034762)	511	17	8.52	+	2.00	7.35E-03	2.94E-01
regulation of developmental growth (GO:0048638)	392	13	6.53	+	1.99	1.62E-02	4.76E-01
regulation of nervous system development (GO:0051960)	573	19	9.55	+	1.99	4.33E-03	2.11E-01
positive regulation of tumor necrosis factor production (GO:0032760)	121	4	2.02	+	1.98	1.44E-01	1.00E00
regulation of anatomical structure morphogenesis (GO:0022603)	940	31	15.67	+	1.98	3.42E-04	3.45E-02
positive regulation of vasculature development (GO:1904018)	182	6	3.03	+	1.98	1.31E-01	1.00E00
respiratory tube development (GO:0030323)	243	8	4.05	+	1.97	6.81E-02	8.31E-01
skin epidermis development (GO:0098773)	152	5	2.53	+	1.97	1.11E-01	1.00E00
T cell differentiation (GO:0030217)	213	7	3.55	+	1.97	9.40E-02	9.73E-01
respiratory system development (GO:0060541)	274	9	4.57	+	1.97	5.07E-02	7.26E-01
innate immune response activating cell surface receptor signaling pathway (GO:0002220)	61	2	1.02	+	1.97	2.70E-01	1.00E00
somatic diversification of immune receptors (GO:0002200)	61	2	1.02	+	1.97	2.70E-01	1.00E00
positive regulation of DNA-templated transcription, elongation (GO:0032786)	61	2	1.02	+	1.97	2.70E-01	1.00E00
positive regulation of interleukin-8 production (GO:0032757)	61	2	1.02	+	1.97	2.70E-01	1.00E00
regulation of endocrine process (GO:0044060)	61	2	1.02	+	1.97	2.70E-01	1.00E00
negative regulation of actin filament polymerization (GO:0030837)	61	2	1.02	+	1.97	2.70E-01	1.00E00
regulation of mRNA splicing, via spliceosome (GO:0048024)	122	4	2.03	+	1.97	1.47E-01	1.00E00
regulation of cytokine production involved in inflammatory response (GO:1900015)	61	2	1.02	+	1.97	2.70E-01	1.00E00
labyrinthine layer development (GO:0060711)	61	2	1.02	+	1.97	2.70E-01	1.00E00
insulin secretion (GO:0030073)	61	2	1.02	+	1.97	2.70E-01	1.00E00
biological process involved in symbiotic interaction (GO:0044403)	214	7	3.57	+	1.96	9.49E-02	9.78E-01
ameboidal-type cell migration (GO:0001667)	153	5	2.55	+	1.96	1.13E-01	1.00E00
metanephros development (GO:0001656)	92	3	1.53	+	1.96	1.98E-01	1.00E00
positive regulation of cell division (GO:0051781)	92	3	1.53	+	1.96	1.98E-01	1.00E00
positive regulation of synaptic transmission (GO:0050806)	184	6	3.07	+	1.96	1.33E-01	1.00E00
regulation of blood circulation (GO:1903522)	276	9	4.60	+	1.96	5.20E-02	7.37E-01
T cell activation (GO:0042110)	399	13	6.65	+	1.95	2.61E-02	5.60E-01
pallium development (GO:0021543)	215	7	3.58	+	1.95	9.58E-02	9.85E-01
cellular response to insulin stimulus (GO:0032869)	215	7	3.58	+	1.95	9.58E-02	9.85E-01
positive regulation of protein localization (GO:1903829)	553	18	9.22	+	1.95	6.49E-03	2.79E-01
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)	123	4	2.05	+	1.95	1.50E-01	1.00E00
head development (GO:0060322)	831	27	13.85	+	1.95	1.21E-03	8.67E-02
glycoprotein biosynthetic process (GO:0009101)	277	9	4.62	+	1.95	5.27E-02	7.42E-01
locomotory behavior (GO:0007626)	277	9	4.62	+	1.95	5.27E-02	7.41E-01
brain development (GO:0007420)	771	25	12.85	+	1.95	1.46E-03	9.87E-02
protein glycosylation (GO:0006486)	216	7	3.60	+	1.94	9.67E-02	9.46E-01
macromolecule glycosylation (GO:0043413)	216	7	3.60	+	1.94	9.67E-02	9.46E-01
negative regulation of cell-cell adhesion (GO:0022408)	216	7	3.60	+	1.94	9.67E-02	9.45E-01
zinc ion transport (GO:0006829)	31	1	.52	+	1.94	4.06E-01	1.00E00
positive regulation of glial cell proliferation (GO:0060252)	31	1	.52	+	1.94	4.06E-01	1.00E00
tumor necrosis factor superfamily cytokine production (GO:0071706)	31	1	.52	+	1.94	4.06E-01	1.00E00
bone resorption (GO:0045453)	31	1	.52	+	1.94	4.06E-01	1.00E00
regulation of monocyte chemotactic protein-1 production (GO:0071637)	31	1	.52	+	1.94	4.06E-01	1.00E00
regulation of the force of heart contraction (GO:0002026)	31	1	.52	+	1.94	4.06E-01	1.00E00
positive regulation of purine nucleotide catabolic process (GO:0033123)	31	1	.52	+	1.94	4.06E-01	1.00E00
tumor necrosis factor production (GO:0032640)	31	1	.52	+	1.94	4.06E-01	1.00E00
cellular response to interleukin-4 (GO:0071353)	31	1	.52	+	1.94	4.06E-01	1.00E00
organophosphate biosynthetic process (GO:0090407)	527	17	8.78	+	1.94	8.94E-03	3.39E-01
intestinal absorption (GO:0050892)	31	1	.52	+	1.94	4.06E-01	1.00E00
negative regulation of behavior (GO:0048521)	31	1	.52	+	1.94	4.06E-01	1.00E00
protein sumoylation (GO:0016925)	31	1	.52	+	1.94	4.06E-01	1.00E00
regulation of vascular endothelial cell proliferation (GO:1905562)	31	1	.52	+	1.94	4.06E-01	1.00E00
release of sequestered calcium ion into cytosol (GO:0051209)	62	2	1.03	+	1.94	2.77E-01	1.00E00
import into nucleus (GO:0051170)	124	4	2.07	+	1.94	1.53E-01	1.00E00
centriole assembly (GO:0098534)	31	1	.52	+	1.94	4.06E-01	1.00E00
response to platelet-derived growth factor (GO:0036119)	31	1	.52	+	1.94	4.06E-01	1.00E00
positive regulation of nucleotide catabolic process (GO:0030813)	31	1	.52	+	1.94	4.06E-01	1.00E00
regulation of cyclase activity (GO:0031279)	31	1	.52	+	1.94	4.06E-01	1.00E00
response to acetylcholine (GO:1905144)	62	2	1.03	+	1.94	2.77E-01	1.00E00
negative regulation of cardiac muscle tissue growth (GO:0055022)	31	1	.52	+	1.94	4.06E-01	1.00E00
regulation of Rac protein signal transduction (GO:0035020)	31	1	.52	+	1.94	4.06E-01	1.00E00
isoprenoid biosynthetic process (GO:0008299)	31	1	.52	+	1.94	4.06E-01	1.00E00
proteoglycan biosynthetic process (GO:0030166)	62	2	1.03	+	1.94	2.77E-01	1.00E00
glycerophospholipid catabolic process (GO:0046475)	31	1	.52	+	1.94	4.06E-01	1.00E00
negative regulation of heart growth (GO:0061117)	31	1	.52	+	1.94	4.06E-01	1.00E00
phototransduction (GO:0007602)	31	1	.52	+	1.94	4.06E-01	1.00E00
cerebral cortex neuron differentiation (GO:0021895)	31	1	.52	+	1.94	4.06E-01	1.00E00
positive regulation of glycolytic process (GO:0045821)	31	1	.52	+	1.94	4.06E-01	1.00E00
regulation of miRNA metabolic process (GO:2000628)	93	3	1.55	+	1.94	2.03E-01	1.00E00
nephron development (GO:0072006)	155	5	2.58	+	1.94	1.18E-01	1.00E00
regulation of mitochondrial membrane potential (GO:0051881)	93	3	1.55	+	1.94	2.03E-01	1.00E00
regulation of monoatomic ion transmembrane transporter activity (GO:0032412)	186	6	3.10	+	1.94	1.35E-01	1.00E00
positive regulation of establishment of protein localization (GO:1904951)	372	12	6.20	+	1.94	3.64E-02	6.41E-01
positive regulation of peptidase activity (GO:0010952)	155	5	2.58	+	1.94	1.18E-01	1.00E00
vasculature development (GO:0001944)	621	20	10.35	+	1.93	5.83E-03	2.60E-01
central nervous system development (GO:0007417)	1025	33	17.09	+	1.93	3.71E-04	3.62E-02
synapse assembly (GO:0007416)	125	4	2.08	+	1.92	1.56E-01	1.00E00
regulation of neural precursor cell proliferation (GO:2000177)	125	4	2.08	+	1.92	1.56E-01	1.00E00
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	219	7	3.65	+	1.92	9.96E-02	9.64E-01
regulation of calcium ion transmembrane transport (GO:1903169)	188	6	3.13	+	1.91	1.37E-01	1.00E00
response to heat (GO:0009408)	94	3	1.57	+	1.91	2.07E-01	1.00E00
lipid homeostasis (GO:0055088)	188	6	3.13	+	1.91	1.37E-01	1.00E00
negative regulation of phosphorus metabolic process (GO:0010563)	376	12	6.27	+	1.91	3.74E-02	6.56E-01
negative regulation of phosphate metabolic process (GO:0045936)	376	12	6.27	+	1.91	3.74E-02	6.55E-01
response to hormone (GO:0009725)	910	29	15.17	+	1.91	8.28E-04	6.94E-02
negative regulation of leukocyte cell-cell adhesion (GO:1903038)	157	5	2.62	+	1.91	1.93E-01	1.00E00
regulation of lipid transport (GO:0032368)	157	5	2.62	+	1.91	1.93E-01	1.00E00
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	157	5	2.62	+	1.91	1.93E-01	1.00E00
circulatory system process (GO:0003013)	503	16	8.38	+	1.91	1.26E-02	4.04E-01
regulation of signaling (GO:0023051)	3648	116	60.81	+	1.91	8.54E-13	1.32E-08
eye morphogenesis (GO:0048592)	189	6	3.15	+	1.90	1.38E-01	1.00E00
hindbrain morphogenesis (GO:0021575)	63	2	1.05	+	1.90	2.83E-01	1.00E00
eye photoreceptor cell differentiation (GO:0001754)	63	2	1.05	+	1.90	2.83E-01	1.00E00
positive regulation of organic acid transport (GO:0032892)	63	2	1.05	+	1.90	2.83E-01	1.00E00
negative regulation of sequestering of calcium ion (GO:0051283)	63	2	1.05	+	1.90	2.83E-01	1.00E00
negative regulation of cell-substrate adhesion (GO:0010812)	63	2	1.05	+	1.90	2.83E-01	1.00E00
alpha-beta T cell activation (GO:0046631)	126	4	2.10	+	1.90	1.59E-01	1.00E00
platelet activation (GO:0030168)	63	2	1.05	+	1.90	2.83E-01	1.00E00
regulation of protein targeting (GO:1903533)	63	2	1.05	+	1.90	2.83E-01	1.00E00
cardiac septum development (GO:0003279)	126	4	2.10	+	1.90	1.59E-01	1.00E00
positive regulation of hydrolase activity (GO:0051345)	347	11	5.78	+	1.90	5.14E-02	7.30E-01
response to organic cyclic compound (GO:0014070)	978	31	16.30	+	1.90	7.31E-04	6.29E-02
regulation of ketone metabolic process (GO:0010565)	158	5	2.63	+	1.90	1.95E-01	1.00E00
intermediate filament cytoskeleton organization (GO:0045104)	95	3	1.58	+	1.89	2.11E-01	1.00E00
vesicle localization (GO:0051648)	190	6	3.17	+	1.89	1.40E-01	1.00E00
positive regulation of lipid localization (GO:1905954)	127	4	2.12	+	1.89	1.63E-01	1.00E00
regulation of cell communication (GO:0010646)	3652	115	60.88	+	1.89	2.57E-12	1.98E-08
membrane lipid metabolic process (GO:0006643)	191	6	3.18	+	1.88	1.41E-01	1.00E00
regulation of postsynapse organization (GO:0099175)	191	6	3.18	+	1.88	1.41E-01	1.00E00
response to peptide hormone (GO:0043434)	478	15	7.97	+	1.88	1.76E-02	4.44E-01
glial cell differentiation (GO:0010001)	255	8	4.25	+	1.88	7.81E-02	9.23E-01
negative regulation of developmental process (GO:0051093)	1022	32	17.04	+	1.88	6.26E-04	5.48E-02
leukocyte activation (GO:0045321)	703	22	11.72	+	1.88	6.12E-03	2.71E-01
regulation of localization (GO:0032879)	2302	72	38.37	+	1.88	1.57E-07	7.78E-05
signal transduction by p53 class mediator (GO:0072331)	96	3	1.60	+	1.87	2.16E-01	1.00E00
regulation of cation channel activity (GO:2001257)	96	3	1.60	+	1.87	2.16E-01	1.00E00
positive regulation of extracellular matrix organization (GO:1903055)	32	1	.53	+	1.87	4.16E-01	1.00E00
cell differentiation in hindbrain (GO:0021533)	32	1	.53	+	1.87	4.16E-01	1.00E00
myeloid dendritic cell activation (GO:0001773)	32	1	.53	+	1.87	4.16E-01	1.00E00
mitotic spindle organization (GO:0007052)	96	3	1.60	+	1.87	2.16E-01	1.00E00
Sertoli cell differentiation (GO:0060008)	32	1	.53	+	1.87	4.16E-01	1.00E00
cellular response to leukemia inhibitory factor (GO:1990830)	128	4	2.13	+	1.87	1.66E-01	1.00E00
response to hypoxia (GO:0001666)	320	10	5.33	+	1.87	4.74E-02	7.69E-01
chondrocyte development (GO:0002063)	32	1	.53	+	1.87	4.16E-01	1.00E00
chondrocyte differentiation (GO:0002062)	96	3	1.60	+	1.87	2.16E-01	1.00E00
intermediate filament-based process (GO:0045103)	96	3	1.60	+	1.87	2.16E-01	1.00E00
epiboly involved in wound healing (GO:0090505)	32	1	.53	+	1.87	4.16E-01	1.00E00
regulation of interleukin-12 production (GO:0032655)	64	2	1.07	+	1.87	2.89E-01	1.00E00
regulation of biological process involved in symbiotic interaction (GO:0043903)	64	2	1.07	+	1.87	2.89E-01	1.00E00
positive regulation of calcium ion import (GO:0090280)	32	1	.53	+	1.87	4.16E-01	1.00E00
wound healing, spreading of cells (GO:0044319)	32	1	.53	+	1.87	4.16E-01	1.00E00
positive regulation of lipid catabolic process (GO:0050996)	32	1	.53	+	1.87	4.16E-01	1.00E00
negative regulation of lipid catabolic process (GO:0050995)	32	1	.53	+	1.87	4.16E-01	1.00E00
protein K63-linked ubiquitination (GO:0070534)	64	2	1.07	+	1.87	2.89E-01	1.00E00
response to glucocorticoid (GO:0051384)	160	5	2.67	+	1.87	1.97E-01	1.00E00
modulation of excitatory postsynaptic potential (GO:0098815)	64	2	1.07	+	1.87	2.89E-01	1.00E00
post-embryonic development (GO:0009791)	128	4	2.13	+	1.87	1.66E-01	1.00E00
negative regulation of ERBB signaling pathway (GO:1901185)	32	1	.53	+	1.87	4.16E-01	1.00E00
presynapse organization (GO:0099172)	32	1	.53	+	1.87	4.16E-01	1.00E00
positive regulation of long-term synaptic potentiation (GO:1900273)	32	1	.53	+	1.87	4.16E-01	1.00E00
phospholipid transport (GO:0015914)	96	3	1.60	+	1.87	2.16E-01	1.00E00
regulation of hair cycle (GO:0042634)	32	1	.53	+	1.87	4.16E-01	1.00E00
ribonucleoside diphosphate catabolic process (GO:0009191)	64	2	1.07	+	1.87	2.89E-01	1.00E00
negative regulation of small molecule metabolic process (GO:0062014)	128	4	2.13	+	1.87	1.66E-01	1.00E00
positive regulation of insulin receptor signaling pathway (GO:0046628)	32	1	.53	+	1.87	4.16E-01	1.00E00
actin filament polymerization (GO:0030041)	32	1	.53	+	1.87	4.16E-01	1.00E00
regulation of cell maturation (GO:1903429)	32	1	.53	+	1.87	4.16E-01	1.00E00
ureteric bud morphogenesis (GO:0060675)	64	2	1.07	+	1.87	2.89E-01	1.00E00
regulation of animal organ formation (GO:0003156)	32	1	.53	+	1.87	4.16E-01	1.00E00
regulation of biological quality (GO:0065008)	3216	100	53.61	+	1.87	2.08E-10	3.57E-07
regulation of response to external stimulus (GO:0032101)	1158	36	19.30	+	1.86	3.36E-04	3.41E-02
regulation of lipid metabolic process (GO:0019216)	386	12	6.43	+	1.86	4.03E-02	6.88E-01
intrinsic apoptotic signaling pathway (GO:0097193)	193	6	3.22	+	1.86	1.43E-01	1.00E00
plasma membrane organization (GO:0007009)	161	5	2.68	+	1.86	1.98E-01	1.00E00
positive regulation of chemotaxis (GO:0050921)	161	5	2.68	+	1.86	1.98E-01	1.00E00
digestive system development (GO:0055123)	161	5	2.68	+	1.86	1.98E-01	1.00E00
cell activation (GO:0001775)	806	25	13.44	+	1.86	2.89E-03	1.60E-01
regulation of type II interferon production (GO:0032649)	129	4	2.15	+	1.86	1.69E-01	1.00E00
endoplasmic reticulum organization (GO:0007029)	97	3	1.62	+	1.86	2.20E-01	1.00E00
regulation of Notch signaling pathway (GO:0008593)	97	3	1.62	+	1.86	2.20E-01	1.00E00
tube morphogenesis (GO:0035239)	776	24	12.94	+	1.86	3.79E-03	1.95E-01
positive regulation of cation transmembrane transport (GO:1904064)	162	5	2.70	+	1.85	2.00E-01	1.00E00
intracellular signal transduction (GO:0035556)	1719	53	28.66	+	1.85	1.26E-05	2.31E-03
positive regulation of response to biotic stimulus (GO:0002833)	357	11	5.95	+	1.85	5.48E-02	7.66E-01
import into cell (GO:0098657)	682	21	11.37	+	1.85	8.62E-03	3.32E-01
localization within membrane (GO:0051668)	585	18	9.75	+	1.85	1.27E-02	4.03E-01
positive regulation of protein localization to plasma membrane (GO:1903078)	65	2	1.08	+	1.85	2.95E-01	1.00E00
mesonephric tubule morphogenesis (GO:0072171)	65	2	1.08	+	1.85	2.95E-01	1.00E00
response to leukemia inhibitory factor (GO:1990823)	130	4	2.17	+	1.85	1.72E-01	1.00E00
organic hydroxy compound catabolic process (GO:1901616)	65	2	1.08	+	1.85	2.95E-01	1.00E00
peptidyl-amino acid modification (GO:0018193)	455	14	7.58	+	1.85	2.51E-02	5.53E-01
zymogen activation (GO:0031638)	65	2	1.08	+	1.85	2.95E-01	1.00E00
cholesterol metabolic process (GO:0008203)	130	4	2.17	+	1.85	1.72E-01	1.00E00
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)	65	2	1.08	+	1.85	2.95E-01	1.00E00
response to type II interferon (GO:0034341)	130	4	2.17	+	1.85	1.72E-01	1.00E00
regulation of T cell differentiation (GO:0045580)	195	6	3.25	+	1.85	1.46E-01	1.00E00
regulation of lipid localization (GO:1905952)	196	6	3.27	+	1.84	1.47E-01	1.00E00
regulation of stress fiber assembly (GO:0051492)	98	3	1.63	+	1.84	2.24E-01	1.00E00
response to interleukin-1 (GO:0070555)	98	3	1.63	+	1.84	2.24E-01	1.00E00
regulation of transmembrane transporter activity (GO:0022898)	196	6	3.27	+	1.84	1.47E-01	1.00E00
inflammatory response (GO:0006954)	588	18	9.80	+	1.84	1.31E-02	4.13E-01
regulation of lymphocyte differentiation (GO:0045619)	229	7	3.82	+	1.83	1.11E-01	1.00E00
cellular response to oxygen levels (GO:0071453)	164	5	2.73	+	1.83	2.03E-01	1.00E00
cell motility (GO:0048870)	1247	38	20.79	+	1.83	3.48E-04	3.48E-02
actin filament-based process (GO:0030029)	591	18	9.85	+	1.83	1.35E-02	4.18E-01
intracellular calcium ion homeostasis (GO:0006874)	230	7	3.83	+	1.83	1.12E-01	1.00E00
negative regulation of cell differentiation (GO:0045596)	723	22	12.05	+	1.83	6.99E-03	2.93E-01
negative regulation of phosphorylation (GO:0042326)	329	10	5.48	+	1.82	7.54E-02	8.98E-01
positive regulation of cilium assembly (GO:0045724)	33	1	.55	+	1.82	4.26E-01	1.00E00
GPI anchored protein biosynthesis (GO:0180046)	33	1	.55	+	1.82	4.26E-01	1.00E00
metanephric nephron development (GO:0072210)	33	1	.55	+	1.82	4.26E-01	1.00E00
cell redox homeostasis (GO:0045454)	33	1	.55	+	1.82	4.26E-01	1.00E00
release of cytochrome c from mitochondria (GO:0001836)	33	1	.55	+	1.82	4.26E-01	1.00E00
nuclear migration (GO:0007097)	33	1	.55	+	1.82	4.26E-01	1.00E00
retina development in camera-type eye (GO:0060041)	198	6	3.30	+	1.82	1.50E-01	1.00E00
GPI anchor biosynthetic process (GO:0006506)	33	1	.55	+	1.82	4.26E-01	1.00E00
GPI anchor metabolic process (GO:0006505)	33	1	.55	+	1.82	4.26E-01	1.00E00
mRNA export from nucleus (GO:0006406)	66	2	1.10	+	1.82	3.01E-01	1.00E00
maintenance of protein location (GO:0045185)	99	3	1.65	+	1.82	2.29E-01	1.00E00
epiboly (GO:0090504)	33	1	.55	+	1.82	4.26E-01	1.00E00
regulation of interleukin-4 production (GO:0032673)	33	1	.55	+	1.82	4.26E-01	1.00E00
positive regulation of protein targeting to membrane (GO:0090314)	33	1	.55	+	1.82	4.26E-01	1.00E00
regulation of protein deacetylation (GO:0090311)	33	1	.55	+	1.82	4.26E-01	1.00E00
negative regulation of stress fiber assembly (GO:0051497)	33	1	.55	+	1.82	4.26E-01	1.00E00
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858)	33	1	.55	+	1.82	4.26E-01	1.00E00
lymph node development (GO:0048535)	33	1	.55	+	1.82	4.26E-01	1.00E00
protein homotetramerization (GO:0051289)	66	2	1.10	+	1.82	3.01E-01	1.00E00
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	33	1	.55	+	1.82	4.26E-01	1.00E00
aorta morphogenesis (GO:0035909)	33	1	.55	+	1.82	4.26E-01	1.00E00
positive regulation of epithelial cell differentiation (GO:0030858)	66	2	1.10	+	1.82	3.01E-01	1.00E00
regulation of circadian sleep/wake cycle (GO:0042749)	33	1	.55	+	1.82	4.26E-01	1.00E00
regulation of synaptic vesicle endocytosis (GO:1900242)	33	1	.55	+	1.82	4.26E-01	1.00E00
ribonucleotide catabolic process (GO:0009261)	99	3	1.65	+	1.82	2.29E-01	1.00E00
nucleoside diphosphate catabolic process (GO:0009134)	66	2	1.10	+	1.82	3.01E-01	1.00E00
cell communication involved in cardiac conduction (GO:0086065)	33	1	.55	+	1.82	4.26E-01	1.00E00
positive regulation of cell growth (GO:0030307)	198	6	3.30	+	1.82	1.50E-01	1.00E00
hyaluronan metabolic process (GO:0030212)	33	1	.55	+	1.82	4.26E-01	1.00E00
B cell differentiation (GO:0030183)	132	4	2.20	+	1.82	2.87E-01	1.00E00
amino acid transmembrane transport (GO:0003333)	99	3	1.65	+	1.82	2.29E-01	1.00E00
response to fluid shear stress (GO:0034405)	33	1	.55	+	1.82	4.26E-01	1.00E00
regulation of immune response to tumor cell (GO:0002837)	33	1	.55	+	1.82	4.26E-01	1.00E00
regulation of morphogenesis of a branching structure (GO:0060688)	66	2	1.10	+	1.82	3.01E-01	1.00E00
cardiac atrium morphogenesis (GO:0003209)	33	1	.55	+	1.82	4.26E-01	1.00E00
regulation of protein polyubiquitination (GO:1902914)	33	1	.55	+	1.82	4.26E-01	1.00E00
negative regulation of wound healing (GO:0061045)	66	2	1.10	+	1.82	3.01E-01	1.00E00
regulation of hormone levels (GO:0010817)	661	20	11.02	+	1.82	1.21E-02	3.90E-01
regulation of protein localization (GO:0032880)	1025	31	17.09	+	1.81	1.54E-03	1.03E-01
regulation of leukocyte differentiation (GO:1902105)	364	11	6.07	+	1.81	5.79E-02	7.85E-01
response to oxygen levels (GO:0070482)	364	11	6.07	+	1.81	5.79E-02	7.84E-01
chemotaxis (GO:0006935)	331	10	5.52	+	1.81	7.64E-02	9.07E-01
regulation of phosphate metabolic process (GO:0019220)	1127	34	18.79	+	1.81	1.08E-03	8.28E-02
sodium ion transport (GO:0006814)	199	6	3.32	+	1.81	1.51E-01	1.00E00
cartilage development (GO:0051216)	199	6	3.32	+	1.81	1.51E-01	1.00E00
regulation of T cell proliferation (GO:0042129)	199	6	3.32	+	1.81	1.51E-01	1.00E00
cardiac chamber development (GO:0003205)	199	6	3.32	+	1.81	1.51E-01	1.00E00
regulation of phosphorus metabolic process (GO:0051174)	1129	34	18.82	+	1.81	1.09E-03	8.27E-02
columnar/cuboidal epithelial cell differentiation (GO:0002065)	133	4	2.22	+	1.80	2.88E-01	1.00E00
cellular response to fibroblast growth factor stimulus (GO:0044344)	133	4	2.22	+	1.80	2.88E-01	1.00E00
nuclear export (GO:0051168)	133	4	2.22	+	1.80	2.88E-01	1.00E00
fertilization (GO:0009566)	233	7	3.88	+	1.80	1.16E-01	1.00E00
taxis (GO:0042330)	333	10	5.55	+	1.80	7.74E-02	9.16E-01
actin cytoskeleton organization (GO:0030036)	533	16	8.88	+	1.80	2.38E-02	5.31E-01
regulation of animal organ morphogenesis (GO:2000027)	100	3	1.67	+	1.80	2.33E-01	1.00E00
kidney morphogenesis (GO:0060993)	100	3	1.67	+	1.80	2.33E-01	1.00E00
ATP metabolic process (GO:0046034)	167	5	2.78	+	1.80	2.07E-01	1.00E00
positive regulation of cell activation (GO:0050867)	401	12	6.68	+	1.80	4.64E-02	7.63E-01
long-term synaptic potentiation (GO:0060291)	67	2	1.12	+	1.79	3.08E-01	1.00E00
regulation of leukocyte mediated cytotoxicity (GO:0001910)	134	4	2.23	+	1.79	2.90E-01	1.00E00
positive regulation of cell junction assembly (GO:1901890)	134	4	2.23	+	1.79	2.90E-01	1.00E00
response to axon injury (GO:0048678)	67	2	1.12	+	1.79	3.08E-01	1.00E00
hair cell differentiation (GO:0035315)	67	2	1.12	+	1.79	3.08E-01	1.00E00
regulation of leukocyte chemotaxis (GO:0002688)	134	4	2.23	+	1.79	2.90E-01	1.00E00
negative regulation of cellular component organization (GO:0051129)	772	23	12.87	+	1.79	8.96E-03	3.39E-01
receptor-mediated endocytosis (GO:0006898)	168	5	2.80	+	1.79	2.09E-01	1.00E00
spindle organization (GO:0007051)	168	5	2.80	+	1.79	2.09E-01	1.00E00
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	168	5	2.80	+	1.79	2.09E-01	1.00E00
response to decreased oxygen levels (GO:0036293)	336	10	5.60	+	1.79	7.91E-02	9.23E-01
protein tetramerization (GO:0051262)	101	3	1.68	+	1.78	2.38E-01	1.00E00
regulation of blood vessel endothelial cell migration (GO:0043535)	101	3	1.68	+	1.78	2.38E-01	1.00E00
positive regulation of MAP kinase activity (GO:0043406)	101	3	1.68	+	1.78	2.38E-01	1.00E00
granulocyte migration (GO:0097530)	101	3	1.68	+	1.78	2.38E-01	1.00E00
regulation of TORC1 signaling (GO:1903432)	101	3	1.68	+	1.78	2.38E-01	1.00E00
anatomical structure morphogenesis (GO:0009653)	2430	72	40.51	+	1.78	1.23E-06	3.51E-04
regulation of cytoplasmic pattern recognition receptor signaling pathway (GO:0039531)	135	4	2.25	+	1.78	2.92E-01	1.00E00
tube development (GO:0035295)	1047	31	17.45	+	1.78	1.85E-03	1.17E-01
regulation of muscle contraction (GO:0006937)	169	5	2.82	+	1.77	2.10E-01	1.00E00
cytoskeleton-dependent intracellular transport (GO:0030705)	203	6	3.38	+	1.77	1.57E-01	1.00E00
cellular response to chemical stimulus (GO:0070887)	2098	62	34.97	+	1.77	8.74E-06	1.68E-03
regulation of cell development (GO:0060284)	948	28	15.80	+	1.77	3.84E-03	1.96E-01
hippocampus development (GO:0021766)	102	3	1.70	+	1.76	2.42E-01	1.00E00
purine nucleotide catabolic process (GO:0006195)	102	3	1.70	+	1.76	2.42E-01	1.00E00
response to reactive oxygen species (GO:0000302)	204	6	3.40	+	1.76	1.59E-01	1.00E00
lung epithelial cell differentiation (GO:0060487)	34	1	.57	+	1.76	4.36E-01	1.00E00
lung cell differentiation (GO:0060479)	34	1	.57	+	1.76	4.36E-01	1.00E00
neuroblast proliferation (GO:0007405)	68	2	1.13	+	1.76	3.14E-01	1.00E00
cerebellar cortex formation (GO:0021697)	34	1	.57	+	1.76	4.36E-01	1.00E00
spermatid nucleus differentiation (GO:0007289)	34	1	.57	+	1.76	4.36E-01	1.00E00
negative regulation of leukocyte mediated cytotoxicity (GO:0001911)	34	1	.57	+	1.76	4.36E-01	1.00E00
protein export from nucleus (GO:0006611)	34	1	.57	+	1.76	4.36E-01	1.00E00
pharyngeal system development (GO:0060037)	34	1	.57	+	1.76	4.36E-01	1.00E00
positive regulation of amino acid transport (GO:0051957)	34	1	.57	+	1.76	4.36E-01	1.00E00
cellular response to hypoxia (GO:0071456)	136	4	2.27	+	1.76	2.93E-01	1.00E00
negative regulation of chemokine production (GO:0032682)	34	1	.57	+	1.76	4.36E-01	1.00E00
negative regulation of endothelial cell apoptotic process (GO:2000352)	34	1	.57	+	1.76	4.36E-01	1.00E00
chemical homeostasis (GO:0048878)	986	29	16.44	+	1.76	3.10E-03	1.68E-01
negative regulation of neural precursor cell proliferation (GO:2000178)	34	1	.57	+	1.76	4.36E-01	1.00E00
response to interleukin-4 (GO:0070670)	34	1	.57	+	1.76	4.36E-01	1.00E00
regulation of protein processing (GO:0070613)	68	2	1.13	+	1.76	3.14E-01	1.00E00
regulation of lyase activity (GO:0051339)	34	1	.57	+	1.76	4.36E-01	1.00E00
regulation of antigen receptor-mediated signaling pathway (GO:0050854)	68	2	1.13	+	1.76	3.14E-01	1.00E00
positive regulation of lymphocyte activation (GO:0051251)	340	10	5.67	+	1.76	8.14E-02	8.95E-01
negative regulation of lipid biosynthetic process (GO:0051055)	68	2	1.13	+	1.76	3.14E-01	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	34	1	.57	+	1.76	4.36E-01	1.00E00
proton motive force-driven ATP synthesis (GO:0015986)	68	2	1.13	+	1.76	3.14E-01	1.00E00
snRNA processing (GO:0016180)	34	1	.57	+	1.76	4.36E-01	1.00E00
lipid modification (GO:0030258)	170	5	2.83	+	1.76	2.12E-01	1.00E00
regulation of response to tumor cell (GO:0002834)	34	1	.57	+	1.76	4.36E-01	1.00E00
motor neuron axon guidance (GO:0008045)	34	1	.57	+	1.76	4.36E-01	1.00E00
establishment of endothelial barrier (GO:0061028)	34	1	.57	+	1.76	4.36E-01	1.00E00
positive regulation of regulated secretory pathway (GO:1903307)	68	2	1.13	+	1.76	3.14E-01	1.00E00
purine-containing compound transmembrane transport (GO:0072530)	34	1	.57	+	1.76	4.36E-01	1.00E00
positive regulation of amide metabolic process (GO:0034250)	34	1	.57	+	1.76	4.36E-01	1.00E00
cell development (GO:0048468)	2620	77	43.67	+	1.76	5.41E-07	1.85E-04
system development (GO:0048731)	3746	110	62.44	+	1.76	6.31E-10	8.84E-07
response to oxygen-containing compound (GO:1901700)	1775	52	29.59	+	1.76	6.29E-05	8.98E-03
protein localization to nucleus (GO:0034504)	205	6	3.42	+	1.76	1.60E-01	1.00E00
negative regulation of response to stimulus (GO:0048585)	1811	53	30.19	+	1.76	7.04E-05	9.87E-03
negative regulation of signaling (GO:0023057)	1538	45	25.64	+	1.76	2.55E-04	2.69E-02
positive regulation of leukocyte activation (GO:0002696)	377	11	6.28	+	1.75	6.50E-02	8.45E-01
positive regulation of epithelial cell proliferation (GO:0050679)	240	7	4.00	+	1.75	1.25E-01	1.00E00
positive regulation of cell development (GO:0010720)	549	16	9.15	+	1.75	2.74E-02	5.82E-01
response to cAMP (GO:0051591)	103	3	1.72	+	1.75	2.46E-01	1.00E00
transition metal ion transport (GO:0000041)	103	3	1.72	+	1.75	2.46E-01	1.00E00
transmembrane transport (GO:0055085)	1202	35	20.04	+	1.75	1.54E-03	1.03E-01
negative regulation of intracellular signal transduction (GO:1902532)	724	21	12.07	+	1.74	1.66E-02	4.79E-01
muscle contraction (GO:0006936)	207	6	3.45	+	1.74	1.64E-01	1.00E00
regulation of transporter activity (GO:0032409)	207	6	3.45	+	1.74	1.64E-01	1.00E00
positive regulation of actin filament bundle assembly (GO:0032233)	69	2	1.15	+	1.74	3.20E-01	1.00E00
membrane biogenesis (GO:0044091)	69	2	1.15	+	1.74	3.20E-01	1.00E00
response to dsRNA (GO:0043331)	69	2	1.15	+	1.74	3.20E-01	1.00E00
regulation of nucleocytoplasmic transport (GO:0046822)	138	4	2.30	+	1.74	2.97E-01	1.00E00
organ growth (GO:0035265)	138	4	2.30	+	1.74	2.97E-01	1.00E00
regulation of blood coagulation (GO:0030193)	69	2	1.15	+	1.74	3.20E-01	1.00E00
response to alcohol (GO:0097305)	311	9	5.18	+	1.74	1.10E-01	1.00E00
positive regulation of canonical NF-kappaB signal transduction (GO:0043123)	173	5	2.88	+	1.73	2.17E-01	1.00E00
positive regulation of locomotion (GO:0040017)	658	19	10.97	+	1.73	1.93E-02	4.67E-01
spindle assembly (GO:0051225)	104	3	1.73	+	1.73	2.51E-01	1.00E00
regulation of GTPase activity (GO:0043087)	208	6	3.47	+	1.73	1.65E-01	1.00E00
positive regulation of developmental process (GO:0051094)	1526	44	25.44	+	1.73	3.74E-04	3.63E-02
cell-cell adhesion (GO:0098609)	487	14	8.12	+	1.72	4.62E-02	7.62E-01
regulation of cell activation (GO:0050865)	662	19	11.04	+	1.72	2.00E-02	4.80E-01
leukocyte migration (GO:0050900)	244	7	4.07	+	1.72	1.31E-01	1.00E00
positive regulation of cellular component biogenesis (GO:0044089)	558	16	9.30	+	1.72	4.13E-02	6.99E-01
response to abiotic stimulus (GO:0009628)	1221	35	20.35	+	1.72	1.74E-03	1.12E-01
phosphate-containing compound metabolic process (GO:0006796)	1539	44	25.65	+	1.72	4.14E-04	3.94E-02
regulation of smooth muscle contraction (GO:0006940)	70	2	1.17	+	1.71	3.26E-01	1.00E00
regulation of membrane repolarization (GO:0060306)	35	1	.58	+	1.71	4.45E-01	1.00E00
response to fibroblast growth factor (GO:0071774)	140	4	2.33	+	1.71	3.00E-01	1.00E00
cellular anatomical entity morphogenesis (GO:0032989)	140	4	2.33	+	1.71	3.00E-01	1.00E00
regulation of syncytium formation by plasma membrane fusion (GO:0060142)	35	1	.58	+	1.71	4.45E-01	1.00E00
maternal process involved in female pregnancy (GO:0060135)	70	2	1.17	+	1.71	3.26E-01	1.00E00
inner ear receptor cell development (GO:0060119)	70	2	1.17	+	1.71	3.26E-01	1.00E00
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253)	35	1	.58	+	1.71	4.45E-01	1.00E00
protein N-linked glycosylation (GO:0006487)	70	2	1.17	+	1.71	3.26E-01	1.00E00
positive regulation of receptor internalization (GO:0002092)	35	1	.58	+	1.71	4.45E-01	1.00E00
glial cell proliferation (GO:0014009)	35	1	.58	+	1.71	4.45E-01	1.00E00
regulation of T-helper 17 type immune response (GO:2000316)	35	1	.58	+	1.71	4.45E-01	1.00E00
interleukin-6 production (GO:0032635)	35	1	.58	+	1.71	4.45E-01	1.00E00
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036)	35	1	.58	+	1.71	4.45E-01	1.00E00
bone growth (GO:0098868)	35	1	.58	+	1.71	4.45E-01	1.00E00
carbohydrate derivative biosynthetic process (GO:1901137)	560	16	9.34	+	1.71	4.16E-02	7.03E-01
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994)	35	1	.58	+	1.71	4.45E-01	1.00E00
spliceosomal snRNP assembly (GO:0000387)	35	1	.58	+	1.71	4.45E-01	1.00E00
potassium ion homeostasis (GO:0055075)	35	1	.58	+	1.71	4.45E-01	1.00E00
cellular component assembly involved in morphogenesis (GO:0010927)	140	4	2.33	+	1.71	3.00E-01	1.00E00
negative regulation of lipid storage (GO:0010888)	35	1	.58	+	1.71	4.45E-01	1.00E00
sterol metabolic process (GO:0016125)	140	4	2.33	+	1.71	3.00E-01	1.00E00
regulation of neuroinflammatory response (GO:0150077)	35	1	.58	+	1.71	4.45E-01	1.00E00
liver regeneration (GO:0097421)	35	1	.58	+	1.71	4.45E-01	1.00E00
negative regulation of viral entry into host cell (GO:0046597)	35	1	.58	+	1.71	4.45E-01	1.00E00
positive regulation of cell population proliferation (GO:0008284)	1015	29	16.92	+	1.71	5.22E-03	2.43E-01
circadian rhythm (GO:0007623)	175	5	2.92	+	1.71	2.21E-01	1.00E00
negative regulation of cytokine production involved in immune response (GO:0002719)	35	1	.58	+	1.71	4.45E-01	1.00E00
negative regulation of cell communication (GO:0010648)	1541	44	25.69	+	1.71	5.78E-04	5.21E-02
regulation of signal transduction (GO:0009966)	3154	90	52.58	+	1.71	1.63E-07	7.61E-05
phosphorus metabolic process (GO:0006793)	1542	44	25.70	+	1.71	5.80E-04	5.20E-02
response to lipid (GO:0033993)	949	27	15.82	+	1.71	6.29E-03	2.75E-01
nucleobase-containing compound transport (GO:0015931)	211	6	3.52	+	1.71	1.70E-01	1.00E00
regulation of response to biotic stimulus (GO:0002831)	598	17	9.97	+	1.71	3.30E-02	6.53E-01
protein localization to cell periphery (GO:1990778)	282	8	4.70	+	1.70	1.50E-01	1.00E00
sulfur compound biosynthetic process (GO:0044272)	141	4	2.35	+	1.70	3.02E-01	1.00E00
sodium ion transmembrane transport (GO:0035725)	141	4	2.35	+	1.70	3.02E-01	1.00E00
neuropeptide signaling pathway (GO:0007218)	106	3	1.77	+	1.70	2.60E-01	1.00E00
regulation of organic acid transport (GO:0032890)	106	3	1.77	+	1.70	2.60E-01	1.00E00
mitochondrial membrane organization (GO:0007006)	106	3	1.77	+	1.70	2.60E-01	1.00E00
cellular response to acid chemical (GO:0071229)	106	3	1.77	+	1.70	2.60E-01	1.00E00
fibroblast growth factor receptor signaling pathway (GO:0008543)	106	3	1.77	+	1.70	2.60E-01	1.00E00
positive regulation of MAPK cascade (GO:0043410)	530	15	8.83	+	1.70	5.52E-02	7.70E-01
anatomical structure formation involved in morphogenesis (GO:0048646)	1061	30	17.69	+	1.70	4.47E-03	2.16E-01
regulation of actin filament organization (GO:0110053)	283	8	4.72	+	1.70	1.51E-01	1.00E00
regulation of phosphorylation (GO:0042325)	991	28	16.52	+	1.69	7.03E-03	2.93E-01
organic hydroxy compound biosynthetic process (GO:1901617)	177	5	2.95	+	1.69	2.25E-01	1.00E00
cytokine-mediated signaling pathway (GO:0019221)	426	12	7.10	+	1.69	8.03E-02	9.31E-01
secondary alcohol metabolic process (GO:1902652)	142	4	2.37	+	1.69	3.04E-01	1.00E00
protein localization to extracellular region (GO:0071692)	142	4	2.37	+	1.69	3.04E-01	1.00E00
regulation of lipid catabolic process (GO:0050994)	71	2	1.18	+	1.69	3.32E-01	1.00E00
protein complex oligomerization (GO:0051259)	284	8	4.73	+	1.69	1.52E-01	1.00E00
regulation of hemostasis (GO:1900046)	71	2	1.18	+	1.69	3.32E-01	1.00E00
ventricular cardiac muscle tissue development (GO:0003229)	71	2	1.18	+	1.69	3.32E-01	1.00E00
regulation of D-glucose import (GO:0046324)	71	2	1.18	+	1.69	3.32E-01	1.00E00
negative regulation of multicellular organismal process (GO:0051241)	1244	35	20.74	+	1.69	2.74E-03	1.55E-01
regulation of cellular localization (GO:0060341)	1138	32	18.97	+	1.69	3.97E-03	2.01E-01
multicellular organismal-level homeostasis (GO:0048871)	748	21	12.47	+	1.68	1.91E-02	4.63E-01
cellular response to cytokine stimulus (GO:0071345)	855	24	14.25	+	1.68	1.32E-02	4.16E-01
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051896)	285	8	4.75	+	1.68	1.53E-01	1.00E00
ossification (GO:0001503)	285	8	4.75	+	1.68	1.53E-01	1.00E00
regulation of T cell activation (GO:0050863)	392	11	6.53	+	1.68	1.05E-01	9.98E-01
endocytosis (GO:0006897)	499	14	8.32	+	1.68	5.10E-02	7.29E-01
cholesterol homeostasis (GO:0042632)	107	3	1.78	+	1.68	2.64E-01	1.00E00
regulation of cellular component biogenesis (GO:0044087)	1108	31	18.47	+	1.68	5.15E-03	2.42E-01
negative regulation of T cell activation (GO:0050868)	143	4	2.38	+	1.68	3.06E-01	1.00E00
regulation of ERK1 and ERK2 cascade (GO:0070372)	322	9	5.37	+	1.68	1.19E-01	1.00E00
myeloid cell homeostasis (GO:0002262)	179	5	2.98	+	1.68	2.29E-01	1.00E00
positive regulation of transmembrane transport (GO:0034764)	251	7	4.18	+	1.67	2.04E-01	1.00E00
negative regulation of growth (GO:0045926)	251	7	4.18	+	1.67	2.04E-01	1.00E00
anatomical structure maturation (GO:0071695)	287	8	4.78	+	1.67	1.55E-01	1.00E00
positive regulation of cell migration (GO:0030335)	611	17	10.19	+	1.67	3.62E-02	6.38E-01
multivesicular body sorting pathway (GO:0071985)	36	1	.60	+	1.67	4.54E-01	1.00E00
negative regulation of double-strand break repair (GO:2000780)	36	1	.60	+	1.67	4.54E-01	1.00E00
transcription by RNA polymerase III (GO:0006383)	36	1	.60	+	1.67	4.54E-01	1.00E00
platelet aggregation (GO:0070527)	36	1	.60	+	1.67	4.54E-01	1.00E00
negative regulation of B cell activation (GO:0050869)	36	1	.60	+	1.67	4.54E-01	1.00E00
keratinocyte proliferation (GO:0043616)	36	1	.60	+	1.67	4.54E-01	1.00E00
aorta development (GO:0035904)	72	2	1.20	+	1.67	3.38E-01	1.00E00
regulation of defense response to virus (GO:0050688)	72	2	1.20	+	1.67	3.38E-01	1.00E00
RNA transport (GO:0050658)	144	4	2.40	+	1.67	3.08E-01	1.00E00
nucleic acid transport (GO:0050657)	144	4	2.40	+	1.67	3.08E-01	1.00E00
chondroitin sulfate proteoglycan metabolic process (GO:0050654)	36	1	.60	+	1.67	4.54E-01	1.00E00
regulation of mast cell degranulation (GO:0043304)	36	1	.60	+	1.67	4.54E-01	1.00E00
embryonic forelimb morphogenesis (GO:0035115)	36	1	.60	+	1.67	4.54E-01	1.00E00
response to gonadotropin (GO:0034698)	36	1	.60	+	1.67	4.54E-01	1.00E00
neural precursor cell proliferation (GO:0061351)	144	4	2.40	+	1.67	3.08E-01	1.00E00
regulation of epithelial cell apoptotic process (GO:1904035)	72	2	1.20	+	1.67	3.38E-01	1.00E00
positive regulation of smooth muscle cell migration (GO:0014911)	72	2	1.20	+	1.67	3.38E-01	1.00E00
positive regulation of smooth muscle contraction (GO:0045987)	36	1	.60	+	1.67	4.54E-01	1.00E00
cell surface receptor signaling pathway (GO:0007166)	2016	56	33.61	+	1.67	1.58E-04	1.89E-02
response to corticosteroid (GO:0031960)	180	5	3.00	+	1.67	2.31E-01	1.00E00
regulation of body fluid levels (GO:0050878)	360	10	6.00	+	1.67	9.67E-02	9.47E-01
sterol homeostasis (GO:0055092)	108	3	1.80	+	1.67	4.31E-01	1.00E00
vesicle-mediated transport (GO:0016192)	1296	36	21.60	+	1.67	3.32E-03	1.76E-01
regulation of epithelial to mesenchymal transition (GO:0010717)	108	3	1.80	+	1.67	4.31E-01	1.00E00
positive regulation of DNA-binding transcription factor activity (GO:0051091)	217	6	3.62	+	1.66	1.81E-01	1.00E00
multicellular organism development (GO:0007275)	4238	117	70.65	+	1.66	6.24E-09	4.37E-06
response to molecule of bacterial origin (GO:0002237)	399	11	6.65	+	1.65	1.08E-01	1.00E00
regulation of smooth muscle cell migration (GO:0014910)	109	3	1.82	+	1.65	4.33E-01	1.00E00
organophosphate metabolic process (GO:0019637)	945	26	15.75	+	1.65	1.28E-02	4.04E-01
regulation of defense response (GO:0031347)	874	24	14.57	+	1.65	2.05E-02	4.90E-01
positive regulation of phosphorus metabolic process (GO:0010562)	692	19	11.54	+	1.65	3.30E-02	6.52E-01
positive regulation of phosphate metabolic process (GO:0045937)	692	19	11.54	+	1.65	3.30E-02	6.52E-01
regulation of intracellular signal transduction (GO:1902531)	2004	55	33.41	+	1.65	2.25E-04	2.46E-02
stem cell differentiation (GO:0048863)	219	6	3.65	+	1.64	1.85E-01	1.00E00
positive regulation of developmental growth (GO:0048639)	219	6	3.65	+	1.64	1.85E-01	1.00E00
protein localization to plasma membrane (GO:0072659)	219	6	3.65	+	1.64	1.85E-01	1.00E00
cellular oxidant detoxification (GO:0098869)	73	2	1.22	+	1.64	3.44E-01	1.00E00
establishment of RNA localization (GO:0051236)	146	4	2.43	+	1.64	3.12E-01	1.00E00
cellular response to decreased oxygen levels (GO:0036294)	146	4	2.43	+	1.64	3.12E-01	1.00E00
synapse organization (GO:0050808)	402	11	6.70	+	1.64	1.10E-01	1.00E00
locomotion (GO:0040011)	366	10	6.10	+	1.64	1.42E-01	1.00E00
mesenchymal cell differentiation (GO:0048762)	183	5	3.05	+	1.64	2.37E-01	1.00E00
regeneration (GO:0031099)	183	5	3.05	+	1.64	2.37E-01	1.00E00
transport along microtubule (GO:0010970)	183	5	3.05	+	1.64	2.37E-01	1.00E00
mononuclear cell differentiation (GO:1903131)	403	11	6.72	+	1.64	1.10E-01	1.00E00
regulation of fatty acid metabolic process (GO:0019217)	110	3	1.83	+	1.64	4.35E-01	1.00E00
positive regulation of JNK cascade (GO:0046330)	110	3	1.83	+	1.64	4.35E-01	1.00E00
negative regulation of immune effector process (GO:0002698)	147	4	2.45	+	1.63	3.14E-01	1.00E00
regulation of cell differentiation (GO:0045595)	1691	46	28.19	+	1.63	1.01E-03	7.86E-02
regulation of system process (GO:0044057)	662	18	11.04	+	1.63	4.28E-02	7.21E-01
positive regulation of signaling (GO:0023056)	1913	52	31.89	+	1.63	4.86E-04	4.49E-02
positive regulation of cellular component organization (GO:0051130)	1288	35	21.47	+	1.63	4.68E-03	2.25E-01
regulation of actin cytoskeleton organization (GO:0032956)	368	10	6.13	+	1.63	1.43E-01	1.00E00
regulation of cellular component size (GO:0032535)	405	11	6.75	+	1.63	1.12E-01	1.00E00
sensory perception of mechanical stimulus (GO:0050954)	221	6	3.68	+	1.63	1.89E-01	1.00E00
regulation of anatomical structure size (GO:0090066)	590	16	9.84	+	1.63	5.01E-02	7.23E-01
regulation of cell growth (GO:0001558)	443	12	7.38	+	1.62	8.94E-02	9.48E-01
positive regulation of cell differentiation (GO:0045597)	998	27	16.64	+	1.62	1.52E-02	4.49E-01
circulatory system development (GO:0072359)	1035	28	17.25	+	1.62	1.21E-02	3.90E-01
negative regulation of DNA repair (GO:0045738)	37	1	.62	+	1.62	4.63E-01	1.00E00
positive regulation of lamellipodium organization (GO:1902745)	37	1	.62	+	1.62	4.63E-01	1.00E00
negative regulation of glial cell differentiation (GO:0045686)	37	1	.62	+	1.62	4.63E-01	1.00E00
production of molecular mediator involved in inflammatory response (GO:0002532)	37	1	.62	+	1.62	4.63E-01	1.00E00
regulation of cilium movement involved in cell motility (GO:0060295)	37	1	.62	+	1.62	4.63E-01	1.00E00
regulation of cytoplasmic translation (GO:2000765)	37	1	.62	+	1.62	4.63E-01	1.00E00
positive regulation of collagen biosynthetic process (GO:0032967)	37	1	.62	+	1.62	4.63E-01	1.00E00
auditory receptor cell development (GO:0060117)	37	1	.62	+	1.62	4.63E-01	1.00E00
positive regulation of T cell migration (GO:2000406)	37	1	.62	+	1.62	4.63E-01	1.00E00
cellular response to low-density lipoprotein particle stimulus (GO:0071404)	37	1	.62	+	1.62	4.63E-01	1.00E00
regulation of intracellular estrogen receptor signaling pathway (GO:0033146)	37	1	.62	+	1.62	4.63E-01	1.00E00
microtubule bundle formation (GO:0001578)	148	4	2.47	+	1.62	3.16E-01	1.00E00
cellular response to estradiol stimulus (GO:0071392)	37	1	.62	+	1.62	4.63E-01	1.00E00
neurotransmitter receptor transport (GO:0099637)	37	1	.62	+	1.62	4.63E-01	1.00E00
regulation of cilium-dependent cell motility (GO:1902019)	37	1	.62	+	1.62	4.63E-01	1.00E00
negative regulation of intracellular protein transport (GO:0090317)	37	1	.62	+	1.62	4.63E-01	1.00E00
synaptic membrane adhesion (GO:0099560)	37	1	.62	+	1.62	4.63E-01	1.00E00
positive regulation of response to endoplasmic reticulum stress (GO:1905898)	37	1	.62	+	1.62	4.63E-01	1.00E00
positive regulation of potassium ion transmembrane transport (GO:1901381)	37	1	.62	+	1.62	4.63E-01	1.00E00
regulation of action potential (GO:0098900)	74	2	1.23	+	1.62	3.50E-01	1.00E00
positive chemotaxis (GO:0050918)	37	1	.62	+	1.62	4.63E-01	1.00E00
sensory perception of taste (GO:0050909)	74	2	1.23	+	1.62	3.50E-01	1.00E00
positive regulation of telomere maintenance via telomerase (GO:0032212)	37	1	.62	+	1.62	4.63E-01	1.00E00
centrosome duplication (GO:0051298)	37	1	.62	+	1.62	4.63E-01	1.00E00
negative regulation of blood vessel endothelial cell migration (GO:0043537)	37	1	.62	+	1.62	4.63E-01	1.00E00
regulation of mRNA processing (GO:0050684)	148	4	2.47	+	1.62	3.16E-01	1.00E00
regulation of B cell proliferation (GO:0030888)	74	2	1.23	+	1.62	3.50E-01	1.00E00
neuron projection regeneration (GO:0031102)	37	1	.62	+	1.62	4.63E-01	1.00E00
response to lipoprotein particle (GO:0055094)	37	1	.62	+	1.62	4.63E-01	1.00E00
positive regulation of cellular response to insulin stimulus (GO:1900078)	37	1	.62	+	1.62	4.63E-01	1.00E00
negative regulation of muscle cell apoptotic process (GO:0010656)	74	2	1.23	+	1.62	3.50E-01	1.00E00
epithelial cell migration (GO:0010631)	37	1	.62	+	1.62	4.63E-01	1.00E00
negative regulation of fatty acid metabolic process (GO:0045922)	37	1	.62	+	1.62	4.63E-01	1.00E00
negative regulation of carbohydrate metabolic process (GO:0045912)	74	2	1.23	+	1.62	3.50E-01	1.00E00
regulation of T cell cytokine production (GO:0002724)	37	1	.62	+	1.62	4.63E-01	1.00E00
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	111	3	1.85	+	1.62	4.36E-01	1.00E00
positive regulation of interleukin-6 production (GO:0032755)	111	3	1.85	+	1.62	4.36E-01	1.00E00
positive regulation of intracellular protein transport (GO:0090316)	111	3	1.85	+	1.62	4.36E-01	1.00E00
carbohydrate derivative metabolic process (GO:1901135)	888	24	14.80	+	1.62	2.16E-02	5.08E-01
axoneme assembly (GO:0035082)	111	3	1.85	+	1.62	4.36E-01	1.00E00
cell population proliferation (GO:0008283)	888	24	14.80	+	1.62	2.16E-02	5.08E-01
positive regulation of carbohydrate metabolic process (GO:0045913)	111	3	1.85	+	1.62	4.36E-01	1.00E00
regulation of Wnt signaling pathway (GO:0030111)	334	9	5.57	+	1.62	1.32E-01	1.00E00
regulation of developmental process (GO:0050793)	2674	72	44.57	+	1.62	3.45E-05	5.42E-03
negative regulation of cell population proliferation (GO:0008285)	745	20	12.42	+	1.61	3.94E-02	6.74E-01
regulation of actomyosin structure organization (GO:0110020)	112	3	1.87	+	1.61	4.38E-01	1.00E00
peptidyl-serine phosphorylation (GO:0018105)	112	3	1.87	+	1.61	4.38E-01	1.00E00
protein processing (GO:0016485)	224	6	3.73	+	1.61	2.82E-01	1.00E00
regulation of protein phosphorylation (GO:0001932)	935	25	15.59	+	1.60	1.85E-02	4.61E-01
regulation of hemopoiesis (GO:1903706)	449	12	7.48	+	1.60	9.34E-02	9.78E-01
regulation of canonical Wnt signaling pathway (GO:0060828)	262	7	4.37	+	1.60	2.15E-01	1.00E00
positive regulation of cell communication (GO:0010647)	1912	51	31.87	+	1.60	9.72E-04	7.64E-02
JNK cascade (GO:0007254)	75	2	1.25	+	1.60	3.56E-01	1.00E00
cellular response to mechanical stimulus (GO:0071260)	75	2	1.25	+	1.60	3.56E-01	1.00E00
cell-cell recognition (GO:0009988)	75	2	1.25	+	1.60	3.56E-01	1.00E00
neutrophil migration (GO:1990266)	75	2	1.25	+	1.60	3.56E-01	1.00E00
regulation of coagulation (GO:0050818)	75	2	1.25	+	1.60	3.56E-01	1.00E00
regulation of morphogenesis of an epithelium (GO:1905330)	75	2	1.25	+	1.60	3.56E-01	1.00E00
regulation of protein modification process (GO:0031399)	1200	32	20.00	+	1.60	1.00E-02	3.56E-01
dendrite development (GO:0016358)	150	4	2.50	+	1.60	3.21E-01	1.00E00
cholesterol transport (GO:0030301)	75	2	1.25	+	1.60	3.56E-01	1.00E00
cardiac chamber morphogenesis (GO:0003206)	150	4	2.50	+	1.60	3.21E-01	1.00E00
regulation of transcription elongation by RNA polymerase II (GO:0034243)	75	2	1.25	+	1.60	3.56E-01	1.00E00
response to cytokine (GO:0034097)	976	26	16.27	+	1.60	2.02E-02	4.84E-01
regulation of pattern recognition receptor signaling pathway (GO:0062207)	188	5	3.13	+	1.60	2.48E-01	1.00E00
positive regulation of T cell proliferation (GO:0042102)	113	3	1.88	+	1.59	4.40E-01	1.00E00
positive regulation of nervous system development (GO:0051962)	377	10	6.28	+	1.59	1.49E-01	1.00E00
positive regulation of cell motility (GO:2000147)	641	17	10.69	+	1.59	5.81E-02	7.87E-01
modified amino acid metabolic process (GO:0006575)	189	5	3.15	+	1.59	2.50E-01	1.00E00
positive regulation of multicellular organismal process (GO:0051240)	1891	50	31.52	+	1.59	1.28E-03	9.02E-02
mRNA splicing, via spliceosome (GO:0000398)	227	6	3.78	+	1.59	2.85E-01	1.00E00
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	227	6	3.78	+	1.59	2.85E-01	1.00E00
RNA splicing, via transesterification reactions (GO:0000375)	227	6	3.78	+	1.59	2.85E-01	1.00E00
plasma membrane bounded cell projection assembly (GO:0120031)	455	12	7.58	+	1.58	1.33E-01	1.00E00
endochondral ossification (GO:0001958)	38	1	.63	+	1.58	4.72E-01	1.00E00
leukocyte activation involved in inflammatory response (GO:0002269)	38	1	.63	+	1.58	4.72E-01	1.00E00
nephron tubule morphogenesis (GO:0072078)	76	2	1.27	+	1.58	3.62E-01	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229)	38	1	.63	+	1.58	4.72E-01	1.00E00
glycosyl compound metabolic process (GO:1901657)	76	2	1.27	+	1.58	3.62E-01	1.00E00
regulation of amyloid-beta formation (GO:1902003)	38	1	.63	+	1.58	4.72E-01	1.00E00
positive regulation of oxidoreductase activity (GO:0051353)	38	1	.63	+	1.58	4.72E-01	1.00E00
replacement ossification (GO:0036075)	38	1	.63	+	1.58	4.72E-01	1.00E00
somatic recombination of immunoglobulin gene segments (GO:0016447)	38	1	.63	+	1.58	4.72E-01	1.00E00
non-canonical Wnt signaling pathway (GO:0035567)	38	1	.63	+	1.58	4.72E-01	1.00E00
animal organ regeneration (GO:0031100)	76	2	1.27	+	1.58	3.62E-01	1.00E00
dephosphorylation (GO:0016311)	152	4	2.53	+	1.58	3.25E-01	1.00E00
lymphocyte proliferation (GO:0046651)	152	4	2.53	+	1.58	3.25E-01	1.00E00
tissue regeneration (GO:0042246)	76	2	1.27	+	1.58	3.62E-01	1.00E00
positive regulation of neuron differentiation (GO:0045666)	114	3	1.90	+	1.58	4.42E-01	1.00E00
regulation of multicellular organismal development (GO:2000026)	1598	42	26.64	+	1.58	3.13E-03	1.68E-01
negative regulation of signal transduction (GO:0009968)	1408	37	23.47	+	1.58	6.70E-03	2.82E-01
intracellular chemical homeostasis (GO:0055082)	609	16	10.15	+	1.58	7.44E-02	8.86E-01
response to lipopolysaccharide (GO:0032496)	381	10	6.35	+	1.57	1.52E-01	1.00E00
response to peptide (GO:1901652)	991	26	16.52	+	1.57	2.16E-02	5.07E-01
monoatomic cation homeostasis (GO:0055080)	534	14	8.90	+	1.57	8.58E-02	9.24E-01
bone development (GO:0060348)	229	6	3.82	+	1.57	2.87E-01	1.00E00
regulation of protein localization to membrane (GO:1905475)	229	6	3.82	+	1.57	2.87E-01	1.00E00
purine ribonucleoside triphosphate metabolic process (GO:0009205)	191	5	3.18	+	1.57	2.54E-01	1.00E00
developmental maturation (GO:0021700)	344	9	5.73	+	1.57	1.95E-01	1.00E00
DNA-templated transcription initiation (GO:0006352)	153	4	2.55	+	1.57	3.28E-01	1.00E00
positive regulation of inflammatory response (GO:0050729)	153	4	2.55	+	1.57	3.28E-01	1.00E00
regulation of multicellular organismal process (GO:0051239)	3257	85	54.29	+	1.57	2.03E-05	3.41E-03
aminoglycan metabolic process (GO:0006022)	115	3	1.92	+	1.56	4.45E-01	1.00E00
regulation of actin filament bundle assembly (GO:0032231)	115	3	1.92	+	1.56	4.45E-01	1.00E00
regulation of receptor signaling pathway via STAT (GO:1904892)	115	3	1.92	+	1.56	4.45E-01	1.00E00
connective tissue development (GO:0061448)	269	7	4.48	+	1.56	2.23E-01	1.00E00
positive regulation of osteoblast differentiation (GO:0045669)	77	2	1.28	+	1.56	3.68E-01	1.00E00
negative regulation of protein phosphorylation (GO:0001933)	308	8	5.13	+	1.56	1.79E-01	1.00E00
secretory granule organization (GO:0033363)	77	2	1.28	+	1.56	3.68E-01	1.00E00
cardiac muscle contraction (GO:0060048)	77	2	1.28	+	1.56	3.68E-01	1.00E00
positive regulation of interleukin-1 production (GO:0032732)	77	2	1.28	+	1.56	3.68E-01	1.00E00
cellular response to external stimulus (GO:0071496)	77	2	1.28	+	1.56	3.68E-01	1.00E00
intermediate filament organization (GO:0045109)	77	2	1.28	+	1.56	3.68E-01	1.00E00
skeletal system development (GO:0001501)	539	14	8.98	+	1.56	8.85E-02	9.48E-01
cellular response to interleukin-1 (GO:0071347)	77	2	1.28	+	1.56	3.68E-01	1.00E00
negative regulation of protein polymerization (GO:0032272)	77	2	1.28	+	1.56	3.68E-01	1.00E00
positive regulation of protein localization to cell periphery (GO:1904377)	77	2	1.28	+	1.56	3.68E-01	1.00E00
regulation of cartilage development (GO:0061035)	77	2	1.28	+	1.56	3.68E-01	1.00E00
transport (GO:0006810)	3620	94	60.34	+	1.56	6.49E-06	1.30E-03
inorganic ion homeostasis (GO:0098771)	463	12	7.72	+	1.55	1.37E-01	1.00E00
regulation of response to stress (GO:0080134)	1468	38	24.47	+	1.55	7.85E-03	3.09E-01
regulation of chemokine production (GO:0032642)	116	3	1.93	+	1.55	4.47E-01	1.00E00
regulation of cell-substrate adhesion (GO:0010810)	232	6	3.87	+	1.55	2.91E-01	1.00E00
mononuclear cell proliferation (GO:0032943)	155	4	2.58	+	1.55	3.33E-01	1.00E00
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)	155	4	2.58	+	1.55	3.33E-01	1.00E00
regulation of TOR signaling (GO:0032006)	155	4	2.58	+	1.55	3.33E-01	1.00E00
response to light stimulus (GO:0009416)	349	9	5.82	+	1.55	1.99E-01	1.00E00
Wnt signaling pathway (GO:0016055)	272	7	4.53	+	1.54	2.27E-01	1.00E00
regulation of leukocyte mediated immunity (GO:0002703)	311	8	5.18	+	1.54	1.83E-01	1.00E00
response to endogenous stimulus (GO:0009719)	1323	34	22.05	+	1.54	1.41E-02	4.24E-01
toll-like receptor 4 signaling pathway (GO:0034142)	39	1	.65	+	1.54	4.81E-01	1.00E00
modified amino acid transport (GO:0072337)	39	1	.65	+	1.54	4.81E-01	1.00E00
nephron epithelium morphogenesis (GO:0072088)	78	2	1.30	+	1.54	3.74E-01	1.00E00
regulation of interleukin-8 production (GO:0032677)	78	2	1.30	+	1.54	3.74E-01	1.00E00
base-excision repair (GO:0006284)	39	1	.65	+	1.54	4.81E-01	1.00E00
negative regulation of actin filament bundle assembly (GO:0032232)	39	1	.65	+	1.54	4.81E-01	1.00E00
circadian behavior (GO:0048512)	39	1	.65	+	1.54	4.81E-01	1.00E00
regulation of actin nucleation (GO:0051125)	39	1	.65	+	1.54	4.81E-01	1.00E00
response to toxic substance (GO:0009636)	234	6	3.90	+	1.54	2.93E-01	1.00E00
detection of biotic stimulus (GO:0009595)	39	1	.65	+	1.54	4.81E-01	1.00E00
negative regulation of cell killing (GO:0031342)	39	1	.65	+	1.54	4.81E-01	1.00E00
regulation of vascular associated smooth muscle cell migration (GO:1904752)	39	1	.65	+	1.54	4.81E-01	1.00E00
embryonic eye morphogenesis (GO:0048048)	39	1	.65	+	1.54	4.81E-01	1.00E00
positive regulation of microtubule polymerization or depolymerization (GO:0031112)	39	1	.65	+	1.54	4.81E-01	1.00E00
epigenetic programming of gene expression (GO:0043045)	39	1	.65	+	1.54	4.81E-01	1.00E00
amino acid import across plasma membrane (GO:0089718)	39	1	.65	+	1.54	4.81E-01	1.00E00
cellular response to oxidative stress (GO:0034599)	234	6	3.90	+	1.54	2.93E-01	1.00E00
cell projection assembly (GO:0030031)	468	12	7.80	+	1.54	1.40E-01	1.00E00
positive regulation of DNA recombination (GO:0045911)	78	2	1.30	+	1.54	3.74E-01	1.00E00
reactive oxygen species metabolic process (GO:0072593)	117	3	1.95	+	1.54	4.49E-01	1.00E00
regulation of miRNA transcription (GO:1902893)	78	2	1.30	+	1.54	3.74E-01	1.00E00
placenta development (GO:0001890)	195	5	3.25	+	1.54	2.64E-01	1.00E00
regulation of epithelial cell proliferation (GO:0050678)	429	11	7.15	+	1.54	1.76E-01	1.00E00
blood vessel diameter maintenance (GO:0097746)	195	5	3.25	+	1.54	2.64E-01	1.00E00
regulation of tube diameter (GO:0035296)	195	5	3.25	+	1.54	2.64E-01	1.00E00
negative regulation of cell growth (GO:0030308)	195	5	3.25	+	1.54	2.64E-01	1.00E00
monoatomic ion homeostasis (GO:0050801)	547	14	9.12	+	1.54	1.23E-01	1.00E00
positive regulation of signal transduction (GO:0009967)	1683	43	28.06	+	1.53	5.25E-03	2.44E-01
regulation of tube size (GO:0035150)	196	5	3.27	+	1.53	2.66E-01	1.00E00
positive regulation of lymphocyte proliferation (GO:0050671)	157	4	2.62	+	1.53	3.37E-01	1.00E00
regulation of cellular component organization (GO:0051128)	2670	68	44.51	+	1.53	3.55E-04	3.53E-02
protein maturation (GO:0051604)	550	14	9.17	+	1.53	1.25E-01	1.00E00
regulation of response to stimulus (GO:0048583)	4210	107	70.18	+	1.52	3.21E-06	7.74E-04
establishment of organelle localization (GO:0051656)	433	11	7.22	+	1.52	1.78E-01	1.00E00
localization (GO:0051179)	4528	115	75.48	+	1.52	1.17E-06	3.40E-04
lymphocyte differentiation (GO:0030098)	315	8	5.25	+	1.52	2.59E-01	1.00E00
ribonucleoside triphosphate metabolic process (GO:0009199)	197	5	3.28	+	1.52	2.69E-01	1.00E00
organophosphate catabolic process (GO:0046434)	197	5	3.28	+	1.52	2.69E-01	1.00E00
positive regulation of intracellular signal transduction (GO:1902533)	1183	30	19.72	+	1.52	2.54E-02	5.48E-01
cell differentiation (GO:0030154)	4023	102	67.06	+	1.52	6.00E-06	1.25E-03
cellular developmental process (GO:0048869)	4025	102	67.10	+	1.52	6.06E-06	1.24E-03
positive regulation of ion transmembrane transporter activity (GO:0032414)	79	2	1.32	+	1.52	3.80E-01	1.00E00
microtubule-based transport (GO:0099111)	237	6	3.95	+	1.52	2.97E-01	1.00E00
regulation of vascular associated smooth muscle cell proliferation (GO:1904705)	79	2	1.32	+	1.52	3.80E-01	1.00E00
response to radiation (GO:0009314)	476	12	7.93	+	1.51	1.45E-01	1.00E00
regulation of cell population proliferation (GO:0042127)	1747	44	29.12	+	1.51	6.10E-03	2.71E-01
cell fate commitment (GO:0045165)	278	7	4.63	+	1.51	2.36E-01	1.00E00
alcohol metabolic process (GO:0006066)	318	8	5.30	+	1.51	2.61E-01	1.00E00
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051897)	199	5	3.32	+	1.51	3.92E-01	1.00E00
regulation of smooth muscle cell proliferation (GO:0048660)	199	5	3.32	+	1.51	3.92E-01	1.00E00
purine nucleoside triphosphate metabolic process (GO:0009144)	199	5	3.32	+	1.51	3.92E-01	1.00E00
establishment of localization (GO:0051234)	3902	98	65.05	+	1.51	1.67E-05	2.86E-03
supramolecular fiber organization (GO:0097435)	598	15	9.97	+	1.50	1.05E-01	9.98E-01
response to oxidative stress (GO:0006979)	399	10	6.65	+	1.50	1.68E-01	1.00E00
fatty acid biosynthetic process (GO:0006633)	120	3	2.00	+	1.50	4.56E-01	1.00E00
nucleotide catabolic process (GO:0009166)	120	3	2.00	+	1.50	4.56E-01	1.00E00
purine-containing compound catabolic process (GO:0072523)	120	3	2.00	+	1.50	4.56E-01	1.00E00
complement activation, classical pathway (GO:0006958)	40	1	.67	+	1.50	4.90E-01	1.00E00
secondary alcohol biosynthetic process (GO:1902653)	40	1	.67	+	1.50	4.90E-01	1.00E00
positive regulation of animal organ morphogenesis (GO:0110110)	40	1	.67	+	1.50	4.90E-01	1.00E00
dicarboxylic acid transport (GO:0006835)	80	2	1.33	+	1.50	3.86E-01	1.00E00
regulation of cytokine-mediated signaling pathway (GO:0001959)	160	4	2.67	+	1.50	3.45E-01	1.00E00
positive regulation of mononuclear cell proliferation (GO:0032946)	160	4	2.67	+	1.50	3.45E-01	1.00E00
cholesterol biosynthetic process (GO:0006695)	40	1	.67	+	1.50	4.90E-01	1.00E00
nephron morphogenesis (GO:0072028)	80	2	1.33	+	1.50	3.86E-01	1.00E00
RNA export from nucleus (GO:0006405)	80	2	1.33	+	1.50	3.86E-01	1.00E00
regulation of cilium assembly (GO:1902017)	80	2	1.33	+	1.50	3.86E-01	1.00E00
regulation of protein autophosphorylation (GO:0031952)	40	1	.67	+	1.50	4.90E-01	1.00E00
epithelium migration (GO:0090132)	40	1	.67	+	1.50	4.90E-01	1.00E00
response to acid chemical (GO:0001101)	160	4	2.67	+	1.50	3.45E-01	1.00E00
rhythmic process (GO:0048511)	320	8	5.33	+	1.50	2.63E-01	1.00E00
sterol transport (GO:0015918)	80	2	1.33	+	1.50	3.86E-01	1.00E00
purine ribonucleoside monophosphate metabolic process (GO:0009167)	40	1	.67	+	1.50	4.90E-01	1.00E00
regulation of hippo signaling (GO:0035330)	40	1	.67	+	1.50	4.90E-01	1.00E00
negative regulation of viral life cycle (GO:1903901)	40	1	.67	+	1.50	4.90E-01	1.00E00
aspartate family amino acid metabolic process (GO:0009066)	40	1	.67	+	1.50	4.90E-01	1.00E00
hormone biosynthetic process (GO:0042446)	40	1	.67	+	1.50	4.90E-01	1.00E00
nucleosome organization (GO:0034728)	80	2	1.33	+	1.50	3.86E-01	1.00E00
positive regulation of collagen metabolic process (GO:0010714)	40	1	.67	+	1.50	4.90E-01	1.00E00
regulatory ncRNA-mediated post-transcriptional gene silencing (GO:0035194)	40	1	.67	+	1.50	4.90E-01	1.00E00
digestive system process (GO:0022600)	80	2	1.33	+	1.50	3.86E-01	1.00E00
regulation of inflammatory response to antigenic stimulus (GO:0002861)	40	1	.67	+	1.50	4.90E-01	1.00E00
cardiac atrium development (GO:0003230)	40	1	.67	+	1.50	4.90E-01	1.00E00
regulation of smooth muscle cell apoptotic process (GO:0034391)	40	1	.67	+	1.50	4.90E-01	1.00E00
mammary gland duct morphogenesis (GO:0060603)	40	1	.67	+	1.50	4.90E-01	1.00E00
cellular homeostasis (GO:0019725)	721	18	12.02	+	1.50	1.01E-01	9.71E-01
regulation of small molecule metabolic process (GO:0062012)	401	10	6.68	+	1.50	2.31E-01	1.00E00
regulation of cell morphogenesis (GO:0022604)	281	7	4.68	+	1.49	2.41E-01	1.00E00
regulation of protein stability (GO:0031647)	362	9	6.03	+	1.49	2.10E-01	1.00E00
microtubule-based movement (GO:0007018)	483	12	8.05	+	1.49	1.50E-01	1.00E00
positive regulation of protein modification process (GO:0031401)	766	19	12.77	+	1.49	8.28E-02	9.07E-01
positive regulation of protein phosphorylation (GO:0001934)	605	15	10.09	+	1.49	1.43E-01	1.00E00
positive regulation of response to external stimulus (GO:0032103)	606	15	10.10	+	1.48	1.43E-01	1.00E00
positive regulation of small molecule metabolic process (GO:0062013)	202	5	3.37	+	1.48	3.95E-01	1.00E00
cellular response to endogenous stimulus (GO:0071495)	970	24	16.17	+	1.48	5.31E-02	7.46E-01
organic hydroxy compound metabolic process (GO:1901615)	485	12	8.08	+	1.48	1.51E-01	1.00E00
homeostatic process (GO:0042592)	1617	40	26.95	+	1.48	1.14E-02	3.69E-01
organelle localization (GO:0051640)	566	14	9.44	+	1.48	1.32E-01	1.00E00
regulation of leukocyte activation (GO:0002694)	607	15	10.12	+	1.48	1.44E-01	1.00E00
cardiac septum morphogenesis (GO:0060411)	81	2	1.35	+	1.48	3.92E-01	1.00E00
ATP biosynthetic process (GO:0006754)	81	2	1.35	+	1.48	3.92E-01	1.00E00
regulation of reactive oxygen species metabolic process (GO:2000377)	162	4	2.70	+	1.48	3.50E-01	1.00E00
protein autophosphorylation (GO:0046777)	162	4	2.70	+	1.48	3.50E-01	1.00E00
regulation of double-strand break repair via homologous recombination (GO:0010569)	81	2	1.35	+	1.48	3.92E-01	1.00E00
mucopolysaccharide metabolic process (GO:1903510)	81	2	1.35	+	1.48	3.92E-01	1.00E00
negative regulation of immune system process (GO:0002683)	567	14	9.45	+	1.48	1.33E-01	1.00E00
positive regulation of innate immune response (GO:0045089)	325	8	5.42	+	1.48	2.67E-01	1.00E00
detoxification (GO:0098754)	122	3	2.03	+	1.48	4.60E-01	1.00E00
positive regulation of protein localization to membrane (GO:1905477)	122	3	2.03	+	1.48	4.60E-01	1.00E00
cytosolic transport (GO:0016482)	122	3	2.03	+	1.48	4.60E-01	1.00E00
purine ribonucleotide metabolic process (GO:0009150)	285	7	4.75	+	1.47	2.47E-01	1.00E00
intracellular monoatomic cation homeostasis (GO:0030003)	448	11	7.47	+	1.47	1.88E-01	1.00E00
liver development (GO:0001889)	163	4	2.72	+	1.47	3.53E-01	1.00E00
negative regulation of protein-containing complex assembly (GO:0031333)	163	4	2.72	+	1.47	3.53E-01	1.00E00
regulation of JNK cascade (GO:0046328)	163	4	2.72	+	1.47	3.53E-01	1.00E00
cellular localization (GO:0051641)	2814	69	46.91	+	1.47	8.83E-04	7.24E-02
cellular response to metal ion (GO:0071248)	204	5	3.40	+	1.47	3.98E-01	1.00E00
negative regulation of biological process (GO:0048519)	5552	136	92.55	+	1.47	4.00E-07	1.51E-04
response to insulin (GO:0032868)	286	7	4.77	+	1.47	3.44E-01	1.00E00
protein phosphorylation (GO:0006468)	491	12	8.18	+	1.47	2.07E-01	1.00E00
osteoblast differentiation (GO:0001649)	123	3	2.05	+	1.46	4.63E-01	1.00E00
carbohydrate catabolic process (GO:0016052)	123	3	2.05	+	1.46	4.63E-01	1.00E00
positive regulation of SMAD protein signal transduction (GO:0060391)	41	1	.68	+	1.46	4.98E-01	1.00E00
face morphogenesis (GO:0060325)	41	1	.68	+	1.46	4.98E-01	1.00E00
superoxide metabolic process (GO:0006801)	41	1	.68	+	1.46	4.98E-01	1.00E00
regulation of lipase activity (GO:0060191)	41	1	.68	+	1.46	4.98E-01	1.00E00
positive regulation of interleukin-2 production (GO:0032743)	41	1	.68	+	1.46	4.98E-01	1.00E00
positive regulation of reactive oxygen species metabolic process (GO:2000379)	82	2	1.37	+	1.46	3.98E-01	1.00E00
transcription elongation by RNA polymerase II (GO:0006368)	41	1	.68	+	1.46	4.98E-01	1.00E00
regulation of protein targeting to membrane (GO:0090313)	41	1	.68	+	1.46	4.98E-01	1.00E00
regulation of fatty acid transport (GO:2000191)	41	1	.68	+	1.46	4.98E-01	1.00E00
response to mineralocorticoid (GO:0051385)	41	1	.68	+	1.46	4.98E-01	1.00E00
receptor internalization (GO:0031623)	82	2	1.37	+	1.46	3.98E-01	1.00E00
blood vessel endothelial cell migration (GO:0043534)	41	1	.68	+	1.46	4.98E-01	1.00E00
regulation of MAPK cascade (GO:0043408)	738	18	12.30	+	1.46	1.05E-01	1.00E00
neuron cellular homeostasis (GO:0070050)	82	2	1.37	+	1.46	3.98E-01	1.00E00
negative regulation of actin filament depolymerization (GO:0030835)	41	1	.68	+	1.46	4.98E-01	1.00E00
sodium ion homeostasis (GO:0055078)	41	1	.68	+	1.46	4.98E-01	1.00E00
positive regulation of telomere maintenance via telomere lengthening (GO:1904358)	41	1	.68	+	1.46	4.98E-01	1.00E00
vasoconstriction (GO:0042310)	41	1	.68	+	1.46	4.98E-01	1.00E00
renal tubule morphogenesis (GO:0061333)	82	2	1.37	+	1.46	3.98E-01	1.00E00
neuroepithelial cell differentiation (GO:0060563)	41	1	.68	+	1.46	4.98E-01	1.00E00
purine nucleotide metabolic process (GO:0006163)	370	9	6.17	+	1.46	2.19E-01	1.00E00
sensory organ morphogenesis (GO:0090596)	329	8	5.48	+	1.46	2.71E-01	1.00E00
cell junction organization (GO:0034330)	617	15	10.29	+	1.46	1.47E-01	1.00E00
positive regulation of molecular function (GO:0044093)	1070	26	17.84	+	1.46	5.00E-02	7.22E-01
positive regulation of cytokine production (GO:0001819)	536	13	8.93	+	1.45	1.69E-01	1.00E00
RNA localization (GO:0006403)	165	4	2.75	+	1.45	3.58E-01	1.00E00
regulation of mRNA stability (GO:0043488)	165	4	2.75	+	1.45	3.58E-01	1.00E00
regulation of actin polymerization or depolymerization (GO:0008064)	165	4	2.75	+	1.45	3.58E-01	1.00E00
negative regulation of cellular process (GO:0048523)	5285	128	88.10	+	1.45	2.38E-06	6.12E-04
anatomical structure homeostasis (GO:0060249)	248	6	4.13	+	1.45	3.13E-01	1.00E00
tissue homeostasis (GO:0001894)	248	6	4.13	+	1.45	3.13E-01	1.00E00
positive regulation of NF-kappaB transcription factor activity (GO:0051092)	124	3	2.07	+	1.45	4.65E-01	1.00E00
response to xenobiotic stimulus (GO:0009410)	496	12	8.27	+	1.45	2.09E-01	1.00E00
immune effector process (GO:0002252)	579	14	9.65	+	1.45	1.84E-01	1.00E00
anatomical structure development (GO:0048856)	5590	135	93.18	+	1.45	1.10E-06	3.26E-04
response to external stimulus (GO:0009605)	2074	50	34.57	+	1.45	8.61E-03	3.32E-01
peripheral nervous system development (GO:0007422)	83	2	1.38	+	1.45	4.04E-01	1.00E00
cell adhesion (GO:0007155)	913	22	15.22	+	1.45	8.42E-02	9.09E-01
regulation of DNA-templated transcription elongation (GO:0032784)	83	2	1.38	+	1.45	4.04E-01	1.00E00
hepaticobiliary system development (GO:0061008)	166	4	2.77	+	1.45	3.61E-01	1.00E00
cytoskeleton organization (GO:0007010)	1248	30	20.80	+	1.44	4.04E-02	6.88E-01
animal organ development (GO:0048513)	3162	76	52.71	+	1.44	8.99E-04	7.33E-02
positive regulation of proteolysis (GO:0045862)	333	8	5.55	+	1.44	2.76E-01	1.00E00
protein polyubiquitination (GO:0000209)	250	6	4.17	+	1.44	3.17E-01	1.00E00
intracellular monoatomic ion homeostasis (GO:0006873)	459	11	7.65	+	1.44	1.97E-01	1.00E00
response to transforming growth factor beta (GO:0071559)	167	4	2.78	+	1.44	3.64E-01	1.00E00
regulation of actin filament-based process (GO:0032970)	418	10	6.97	+	1.44	2.42E-01	1.00E00
regulation of protein modification by small protein conjugation or removal (GO:1903320)	251	6	4.18	+	1.43	3.18E-01	1.00E00
positive regulation of cellular process (GO:0048522)	6113	146	101.90	+	1.43	4.95E-07	1.74E-04
positive regulation of biological process (GO:0048518)	6425	153	107.10	+	1.43	2.79E-07	1.07E-04
positive regulation of phosphorylation (GO:0042327)	630	15	10.50	+	1.43	1.54E-01	1.00E00
alcohol catabolic process (GO:0046164)	42	1	.70	+	1.43	5.07E-01	1.00E00
regulation of steroid metabolic process (GO:0019218)	126	3	2.10	+	1.43	4.70E-01	1.00E00
NADP metabolic process (GO:0006739)	42	1	.70	+	1.43	5.07E-01	1.00E00
toll-like receptor signaling pathway (GO:0002224)	42	1	.70	+	1.43	5.07E-01	1.00E00
B cell homeostasis (GO:0001782)	42	1	.70	+	1.43	5.07E-01	1.00E00
retina morphogenesis in camera-type eye (GO:0060042)	84	2	1.40	+	1.43	6.53E-01	1.00E00
positive regulation of type II interferon production (GO:0032729)	84	2	1.40	+	1.43	6.53E-01	1.00E00
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144)	42	1	.70	+	1.43	5.07E-01	1.00E00
cellular response to fatty acid (GO:0071398)	42	1	.70	+	1.43	5.07E-01	1.00E00
positive regulation of transporter activity (GO:0032411)	84	2	1.40	+	1.43	6.53E-01	1.00E00
establishment of mitotic spindle localization (GO:0040001)	42	1	.70	+	1.43	5.07E-01	1.00E00
negative regulation of ERK1 and ERK2 cascade (GO:0070373)	84	2	1.40	+	1.43	6.53E-01	1.00E00
cranial skeletal system development (GO:1904888)	84	2	1.40	+	1.43	6.53E-01	1.00E00
regulation of fibroblast proliferation (GO:0048145)	126	3	2.10	+	1.43	4.70E-01	1.00E00
defense response to protozoan (GO:0042832)	42	1	.70	+	1.43	5.07E-01	1.00E00
regulation of actin filament length (GO:0030832)	168	4	2.80	+	1.43	3.66E-01	1.00E00
RNA 3'-end processing (GO:0031123)	84	2	1.40	+	1.43	6.53E-01	1.00E00
pancreas development (GO:0031016)	84	2	1.40	+	1.43	6.53E-01	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	84	2	1.40	+	1.43	6.53E-01	1.00E00
erythrocyte differentiation (GO:0030218)	126	3	2.10	+	1.43	4.70E-01	1.00E00
regulation of cardiac muscle hypertrophy (GO:0010611)	84	2	1.40	+	1.43	6.53E-01	1.00E00
photoreceptor cell differentiation (GO:0046530)	84	2	1.40	+	1.43	6.53E-01	1.00E00
regulation of synaptic vesicle recycling (GO:1903421)	42	1	.70	+	1.43	5.07E-01	1.00E00
rhythmic behavior (GO:0007622)	42	1	.70	+	1.43	5.07E-01	1.00E00
positive regulation of lymphocyte mediated immunity (GO:0002708)	168	4	2.80	+	1.43	3.66E-01	1.00E00
regulation of response to oxidative stress (GO:1902882)	42	1	.70	+	1.43	5.07E-01	1.00E00
signaling (GO:0023052)	5604	133	93.42	+	1.42	3.82E-06	8.78E-04
mesenchyme development (GO:0060485)	253	6	4.22	+	1.42	3.22E-01	1.00E00
cell communication (GO:0007154)	5654	134	94.25	+	1.42	4.00E-06	8.94E-04
hemopoiesis (GO:0030097)	803	19	13.39	+	1.42	1.21E-01	1.00E00
developmental process (GO:0032502)	6051	143	100.87	+	1.42	1.52E-06	4.18E-04
pyridine nucleotide metabolic process (GO:0019362)	127	3	2.12	+	1.42	4.73E-01	1.00E00
inner ear morphogenesis (GO:0042472)	127	3	2.12	+	1.42	4.73E-01	1.00E00
nicotinamide nucleotide metabolic process (GO:0046496)	127	3	2.12	+	1.42	4.73E-01	1.00E00
establishment of localization in cell (GO:0051649)	1694	40	28.24	+	1.42	2.89E-02	5.97E-01
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	212	5	3.53	+	1.41	4.09E-01	1.00E00
regulation of cytokine production (GO:0001817)	849	20	14.15	+	1.41	1.30E-01	1.00E00
positive regulation of defense response (GO:0031349)	467	11	7.78	+	1.41	2.67E-01	1.00E00
regulation of cytoskeleton organization (GO:0051493)	552	13	9.20	+	1.41	2.34E-01	1.00E00
mitotic cytokinesis (GO:0000281)	85	2	1.42	+	1.41	6.54E-01	1.00E00
negative regulation of autophagy (GO:0010507)	85	2	1.42	+	1.41	6.54E-01	1.00E00
regulation of response to cytokine stimulus (GO:0060759)	170	4	2.83	+	1.41	3.72E-01	1.00E00
heart development (GO:0007507)	640	15	10.67	+	1.41	2.06E-01	1.00E00
branching morphogenesis of an epithelial tube (GO:0048754)	171	4	2.85	+	1.40	3.75E-01	1.00E00
negative regulation of Wnt signaling pathway (GO:0030178)	171	4	2.85	+	1.40	3.75E-01	1.00E00
positive regulation of leukocyte migration (GO:0002687)	171	4	2.85	+	1.40	3.75E-01	1.00E00
response to metal ion (GO:0010038)	385	9	6.42	+	1.40	3.09E-01	1.00E00
nucleoside triphosphate metabolic process (GO:0009141)	214	5	3.57	+	1.40	4.12E-01	1.00E00
regulation of post-translational protein modification (GO:1901873)	257	6	4.28	+	1.40	3.29E-01	1.00E00
response to stress (GO:0006950)	3563	83	59.39	+	1.40	1.23E-03	8.81E-02
positive regulation of G protein-coupled receptor signaling pathway (GO:0045745)	43	1	.72	+	1.40	5.15E-01	1.00E00
cell surface toll-like receptor signaling pathway (GO:0140895)	43	1	.72	+	1.40	5.15E-01	1.00E00
regulation of activated T cell proliferation (GO:0046006)	43	1	.72	+	1.40	5.15E-01	1.00E00
positive regulation of synaptic transmission, glutamatergic (GO:0051968)	43	1	.72	+	1.40	5.15E-01	1.00E00
acrosome assembly (GO:0001675)	43	1	.72	+	1.40	5.15E-01	1.00E00
positive regulation of chemokine production (GO:0032722)	86	2	1.43	+	1.40	6.56E-01	1.00E00
negative regulation of type II interferon production (GO:0032689)	43	1	.72	+	1.40	5.15E-01	1.00E00
nucleus localization (GO:0051647)	43	1	.72	+	1.40	5.15E-01	1.00E00
positive regulation of double-strand break repair via homologous recombination (GO:1905168)	43	1	.72	+	1.40	5.15E-01	1.00E00
cellular response to amyloid-beta (GO:1904646)	43	1	.72	+	1.40	5.15E-01	1.00E00
embryonic camera-type eye development (GO:0031076)	43	1	.72	+	1.40	5.15E-01	1.00E00
purine nucleoside monophosphate metabolic process (GO:0009126)	43	1	.72	+	1.40	5.15E-01	1.00E00
establishment of skin barrier (GO:0061436)	43	1	.72	+	1.40	5.15E-01	1.00E00
negative regulation of organ growth (GO:0046621)	43	1	.72	+	1.40	5.15E-01	1.00E00
icosanoid biosynthetic process (GO:0046456)	43	1	.72	+	1.40	5.15E-01	1.00E00
pituitary gland development (GO:0021983)	43	1	.72	+	1.40	5.15E-01	1.00E00
regulation of fatty acid oxidation (GO:0046320)	43	1	.72	+	1.40	5.15E-01	1.00E00
regulation of protein ubiquitination (GO:0031396)	215	5	3.58	+	1.40	4.13E-01	1.00E00
regulation of lymphocyte proliferation (GO:0050670)	259	6	4.32	+	1.39	3.33E-01	1.00E00
cell chemotaxis (GO:0060326)	216	5	3.60	+	1.39	4.15E-01	1.00E00
positive regulation of adaptive immune response (GO:0002821)	173	4	2.88	+	1.39	5.40E-01	1.00E00
ribonucleoprotein complex biogenesis (GO:0022613)	433	10	7.22	+	1.39	2.56E-01	1.00E00
positive regulation of cysteine-type endopeptidase activity (GO:2001056)	130	3	2.17	+	1.38	4.81E-01	1.00E00
leukocyte differentiation (GO:0002521)	477	11	7.95	+	1.38	2.73E-01	1.00E00
response to chemical (GO:0042221)	4044	93	67.41	+	1.38	8.22E-04	7.00E-02
regulation of myoblast differentiation (GO:0045661)	87	2	1.45	+	1.38	6.58E-01	1.00E00
lymphocyte homeostasis (GO:0002260)	87	2	1.45	+	1.38	6.58E-01	1.00E00
regulation of multicellular organism growth (GO:0040014)	87	2	1.45	+	1.38	6.58E-01	1.00E00
negative regulation of cytoskeleton organization (GO:0051494)	174	4	2.90	+	1.38	5.41E-01	1.00E00
peptide hormone secretion (GO:0030072)	87	2	1.45	+	1.38	6.58E-01	1.00E00
regulation of muscle hypertrophy (GO:0014743)	87	2	1.45	+	1.38	6.58E-01	1.00E00
cell maturation (GO:0048469)	218	5	3.63	+	1.38	4.18E-01	1.00E00
multicellular organismal process (GO:0032501)	7284	167	121.42	+	1.38	6.99E-07	2.24E-04
membrane organization (GO:0061024)	742	17	12.37	+	1.37	1.86E-01	1.00E00
pattern recognition receptor signaling pathway (GO:0002221)	131	3	2.18	+	1.37	4.83E-01	1.00E00
gland morphogenesis (GO:0022612)	131	3	2.18	+	1.37	4.83E-01	1.00E00
lipid localization (GO:0010876)	393	9	6.55	+	1.37	3.16E-01	1.00E00
positive regulation of protein metabolic process (GO:0051247)	1223	28	20.39	+	1.37	8.42E-02	9.09E-01
protein localization (GO:0008104)	2056	47	34.27	+	1.37	2.92E-02	6.00E-01
hexose metabolic process (GO:0019318)	175	4	2.92	+	1.37	5.42E-01	1.00E00
negative regulation of supramolecular fiber organization (GO:1902904)	175	4	2.92	+	1.37	5.42E-01	1.00E00
protein stabilization (GO:0050821)	219	5	3.65	+	1.37	4.20E-01	1.00E00
purine-containing compound biosynthetic process (GO:0072522)	219	5	3.65	+	1.37	4.20E-01	1.00E00
regulation of hydrolase activity (GO:0051336)	614	14	10.24	+	1.37	2.59E-01	1.00E00
ribonucleotide metabolic process (GO:0009259)	307	7	5.12	+	1.37	3.64E-01	1.00E00
cellular macromolecule localization (GO:0070727)	2064	47	34.41	+	1.37	2.95E-02	6.05E-01
lymphocyte activation (GO:0046649)	571	13	9.52	+	1.37	2.44E-01	1.00E00
regulation of mononuclear cell proliferation (GO:0032944)	264	6	4.40	+	1.36	4.60E-01	1.00E00
protein secretion (GO:0009306)	132	3	2.20	+	1.36	4.86E-01	1.00E00
carboxylic acid transmembrane transport (GO:1905039)	132	3	2.20	+	1.36	4.86E-01	1.00E00
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	132	3	2.20	+	1.36	4.86E-01	1.00E00
olfactory bulb development (GO:0021772)	44	1	.73	+	1.36	5.23E-01	1.00E00
endoderm development (GO:0007492)	88	2	1.47	+	1.36	6.60E-01	1.00E00
negative regulation of cytokine-mediated signaling pathway (GO:0001960)	88	2	1.47	+	1.36	6.60E-01	1.00E00
immunoglobulin production involved in immunoglobulin-mediated immune response (GO:0002381)	44	1	.73	+	1.36	5.23E-01	1.00E00
membraneless organelle assembly (GO:0140694)	352	8	5.87	+	1.36	3.94E-01	1.00E00
CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294)	44	1	.73	+	1.36	5.23E-01	1.00E00
regulation of intracellular protein transport (GO:0033157)	176	4	2.93	+	1.36	5.43E-01	1.00E00
regulation of carbohydrate metabolic process (GO:0006109)	220	5	3.67	+	1.36	4.21E-01	1.00E00
positive regulation of leukocyte proliferation (GO:0070665)	176	4	2.93	+	1.36	5.43E-01	1.00E00
leukocyte proliferation (GO:0070661)	176	4	2.93	+	1.36	5.43E-01	1.00E00
sulfur compound catabolic process (GO:0044273)	44	1	.73	+	1.36	5.23E-01	1.00E00
negative regulation of neuron apoptotic process (GO:0043524)	220	5	3.67	+	1.36	4.21E-01	1.00E00
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	44	1	.73	+	1.36	5.23E-01	1.00E00
regulation of microtubule depolymerization (GO:0031114)	44	1	.73	+	1.36	5.23E-01	1.00E00
response to antibiotic (GO:0046677)	44	1	.73	+	1.36	5.23E-01	1.00E00
negative regulation of epithelial cell apoptotic process (GO:1904036)	44	1	.73	+	1.36	5.23E-01	1.00E00
T-helper cell differentiation (GO:0042093)	44	1	.73	+	1.36	5.23E-01	1.00E00
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)	44	1	.73	+	1.36	5.23E-01	1.00E00
apoptotic signaling pathway (GO:0097190)	352	8	5.87	+	1.36	3.94E-01	1.00E00
mating behavior (GO:0007617)	44	1	.73	+	1.36	5.23E-01	1.00E00
cellular component organization (GO:0016043)	6075	138	101.27	+	1.36	2.63E-05	4.26E-03
lipid transport (GO:0006869)	353	8	5.88	+	1.36	3.95E-01	1.00E00
signal transduction (GO:0007165)	5302	120	88.38	+	1.36	1.62E-04	1.92E-02
camera-type eye development (GO:0043010)	398	9	6.63	+	1.36	3.21E-01	1.00E00
intracellular receptor signaling pathway (GO:0030522)	177	4	2.95	+	1.36	5.44E-01	1.00E00
negative regulation of programmed cell death (GO:0043069)	1019	23	16.99	+	1.35	1.32E-01	1.00E00
macromolecule localization (GO:0033036)	2484	56	41.41	+	1.35	1.94E-02	4.68E-01
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	400	9	6.67	+	1.35	3.23E-01	1.00E00
regulation of cellular response to stress (GO:0080135)	534	12	8.90	+	1.35	3.00E-01	1.00E00
regulation of osteoclast differentiation (GO:0045670)	89	2	1.48	+	1.35	6.62E-01	1.00E00
diencephalon development (GO:0021536)	89	2	1.48	+	1.35	6.62E-01	1.00E00
inner ear receptor cell differentiation (GO:0060113)	89	2	1.48	+	1.35	6.62E-01	1.00E00
male gonad development (GO:0008584)	178	4	2.97	+	1.35	5.46E-01	1.00E00
proteasomal protein catabolic process (GO:0010498)	490	11	8.17	+	1.35	2.83E-01	1.00E00
positive regulation of neurogenesis (GO:0050769)	312	7	5.20	+	1.35	3.71E-01	1.00E00
cellular response to lipid (GO:0071396)	581	13	9.69	+	1.34	2.51E-01	1.00E00
negative regulation of cytokine production (GO:0001818)	313	7	5.22	+	1.34	3.72E-01	1.00E00
negative regulation of apoptotic process (GO:0043066)	984	22	16.40	+	1.34	1.59E-01	1.00E00
regulation of growth (GO:0040008)	671	15	11.19	+	1.34	2.21E-01	1.00E00
limb morphogenesis (GO:0035108)	179	4	2.98	+	1.34	5.47E-01	1.00E00
appendage morphogenesis (GO:0035107)	179	4	2.98	+	1.34	5.47E-01	1.00E00
development of primary male sexual characteristics (GO:0046546)	179	4	2.98	+	1.34	5.47E-01	1.00E00
cellular component organization or biogenesis (GO:0071840)	6271	140	104.54	+	1.34	5.31E-05	7.87E-03
establishment of protein localization to membrane (GO:0090150)	224	5	3.73	+	1.34	4.28E-01	1.00E00
endomembrane system organization (GO:0010256)	538	12	8.97	+	1.34	3.02E-01	1.00E00
phagocytosis, engulfment (GO:0006911)	45	1	.75	+	1.33	5.31E-01	1.00E00
humoral immune response mediated by circulating immunoglobulin (GO:0002455)	45	1	.75	+	1.33	5.31E-01	1.00E00
modulation by host of viral process (GO:0044788)	45	1	.75	+	1.33	5.31E-01	1.00E00
positive regulation of interleukin-12 production (GO:0032735)	45	1	.75	+	1.33	5.31E-01	1.00E00
positive regulation of lymphocyte migration (GO:2000403)	45	1	.75	+	1.33	5.31E-01	1.00E00
cellular response to lipoprotein particle stimulus (GO:0071402)	45	1	.75	+	1.33	5.31E-01	1.00E00
regulation of interleukin-17 production (GO:0032660)	45	1	.75	+	1.33	5.31E-01	1.00E00
regulation of neurotransmitter receptor activity (GO:0099601)	45	1	.75	+	1.33	5.31E-01	1.00E00
negative regulation of lymphocyte activation (GO:0051250)	180	4	3.00	+	1.33	5.48E-01	1.00E00
maintenance of location (GO:0051235)	180	4	3.00	+	1.33	5.48E-01	1.00E00
regulation of RNA stability (GO:0043487)	180	4	3.00	+	1.33	5.48E-01	1.00E00
protein modification process (GO:0036211)	1890	42	31.51	+	1.33	5.92E-02	7.98E-01
eating behavior (GO:0042755)	45	1	.75	+	1.33	5.31E-01	1.00E00
hydrogen peroxide metabolic process (GO:0042743)	45	1	.75	+	1.33	5.31E-01	1.00E00
regulation of bone mineralization (GO:0030500)	90	2	1.50	+	1.33	6.64E-01	1.00E00
regulation of endothelial cell migration (GO:0010594)	180	4	3.00	+	1.33	5.48E-01	1.00E00
regulation of cell fate commitment (GO:0010453)	45	1	.75	+	1.33	5.31E-01	1.00E00
regulation of amyloid precursor protein catabolic process (GO:1902991)	45	1	.75	+	1.33	5.31E-01	1.00E00
regulation of supramolecular fiber organization (GO:1902903)	405	9	6.75	+	1.33	3.28E-01	1.00E00
maintenance of protein localization in organelle (GO:0072595)	45	1	.75	+	1.33	5.31E-01	1.00E00
limbic system development (GO:0021761)	135	3	2.25	+	1.33	4.94E-01	1.00E00
embryonic organ development (GO:0048568)	540	12	9.00	+	1.33	3.04E-01	1.00E00
regulation of sequestering of calcium ion (GO:0051282)	135	3	2.25	+	1.33	4.94E-01	1.00E00
establishment of protein localization to extracellular region (GO:0035592)	135	3	2.25	+	1.33	4.94E-01	1.00E00
protein-containing complex assembly (GO:0065003)	1218	27	20.30	+	1.33	1.33E-01	1.00E00
ribose phosphate metabolic process (GO:0019693)	316	7	5.27	+	1.33	3.76E-01	1.00E00
negative regulation of MAPK cascade (GO:0043409)	181	4	3.02	+	1.33	5.50E-01	1.00E00
muscle system process (GO:0003012)	272	6	4.53	+	1.32	4.67E-01	1.00E00
cerebellum development (GO:0021549)	136	3	2.27	+	1.32	4.97E-01	1.00E00
regulation of muscle system process (GO:0090257)	272	6	4.53	+	1.32	4.67E-01	1.00E00
response to amino acid (GO:0043200)	136	3	2.27	+	1.32	4.97E-01	1.00E00
organic acid transmembrane transport (GO:1903825)	136	3	2.27	+	1.32	4.97E-01	1.00E00
multicellular organismal-level chemical homeostasis (GO:0140962)	91	2	1.52	+	1.32	6.66E-01	1.00E00
cellular response to amino acid stimulus (GO:0071230)	91	2	1.52	+	1.32	6.66E-01	1.00E00
sensory system development (GO:0048880)	455	10	7.58	+	1.32	3.51E-01	1.00E00
skeletal muscle organ development (GO:0060538)	182	4	3.03	+	1.32	5.51E-01	1.00E00
pyridine-containing compound metabolic process (GO:0072524)	137	3	2.28	+	1.31	5.00E-01	1.00E00
lipid metabolic process (GO:0006629)	1236	27	20.60	+	1.31	1.38E-01	1.00E00
B cell activation (GO:0042113)	229	5	3.82	+	1.31	4.38E-01	1.00E00
purine-containing compound metabolic process (GO:0072521)	505	11	8.42	+	1.31	3.75E-01	1.00E00
regulation of myeloid cell differentiation (GO:0045637)	230	5	3.83	+	1.30	4.40E-01	1.00E00
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)	46	1	.77	+	1.30	5.39E-01	1.00E00
alpha-beta T cell differentiation involved in immune response (GO:0002293)	46	1	.77	+	1.30	5.39E-01	1.00E00
microtubule-based process (GO:0007017)	920	20	15.34	+	1.30	2.34E-01	1.00E00
signal transduction in absence of ligand (GO:0038034)	46	1	.77	+	1.30	5.39E-01	1.00E00
response to protozoan (GO:0001562)	46	1	.77	+	1.30	5.39E-01	1.00E00
small molecule biosynthetic process (GO:0044283)	460	10	7.67	+	1.30	3.56E-01	1.00E00
regulation of synaptic transmission, GABAergic (GO:0032228)	46	1	.77	+	1.30	5.39E-01	1.00E00
embryonic axis specification (GO:0000578)	46	1	.77	+	1.30	5.39E-01	1.00E00
regulation of potassium ion transmembrane transporter activity (GO:1901016)	46	1	.77	+	1.30	5.39E-01	1.00E00
regulation of NLRP3 inflammasome complex assembly (GO:1900225)	46	1	.77	+	1.30	5.39E-01	1.00E00
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	92	2	1.53	+	1.30	6.67E-01	1.00E00
vesicle transport along microtubule (GO:0047496)	46	1	.77	+	1.30	5.39E-01	1.00E00
regulation of D-glucose transmembrane transport (GO:0010827)	92	2	1.53	+	1.30	6.67E-01	1.00E00
sterol biosynthetic process (GO:0016126)	46	1	.77	+	1.30	5.39E-01	1.00E00
alpha-beta T cell differentiation (GO:0046632)	92	2	1.53	+	1.30	6.67E-01	1.00E00
negative regulation of response to cytokine stimulus (GO:0060761)	92	2	1.53	+	1.30	6.67E-01	1.00E00
cellular component disassembly (GO:0022411)	276	6	4.60	+	1.30	4.72E-01	1.00E00
long-term memory (GO:0007616)	46	1	.77	+	1.30	5.39E-01	1.00E00
positive regulation of D-glucose import (GO:0046326)	46	1	.77	+	1.30	5.39E-01	1.00E00
negative regulation of production of molecular mediator of immune response (GO:0002701)	46	1	.77	+	1.30	5.39E-01	1.00E00
programmed cell death (GO:0012501)	1106	24	18.44	+	1.30	1.84E-01	1.00E00
regulation of lipid biosynthetic process (GO:0046890)	231	5	3.85	+	1.30	4.42E-01	1.00E00
cell death (GO:0008219)	1110	24	18.50	+	1.30	1.85E-01	1.00E00
regulation of DNA-binding transcription factor activity (GO:0051090)	370	8	6.17	+	1.30	4.10E-01	1.00E00
erythrocyte homeostasis (GO:0034101)	139	3	2.32	+	1.29	5.05E-01	1.00E00
tissue remodeling (GO:0048771)	139	3	2.32	+	1.29	5.05E-01	1.00E00
glucose metabolic process (GO:0006006)	139	3	2.32	+	1.29	5.05E-01	1.00E00
regulation of protein-containing complex disassembly (GO:0043244)	139	3	2.32	+	1.29	5.05E-01	1.00E00
regulation of DNA recombination (GO:0000018)	139	3	2.32	+	1.29	5.05E-01	1.00E00
leukocyte chemotaxis (GO:0030595)	139	3	2.32	+	1.29	5.05E-01	1.00E00
positive regulation of response to stimulus (GO:0048584)	2415	52	40.26	+	1.29	5.24E-02	7.38E-01
regulation of molecular function (GO:0065009)	1905	41	31.76	+	1.29	9.11E-02	9.64E-01
nephron tubule development (GO:0072080)	93	2	1.55	+	1.29	6.69E-01	1.00E00
regulation of cell division (GO:0051302)	186	4	3.10	+	1.29	5.56E-01	1.00E00
purine nucleoside triphosphate biosynthetic process (GO:0009145)	93	2	1.55	+	1.29	6.69E-01	1.00E00
myeloid cell development (GO:0061515)	93	2	1.55	+	1.29	6.69E-01	1.00E00
neural retina development (GO:0003407)	93	2	1.55	+	1.29	6.69E-01	1.00E00
polyol metabolic process (GO:0019751)	93	2	1.55	+	1.29	6.69E-01	1.00E00
regulation of embryonic development (GO:0045995)	93	2	1.55	+	1.29	6.69E-01	1.00E00
peptide secretion (GO:0002790)	93	2	1.55	+	1.29	6.69E-01	1.00E00
defense response (GO:0006952)	1536	33	25.60	+	1.29	1.46E-01	1.00E00
homeostasis of number of cells (GO:0048872)	373	8	6.22	+	1.29	4.13E-01	1.00E00
regulation of gliogenesis (GO:0014013)	140	3	2.33	+	1.29	5.08E-01	1.00E00
nucleoside phosphate catabolic process (GO:1901292)	140	3	2.33	+	1.29	5.08E-01	1.00E00
positive regulation of apoptotic process (GO:0043065)	654	14	10.90	+	1.28	3.49E-01	1.00E00
positive regulation of supramolecular fiber organization (GO:1902905)	187	4	3.12	+	1.28	5.58E-01	1.00E00
regulation of mRNA catabolic process (GO:0061013)	187	4	3.12	+	1.28	5.58E-01	1.00E00
epithelial tube morphogenesis (GO:0060562)	374	8	6.23	+	1.28	4.14E-01	1.00E00
regulation of cellular process (GO:0050794)	11988	256	199.84	+	1.28	1.47E-09	1.62E-06
regulation of biological process (GO:0050789)	12379	264	206.35	+	1.28	4.35E-10	6.71E-07
positive regulation of translation (GO:0045727)	141	3	2.35	+	1.28	5.11E-01	1.00E00
positive regulation of cation channel activity (GO:2001259)	47	1	.78	+	1.28	5.47E-01	1.00E00
response to testosterone (GO:0033574)	47	1	.78	+	1.28	5.47E-01	1.00E00
negative regulation of endothelial cell proliferation (GO:0001937)	47	1	.78	+	1.28	5.47E-01	1.00E00
alpha-beta T cell activation involved in immune response (GO:0002287)	47	1	.78	+	1.28	5.47E-01	1.00E00
double-strand break repair via nonhomologous end joining (GO:0006303)	47	1	.78	+	1.28	5.47E-01	1.00E00
mitochondrial RNA metabolic process (GO:0000959)	47	1	.78	+	1.28	5.47E-01	1.00E00
tissue migration (GO:0090130)	47	1	.78	+	1.28	5.47E-01	1.00E00
ERAD pathway (GO:0036503)	94	2	1.57	+	1.28	6.72E-01	1.00E00
positive regulation of potassium ion transport (GO:0043268)	47	1	.78	+	1.28	5.47E-01	1.00E00
developmental pigmentation (GO:0048066)	47	1	.78	+	1.28	5.47E-01	1.00E00
forelimb morphogenesis (GO:0035136)	47	1	.78	+	1.28	5.47E-01	1.00E00
olfactory lobe development (GO:0021988)	47	1	.78	+	1.28	5.47E-01	1.00E00
anterograde axonal transport (GO:0008089)	47	1	.78	+	1.28	5.47E-01	1.00E00
innate immune response-activating signaling pathway (GO:0002758)	141	3	2.35	+	1.28	5.11E-01	1.00E00
positive regulation of T cell mediated immunity (GO:0002711)	94	2	1.57	+	1.28	6.72E-01	1.00E00
cellular response to stimulus (GO:0051716)	6973	148	116.24	+	1.27	4.26E-04	4.03E-02
protein-containing complex organization (GO:0043933)	1368	29	22.80	+	1.27	1.89E-01	1.00E00
organelle fusion (GO:0048284)	142	3	2.37	+	1.27	5.14E-01	1.00E00
purine ribonucleotide biosynthetic process (GO:0009152)	142	3	2.37	+	1.27	5.14E-01	1.00E00
cellular component assembly (GO:0022607)	2465	52	41.09	+	1.27	7.88E-02	9.28E-01
carbohydrate metabolic process (GO:0005975)	427	9	7.12	+	1.26	4.42E-01	1.00E00
regulation of glial cell differentiation (GO:0045685)	95	2	1.58	+	1.26	6.74E-01	1.00E00
regulation of endopeptidase activity (GO:0052548)	285	6	4.75	+	1.26	4.83E-01	1.00E00
stem cell proliferation (GO:0072089)	95	2	1.58	+	1.26	6.74E-01	1.00E00
cell fate specification (GO:0001708)	95	2	1.58	+	1.26	6.74E-01	1.00E00
positive regulation of B cell activation (GO:0050871)	95	2	1.58	+	1.26	6.74E-01	1.00E00
biological regulation (GO:0065007)	12802	269	213.41	+	1.26	1.01E-09	1.30E-06
cellular response to tumor necrosis factor (GO:0071356)	143	3	2.38	+	1.26	5.17E-01	1.00E00
regulation of leukocyte proliferation (GO:0070663)	286	6	4.77	+	1.26	4.84E-01	1.00E00
regulation of cell shape (GO:0008360)	143	3	2.38	+	1.26	5.17E-01	1.00E00
embryo development (GO:0009790)	1287	27	21.45	+	1.26	2.16E-01	1.00E00
nucleotide metabolic process (GO:0009117)	429	9	7.15	+	1.26	4.43E-01	1.00E00
regulation of immune system process (GO:0002682)	1722	36	28.71	+	1.25	1.69E-01	1.00E00
regulation of cellular response to growth factor stimulus (GO:0090287)	335	7	5.58	+	1.25	5.14E-01	1.00E00
gland development (GO:0048732)	527	11	8.78	+	1.25	3.90E-01	1.00E00
regulation of lymphocyte activation (GO:0051249)	527	11	8.78	+	1.25	3.90E-01	1.00E00
unsaturated fatty acid metabolic process (GO:0033559)	144	3	2.40	+	1.25	5.20E-01	1.00E00
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562)	48	1	.80	+	1.25	5.54E-01	1.00E00
apoptotic process (GO:0006915)	1056	22	17.60	+	1.25	2.67E-01	1.00E00
post-Golgi vesicle-mediated transport (GO:0006892)	96	2	1.60	+	1.25	6.76E-01	1.00E00
response to zinc ion (GO:0010043)	48	1	.80	+	1.25	5.54E-01	1.00E00
heart contraction (GO:0060047)	96	2	1.60	+	1.25	6.76E-01	1.00E00
temperature homeostasis (GO:0001659)	48	1	.80	+	1.25	5.54E-01	1.00E00
protein lipidation (GO:0006497)	48	1	.80	+	1.25	5.54E-01	1.00E00
Schwann cell development (GO:0014044)	48	1	.80	+	1.25	5.54E-01	1.00E00
nucleotide-excision repair (GO:0006289)	48	1	.80	+	1.25	5.54E-01	1.00E00
somatic cell DNA recombination (GO:0016444)	48	1	.80	+	1.25	5.54E-01	1.00E00
positive regulation of programmed cell death (GO:0043068)	672	14	11.20	+	1.25	3.58E-01	1.00E00
regulation of peptidyl-threonine phosphorylation (GO:0010799)	48	1	.80	+	1.25	5.54E-01	1.00E00
cellular response to UV (GO:0034644)	96	2	1.60	+	1.25	6.76E-01	1.00E00
regulation of lymphocyte mediated immunity (GO:0002706)	240	5	4.00	+	1.25	6.05E-01	1.00E00
digestion (GO:0007586)	96	2	1.60	+	1.25	6.76E-01	1.00E00
regulation of B cell activation (GO:0050864)	145	3	2.42	+	1.24	5.23E-01	1.00E00
response to steroid hormone (GO:0048545)	290	6	4.83	+	1.24	4.90E-01	1.00E00
regulation of actin filament polymerization (GO:0030833)	145	3	2.42	+	1.24	5.23E-01	1.00E00
embryonic limb morphogenesis (GO:0030326)	145	3	2.42	+	1.24	5.23E-01	1.00E00
embryonic appendage morphogenesis (GO:0035113)	145	3	2.42	+	1.24	5.23E-01	1.00E00
ceramide metabolic process (GO:0006672)	97	2	1.62	+	1.24	6.78E-01	1.00E00
T cell activation involved in immune response (GO:0002286)	97	2	1.62	+	1.24	6.78E-01	1.00E00
biogenic amine metabolic process (GO:0006576)	97	2	1.62	+	1.24	6.78E-01	1.00E00
regulation of non-canonical NF-kappaB signal transduction (GO:1901222)	97	2	1.62	+	1.24	6.78E-01	1.00E00
regulation of RNA splicing (GO:0043484)	194	4	3.23	+	1.24	5.69E-01	1.00E00
ribonucleoside triphosphate biosynthetic process (GO:0009201)	97	2	1.62	+	1.24	6.78E-01	1.00E00
adult behavior (GO:0030534)	194	4	3.23	+	1.24	5.69E-01	1.00E00
mechanoreceptor differentiation (GO:0042490)	97	2	1.62	+	1.24	6.78E-01	1.00E00
positive regulation of leukocyte mediated immunity (GO:0002705)	194	4	3.23	+	1.24	5.69E-01	1.00E00
regulation of binding (GO:0051098)	340	7	5.67	+	1.24	5.18E-01	1.00E00
regulation of apoptotic process (GO:0042981)	1605	33	26.75	+	1.23	2.23E-01	1.00E00
macromolecule modification (GO:0043412)	2043	42	34.06	+	1.23	1.47E-01	1.00E00
regulation of programmed cell death (GO:0043067)	1654	34	27.57	+	1.23	1.94E-01	1.00E00
cellular response to steroid hormone stimulus (GO:0071383)	146	3	2.43	+	1.23	7.38E-01	1.00E00
neural tube development (GO:0021915)	195	4	3.25	+	1.23	5.71E-01	1.00E00
negative regulation of transcription by RNA polymerase II (GO:0000122)	976	20	16.27	+	1.23	3.07E-01	1.00E00
cellular catabolic process (GO:0044248)	293	6	4.88	+	1.23	4.94E-01	1.00E00
positive regulation of DNA replication (GO:0045740)	49	1	.82	+	1.22	5.62E-01	1.00E00
binding of sperm to zona pellucida (GO:0007339)	49	1	.82	+	1.22	5.62E-01	1.00E00
positive regulation of leukocyte mediated cytotoxicity (GO:0001912)	98	2	1.63	+	1.22	6.80E-01	1.00E00
transforming growth factor beta receptor signaling pathway (GO:0007179)	98	2	1.63	+	1.22	6.80E-01	1.00E00
regulation of release of cytochrome c from mitochondria (GO:0090199)	49	1	.82	+	1.22	5.62E-01	1.00E00
musculoskeletal movement (GO:0050881)	49	1	.82	+	1.22	5.62E-01	1.00E00
RNA polymerase II preinitiation complex assembly (GO:0051123)	49	1	.82	+	1.22	5.62E-01	1.00E00
mRNA transcription by RNA polymerase II (GO:0042789)	49	1	.82	+	1.22	5.62E-01	1.00E00
response to amyloid-beta (GO:1904645)	49	1	.82	+	1.22	5.62E-01	1.00E00
T cell homeostasis (GO:0043029)	49	1	.82	+	1.22	5.62E-01	1.00E00
positive regulation of calcium ion transmembrane transport (GO:1904427)	98	2	1.63	+	1.22	6.80E-01	1.00E00
positive regulation of bone mineralization (GO:0030501)	49	1	.82	+	1.22	5.62E-01	1.00E00
regulation of viral entry into host cell (GO:0046596)	49	1	.82	+	1.22	5.62E-01	1.00E00
regulation of cilium movement (GO:0003352)	49	1	.82	+	1.22	5.62E-01	1.00E00
positive regulation of fatty acid metabolic process (GO:0045923)	49	1	.82	+	1.22	5.62E-01	1.00E00
negative regulation of mRNA metabolic process (GO:1903312)	98	2	1.63	+	1.22	6.80E-01	1.00E00
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	1520	31	25.34	+	1.22	2.52E-01	1.00E00
tissue development (GO:0009888)	1964	40	32.74	+	1.22	1.95E-01	1.00E00
cilium organization (GO:0044782)	394	8	6.57	+	1.22	5.47E-01	1.00E00
biosynthetic process (GO:0009058)	4091	83	68.20	+	1.22	4.93E-02	7.14E-01
cellular component biogenesis (GO:0044085)	2714	55	45.24	+	1.22	1.27E-01	1.00E00
eye development (GO:0001654)	445	9	7.42	+	1.21	5.71E-01	1.00E00
regulation of steroid biosynthetic process (GO:0050810)	99	2	1.65	+	1.21	6.82E-01	1.00E00
protein-containing complex localization (GO:0031503)	198	4	3.30	+	1.21	5.76E-01	1.00E00
glycosaminoglycan metabolic process (GO:0030203)	99	2	1.65	+	1.21	6.82E-01	1.00E00
negative regulation of metabolic process (GO:0009892)	2972	60	49.54	+	1.21	1.06E-01	1.00E00
cellular response to chemical stress (GO:0062197)	298	6	4.97	+	1.21	6.44E-01	1.00E00
regulation of myeloid leukocyte differentiation (GO:0002761)	149	3	2.48	+	1.21	7.40E-01	1.00E00
regulation of innate immune response (GO:0045088)	497	10	8.28	+	1.21	4.79E-01	1.00E00
monosaccharide metabolic process (GO:0005996)	199	4	3.32	+	1.21	5.77E-01	1.00E00
positive regulation of cytoskeleton organization (GO:0051495)	199	4	3.32	+	1.21	5.77E-01	1.00E00
visual system development (GO:0150063)	448	9	7.47	+	1.21	5.72E-01	1.00E00
response to stimulus (GO:0050896)	9180	184	153.03	+	1.20	1.07E-03	8.22E-02
cellular response to stress (GO:0033554)	1649	33	27.49	+	1.20	2.70E-01	1.00E00
polyol biosynthetic process (GO:0046173)	50	1	.83	+	1.20	5.69E-01	1.00E00
regulation of erythrocyte differentiation (GO:0045646)	50	1	.83	+	1.20	5.69E-01	1.00E00
metencephalon development (GO:0022037)	150	3	2.50	+	1.20	7.41E-01	1.00E00
embryonic epithelial tube formation (GO:0001838)	150	3	2.50	+	1.20	7.41E-01	1.00E00
positive regulation of stem cell population maintenance (GO:1902459)	50	1	.83	+	1.20	5.69E-01	1.00E00
T cell differentiation involved in immune response (GO:0002292)	50	1	.83	+	1.20	5.69E-01	1.00E00
regulation of cardiac muscle cell proliferation (GO:0060043)	50	1	.83	+	1.20	5.69E-01	1.00E00
regulation of protein depolymerization (GO:1901879)	100	2	1.67	+	1.20	6.84E-01	1.00E00
cell-cell junction organization (GO:0045216)	200	4	3.33	+	1.20	5.79E-01	1.00E00
cellular detoxification (GO:1990748)	100	2	1.67	+	1.20	6.84E-01	1.00E00
regulation of dendrite morphogenesis (GO:0048814)	100	2	1.67	+	1.20	6.84E-01	1.00E00
peptidyl-threonine phosphorylation (GO:0018107)	50	1	.83	+	1.20	5.69E-01	1.00E00
synaptic vesicle transport (GO:0048489)	50	1	.83	+	1.20	5.69E-01	1.00E00
positive regulation of B cell proliferation (GO:0030890)	50	1	.83	+	1.20	5.69E-01	1.00E00
phospholipid catabolic process (GO:0009395)	50	1	.83	+	1.20	5.69E-01	1.00E00
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)	50	1	.83	+	1.20	5.69E-01	1.00E00
renal tubule development (GO:0061326)	100	2	1.67	+	1.20	6.84E-01	1.00E00
stem cell population maintenance (GO:0019827)	150	3	2.50	+	1.20	7.41E-01	1.00E00
regulation of humoral immune response (GO:0002920)	50	1	.83	+	1.20	5.69E-01	1.00E00
adult walking behavior (GO:0007628)	50	1	.83	+	1.20	5.69E-01	1.00E00
cell recognition (GO:0008037)	150	3	2.50	+	1.20	7.41E-01	1.00E00
neuromuscular junction development (GO:0007528)	50	1	.83	+	1.20	5.69E-01	1.00E00
negative regulation of protein metabolic process (GO:0051248)	854	17	14.24	+	1.19	4.13E-01	1.00E00
regulation of protein metabolic process (GO:0051246)	2110	42	35.17	+	1.19	2.11E-01	1.00E00
hindbrain development (GO:0030902)	201	4	3.35	+	1.19	5.81E-01	1.00E00
regulation of heart contraction (GO:0008016)	201	4	3.35	+	1.19	5.81E-01	1.00E00
animal organ morphogenesis (GO:0009887)	1106	22	18.44	+	1.19	3.97E-01	1.00E00
positive regulation of immune system process (GO:0002684)	1106	22	18.44	+	1.19	3.97E-01	1.00E00
regulation of kinase activity (GO:0043549)	503	10	8.38	+	1.19	4.84E-01	1.00E00
response to ethanol (GO:0045471)	151	3	2.52	+	1.19	7.42E-01	1.00E00
ear morphogenesis (GO:0042471)	151	3	2.52	+	1.19	7.42E-01	1.00E00
establishment of cell polarity (GO:0030010)	151	3	2.52	+	1.19	7.42E-01	1.00E00
positive regulation of cold-induced thermogenesis (GO:0120162)	101	2	1.68	+	1.19	6.86E-01	1.00E00
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)	101	2	1.68	+	1.19	6.86E-01	1.00E00
regulation of canonical NF-kappaB signal transduction (GO:0043122)	253	5	4.22	+	1.19	6.18E-01	1.00E00
cilium assembly (GO:0060271)	355	7	5.92	+	1.18	6.72E-01	1.00E00
proteolysis involved in protein catabolic process (GO:0051603)	710	14	11.84	+	1.18	4.58E-01	1.00E00
male sex differentiation (GO:0046661)	203	4	3.38	+	1.18	5.84E-01	1.00E00
cell junction assembly (GO:0034329)	305	6	5.08	+	1.18	6.48E-01	1.00E00
positive regulation of protein catabolic process (GO:0045732)	204	4	3.40	+	1.18	5.86E-01	1.00E00
immune system development (GO:0002520)	204	4	3.40	+	1.18	5.86E-01	1.00E00
regulation of cellular senescence (GO:2000772)	51	1	.85	+	1.18	5.76E-01	1.00E00
columnar/cuboidal epithelial cell development (GO:0002066)	51	1	.85	+	1.18	5.76E-01	1.00E00
negative regulation of reactive oxygen species metabolic process (GO:2000378)	51	1	.85	+	1.18	5.76E-01	1.00E00
genitalia development (GO:0048806)	51	1	.85	+	1.18	5.76E-01	1.00E00
gluconeogenesis (GO:0006094)	51	1	.85	+	1.18	5.76E-01	1.00E00
post-transcriptional gene silencing (GO:0016441)	51	1	.85	+	1.18	5.76E-01	1.00E00
positive regulation of protein localization to nucleus (GO:1900182)	102	2	1.70	+	1.18	6.88E-01	1.00E00
neutral amino acid transport (GO:0015804)	51	1	.85	+	1.18	5.76E-01	1.00E00
regulation of striated muscle tissue development (GO:0016202)	51	1	.85	+	1.18	5.76E-01	1.00E00
regulation of keratinocyte proliferation (GO:0010837)	51	1	.85	+	1.18	5.76E-01	1.00E00
snRNA metabolic process (GO:0016073)	51	1	.85	+	1.18	5.76E-01	1.00E00
regulation of fatty acid biosynthetic process (GO:0042304)	51	1	.85	+	1.18	5.76E-01	1.00E00
protein localization to postsynaptic membrane (GO:1903539)	51	1	.85	+	1.18	5.76E-01	1.00E00
morphogenesis of a branching epithelium (GO:0061138)	204	4	3.40	+	1.18	5.86E-01	1.00E00
cellular response to starvation (GO:0009267)	205	4	3.42	+	1.17	5.88E-01	1.00E00
response to growth factor (GO:0070848)	564	11	9.40	+	1.17	6.14E-01	1.00E00
regulation of catalytic activity (GO:0050790)	1231	24	20.52	+	1.17	4.21E-01	1.00E00
positive regulation of protein serine/threonine kinase activity (GO:0071902)	154	3	2.57	+	1.17	7.45E-01	1.00E00
positive regulation of intracellular transport (GO:0032388)	154	3	2.57	+	1.17	7.45E-01	1.00E00
positive regulation of immune response (GO:0050778)	719	14	11.99	+	1.17	5.51E-01	1.00E00
negative regulation of DNA-templated transcription (GO:0045892)	1286	25	21.44	+	1.17	4.31E-01	1.00E00
protein metabolic process (GO:0019538)	3501	68	58.36	+	1.17	1.71E-01	1.00E00
positive regulation of mononuclear cell migration (GO:0071677)	103	2	1.72	+	1.16	6.91E-01	1.00E00
rRNA processing (GO:0006364)	206	4	3.43	+	1.16	5.90E-01	1.00E00
amide metabolic process (GO:0043603)	412	8	6.87	+	1.16	5.62E-01	1.00E00
positive regulation of catalytic activity (GO:0043085)	721	14	12.02	+	1.16	5.52E-01	1.00E00
regulation of receptor signaling pathway via JAK-STAT (GO:0046425)	103	2	1.72	+	1.16	6.91E-01	1.00E00
female pregnancy (GO:0007565)	206	4	3.43	+	1.16	5.90E-01	1.00E00
negative regulation of macromolecule metabolic process (GO:0010605)	2733	53	45.56	+	1.16	2.31E-01	1.00E00
G protein-coupled receptor signaling pathway (GO:0007186)	1910	37	31.84	+	1.16	3.49E-01	1.00E00
negative regulation of RNA metabolic process (GO:0051253)	1394	27	23.24	+	1.16	3.88E-01	1.00E00
positive regulation of growth (GO:0045927)	310	6	5.17	+	1.16	6.52E-01	1.00E00
membrane fusion (GO:0061025)	155	3	2.58	+	1.16	7.46E-01	1.00E00
regulation of immune response (GO:0050776)	1034	20	17.24	+	1.16	4.55E-01	1.00E00
negative regulation of RNA biosynthetic process (GO:1902679)	1294	25	21.57	+	1.16	4.32E-01	1.00E00
RNA splicing (GO:0008380)	363	7	6.05	+	1.16	6.76E-01	1.00E00
vesicle fusion (GO:0006906)	104	2	1.73	+	1.15	6.93E-01	1.00E00
roof of mouth development (GO:0060021)	104	2	1.73	+	1.15	6.93E-01	1.00E00
branching involved in ureteric bud morphogenesis (GO:0001658)	52	1	.87	+	1.15	5.83E-01	1.00E00
regulation of T cell migration (GO:2000404)	52	1	.87	+	1.15	5.83E-01	1.00E00
positive regulation of interferon-beta production (GO:0032728)	52	1	.87	+	1.15	5.83E-01	1.00E00
regulation of cysteine-type endopeptidase activity (GO:2000116)	208	4	3.47	+	1.15	7.81E-01	1.00E00
sensory perception of bitter taste (GO:0050913)	52	1	.87	+	1.15	5.83E-01	1.00E00
spleen development (GO:0048536)	52	1	.87	+	1.15	5.83E-01	1.00E00
vitamin transport (GO:0051180)	52	1	.87	+	1.15	5.83E-01	1.00E00
positive regulation of neuron apoptotic process (GO:0043525)	104	2	1.73	+	1.15	6.93E-01	1.00E00
amine metabolic process (GO:0009308)	104	2	1.73	+	1.15	6.93E-01	1.00E00
nucleoside triphosphate biosynthetic process (GO:0009142)	104	2	1.73	+	1.15	6.93E-01	1.00E00
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)	52	1	.87	+	1.15	5.83E-01	1.00E00
bone remodeling (GO:0046849)	52	1	.87	+	1.15	5.83E-01	1.00E00
regulation of mRNA metabolic process (GO:1903311)	312	6	5.20	+	1.15	6.53E-01	1.00E00
positive regulation of gene expression (GO:0010628)	1302	25	21.70	+	1.15	4.35E-01	1.00E00
cellular process (GO:0009987)	16249	312	270.87	+	1.15	1.59E-07	7.65E-05
leukocyte mediated immunity (GO:0002443)	417	8	6.95	+	1.15	6.96E-01	1.00E00
regulation of peptidase activity (GO:0052547)	313	6	5.22	+	1.15	6.54E-01	1.00E00
ubiquitin-dependent protein catabolic process (GO:0006511)	574	11	9.57	+	1.15	6.18E-01	1.00E00
macromolecule biosynthetic process (GO:0009059)	3081	59	51.36	+	1.15	2.54E-01	1.00E00
biological process involved in interspecies interaction between organisms (GO:0044419)	1677	32	27.96	+	1.14	4.26E-01	1.00E00
organelle assembly (GO:0070925)	891	17	14.85	+	1.14	5.05E-01	1.00E00
regulation of transferase activity (GO:0051338)	577	11	9.62	+	1.14	6.19E-01	1.00E00
skin development (GO:0043588)	315	6	5.25	+	1.14	6.56E-01	1.00E00
ribosomal small subunit biogenesis (GO:0042274)	105	2	1.75	+	1.14	6.95E-01	1.00E00
regulation of signaling receptor activity (GO:0010469)	105	2	1.75	+	1.14	6.95E-01	1.00E00
epithelial tube formation (GO:0072175)	158	3	2.63	+	1.14	7.49E-01	1.00E00
maintenance of cell number (GO:0098727)	158	3	2.63	+	1.14	7.49E-01	1.00E00
regulation of MAP kinase activity (GO:0043405)	158	3	2.63	+	1.14	7.49E-01	1.00E00
ribonucleotide biosynthetic process (GO:0009260)	158	3	2.63	+	1.14	7.49E-01	1.00E00
metabolic process (GO:0008152)	7856	149	130.96	+	1.14	4.76E-02	7.71E-01
chromatin remodeling (GO:0006338)	1215	23	20.25	+	1.14	4.89E-01	1.00E00
regulation of immune effector process (GO:0002697)	476	9	7.93	+	1.13	7.15E-01	1.00E00
primary metabolic process (GO:0044238)	6829	129	113.84	+	1.13	8.73E-02	9.38E-01
positive regulation of transcription elongation by RNA polymerase II (GO:0032968)	53	1	.88	+	1.13	5.90E-01	1.00E00
cellular response to transforming growth factor beta stimulus (GO:0071560)	159	3	2.65	+	1.13	7.50E-01	1.00E00
regulation of muscle tissue development (GO:1901861)	53	1	.88	+	1.13	5.90E-01	1.00E00
tumor necrosis factor-mediated signaling pathway (GO:0033209)	53	1	.88	+	1.13	5.90E-01	1.00E00
Schwann cell differentiation (GO:0014037)	53	1	.88	+	1.13	5.90E-01	1.00E00
regulation of bone resorption (GO:0045124)	53	1	.88	+	1.13	5.90E-01	1.00E00
regulation of triglyceride metabolic process (GO:0090207)	53	1	.88	+	1.13	5.90E-01	1.00E00
embryonic skeletal system development (GO:0048706)	159	3	2.65	+	1.13	7.50E-01	1.00E00
embryonic cranial skeleton morphogenesis (GO:0048701)	53	1	.88	+	1.13	5.90E-01	1.00E00
glycolytic process (GO:0006096)	53	1	.88	+	1.13	5.90E-01	1.00E00
organelle membrane fusion (GO:0090174)	106	2	1.77	+	1.13	6.97E-01	1.00E00
multicellular organismal movement (GO:0050879)	53	1	.88	+	1.13	5.90E-01	1.00E00
positive regulation of protein import into nucleus (GO:0042307)	53	1	.88	+	1.13	5.90E-01	1.00E00
organic acid biosynthetic process (GO:0016053)	265	5	4.42	+	1.13	6.32E-01	1.00E00
lipoprotein biosynthetic process (GO:0042158)	53	1	.88	+	1.13	5.90E-01	1.00E00
negative regulation of DNA recombination (GO:0045910)	53	1	.88	+	1.13	5.90E-01	1.00E00
regulation of reactive oxygen species biosynthetic process (GO:1903426)	53	1	.88	+	1.13	5.90E-01	1.00E00
positive regulation of leukocyte chemotaxis (GO:0002690)	106	2	1.77	+	1.13	6.97E-01	1.00E00
muscle organ development (GO:0007517)	319	6	5.32	+	1.13	6.59E-01	1.00E00
proteolysis (GO:0006508)	1330	25	22.17	+	1.13	5.07E-01	1.00E00
microtubule cytoskeleton organization (GO:0000226)	586	11	9.77	+	1.13	6.23E-01	1.00E00
modification-dependent protein catabolic process (GO:0019941)	586	11	9.77	+	1.13	6.23E-01	1.00E00
intracellular transport (GO:0046907)	1173	22	19.55	+	1.13	5.57E-01	1.00E00
positive regulation of biosynthetic process (GO:0009891)	2774	52	46.24	+	1.12	3.42E-01	1.00E00
cellular response to nutrient levels (GO:0031669)	267	5	4.45	+	1.12	8.07E-01	1.00E00
macromolecule metabolic process (GO:0043170)	5617	105	93.63	+	1.12	1.83E-01	1.00E00
mononuclear cell migration (GO:0071674)	107	2	1.78	+	1.12	7.00E-01	1.00E00
cellular response to growth factor stimulus (GO:0071363)	535	10	8.92	+	1.12	6.10E-01	1.00E00
positive regulation of cell killing (GO:0031343)	107	2	1.78	+	1.12	7.00E-01	1.00E00
epithelium development (GO:0060429)	1284	24	21.40	+	1.12	5.73E-01	1.00E00
protein modification by small protein conjugation (GO:0032446)	642	12	10.70	+	1.12	6.38E-01	1.00E00
protein ubiquitination (GO:0016567)	589	11	9.82	+	1.12	6.25E-01	1.00E00
positive regulation of macromolecule metabolic process (GO:0010604)	3428	64	57.14	+	1.12	3.10E-01	1.00E00
positive regulation of metabolic process (GO:0009893)	3753	70	62.56	+	1.12	2.94E-01	1.00E00
negative regulation of biosynthetic process (GO:0009890)	2254	42	37.57	+	1.12	4.34E-01	1.00E00
modification-dependent macromolecule catabolic process (GO:0043632)	591	11	9.85	+	1.12	6.26E-01	1.00E00
morphogenesis of a branching structure (GO:0001763)	215	4	3.58	+	1.12	7.85E-01	1.00E00
system process (GO:0003008)	2855	53	47.59	+	1.11	3.89E-01	1.00E00
chordate embryonic development (GO:0043009)	862	16	14.37	+	1.11	5.88E-01	1.00E00
regulation of metabolic process (GO:0019222)	6523	121	108.74	+	1.11	1.66E-01	1.00E00
positive regulation of axon extension (GO:0045773)	54	1	.90	+	1.11	5.97E-01	1.00E00
neural tube closure (GO:0001843)	108	2	1.80	+	1.11	7.02E-01	1.00E00
mitotic metaphase chromosome alignment (GO:0007080)	54	1	.90	+	1.11	5.97E-01	1.00E00
canonical Wnt signaling pathway (GO:0060070)	108	2	1.80	+	1.11	7.02E-01	1.00E00
modulation by symbiont of entry into host (GO:0052372)	54	1	.90	+	1.11	5.97E-01	1.00E00
regulation of calcium ion import (GO:0090279)	54	1	.90	+	1.11	5.97E-01	1.00E00
positive regulation of nervous system process (GO:0031646)	54	1	.90	+	1.11	5.97E-01	1.00E00
plasma membrane invagination (GO:0099024)	54	1	.90	+	1.11	5.97E-01	1.00E00
mRNA transcription (GO:0009299)	54	1	.90	+	1.11	5.97E-01	1.00E00
protein localization to postsynapse (GO:0062237)	54	1	.90	+	1.11	5.97E-01	1.00E00
regulation of BMP signaling pathway (GO:0030510)	108	2	1.80	+	1.11	7.02E-01	1.00E00
hormone secretion (GO:0046879)	108	2	1.80	+	1.11	7.02E-01	1.00E00
cellular response to heat (GO:0034605)	54	1	.90	+	1.11	5.97E-01	1.00E00
intraciliary transport (GO:0042073)	54	1	.90	+	1.11	5.97E-01	1.00E00
nucleobase-containing small molecule metabolic process (GO:0055086)	595	11	9.92	+	1.11	6.28E-01	1.00E00
regulation of primary metabolic process (GO:0080090)	5523	102	92.07	+	1.11	2.24E-01	1.00E00
negative regulation of macromolecule biosynthetic process (GO:0010558)	2167	40	36.12	+	1.11	4.79E-01	1.00E00
response to UV (GO:0009411)	163	3	2.72	+	1.10	7.55E-01	1.00E00
regionalization (GO:0003002)	435	8	7.25	+	1.10	7.04E-01	1.00E00
regulation of pH (GO:0006885)	109	2	1.82	+	1.10	7.04E-01	1.00E00
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	109	2	1.82	+	1.10	7.04E-01	1.00E00
limb development (GO:0060173)	218	4	3.63	+	1.10	7.87E-01	1.00E00
appendage development (GO:0048736)	218	4	3.63	+	1.10	7.87E-01	1.00E00
pigmentation (GO:0043473)	109	2	1.82	+	1.10	7.04E-01	1.00E00
regulation of biomineral tissue development (GO:0070167)	109	2	1.82	+	1.10	7.04E-01	1.00E00
tube closure (GO:0060606)	109	2	1.82	+	1.10	7.04E-01	1.00E00
morphogenesis of an epithelium (GO:0002009)	546	10	9.10	+	1.10	7.33E-01	1.00E00
ear development (GO:0043583)	273	5	4.55	+	1.10	8.09E-01	1.00E00
monocarboxylic acid biosynthetic process (GO:0072330)	164	3	2.73	+	1.10	7.56E-01	1.00E00
gene expression (GO:0010467)	2683	49	44.72	+	1.10	4.69E-01	1.00E00
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	274	5	4.57	+	1.09	8.09E-01	1.00E00
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824)	165	3	2.75	+	1.09	7.57E-01	1.00E00
heart process (GO:0003015)	110	2	1.83	+	1.09	7.06E-01	1.00E00
hexose biosynthetic process (GO:0019319)	55	1	.92	+	1.09	6.04E-01	1.00E00
regulation of collagen biosynthetic process (GO:0032965)	55	1	.92	+	1.09	6.04E-01	1.00E00
peptide metabolic process (GO:0006518)	55	1	.92	+	1.09	6.04E-01	1.00E00
positive regulation of proteasomal protein catabolic process (GO:1901800)	110	2	1.83	+	1.09	7.06E-01	1.00E00
response to amine (GO:0014075)	55	1	.92	+	1.09	6.04E-01	1.00E00
regulation of oligodendrocyte differentiation (GO:0048713)	55	1	.92	+	1.09	6.04E-01	1.00E00
regulation of muscle organ development (GO:0048634)	55	1	.92	+	1.09	6.04E-01	1.00E00
regulation of telomere maintenance via telomerase (GO:0032210)	55	1	.92	+	1.09	6.04E-01	1.00E00
embryo development ending in birth or egg hatching (GO:0009792)	880	16	14.67	+	1.09	6.86E-01	1.00E00
negative regulation of immune response (GO:0050777)	220	4	3.67	+	1.09	7.88E-01	1.00E00
regulation of actin filament depolymerization (GO:0030834)	55	1	.92	+	1.09	6.04E-01	1.00E00
acidic amino acid transport (GO:0015800)	55	1	.92	+	1.09	6.04E-01	1.00E00
positive regulation of alpha-beta T cell differentiation (GO:0046638)	55	1	.92	+	1.09	6.04E-01	1.00E00
adipose tissue development (GO:0060612)	55	1	.92	+	1.09	6.04E-01	1.00E00
adherens junction organization (GO:0034332)	55	1	.92	+	1.09	6.04E-01	1.00E00
organelle organization (GO:0006996)	3139	57	52.33	+	1.09	4.97E-01	1.00E00
cardiac muscle tissue development (GO:0048738)	221	4	3.68	+	1.09	7.89E-01	1.00E00
regulation of generation of precursor metabolites and energy (GO:0043467)	166	3	2.77	+	1.08	7.58E-01	1.00E00
ribose phosphate biosynthetic process (GO:0046390)	166	3	2.77	+	1.08	7.58E-01	1.00E00
cytoskeleton-dependent cytokinesis (GO:0061640)	111	2	1.85	+	1.08	7.09E-01	1.00E00
small molecule metabolic process (GO:0044281)	1611	29	26.85	+	1.08	6.14E-01	1.00E00
chromatin organization (GO:0006325)	1343	24	22.39	+	1.07	6.61E-01	1.00E00
cellular response to amino acid starvation (GO:0034198)	56	1	.93	+	1.07	6.10E-01	1.00E00
complement activation (GO:0006956)	56	1	.93	+	1.07	6.10E-01	1.00E00
vesicle targeting (GO:0006903)	56	1	.93	+	1.07	6.10E-01	1.00E00
regulation of neuroblast proliferation (GO:1902692)	56	1	.93	+	1.07	6.10E-01	1.00E00
type I interferon-mediated signaling pathway (GO:0060337)	56	1	.93	+	1.07	6.10E-01	1.00E00
cellular response to type I interferon (GO:0071357)	56	1	.93	+	1.07	6.10E-01	1.00E00
regulation of microtubule cytoskeleton organization (GO:0070507)	168	3	2.80	+	1.07	7.60E-01	1.00E00
digestive tract morphogenesis (GO:0048546)	56	1	.93	+	1.07	6.10E-01	1.00E00
positive regulation of actin filament polymerization (GO:0030838)	56	1	.93	+	1.07	6.10E-01	1.00E00
proteinogenic amino acid biosynthetic process (GO:0170038)	56	1	.93	+	1.07	6.10E-01	1.00E00
L-amino acid biosynthetic process (GO:0170034)	56	1	.93	+	1.07	6.10E-01	1.00E00
ventricular cardiac muscle tissue morphogenesis (GO:0055010)	56	1	.93	+	1.07	6.10E-01	1.00E00
positive regulation of D-glucose transmembrane transport (GO:0010828)	56	1	.93	+	1.07	6.10E-01	1.00E00
positive regulation of TORC1 signaling (GO:1904263)	56	1	.93	+	1.07	6.10E-01	1.00E00
lipid storage (GO:0019915)	56	1	.93	+	1.07	6.10E-01	1.00E00
positive regulation of epithelial cell migration (GO:0010634)	56	1	.93	+	1.07	6.10E-01	1.00E00
cardiac conduction (GO:0061337)	56	1	.93	+	1.07	6.10E-01	1.00E00
glycerolipid catabolic process (GO:0046503)	56	1	.93	+	1.07	6.10E-01	1.00E00
epithelial cilium movement involved in extracellular fluid movement (GO:0003351)	56	1	.93	+	1.07	6.10E-01	1.00E00
actin polymerization or depolymerization (GO:0008154)	56	1	.93	+	1.07	6.10E-01	1.00E00
lymphocyte migration (GO:0072676)	56	1	.93	+	1.07	6.10E-01	1.00E00
embryo implantation (GO:0007566)	56	1	.93	+	1.07	6.10E-01	1.00E00
sulfur compound metabolic process (GO:0006790)	337	6	5.62	+	1.07	8.28E-01	1.00E00
positive regulation of macromolecule biosynthetic process (GO:0010557)	2643	47	44.06	+	1.07	6.27E-01	1.00E00
response to tumor necrosis factor (GO:0034612)	169	3	2.82	+	1.06	7.61E-01	1.00E00
positive regulation of transcription by RNA polymerase II (GO:0045944)	1299	23	21.65	+	1.06	7.37E-01	1.00E00
striated muscle contraction (GO:0006941)	113	2	1.88	+	1.06	7.13E-01	1.00E00
peptidyl-lysine modification (GO:0018205)	113	2	1.88	+	1.06	7.13E-01	1.00E00
adult locomotory behavior (GO:0008344)	113	2	1.88	+	1.06	7.13E-01	1.00E00
regulation of biosynthetic process (GO:0009889)	5258	93	87.65	+	1.06	4.97E-01	1.00E00
positive regulation of protein kinase activity (GO:0045860)	283	5	4.72	+	1.06	8.14E-01	1.00E00
regulation of macromolecule metabolic process (GO:0060255)	6002	106	100.05	+	1.06	4.78E-01	1.00E00
regulation of gene expression (GO:0010468)	4935	87	82.27	+	1.06	5.69E-01	1.00E00
hormone metabolic process (GO:0042445)	227	4	3.78	+	1.06	7.93E-01	1.00E00
response to other organism (GO:0051707)	1534	27	25.57	+	1.06	7.56E-01	1.00E00
organic anion transport (GO:0015711)	398	7	6.63	+	1.06	8.42E-01	1.00E00
immune system process (GO:0002376)	2504	44	41.74	+	1.05	6.79E-01	1.00E00
response to external biotic stimulus (GO:0043207)	1538	27	25.64	+	1.05	7.56E-01	1.00E00
response to nutrient (GO:0007584)	171	3	2.85	+	1.05	7.64E-01	1.00E00
iron ion transport (GO:0006826)	57	1	.95	+	1.05	6.17E-01	1.00E00
negative regulation of T cell differentiation (GO:0045581)	57	1	.95	+	1.05	6.17E-01	1.00E00
embryonic placenta development (GO:0001892)	114	2	1.90	+	1.05	7.16E-01	1.00E00
endothelial cell development (GO:0001885)	57	1	.95	+	1.05	6.17E-01	1.00E00
cellular response to light stimulus (GO:0071482)	114	2	1.90	+	1.05	7.16E-01	1.00E00
regulation of chondrocyte differentiation (GO:0032330)	57	1	.95	+	1.05	6.17E-01	1.00E00
negative regulation of viral process (GO:0048525)	114	2	1.90	+	1.05	7.16E-01	1.00E00
prostate gland development (GO:0030850)	57	1	.95	+	1.05	6.17E-01	1.00E00
ribonucleoside monophosphate metabolic process (GO:0009161)	57	1	.95	+	1.05	6.17E-01	1.00E00
cellular response to toxic substance (GO:0097237)	114	2	1.90	+	1.05	7.16E-01	1.00E00
phosphatidylcholine metabolic process (GO:0046470)	57	1	.95	+	1.05	6.17E-01	1.00E00
nucleoside phosphate metabolic process (GO:0006753)	571	10	9.52	+	1.05	8.68E-01	1.00E00
post-translational protein modification (GO:0043687)	800	14	13.34	+	1.05	7.79E-01	1.00E00
positive regulation of transferase activity (GO:0051347)	343	6	5.72	+	1.05	8.30E-01	1.00E00
embryonic organ morphogenesis (GO:0048562)	343	6	5.72	+	1.05	8.30E-01	1.00E00
protein catabolic process (GO:0030163)	858	15	14.30	+	1.05	7.86E-01	1.00E00
tube formation (GO:0035148)	172	3	2.87	+	1.05	7.65E-01	1.00E00
protein modification by small protein conjugation or removal (GO:0070647)	747	13	12.45	+	1.04	8.84E-01	1.00E00
epithelial cell development (GO:0002064)	230	4	3.83	+	1.04	7.95E-01	1.00E00
primary neural tube formation (GO:0014020)	115	2	1.92	+	1.04	7.18E-01	1.00E00
regulation of heart rate (GO:0002027)	115	2	1.92	+	1.04	7.18E-01	1.00E00
energy derivation by oxidation of organic compounds (GO:0015980)	288	5	4.80	+	1.04	8.16E-01	1.00E00
catabolic process (GO:0009056)	2074	36	34.57	+	1.04	7.87E-01	1.00E00
purine nucleotide biosynthetic process (GO:0006164)	173	3	2.88	+	1.04	7.66E-01	1.00E00
heart morphogenesis (GO:0003007)	289	5	4.82	+	1.04	8.17E-01	1.00E00
cellular response to abiotic stimulus (GO:0071214)	347	6	5.78	+	1.04	8.32E-01	1.00E00
cellular response to environmental stimulus (GO:0104004)	347	6	5.78	+	1.04	8.32E-01	1.00E00
regulation of protein-containing complex assembly (GO:0043254)	463	8	7.72	+	1.04	8.54E-01	1.00E00
innate immune response (GO:0045087)	811	14	13.52	+	1.04	8.88E-01	1.00E00
reproductive process (GO:0022414)	1738	30	28.97	+	1.04	8.45E-01	1.00E00
carbohydrate transmembrane transport (GO:0034219)	58	1	.97	+	1.03	6.23E-01	1.00E00
positive regulation of blood pressure (GO:0045777)	58	1	.97	+	1.03	6.23E-01	1.00E00
prostaglandin metabolic process (GO:0006693)	58	1	.97	+	1.03	6.23E-01	1.00E00
regulation of inflammasome-mediated signaling pathway (GO:0141085)	58	1	.97	+	1.03	6.23E-01	1.00E00
transcription preinitiation complex assembly (GO:0070897)	58	1	.97	+	1.03	6.23E-01	1.00E00
alpha-amino acid biosynthetic process (GO:1901607)	58	1	.97	+	1.03	6.23E-01	1.00E00
negative regulation of intracellular transport (GO:0032387)	58	1	.97	+	1.03	6.23E-01	1.00E00
regulation of muscle adaptation (GO:0043502)	116	2	1.93	+	1.03	7.20E-01	1.00E00
glutamine family amino acid metabolic process (GO:0009064)	58	1	.97	+	1.03	6.23E-01	1.00E00
positive regulation of lipid metabolic process (GO:0045834)	174	3	2.90	+	1.03	7.67E-01	1.00E00
negative regulation of innate immune response (GO:0045824)	116	2	1.93	+	1.03	7.20E-01	1.00E00
regulation of macromolecule biosynthetic process (GO:0010556)	5051	87	84.20	+	1.03	7.07E-01	1.00E00
biological_process (GO:0008150)	20571	353	342.91	+	1.03	2.27E-02	5.16E-01
macromolecule catabolic process (GO:0009057)	1111	19	18.52	+	1.03	9.04E-01	1.00E00
response to biotic stimulus (GO:0009607)	1579	27	26.32	+	1.03	8.39E-01	1.00E00
protein-DNA complex organization (GO:0071824)	176	3	2.93	+	1.02	7.70E-01	1.00E00
epithelial cell differentiation (GO:0030855)	704	12	11.74	+	1.02	8.81E-01	1.00E00
multi-organism reproductive process (GO:0044703)	235	4	3.92	+	1.02	7.99E-01	1.00E00
regulation of protein kinase activity (GO:0045859)	471	8	7.85	+	1.02	8.56E-01	1.00E00
lipid translocation (GO:0034204)	59	1	.98	+	1.02	1.00E00	1.00E00
positive regulation of kinase activity (GO:0033674)	295	5	4.92	+	1.02	8.20E-01	1.00E00
extracellular transport (GO:0006858)	59	1	.98	+	1.02	1.00E00	1.00E00
prostanoid metabolic process (GO:0006692)	59	1	.98	+	1.02	1.00E00	1.00E00
translational elongation (GO:0006414)	59	1	.98	+	1.02	1.00E00	1.00E00
regulation of endothelial cell apoptotic process (GO:2000351)	59	1	.98	+	1.02	1.00E00	1.00E00
cytokinesis (GO:0000910)	118	2	1.97	+	1.02	7.25E-01	1.00E00
aminoglycan biosynthetic process (GO:0006023)	59	1	.98	+	1.02	1.00E00	1.00E00
hormone transport (GO:0009914)	118	2	1.97	+	1.02	7.25E-01	1.00E00
positive regulation of biomineral tissue development (GO:0070169)	59	1	.98	+	1.02	1.00E00	1.00E00
peptide transport (GO:0015833)	118	2	1.97	+	1.02	7.25E-01	1.00E00
inner ear auditory receptor cell differentiation (GO:0042491)	59	1	.98	+	1.02	1.00E00	1.00E00
synaptic vesicle localization (GO:0097479)	59	1	.98	+	1.02	1.00E00	1.00E00
response to gamma radiation (GO:0010332)	59	1	.98	+	1.02	1.00E00	1.00E00
morphogenesis of embryonic epithelium (GO:0016331)	177	3	2.95	+	1.02	7.71E-01	1.00E00
regulation of RNA metabolic process (GO:0051252)	3619	61	60.33	+	1.01	9.43E-01	1.00E00
epidermis development (GO:0008544)	356	6	5.93	+	1.01	8.36E-01	1.00E00
establishment of protein localization (GO:0045184)	1307	22	21.79	+	1.01	9.11E-01	1.00E00
intracellular protein transport (GO:0006886)	535	9	8.92	+	1.01	8.65E-01	1.00E00
mRNA transport (GO:0051028)	119	2	1.98	+	1.01	1.00E00	1.00E00
positive regulation of lipid biosynthetic process (GO:0046889)	119	2	1.98	+	1.01	1.00E00	1.00E00
establishment of protein localization to organelle (GO:0072594)	357	6	5.95	+	1.01	8.36E-01	1.00E00
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	2026	34	33.77	+	1.01	9.27E-01	1.00E00
regulation of viral process (GO:0050792)	179	3	2.98	+	1.01	1.00E00	1.00E00
mitochondrial transport (GO:0006839)	180	3	3.00	-	1.00	1.00E00	1.00E00
T cell mediated immunity (GO:0002456)	60	1	1.00	-	1.00	1.00E00	1.00E00
positive regulation of cytokine-mediated signaling pathway (GO:0001961)	60	1	1.00	-	1.00	1.00E00	1.00E00
blastocyst formation (GO:0001825)	60	1	1.00	-	1.00	1.00E00	1.00E00
walking behavior (GO:0090659)	60	1	1.00	-	1.00	1.00E00	1.00E00
multi-multicellular organism process (GO:0044706)	240	4	4.00	-	1.00	1.00E00	1.00E00
morphogenesis of an epithelial sheet (GO:0002011)	60	1	1.00	-	1.00	1.00E00	1.00E00
establishment of spindle localization (GO:0051293)	60	1	1.00	-	1.00	1.00E00	1.00E00
macromolecule methylation (GO:0043414)	120	2	2.00	-	1.00	1.00E00	1.00E00
regulation of long-term synaptic potentiation (GO:1900271)	60	1	1.00	-	1.00	1.00E00	1.00E00
carboxylic acid transport (GO:0046942)	300	5	5.00	-	1.00	1.00E00	1.00E00
rRNA metabolic process (GO:0016072)	240	4	4.00	-	1.00	1.00E00	1.00E00
ribosome assembly (GO:0042255)	60	1	1.00	-	1.00	1.00E00	1.00E00
collagen fibril organization (GO:0030199)	60	1	1.00	-	1.00	1.00E00	1.00E00
cellular response to glucose starvation (GO:0042149)	60	1	1.00	-	1.00	1.00E00	1.00E00
regulation of alcohol biosynthetic process (GO:1902930)	60	1	1.00	-	1.00	1.00E00	1.00E00
positive regulation of organelle organization (GO:0010638)	541	9	9.02	-	1.00	1.00E00	1.00E00
positive regulation of DNA-templated transcription (GO:0045893)	1684	28	28.07	-	1.00	1.00E00	1.00E00
positive regulation of RNA biosynthetic process (GO:1902680)	1687	28	28.12	-	1.00	1.00E00	1.00E00
inner ear development (GO:0048839)	241	4	4.02	-	1.00	1.00E00	1.00E00
response to endoplasmic reticulum stress (GO:0034976)	241	4	4.02	-	1.00	1.00E00	1.00E00
regulation of nucleobase-containing compound metabolic process (GO:0019219)	3919	65	65.33	-	.99	1.00E00	1.00E00
organic acid transport (GO:0015849)	302	5	5.03	-	.99	1.00E00	1.00E00
protein transport (GO:0015031)	1089	18	18.15	-	.99	1.00E00	1.00E00
pattern specification process (GO:0007389)	484	8	8.07	-	.99	1.00E00	1.00E00
transcription initiation at RNA polymerase II promoter (GO:0006367)	121	2	2.02	-	.99	1.00E00	1.00E00
response to topologically incorrect protein (GO:0035966)	121	2	2.02	-	.99	1.00E00	1.00E00
response to alkaloid (GO:0043279)	121	2	2.02	-	.99	1.00E00	1.00E00
sensory perception of sound (GO:0007605)	182	3	3.03	-	.99	1.00E00	1.00E00
protein targeting (GO:0006605)	243	4	4.05	-	.99	1.00E00	1.00E00
nitrogen compound transport (GO:0071705)	1520	25	25.34	-	.99	1.00E00	1.00E00
negative regulation of organelle organization (GO:0010639)	365	6	6.08	-	.99	1.00E00	1.00E00
regulation of DNA-templated transcription (GO:0006355)	3346	55	55.78	-	.99	1.00E00	1.00E00
embryonic morphogenesis (GO:0048598)	670	11	11.17	-	.98	1.00E00	1.00E00
tissue morphogenesis (GO:0048729)	671	11	11.19	-	.98	1.00E00	1.00E00
reproductive structure development (GO:0048608)	366	6	6.10	-	.98	1.00E00	1.00E00
pyridine nucleotide catabolic process (GO:0019364)	61	1	1.02	-	.98	1.00E00	1.00E00
response to amino acid starvation (GO:1990928)	61	1	1.02	-	.98	1.00E00	1.00E00
regulation of interleukin-1 production (GO:0032652)	122	2	2.03	-	.98	1.00E00	1.00E00
cellular response to retinoic acid (GO:0071300)	61	1	1.02	-	.98	1.00E00	1.00E00
response to exogenous dsRNA (GO:0043330)	61	1	1.02	-	.98	1.00E00	1.00E00
membrane invagination (GO:0010324)	61	1	1.02	-	.98	1.00E00	1.00E00
regulation of RNA biosynthetic process (GO:2001141)	3356	55	55.94	-	.98	9.42E-01	1.00E00
in utero embryonic development (GO:0001701)	551	9	9.19	-	.98	1.00E00	1.00E00
response to starvation (GO:0042594)	245	4	4.08	-	.98	1.00E00	1.00E00
cellular response to radiation (GO:0071478)	184	3	3.07	-	.98	1.00E00	1.00E00
response to virus (GO:0009615)	368	6	6.13	-	.98	1.00E00	1.00E00
mesoderm development (GO:0007498)	123	2	2.05	-	.98	1.00E00	1.00E00
negative regulation of leukocyte differentiation (GO:1902106)	123	2	2.05	-	.98	1.00E00	1.00E00
developmental process involved in reproduction (GO:0003006)	1173	19	19.55	-	.97	1.00E00	1.00E00
cellular response to lipopolysaccharide (GO:0071222)	247	4	4.12	-	.97	1.00E00	1.00E00
reproductive system development (GO:0061458)	371	6	6.18	-	.97	1.00E00	1.00E00
NADH dehydrogenase complex assembly (GO:0010257)	62	1	1.03	-	.97	1.00E00	1.00E00
mitochondrial respiratory chain complex I assembly (GO:0032981)	62	1	1.03	-	.97	1.00E00	1.00E00
regulation of organelle assembly (GO:1902115)	248	4	4.13	-	.97	1.00E00	1.00E00
nucleosome assembly (GO:0006334)	62	1	1.03	-	.97	1.00E00	1.00E00
regulation of DNA replication (GO:0006275)	124	2	2.07	-	.97	1.00E00	1.00E00
sperm flagellum assembly (GO:0120316)	62	1	1.03	-	.97	1.00E00	1.00E00
non-motile cilium assembly (GO:1905515)	62	1	1.03	-	.97	1.00E00	1.00E00
positive regulation of blood vessel endothelial cell migration (GO:0043536)	62	1	1.03	-	.97	1.00E00	1.00E00
proton motive force-driven mitochondrial ATP synthesis (GO:0042776)	62	1	1.03	-	.97	1.00E00	1.00E00
carbohydrate transport (GO:0008643)	62	1	1.03	-	.97	1.00E00	1.00E00
extrinsic apoptotic signaling pathway (GO:0097191)	124	2	2.07	-	.97	1.00E00	1.00E00
regulation of dendritic spine morphogenesis (GO:0061001)	62	1	1.03	-	.97	1.00E00	1.00E00
activation of innate immune response (GO:0002218)	186	3	3.10	-	.97	1.00E00	1.00E00
cell-substrate adhesion (GO:0031589)	186	3	3.10	-	.97	1.00E00	1.00E00
immune response (GO:0006955)	1738	28	28.97	-	.97	9.22E-01	1.00E00
defense response to other organism (GO:0098542)	1121	18	18.69	-	.96	1.00E00	1.00E00
negative regulation of kinase activity (GO:0033673)	187	3	3.12	-	.96	1.00E00	1.00E00
organic hydroxy compound transport (GO:0015850)	187	3	3.12	-	.96	1.00E00	1.00E00
muscle structure development (GO:0061061)	562	9	9.37	-	.96	1.00E00	1.00E00
hormone-mediated signaling pathway (GO:0009755)	125	2	2.08	-	.96	1.00E00	1.00E00
actomyosin structure organization (GO:0031032)	125	2	2.08	-	.96	1.00E00	1.00E00
positive regulation of RNA metabolic process (GO:0051254)	1813	29	30.22	-	.96	9.24E-01	1.00E00
generation of precursor metabolites and energy (GO:0006091)	377	6	6.28	-	.95	1.00E00	1.00E00
sensory organ development (GO:0007423)	693	11	11.55	-	.95	1.00E00	1.00E00
face development (GO:0060324)	63	1	1.05	-	.95	1.00E00	1.00E00
leukocyte homeostasis (GO:0001776)	126	2	2.10	-	.95	1.00E00	1.00E00
sprouting angiogenesis (GO:0002040)	63	1	1.05	-	.95	1.00E00	1.00E00
export across plasma membrane (GO:0140115)	63	1	1.05	-	.95	1.00E00	1.00E00
keratinization (GO:0031424)	63	1	1.05	-	.95	1.00E00	1.00E00
regulation of bone remodeling (GO:0046850)	63	1	1.05	-	.95	1.00E00	1.00E00
regulation of collagen metabolic process (GO:0010712)	63	1	1.05	-	.95	1.00E00	1.00E00
ribosomal large subunit biogenesis (GO:0042273)	63	1	1.05	-	.95	1.00E00	1.00E00
monosaccharide biosynthetic process (GO:0046364)	63	1	1.05	-	.95	1.00E00	1.00E00
response to nutrient levels (GO:0031667)	569	9	9.49	-	.95	1.00E00	1.00E00
striated muscle cell differentiation (GO:0051146)	253	4	4.22	-	.95	1.00E00	1.00E00
positive regulation of immune effector process (GO:0002699)	317	5	5.28	-	.95	1.00E00	1.00E00
regulation of adaptive immune response (GO:0002819)	254	4	4.23	-	.94	1.00E00	1.00E00
regulation of T cell mediated immunity (GO:0002709)	127	2	2.12	-	.94	1.00E00	1.00E00
regulation of transcription by RNA polymerase II (GO:0006357)	2614	41	43.57	-	.94	7.45E-01	1.00E00
mitotic cell cycle (GO:0000278)	574	9	9.57	-	.94	1.00E00	1.00E00
RNA processing (GO:0006396)	830	13	13.84	-	.94	1.00E00	1.00E00
interferon-mediated signaling pathway (GO:0140888)	64	1	1.07	-	.94	1.00E00	1.00E00
regulation of intrinsic apoptotic signaling pathway (GO:2001242)	192	3	3.20	-	.94	1.00E00	1.00E00
cranial nerve development (GO:0021545)	64	1	1.07	-	.94	1.00E00	1.00E00
cellular response to molecule of bacterial origin (GO:0071219)	256	4	4.27	-	.94	1.00E00	1.00E00
cochlea development (GO:0090102)	64	1	1.07	-	.94	1.00E00	1.00E00
positive regulation of calcium-mediated signaling (GO:0050850)	64	1	1.07	-	.94	1.00E00	1.00E00
positive regulation of viral process (GO:0048524)	64	1	1.07	-	.94	1.00E00	1.00E00
mRNA stabilization (GO:0048255)	64	1	1.07	-	.94	1.00E00	1.00E00
regulation of telomere maintenance via telomere lengthening (GO:1904356)	64	1	1.07	-	.94	1.00E00	1.00E00
regulation of proteolysis (GO:0030162)	642	10	10.70	-	.93	1.00E00	1.00E00
negative regulation of catalytic activity (GO:0043086)	450	7	7.50	-	.93	1.00E00	1.00E00
cell surface receptor protein serine/threonine kinase signaling pathway (GO:0007178)	193	3	3.22	-	.93	1.00E00	1.00E00
nervous system process (GO:0050877)	2252	35	37.54	-	.93	7.28E-01	1.00E00
mRNA processing (GO:0006397)	451	7	7.52	-	.93	1.00E00	1.00E00
response to bacterium (GO:0009617)	838	13	13.97	-	.93	8.91E-01	1.00E00
regulation of organelle organization (GO:0033043)	1225	19	20.42	-	.93	9.08E-01	1.00E00
neural tube formation (GO:0001841)	129	2	2.15	-	.93	1.00E00	1.00E00
negative regulation of hemopoiesis (GO:1903707)	129	2	2.15	-	.93	1.00E00	1.00E00
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744)	65	1	1.08	-	.92	1.00E00	1.00E00
regulation of SMAD protein signal transduction (GO:0060390)	65	1	1.08	-	.92	1.00E00	1.00E00
positive regulation of proteolysis involved in protein catabolic process (GO:1903052)	130	2	2.17	-	.92	1.00E00	1.00E00
glycogen metabolic process (GO:0005977)	65	1	1.08	-	.92	1.00E00	1.00E00
negative regulation of lipid localization (GO:1905953)	65	1	1.08	-	.92	1.00E00	1.00E00
spindle localization (GO:0051653)	65	1	1.08	-	.92	1.00E00	1.00E00
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	65	1	1.08	-	.92	1.00E00	1.00E00
axonal transport (GO:0098930)	65	1	1.08	-	.92	1.00E00	1.00E00
positive regulation of receptor-mediated endocytosis (GO:0048260)	65	1	1.08	-	.92	1.00E00	1.00E00
regulation of lipid storage (GO:0010883)	65	1	1.08	-	.92	1.00E00	1.00E00
pyridine-containing compound catabolic process (GO:0072526)	65	1	1.08	-	.92	1.00E00	1.00E00
positive regulation of cell cycle G1/S phase transition (GO:1902808)	65	1	1.08	-	.92	1.00E00	1.00E00
defense response to symbiont (GO:0140546)	978	15	16.30	-	.92	8.98E-01	1.00E00
carboxylic acid biosynthetic process (GO:0046394)	261	4	4.35	-	.92	1.00E00	1.00E00
hematopoietic or lymphoid organ development (GO:0048534)	131	2	2.18	-	.92	1.00E00	1.00E00
regulation of cytokine production involved in immune response (GO:0002718)	131	2	2.18	-	.92	1.00E00	1.00E00
regulation of neuron apoptotic process (GO:0043523)	328	5	5.47	-	.91	1.00E00	1.00E00
negative regulation of gene expression (GO:0010629)	1116	17	18.60	-	.91	8.10E-01	1.00E00
transcription by RNA polymerase II (GO:0006366)	395	6	6.58	-	.91	1.00E00	1.00E00
muscle tissue development (GO:0060537)	395	6	6.58	-	.91	1.00E00	1.00E00
protein localization to organelle (GO:0033365)	791	12	13.19	-	.91	8.87E-01	1.00E00
regulation of epidermis development (GO:0045682)	66	1	1.10	-	.91	1.00E00	1.00E00
negative regulation of lymphocyte differentiation (GO:0045620)	66	1	1.10	-	.91	1.00E00	1.00E00
sulfur compound transport (GO:0072348)	66	1	1.10	-	.91	1.00E00	1.00E00
positive regulation of interleukin-1 beta production (GO:0032731)	66	1	1.10	-	.91	1.00E00	1.00E00
regulation of oxidoreductase activity (GO:0051341)	66	1	1.10	-	.91	1.00E00	1.00E00
negative regulation of translation (GO:0017148)	132	2	2.20	-	.91	1.00E00	1.00E00
regulation of tyrosine phosphorylation of STAT protein (GO:0042509)	66	1	1.10	-	.91	1.00E00	1.00E00
negative regulation of cytoplasmic pattern recognition receptor signaling pathway (GO:0039532)	66	1	1.10	-	.91	1.00E00	1.00E00
positive regulation of response to cytokine stimulus (GO:0060760)	66	1	1.10	-	.91	1.00E00	1.00E00
regulation of microtubule-based movement (GO:0060632)	66	1	1.10	-	.91	1.00E00	1.00E00
response to type I interferon (GO:0034340)	66	1	1.10	-	.91	1.00E00	1.00E00
nucleobase-containing compound catabolic process (GO:0034655)	331	5	5.52	-	.91	1.00E00	1.00E00
sex differentiation (GO:0007548)	332	5	5.53	-	.90	1.00E00	1.00E00
odontogenesis (GO:0042476)	133	2	2.22	-	.90	1.00E00	1.00E00
detection of stimulus (GO:0051606)	602	9	10.04	-	.90	8.72E-01	1.00E00
regulation of catabolic process (GO:0009894)	1004	15	16.74	-	.90	8.00E-01	1.00E00
positive regulation of ossification (GO:0045778)	67	1	1.12	-	.90	1.00E00	1.00E00
regulation of extracellular matrix organization (GO:1903053)	67	1	1.12	-	.90	1.00E00	1.00E00
antiviral innate immune response (GO:0140374)	67	1	1.12	-	.90	1.00E00	1.00E00
positive regulation of non-canonical NF-kappaB signal transduction (GO:1901224)	67	1	1.12	-	.90	1.00E00	1.00E00
glucan metabolic process (GO:0044042)	67	1	1.12	-	.90	1.00E00	1.00E00
negative regulation of DNA metabolic process (GO:0051053)	134	2	2.23	-	.90	1.00E00	1.00E00
cytoplasmic microtubule organization (GO:0031122)	67	1	1.12	-	.90	1.00E00	1.00E00
amino acid biosynthetic process (GO:0008652)	67	1	1.12	-	.90	1.00E00	1.00E00
protein localization to cilium (GO:0061512)	67	1	1.12	-	.90	1.00E00	1.00E00
positive regulation of mitotic cell cycle (GO:0045931)	134	2	2.23	-	.90	1.00E00	1.00E00
regulation of membrane lipid distribution (GO:0097035)	67	1	1.12	-	.90	1.00E00	1.00E00
negative regulation of lymphocyte mediated immunity (GO:0002707)	67	1	1.12	-	.90	1.00E00	1.00E00
cilium movement (GO:0003341)	270	4	4.50	-	.89	1.00E00	1.00E00
mRNA metabolic process (GO:0016071)	608	9	10.14	-	.89	8.72E-01	1.00E00
autophagy (GO:0006914)	339	5	5.65	-	.88	1.00E00	1.00E00
process utilizing autophagic mechanism (GO:0061919)	339	5	5.65	-	.88	1.00E00	1.00E00
xenobiotic metabolic process (GO:0006805)	136	2	2.27	-	.88	1.00E00	1.00E00
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	68	1	1.13	-	.88	1.00E00	1.00E00
positive regulation of transcription initiation by RNA polymerase II (GO:0060261)	68	1	1.13	-	.88	1.00E00	1.00E00
positive regulation of dendritic spine development (GO:0060999)	68	1	1.13	-	.88	1.00E00	1.00E00
vesicle organization (GO:0016050)	341	5	5.68	-	.88	1.00E00	1.00E00
cell-cell junction assembly (GO:0007043)	137	2	2.28	-	.88	1.00E00	1.00E00
mitotic sister chromatid segregation (GO:0000070)	137	2	2.28	-	.88	1.00E00	1.00E00
intracellular iron ion homeostasis (GO:0006879)	69	1	1.15	-	.87	1.00E00	1.00E00
cellular response to interferon-beta (GO:0035458)	69	1	1.15	-	.87	1.00E00	1.00E00
positive regulation of glucose metabolic process (GO:0010907)	69	1	1.15	-	.87	1.00E00	1.00E00
myofibril assembly (GO:0030239)	69	1	1.15	-	.87	1.00E00	1.00E00
steroid metabolic process (GO:0008202)	277	4	4.62	-	.87	1.00E00	1.00E00
regulation of protein polymerization (GO:0032271)	208	3	3.47	-	.87	1.00E00	1.00E00
methylation (GO:0032259)	208	3	3.47	-	.87	1.00E00	1.00E00
vesicle-mediated transport to the plasma membrane (GO:0098876)	139	2	2.32	-	.86	1.00E00	1.00E00
negative regulation of canonical Wnt signaling pathway (GO:0090090)	139	2	2.32	-	.86	1.00E00	1.00E00
negative regulation of molecular function (GO:0044092)	765	11	12.75	-	.86	7.73E-01	1.00E00
sexual reproduction (GO:0019953)	1184	17	19.74	-	.86	6.40E-01	1.00E00
gonad development (GO:0008406)	279	4	4.65	-	.86	1.00E00	1.00E00
nucleobase-containing compound biosynthetic process (GO:0034654)	1675	24	27.92	-	.86	4.88E-01	1.00E00
myeloid cell differentiation (GO:0030099)	349	5	5.82	-	.86	1.00E00	1.00E00
RNA biosynthetic process (GO:0032774)	1330	19	22.17	-	.86	5.80E-01	1.00E00
regulation of interleukin-2 production (GO:0032663)	70	1	1.17	-	.86	1.00E00	1.00E00
nucleoside phosphate biosynthetic process (GO:1901293)	280	4	4.67	-	.86	1.00E00	1.00E00
vasodilation (GO:0042311)	70	1	1.17	-	.86	1.00E00	1.00E00
mammary gland epithelium development (GO:0061180)	70	1	1.17	-	.86	1.00E00	1.00E00
DNA metabolic process (GO:0006259)	701	10	11.69	-	.86	7.64E-01	1.00E00
mitochondrion organization (GO:0007005)	421	6	7.02	-	.85	8.48E-01	1.00E00
regulation of microtubule-based process (GO:0032886)	281	4	4.68	-	.85	1.00E00	1.00E00
negative regulation of transferase activity (GO:0051348)	211	3	3.52	-	.85	1.00E00	1.00E00
post-transcriptional regulation of gene expression (GO:0010608)	493	7	8.22	-	.85	8.58E-01	1.00E00
sister chromatid segregation (GO:0000819)	141	2	2.35	-	.85	1.00E00	1.00E00
establishment or maintenance of cell polarity (GO:0007163)	212	3	3.53	-	.85	1.00E00	1.00E00
development of primary sexual characteristics (GO:0045137)	283	4	4.72	-	.85	1.00E00	1.00E00
nucleobase-containing compound metabolic process (GO:0006139)	2626	37	43.77	-	.85	2.91E-01	1.00E00
nucleotide biosynthetic process (GO:0009165)	213	3	3.55	-	.84	1.00E00	1.00E00
endochondral bone morphogenesis (GO:0060350)	71	1	1.18	-	.84	1.00E00	1.00E00
circadian regulation of gene expression (GO:0032922)	71	1	1.18	-	.84	1.00E00	1.00E00
somitogenesis (GO:0001756)	71	1	1.18	-	.84	1.00E00	1.00E00
endosome organization (GO:0007032)	71	1	1.18	-	.84	1.00E00	1.00E00
positive regulation of DNA biosynthetic process (GO:2000573)	71	1	1.18	-	.84	1.00E00	1.00E00
regulation of lymphocyte migration (GO:2000401)	71	1	1.18	-	.84	1.00E00	1.00E00
regulation of translational initiation (GO:0006446)	71	1	1.18	-	.84	1.00E00	1.00E00
glandular epithelial cell differentiation (GO:0002067)	71	1	1.18	-	.84	1.00E00	1.00E00
cellular response to biotic stimulus (GO:0071216)	284	4	4.73	-	.84	1.00E00	1.00E00
aldehyde metabolic process (GO:0006081)	71	1	1.18	-	.84	1.00E00	1.00E00
response to fatty acid (GO:0070542)	71	1	1.18	-	.84	1.00E00	1.00E00
skeletal muscle cell differentiation (GO:0035914)	71	1	1.18	-	.84	1.00E00	1.00E00
regulation of immunoglobulin mediated immune response (GO:0002889)	71	1	1.18	-	.84	1.00E00	1.00E00
regulation of B cell mediated immunity (GO:0002712)	71	1	1.18	-	.84	1.00E00	1.00E00
cellular response to xenobiotic stimulus (GO:0071466)	214	3	3.57	-	.84	1.00E00	1.00E00
negative regulation of hydrolase activity (GO:0051346)	214	3	3.57	-	.84	1.00E00	1.00E00
regulation of double-strand break repair (GO:2000779)	143	2	2.38	-	.84	1.00E00	1.00E00
icosanoid metabolic process (GO:0006690)	143	2	2.38	-	.84	1.00E00	1.00E00
immune response-activating cell surface receptor signaling pathway (GO:0002429)	215	3	3.58	-	.84	1.00E00	1.00E00
positive regulation of fat cell differentiation (GO:0045600)	72	1	1.20	-	.83	1.00E00	1.00E00
regulation of interferon-beta production (GO:0032648)	72	1	1.20	-	.83	1.00E00	1.00E00
regulation of ERBB signaling pathway (GO:1901184)	72	1	1.20	-	.83	1.00E00	1.00E00
non-proteinogenic amino acid metabolic process (GO:0170041)	72	1	1.20	-	.83	1.00E00	1.00E00
cardiac muscle tissue morphogenesis (GO:0055008)	72	1	1.20	-	.83	1.00E00	1.00E00
natural killer cell activation (GO:0030101)	72	1	1.20	-	.83	1.00E00	1.00E00
positive regulation of protein modification by small protein conjugation or removal (GO:1903322)	144	2	2.40	-	.83	1.00E00	1.00E00
epidermal cell differentiation (GO:0009913)	217	3	3.62	-	.83	1.00E00	1.00E00
negative regulation of catabolic process (GO:0009895)	362	5	6.03	-	.83	8.37E-01	1.00E00
positive regulation of post-translational protein modification (GO:1901875)	145	2	2.42	-	.83	1.00E00	1.00E00
mitotic cell cycle process (GO:1903047)	511	7	8.52	-	.82	7.27E-01	1.00E00
positive regulation of protein-containing complex assembly (GO:0031334)	219	3	3.65	-	.82	1.00E00	1.00E00
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)	73	1	1.22	-	.82	1.00E00	1.00E00
organelle disassembly (GO:1903008)	73	1	1.22	-	.82	1.00E00	1.00E00
chromatin looping (GO:0140588)	146	2	2.43	-	.82	1.00E00	1.00E00
urogenital system development (GO:0001655)	73	1	1.22	-	.82	1.00E00	1.00E00
protein autoubiquitination (GO:0051865)	73	1	1.22	-	.82	1.00E00	1.00E00
maintenance of protein location in cell (GO:0032507)	73	1	1.22	-	.82	1.00E00	1.00E00
protein acylation (GO:0043543)	73	1	1.22	-	.82	1.00E00	1.00E00
embryonic digit morphogenesis (GO:0042733)	73	1	1.22	-	.82	1.00E00	1.00E00
endosome to lysosome transport (GO:0008333)	73	1	1.22	-	.82	1.00E00	1.00E00
regulation of cell cycle (GO:0051726)	1099	15	18.32	-	.82	5.44E-01	1.00E00
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	367	5	6.12	-	.82	8.37E-01	1.00E00
fat cell differentiation (GO:0045444)	147	2	2.45	-	.82	1.00E00	1.00E00
regulation of macroautophagy (GO:0016241)	147	2	2.45	-	.82	1.00E00	1.00E00
regulation of ossification (GO:0030278)	147	2	2.45	-	.82	1.00E00	1.00E00
nucleic acid biosynthetic process (GO:0141187)	1397	19	23.29	-	.82	4.48E-01	1.00E00
RNA stabilization (GO:0043489)	74	1	1.23	-	.81	1.00E00	1.00E00
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	148	2	2.47	-	.81	1.00E00	1.00E00
regulation of cardiac muscle contraction (GO:0055117)	74	1	1.23	-	.81	1.00E00	1.00E00
negative regulation of response to biotic stimulus (GO:0002832)	148	2	2.47	-	.81	1.00E00	1.00E00
regulation of amide metabolic process (GO:0034248)	74	1	1.23	-	.81	1.00E00	1.00E00
negative regulation of cell cycle G1/S phase transition (GO:1902807)	74	1	1.23	-	.81	1.00E00	1.00E00
regulation of protein catabolic process (GO:0042176)	370	5	6.17	-	.81	8.37E-01	1.00E00
immune response-activating signaling pathway (GO:0002757)	297	4	4.95	-	.81	1.00E00	1.00E00
regulation of osteoblast differentiation (GO:0045667)	149	2	2.48	-	.81	1.00E00	1.00E00
regulation of intracellular transport (GO:0032386)	298	4	4.97	-	.81	1.00E00	1.00E00
striated muscle tissue development (GO:0014706)	373	5	6.22	-	.80	8.37E-01	1.00E00
negative regulation of proteolysis involved in protein catabolic process (GO:1903051)	75	1	1.25	-	.80	1.00E00	1.00E00
negative regulation of mRNA catabolic process (GO:1902373)	75	1	1.25	-	.80	1.00E00	1.00E00
positive regulation of DNA-templated transcription initiation (GO:2000144)	75	1	1.25	-	.80	1.00E00	1.00E00
regulation of stem cell population maintenance (GO:2000036)	75	1	1.25	-	.80	1.00E00	1.00E00
positive regulation of protein binding (GO:0032092)	75	1	1.25	-	.80	1.00E00	1.00E00
cilium movement involved in cell motility (GO:0060294)	226	3	3.77	-	.80	1.00E00	1.00E00
regulation of cold-induced thermogenesis (GO:0120161)	151	2	2.52	-	.79	1.00E00	1.00E00
regulation of viral life cycle (GO:1903900)	151	2	2.52	-	.79	1.00E00	1.00E00
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844)	151	2	2.52	-	.79	1.00E00	1.00E00
regulation of autophagy (GO:0010506)	303	4	5.05	-	.79	8.22E-01	1.00E00
astrocyte differentiation (GO:0048708)	76	1	1.27	-	.79	1.00E00	1.00E00
G1/S transition of mitotic cell cycle (GO:0000082)	76	1	1.27	-	.79	1.00E00	1.00E00
nucleus organization (GO:0006997)	153	2	2.55	-	.78	1.00E00	1.00E00
phagocytosis (GO:0006909)	153	2	2.55	-	.78	1.00E00	1.00E00
ribosome biogenesis (GO:0042254)	306	4	5.10	-	.78	8.22E-01	1.00E00
positive regulation of catabolic process (GO:0009896)	536	7	8.93	-	.78	6.10E-01	1.00E00
regulation of proteolysis involved in protein catabolic process (GO:1903050)	230	3	3.83	-	.78	1.00E00	1.00E00
DNA-templated transcription (GO:0006351)	537	7	8.95	-	.78	6.10E-01	1.00E00
cilium-dependent cell motility (GO:0060285)	231	3	3.85	-	.78	1.00E00	1.00E00
cilium or flagellum-dependent cell motility (GO:0001539)	231	3	3.85	-	.78	1.00E00	1.00E00
negative regulation of NF-kappaB transcription factor activity (GO:0032088)	77	1	1.28	-	.78	1.00E00	1.00E00
positive regulation of TOR signaling (GO:0032008)	77	1	1.28	-	.78	1.00E00	1.00E00
coronary vasculature development (GO:0060976)	77	1	1.28	-	.78	1.00E00	1.00E00
DNA damage response (GO:0006974)	778	10	12.97	-	.77	4.76E-01	1.00E00
RNA metabolic process (GO:0016070)	1479	19	24.65	-	.77	2.92E-01	1.00E00
arachidonate metabolic process (GO:0019369)	78	1	1.30	-	.77	1.00E00	1.00E00
regulation of transcription initiation by RNA polymerase II (GO:0060260)	78	1	1.30	-	.77	1.00E00	1.00E00
protein-DNA complex assembly (GO:0065004)	156	2	2.60	-	.77	1.00E00	1.00E00
cell cycle G1/S phase transition (GO:0044843)	78	1	1.30	-	.77	1.00E00	1.00E00
negative regulation of protein depolymerization (GO:1901880)	78	1	1.30	-	.77	1.00E00	1.00E00
endocytic recycling (GO:0032456)	78	1	1.30	-	.77	1.00E00	1.00E00
positive regulation of telomere maintenance (GO:0032206)	78	1	1.30	-	.77	1.00E00	1.00E00
response to interferon-beta (GO:0035456)	78	1	1.30	-	.77	1.00E00	1.00E00
nucleoside monophosphate metabolic process (GO:0009123)	78	1	1.30	-	.77	1.00E00	1.00E00
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)	78	1	1.30	-	.77	1.00E00	1.00E00
spermatid development (GO:0007286)	313	4	5.22	-	.77	8.23E-01	1.00E00
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	235	3	3.92	-	.77	1.00E00	1.00E00
activation of immune response (GO:0002253)	392	5	6.53	-	.77	6.91E-01	1.00E00
response to ionizing radiation (GO:0010212)	157	2	2.62	-	.76	1.00E00	1.00E00
lymphocyte activation involved in immune response (GO:0002285)	157	2	2.62	-	.76	1.00E00	1.00E00
positive regulation of DNA metabolic process (GO:0051054)	315	4	5.25	-	.76	8.23E-01	1.00E00
multicellular organismal reproductive process (GO:0048609)	1106	14	18.44	-	.76	3.35E-01	1.00E00
cardiac muscle cell development (GO:0055013)	79	1	1.32	-	.76	1.00E00	1.00E00
regulation of protein import into nucleus (GO:0042306)	79	1	1.32	-	.76	1.00E00	1.00E00
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822)	238	3	3.97	-	.76	1.00E00	1.00E00
nucleic acid metabolic process (GO:0090304)	2064	26	34.41	-	.76	1.48E-01	1.00E00
cell cycle (GO:0007049)	1037	13	17.29	-	.75	3.82E-01	1.00E00
regulation of alpha-beta T cell differentiation (GO:0046637)	80	1	1.33	-	.75	1.00E00	1.00E00
lipoprotein metabolic process (GO:0042157)	80	1	1.33	-	.75	1.00E00	1.00E00
amide transport (GO:0042886)	161	2	2.68	-	.75	1.00E00	1.00E00
spermatogenesis (GO:0007283)	729	9	12.15	-	.74	4.60E-01	1.00E00
vitamin metabolic process (GO:0006766)	81	1	1.35	-	.74	1.00E00	1.00E00
T cell differentiation in thymus (GO:0033077)	81	1	1.35	-	.74	1.00E00	1.00E00
pyruvate metabolic process (GO:0006090)	81	1	1.35	-	.74	1.00E00	1.00E00
spermatid differentiation (GO:0048515)	324	4	5.40	-	.74	8.25E-01	1.00E00
positive regulation of autophagy (GO:0010508)	162	2	2.70	-	.74	1.00E00	1.00E00
regulation of protein localization to nucleus (GO:1900180)	163	2	2.72	-	.74	1.00E00	1.00E00
DNA repair (GO:0006281)	492	6	8.20	-	.73	5.91E-01	1.00E00
nuclear receptor-mediated signaling pathway (GO:0141193)	82	1	1.37	-	.73	1.00E00	1.00E00
mitotic DNA damage checkpoint signaling (GO:0044773)	82	1	1.37	-	.73	1.00E00	1.00E00
cellular response to ionizing radiation (GO:0071479)	82	1	1.37	-	.73	1.00E00	1.00E00
regulation of intracellular pH (GO:0051453)	82	1	1.37	-	.73	1.00E00	1.00E00
metaphase chromosome alignment (GO:0051310)	82	1	1.37	-	.73	1.00E00	1.00E00
mitotic nuclear division (GO:0140014)	165	2	2.75	-	.73	1.00E00	1.00E00
aerobic respiration (GO:0009060)	165	2	2.75	-	.73	1.00E00	1.00E00
muscle cell differentiation (GO:0042692)	331	4	5.52	-	.72	6.66E-01	1.00E00
organelle transport along microtubule (GO:0072384)	83	1	1.38	-	.72	1.00E00	1.00E00
epithelial to mesenchymal transition (GO:0001837)	83	1	1.38	-	.72	1.00E00	1.00E00
modulation by host of symbiont process (GO:0051851)	83	1	1.38	-	.72	1.00E00	1.00E00
polysaccharide metabolic process (GO:0005976)	83	1	1.38	-	.72	1.00E00	1.00E00
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143)	83	1	1.38	-	.72	1.00E00	1.00E00
regulation of cardiac muscle tissue growth (GO:0055021)	83	1	1.38	-	.72	1.00E00	1.00E00
immune response-regulating signaling pathway (GO:0002764)	332	4	5.53	-	.72	6.67E-01	1.00E00
negative regulation of apoptotic signaling pathway (GO:2001234)	250	3	4.17	-	.72	8.03E-01	1.00E00
male gamete generation (GO:0048232)	750	9	12.50	-	.72	3.83E-01	1.00E00
regulation of G1/S transition of mitotic cell cycle (GO:2000045)	167	2	2.78	-	.72	1.00E00	1.00E00
regulation of DNA metabolic process (GO:0051052)	502	6	8.37	-	.72	5.94E-01	1.00E00
muscle tissue morphogenesis (GO:0060415)	84	1	1.40	-	.71	1.00E00	1.00E00
regulation of stem cell differentiation (GO:2000736)	84	1	1.40	-	.71	1.00E00	1.00E00
DNA duplex unwinding (GO:0032508)	84	1	1.40	-	.71	1.00E00	1.00E00
negative regulation of cysteine-type endopeptidase activity (GO:2000117)	84	1	1.40	-	.71	1.00E00	1.00E00
detection of stimulus involved in sensory perception (GO:0050906)	504	6	8.40	-	.71	4.84E-01	1.00E00
regulation of release of sequestered calcium ion into cytosol (GO:0051279)	84	1	1.40	-	.71	1.00E00	1.00E00
endothelial cell migration (GO:0043542)	84	1	1.40	-	.71	1.00E00	1.00E00
negative regulation of epithelial cell proliferation (GO:0050680)	168	2	2.80	-	.71	1.00E00	1.00E00
phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0043491)	84	1	1.40	-	.71	1.00E00	1.00E00
mammary gland development (GO:0030879)	168	2	2.80	-	.71	1.00E00	1.00E00
L-amino acid transport (GO:0015807)	84	1	1.40	-	.71	1.00E00	1.00E00
positive regulation of apoptotic signaling pathway (GO:2001235)	169	2	2.82	-	.71	1.00E00	1.00E00
regulation of apoptotic signaling pathway (GO:2001233)	425	5	7.08	-	.71	5.65E-01	1.00E00
chromosome segregation (GO:0007059)	341	4	5.68	-	.70	6.68E-01	1.00E00
regulation of protein serine/threonine kinase activity (GO:0071900)	257	3	4.28	-	.70	8.04E-01	1.00E00
mitotic DNA integrity checkpoint signaling (GO:0044774)	86	1	1.43	-	.70	1.00E00	1.00E00
cellular response to topologically incorrect protein (GO:0035967)	86	1	1.43	-	.70	1.00E00	1.00E00
positive regulation of muscle cell differentiation (GO:0051149)	86	1	1.43	-	.70	1.00E00	1.00E00
antigen processing and presentation of peptide antigen (GO:0048002)	86	1	1.43	-	.70	1.00E00	1.00E00
cellular process involved in reproduction in multicellular organism (GO:0022412)	519	6	8.65	-	.69	4.85E-01	1.00E00
adaptive immune response (GO:0002250)	522	6	8.70	-	.69	4.86E-01	1.00E00
regulation of mitotic cell cycle phase transition (GO:1901990)	348	4	5.80	-	.69	6.70E-01	1.00E00
negative regulation of protein kinase activity (GO:0006469)	174	2	2.90	-	.69	1.00E00	1.00E00
regulation of DNA-templated transcription initiation (GO:2000142)	87	1	1.45	-	.69	1.00E00	1.00E00
regulation of response to endoplasmic reticulum stress (GO:1905897)	87	1	1.45	-	.69	1.00E00	1.00E00
protein deubiquitination (GO:0016579)	87	1	1.45	-	.69	1.00E00	1.00E00
small molecule catabolic process (GO:0044282)	349	4	5.82	-	.69	6.70E-01	1.00E00
regulation of epithelial cell differentiation (GO:0030856)	175	2	2.92	-	.69	1.00E00	1.00E00
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	176	2	2.93	-	.68	1.00E00	1.00E00
negative regulation of RNA catabolic process (GO:1902369)	88	1	1.47	-	.68	1.00E00	1.00E00
response to vitamin (GO:0033273)	88	1	1.47	-	.68	1.00E00	1.00E00
lens development in camera-type eye (GO:0002088)	88	1	1.47	-	.68	1.00E00	1.00E00
motile cilium assembly (GO:0044458)	88	1	1.47	-	.68	1.00E00	1.00E00
embryonic pattern specification (GO:0009880)	88	1	1.47	-	.68	1.00E00	1.00E00
negative regulation of protein-containing complex disassembly (GO:0043242)	88	1	1.47	-	.68	1.00E00	1.00E00
cardiac cell development (GO:0055006)	88	1	1.47	-	.68	1.00E00	1.00E00
somite development (GO:0061053)	88	1	1.47	-	.68	1.00E00	1.00E00
outflow tract morphogenesis (GO:0003151)	88	1	1.47	-	.68	1.00E00	1.00E00
regulation of translation (GO:0006417)	353	4	5.88	-	.68	6.71E-01	1.00E00
positive regulation of cell cycle (GO:0045787)	355	4	5.92	-	.68	5.34E-01	1.00E00
regulation of heart growth (GO:0060420)	89	1	1.48	-	.67	1.00E00	1.00E00
transforming growth factor beta receptor superfamily signaling pathway (GO:0141091)	178	2	2.97	-	.67	1.00E00	1.00E00
centrosome cycle (GO:0007098)	89	1	1.48	-	.67	1.00E00	1.00E00
positive regulation of type I interferon production (GO:0032481)	89	1	1.48	-	.67	1.00E00	1.00E00
retrograde transport, endosome to Golgi (GO:0042147)	89	1	1.48	-	.67	1.00E00	1.00E00
positive regulation of cytokine production involved in immune response (GO:0002720)	89	1	1.48	-	.67	1.00E00	1.00E00
cell cycle process (GO:0022402)	899	10	14.99	-	.67	2.29E-01	1.00E00
positive regulation of gliogenesis (GO:0014015)	90	1	1.50	-	.67	1.00E00	1.00E00
vasculogenesis (GO:0001570)	90	1	1.50	-	.67	1.00E00	1.00E00
DNA geometric change (GO:0032392)	90	1	1.50	-	.67	1.00E00	1.00E00
regulation of cellular pH (GO:0030641)	90	1	1.50	-	.67	1.00E00	1.00E00
negative regulation of proteolysis (GO:0045861)	271	3	4.52	-	.66	6.34E-01	1.00E00
regulation of striated muscle contraction (GO:0006942)	91	1	1.52	-	.66	1.00E00	1.00E00
endothelial cell differentiation (GO:0045446)	91	1	1.52	-	.66	1.00E00	1.00E00
positive regulation of cell cycle process (GO:0090068)	273	3	4.55	-	.66	6.35E-01	1.00E00
myeloid leukocyte differentiation (GO:0002573)	183	2	3.05	-	.66	7.73E-01	1.00E00
nucleic acid catabolic process (GO:0141188)	184	2	3.07	-	.65	7.73E-01	1.00E00
odontogenesis of dentin-containing tooth (GO:0042475)	92	1	1.53	-	.65	1.00E00	1.00E00
gamete generation (GO:0007276)	923	10	15.39	-	.65	1.88E-01	1.00E00
positive regulation of double-strand break repair (GO:2000781)	93	1	1.55	-	.65	1.00E00	1.00E00
muscle organ morphogenesis (GO:0048644)	93	1	1.55	-	.65	1.00E00	1.00E00
regulation of protein binding (GO:0043393)	186	2	3.10	-	.65	7.74E-01	1.00E00
defense response to virus (GO:0051607)	281	3	4.68	-	.64	6.36E-01	1.00E00
negative regulation of myeloid cell differentiation (GO:0045638)	94	1	1.57	-	.64	1.00E00	1.00E00
positive regulation of organelle assembly (GO:1902117)	94	1	1.57	-	.64	1.00E00	1.00E00
positive regulation of protein polymerization (GO:0032273)	94	1	1.57	-	.64	1.00E00	1.00E00
disruption of cell in another organism (GO:0141061)	95	1	1.58	-	.63	1.00E00	1.00E00
lysosome organization (GO:0007040)	95	1	1.58	-	.63	1.00E00	1.00E00
killing of cells of another organism (GO:0031640)	95	1	1.58	-	.63	1.00E00	1.00E00
lytic vacuole organization (GO:0080171)	95	1	1.58	-	.63	1.00E00	1.00E00
fatty acid metabolic process (GO:0006631)	384	4	6.40	-	.62	4.24E-01	1.00E00
dicarboxylic acid metabolic process (GO:0043648)	96	1	1.60	-	.62	1.00E00	1.00E00
ketone metabolic process (GO:0042180)	96	1	1.60	-	.62	1.00E00	1.00E00
regulation of cell cycle process (GO:0010564)	771	8	12.85	-	.62	1.96E-01	1.00E00
organic acid metabolic process (GO:0006082)	868	9	14.47	-	.62	1.74E-01	1.00E00
regulation of proteasomal protein catabolic process (GO:0061136)	193	2	3.22	-	.62	7.75E-01	1.00E00
germ cell development (GO:0007281)	483	5	8.05	-	.62	3.67E-01	1.00E00
telomere maintenance (GO:0000723)	97	1	1.62	-	.62	1.00E00	1.00E00
monocarboxylic acid metabolic process (GO:0032787)	585	6	9.75	-	.62	3.22E-01	1.00E00
regulation of cell cycle G1/S phase transition (GO:1902806)	195	2	3.25	-	.62	7.76E-01	1.00E00
positive regulation of mitotic cell cycle phase transition (GO:1901992)	98	1	1.63	-	.61	1.00E00	1.00E00
establishment of chromosome localization (GO:0051303)	98	1	1.63	-	.61	1.00E00	1.00E00
protein localization to chromosome (GO:0034502)	98	1	1.63	-	.61	1.00E00	1.00E00
maintenance of location in cell (GO:0051651)	99	1	1.65	-	.61	1.00E00	1.00E00
positive regulation of macroautophagy (GO:0016239)	99	1	1.65	-	.61	1.00E00	1.00E00
DNA conformation change (GO:0071103)	100	1	1.67	-	.60	1.00E00	1.00E00
regulation of microtubule polymerization or depolymerization (GO:0031110)	100	1	1.67	-	.60	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process (GO:0000956)	101	1	1.68	-	.59	1.00E00	1.00E00
organic cation transport (GO:0015695)	101	1	1.68	-	.59	1.00E00	1.00E00
regulation of interleukin-1 beta production (GO:0032651)	102	1	1.70	-	.59	1.00E00	1.00E00
response to unfolded protein (GO:0006986)	103	1	1.72	-	.58	1.00E00	1.00E00
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	103	1	1.72	-	.58	1.00E00	1.00E00
cellular respiration (GO:0045333)	206	2	3.43	-	.58	7.80E-01	1.00E00
mitochondrial respiratory chain complex assembly (GO:0033108)	103	1	1.72	-	.58	1.00E00	1.00E00
protein polymerization (GO:0051258)	103	1	1.72	-	.58	1.00E00	1.00E00
regulation of stem cell proliferation (GO:0072091)	104	1	1.73	-	.58	1.00E00	1.00E00
regulation of telomere maintenance (GO:0032204)	104	1	1.73	-	.58	1.00E00	1.00E00
telomere organization (GO:0032200)	104	1	1.73	-	.58	1.00E00	1.00E00
regulation of calcium-mediated signaling (GO:0050848)	104	1	1.73	-	.58	1.00E00	1.00E00
axis specification (GO:0009798)	104	1	1.73	-	.58	1.00E00	1.00E00
microtubule organizing center organization (GO:0031023)	104	1	1.73	-	.58	1.00E00	1.00E00
regulation of mitotic cell cycle (GO:0007346)	521	5	8.68	-	.58	2.94E-01	1.00E00
chromosome localization (GO:0050000)	105	1	1.75	-	.57	1.00E00	1.00E00
regulation of production of molecular mediator of immune response (GO:0002700)	210	2	3.50	-	.57	5.90E-01	1.00E00
flagellated sperm motility (GO:0030317)	211	2	3.52	-	.57	5.91E-01	1.00E00
oxoacid metabolic process (GO:0043436)	852	8	14.20	-	.56	1.00E-01	9.70E-01
T cell receptor signaling pathway (GO:0050852)	107	1	1.78	-	.56	1.00E00	1.00E00
embryonic skeletal system morphogenesis (GO:0048704)	108	1	1.80	-	.56	1.00E00	1.00E00
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)	108	1	1.80	-	.56	1.00E00	1.00E00
smoothened signaling pathway (GO:0007224)	109	1	1.82	-	.55	1.00E00	1.00E00
positive regulation of chromosome organization (GO:2001252)	110	1	1.83	-	.55	1.00E00	1.00E00
regulation of DNA repair (GO:0006282)	220	2	3.67	-	.55	5.93E-01	1.00E00
protein modification by small protein removal (GO:0070646)	110	1	1.83	-	.55	1.00E00	1.00E00
epithelial cell proliferation (GO:0050673)	220	2	3.67	-	.55	5.93E-01	1.00E00
regulatory ncRNA-mediated gene silencing (GO:0031047)	110	1	1.83	-	.55	1.00E00	1.00E00
endothelium development (GO:0003158)	110	1	1.83	-	.55	1.00E00	1.00E00
sperm motility (GO:0097722)	221	2	3.68	-	.54	5.93E-01	1.00E00
isoprenoid metabolic process (GO:0006720)	111	1	1.85	-	.54	1.00E00	1.00E00
steroid biosynthetic process (GO:0006694)	111	1	1.85	-	.54	1.00E00	1.00E00
regulation of DNA biosynthetic process (GO:2000278)	111	1	1.85	-	.54	1.00E00	1.00E00
response to retinoic acid (GO:0032526)	111	1	1.85	-	.54	1.00E00	1.00E00
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	111	1	1.85	-	.54	1.00E00	1.00E00
biological process involved in interaction with symbiont (GO:0051702)	112	1	1.87	-	.54	1.00E00	1.00E00
segmentation (GO:0035282)	112	1	1.87	-	.54	1.00E00	1.00E00
mitochondrial respirasome assembly (GO:0097250)	112	1	1.87	-	.54	1.00E00	1.00E00
sensory perception (GO:0007600)	1684	15	28.07	-	.53	7.23E-03	2.97E-01
bone morphogenesis (GO:0060349)	114	1	1.90	-	.53	1.00E00	1.00E00
DNA damage checkpoint signaling (GO:0000077)	114	1	1.90	-	.53	1.00E00	1.00E00
Unclassified (UNCLASSIFIED)	1265	11	21.09	-	.52	2.27E-02	5.17E-01
positive regulation of endothelial cell migration (GO:0010595)	115	1	1.92	-	.52	1.00E00	1.00E00
regulation of cell cycle phase transition (GO:1901987)	465	4	7.75	-	.52	2.01E-01	1.00E00
anterior/posterior pattern specification (GO:0009952)	233	2	3.88	-	.51	6.00E-01	1.00E00
positive regulation of protein ubiquitination (GO:0031398)	117	1	1.95	-	.51	1.00E00	1.00E00
cardiac muscle cell differentiation (GO:0055007)	118	1	1.97	-	.51	1.00E00	1.00E00
carboxylic acid metabolic process (GO:0019752)	831	7	13.85	-	.51	7.02E-02	8.49E-01
monocarboxylic acid catabolic process (GO:0072329)	119	1	1.98	-	.50	7.26E-01	1.00E00
lymphocyte mediated immunity (GO:0002449)	357	3	5.95	-	.50	2.95E-01	1.00E00
positive regulation of cell cycle phase transition (GO:1901989)	119	1	1.98	-	.50	7.26E-01	1.00E00
oxidative phosphorylation (GO:0006119)	119	1	1.98	-	.50	7.26E-01	1.00E00
nuclear chromosome segregation (GO:0098813)	239	2	3.98	-	.50	4.47E-01	1.00E00
chromosome organization (GO:0051276)	485	4	8.08	-	.49	2.04E-01	1.00E00
carbohydrate biosynthetic process (GO:0016051)	122	1	2.03	-	.49	7.26E-01	1.00E00
regulation of organ growth (GO:0046620)	122	1	2.03	-	.49	7.26E-01	1.00E00
DNA integrity checkpoint signaling (GO:0031570)	123	1	2.05	-	.49	7.27E-01	1.00E00
regulation of cell cycle G2/M phase transition (GO:1902749)	125	1	2.08	-	.48	7.27E-01	1.00E00
Golgi organization (GO:0007030)	125	1	2.08	-	.48	7.27E-01	1.00E00
DNA-templated DNA replication (GO:0006261)	126	1	2.10	-	.48	7.27E-01	1.00E00
regulation of mitochondrion organization (GO:0010821)	126	1	2.10	-	.48	7.27E-01	1.00E00
antigen processing and presentation (GO:0019882)	126	1	2.10	-	.48	7.27E-01	1.00E00
endosomal transport (GO:0016197)	254	2	4.23	-	.47	4.52E-01	1.00E00
regulation of glucose metabolic process (GO:0010906)	128	1	2.13	-	.47	7.28E-01	1.00E00
long-chain fatty acid metabolic process (GO:0001676)	130	1	2.17	-	.46	7.28E-01	1.00E00
mRNA catabolic process (GO:0006402)	130	1	2.17	-	.46	7.28E-01	1.00E00
inorganic anion transmembrane transport (GO:0098661)	130	1	2.17	-	.46	7.28E-01	1.00E00
skeletal system morphogenesis (GO:0048705)	261	2	4.35	-	.46	3.34E-01	1.00E00
cell division (GO:0051301)	522	4	8.70	-	.46	1.18E-01	1.00E00
lysosomal transport (GO:0007041)	131	1	2.18	-	.46	7.29E-01	1.00E00
defense response to Gram-negative bacterium (GO:0050829)	133	1	2.22	-	.45	7.30E-01	1.00E00
immunoglobulin mediated immune response (GO:0016064)	267	2	4.45	-	.45	3.35E-01	1.00E00
disruption of anatomical structure in another organism (GO:0141060)	134	1	2.23	-	.45	7.30E-01	1.00E00
monoatomic anion transmembrane transport (GO:0098656)	135	1	2.25	-	.44	7.31E-01	1.00E00
B cell mediated immunity (GO:0019724)	273	2	4.55	-	.44	3.37E-01	1.00E00
positive regulation of DNA repair (GO:0045739)	137	1	2.28	-	.44	7.32E-01	1.00E00
keratinocyte differentiation (GO:0030216)	137	1	2.28	-	.44	7.32E-01	1.00E00
Golgi vesicle transport (GO:0048193)	275	2	4.58	-	.44	3.37E-01	1.00E00
antigen receptor-mediated signaling pathway (GO:0050851)	138	1	2.30	-	.43	7.32E-01	1.00E00
humoral immune response (GO:0006959)	277	2	4.62	-	.43	3.38E-01	1.00E00
mitotic cell cycle checkpoint signaling (GO:0007093)	139	1	2.32	-	.43	7.33E-01	1.00E00
regulation of type I interferon production (GO:0032479)	139	1	2.32	-	.43	7.33E-01	1.00E00
female sex differentiation (GO:0046660)	140	1	2.33	-	.43	7.34E-01	1.00E00
mitotic cell cycle phase transition (GO:0044772)	141	1	2.35	-	.43	7.34E-01	1.00E00
negative regulation of endopeptidase activity (GO:0010951)	141	1	2.35	-	.43	7.34E-01	1.00E00
determination of bilateral symmetry (GO:0009855)	142	1	2.37	-	.42	7.35E-01	1.00E00
specification of symmetry (GO:0009799)	142	1	2.37	-	.42	7.35E-01	1.00E00
protein-containing complex disassembly (GO:0032984)	147	1	2.45	-	.41	5.25E-01	1.00E00
mitochondrial gene expression (GO:0140053)	147	1	2.45	-	.41	5.25E-01	1.00E00
lipid catabolic process (GO:0016042)	294	2	4.90	-	.41	2.49E-01	1.00E00
signal transduction in response to DNA damage (GO:0042770)	148	1	2.47	-	.41	5.25E-01	1.00E00
positive regulation of production of molecular mediator of immune response (GO:0002702)	148	1	2.47	-	.41	5.25E-01	1.00E00
regulation of fat cell differentiation (GO:0045598)	149	1	2.48	-	.40	5.25E-01	1.00E00
epigenetic regulation of gene expression (GO:0040029)	303	2	5.05	-	.40	2.52E-01	1.00E00
cardiocyte differentiation (GO:0035051)	152	1	2.53	-	.39	5.25E-01	1.00E00
negative regulation of DNA-binding transcription factor activity (GO:0043433)	153	1	2.55	-	.39	5.26E-01	1.00E00
monocarboxylic acid transport (GO:0015718)	153	1	2.55	-	.39	5.26E-01	1.00E00
monoatomic anion transport (GO:0006820)	154	1	2.57	-	.39	5.26E-01	1.00E00
cell killing (GO:0001906)	155	1	2.58	-	.39	5.26E-01	1.00E00
cell cycle phase transition (GO:0044770)	155	1	2.58	-	.39	5.26E-01	1.00E00
blastocyst development (GO:0001824)	157	1	2.62	-	.38	5.27E-01	1.00E00
proteinogenic amino acid metabolic process (GO:0170039)	157	1	2.62	-	.38	5.27E-01	1.00E00
negative regulation of peptidase activity (GO:0010466)	157	1	2.62	-	.38	5.27E-01	1.00E00
inorganic anion transport (GO:0015698)	158	1	2.63	-	.38	5.28E-01	1.00E00
heterochromatin formation (GO:0031507)	160	1	2.67	-	.37	5.29E-01	1.00E00
striated muscle cell development (GO:0055002)	161	1	2.68	-	.37	5.29E-01	1.00E00
visual perception (GO:0007601)	162	1	2.70	-	.37	5.30E-01	1.00E00
RNA catabolic process (GO:0006401)	164	1	2.73	-	.37	5.31E-01	1.00E00
sensory perception of light stimulus (GO:0050953)	166	1	2.77	-	.36	5.33E-01	1.00E00
nuclear division (GO:0000280)	332	2	5.53	-	.36	1.88E-01	1.00E00
vacuolar transport (GO:0007034)	167	1	2.78	-	.36	5.34E-01	1.00E00
regulation of muscle cell differentiation (GO:0051147)	167	1	2.78	-	.36	5.34E-01	1.00E00
skeletal muscle tissue development (GO:0007519)	167	1	2.78	-	.36	5.34E-01	1.00E00
olefinic compound metabolic process (GO:0120254)	170	1	2.83	-	.35	5.37E-01	1.00E00
negative regulation of mitotic cell cycle phase transition (GO:1901991)	172	1	2.87	-	.35	3.77E-01	1.00E00
L-amino acid metabolic process (GO:0170033)	173	1	2.88	-	.35	3.77E-01	1.00E00
defense response to Gram-positive bacterium (GO:0050830)	177	1	2.95	-	.34	3.77E-01	1.00E00
DNA replication (GO:0006260)	178	1	2.97	-	.34	3.77E-01	1.00E00
cell cycle checkpoint signaling (GO:0000075)	179	1	2.98	-	.34	3.78E-01	1.00E00
protein folding (GO:0006457)	181	1	3.02	-	.33	3.78E-01	1.00E00
organelle fission (GO:0048285)	362	2	6.03	-	.33	1.40E-01	1.00E00
muscle cell development (GO:0055001)	194	1	3.23	-	.31	3.87E-01	1.00E00
defense response to bacterium (GO:0042742)	395	2	6.58	-	.30	7.22E-02	8.69E-01
alpha-amino acid metabolic process (GO:1901605)	199	1	3.32	-	.30	2.69E-01	1.00E00
vacuole organization (GO:0007033)	203	1	3.38	-	.30	2.70E-01	1.00E00
double-strand break repair (GO:0006302)	207	1	3.45	-	.29	2.71E-01	1.00E00
negative regulation of gene expression, epigenetic (GO:0045814)	210	1	3.50	-	.29	2.72E-01	1.00E00
detection of chemical stimulus (GO:0009593)	440	2	7.33	-	.27	3.77E-02	6.60E-01
regulation of reproductive process (GO:2000241)	224	1	3.73	-	.27	1.92E-01	1.00E00
organic acid catabolic process (GO:0016054)	227	1	3.78	-	.26	1.92E-01	1.00E00
carboxylic acid catabolic process (GO:0046395)	227	1	3.78	-	.26	1.92E-01	1.00E00
negative regulation of mitotic cell cycle (GO:0045930)	228	1	3.80	-	.26	1.92E-01	1.00E00
DNA recombination (GO:0006310)	244	1	4.07	-	.25	1.99E-01	1.00E00
regulation of chromosome organization (GO:0033044)	245	1	4.08	-	.24	1.99E-01	1.00E00
negative regulation of cell cycle phase transition (GO:1901988)	247	1	4.12	-	.24	2.01E-01	1.00E00
sensory perception of chemical stimulus (GO:0007606)	1259	5	20.99	-	.24	3.58E-05	5.52E-03
amino acid metabolic process (GO:0006520)	272	1	4.53	-	.22	9.64E-02	9.44E-01
negative regulation of cell cycle process (GO:0010948)	294	1	4.90	-	.20	1.01E-01	9.73E-01
meiotic cell cycle (GO:0051321)	333	1	5.55	-	.18	4.85E-02	7.79E-01
negative regulation of cell cycle (GO:0045786)	377	1	6.28	-	.16	2.37E-02	5.30E-01
translation (GO:0006412)	386	1	6.43	-	.16	2.43E-02	5.42E-01
detection of chemical stimulus involved in sensory perception (GO:0050907)	408	1	6.80	-	.15	1.69E-02	4.30E-01
sensory perception of smell (GO:0007608)	1154	1	19.24	-	.05	8.75E-08	4.65E-05
respiratory burst involved in defense response (GO:0002679)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
response to lead ion (GO:0010288)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
positive regulation of chronic inflammatory response (GO:0002678)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of chronic inflammatory response (GO:0002677)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
heat acclimation (GO:0010286)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of chronic inflammatory response (GO:0002676)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of acute inflammatory response (GO:0002675)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of acute inflammatory response (GO:0002674)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
protein hexamerization (GO:0034214)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
quinolinate catabolic process (GO:0034213)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell anergy (GO:0002669)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell anergy (GO:0002668)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of T cell anergy (GO:0002667)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell tolerance induction (GO:0002666)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell tolerance induction (GO:0002665)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of T cell tolerance induction (GO:0002664)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
detoxification of copper ion (GO:0010273)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell tolerance induction (GO:0002663)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to silver ion (GO:0010272)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of B cell tolerance induction (GO:0002661)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of peripheral tolerance induction (GO:0002660)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
amyloid-beta formation (GO:0034205)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
glycolipid translocation (GO:0034203)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to selenium ion (GO:0010269)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
regulation of peripheral tolerance induction (GO:0002658)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to vitamin B1 (GO:0010266)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
SCF complex assembly (GO:0010265)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of tolerance induction dependent upon immune response (GO:0002654)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of tolerance induction dependent upon immune response (GO:0002652)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of tolerance induction to self antigen (GO:0002651)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of intestinal cholesterol absorption (GO:0045797)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of intestinal cholesterol absorption (GO:0045796)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell volume (GO:0045795)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell volume (GO:0045794)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell size (GO:0045792)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of tolerance induction to self antigen (GO:0002649)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of central tolerance induction (GO:0002648)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of central tolerance induction (GO:0002646)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glucose mediated signaling pathway (GO:0010255)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of tolerance induction (GO:0002645)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of tolerance induction (GO:0002644)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tolerance induction (GO:0002643)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of immunoglobulin production (GO:0002639)	61	0	1.02	-	 < 0.01	6.29E-01	1.00E00
negative regulation of immunoglobulin production (GO:0002638)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of immunoglobulin production (GO:0002637)	88	0	1.47	-	 < 0.01	4.09E-01	1.00E00
positive regulation of germinal center formation (GO:0002636)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of germinal center formation (GO:0002635)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of germinal center formation (GO:0002634)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of granuloma formation (GO:0002632)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of granuloma formation (GO:0002631)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of bone resorption (GO:0045779)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of T cell antigen processing and presentation (GO:0002625)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vascular transport (GO:0010232)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of asymmetric cell division (GO:0045769)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of amino acid metabolic process (GO:0045764)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of amino acid metabolic process (GO:0045763)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of action potential (GO:0045760)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage antigen processing and presentation (GO:0002618)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage antigen processing and presentation (GO:0002617)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to lithium ion (GO:0010226)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage antigen processing and presentation (GO:0002616)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to UV-C (GO:0010225)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of action potential (GO:0045759)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of Toll signaling pathway (GO:0045752)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of Toll signaling pathway (GO:0045751)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell antigen processing and presentation (GO:0002606)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic cell antigen processing and presentation (GO:0002605)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell antigen processing and presentation (GO:0002604)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of hexokinase activity (GO:1903299)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate secretion, neurotransmission (GO:1903296)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of Notch signaling pathway (GO:0045746)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate secretion, neurotransmission (GO:1903294)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
protein localization to Golgi membrane (GO:1903292)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion import across plasma membrane (GO:1903288)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process to proline (GO:0019493)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of potassium ion import (GO:1903286)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide catabolic process (GO:1903285)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutathione peroxidase activity (GO:1903284)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glutathione peroxidase activity (GO:1903282)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium:sodium antiporter activity (GO:1903281)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
forebrain anterior/posterior pattern specification (GO:0021797)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
thalamus development (GO:0021794)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
chemorepulsion of branchiomotor axon (GO:0021793)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of calcium:sodium antiporter activity (GO:1903279)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
beta-alanine catabolic process (GO:0019484)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
respiratory burst after phagocytosis (GO:0045728)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of sodium ion export across plasma membrane (GO:1903277)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
beta-alanine biosynthetic process (GO:0019483)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
beta-alanine metabolic process (GO:0019482)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of integrin biosynthetic process (GO:0045726)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
L-alanine catabolic process, by transamination (GO:0019481)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycogen biosynthetic process (GO:0045725)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of gluconeogenesis (GO:0045722)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
negative regulation of gluconeogenesis (GO:0045721)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of integrin biosynthetic process (GO:0045720)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ribosome localization (GO:0033750)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
branchiomotor neuron axon guidance (GO:0021785)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
postganglionic parasympathetic fiber development (GO:0021784)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
preganglionic parasympathetic fiber development (GO:0021783)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
D-amino acid catabolic process (GO:0019478)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glial cell fate commitment (GO:0021781)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
L-lysine catabolic process (GO:0019477)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glial cell fate specification (GO:0021780)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen biosynthetic process (GO:0045719)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
L-lysine catabolic process to acetyl-CoA (GO:0019474)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of ornithine catabolic process (GO:1903267)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid biosynthetic process (GO:0045717)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of ornithine catabolic process (GO:1903266)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
4-hydroxyproline metabolic process (GO:0019471)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
4-hydroxyproline catabolic process (GO:0019470)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte cell fate commitment (GO:0021779)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte cell fate specification (GO:0021778)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in spinal cord motor neuron cell fate specification (GO:0021776)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in ventral spinal cord interneuron specification (GO:0021775)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
striatal medium spiny neuron differentiation (GO:0021773)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
lateral geniculate nucleus development (GO:0021771)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
exon-exon junction complex disassembly (GO:1903259)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycine decarboxylation via glycine cleavage system (GO:0019464)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ectoderm and mesoderm interaction (GO:0007499)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
multi-ciliated epithelial cell differentiation (GO:1903251)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
posterior midgut development (GO:0007497)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
visceral mesoderm-endoderm interaction involved in midgut development (GO:0007495)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endodermal cell fate determination (GO:0007493)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
orbitofrontal cortex development (GO:0021769)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleus accumbens development (GO:0021768)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mammillary body development (GO:0021767)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
amygdala development (GO:0021764)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
subthalamic nucleus development (GO:0021763)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
substantia nigra development (GO:0021762)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of citrulline biosynthetic process (GO:1903249)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of citrulline biosynthetic process (GO:1903248)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-cysteine catabolic process to taurine (GO:0019452)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
piRNA-mediated gene silencing by mRNA destabilization (GO:0140991)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle hypertrophy in response to stress (GO:1903243)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
primary piRNA processing (GO:0140990)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
putamen development (GO:0021758)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
caudate nucleus development (GO:0021757)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
striatum development (GO:0021756)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
facial nucleus development (GO:0021754)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pronephric nephron tubule development (GO:0039020)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-cysteine catabolic process to hypotaurine (GO:0019449)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-cysteine catabolic process (GO:0019448)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte tethering or rolling (GO:1903237)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
tryptophan catabolic process to acetyl-CoA (GO:0019442)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903235)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tryptophan catabolic process to kynurenine (GO:0019441)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
tryptophan catabolic process to indole-3-acetate (GO:0019440)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903233)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
melanosome assembly (GO:1903232)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
pronephric nephron development (GO:0039019)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pattern specification involved in pronephros development (GO:0039017)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cochlear nucleus development (GO:0021747)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
hypoglossal nucleus development (GO:0021743)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
abducens nucleus development (GO:0021742)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
embryonic skeletal joint development (GO:0072498)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
principal sensory nucleus of trigeminal nerve development (GO:0021740)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mesenchymal stem cell differentiation (GO:0072497)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
disruption of cellular anatomical structure in another organism (GO:0140975)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
triglyceride catabolic process (GO:0019433)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of endodermal cell differentiation (GO:1903226)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
triglyceride biosynthetic process (GO:0019432)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of AIM2 inflammasome complex assembly (GO:0140973)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of endodermal cell differentiation (GO:1903225)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of AIM2 inflammasome complex assembly (GO:0140972)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of endodermal cell differentiation (GO:1903224)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
removal of superoxide radicals (GO:0019430)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of AIM2 inflammasome complex assembly (GO:0140971)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
AIM2 inflammasome complex assembly (GO:0140970)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA integration (GO:0015074)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
phospholipid efflux (GO:0033700)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
pronephric field specification (GO:0039003)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
midbrain-hindbrain boundary maturation (GO:0021732)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
methylammonium transmembrane transport (GO:0072489)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ammonium transmembrane transport (GO:0072488)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA biosynthetic process from acetate (GO:0019427)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trigeminal sensory nucleus development (GO:0021730)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
piRNA-mediated heterochromatin formation (GO:0140966)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
secondary piRNA processing (GO:0140965)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein processing involved in protein targeting to mitochondrion (GO:1903217)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of metal ion (GO:0140961)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
podocyte apoptotic process (GO:1903210)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of the force of heart contraction by chemical signal (GO:0003099)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
renal water transport (GO:0003097)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
renal sodium ion transport (GO:0003096)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of glomerular filtration (GO:0003093)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
renal water homeostasis (GO:0003091)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
medullary reticular formation development (GO:0021723)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
superior olivary nucleus maturation (GO:0021722)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
sulfide oxidation (GO:0019418)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sulfur oxidation (GO:0019417)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
target-directed miRNA degradation (GO:0140958)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
acetate biosynthetic process (GO:0019413)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-dopa decarboxylase activity (GO:1903200)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hindgut morphogenesis (GO:0007442)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
foregut morphogenesis (GO:0007440)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of systemic arterial blood pressure (GO:0003084)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of renal output by angiotensin (GO:0003083)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
superior olivary nucleus development (GO:0021718)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of behavioral fear response (GO:2000987)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of behavioral fear response (GO:2000986)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hexitol catabolic process (GO:0019407)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hexitol biosynthetic process (GO:0019406)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATP citrate synthase activity (GO:2000984)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
alditol catabolic process (GO:0019405)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of ATP citrate synthase activity (GO:2000983)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of inner ear receptor cell differentiation (GO:2000982)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of inner ear receptor cell differentiation (GO:2000981)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
galactitol metabolic process (GO:0019402)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of inner ear receptor cell differentiation (GO:2000980)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
alditol biosynthetic process (GO:0019401)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
alditol metabolic process (GO:0019400)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
ectodermal digestive tract development (GO:0007439)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchymal-epithelial cell signaling involved in lung development (GO:0060496)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
salivary gland morphogenesis (GO:0007435)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in lung development (GO:0060495)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
salivary gland development (GO:0007431)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
lateral sprouting involved in lung morphogenesis (GO:0060490)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar granule cell differentiation (GO:0021707)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by neurotransmitter (GO:0003070)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of forebrain neuron differentiation (GO:2000979)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
locus ceruleus development (GO:0021703)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of forebrain neuron differentiation (GO:2000978)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of forebrain neuron differentiation (GO:2000977)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of pro-B cell differentiation (GO:2000975)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of pro-B cell differentiation (GO:2000974)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of pro-B cell differentiation (GO:2000973)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of detection of glucose (GO:2000972)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of detection of glucose (GO:2000970)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
planar dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060489)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060488)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lung-associated mesenchyme development (GO:0060484)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
lobar bronchus development (GO:0060482)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
lobar bronchus epithelium development (GO:0060481)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0003069)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lung goblet cell differentiation (GO:0060480)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by acetylcholine (GO:0003068)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart rate by epinephrine (GO:0003065)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart rate by acetylcholine (GO:0003063)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of heart rate by chemical signal (GO:0003062)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of the force of heart contraction by norepinephrine (GO:0003061)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of AMPA receptor activity (GO:2000969)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
L-kynurenine transmembrane transport (GO:0140924)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ventral midline development (GO:0007418)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization involved in acrosome reaction (GO:0060476)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of flagellated sperm motility involved in capacitation (GO:0060474)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
axonal fasciculation (GO:0007413)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
axon target recognition (GO:0007412)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cortical granule exocytosis (GO:0060471)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of the force of heart contraction by epinephrine (GO:0003059)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytosolic calcium ion concentration involved in egg activation (GO:0060470)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of the force of heart contraction by chemical signal (GO:0003057)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of vascular associated smooth muscle contraction (GO:0003056)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
angiotensin-mediated drinking behavior (GO:0003051)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by atrial natriuretic peptide (GO:0003050)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
zinc ion import into mitochondrion (GO:0140917)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
zinc ion import into lysosome (GO:0140916)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
zinc ion import into zymogen granule (GO:0140915)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
zinc ion import into secretory vesicle (GO:0140914)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
prevention of polyspermy (GO:0060468)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of fertilization (GO:0060467)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
activation of meiosis involved in egg activation (GO:0060466)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
pharynx development (GO:0060465)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
lung lobe formation (GO:0060464)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glial cell fate determination (GO:0007403)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lung lobe morphogenesis (GO:0060463)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
ganglion mother cell fate determination (GO:0007402)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lung lobe development (GO:0060462)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
right lung morphogenesis (GO:0060461)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neuroblast fate determination (GO:0007400)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
left lung morphogenesis (GO:0060460)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
aldehyde catabolic process (GO:0046185)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
response to intra-S DNA damage checkpoint signaling (GO:0072429)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to DNA damage checkpoint signaling (GO:0072423)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
left lung development (GO:0060459)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
right lung development (GO:0060458)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of digestive system process (GO:0060457)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of digestive system process (GO:0060456)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
somatic sex determination (GO:0018993)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of gastric acid secretion (GO:0060455)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
germ-line sex determination (GO:0018992)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of gastric acid secretion (GO:0060453)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle contraction (GO:0060452)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of hindgut contraction (GO:0060450)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of oxygen (GO:0003032)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of carbon dioxide (GO:0003031)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-gluconate catabolic process (GO:0046177)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
aldonic acid catabolic process (GO:0046176)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
polyol catabolic process (GO:0046174)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
response to benzoic acid (GO:0080021)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
bud elongation involved in lung branching (GO:0060449)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
dichotomous subdivision of terminal units involved in lung branching (GO:0060448)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
bud outgrowth involved in lung branching (GO:0060447)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
branching involved in salivary gland morphogenesis (GO:0060445)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
branching involved in mammary gland duct morphogenesis (GO:0060444)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
mitochondrial large ribosomal subunit assembly (GO:1902775)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
late endosome to lysosome transport (GO:1902774)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
detection of hypoxic conditions in blood by carotid body chemoreceptor signaling (GO:0003029)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
trachea formation (GO:0060440)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling (GO:0003027)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback (GO:0003026)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by baroreceptor feedback (GO:0003025)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
glycerol-3-phosphate biosynthetic process (GO:0046167)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
heme a metabolic process (GO:0046160)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
activation of protein kinase A activity (GO:0034199)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to DNA integrity checkpoint signaling (GO:0072402)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
trichloroethylene metabolic process (GO:0018979)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
triglyceride transport (GO:0034197)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
acylglycerol transport (GO:0034196)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
bronchiole morphogenesis (GO:0060436)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
isoprenoid biosynthetic process via mevalonate (GO:1902767)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
bronchiole development (GO:0060435)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell migration (GO:1902766)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
bronchus morphogenesis (GO:0060434)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
bronchus development (GO:0060433)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
lung pattern specification process (GO:0060432)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
primary lung bud formation (GO:0060431)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of chondrocyte development (GO:1902761)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lymph circulation (GO:0003017)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
involuntary skeletal muscle contraction (GO:0003011)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
voluntary skeletal muscle contraction (GO:0003010)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
rhodopsin metabolic process (GO:0046154)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
thiocyanate metabolic process (GO:0018969)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of maintenance of mitotic sister chromatid cohesion (GO:0034183)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lung connective tissue development (GO:0060427)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
propylene metabolic process (GO:0018964)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
phthalate metabolic process (GO:0018963)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 13 signaling pathway (GO:0034181)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
4-nitrophenol metabolic process (GO:0018960)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear pore organization (GO:0006999)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart growth (GO:0060421)	51	0	.85	-	 < 0.01	1.00E00	1.00E00
skeletal muscle contraction (GO:0003009)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
nuclear envelope organization (GO:0006998)	54	0	.90	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell cycle G2/M phase transition (GO:1902751)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell cycle G2/M phase transition (GO:1902750)	76	0	1.27	-	 < 0.01	6.40E-01	1.00E00
cellular response to nitrogen starvation (GO:0006995)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
response to sterol depletion (GO:0006991)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
pigment catabolic process (GO:0046149)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
pigment biosynthetic process (GO:0046148)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
tetrahydrobiopterin metabolic process (GO:0046146)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 13 signaling pathway (GO:0034179)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 13 signaling pathway (GO:0034178)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cyclodextrin metabolic process (GO:2000900)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of lens fiber cell differentiation (GO:1902748)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lens fiber cell differentiation (GO:1902747)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of lens fiber cell differentiation (GO:1902746)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
imidazole-containing compound catabolic process (GO:0052805)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
aorta smooth muscle tissue morphogenesis (GO:0060414)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
imidazole-containing compound metabolic process (GO:0052803)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in development (GO:1902742)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
ER-nucleus signaling pathway (GO:0006984)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
ER overload response (GO:0006983)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
response to lipid hydroperoxide (GO:0006982)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vitamin metabolic process (GO:0046137)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of vitamin metabolic process (GO:0046136)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside catabolic process (GO:0046135)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside biosynthetic process (GO:0046134)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside catabolic process (GO:0046133)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside metabolic process (GO:0046131)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside catabolic process (GO:0046130)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 9 signaling pathway (GO:0034165)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of acetylcholine metabolic process (GO:0060409)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 9 signaling pathway (GO:0034164)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of acetylcholine metabolic process (GO:0060408)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 9 signaling pathway (GO:0034163)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of penile erection (GO:0060407)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 9 signaling pathway (GO:0034162)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of penile erection (GO:0060406)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 8 signaling pathway (GO:0034161)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of penile erection (GO:0060405)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
axonemal microtubule depolymerization (GO:0060404)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
calcium ion transport into cytosol (GO:0060402)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of chondrocyte proliferation (GO:1902732)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of growth hormone receptor signaling pathway (GO:0060400)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of chondrocyte proliferation (GO:1902731)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of proteoglycan biosynthetic process (GO:1902730)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
hypotonic response (GO:0006971)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside catabolic process (GO:0046127)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside biosynthetic process (GO:0046126)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside metabolic process (GO:0046125)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside catabolic process (GO:0046124)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside metabolic process (GO:0046122)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside catabolic process (GO:0046121)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside biosynthetic process (GO:0046120)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 8 signaling pathway (GO:0034159)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 8 signaling pathway (GO:0034158)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 7 signaling pathway (GO:0034157)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
nitroglycerin metabolic process (GO:0018937)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 7 signaling pathway (GO:0034155)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 7 signaling pathway (GO:0034154)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of proteoglycan biosynthetic process (GO:1902729)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 6 signaling pathway (GO:0034151)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle satellite cell differentiation (GO:1902726)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of satellite cell differentiation (GO:1902725)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle satellite cell proliferation (GO:1902723)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of prolactin secretion (GO:1902722)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular defense response (GO:0006968)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0006965)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of antibacterial peptide biosynthetic process (GO:0006963)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
guanosine catabolic process (GO:0046115)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleobase catabolic process (GO:0046113)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
nucleobase biosynthetic process (GO:0046112)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
xanthine biosynthetic process (GO:0046111)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
xanthine metabolic process (GO:0046110)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 5 signaling pathway (GO:0034148)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 5 signaling pathway (GO:0034147)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 5 signaling pathway (GO:0034146)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 4 signaling pathway (GO:0034144)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
mandelate metabolic process (GO:0018924)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 3 signaling pathway (GO:0034140)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
complement activation, alternative pathway (GO:0006957)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
uridine metabolic process (GO:0046108)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
thymidine biosynthetic process (GO:0046105)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
thymidine metabolic process (GO:0046104)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
inosine biosynthetic process (GO:0046103)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
inosine metabolic process (GO:0046102)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002591)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hypoxanthine biosynthetic process (GO:0046101)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002590)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
hypoxanthine metabolic process (GO:0046100)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 3 signaling pathway (GO:0034138)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 2 signaling pathway (GO:0034137)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 2 signaling pathway (GO:0034136)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 2 signaling pathway (GO:0034135)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
nitrobenzene metabolic process (GO:0018916)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 2 signaling pathway (GO:0034134)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cell gliding (GO:0071976)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
extracellular exosome assembly (GO:0071971)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002589)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002588)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002587)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002586)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen processing and presentation of peptide antigen (GO:0002585)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of antigen processing and presentation of peptide antigen (GO:0002584)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to ozone (GO:0010193)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of antigen processing and presentation of peptide antigen (GO:0002583)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002582)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002581)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002580)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034125)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034124)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor signaling pathway (GO:0034123)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
multicellular organismal locomotion (GO:0071965)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
ether metabolic process (GO:0018904)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor signaling pathway (GO:0034122)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor signaling pathway (GO:0034121)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of cell polarity regulating cell shape (GO:0071963)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of erythrocyte aggregation (GO:0034120)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic sister chromatid cohesion, centromeric (GO:0071962)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
dichloromethane metabolic process (GO:0018900)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
substrate-dependent cell migration, cell attachment to substrate (GO:0006931)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vitamin E biosynthetic process (GO:0010189)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen processing and presentation (GO:0002579)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of antigen processing and presentation (GO:0002578)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of antigen processing and presentation (GO:0002577)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular defense response (GO:0010186)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
platelet degranulation (GO:0002576)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of cellular defense response (GO:0010185)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
basophil chemotaxis (GO:0002575)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
thrombocyte differentiation (GO:0002574)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sugar mediated signaling pathway (GO:0010182)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
pro-T cell differentiation (GO:0002572)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of heterotypic cell-cell adhesion (GO:0034115)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
heterotypic cell-cell adhesion (GO:0034113)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
recycling endosome to Golgi transport (GO:0071955)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
chemokine (C-C motif) ligand 11 production (GO:0071954)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA (GO:0071951)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
activation-induced cell death of T cells (GO:0006924)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
somatic diversification of T cell receptor genes (GO:0002568)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
embryonic body morphogenesis (GO:0010172)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
basophil degranulation (GO:0002561)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
basophil mediated immunity (GO:0002560)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of tissue remodeling (GO:0034105)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
phagocytosis, recognition (GO:0006910)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
wax metabolic process (GO:0010166)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to X-ray (GO:0010165)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
response to cesium ion (GO:0010164)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
serotonin secretion by platelet (GO:0002554)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
histamine secretion by mast cell (GO:0002553)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
serotonin secretion by mast cell (GO:0002552)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mast cell chemotaxis (GO:0002551)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
formation of animal organ boundary (GO:0010160)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
thiamine transmembrane transport (GO:0071934)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
replication fork reversal (GO:0071932)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
pinocytosis (GO:0006907)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
vesicle coating (GO:0006901)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
specification of animal organ position (GO:0010159)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vesicle budding from membrane (GO:0006900)	76	0	1.27	-	 < 0.01	6.40E-01	1.00E00
monocyte chemotaxis (GO:0002548)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
response to chlorate (GO:0010157)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of proton transport (GO:0010155)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
activation of blood coagulation via clotting cascade (GO:0002543)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
Factor XII activation (GO:0002542)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
activation of plasma proteins involved in acute inflammatory response (GO:0002541)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leukotriene production involved in inflammatory response (GO:0002540)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glial cell differentiation (GO:0045687)	54	0	.90	-	 < 0.01	1.00E00	1.00E00
alpha-tubulin acetylation (GO:0071929)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermis development (GO:0045683)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
endocannabinoid signaling pathway (GO:0071926)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
prostaglandin production involved in inflammatory response (GO:0002539)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
arachidonate metabolite production involved in inflammatory response (GO:0002538)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
nitric oxide production involved in inflammatory response (GO:0002537)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
respiratory burst involved in inflammatory response (GO:0002536)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate biosynthetic process, mevalonate pathway (GO:0010142)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
G-quadruplex DNA formation (GO:0071919)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
urea transmembrane transport (GO:0071918)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoclast differentiation (GO:0045671)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
synchronous neurotransmitter secretion (GO:0071911)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
determination of liver left/right asymmetry (GO:0071910)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide salvage (GO:0010138)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of vascular permeability involved in acute inflammatory response (GO:0002528)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
acute inflammatory response to non-antigenic stimulus (GO:0002525)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hypersensitivity (GO:0002524)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
proline catabolic process to glutamate (GO:0010133)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
leukocyte migration involved in immune response (GO:0002522)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoblast differentiation (GO:0045668)	60	0	1.00	-	 < 0.01	6.29E-01	1.00E00
determination of stomach left/right asymmetry (GO:0071909)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
determination of intestine left/right asymmetry (GO:0071908)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
determination of digestive tract left/right asymmetry (GO:0071907)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil differentiation (GO:0045660)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein serine/threonine kinase activity (GO:0071901)	91	0	1.52	-	 < 0.01	4.10E-01	1.00E00
heterochromatin boundary formation (GO:0033696)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neurofilament bundle assembly (GO:0033693)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of osteoblast proliferation (GO:0033690)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
natural killer cell tolerance induction (GO:0002519)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lymphocyte chemotaxis across high endothelial venule (GO:0002518)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
T cell tolerance induction (GO:0002517)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
phenylacetate catabolic process (GO:0010124)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
B cell tolerance induction (GO:0002514)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tolerance induction to self antigen (GO:0002513)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process to proline via ornithine (GO:0010121)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil differentiation (GO:0045659)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil differentiation (GO:0045658)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of monocyte differentiation (GO:0045657)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of monocyte differentiation (GO:0045656)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of monocyte differentiation (GO:0045655)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of megakaryocyte differentiation (GO:0045654)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of megakaryocyte differentiation (GO:0045653)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of megakaryocyte differentiation (GO:0045652)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage differentiation (GO:0045650)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoblast proliferation (GO:0033689)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of osteoblast proliferation (GO:0033688)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
osteoblast proliferation (GO:0033687)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of luteinizing hormone secretion (GO:0033686)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of luteinizing hormone secretion (GO:0033685)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of luteinizing hormone secretion (GO:0033684)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
central tolerance induction to self antigen (GO:0002509)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
central tolerance induction (GO:0002508)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tolerance induction (GO:0002507)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of polysaccharide antigen via MHC class II (GO:0002505)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
peptide antigen assembly with MHC class II protein complex (GO:0002503)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
peptide antigen assembly with MHC class I protein complex (GO:0002502)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
peptide antigen assembly with MHC protein complex (GO:0002501)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of L-dopa decarboxylase activity (GO:1903198)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-dopa biosynthetic process (GO:1903197)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of erythrocyte differentiation (GO:0045647)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of L-dopa biosynthetic process (GO:1903195)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of eosinophil differentiation (GO:0045645)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of eosinophil differentiation (GO:0045643)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glyoxal catabolic process (GO:1903190)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to iron ion starvation (GO:0010106)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glyoxal metabolic process (GO:1903189)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fatty acid oxidation (GO:0019395)	82	0	1.37	-	 < 0.01	6.49E-01	1.00E00
positive regulation of melanocyte differentiation (GO:0045636)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mechanoreceptor differentiation (GO:0045633)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of SUMO transferase activity (GO:1903182)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mechanoreceptor differentiation (GO:0045632)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopamine biosynthetic process (GO:1903181)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mechanoreceptor differentiation (GO:0045631)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 2 cell differentiation (GO:0045630)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cerebellar cortex maturation (GO:0021699)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebellar cortex structural organization (GO:0021698)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell layer structural organization (GO:0021693)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
galactose catabolic process (GO:0019388)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell layer maturation (GO:0021691)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dopamine biosynthetic process (GO:1903179)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 2 cell differentiation (GO:0045629)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of tyrosine 3-monooxygenase activity (GO:1903178)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 2 cell differentiation (GO:0045628)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 1 cell differentiation (GO:0045627)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of tyrosine 3-monooxygenase activity (GO:1903176)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 1 cell differentiation (GO:0045626)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 1 cell differentiation (GO:0045625)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper cell differentiation (GO:0045624)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
fatty alcohol metabolic process (GO:1903173)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper cell differentiation (GO:0045623)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper cell differentiation (GO:0045622)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
cerebellar molecular layer formation (GO:0021688)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebellar molecular layer morphogenesis (GO:0021687)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar granular layer maturation (GO:0021686)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebellar granular layer structural organization (GO:0021685)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebellar granular layer formation (GO:0021684)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
cerebellar granular layer morphogenesis (GO:0021683)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
nerve maturation (GO:0021682)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebellar granular layer development (GO:0021681)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
glycolipid catabolic process (GO:0019377)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
galactolipid catabolic process (GO:0019376)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
galactolipid biosynthetic process (GO:0019375)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of pyrroline-5-carboxylate reductase activity (GO:1903168)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
galactolipid metabolic process (GO:0019374)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of keratinocyte differentiation (GO:0045618)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of pyrroline-5-carboxylate reductase activity (GO:1903167)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of keratinocyte differentiation (GO:0045617)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cellular response to polycyclic arene (GO:1903166)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipoxygenase pathway (GO:0019372)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of keratinocyte differentiation (GO:0045616)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
response to polycyclic arene (GO:1903165)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cyclooxygenase pathway (GO:0019371)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
leukotriene biosynthetic process (GO:0019370)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of hemocyte differentiation (GO:0045611)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of hemocyte differentiation (GO:0045610)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lysobisphosphatidic acid metabolic process (GO:2001311)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty acid elongation, unsaturated fatty acid (GO:0019368)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
fatty acid elongation, saturated fatty acid (GO:0019367)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
pyridine nucleotide salvage (GO:0019365)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of inner ear auditory receptor cell differentiation (GO:0045609)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of inner ear auditory receptor cell differentiation (GO:0045608)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
pyridine nucleotide biosynthetic process (GO:0019363)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of inner ear auditory receptor cell differentiation (GO:0045607)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of epidermal cell differentiation (GO:0045606)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermal cell differentiation (GO:0045605)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of epidermal cell differentiation (GO:0045604)	58	0	.97	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell differentiation (GO:0045603)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
ectoderm development (GO:0007398)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelial cell differentiation (GO:0045602)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell differentiation (GO:0045601)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-cell adhesion mediated by integrin (GO:0033633)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion mediated by integrin (GO:0033631)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
lipoxin B4 biosynthetic process (GO:2001306)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipoxin B4 metabolic process (GO:2001304)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere 5 formation (GO:0021666)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipoxin A4 biosynthetic process (GO:2001303)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
rhombomere 5 structural organization (GO:0021665)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipoxin A4 metabolic process (GO:2001302)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
rhombomere 5 morphogenesis (GO:0021664)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipoxin biosynthetic process (GO:2001301)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
lipoxin metabolic process (GO:2001300)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
nicotinamide nucleotide biosynthetic process (GO:0019359)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
rhombomere 3 formation (GO:0021660)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cGAS/STING signaling pathway (GO:0140896)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of autophagy of mitochondrion (GO:1903147)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
endolysosomal toll-like receptor signaling pathway (GO:0140894)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
regulation of autophagy of mitochondrion (GO:1903146)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of endothelial barrier (GO:1903142)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of endothelial barrier (GO:1903141)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dolichol phosphate mannose biosynthetic process (GO:0180047)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of endothelial barrier (GO:1903140)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
compartment pattern specification (GO:0007386)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell adhesion mediated by integrin (GO:0033629)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
cell adhesion mediated by integrin (GO:0033627)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
specification of segmental identity, maxillary segment (GO:0007382)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of integrin activation by cell surface receptor linked signal transduction (GO:0033626)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
specification of segmental identity, head (GO:0007380)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of integrin activation (GO:0033624)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
rhombomere 3 structural organization (GO:0021659)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
rhombomere 3 morphogenesis (GO:0021658)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA replication-dependent chromatin disassembly (GO:0140889)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vestibulocochlear nerve formation (GO:0021650)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
transsulfuration (GO:0019346)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cysteine biosynthetic process (GO:0019344)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cysteine biosynthetic process via cystathionine (GO:0019343)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dibenzo-p-dioxin catabolic process (GO:0019341)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
zinc export across plasma membrane (GO:0140882)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
co-transcriptional lncRNA 3' end processing, cleavage and polyadenylation pathway (GO:0180034)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial cytochrome c oxidase assembly (GO:0033617)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
ventral midline determination (GO:0007371)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
vestibulocochlear nerve structural organization (GO:0021649)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
vestibulocochlear nerve morphogenesis (GO:0021648)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
vestibulocochlear nerve maturation (GO:0021647)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vagus nerve morphogenesis (GO:0021644)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
trochlear nerve formation (GO:0021642)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to cell cycle checkpoint signaling (GO:0072396)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
microtubule anchoring at microtubule organizing center (GO:0072393)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of centriole-centriole cohesion (GO:1903126)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation (GO:1903125)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
gastrulation (GO:0007369)	180	0	3.00	-	 < 0.01	7.96E-02	9.24E-01
negative regulation of TRAIL-activated apoptotic signaling pathway (GO:1903122)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
determination of left/right symmetry (GO:0007368)	136	0	2.27	-	 < 0.01	1.79E-01	1.00E00
regulation of TRAIL-activated apoptotic signaling pathway (GO:1903121)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial small ribosomal subunit assembly (GO:0180026)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
oxalate metabolic process (GO:0033609)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cytosolic small ribosomal subunit assembly (GO:0180025)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mammary gland epithelial cell proliferation (GO:0033601)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of mammary gland epithelial cell proliferation (GO:0033600)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
trochlear nerve morphogenesis (GO:0021639)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trigeminal nerve structural organization (GO:0021637)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
trigeminal nerve morphogenesis (GO:0021636)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
optic nerve structural organization (GO:0021633)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
flavin adenine dinucleotide catabolic process (GO:0072389)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
optic nerve morphogenesis (GO:0021631)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
flavin adenine dinucleotide biosynthetic process (GO:0072388)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
olfactory nerve maturation (GO:0021630)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
flavin adenine dinucleotide metabolic process (GO:0072387)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
plus-end-directed organelle transport along microtubule (GO:0072386)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to actin cytoskeleton (GO:1903119)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
minus-end-directed organelle transport along microtubule (GO:0072385)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
interleukin-22-mediated signaling pathway (GO:0140865)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pentose catabolic process (GO:0019323)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
plus-end-directed vesicle transport along microtubule (GO:0072383)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament-based movement (GO:1903116)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pentose biosynthetic process (GO:0019322)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
minus-end-directed vesicle transport along microtubule (GO:0072382)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament-based movement (GO:1903115)	49	0	.82	-	 < 0.01	1.00E00	1.00E00
pentose metabolic process (GO:0019321)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
DNA repair-dependent chromatin remodeling (GO:0140861)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
thorax and anterior abdomen determination (GO:0007356)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleoside import across plasma membrane (GO:0180015)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
zygotic determination of anterior/posterior axis, embryo (GO:0007354)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
zygotic specification of dorsal/ventral axis (GO:0007352)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
co-transcriptional RNA 3'-end processing, cleavage and polyadenylation pathway (GO:0180012)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
tripartite regional subdivision (GO:0007351)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
cytosolic mRNA polyadenylation (GO:0180011)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
blastoderm segmentation (GO:0007350)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway (GO:0180010)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
olfactory nerve structural organization (GO:0021629)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
olfactory nerve formation (GO:0021628)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
olfactory nerve morphogenesis (GO:0021627)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
oculomotor nerve formation (GO:0021623)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
oculomotor nerve morphogenesis (GO:0021622)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
amylopectin metabolic process (GO:2000896)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
blood coagulation, common pathway (GO:0072377)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial transcription (GO:1903109)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
medium-term memory (GO:0072375)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial transcription (GO:1903108)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cellobiose catabolic process (GO:2000892)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellobiose metabolic process (GO:2000891)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inositol catabolic process (GO:0019310)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellularization (GO:0007349)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process (GO:1903100)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
egg activation (GO:0007343)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
penetration of zona pellucida (GO:0007341)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
hypoglossal nerve morphogenesis (GO:0021618)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glossopharyngeal nerve morphogenesis (GO:0021615)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mannose catabolic process (GO:0019309)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
facial nerve structural organization (GO:0021612)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
facial nerve morphogenesis (GO:0021610)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
D-ribose catabolic process (GO:0019303)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dipeptide transport (GO:2000880)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of growth hormone receptor signaling pathway (GO:0060399)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of growth hormone receptor signaling pathway (GO:0060398)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
SMAD protein signal transduction (GO:0060395)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of SMAD protein signal transduction (GO:0060392)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
cranial nerve maturation (GO:0021605)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cranial nerve structural organization (GO:0021604)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
cranial nerve formation (GO:0021603)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of oligopeptide transport (GO:2000878)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cranial nerve morphogenesis (GO:0021602)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
chromosome passenger complex localization to kinetochore (GO:0072356)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of progesterone secretion (GO:2000872)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of progesterone secretion (GO:2000870)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
synapse assembly involved in innervation (GO:0060386)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
axonogenesis involved in innervation (GO:0060385)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
peptide pheromone maturation (GO:0007323)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA strand elongation (GO:0060383)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA strand elongation (GO:0060382)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of single-stranded telomeric DNA binding (GO:0060381)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
insemination (GO:0007320)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of single-stranded telomeric DNA binding (GO:0060380)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of estradiol secretion (GO:2000866)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to anesthetic (GO:0072347)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of estradiol secretion (GO:2000864)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of estrogen secretion (GO:2000863)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
rescue of stalled ribosome (GO:0072344)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of estrogen secretion (GO:2000861)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of aldosterone secretion (GO:2000860)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell myoblast differentiation (GO:0060379)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
cytosol to Golgi apparatus transport (GO:0140820)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of brood size (GO:0060378)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell differentiation (GO:0060377)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell differentiation (GO:0060376)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pole plasm assembly (GO:0007315)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell differentiation (GO:0060375)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
oocyte anterior/posterior axis specification (GO:0007314)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
mast cell differentiation (GO:0060374)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
susceptibility to T cell mediated cytotoxicity (GO:0060370)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
guanine biosynthetic process (GO:0046099)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
guanine metabolic process (GO:0046098)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of aldosterone secretion (GO:2000859)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mineralocorticoid secretion (GO:2000857)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
deoxyinosine metabolic process (GO:0046094)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of mineralocorticoid secretion (GO:2000856)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
deoxycytidine metabolic process (GO:0046092)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of corticosterone secretion (GO:2000854)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of corticosterone secretion (GO:2000853)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
deoxyadenosine metabolic process (GO:0046090)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
UDP-galactose transmembrane transport (GO:0072334)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of corticosterone secretion (GO:2000852)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucocorticoid secretion (GO:2000851)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucocorticoid secretion (GO:2000850)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060369)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
oocyte axis specification (GO:0007309)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
oocyte construction (GO:0007308)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
sagittal suture morphogenesis (GO:0060367)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lambdoid suture morphogenesis (GO:0060366)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
coronal suture morphogenesis (GO:0060365)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
frontal suture morphogenesis (GO:0060364)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cranial suture morphogenesis (GO:0060363)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
respiratory basal cell differentiation (GO:1902691)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cytidine metabolic process (GO:0046087)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of glucocorticoid secretion (GO:2000849)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of corticosteroid hormone secretion (GO:2000848)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of corticosteroid hormone secretion (GO:2000847)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
adenine biosynthetic process (GO:0046084)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
adenine metabolic process (GO:0046083)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of testosterone secretion (GO:2000845)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of testosterone secretion (GO:2000844)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dUTP catabolic process (GO:0046081)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of testosterone secretion (GO:2000843)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
dUTP metabolic process (GO:0046080)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of NAD metabolic process (GO:1902688)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dibenzo-p-dioxin metabolic process (GO:0018894)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell adhesion molecule production (GO:0060355)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell adhesion molecule production (GO:0060354)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor localization to synapse (GO:1902685)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of cell adhesion molecule production (GO:0060353)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor localization to synapse (GO:1902684)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell adhesion molecule production (GO:0060352)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cartilage development involved in endochondral bone morphogenesis (GO:0060351)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
protein localization to pericentric heterochromatin (GO:1902682)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dUMP catabolic process (GO:0046079)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
dUMP metabolic process (GO:0046078)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
dUDP metabolic process (GO:0046077)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
dTTP metabolic process (GO:0046075)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
vesicle uncoating (GO:0072319)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
dTMP catabolic process (GO:0046074)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
clathrin coat disassembly (GO:0072318)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of androgen secretion (GO:2000836)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dTMP metabolic process (GO:0046073)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
dTDP metabolic process (GO:0046072)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of androgen secretion (GO:2000834)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid hormone secretion (GO:2000833)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
dGTP metabolic process (GO:0046070)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of steroid hormone secretion (GO:2000832)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular epithelial cell development (GO:0072313)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular epithelial cell differentiation (GO:0072312)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of parathyroid hormone secretion (GO:2000830)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
heart trabecula formation (GO:0060347)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
bone trabecula formation (GO:0060346)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
spleen trabecula formation (GO:0060345)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trabecula formation (GO:0060343)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
4-chlorobiphenyl metabolic process (GO:0018880)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of type I interferon-mediated signaling pathway (GO:0060340)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
cGMP catabolic process (GO:0046069)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cGMP metabolic process (GO:0046068)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
dGDP catabolic process (GO:0046067)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dGDP metabolic process (GO:0046066)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dCTP metabolic process (GO:0046065)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis (GO:0072309)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA surveillance (GO:2000827)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072308)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of heart morphogenesis (GO:2000826)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
dCMP metabolic process (GO:0046063)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of androgen receptor activity (GO:2000825)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
dCDP metabolic process (GO:0046062)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dATP catabolic process (GO:0046061)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072305)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dATP metabolic process (GO:0046060)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072304)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of behavioral fear response (GO:2000822)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of glomerular metanephric mesangial cell proliferation (GO:0072303)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of grooming behavior (GO:2000821)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of metanephric glomerular mesangial cell proliferation (GO:0072302)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric glomerular mesangial cell proliferation (GO:0072301)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
biphenyl metabolic process (GO:0018879)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of maintenance of meiotic sister chromatid cohesion (GO:0034096)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of type I interferon-mediated signaling pathway (GO:0060339)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
regulation of type I interferon-mediated signaling pathway (GO:0060338)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of meiotic sister chromatid cohesion (GO:0034094)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of maintenance of sister chromatid cohesion (GO:0034093)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of type II interferon-mediated signaling pathway (GO:0060336)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of maintenance of sister chromatid cohesion (GO:0034092)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of type II interferon-mediated signaling pathway (GO:0060335)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of sister chromatid cohesion (GO:0034091)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of type II interferon-mediated signaling pathway (GO:0060334)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
arsonoacetate metabolic process (GO:0018872)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of meiotic sister chromatid cohesion (GO:0034090)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to type II interferon (GO:0060332)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to type II interferon (GO:0060331)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of response to type II interferon (GO:0060330)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucose mediated signaling pathway (GO:1902661)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
dAMP catabolic process (GO:0046059)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
dADP catabolic process (GO:0046057)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide-excision repair (GO:2000819)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
dADP metabolic process (GO:0046056)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of myoblast proliferation (GO:2000818)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dGMP catabolic process (GO:0046055)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
dGMP metabolic process (GO:0046054)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic sister chromatid separation (GO:2000816)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
dAMP metabolic process (GO:0046053)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
UTP catabolic process (GO:0046052)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of barbed-end actin filament capping (GO:2000814)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
UTP metabolic process (GO:0046051)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of barbed-end actin filament capping (GO:2000813)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
UMP catabolic process (GO:0046050)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of barbed-end actin filament capping (GO:2000812)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of anoikis (GO:2000811)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
establishment of meiotic sister chromatid cohesion (GO:0034089)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of mitotic sister chromatid cohesion (GO:0034088)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
establishment of mitotic sister chromatid cohesion (GO:0034087)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of sister chromatid cohesion (GO:0034086)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of sister chromatid cohesion (GO:0034085)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of glucose mediated signaling pathway (GO:1902659)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
CENP-A containing chromatin assembly (GO:0034080)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
Golgi to vacuole transport (GO:0006896)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
Golgi to plasma membrane transport (GO:0006893)	55	0	.92	-	 < 0.01	1.00E00	1.00E00
intra-Golgi vesicle-mediated transport (GO:0006891)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
UMP metabolic process (GO:0046049)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
UDP metabolic process (GO:0046048)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle clustering (GO:2000809)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic vesicle clustering (GO:2000808)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle clustering (GO:2000807)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000806)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000804)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ITP metabolic process (GO:0046041)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000802)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
IMP metabolic process (GO:0046040)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000800)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
primitive erythrocyte differentiation (GO:0060319)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
definitive erythrocyte differentiation (GO:0060318)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
tertiary alcohol biosynthetic process (GO:1902645)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tertiary alcohol metabolic process (GO:1902644)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation of elastin catabolic process (GO:0060311)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of elastin catabolic process (GO:0060310)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	115	0	1.92	-	 < 0.01	2.70E-01	1.00E00
cell volume homeostasis (GO:0006884)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
intracellular zinc ion homeostasis (GO:0006882)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
intracellular sequestering of iron ion (GO:0006880)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GTP metabolic process (GO:0046039)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
GMP catabolic process (GO:0046038)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
GMP metabolic process (GO:0046037)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
CTP metabolic process (GO:0046036)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
CMP metabolic process (GO:0046035)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
protein localization to Golgi apparatus (GO:0034067)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
mRNA methylguanosine-cap decapping (GO:0110156)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
NAD-cap decapping (GO:0110155)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
RNA decapping (GO:0110154)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of cell diameter (GO:0060305)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylinositol dephosphorylation (GO:0060304)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process (GO:1902635)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytokine activity (GO:0060302)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process (GO:1902633)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane hyperpolarization (GO:1902632)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cytokine activity (GO:0060300)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane hyperpolarization (GO:1902631)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of membrane hyperpolarization (GO:1902630)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
response to anoxia (GO:0034059)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
endosomal vesicle fusion (GO:0034058)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
DNA biosynthetic process (GO:0071897)	77	0	1.28	-	 < 0.01	6.42E-01	1.00E00
regulation of mRNA stability involved in cellular response to UV (GO:1902629)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
odontoblast differentiation (GO:0071895)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
assembly of large subunit precursor of preribosome (GO:1902626)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
symbiont-induced defense-related programmed cell death (GO:0034050)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glutamine transport (GO:0006868)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
asparagine transport (GO:0006867)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide transport (GO:0006864)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
purine nucleobase transport (GO:0006863)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by glucose (GO:0046016)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of transcription by glucose (GO:0046015)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
macrophage apoptotic process (GO:0071888)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Norrin signaling pathway (GO:0110135)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to fluoride (GO:1902618)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to fluoride (GO:1902617)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
acyl carnitine transmembrane transport (GO:1902616)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
immune response involved in response to exogenous dsRNA (GO:1902615)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phospholipase C-activating adrenergic receptor signaling pathway (GO:0071882)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071881)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oligopeptide transport (GO:0006857)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
mitochondrial calcium ion transmembrane transport (GO:0006851)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
mitochondrial pyruvate transmembrane transport (GO:0006850)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of activated T cell proliferation (GO:0046007)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of circadian sleep/wake cycle, REM sleep (GO:0046005)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class II (GO:0002491)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071879)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside bisphosphate biosynthetic process (GO:0034036)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071878)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside bisphosphate metabolic process (GO:0034035)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071877)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of large conductance calcium-activated potassium channel activity (GO:1902608)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
purine nucleoside bisphosphate biosynthetic process (GO:0034033)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of large conductance calcium-activated potassium channel activity (GO:1902607)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine nucleoside bisphosphate metabolic process (GO:0034032)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
cellular response to norepinephrine stimulus (GO:0071874)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of large conductance calcium-activated potassium channel activity (GO:1902606)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to norepinephrine (GO:0071873)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
heterotrimeric G-protein complex assembly (GO:1902605)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ribonucleoside bisphosphate biosynthetic process (GO:0034030)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to epinephrine stimulus (GO:0071872)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
response to epinephrine (GO:0071871)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
carnitine transmembrane transport (GO:1902603)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
silver ion transmembrane transport (GO:1902601)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyruvate transport (GO:0006848)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
acetate transport (GO:0006846)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acyl carnitine transport (GO:0006844)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial citrate transmembrane transport (GO:0006843)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid transport (GO:0006842)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent (GO:0002489)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway (GO:0002488)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent (GO:0002485)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen (GO:0002483)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
specification of animal organ identity (GO:0010092)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent (GO:0002481)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid transporter activity (GO:0110114)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process in bone marrow cell (GO:0071866)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid transporter activity (GO:0110113)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process in bone marrow cell (GO:0071865)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of lipid transporter activity (GO:0110112)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to silicon dioxide (GO:0034021)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
serotonin transport (GO:0006837)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
water transport (GO:0006833)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen (GO:0002478)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
phloem or xylem histogenesis (GO:0010087)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class Ib (GO:0002477)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class Ib (GO:0002476)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
polarity specification of proximal/distal axis (GO:0010085)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation via MHC class Ib (GO:0002475)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474)	60	0	1.00	-	 < 0.01	6.29E-01	1.00E00
plasmacytoid dendritic cell antigen processing and presentation (GO:0002470)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mRNA alternative polyadenylation (GO:0110104)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to triglyceride (GO:0034014)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
copper ion transport (GO:0006825)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
cobalt ion transport (GO:0006824)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
chloride transport (GO:0006821)	123	0	2.05	-	 < 0.01	2.76E-01	1.00E00
myeloid dendritic cell antigen processing and presentation (GO:0002469)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dendritic cell antigen processing and presentation (GO:0002468)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
germinal center formation (GO:0002467)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
peripheral tolerance induction (GO:0002465)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tolerance induction to nonself antigen (GO:0002462)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tolerance induction dependent upon immune response (GO:0002461)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
zygote asymmetric cell division (GO:0010070)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
actin filament debranching (GO:0071846)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
peripheral T cell tolerance induction (GO:0002458)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T cell antigen processing and presentation (GO:0002457)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
peripheral B cell tolerance induction (GO:0002451)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of fat cell differentiation (GO:0045599)	59	0	.98	-	 < 0.01	6.29E-01	1.00E00
B cell antigen processing and presentation (GO:0002450)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
apoptotic process in bone marrow cell (GO:0071839)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell proliferation in bone marrow (GO:0071838)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
intermediate-density lipoprotein particle clearance (GO:0071831)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
triglyceride-rich lipoprotein particle clearance (GO:0071830)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
nitric oxide biosynthetic process (GO:0006809)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
interkinetic nuclear migration (GO:0022027)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of nitrogen utilization (GO:0006808)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
N(omega),N(omega)-dimethyl-L-arginine catabolic process (GO:2001299)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N(omega),N(omega)-dimethyl-L-arginine metabolic process (GO:2001298)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
malonyl-CoA biosynthetic process (GO:2001295)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
malonyl-CoA catabolic process (GO:2001294)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
malonyl-CoA metabolic process (GO:2001293)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
type II hypersensitivity (GO:0002445)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
serotonin secretion involved in inflammatory response (GO:0002442)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
histamine secretion involved in inflammatory response (GO:0002441)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytotoxic T cell differentiation (GO:0045585)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytotoxic T cell differentiation (GO:0045584)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cytotoxic T cell differentiation (GO:0045583)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle organization (GO:0071827)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
protein-lipid complex organization (GO:0071825)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
lateral ganglionic eminence cell proliferation (GO:0022018)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pallium cell proliferation in forebrain (GO:0022013)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of caveolin-mediated endocytosis (GO:2001287)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
subpallium cell proliferation in forebrain (GO:0022012)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myelination in peripheral nervous system (GO:0022011)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
chronic inflammatory response to antigenic stimulus (GO:0002439)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
response to nickel cation (GO:0010045)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to aluminum ion (GO:0010044)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
immune complex clearance (GO:0002434)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002433)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
granuloma formation (GO:0002432)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to iron(III) ion (GO:0010041)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
Fc receptor mediated stimulatory signaling pathway (GO:0002431)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to iron(II) ion (GO:0010040)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
complement receptor mediated signaling pathway (GO:0002430)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell differentiation (GO:0045578)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
basophil activation (GO:0045575)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
tail-anchored membrane protein insertion into ER membrane (GO:0071816)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
positive regulation of fever generation by positive regulation of prostaglandin secretion (GO:0071812)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
central nervous system vasculogenesis (GO:0022009)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in neural plate elongation (GO:0022007)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
zona limitans intrathalamica formation (GO:0022006)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of unsaturated fatty acid biosynthetic process (GO:2001279)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
midbrain-hindbrain boundary maturation during brain development (GO:0022004)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to iron ion (GO:0010039)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen via MHC class Ib (GO:0002428)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
immunoglobulin production in mucosal tissue (GO:0002426)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
natural killer cell mediated immune response to tumor cell (GO:0002423)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
meiotic chromosome condensation (GO:0010032)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002420)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein transmembrane transport (GO:0071806)	72	0	1.20	-	 < 0.01	6.36E-01	1.00E00
positive regulation of podosome assembly (GO:0071803)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
mammary gland epithelial cell proliferation (GO:0033598)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of podosome assembly (GO:0071802)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of podosome assembly (GO:0071801)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
podosome assembly (GO:0071800)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
response to genistein (GO:0033595)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to hydroxyisoflavone (GO:0033594)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to L-ascorbic acid (GO:0033591)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to cobalamin (GO:0033590)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of semaphorin-plexin signaling pathway (GO:2001262)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
immune response to tumor cell (GO:0002418)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of semaphorin-plexin signaling pathway (GO:2001260)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
wax biosynthetic process (GO:0010025)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor (GO:0002415)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
immunoglobulin transcytosis in epithelial cells (GO:0002414)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
antigen transcytosis by M cells in mucosal-associated lymphoid tissue (GO:0002412)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
amylopectin biosynthetic process (GO:0010021)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
plasmacytoid dendritic cell chemotaxis (GO:0002410)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of store-operated calcium entry (GO:2001256)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
RNA glycosylation (GO:0141217)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myeloid dendritic cell chemotaxis (GO:0002408)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
red or far-red light signaling pathway (GO:0010017)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromosome organization (GO:2001251)	81	0	1.35	-	 < 0.01	6.48E-01	1.00E00
dendritic cell chemotaxis (GO:0002407)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of ammonia assimilation cycle (GO:2001250)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antigen sampling by M cells in mucosal-associated lymphoid tissue (GO:0002406)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phospholipase C/protein kinase C signal transduction (GO:0141212)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen sampling in mucosal-associated lymphoid tissue (GO:0002404)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to meiotic spindle midzone (GO:1903096)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein K48-linked deubiquitination (GO:1903094)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein K48-linked deubiquitination (GO:1903093)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol biosynthetic process (GO:0045542)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol biosynthetic process (GO:0045541)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol biosynthetic process (GO:0045540)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
transferrin transport (GO:0033572)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of ammonia assimilation cycle (GO:2001248)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidylcholine biosynthetic process (GO:2001247)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylcholine biosynthetic process (GO:2001246)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylcholine biosynthetic process (GO:2001245)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
dipeptide transmembrane transport from lysosomal lumen to cytosol (GO:0141204)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
pyroptotic cell death (GO:0141201)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cardioblast differentiation (GO:0010002)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
tyrosine biosynthetic process, by oxidation of phenylalanine (GO:0019293)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to condensed chromosome (GO:1903083)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
siderophore biosynthetic process (GO:0019290)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903082)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903080)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA replication, Okazaki fragment processing (GO:0033567)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
gamma-tubulin complex localization (GO:0033566)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
anterior/posterior axon guidance (GO:0033564)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
abducens nerve formation (GO:0021599)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
abducens nerve morphogenesis (GO:0021598)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere structural organization (GO:0021595)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
rhombomere formation (GO:0021594)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
rhombomere morphogenesis (GO:0021593)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
glycine betaine biosynthetic process from choline (GO:0019285)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of death-inducing signaling complex assembly (GO:1903073)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of death-inducing signaling complex assembly (GO:1903072)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to gamma radiation (GO:2001229)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to vitamin B3 (GO:0033552)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of response to gamma radiation (GO:2001228)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of chloride transport (GO:2001226)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebellum structural organization (GO:0021589)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chloride transport (GO:2001225)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cerebellum formation (GO:0021588)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pons maturation (GO:0021586)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
UDP-N-acetylgalactosamine metabolic process (GO:0019276)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of reverse cholesterol transport (GO:1903064)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of reverse cholesterol transport (GO:1903062)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein lipidation (GO:1903061)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein lipidation (GO:1903060)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of vasculogenesis (GO:2001214)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
hindbrain structural organization (GO:0021577)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vasculogenesis (GO:2001213)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
hindbrain formation (GO:0021576)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vasculogenesis (GO:2001212)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
rhombomere 6 development (GO:0021572)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
rhombomere 5 development (GO:0021571)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
rhombomere 4 development (GO:0021570)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein lipidation (GO:1903059)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
glycine biosynthetic process, by transamination of glyoxylate (GO:0019265)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001998)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glycine biosynthetic process from serine (GO:0019264)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of melanosome organization (GO:1903056)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of the force of heart contraction by epinephrine-norepinephrine (GO:0001997)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
N-acetylneuraminate catabolic process (GO:0019262)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of extracellular matrix organization (GO:1903054)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001994)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by norepinephrine-epinephrine (GO:0001993)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by vasopressin (GO:0001992)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
vitellogenesis (GO:0007296)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
female gamete generation (GO:0007292)	181	0	3.02	-	 < 0.01	7.96E-02	9.24E-01
sperm individualization (GO:0007291)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
spermatid nucleus elongation (GO:0007290)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of osteoclast development (GO:2001206)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
rhombomere 3 development (GO:0021569)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoclast development (GO:2001205)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
rhombomere 2 development (GO:0021568)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of osteoclast development (GO:2001204)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
hypoglossal nerve development (GO:0021566)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vagus nerve development (GO:0021564)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell differentiation (GO:2001200)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glossopharyngeal nerve development (GO:0021563)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
vestibulocochlear nerve development (GO:0021562)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
facial nerve development (GO:0021561)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
abducens nerve development (GO:0021560)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glucose 1-phosphate metabolic process (GO:0019255)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure (GO:0001988)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
carnitine metabolic process, CoA-linked (GO:0019254)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
meiotic cell cycle process (GO:1903046)	220	0	3.67	-	 < 0.01	5.60E-02	7.63E-01
vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure (GO:0001987)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neural crest cell migration involved in sympathetic nervous system development (GO:1903045)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001986)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001985)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of chondrocyte hypertrophy (GO:1903043)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001984)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
baroreceptor response to increased systemic arterial blood pressure (GO:0001983)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of chondrocyte hypertrophy (GO:1903041)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
baroreceptor response to decreased systemic arterial blood pressure (GO:0001982)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
sperm axoneme assembly (GO:0007288)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by ischemic conditions (GO:0001980)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
primary spermatocyte growth (GO:0007285)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spermatogonial cell division (GO:0007284)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
trochlear nerve development (GO:0021558)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
oculomotor nerve development (GO:0021557)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
central nervous system formation (GO:0021556)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
midbrain-hindbrain boundary morphogenesis (GO:0021555)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
optic nerve development (GO:0021554)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
olfactory nerve development (GO:0021553)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
lactate biosynthetic process (GO:0019249)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
central nervous system morphogenesis (GO:0021551)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by chemoreceptor signaling (GO:0001979)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback (GO:0001978)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
lactate biosynthetic process from pyruvate (GO:0019244)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
renal system process involved in regulation of blood volume (GO:0001977)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (GO:0019243)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
methylglyoxal biosynthetic process (GO:0019242)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to amphetamine (GO:0001975)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule plus-end binding (GO:1903033)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
blood vessel remodeling (GO:0001974)	51	0	.85	-	 < 0.01	1.00E00	1.00E00
citrulline biosynthetic process (GO:0019240)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
G protein-coupled adenosine receptor signaling pathway (GO:0001973)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule plus-end binding (GO:1903031)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of activation of membrane attack complex (GO:0001971)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of activation of membrane attack complex (GO:0001970)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-lysine catabolic process to acetyl-CoA via L-pipecolate (GO:0033514)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-lysine catabolic process to acetyl-CoA via saccharopine (GO:0033512)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
rhombomere development (GO:0021546)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
subpallium development (GO:0021544)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
dentate gyrus development (GO:0021542)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
ammon gyrus development (GO:0021541)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to pheromone (GO:0019236)	105	0	1.75	-	 < 0.01	4.26E-01	1.00E00
positive regulation of opsonization (GO:1903028)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of activation of membrane attack complex (GO:0001969)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of opsonization (GO:1903027)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
startle response (GO:0001964)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, dopaminergic (GO:0001963)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycoprotein metabolic process (GO:1903020)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
floor plate morphogenesis (GO:0033505)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
subthalamus development (GO:0021539)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell proliferation in hindbrain (GO:0021534)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
metanephric nephron tubule formation (GO:0072289)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
neuronal action potential propagation (GO:0019227)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
spinal cord oligodendrocyte cell fate specification (GO:0021530)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephric distal tubule morphogenesis (GO:0072287)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycoprotein metabolic process (GO:1903019)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
metanephric connecting tubule development (GO:0072286)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
siRNA-mediated post-transcriptional gene silencing (GO:0140766)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glycoprotein metabolic process (GO:1903018)	49	0	.82	-	 < 0.01	1.00E00	1.00E00
mesenchymal to epithelial transition involved in metanephric renal vesicle formation (GO:0072285)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric S-shaped body morphogenesis (GO:0072284)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of exo-alpha-sialidase activity (GO:1903016)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
intramembranous ossification (GO:0001957)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of exo-alpha-sialidase activity (GO:1903015)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotransmitter secretion (GO:0001956)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
metanephric nephron tubule morphogenesis (GO:0072282)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
blood vessel maturation (GO:0001955)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell-matrix adhesion (GO:0001954)	66	0	1.10	-	 < 0.01	6.31E-01	1.00E00
positive regulation of bone development (GO:1903012)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-matrix adhesion (GO:0001953)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
negative regulation of bone development (GO:1903011)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of cell-matrix adhesion (GO:0001952)	129	0	2.15	-	 < 0.01	2.83E-01	1.00E00
JUN phosphorylation (GO:0007258)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of bone development (GO:1903010)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
intestinal D-glucose absorption (GO:0001951)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of NF-kappaB (GO:0007253)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
I-kappaB phosphorylation (GO:0007252)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
activation of NF-kappaB-inducing kinase activity (GO:0007250)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
spinal cord oligodendrocyte cell differentiation (GO:0021529)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
commissural neuron differentiation in spinal cord (GO:0021528)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spinal cord association neuron differentiation (GO:0021527)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
medial motor column neuron differentiation (GO:0021526)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of amniotic stem cell differentiation (GO:2000798)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
somatic motor neuron differentiation (GO:0021523)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of amniotic stem cell differentiation (GO:2000797)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ventral spinal cord interneuron specification (GO:0021521)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
metanephric comma-shaped body morphogenesis (GO:0072278)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000795)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular capillary formation (GO:0072277)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000794)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
metanephric glomerulus vasculature morphogenesis (GO:0072276)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in heart valve development (GO:2000793)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sebaceous gland cell differentiation (GO:0001949)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephric glomerulus morphogenesis (GO:0072275)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of Lys63-specific deubiquitinase activity (GO:1903007)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular basement membrane development (GO:0072274)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
reorganization of cellular membranes to establish viral sites of replication (GO:0140754)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein K63-linked deubiquitination (GO:1903006)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell proliferation involved in lung development (GO:2000791)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
heart looping (GO:0001947)	64	0	1.07	-	 < 0.01	6.30E-01	1.00E00
regulation of mesenchymal cell proliferation involved in lung development (GO:2000790)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lymphangiogenesis (GO:0001946)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
proximal/distal pattern formation involved in metanephric nephron development (GO:0072272)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein K63-linked deubiquitination (GO:1903004)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lymph vessel development (GO:0001945)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein deubiquitination (GO:1903003)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid transport across blood-brain barrier (GO:1903002)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
canonical NF-kappaB signal transduction (GO:0007249)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid transport across blood-brain barrier (GO:1903001)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of lipid transport across blood-brain barrier (GO:1903000)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
xenobiotic glucuronidation (GO:0052697)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
flavonoid glucuronidation (GO:0052696)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular glucuronidation (GO:0052695)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
dorsal spinal cord development (GO:0021516)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
ventral spinal cord interneuron differentiation (GO:0021514)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
spinal cord dorsal/ventral patterning (GO:0021513)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
spinal cord anterior/posterior patterning (GO:0021512)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagosome assembly (GO:2000786)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
spinal cord patterning (GO:0021511)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
pattern specification involved in metanephros development (GO:0072268)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of autophagosome assembly (GO:2000785)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
metanephric capsule specification (GO:0072267)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of cell polarity regulating cell shape (GO:2000784)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric capsule formation (GO:0072266)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric capsule morphogenesis (GO:0072265)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
siRNA transcription (GO:0140745)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of cell polarity regulating cell shape (GO:2000782)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular endothelium development (GO:0072264)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of lncRNA transcription (GO:0140744)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lncRNA transcription (GO:0140743)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular mesangial cell proliferation involved in metanephros development (GO:0072262)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lncRNA transcription (GO:0140742)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
endothelial cell proliferation (GO:0001935)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of sarcomere organization (GO:0060299)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of sarcomere organization (GO:0060298)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of sarcomere organization (GO:0060297)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of cilium beat frequency involved in ciliary motility (GO:0060296)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
long-term synaptic depression (GO:0060292)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
osmosensory signaling pathway (GO:0007231)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
transdifferentiation (GO:0060290)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
roof plate formation (GO:0021509)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
floor plate formation (GO:0021508)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
anterior neuropore closure (GO:0021506)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neural fold bending (GO:0021503)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neural fold elevation formation (GO:0021502)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephric interstitial fibroblast development (GO:0072259)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
NLRP6 inflammasome complex assembly (GO:0140739)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric interstitial fibroblast differentiation (GO:0072258)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular senescence (GO:2000774)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular senescence (GO:2000773)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular mesangial cell development (GO:0072255)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of exocyst assembly (GO:0001928)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular mesangial cell differentiation (GO:0072254)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000771)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
B-1 B cell differentiation (GO:0001923)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
integrin-mediated signaling pathway (GO:0007229)	87	0	1.45	-	 < 0.01	4.08E-01	1.00E00
B-1 B cell homeostasis (GO:0001922)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
patched ligand maturation (GO:0007225)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway, calcium modulating pathway (GO:0007223)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of oocyte development (GO:0060283)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of oocyte development (GO:0060282)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription of Notch receptor target (GO:0007221)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of oocyte development (GO:0060281)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
Notch receptor processing (GO:0007220)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of ovulation (GO:0060280)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000769)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic translation (GO:2000767)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
metanephric podocyte development (GO:0072249)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric podocyte differentiation (GO:0072248)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular epithelium development (GO:0072244)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephric nephron epithelium development (GO:0072243)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell mediated cytotoxicity (GO:0001916)	61	0	1.02	-	 < 0.01	6.29E-01	1.00E00
negative regulation of T cell mediated cytotoxicity (GO:0001915)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of T cell mediated cytotoxicity (GO:0001914)	69	0	1.15	-	 < 0.01	6.33E-01	1.00E00
metanephric DCT cell differentiation (GO:0072240)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T cell mediated cytotoxicity (GO:0001913)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
Notch signaling pathway (GO:0007219)	130	0	2.17	-	 < 0.01	2.84E-01	1.00E00
positive regulation of ovulation (GO:0060279)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ovulation (GO:0060278)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
tachykinin receptor signaling pathway (GO:0007217)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
G protein-coupled glutamate receptor signaling pathway (GO:0007216)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
embryonic skeletal joint morphogenesis (GO:0060272)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-lysine acetylation (GO:2000757)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
metanephric glomerulus vasculature development (GO:0072239)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
constitutive heterochromatin formation (GO:0140719)	56	0	.93	-	 < 0.01	1.00E00	1.00E00
facultative heterochromatin formation (GO:0140718)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of sphingomyelin catabolic process (GO:2000755)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric proximal tubule development (GO:0072237)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of sphingomyelin catabolic process (GO:2000754)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric loop of Henle development (GO:0072236)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucosylceramide catabolic process (GO:2000753)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leukocyte mediated cytotoxicity (GO:0001909)	74	0	1.23	-	 < 0.01	6.38E-01	1.00E00
metanephric distal tubule development (GO:0072235)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of glucosylceramide catabolic process (GO:2000752)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric nephron tubule development (GO:0072234)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
metanephric thick ascending limb development (GO:0072233)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric proximal convoluted tubule segment 2 development (GO:0072232)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
activation of membrane attack complex (GO:0001905)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric proximal straight tubule development (GO:0072230)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of respiratory burst (GO:0060268)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
phospholipase C-activating G protein-coupled glutamate receptor signaling pathway (GO:0007206)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of respiratory burst involved in inflammatory response (GO:0060266)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of N-terminal protein palmitoylation (GO:0060262)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
monoacylglycerol catabolic process (GO:0052651)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
metanephric proximal convoluted tubule development (GO:0072229)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
CAT tailing (GO:0140708)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric macula densa development (GO:0072227)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein-containing complex localization to centriolar satellite (GO:0140706)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric glomerulus development (GO:0072224)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal stem cell differentiation (GO:2000741)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular mesangium development (GO:0072223)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal stem cell differentiation (GO:2000740)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric distal convoluted tubule development (GO:0072221)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
metanephric descending thin limb development (GO:0072220)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of N-terminal protein palmitoylation (GO:0060254)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal stem cell differentiation (GO:2000739)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of stem cell differentiation (GO:2000738)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
metanephric cortical collecting duct development (GO:0072219)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric ascending thin limb development (GO:0072218)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of metanephros development (GO:0072217)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000734)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000733)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric cortex development (GO:0072214)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium import into the mitochondrion (GO:0110099)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
metanephric capsule development (GO:0072213)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of termination of RNA polymerase I transcription (GO:2000730)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of calcium import into the mitochondrion (GO:0110097)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to aldehyde (GO:0110096)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of aldehyde (GO:0110095)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of hippocampal neuron apoptotic process (GO:0110091)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
detection of cell density (GO:0060245)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of hippocampal neuron apoptotic process (GO:0110090)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in contact inhibition (GO:0060244)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell growth involved in contact inhibition (GO:0060243)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
contact inhibition (GO:0060242)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of serine-type peptidase activity (GO:1902572)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of serine-type peptidase activity (GO:1902571)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to nucleolus (GO:1902570)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal cell proliferation involved in ureter development (GO:2000729)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle cell differentiation (GO:2000727)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
metanephric mesangial cell differentiation (GO:0072209)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle cell differentiation (GO:2000726)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
metanephric smooth muscle tissue development (GO:0072208)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell differentiation (GO:2000725)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
metanephric epithelium development (GO:0072207)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac vascular smooth muscle cell differentiation (GO:2000724)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric juxtaglomerular apparatus development (GO:0072206)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac vascular smooth muscle cell differentiation (GO:2000723)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric collecting duct development (GO:0072205)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac vascular smooth muscle cell differentiation (GO:2000722)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hippocampal neuron apoptotic process (GO:0110089)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in metanephros development (GO:0072203)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
hippocampal neuron apoptotic process (GO:0110088)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of maintenance of mitotic sister chromatid cohesion, centromeric (GO:2000720)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell differentiation involved in metanephros development (GO:0072202)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell proliferation (GO:0072201)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell proliferation involved in ureter development (GO:0072200)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of eosinophil activation (GO:1902567)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic spindle organization (GO:0060236)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
regulation of eosinophil activation (GO:1902566)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lens induction in camera-type eye (GO:0060235)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil activation (GO:1902565)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
neuroblast delamination (GO:0060234)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil activation (GO:1902564)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil activation (GO:1902563)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
delamination (GO:0060232)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
mesenchymal to epithelial transition (GO:0060231)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric (GO:2000719)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of mitotic sister chromatid cohesion, centromeric (GO:2000718)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of maintenance of meiotic sister chromatid cohesion, centromeric (GO:2000711)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated intercellular transport (GO:0110077)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ferroptosis (GO:0110076)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of ferroptosis (GO:0110075)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
3'-phospho-5'-adenylyl sulfate transmembrane transport (GO:1902559)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
5'-adenylyl sulfate transmembrane transport (GO:1902558)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of catalase activity (GO:1902553)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of catalase activity (GO:1902551)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of meiotic sister chromatid cohesion, centromeric (GO:2000709)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of dense core granule biogenesis (GO:2000706)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000703)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000702)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lncRNA catabolic process (GO:0110064)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
hemangioblast cell differentiation (GO:0060217)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of angiotensin-activated signaling pathway (GO:0110062)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
definitive hemopoiesis (GO:0060216)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
primitive hemopoiesis (GO:0060215)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
endocardium formation (GO:0060214)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060212)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
heme oxidation (GO:0006788)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
porphyrin-containing compound catabolic process (GO:0006787)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
heme B biosynthetic process (GO:0006785)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
heme A biosynthetic process (GO:0006784)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
heme biosynthetic process (GO:0006783)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
protoporphyrinogen IX biosynthetic process (GO:0006782)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
uroporphyrinogen III biosynthetic process (GO:0006780)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel endothelial cell differentiation (GO:0110059)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of blood vessel endothelial cell differentiation (GO:0110057)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
estrous cycle phase (GO:0060206)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metabolite repair (GO:0110051)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
porphyrin-containing compound biosynthetic process (GO:0006779)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
porphyrin-containing compound metabolic process (GO:0006778)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein linear polyubiquitination (GO:1902530)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
Mo-molybdopterin cofactor biosynthetic process (GO:0006777)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
vitamin A metabolic process (GO:0006776)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
thiamine metabolic process (GO:0006772)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
riboflavin metabolic process (GO:0006771)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of protein linear polyubiquitination (GO:1902528)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein monoubiquitination (GO:1902527)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein monoubiquitination (GO:1902525)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein K48-linked ubiquitination (GO:1902524)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein K63-linked ubiquitination (GO:1902523)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
nicotinamide metabolic process (GO:0006769)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
biotin metabolic process (GO:0006768)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
water-soluble vitamin metabolic process (GO:0006767)	51	0	.85	-	 < 0.01	1.00E00	1.00E00
folic acid-containing compound metabolic process (GO:0006760)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum tubular network maintenance (GO:0071788)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum tubular network formation (GO:0071787)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum tubular network organization (GO:0071786)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of G2/MI transition of meiotic cell cycle (GO:0110032)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of G2/MI transition of meiotic cell cycle (GO:0110031)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of G2/MI transition of meiotic cell cycle (GO:0110030)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of organelle transport along microtubule (GO:1902513)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic DNA fragmentation (GO:1902512)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic DNA fragmentation (GO:1902511)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic DNA fragmentation (GO:1902510)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
AMP phosphorylation (GO:0006756)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glutathione catabolic process (GO:0006751)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
MHC class II protein complex assembly (GO:0002399)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
glutathione biosynthetic process (GO:0006750)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
MHC class Ib protein complex assembly (GO:0002398)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
MHC class I protein complex assembly (GO:0002397)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
MHC protein complex assembly (GO:0002396)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
immune response in nasopharyngeal-associated lymphoid tissue (GO:0002395)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA strand resection involved in replication fork processing (GO:0110027)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of DNA strand resection involved in replication fork processing (GO:0110026)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA strand resection involved in replication fork processing (GO:0110025)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle myoblast proliferation (GO:0110024)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle myoblast proliferation (GO:0110022)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to BMP stimulus (GO:0071773)	104	0	1.73	-	 < 0.01	4.24E-01	1.00E00
response to BMP (GO:0071772)	104	0	1.73	-	 < 0.01	4.24E-01	1.00E00
glutathione metabolic process (GO:0006749)	62	0	1.03	-	 < 0.01	6.29E-01	1.00E00
FAD biosynthetic process (GO:0006747)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ubiquinone biosynthetic process (GO:0006744)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
GDP-mannose biosynthetic process from glucose (GO:0141199)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
ubiquinone metabolic process (GO:0006743)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
protein branched polyubiquitination (GO:0141198)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
NADP catabolic process (GO:0006742)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
NADP biosynthetic process (GO:0006741)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
transposable element silencing by piRNA-mediated DNA methylation (GO:0141196)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
NADPH regeneration (GO:0006740)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
immune response in gut-associated lymphoid tissue (GO:0002387)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mucosal immune response (GO:0002385)	82	0	1.37	-	 < 0.01	6.49E-01	1.00E00
negative regulation of HRI-mediated signaling (GO:0141191)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
hepatic immune response (GO:0002384)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
immune response in brain or nervous system (GO:0002383)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cap-independent translational initiation of linear mRNA (GO:0110017)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear inner membrane organization (GO:0071765)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear membrane organization (GO:0071763)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
regulation of basement membrane organization (GO:0110011)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
basolateral protein secretion (GO:0110010)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
nicotinamide riboside catabolic process (GO:0006738)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
one-carbon metabolic process (GO:0006730)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
plasmacytoid dendritic cell cytokine production (GO:0002373)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dendritic cell cytokine production (GO:0002371)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
natural killer cell cytokine production (GO:0002370)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
formin-nucleated actin cable organization (GO:0110009)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of tRNA methylation (GO:0110002)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tetrahydrobiopterin biosynthetic process (GO:0006729)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
triterpenoid metabolic process (GO:0006722)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
terpenoid metabolic process (GO:0006721)	90	0	1.50	-	 < 0.01	4.09E-01	1.00E00
gene silencing by piRNA-directed DNA methylation (GO:0141176)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
gamma-delta T cell lineage commitment (GO:0002365)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
NK T cell lineage commitment (GO:0002364)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment (GO:0002362)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0002361)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
sesquiterpenoid metabolic process (GO:0006714)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glucocorticoid catabolic process (GO:0006713)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
estrogen catabolic process (GO:0006711)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
chromosomal 5-methylcytosine DNA demethylation, oxidation pathway (GO:0141167)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
androgen catabolic process (GO:0006710)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
chromosomal 5-methylcytosine DNA demethylation pathway (GO:0141166)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
B cell homeostatic proliferation (GO:0002358)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
defense response to tumor cell (GO:0002357)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
mitochondrial protein quality control (GO:0141164)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cAMP/PKA signal transduction (GO:0141163)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
detection of tumor cell (GO:0002355)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cAMP/PKA signal transduction (GO:0141162)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cAMP/PKA signal transduction (GO:0141161)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
plasma kallikrein-kinin cascade (GO:0002353)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
B cell negative selection (GO:0002352)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
serotonin production involved in inflammatory response (GO:0002351)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell maintenance (GO:0045494)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
cellular response to nitric oxide (GO:0071732)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
progesterone catabolic process (GO:0006709)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cholesterol catabolic process (GO:0006707)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
steroid catabolic process (GO:0006706)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
mineralocorticoid biosynthetic process (GO:0006705)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glucocorticoid biosynthetic process (GO:0006704)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
estrogen biosynthetic process (GO:0006703)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
androgen biosynthetic process (GO:0006702)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
progesterone biosynthetic process (GO:0006701)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
histamine production involved in inflammatory response (GO:0002349)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
C21-steroid hormone biosynthetic process (GO:0006700)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
response to tumor cell (GO:0002347)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001190)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to triacyl bacterial lipopeptide (GO:0071727)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to diacyl bacterial lipopeptide (GO:0071726)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to triacyl bacterial lipopeptide (GO:0071725)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to diacyl bacterial lipopeptide (GO:0071724)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
detoxification of arsenic-containing substance (GO:0071722)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sodium-independent prostaglandin transport (GO:0071720)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001189)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
B-1a B cell differentiation (GO:0002337)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
B-1 B cell lineage commitment (GO:0002336)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mature B cell differentiation (GO:0002335)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
transitional one stage B cell differentiation (GO:0002333)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pre-B cell allelic exclusion (GO:0002331)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
locomotor rhythm (GO:0045475)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
sodium-independent icosanoid transport (GO:0071718)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to ether (GO:0045472)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
leukotriene transport (GO:0071716)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
icosanoid transport (GO:0071715)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
basement membrane organization (GO:0071711)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of mediator complex assembly (GO:2001178)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mediator complex assembly (GO:2001176)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of gene expression, epigenetic (GO:0141137)	57	0	.95	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATP biosynthetic process (GO:2001170)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
B cell lineage commitment (GO:0002326)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
natural killer cell activation involved in immune response (GO:0002323)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
B cell proliferation involved in immune response (GO:0002322)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
immunoglobulin heavy chain V-D-J recombination (GO:0071707)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
galactose catabolic process via UDP-galactose (GO:0033499)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cholesterol biosynthetic process via lathosterol (GO:0033490)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
memory B cell differentiation (GO:0002319)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myeloid progenitor cell differentiation (GO:0002318)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
plasma cell differentiation (GO:0002317)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
follicular B cell differentiation (GO:0002316)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
marginal zone B cell differentiation (GO:0002315)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
germinal center B cell differentiation (GO:0002314)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
mature B cell differentiation involved in immune response (GO:0002313)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
B cell activation involved in immune response (GO:0002312)	87	0	1.45	-	 < 0.01	4.08E-01	1.00E00
cholesterol biosynthetic process via desmosterol (GO:0033489)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cholesterol biosynthetic process via 24,25-dihydrolanosterol (GO:0033488)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intracellular nitric oxide homeostasis (GO:0033484)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
chromosomal DNA methylation maintenance following DNA replication (GO:0141119)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of renal water transport (GO:2001153)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T cell proliferation involved in immune response (GO:0002309)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of renal water transport (GO:2001151)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of dipeptide transmembrane transport (GO:2001150)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
CD8-positive, gamma-delta intraepithelial T cell differentiation (GO:0002305)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
broken chromosome clustering (GO:0141112)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
gamma-delta intraepithelial T cell differentiation (GO:0002304)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cGAS/STING signaling pathway (GO:0141111)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell differentiation involved in immune response (GO:0002302)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta intraepithelial T cell differentiation (GO:0002300)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myoblast differentiation (GO:0045445)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
S-methylmethionine metabolic process (GO:0033477)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of dipeptide transmembrane transport (GO:2001148)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001145)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001144)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nicotinate transport (GO:2001142)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipid transport (GO:2001139)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of endocytic recycling (GO:2001137)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of endocytic recycling (GO:2001136)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of endocytic recycling (GO:2001135)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
protein-lipid complex assembly (GO:0065005)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
intracellular protein transmembrane transport (GO:0065002)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
specification of axis polarity (GO:0065001)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
nonribosomal peptide biosynthetic process (GO:0019184)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of translational frameshifting (GO:2001125)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translational frameshifting (GO:2001124)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to hepatocyte growth factor stimulus (GO:2001113)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to hepatocyte growth factor stimulus (GO:2001112)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of lens epithelial cell proliferation (GO:2001111)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
retina homeostasis (GO:0001895)	63	0	1.05	-	 < 0.01	6.29E-01	1.00E00
G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway (GO:0007196)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase activity (GO:0007194)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of lens epithelial cell proliferation (GO:2001109)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001108)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001107)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001106)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
selenium compound metabolic process (GO:0001887)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
endothelial cell morphogenesis (GO:0001886)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
receptor recycling (GO:0001881)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
Mullerian duct regression (GO:0001880)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cell surface receptor protein tyrosine phosphatase signaling pathway (GO:0007185)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta receptor complex assembly (GO:0007181)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of yeast (GO:0001879)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to yeast (GO:0001878)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
epidermal growth factor catabolic process (GO:0007174)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
signal complex assembly (GO:0007172)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell proliferation involved in ureter development (GO:0072199)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell proliferation involved in ureter development (GO:0072198)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ureter morphogenesis (GO:0072197)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of complement activation, lectin pathway (GO:0001869)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney smooth muscle cell differentiation (GO:0072195)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of complement activation, lectin pathway (GO:0001868)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney smooth muscle tissue development (GO:0072194)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
complement activation, lectin pathway (GO:0001867)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
ureter smooth muscle cell differentiation (GO:0072193)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
NK T cell proliferation (GO:0001866)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
NK T cell differentiation (GO:0001865)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
ureter smooth muscle development (GO:0072191)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ureter urothelium development (GO:0072190)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
receptor guanylyl cyclase signaling pathway (GO:0007168)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
establishment of tissue polarity (GO:0007164)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
calcium-independent cell-matrix adhesion (GO:0007161)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cell-matrix adhesion (GO:0007160)	132	0	2.20	-	 < 0.01	1.78E-01	1.00E00
positive regulation of oxytocin production (GO:0140668)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric cap morphogenesis (GO:0072186)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of oxytocin production (GO:0140667)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric cap development (GO:0072185)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
renal vesicle progenitor cell differentiation (GO:0072184)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of nephron tubule epithelial cell differentiation (GO:0072183)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mesonephric duct formation (GO:0072181)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mesonephric duct morphogenesis (GO:0072180)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial cell differentiation involved in kidney development (GO:2000697)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
nephric duct formation (GO:0072179)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
nephric duct morphogenesis (GO:0072178)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
mesonephric duct development (GO:0072177)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
nephric duct development (GO:0072176)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
metanephric tubule formation (GO:0072174)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle cell myoblast differentiation (GO:2000691)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric tubule morphogenesis (GO:0072173)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell myoblast differentiation (GO:2000690)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesonephric tubule formation (GO:0072172)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
phagolysosome assembly (GO:0001845)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
metanephric tubule development (GO:0072170)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
futile creatine cycle (GO:0140651)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
radial glia-guided pyramidal neuron migration (GO:0140650)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
neural fold formation (GO:0001842)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
female meiosis II (GO:0007147)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neural plate development (GO:0001840)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
meiotic recombination nodule assembly (GO:0007146)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
female meiosis I (GO:0007144)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
female meiotic nuclear division (GO:0007143)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
male meiosis I (GO:0007141)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
male meiotic nuclear division (GO:0007140)	63	0	1.05	-	 < 0.01	6.29E-01	1.00E00
actomyosin contractile ring assembly actin filament organization (GO:2000689)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
specification of posterior mesonephric tubule identity (GO:0072169)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
specification of anterior mesonephric tubule identity (GO:0072168)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
specification of mesonephric tubule identity (GO:0072167)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
posterior mesonephric tubule development (GO:0072166)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
P450-containing electron transport chain (GO:0140647)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to X-ray (GO:2000683)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neural plate morphogenesis (GO:0001839)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
anterior mesonephric tubule development (GO:0072165)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of pre-B cell receptor expression (GO:0140646)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
male somatic sex determination (GO:0019102)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric mesenchymal cell differentiation (GO:0072162)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
blastocyst hatching (GO:0001835)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
female somatic sex determination (GO:0019101)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell differentiation involved in kidney development (GO:0072161)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
trophectodermal cell proliferation (GO:0001834)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
male germ-line sex determination (GO:0019100)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nephron tubule epithelial cell differentiation (GO:0072160)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
inner cell mass cell proliferation (GO:0001833)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
blastocyst growth (GO:0001832)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
trophectodermal cellular morphogenesis (GO:0001831)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cloacal septation (GO:0060197)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
trophectodermal cell fate commitment (GO:0001830)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
meiosis II (GO:0007135)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic metaphase I (GO:0007132)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipase activity (GO:0060192)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
reciprocal meiotic recombination (GO:0007131)	56	0	.93	-	 < 0.01	1.00E00	1.00E00
synaptonemal complex assembly (GO:0007130)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription initiation-coupled chromatin remodeling (GO:0160217)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription regulatory region DNA binding (GO:2000678)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of type B pancreatic cell apoptotic process (GO:2000676)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
proximal tubule morphogenesis (GO:0072158)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pyroptotic inflammatory response (GO:0140639)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of type B pancreatic cell apoptotic process (GO:2000675)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of type B pancreatic cell apoptotic process (GO:2000674)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
distal tubule morphogenesis (GO:0072156)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of motor neuron apoptotic process (GO:2000673)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
trophectodermal cell differentiation (GO:0001829)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
negative regulation of motor neuron apoptotic process (GO:2000672)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
inner cell mass cellular morphogenesis (GO:0001828)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of motor neuron apoptotic process (GO:2000671)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
inner cell mass cell fate commitment (GO:0001827)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell apoptotic process (GO:2000670)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
inner cell mass cell differentiation (GO:0001826)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
canonical inflammasome complex assembly (GO:0140632)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
homologous chromosome pairing at meiosis (GO:0007129)	61	0	1.02	-	 < 0.01	6.29E-01	1.00E00
meiotic prophase I (GO:0007128)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
histamine secretion (GO:0001821)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
meiosis I (GO:0007127)	133	0	2.22	-	 < 0.01	1.78E-01	1.00E00
serotonin secretion (GO:0001820)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cell cycle switching (GO:0060184)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
apelin receptor signaling pathway (GO:0060183)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
female mating behavior (GO:0060180)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
mitochondrial disulfide relay system (GO:0160203)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic cell apoptotic process (GO:2000669)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell apoptotic process (GO:2000668)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
epithelial cell fate commitment (GO:0072148)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent protein catabolic process via the C-end degron rule pathway (GO:0140627)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
glomerular mesangial cell development (GO:0072144)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-1-mediated signaling pathway (GO:2000661)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesangial cell development (GO:0072143)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-1-mediated signaling pathway (GO:2000660)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of antibody-dependent cellular cytotoxicity (GO:0001815)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
renal interstitial fibroblast development (GO:0072141)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antibody-dependent cellular cytotoxicity (GO:0001813)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
male mating behavior (GO:0060179)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of type I hypersensitivity (GO:0001812)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of exocyst localization (GO:0060178)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of type I hypersensitivity (GO:0001811)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of angiotensin metabolic process (GO:0060177)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of type I hypersensitivity (GO:0001810)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
limb bud formation (GO:0060174)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
endomitotic cell cycle (GO:0007113)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
male meiosis cytokinesis (GO:0007112)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein-RNA complex disassembly (GO:0032988)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
protein-DNA complex disassembly (GO:0032986)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-1-mediated signaling pathway (GO:2000659)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of apolipoprotein binding (GO:2000657)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
keratinocyte activation (GO:0032980)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of apolipoprotein binding (GO:2000656)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell proliferation involved in ureteric bud development (GO:0072138)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to testosterone stimulus (GO:2000655)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
condensed mesenchymal cell proliferation (GO:0072137)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to testosterone stimulus (GO:2000654)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric mesenchymal cell proliferation involved in metanephros development (GO:0072136)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of type IV hypersensitivity (GO:0001809)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
kidney mesenchymal cell proliferation (GO:0072135)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of type IV hypersensitivity (GO:0001808)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nephrogenic mesenchyme morphogenesis (GO:0072134)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium ion transmembrane transporter activity (GO:2000651)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of type IV hypersensitivity (GO:0001807)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
metanephric mesenchyme morphogenesis (GO:0072133)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
type IV hypersensitivity (GO:0001806)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchyme morphogenesis (GO:0072132)	57	0	.95	-	 < 0.01	1.00E00	1.00E00
positive regulation of type III hypersensitivity (GO:0001805)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
kidney mesenchyme morphogenesis (GO:0072131)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
renal capsule specification (GO:0072130)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of type III hypersensitivity (GO:0001803)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenosine receptor signaling pathway (GO:0060169)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein autoubiquitination (GO:1902499)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenosine receptor signaling pathway (GO:0060168)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein autoubiquitination (GO:1902498)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of adenosine receptor signaling pathway (GO:0060167)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
iron-sulfur cluster transmembrane transport (GO:1902497)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
olfactory pit development (GO:0060166)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of timing of subpallium neuron differentiation (GO:0060165)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of timing of neuron differentiation (GO:0060164)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
subpallium neuron fate commitment (GO:0060163)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of sperm capacitation (GO:1902492)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopamine receptor signaling pathway (GO:0060161)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of sperm capacitation (GO:1902491)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic centrosome separation (GO:0007100)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopamine receptor signaling pathway (GO:0060160)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of sperm capacitation (GO:1902490)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial inner membrane from matrix (GO:0032979)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein insertion into membrane from inner side (GO:0032978)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
release of matrix enzymes from mitochondria (GO:0032976)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
amino acid transmembrane export from vacuole (GO:0032974)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
amino acid export across plasma membrane (GO:0032973)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of muscle filament sliding speed (GO:0032972)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of stem cell proliferation (GO:2000648)	61	0	1.02	-	 < 0.01	6.29E-01	1.00E00
regulation of muscle filament sliding (GO:0032971)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
renal capsule formation (GO:0072129)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor catabolic process (GO:2000646)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
renal capsule morphogenesis (GO:0072128)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor catabolic process (GO:2000645)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
renal capsule development (GO:0072127)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of receptor catabolic process (GO:2000644)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of glomerular mesangial cell proliferation (GO:0072126)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of early endosome to late endosome transport (GO:2000643)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of glomerular mesangial cell proliferation (GO:0072125)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of early endosome to late endosome transport (GO:2000642)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glomerular mesangial cell proliferation (GO:0072124)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of early endosome to late endosome transport (GO:2000641)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of SREBP signaling pathway (GO:2000640)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dopamine receptor signaling pathway (GO:0060159)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
urinary bladder development (GO:0060157)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
milk ejection reflex (GO:0060156)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
platelet dense granule organization (GO:0060155)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
cytotoxic T cell pyroptotic cell death (GO:1902483)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
microtubule-based peroxisome localization (GO:0060152)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulatory T cell apoptotic process (GO:1902482)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peroxisome localization (GO:0060151)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to mitotic spindle (GO:1902480)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of collagen biosynthetic process (GO:0032966)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
collagen biosynthetic process (GO:0032964)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of SREBP signaling pathway (GO:2000639)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of inositol trisphosphate biosynthetic process (GO:0032962)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of SREBP signaling pathway (GO:2000638)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of inositol trisphosphate biosynthetic process (GO:0032960)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of primary miRNA processing (GO:2000636)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pre-miRNA processing (GO:2000633)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of pre-miRNA processing (GO:2000632)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pronephros morphogenesis (GO:0072114)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of pre-miRNA processing (GO:2000631)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in kidney development (GO:0072111)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
glomerular mesangial cell proliferation (GO:0072110)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
chloride transmembrane transport (GO:1902476)	112	0	1.87	-	 < 0.01	2.69E-01	1.00E00
L-alpha-amino acid transmembrane transport (GO:1902475)	64	0	1.07	-	 < 0.01	6.30E-01	1.00E00
positive regulation of protein localization to synapse (GO:1902474)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
inositol trisphosphate biosynthetic process (GO:0032959)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cytokinetic process (GO:0032954)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of miRNA metabolic process (GO:2000629)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of miRNA catabolic process (GO:2000627)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glomerular mesangium development (GO:0072109)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of miRNA catabolic process (GO:2000626)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0072108)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of miRNA catabolic process (GO:2000625)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of ureteric bud formation (GO:0072107)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of ureteric bud formation (GO:0072106)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000623)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
ureteric peristalsis (GO:0072105)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000622)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
glomerular capillary formation (GO:0072104)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
glomerulus vasculature morphogenesis (GO:0072103)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
glomerulus morphogenesis (GO:0072102)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
maternal process involved in parturition (GO:0060137)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
embryonic process involved in female pregnancy (GO:0060136)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
prepulse inhibition (GO:0060134)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
somatotropin secreting cell development (GO:0060133)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to cell leading edge (GO:1902463)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal stem cell proliferation (GO:1902462)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal stem cell proliferation (GO:1902460)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of thyroid-stimulating hormone secretion (GO:2000614)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of thyroid-stimulating hormone secretion (GO:2000612)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of thyroid hormone generation (GO:2000611)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
thyroid-stimulating hormone-secreting cell differentiation (GO:0060129)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
corticotropin hormone secreting cell differentiation (GO:0060128)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
prolactin secreting cell differentiation (GO:0060127)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
somatotropin secreting cell differentiation (GO:0060126)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of growth hormone secretion (GO:0060125)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of growth hormone secretion (GO:0060124)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of growth hormone secretion (GO:0060123)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
bile acid biosynthetic process (GO:0006699)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
vestibular receptor cell stereocilium organization (GO:0060121)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inner ear receptor cell fate commitment (GO:0060120)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of translation in response to oxidative stress (GO:0032938)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leukotriene metabolic process (GO:0006691)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
SREBP signaling pathway (GO:0032933)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of thyroid hormone generation (GO:2000609)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in mesonephros development (GO:2000607)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in mesonephros development (GO:2000606)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
vestibular receptor cell development (GO:0060118)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vestibular receptor cell morphogenesis (GO:0060116)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death (GO:1902445)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vestibular receptor cell differentiation (GO:0060114)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ripoptosome assembly involved in necroptotic process (GO:1902443)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
generation of ovulation cycle rhythm (GO:0060112)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of ripoptosome assembly involved in necroptotic process (GO:1902442)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ganglioside catabolic process (GO:0006689)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
sphingomyelin catabolic process (GO:0006685)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of superoxide anion generation (GO:0032929)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
galactosylceramide catabolic process (GO:0006683)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of activin receptor signaling pathway (GO:0032927)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
galactosylceramide biosynthetic process (GO:0006682)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of activin receptor signaling pathway (GO:0032926)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
galactosylceramide metabolic process (GO:0006681)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of activin receptor signaling pathway (GO:0032925)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
glucosylceramide catabolic process (GO:0006680)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
activin receptor signaling pathway (GO:0032924)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
putrescine acetylation (GO:0032920)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of male mating behavior (GO:1902437)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of male mating behavior (GO:1902436)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of male mating behavior (GO:1902435)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glucosylceramide biosynthetic process (GO:0006679)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phagocytosis, engulfment (GO:0060101)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glucosylceramide metabolic process (GO:0006678)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid-beta formation (GO:1902430)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
spermine acetylation (GO:0032919)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spermidine acetylation (GO:0032918)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
polyamine acetylation (GO:0032917)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta3 production (GO:0032916)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
phytosphingosine metabolic process (GO:0006671)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta2 production (GO:0032915)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
sphingosine metabolic process (GO:0006670)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta1 production (GO:0032914)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of transforming growth factor beta2 production (GO:0032912)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
olfactory placode morphogenesis (GO:0071699)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
olfactory placode development (GO:0071698)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
deactivation of mitotic spindle assembly checkpoint (GO:1902426)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein transport within extracellular region (GO:0071693)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902425)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902424)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac muscle thin filament assembly (GO:0071691)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902423)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
sphinganine-1-phosphate biosynthetic process (GO:0006669)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sphinganine-1-phosphate metabolic process (GO:0006668)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
sphinganine metabolic process (GO:0006667)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
3-keto-sphinganine metabolic process (GO:0006666)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of transforming growth factor beta2 production (GO:0032909)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
platelet activating factor biosynthetic process (GO:0006663)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
glycerol ether metabolic process (GO:0006662)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta1 production (GO:0032905)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine catabolic process (GO:0006660)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of nerve growth factor production (GO:0032903)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nerve growth factor production (GO:0032902)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotrophin production (GO:0032901)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neurotrophin production (GO:0032900)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
TORC2 signaling (GO:0038203)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
TORC1 signaling (GO:0038202)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
striated muscle myosin thick filament assembly (GO:0071688)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
organism emergence from protective structure (GO:0071684)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA binding (GO:1902416)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA binding (GO:1902415)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to indole-3-methanol (GO:0071681)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to indole-3-methanol (GO:0071680)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cytokinesis (GO:1902412)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine biosynthetic process (GO:0006659)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mitotic cytokinetic process (GO:1902410)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
CDP-choline pathway (GO:0006657)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
phosphatidylcholine biosynthetic process (GO:0006656)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
phosphatidylglycerol biosynthetic process (GO:0006655)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
1,2-diacyl-sn-glycero-3-phosphocholine metabolic process (GO:0006653)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
diacylglycerol biosynthetic process (GO:0006651)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
alpha-beta intraepithelial T cell differentiation (GO:0002299)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T-helper 1 cell lineage commitment (GO:0002296)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
olfactory bulb axon guidance (GO:0071678)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
assembly of actomyosin apparatus involved in mitotic cytokinesis (GO:1902407)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle cell chemotaxis (GO:0071673)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell chemotaxis (GO:0071670)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
phospholipid transfer to membrane (GO:0006649)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylethanolamine biosynthetic process (GO:0006646)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
triglyceride mobilization (GO:0006642)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
triglyceride metabolic process (GO:0006641)	75	0	1.25	-	 < 0.01	6.39E-01	1.00E00
monoacylglycerol biosynthetic process (GO:0006640)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
microglial cell activation involved in immune response (GO:0002282)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
monocyte activation involved in immune response (GO:0002280)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of granzyme B production (GO:0071663)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of granzyme B production (GO:0071661)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of IP-10 production (GO:0071660)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acyl-CoA metabolic process (GO:0006637)	93	0	1.55	-	 < 0.01	4.11E-01	1.00E00
fatty acid beta-oxidation (GO:0006635)	58	0	.97	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation by tRNA modification (GO:1990983)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of inflammasome-mediated signaling pathway (GO:0141087)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
negative regulation of inflammasome-mediated signaling pathway (GO:0141086)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
eosinophil activation involved in immune response (GO:0002278)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
myeloid dendritic cell activation involved in immune response (GO:0002277)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
inflammasome-mediated signaling pathway (GO:0141084)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
basophil activation involved in immune response (GO:0002276)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
plasmacytoid dendritic cell differentiation (GO:0002273)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
plasmacytoid dendritic cell activation (GO:0002270)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of IP-10 production (GO:0071659)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of IP-10 production (GO:0071658)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of granulocyte colony-stimulating factor production (GO:0071657)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of granulocyte colony-stimulating factor production (GO:0071656)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of granulocyte colony-stimulating factor production (GO:0071655)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine (C-C motif) ligand 1 production (GO:0071654)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-C motif) ligand 1 production (GO:0071652)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine (C-C motif) ligand 5 production (GO:0071651)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemokine (C-C motif) ligand 5 production (GO:0071650)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein processing involved in protein targeting to mitochondrion (GO:0006627)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein targeting to mitochondrion (GO:0006626)	59	0	.98	-	 < 0.01	6.29E-01	1.00E00
protein targeting to peroxisome (GO:0006625)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
vacuolar protein processing (GO:0006624)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein targeting to vacuole (GO:0006623)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
protein targeting to lysosome (GO:0006622)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
protein retention in ER lumen (GO:0006621)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
post-translational protein targeting to endoplasmic reticulum membrane (GO:0006620)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
follicular dendritic cell differentiation (GO:0002268)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
follicular dendritic cell activation (GO:0002266)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
astrocyte activation involved in immune response (GO:0002265)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
endothelial cell activation involved in immune response (GO:0002264)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-C motif) ligand 5 production (GO:0071649)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemokine (C-C motif) ligand 4 production (GO:0071644)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-C motif) ligand 4 production (GO:0071643)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage inflammatory protein 1 alpha production (GO:0071642)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage inflammatory protein 1 alpha production (GO:0071640)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral RNA-binding transcription factor activity (GO:1990969)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
modulation by host of RNA binding by virus (GO:1990968)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
ATP generation from poly-ADP-D-ribose (GO:1990966)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
cotranslational protein targeting to membrane (GO:0006613)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
autosome genomic imprinting (GO:0141068)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
establishment of blood-retinal barrier (GO:1990963)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
intracellular nitrogen homeostasis (GO:0141067)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
xenobiotic transport across blood-brain barrier (GO:1990962)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
xenobiotic detoxification by transmembrane export across the plasma membrane (GO:1990961)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
maternal mRNA clearance (GO:0141065)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
basophil homeostasis (GO:1990960)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tissue kallikrein-kinin cascade (GO:0002255)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
kinin cascade (GO:0002254)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
organ or tissue specific immune response (GO:0002251)	86	0	1.43	-	 < 0.01	4.08E-01	1.00E00
positive regulation of monocyte chemotactic protein-1 production (GO:0071639)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta production (GO:0071636)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
homogentisate metabolic process (GO:1901999)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic cell cycle phase transition (GO:1901995)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic cell cycle phase transition (GO:1901994)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
phosphocreatine metabolic process (GO:0006603)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic cell cycle phase transition (GO:1901993)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
intramanchette transport (GO:1990953)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
creatine biosynthetic process (GO:0006601)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lymphocyte anergy (GO:0002249)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
creatine metabolic process (GO:0006600)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
connective tissue replacement involved in inflammatory response wound healing (GO:0002248)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cytoplasm protein quality control by the ubiquitin-proteasome system (GO:0071629)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mastication (GO:0071626)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
metaphase/anaphase transition of meiosis I (GO:1990949)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to ketamine (GO:1901986)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein acetylation (GO:1901984)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of inward rectifier potassium channel activity (GO:1901980)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to molecule of fungal origin (GO:0002238)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
acyl-CoA biosynthetic process (GO:0071616)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
regulation of inward rectifier potassium channel activity (GO:1901979)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell cycle checkpoint (GO:1901978)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell cycle checkpoint (GO:1901977)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
peptidyl-aspartic acid autophosphorylation (GO:1990938)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell cycle checkpoint (GO:1901976)	52	0	.87	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephric ureteric bud development (GO:2001076)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric ureteric bud development (GO:2001074)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic sister chromatid separation (GO:1901970)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
natural killer cell mediated immunity (GO:0002228)	39	0	.65	-	 < 0.01	1.00E00	1.00E00
innate immune response in mucosa (GO:0002227)	69	0	1.15	-	 < 0.01	6.33E-01	1.00E00
positive regulation of antimicrobial peptide production (GO:0002225)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
stimulatory C-type lectin receptor signaling pathway (GO:0002223)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
stimulatory killer cell immunoglobulin-like receptor signaling pathway (GO:0002222)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chemokine (C-C motif) ligand 5 production (GO:0071609)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
macrophage inflammatory protein-1 alpha production (GO:0071608)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta production (GO:0071604)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
phytosphingosine biosynthetic process (GO:0071602)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
beta-alanine biosynthetic process via 3-ureidopropionate (GO:0033396)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
otic vesicle morphogenesis (GO:0071600)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
short-term synaptic potentiation (GO:1990926)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
S-adenosyl-L-methionine transmembrane transport (GO:1901962)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
defense response to nematode (GO:0002215)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process from arginine, using agmatinase (GO:0033389)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process from arginine (GO:0033388)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process from ornithine (GO:0033387)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
geranylgeranyl diphosphate biosynthetic process (GO:0033386)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
geranylgeranyl diphosphate metabolic process (GO:0033385)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
geranyl diphosphate biosynthetic process (GO:0033384)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
geranyl diphosphate metabolic process (GO:0033383)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
double-strand break repair involved in meiotic recombination (GO:1990918)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
maintenance of granzyme B location in T cell secretory granule (GO:0033382)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of retrograde dense core granule transport (GO:1901956)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
reactive nitrogen species metabolic process (GO:2001057)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
granzyme B localization to T cell secretory granule (GO:0033380)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde dense core granule transport (GO:1901954)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of anterograde dense core granule transport (GO:1901953)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal cell apoptotic process (GO:2001055)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell apoptotic process (GO:2001054)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of anterograde dense core granule transport (GO:1901951)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell apoptotic process (GO:2001053)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
response to psychosocial stress (GO:1990911)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immunoglobulins involved in immune response (GO:0002208)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
response to hypobaric hypoxia (GO:1990910)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of tendon cell differentiation (GO:2001051)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ribosome hibernation (GO:0141014)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
purine nucleotide import into lysosome (GO:0141013)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of MHC class II biosynthetic process (GO:0045348)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of MHC class II biosynthetic process (GO:0045347)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of MHC class II biosynthetic process (GO:0045346)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of MHC class I biosynthetic process (GO:0045345)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of MHC class I biosynthetic process (GO:0045344)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of MHC class I biosynthetic process (GO:0045343)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
MHC class II biosynthetic process (GO:0045342)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of protease location in T cell secretory granule (GO:0033379)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in T cell secretory granule (GO:0033377)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protease localization to T cell secretory granule (GO:0033375)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to T cell secretory granule (GO:0033374)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of protease location in mast cell secretory granule (GO:0033373)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of tendon cell differentiation (GO:2001049)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T cell secretory granule organization (GO:0033371)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in mast cell secretory granule (GO:0033370)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of integrin-mediated signaling pathway (GO:2001046)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of integrin-mediated signaling pathway (GO:2001045)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
transposable element silencing by mRNA destabilization (GO:0141008)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of integrin-mediated signaling pathway (GO:2001044)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
transposable element silencing by piRNA-mediated heterochromatin formation (GO:0141006)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
transposable element silencing by heterochromatin formation (GO:0141005)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular response to drug (GO:2001040)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate catabolic process (GO:0045339)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate metabolic process (GO:0045338)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate biosynthetic process (GO:0045337)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
phospholipid translocation (GO:0045332)	54	0	.90	-	 < 0.01	1.00E00	1.00E00
protease localization to mast cell secretory granule (GO:0033368)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to mast cell secretory granule (GO:0033367)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mast cell secretory granule organization (GO:0033364)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to drug (GO:2001038)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of tongue muscle cell differentiation (GO:2001037)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tongue muscle cell differentiation (GO:2001035)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of double-strand break repair via nonhomologous end joining (GO:2001032)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular glucuronidation (GO:2001030)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
late viral transcription (GO:0019086)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
early viral transcription (GO:0019085)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
carnitine biosynthetic process (GO:0045329)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
viral transcription (GO:0019083)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
viral protein processing (GO:0019082)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
viral translation (GO:0019081)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
viral gene expression (GO:0019080)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
late endosome to vacuole transport (GO:0045324)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethionine cycle (GO:0033353)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell chemotaxis (GO:2001028)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelial cell chemotaxis (GO:2001027)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell chemotaxis (GO:2001026)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to drug (GO:2001025)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
stereocilium bundle organization (GO:0160194)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to drug (GO:2001023)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
viral genome replication (GO:0019079)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
virus maturation (GO:0019075)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
viral RNA genome packaging (GO:0019074)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
viral genome packaging (GO:0019072)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
asparagine catabolic process via L-aspartate (GO:0033345)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of retrograde axon cargo transport (GO:2001019)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of collagen binding (GO:0033342)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of collagen binding (GO:0033341)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde axon cargo transport (GO:2001017)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle cell differentiation (GO:2001016)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle cell differentiation (GO:2001015)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
paracellular transport (GO:0160184)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in renal tubule morphogenesis (GO:2001013)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell differentiation involved in renal system development (GO:2001012)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
virion assembly (GO:0019068)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
receptor-mediated endocytosis of virus by host cell (GO:0019065)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of type IIa hypersensitivity (GO:0001798)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
fusion of virus membrane with host plasma membrane (GO:0019064)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of type IIa hypersensitivity (GO:0001796)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
virion attachment to host cell (GO:0019062)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
type IIa hypersensitivity (GO:0001794)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
intracellular transport of viral protein in host cell (GO:0019060)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of exit from mitosis (GO:0007096)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
mitotic G2 DNA damage checkpoint signaling (GO:0007095)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
mitotic spindle assembly checkpoint signaling (GO:0007094)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
diadenosine hexaphosphate catabolic process (GO:1901909)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
diadenosine hexaphosphate metabolic process (GO:1901908)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
diadenosine pentaphosphate catabolic process (GO:1901907)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
intestinal iron absorption (GO:0160179)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
diadenosine pentaphosphate metabolic process (GO:1901906)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagosome-lysosome fusion (GO:0160177)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
magnesium ion transport from cytosol to endoplasmic reticulum (GO:0160176)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antibody-dependent cellular cytotoxicity (GO:0001788)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
natural killer cell proliferation (GO:0001787)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
traversing start control point of mitotic cell cycle (GO:0007089)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic nuclear division (GO:0007088)	124	0	2.07	-	 < 0.01	2.77E-01	1.00E00
neutrophil apoptotic process (GO:0001781)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
neutrophil homeostasis (GO:0001780)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
mitotic nuclear membrane reassembly (GO:0007084)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cerebrospinal fluid secretion (GO:0033326)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
UDP-D-xylose biosynthetic process (GO:0033320)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell homeostasis (GO:0160165)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CD27 signaling pathway (GO:0160162)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
release from viral latency (GO:0019046)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
natural killer cell differentiation (GO:0001779)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
latent virus replication (GO:0019045)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of viral latency (GO:0019043)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
viral latency (GO:0019042)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via telomere trimming (GO:0090737)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
microglial cell activation (GO:0001774)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
DNA repair complex assembly (GO:0090735)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
immunological synapse formation (GO:0001771)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
mitotic nuclear membrane disassembly (GO:0007077)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic chromosome condensation (GO:0007076)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
UDP-D-xylose metabolic process (GO:0033319)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
meiotic spindle assembly checkpoint signaling (GO:0033316)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication checkpoint signaling (GO:0033314)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
meiotic cell cycle checkpoint signaling (GO:0033313)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
anterior/posterior pattern specification involved in kidney development (GO:0072098)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of branch elongation involved in ureteric bud branching (GO:0072095)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ascorbate homeostasis (GO:0140576)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane raft polarization (GO:0001766)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
extraction of mislocalized protein from mitochondrial outer membrane (GO:0140570)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
beta-alanine transport (GO:0001762)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
female meiosis sister chromatid cohesion (GO:0007066)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
primary adaptive immune response involving T cells and B cells (GO:0090721)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
male meiosis sister chromatid cohesion (GO:0007065)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
primary adaptive immune response (GO:0090720)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic sister chromatid cohesion (GO:0007064)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of sister chromatid cohesion (GO:0007063)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
sister chromatid cohesion (GO:0007062)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
phytol metabolic process (GO:0033306)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
male meiosis chromosome segregation (GO:0007060)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cell cycle comprising mitosis without cytokinesis (GO:0033301)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of GDF15-GFRAL signaling pathway (GO:0160145)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
extraction of mislocalized protein from ER membrane (GO:0140569)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
extraction of mislocalized protein from membrane (GO:0140568)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
specification of loop of Henle identity (GO:0072086)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
adaptive immune memory response involving T cells and B cells (GO:0090717)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
specification of nephron tubule identity (GO:0072081)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
adaptive immune memory response (GO:0090716)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
immunological memory formation process (GO:0090715)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
immunological memory process (GO:0090713)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
spindle assembly involved in female meiosis I (GO:0007057)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
spindle assembly involved in female meiosis (GO:0007056)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
phospholipase C-activating endothelin receptor signaling pathway (GO:0160135)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of optic nerve formation (GO:2000597)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nephron tubule formation (GO:0072079)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of optic nerve formation (GO:2000595)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephric DCT cell differentiation (GO:2000594)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nephrogenic mesenchyme development (GO:0072076)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephric mesenchyme development (GO:0072075)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric DCT cell differentiation (GO:2000592)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney mesenchyme development (GO:0072074)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephric mesenchymal cell migration (GO:2000591)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of metanephric mesenchymal cell migration (GO:2000590)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
kidney interstitial fibroblast differentiation (GO:0072071)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
loop of Henle development (GO:0072070)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
lens placode formation (GO:0001743)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-substrate junction assembly (GO:0007044)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
lysosomal lumen acidification (GO:0007042)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
protein-RNA covalent cross-linking repair (GO:0160127)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric mesenchymal cell migration (GO:2000589)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000588)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
DCT cell differentiation (GO:0072069)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000584)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
morphogenesis of a polarized epithelium (GO:0001738)	55	0	.92	-	 < 0.01	1.00E00	1.00E00
establishment of planar polarity (GO:0001736)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
positive regulation of piRNA transcription (GO:0140543)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inner medullary collecting duct development (GO:0072061)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of piRNA transcription (GO:0140542)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
outer medullary collecting duct development (GO:0072060)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
piRNA transcription (GO:0140541)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein catabolic process in the vacuole (GO:0007039)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
formation of cytoplasmic translation initiation complex (GO:0001732)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
formation of translation preinitiation complex (GO:0001731)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
cytoskeletal rearrangement involved in phagocytosis, engulfment (GO:0060097)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic cytokinesis checkpoint signaling (GO:0044878)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
serotonin secretion, neurotransmission (GO:0060096)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vacuolar acidification (GO:0007035)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic transmission, glycinergic (GO:0060094)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic transmission, glycinergic (GO:0060092)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
peroxisome organization (GO:0007031)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
lipoprotein localization to membrane (GO:0044873)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipoprotein localization (GO:0044872)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation by host of viral glycoprotein metabolic process (GO:0044871)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral glycoprotein metabolic process (GO:0044870)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cortical collecting duct development (GO:0072059)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
renal cortex development (GO:0072055)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000572)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
renal outer medulla development (GO:0072054)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000571)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
renal inner medulla development (GO:0072053)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
juxtaglomerular apparatus development (GO:0072051)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
S-shaped body morphogenesis (GO:0072050)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cytoplasm organization (GO:0007028)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation by host of viral exo-alpha-sialidase activity (GO:0044869)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
relaxation of vascular associated smooth muscle (GO:0060087)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule depolymerization (GO:0007026)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral molecular function (GO:0044868)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
circadian temperature homeostasis (GO:0060086)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral catalytic activity (GO:0044867)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral exo-alpha-sialidase activity (GO:0044866)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic transmission involved in micturition (GO:0060084)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
post-chaperonin tubulin folding pathway (GO:0007023)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
smooth muscle contraction involved in micturition (GO:0060083)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
eye blink reflex (GO:0060082)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tubulin complex assembly (GO:0007021)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
modulation by host of symbiont transcription (GO:0052472)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane hyperpolarization (GO:0060081)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
microtubule nucleation (GO:0007020)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
protein transport into plasma membrane raft (GO:0044861)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to plasma membrane raft (GO:0044860)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of neurotrophin production (GO:0032899)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
neurotrophin production (GO:0032898)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of viral transcription (GO:0032897)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of memory T cell activation (GO:2000568)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of memory T cell activation (GO:2000567)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
type III interferon-mediated signaling pathway (GO:0038196)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
comma-shaped body morphogenesis (GO:0072049)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000566)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
urokinase plasminogen activator signaling pathway (GO:0038195)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
renal system pattern specification (GO:0072048)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000565)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
thyroid-stimulating hormone signaling pathway (GO:0038194)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proximal/distal pattern formation involved in nephron development (GO:0072047)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
establishment of planar polarity involved in nephron morphogenesis (GO:0072046)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
reciprocal homologous recombination (GO:0140527)	56	0	.93	-	 < 0.01	1.00E00	1.00E00
gastric inhibitory peptide signaling pathway (GO:0038192)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
collecting duct development (GO:0072044)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
conversion of seryl-tRNAsec to selenocys-tRNAsec (GO:0001717)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
VEGF-activated neuropilin signaling pathway (GO:0038190)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD24 production (GO:2000560)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endodermal cell fate specification (GO:0001714)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072040)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
microtubule depolymerization (GO:0007019)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
ectodermal cell fate commitment (GO:0001712)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
endodermal cell fate commitment (GO:0001711)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
mesodermal cell fate commitment (GO:0001710)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
actin ubiquitination (GO:0007014)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
plasma membrane raft localization (GO:0044856)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synapse maturation (GO:0060074)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
plasma membrane raft distribution (GO:0044855)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic spindle elongation (GO:0032888)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of spindle elongation (GO:0032887)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of polysaccharide biosynthetic process (GO:0032885)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
neuropilin signaling pathway (GO:0038189)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of CD24 production (GO:2000559)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cholecystokinin signaling pathway (GO:0038188)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of immunoglobulin production in mucosal tissue (GO:2000558)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of polysaccharide metabolic process (GO:0032881)	55	0	.92	-	 < 0.01	1.00E00	1.00E00
regulation of immunoglobulin production in mucosal tissue (GO:2000557)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072039)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 1 cell cytokine production (GO:2000556)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
nuclear receptor-mediated bile acid signaling pathway (GO:0038185)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchymal stem cell maintenance involved in nephron morphogenesis (GO:0072038)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating G protein-coupled bile acid receptor signaling pathway (GO:0038184)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 1 cell cytokine production (GO:2000554)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
bile acid signaling pathway (GO:0038183)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mesenchymal to epithelial transition involved in renal vesicle formation (GO:0072036)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 2 cell cytokine production (GO:2000553)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cell fate determination (GO:0001709)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 2 cell cytokine production (GO:2000552)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
renal vesicle induction (GO:0072034)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 2 cell cytokine production (GO:2000551)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
mesoderm formation (GO:0001707)	74	0	1.23	-	 < 0.01	6.38E-01	1.00E00
nerve growth factor signaling pathway (GO:0038180)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
endoderm formation (GO:0001706)	51	0	.85	-	 < 0.01	1.00E00	1.00E00
proximal convoluted tubule segment 2 development (GO:0072032)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ectoderm formation (GO:0001705)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
formation of primary germ layer (GO:0001704)	122	0	2.03	-	 < 0.01	2.75E-01	1.00E00
gastrulation with mouth forming second (GO:0001702)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
outer mitochondrial membrane organization (GO:0007008)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
vagina development (GO:0060068)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
inner mitochondrial membrane organization (GO:0007007)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
estrous cycle (GO:0044849)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
cervix development (GO:0060067)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
oviduct development (GO:0060066)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via telomerase (GO:0007004)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
Spemann organizer formation at the anterior end of the primitive streak (GO:0060064)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Spemann organizer formation (GO:0060061)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
nucleolus organization (GO:0007000)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
post-embryonic retina morphogenesis in camera-type eye (GO:0060060)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA endoreduplication (GO:0032877)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA endoreduplication (GO:0032876)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of DNA endoreduplication (GO:0032875)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of stress-activated MAPK cascade (GO:0032874)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of stress-activated MAPK cascade (GO:0032873)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell dendrite assembly (GO:2000549)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of stress-activated MAPK cascade (GO:0032872)	39	0	.65	-	 < 0.01	1.00E00	1.00E00
complement component C5a signaling pathway (GO:0038178)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic cell dendrite assembly (GO:2000548)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell dendrite assembly (GO:2000547)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000546)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000545)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
connecting tubule development (GO:0072027)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
granzyme-mediated programmed cell death signaling pathway (GO:0140507)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of gastrulation (GO:2000543)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
interleukin-33-mediated signaling pathway (GO:0038172)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
distal convoluted tubule development (GO:0072025)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cannabinoid signaling pathway (GO:0038171)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
macula densa development (GO:0072024)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein geranylgeranylation (GO:2000541)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
thick ascending limb development (GO:0072023)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
descending thin limb development (GO:0072022)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ascending thin limb development (GO:0072021)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
proximal straight tubule development (GO:0072020)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of reticulophagy (GO:0140501)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
embryonic retina morphogenesis in camera-type eye (GO:0060059)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of reticulophagy (GO:0140500)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ceramide 1-phosphate transport (GO:1902389)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic process involved in mammary gland involution (GO:0060058)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cell cycle G2/M phase transition (GO:0044839)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in mammary gland involution (GO:0060057)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cell quiescence (GO:0044838)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
actomyosin contractile ring organization (GO:0044837)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
angiogenesis involved in wound healing (GO:0060055)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein glycosylation (GO:0060051)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein glycosylation (GO:0060050)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of protein geranylgeranylation (GO:2000539)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell chemotaxis (GO:2000538)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of B cell chemotaxis (GO:2000537)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
proximal convoluted tubule development (GO:0072019)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of entry of bacterium into host cell (GO:2000536)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of entry of bacterium into host cell (GO:2000535)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
distal tubule development (GO:0072017)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of renal albumin absorption (GO:2000534)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
thrombopoietin-mediated signaling pathway (GO:0038163)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
glomerular parietal epithelial cell development (GO:0072016)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of renal albumin absorption (GO:2000533)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
erythropoietin-mediated signaling pathway (GO:0038162)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of renal albumin absorption (GO:2000532)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
prolactin signaling pathway (GO:0038161)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
proximal tubule development (GO:0072014)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
CXCL12-activated CXCR4 signaling pathway (GO:0038160)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
glomerulus vasculature development (GO:0072012)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
glomerular endothelium development (GO:0072011)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein glycosylation (GO:0060049)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation by host of viral genome replication (GO:0044829)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation by host of viral genome replication (GO:0044828)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of acrosome reaction (GO:0060046)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle cell proliferation (GO:0060045)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
regulation of rRNA catabolic process (GO:1902374)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of tRNA catabolic process (GO:1902372)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of tRNA catabolic process (GO:1902371)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of tRNA catabolic process (GO:1902370)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
meiotic telomere tethering at nuclear periphery (GO:0044821)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
C-X-C chemokine receptor CXCR4 signaling pathway (GO:0038159)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid dendritic cell chemotaxis (GO:2000529)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
granulocyte colony-stimulating factor signaling pathway (GO:0038158)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
granulocyte-macrophage colony-stimulating factor signaling pathway (GO:0038157)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid dendritic cell chemotaxis (GO:2000527)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-3-mediated signaling pathway (GO:0038156)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation (GO:2000526)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glomerular mesangial cell differentiation (GO:0072008)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell costimulation (GO:2000525)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mesangial cell differentiation (GO:0072007)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell costimulation (GO:2000524)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of T cell costimulation (GO:2000523)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of immunological synapse formation (GO:2000522)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
kidney field specification (GO:0072004)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of immunological synapse formation (GO:2000521)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney rudiment formation (GO:0072003)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of immunological synapse formation (GO:2000520)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
pericardium development (GO:0060039)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of Notch signaling pathway involved in somitogenesis (GO:1902367)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic G2/M transition checkpoint (GO:0044818)	59	0	.98	-	 < 0.01	6.29E-01	1.00E00
regulation of Notch signaling pathway involved in somitogenesis (GO:1902366)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
notochord cell development (GO:0060035)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to spindle pole body (GO:1902365)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
notochord cell differentiation (GO:0060034)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
anatomical structure regression (GO:0060033)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to spindle pole body (GO:1902363)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
notochord regression (GO:0060032)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
melanocyte apoptotic process (GO:1902362)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by host of symbiont catalytic activity (GO:0052422)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular pH reduction (GO:0032849)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular pH reduction (GO:0032848)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cellular pH reduction (GO:0032847)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 1 cell activation (GO:2000518)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 1 cell activation (GO:2000517)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of granzyme A production (GO:2000513)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of granzyme A production (GO:2000511)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell chemotaxis (GO:2000510)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in organogenesis (GO:0060029)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in axis elongation (GO:0060028)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
sulfate transmembrane transport (GO:1902358)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in gastrulation (GO:0060027)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
convergent extension (GO:0060026)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
oxaloacetate(2-) transmembrane transport (GO:1902356)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic activity (GO:0060025)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
G-quadruplex DNA unwinding (GO:0044806)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
soft palate development (GO:0060023)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleophagy (GO:0044804)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
phosphagen metabolic process (GO:0006599)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
polyamine catabolic process (GO:0006598)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
Bergmann glial cell differentiation (GO:0060020)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
cellular response to chloroquine (GO:1902350)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spermine biosynthetic process (GO:0006597)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
polyamine biosynthetic process (GO:0006596)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
polyamine metabolic process (GO:0006595)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
ornithine catabolic process (GO:0006593)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ornithine biosynthetic process (GO:0006592)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ornithine metabolic process (GO:0006591)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032834)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic cell chemotaxis (GO:2000509)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032832)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ERBB4-ERBB4 signaling pathway (GO:0038138)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell chemotaxis (GO:2000508)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
ERBB2-ERBB4 signaling pathway (GO:0038135)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
ERBB2-EGFR signaling pathway (GO:0038134)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood vessel remodeling (GO:2000504)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell chemotaxis (GO:2000503)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell chemotaxis (GO:2000502)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell chemotaxis (GO:2000501)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
ERBB4 signaling pathway (GO:0038130)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
astrocyte fate commitment (GO:0060018)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
parathyroid gland development (GO:0060017)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
granulosa cell differentiation (GO:0060014)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation by host of symbiont catalytic activity (GO:0052403)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, glycinergic (GO:0060012)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
Sertoli cell proliferation (GO:0060011)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
Sertoli cell fate commitment (GO:0060010)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromosome condensation (GO:1902340)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
serotonin biosynthetic process from tryptophan (GO:0006587)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
indolalkylamine metabolic process (GO:0006586)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
dopamine biosynthetic process from tyrosine (GO:0006585)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032829)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
melanin biosynthetic process from tyrosine (GO:0006583)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell differentiation involved in immune response (GO:0032827)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
melanin metabolic process (GO:0006582)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell differentiation involved in immune response (GO:0032826)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
acetylcholine catabolic process (GO:0006581)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ethanolamine metabolic process (GO:0006580)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell differentiation (GO:0032824)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
toll-like receptor TLR6:TLR2 signaling pathway (GO:0038124)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
toll-like receptor TLR1:TLR2 signaling pathway (GO:0038123)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Sertoli cell development (GO:0060009)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic process involved in morphogenesis (GO:1902339)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process involved in morphogenesis (GO:1902338)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
linear vestibuloocular reflex (GO:0060007)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process involved in morphogenesis (GO:1902337)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of retinal ganglion cell axon guidance (GO:1902336)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vestibular reflex (GO:0060005)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
copper ion export (GO:0060003)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine catabolic process (GO:0006579)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine biosynthetic process (GO:0006578)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine metabolic process (GO:0006577)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell proliferation (GO:0032819)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
valine catabolic process (GO:0006574)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
valine metabolic process (GO:0006573)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell proliferation (GO:0032817)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
tyrosine catabolic process (GO:0006572)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
tyrosine biosynthetic process (GO:0006571)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
tyrosine metabolic process (GO:0006570)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of epinephrine secretion (GO:0032812)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of epinephrine secretion (GO:0032811)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
chemokine (C-C motif) ligand 21 signaling pathway (GO:0038116)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
chemokine (C-C motif) ligand 19 signaling pathway (GO:0038115)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
interleukin-8-mediated signaling pathway (GO:0038112)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
interleukin-7-mediated signaling pathway (GO:0038111)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
otic vesicle development (GO:0071599)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
lymphocyte aggregation (GO:0071593)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
tryptophan catabolic process (GO:0006569)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
tryptophan metabolic process (GO:0006568)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
threonine catabolic process (GO:0006567)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
threonine metabolic process (GO:0006566)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
L-serine catabolic process (GO:0006565)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
L-serine biosynthetic process (GO:0006564)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
lacrimal gland development (GO:0032808)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
L-serine metabolic process (GO:0006563)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
proline catabolic process (GO:0006562)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
proline biosynthetic process (GO:0006561)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of low-density lipoprotein particle receptor catabolic process (GO:0032805)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
proline metabolic process (GO:0006560)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of low-density lipoprotein particle receptor catabolic process (GO:0032804)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
low-density lipoprotein particle receptor catabolic process (GO:0032802)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of appetite by leptin-mediated signaling pathway (GO:0038108)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
sequestering of nodal from receptor via nodal binding (GO:0038101)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation involved in nuclear cell cycle DNA replication (GO:1902319)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CAAX-box protein processing (GO:0071586)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
detoxification of cadmium ion (GO:0071585)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
nuclear DNA replication termination (GO:1902317)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of zinc ion transmembrane import (GO:0071584)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of zinc ion transmembrane transport (GO:0071583)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear cell cycle DNA replication initiation (GO:1902315)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of zinc ion transport (GO:0071582)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of zinc ion transmembrane import (GO:0071581)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of zinc ion transmembrane transport (GO:0071580)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
L-phenylalanine catabolic process (GO:0006559)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of copper ion transmembrane transport (GO:1902311)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-phenylalanine metabolic process (GO:0006558)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethionine biosynthetic process (GO:0006556)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
methionine metabolic process (GO:0006555)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
lysine catabolic process (GO:0006554)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
lysine metabolic process (GO:0006553)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
L-leucine catabolic process (GO:0006552)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
L-leucine metabolic process (GO:0006551)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
isoleucine catabolic process (GO:0006550)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
hepatocyte cell migration (GO:0002194)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
IRES-dependent translational initiation of linear mRNA (GO:0002192)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cap-dependent translational initiation (GO:0002191)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cap-independent translational initiation (GO:0002190)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of zinc ion transport (GO:0071579)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
zinc ion import across plasma membrane (GO:0071578)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
isoleucine metabolic process (GO:0006549)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
L-histidine catabolic process (GO:0006548)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
L-histidine metabolic process (GO:0006547)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
glycine catabolic process (GO:0006546)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
glycine biosynthetic process (GO:0006545)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
glycine metabolic process (GO:0006544)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
glutamine catabolic process (GO:0006543)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
glutamine biosynthetic process (GO:0006542)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glutamine metabolic process (GO:0006541)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyrate shunt (GO:0006540)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
translation reinitiation (GO:0002188)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translational termination (GO:0002184)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translational initiation (GO:0002183)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translational elongation (GO:0002182)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translation (GO:0002181)	131	0	2.18	-	 < 0.01	2.85E-01	1.00E00
protein ufmylation (GO:0071569)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
glutamate catabolic process (GO:0006538)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
glutamate biosynthetic process (GO:0006537)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of attachment of spindle microtubules to kinetochore (GO:0051988)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
glutamate metabolic process (GO:0006536)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
cysteine biosynthetic process from serine (GO:0006535)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of attachment of spindle microtubules to kinetochore (GO:0051986)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cysteine metabolic process (GO:0006534)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromosome segregation (GO:0051985)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
aspartate catabolic process (GO:0006533)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromosome segregation (GO:0051984)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
RNA acetylation (GO:1990884)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aspartate biosynthetic process (GO:0006532)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of chromosome segregation (GO:0051983)	135	0	2.25	-	 < 0.01	1.78E-01	1.00E00
rRNA acetylation (GO:1990882)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
asparagine catabolic process (GO:0006530)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
male germ cell proliferation (GO:0002176)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein localization to paranode region of axon (GO:0002175)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
death-inducing signaling complex assembly (GO:0071550)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
asparagine biosynthetic process (GO:0006529)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
asparagine metabolic process (GO:0006528)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process (GO:0006527)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to gastrin (GO:1990878)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lysophospholipid transport (GO:0051977)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
alanine catabolic process (GO:0006524)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
alanine metabolic process (GO:0006522)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of amino acid metabolic process (GO:0006521)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of transmission of nerve impulse (GO:0051970)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
desmosome maintenance (GO:0002160)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
inositol phosphate catabolic process (GO:0071545)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
diphosphoinositol polyphosphate catabolic process (GO:0071544)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
diphosphoinositol polyphosphate metabolic process (GO:0071543)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to chemokine (GO:1990869)	80	0	1.33	-	 < 0.01	6.46E-01	1.00E00
protein deglycosylation (GO:0006517)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
response to chemokine (GO:1990868)	80	0	1.33	-	 < 0.01	6.46E-01	1.00E00
response to gastrin (GO:1990867)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of synapse assembly (GO:0051964)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
response to growth hormone-releasing hormone (GO:1990864)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acinar cell proliferation (GO:1990863)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
osteoclast proliferation (GO:0002158)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of thyroid hormone receptor signaling pathway (GO:0002157)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of thyroid hormone receptor signaling pathway (GO:0002155)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
thyroid hormone receptor signaling pathway (GO:0002154)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
bile acid conjugation (GO:0002152)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
otolith mineralization (GO:0045299)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein localization to centrosome (GO:0071539)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
mRNA cis splicing, via spliceosome (GO:0045292)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of relaxation of cardiac muscle (GO:1901899)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of relaxation of cardiac muscle (GO:1901898)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to endothelin (GO:1990859)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
methotrexate transport (GO:0051958)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of relaxation of cardiac muscle (GO:1901897)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to lectin (GO:1990858)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901896)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901895)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901894)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
C-terminal protein lipidation (GO:0006501)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
hypochlorous acid biosynthetic process (GO:0002149)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N-terminal protein palmitoylation (GO:0006500)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051951)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
hypochlorous acid metabolic process (GO:0002148)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA wobble position uridine thiolation (GO:0002143)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cementum mineralization (GO:0071529)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
tRNA re-export from nucleus (GO:0071528)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell junction assembly (GO:1901889)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051946)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of catecholamine uptake involved in synaptic transmission (GO:0051945)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adaptive thermogenesis (GO:1990845)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of catecholamine uptake involved in synaptic transmission (GO:0051944)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of amino acid uptake involved in synaptic transmission (GO:0051943)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of amino acid uptake involved in synaptic transmission (GO:0051941)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
retinoic acid biosynthetic process (GO:0002138)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of catecholamine uptake involved in synaptic transmission (GO:0051940)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to lectin (GO:1990840)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
wobble position ribose methylation (GO:0002130)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid import (GO:0051939)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
L-glutamate import (GO:0051938)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion binding (GO:1901877)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
catecholamine transport (GO:0051937)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion binding (GO:1901876)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
glutamate reuptake (GO:0051935)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
catecholamine uptake involved in synaptic transmission (GO:0051934)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to odorant (GO:1990834)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
amino acid neurotransmitter reuptake (GO:0051933)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
slow axonal transport (GO:1990832)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA nucleoside ribose methylation (GO:0002128)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA wobble base cytosine methylation (GO:0002127)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maternal aggressive behavior (GO:0002125)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
territorial aggressive behavior (GO:0002124)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
inter-male aggressive behavior (GO:0002121)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to mycophenolic acid (GO:0071506)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to mycophenolic acid (GO:0071505)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
secretion of lysosomal enzymes (GO:0033299)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to temperature stimulus (GO:0071502)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to sterol depletion (GO:0071501)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular response to nitrosative stress (GO:0071500)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
hepatocyte dedifferentiation (GO:1990828)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T-tubule organization (GO:0033292)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
sulfation (GO:0051923)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle tissue development (GO:1901862)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
basic amino acid transmembrane transport (GO:1990822)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial DNA metabolic process (GO:1901860)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
aggressive behavior (GO:0002118)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
store-operated calcium entry (GO:0002115)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial DNA metabolic process (GO:1901859)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of fibrinolysis (GO:0051919)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial DNA metabolic process (GO:1901858)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibrinolysis (GO:0051918)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular respiration (GO:1901857)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
regulation of fibrinolysis (GO:0051917)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular respiration (GO:1901856)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
induction of synaptic plasticity by chemical substance (GO:0051915)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic plasticity by chemical substance (GO:0051914)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic plasticity by chemical substance (GO:0051913)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA wobble cytosine modification (GO:0002101)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA wobble adenosine to inosine editing (GO:0002100)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell proliferation in midbrain (GO:0033278)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
actin-myosin filament sliding (GO:0033275)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum tubular network membrane organization (GO:1990809)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901845)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of pigment granule localization (GO:0051905)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pigment granule transport (GO:0051904)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of high voltage-gated calcium channel activity (GO:1901843)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of high voltage-gated calcium channel activity (GO:1901842)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial depolarization (GO:0051902)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of high voltage-gated calcium channel activity (GO:1901841)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial depolarization (GO:0051901)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial depolarization (GO:0051900)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
protein palmitoleylation (GO:0045234)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA localization to nucleus (GO:0090685)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901837)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear cell cycle DNA replication (GO:0033262)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901835)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear DNA replication (GO:0033260)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901834)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD4 production (GO:0045225)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
calcium ion transmembrane transport via low voltage-gated calcium channel (GO:0090676)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intermicrovillar adhesion (GO:0090675)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD4 production (GO:0045223)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endothelial cell-matrix adhesion (GO:0090673)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of FasL production (GO:0045221)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
telomerase RNA localization (GO:0090672)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
telomerase RNA localization to Cajal body (GO:0090671)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA localization to Cajal body (GO:0090670)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
zeaxanthin biosynthetic process (GO:1901827)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
zeaxanthin catabolic process (GO:1901826)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
zeaxanthin metabolic process (GO:1901825)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
chordate pharynx development (GO:0160093)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
spliceosome-depend formation of circular RNA (GO:0160091)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of FasL production (GO:0045219)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
zonula adherens maintenance (GO:0045218)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
telomerase RNA stabilization (GO:0090669)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
scaRNA localization to Cajal body (GO:0090666)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
sarcomere organization (GO:0045214)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
galanin-activated signaling pathway (GO:0090663)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
FasL biosynthetic process (GO:0045210)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebrospinal fluid circulation (GO:0090660)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of amine catabolic process (GO:0033242)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of amine catabolic process (GO:0033241)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of amine metabolic process (GO:0033240)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
spermatid cytoplasm removal during spermiation of flagellated sperm (GO:0160087)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
beta-carotene metabolic process (GO:1901810)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
gastrin-induced gastric acid secretion (GO:0001698)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
histamine-induced gastric acid secretion (GO:0001697)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
gastric acid secretion (GO:0001696)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
telomeric loop disassembly (GO:0090657)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
histamine catabolic process (GO:0001695)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
t-circle formation (GO:0090656)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
histamine biosynthetic process (GO:0001694)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
histamine metabolic process (GO:0001692)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
establishment of neuroblast polarity (GO:0045200)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of amine metabolic process (GO:0033239)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to oxygen-glucose deprivation (GO:0090650)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein sumoylation (GO:0033234)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid droplet fusion (GO:0160078)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
beta-glucoside catabolic process (GO:1901805)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipid droplet fusion (GO:0160077)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
beta-glucoside metabolic process (GO:1901804)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of non-canonical inflammasome complex assembly (GO:0160076)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
non-canonical inflammasome complex assembly (GO:0160075)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic spindle assembly checkpoint signaling (GO:0140499)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to oxygen-glucose deprivation (GO:0090649)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
migracytosis (GO:0140495)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
response to environmental enrichment (GO:0090648)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty acid beta-oxidation (GO:0140493)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA processing (GO:0090646)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
tRNA 5'-leader removal (GO:0001682)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
tRNA 3'-terminal CCA addition (GO:0001680)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
surfactant secretion (GO:0160069)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
multi-pass transmembrane protein insertion into ER membrane (GO:0160063)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
5-aminolevulinic acid import across plasma membrane (GO:0140484)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
iron import into cell (GO:0033212)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
adiponectin-activated signaling pathway (GO:0033211)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
microfibril assembly (GO:0160054)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
siRNA-mediated gene silencing by mRNA destabilization (GO:0090625)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
conditioned taste aversion (GO:0001661)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
fever generation (GO:0001660)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
meiotic cytokinesis (GO:0033206)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
mitocytosis (GO:0160040)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
GCN2-mediated signaling (GO:0140469)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
HRI-mediated signaling (GO:0140468)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
integrated stress response signaling (GO:0140467)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
iron-sulfur cluster export from the mitochondrion (GO:0140466)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA clamp unloading (GO:0090618)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA 3'-end processing (GO:0090616)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pericentric heterochromatin organization (GO:0140462)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA processing (GO:0090615)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to Gram-negative bacterium (GO:0140460)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
trans-Golgi network to recycling endosome transport (GO:0044795)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation by host of viral process (GO:0044794)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation by host of viral process (GO:0044793)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
somatic sensory system development (GO:0160038)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to Gram-positive bacterium (GO:0140459)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-18-mediated signaling pathway (GO:2000494)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-18-mediated signaling pathway (GO:2000493)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-18-mediated signaling pathway (GO:2000492)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cytoplasm protein quality control (GO:0140455)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein aggregate center assembly (GO:0140454)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatic stellate cell activation (GO:2000490)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein targeting to Golgi apparatus (GO:0140450)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
enucleation (GO:0090601)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication (GO:0044786)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
metaphase/anaphase transition of meiotic cell cycle (GO:0044785)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metaphase/anaphase transition of cell cycle (GO:0044784)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
Leydig cell proliferation (GO:0160024)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
sneeze reflex (GO:0160023)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
maternal-to-zygotic transition of gene expression (GO:0160021)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of ferroptosis (GO:0160020)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamine transport (GO:2000487)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of glutamine transport (GO:2000486)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glutamine transport (GO:2000485)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cytokine precursor processing (GO:0140447)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of cAMP-dependent protein kinase activity (GO:2000481)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of cAMP-dependent protein kinase activity (GO:2000480)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
meiotic spindle checkpoint signaling (GO:0044779)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic DNA integrity checkpoint signaling (GO:0044778)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic cell cycle phase transition (GO:0044771)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of cAMP-dependent protein kinase activity (GO:2000479)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephric podocyte development (GO:2000478)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric podocyte development (GO:2000477)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of opioid receptor signaling pathway (GO:2000476)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of opioid receptor signaling pathway (GO:2000475)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein stearoylation (GO:0140438)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of opioid receptor signaling pathway (GO:2000474)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of hematopoietic stem cell migration (GO:2000473)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic stem cell migration (GO:2000471)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of peroxidase activity (GO:2000470)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
suppression of symbiont entry into host (GO:0052373)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
low-density lipoprotein receptor particle metabolic process (GO:0032799)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glutathione import into mitochondrion (GO:0160007)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Fc receptor-mediated immune complex endocytosis (GO:0160006)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
uropod organization (GO:0032796)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of CREB transcription factor activity (GO:0032792)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of peroxidase activity (GO:2000468)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway (GO:0038097)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycogen (starch) synthase activity (GO:2000467)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
ribosome disassembly (GO:0032790)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen (starch) synthase activity (GO:2000466)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Fc-epsilon receptor signaling pathway (GO:0038095)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of glycogen (starch) synthase activity (GO:2000465)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
Fc-gamma receptor signaling pathway (GO:0038094)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of astrocyte chemotaxis (GO:2000464)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Fc receptor signaling pathway (GO:0038093)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of excitatory postsynaptic potential (GO:2000463)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
nodal signaling pathway (GO:0038092)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to human chorionic gonadotropin (GO:0044752)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to human chorionic gonadotropin stimulus (GO:0044751)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
unsaturated monocarboxylic acid metabolic process (GO:0032789)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
saturated monocarboxylic acid metabolic process (GO:0032788)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
bile acid secretion (GO:0032782)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of astrocyte chemotaxis (GO:2000458)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ATP-dependent activity (GO:0032781)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATP-dependent activity (GO:0032780)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
VEGF-activated platelet-derived growth factor receptor signaling pathway (GO:0038086)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000454)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-tyrosine autophosphorylation (GO:0038083)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000452)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000451)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication maintenance of fidelity (GO:1902298)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation involved in cell cycle DNA replication (GO:1902296)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication termination (GO:1902294)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication initiation (GO:1902292)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein transmembrane import into intracellular organelle (GO:0044743)	39	0	.65	-	 < 0.01	1.00E00	1.00E00
positive regulation of tyrosinase activity (GO:0032773)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000449)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage migration inhibitory factor signaling pathway (GO:2000448)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tyrosinase activity (GO:0032771)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of monooxygenase activity (GO:0032770)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage migration inhibitory factor signaling pathway (GO:2000446)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of primary amine oxidase activity (GO:1902283)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of monooxygenase activity (GO:0032769)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of monooxygenase activity (GO:0032768)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell cytokine production (GO:0032765)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of monocyte extravasation (GO:2000438)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphotoxin A production (GO:0032761)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein neddylation (GO:2000436)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein neddylation (GO:2000435)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein neddylation (GO:2000434)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
non-canonical NF-kappaB signal transduction (GO:0038061)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
regulation of cytokinesis, actomyosin contractile ring assembly (GO:2000431)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nitric oxide-cGMP-mediated signaling (GO:0038060)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of pancreatic amylase secretion (GO:1902278)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of pancreatic amylase secretion (GO:1902277)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic amylase secretion (GO:1902276)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
epigenetic programing of male pronucleus (GO:0044727)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of chromatin organization (GO:1902275)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
epigenetic programing of female pronucleus (GO:0044726)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
epigenetic programming in the zygotic pronuclei (GO:0044725)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
(R)-carnitine transmembrane transport (GO:1902270)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix, substrate release (GO:0044721)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of TRAIL production (GO:0032759)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-5 production (GO:0032754)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil aggregation (GO:2000429)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-3 production (GO:0032752)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil aggregation (GO:2000428)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic cell clearance (GO:2000427)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic cell clearance (GO:2000426)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic cell clearance (GO:2000425)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of eosinophil chemotaxis (GO:2000424)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of eosinophil chemotaxis (GO:2000422)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of eosinophil extravasation (GO:2000420)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of polyamine transmembrane transport (GO:1902269)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of polyamine transmembrane transport (GO:1902268)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of polyamine transmembrane transport (GO:1902267)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in embryonic digit morphogenesis (GO:1902263)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in blood vessel morphogenesis (GO:1902262)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of delayed rectifier potassium channel activity (GO:1902261)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of delayed rectifier potassium channel activity (GO:1902260)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-23 production (GO:0032747)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-21 production (GO:0032745)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of eosinophil extravasation (GO:2000419)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of eosinophil migration (GO:2000418)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-18 production (GO:0032741)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of eosinophil migration (GO:2000417)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of eosinophil migration (GO:2000416)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of fibronectin-dependent thymocyte migration (GO:2000415)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
interleukin-5-mediated signaling pathway (GO:0038043)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of fibronectin-dependent thymocyte migration (GO:2000413)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of thymocyte migration (GO:2000412)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cross-receptor inhibition within G protein-coupled receptor heterodimer (GO:0038041)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of thymocyte migration (GO:2000410)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of delayed rectifier potassium channel activity (GO:1902259)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902257)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902256)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
phytoalexin metabolic process (GO:0052314)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N-terminal protein myristoylation (GO:0006499)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of erythrocyte apoptotic process (GO:1902251)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N-terminal protein lipidation (GO:0006498)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of erythrocyte apoptotic process (GO:1902250)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-16 production (GO:0032739)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-15 production (GO:0032738)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-13 production (GO:0032736)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
N-glycan processing (GO:0006491)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell extravasation (GO:2000409)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell extravasation (GO:2000408)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of T cell extravasation (GO:2000407)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-1 alpha production (GO:0032730)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
ligand-independent adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0038035)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell migration (GO:2000405)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
termination of G protein-coupled receptor signaling pathway (GO:0038032)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphocyte migration (GO:2000402)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
geranylgeranyl diphosphate catabolic process (GO:1902247)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dolichyl diphosphate biosynthetic process (GO:0006489)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interferon-alpha production (GO:0032727)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
protein demethylation (GO:0006482)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
C-terminal protein methylation (GO:0006481)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
N-terminal protein amino acid methylation (GO:0006480)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of fractalkine production (GO:0032724)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of connective tissue growth factor production (GO:0032723)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
apolipoprotein A-I-mediated signaling pathway (GO:0038027)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
reelin-mediated signaling pathway (GO:0038026)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
insulin receptor recycling (GO:0038020)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902239)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902238)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of positive thymic T cell selection (GO:1902233)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of positive thymic T cell selection (GO:1902232)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902231)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
peptidyl-tyrosine sulfation (GO:0006478)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein sulfation (GO:0006477)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
protein deacetylation (GO:0006476)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
internal protein amino acid acetylation (GO:0006475)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
N-terminal protein amino acid acetylation (GO:0006474)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
protein acetylation (GO:0006473)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-8 production (GO:0032717)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-5 production (GO:0032714)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-4 production (GO:0032713)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-3 production (GO:0032712)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Wnt receptor catabolic process (GO:0038018)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
insulin receptor internalization (GO:0038016)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to freezing (GO:0071497)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage colony-stimulating factor signaling pathway (GO:1902228)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage colony-stimulating factor signaling pathway (GO:1902227)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to UV-C (GO:0071494)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage colony-stimulating factor signaling pathway (GO:1902226)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of acrosome reaction (GO:1902225)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to UV-A (GO:0071492)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
ketone body metabolic process (GO:1902224)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
erythrose 4-phosphate/phosphoenolpyruvate family amino acid biosynthetic process (GO:1902223)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
signal peptide processing (GO:0006465)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
steroid hormone receptor complex assembly (GO:0006463)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-23 production (GO:0032707)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-2 production (GO:0032703)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of signal transduction by receptor internalization (GO:0038009)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-18 production (GO:0032701)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-17 production (GO:0032700)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
epidermal growth factor receptor ligand maturation (GO:0038004)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
G protein-coupled opioid receptor signaling pathway (GO:0038003)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
paracrine signaling (GO:0038001)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to red or far red light (GO:0071489)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902219)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to high light intensity (GO:0071486)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to absence of light (GO:0071485)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
erythrocyte apoptotic process (GO:1902217)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to light intensity (GO:0071484)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-4-mediated signaling pathway (GO:1902216)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-4-mediated signaling pathway (GO:1902215)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-4-mediated signaling pathway (GO:1902214)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to X-ray (GO:0071481)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of prolactin signaling pathway (GO:1902213)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of prolactin signaling pathway (GO:1902211)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
'de novo' protein folding (GO:0006458)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
positive regulation of serotonin secretion (GO:0014064)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of serotonin secretion (GO:0014063)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of norepinephrine secretion (GO:0014061)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
translational readthrough (GO:0006451)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of epinephrine secretion (GO:0014060)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of translational fidelity (GO:0006450)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
tRNA wobble uridine modification (GO:0002098)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
tRNA wobble base modification (GO:0002097)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
cellular hypotonic salinity response (GO:0071477)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular hypotonic response (GO:0071476)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
cellular hyperosmotic salinity response (GO:0071475)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular hyperosmotic response (GO:0071474)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-2-mediated signaling pathway (GO:1902206)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-2-mediated signaling pathway (GO:1902205)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to salt stress (GO:0071472)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatocyte growth factor receptor signaling pathway (GO:1902204)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to non-ionic osmotic stress (GO:0071471)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatocyte growth factor receptor signaling pathway (GO:1902203)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
C-terminal protein amino acid modification (GO:0018410)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
cellular response to osmotic stress (GO:0071470)	57	0	.95	-	 < 0.01	1.00E00	1.00E00
regulation of hepatocyte growth factor receptor signaling pathway (GO:1902202)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of acetylcholine secretion, neurotransmission (GO:0014058)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of acetylcholine secretion, neurotransmission (GO:0014057)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation by iron (GO:0006447)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051898)	68	0	1.13	-	 < 0.01	6.32E-01	1.00E00
pancreas regeneration (GO:1990798)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of gamma-aminobutyric acid secretion (GO:0014054)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of focal adhesion assembly (GO:0051895)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of focal adhesion assembly (GO:0051894)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
regulation of focal adhesion assembly (GO:0051893)	64	0	1.07	-	 < 0.01	6.30E-01	1.00E00
negative regulation of glutamate secretion (GO:0014050)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardioblast differentiation (GO:0051892)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to glial cell derived neurotrophic factor (GO:1990792)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardioblast differentiation (GO:0051891)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
dorsal root ganglion development (GO:1990791)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of cardioblast differentiation (GO:0051890)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to glial cell derived neurotrophic factor (GO:1990790)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of respiratory gaseous exchange by nervous system process (GO:0002087)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
diaphragm contraction (GO:0002086)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
inhibition of neuroepithelial cell differentiation (GO:0002085)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
protein depalmitoylation (GO:0002084)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative phosphorylation (GO:0002082)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
cellular response to acidic pH (GO:0071468)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
cellular response to hydrostatic pressure (GO:0071464)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to water stimulus (GO:0071462)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to redox state (GO:0071461)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-proline hydroxylation to 3-hydroxy-L-proline (GO:0018400)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to cell-matrix adhesion (GO:0071460)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
valyl-tRNA aminoacylation (GO:0006438)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tyrosyl-tRNA aminoacylation (GO:0006437)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dopamine secretion (GO:0014046)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
tryptophanyl-tRNA aminoacylation (GO:0006436)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of endothelial blood-brain barrier (GO:0014045)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hh target transcription factor activity (GO:1990787)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
threonyl-tRNA aminoacylation (GO:0006435)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of timing of anagen (GO:0051886)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to dsDNA (GO:1990786)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
seryl-tRNA aminoacylation (GO:0006434)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuron maturation (GO:0014043)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of timing of anagen (GO:0051885)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to water-immersion restraint stress (GO:1990785)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
prolyl-tRNA aminoacylation (GO:0006433)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of timing of anagen (GO:0051884)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to dsDNA (GO:1990784)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
phenylalanyl-tRNA aminoacylation (GO:0006432)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
methionyl-tRNA aminoacylation (GO:0006431)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Schwann cell differentiation (GO:0014040)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mitochondrial depolarization (GO:0051882)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
lysyl-tRNA aminoacylation (GO:0006430)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acrosome matrix dispersal (GO:0002077)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
osteoblast development (GO:0002076)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
extraocular skeletal muscle development (GO:0002074)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
optic cup morphogenesis involved in camera-type eye development (GO:0002072)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
glandular epithelial cell maturation (GO:0002071)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
protein localization to chromosome, centromeric region (GO:0071459)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
cellular response to hyperoxia (GO:0071455)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to anoxia (GO:0071454)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to superoxide (GO:0071451)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
cellular response to oxygen radical (GO:0071450)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
leucyl-tRNA aminoacylation (GO:0006429)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell differentiation (GO:0014038)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
isoleucyl-tRNA aminoacylation (GO:0006428)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
histidyl-tRNA aminoacylation (GO:0006427)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neural crest cell fate specification (GO:0014036)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral element assembly (GO:0051878)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glycyl-tRNA aminoacylation (GO:0006426)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glutaminyl-tRNA aminoacylation (GO:0006425)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neural crest cell fate commitment (GO:0014034)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
glutamyl-tRNA aminoacylation (GO:0006424)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pigment granule localization (GO:0051875)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
endothelin production (GO:1990775)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cysteinyl-tRNA aminoacylation (GO:0006423)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
aspartyl-tRNA aminoacylation (GO:0006422)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell development (GO:0014031)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
killing by host of symbiont cells (GO:0051873)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
asparaginyl-tRNA aminoacylation (GO:0006421)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell fate commitment (GO:0014030)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
columnar/cuboidal epithelial cell maturation (GO:0002069)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
arginyl-tRNA aminoacylation (GO:0006420)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
clathrin-dependent extracellular exosome endocytosis (GO:1990771)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glandular epithelial cell development (GO:0002068)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
cellular response to lipid hydroperoxide (GO:0071449)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to alkyl hydroperoxide (GO:0071448)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to hydroperoxide (GO:0071447)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cellular response to pheromone (GO:0071444)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neural crest formation (GO:0014029)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
alanyl-tRNA aminoacylation (GO:0006419)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA aminoacylation for protein translation (GO:0006418)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
general adaptation syndrome, behavioral process (GO:0051867)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
prostaglandin receptor internalization (GO:1990767)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
translational termination (GO:0006415)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
general adaptation syndrome (GO:0051866)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
translational initiation (GO:0006413)	78	0	1.30	-	 < 0.01	6.43E-01	1.00E00
neural plate elongation (GO:0014022)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
myofibroblast contraction (GO:1990764)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal cell proliferation (GO:0002053)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuroblast proliferation (GO:0002052)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
osteoblast fate commitment (GO:0002051)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
maintenance of epithelial cell apical/basal polarity (GO:0045199)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
establishment of epithelial cell apical/basal polarity (GO:0045198)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of neuroblast polarity (GO:0045196)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of isotype switching (GO:0045191)	39	0	.65	-	 < 0.01	1.00E00	1.00E00
isotype switching (GO:0045190)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
tRNA export from nucleus (GO:0006409)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of proteasomal protein catabolic process (GO:1901799)	57	0	.95	-	 < 0.01	1.00E00	1.00E00
snRNA export from nucleus (GO:0006408)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
neuroblast fate commitment (GO:0014017)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of signal transduction by p53 class mediator (GO:1901798)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
neuroblast differentiation (GO:0014016)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
mitotic sister chromatid biorientation (GO:1990758)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic spindle microtubule depolymerization (GO:1990755)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system axon regeneration (GO:0014012)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
Schwann cell proliferation (GO:0014010)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
tRNA modification (GO:0006400)	89	0	1.48	-	 < 0.01	4.09E-01	1.00E00
blood vessel endothelial cell migration involved in intussusceptive angiogenesis (GO:0002044)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
intussusceptive angiogenesis (GO:0002041)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
zonula adherens assembly (GO:0045186)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
malate transmembrane transport (GO:0071423)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
succinate transmembrane transport (GO:0071422)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of microglia differentiation (GO:0014008)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of microglia differentiation (GO:0014006)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
benzoyl-CoA metabolic process (GO:1901787)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
microglia development (GO:0014005)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
microglia differentiation (GO:0014004)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
astrocyte development (GO:0014002)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
protein sialylation (GO:1990743)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-glutamate import across plasma membrane (GO:0002038)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of L-glutamate import across plasma membrane (GO:0002037)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of L-glutamate import across plasma membrane (GO:0002036)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor internalization (GO:0002031)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
inhibitory G protein-coupled receptor phosphorylation (GO:0002030)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
apical protein localization (GO:0045176)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
basal protein localization (GO:0045175)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to purine-containing compound (GO:0071415)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
cellular response to hydroxyisoflavone (GO:0071413)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to genistein (GO:0071412)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
granulosa cell proliferation (GO:1990739)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cytolysis by host of symbiont cells (GO:0051838)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
response to manganese-induced endoplasmic reticulum stress (GO:1990737)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of synapse structural plasticity (GO:0051835)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
desensitization of G protein-coupled receptor signaling pathway (GO:0002029)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002025)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
diet induced thermogenesis (GO:0002024)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
reduction of food intake in response to dietary excess (GO:0002023)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
response to dietary excess (GO:0002021)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in cell fate commitment (GO:0045168)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
asymmetric protein localization involved in cell fate determination (GO:0045167)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to cycloheximide (GO:0071409)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
clustering of voltage-gated potassium channels (GO:0045163)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
clustering of voltage-gated sodium channels (GO:0045162)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
neuronal ion channel clustering (GO:0045161)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
cellular response to high density lipoprotein particle stimulus (GO:0071403)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to vitamin E (GO:0033197)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular response to triglyceride (GO:0071401)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to alkyl hydroperoxide (GO:0033195)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to hydroperoxide (GO:0033194)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of synapse structural plasticity (GO:0051823)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of blood volume by renal aldosterone (GO:0002017)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure (GO:0002014)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to vitamin A (GO:0033189)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
leukotriene A4 biosynthetic process (GO:1901753)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leukotriene A4 metabolic process (GO:1901751)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
leukotriene D4 biosynthetic process (GO:1901750)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
xylulose metabolic process (GO:0005997)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of hypoxic conditions in blood by chemoreceptor signaling (GO:0002007)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
trehalose catabolic process (GO:0005993)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trehalose metabolic process (GO:0005991)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lactose catabolic process (GO:0005990)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
male anatomical structure morphogenesis (GO:0090598)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
homologous chromosome segregation (GO:0045143)	76	0	1.27	-	 < 0.01	6.40E-01	1.00E00
meiotic telomere clustering (GO:0045141)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
DNA synthesis involved in DNA replication (GO:0090592)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leukotriene D4 catabolic process (GO:1901749)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
leukotriene D4 metabolic process (GO:1901748)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
presynaptic active zone organization (GO:1990709)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
calcineurin-NFAT signaling cascade (GO:0033173)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
conditioned place preference (GO:1990708)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cholangiocyte proliferation (GO:1990705)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
lactose biosynthetic process (GO:0005989)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lactose metabolic process (GO:0005988)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of myoblast fusion (GO:1901740)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
sucrose catabolic process (GO:0005987)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleolar chromatin organization (GO:1990700)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
sucrose metabolic process (GO:0005985)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
disaccharide metabolic process (GO:0005984)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of glycogen catabolic process (GO:0005981)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
glycogen catabolic process (GO:0005980)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
meiotic chromosome segregation (GO:0045132)	105	0	1.75	-	 < 0.01	4.26E-01	1.00E00
regulation of vitamin A metabolic process (GO:1901738)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
quercetin catabolic process (GO:1901733)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
quercetin metabolic process (GO:1901732)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glycogen biosynthetic process (GO:0005979)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet aggregation (GO:1901731)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
glycogen biosynthetic process (GO:0005978)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
cellular extravasation (GO:0045123)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
T cell receptor V(D)J recombination (GO:0033153)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
detection of oxidative stress (GO:0070994)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell proliferation involved in kidney development (GO:1901724)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in kidney development (GO:1901723)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in kidney development (GO:1901722)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
azole transmembrane transport (GO:0045117)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
protein neddylation (GO:0045116)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of integrin biosynthetic process (GO:0045113)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
integrin biosynthetic process (GO:0045112)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intermediate filament bundle assembly (GO:0045110)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
oxidative demethylation (GO:0070989)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
demethylation (GO:0070988)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
error-free translesion synthesis (GO:0070987)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
left/right axis specification (GO:0070986)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033140)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-asparagine metabolic process (GO:0070982)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
L-asparagine biosynthetic process (GO:0070981)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
biphenyl catabolic process (GO:0070980)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intermediate filament polymerization or depolymerization (GO:0045108)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intermediate filament polymerization (GO:0045107)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intermediate filament polymerization or depolymerization (GO:0045105)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein K11-linked ubiquitination (GO:0070979)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
bone maturation (GO:0070977)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucokinase activity (GO:0033132)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell differentiation involved in bone development (GO:1901706)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glucokinase activity (GO:0033131)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein localization to endoplasmic reticulum exit site (GO:0070973)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
protein localization to endoplasmic reticulum (GO:0070972)	75	0	1.25	-	 < 0.01	6.39E-01	1.00E00
detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception of sour taste (GO:0001581)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil mediated killing of fungus (GO:0070965)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070963)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA splicing (GO:0033120)	59	0	.98	-	 < 0.01	6.29E-01	1.00E00
positive regulation of neutrophil mediated killing of bacterium (GO:0070962)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil mediated killing of symbiont cell (GO:0070961)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil mediated cytotoxicity (GO:0070960)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty acid transport (GO:0001579)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
globoside biosynthetic process (GO:0001576)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
globoside metabolic process (GO:0001575)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lactosylceramide biosynthetic process (GO:0001572)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil mediated killing of fungus (GO:0070953)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070951)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil mediated killing of bacterium (GO:0070950)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
branching involved in blood vessel morphogenesis (GO:0001569)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
fatty acid alpha-oxidation (GO:0001561)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
vesicle tethering involved in exocytosis (GO:0090522)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of cell growth by extracellular stimulus (GO:0001560)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
podocyte cell migration (GO:0090521)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
sphingolipid mediated signaling pathway (GO:0090520)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil mediated killing of symbiont cell (GO:0070949)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
neutrophil-mediated killing of fungus (GO:0070947)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neutrophil-mediated killing of gram-positive bacterium (GO:0070946)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
neutrophil-mediated killing of gram-negative bacterium (GO:0070945)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
neutrophil-mediated killing of bacterium (GO:0070944)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
neutrophil-mediated killing of symbiont cell (GO:0070943)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
neutrophil mediated cytotoxicity (GO:0070942)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
antibacterial innate immune response (GO:0140367)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
oocyte maturation (GO:0001556)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
oocyte growth (GO:0001555)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
luteolysis (GO:0001554)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
luteinization (GO:0001553)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
ovarian follicle atresia (GO:0001552)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ovarian cumulus expansion (GO:0001550)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
tooth eruption (GO:0044691)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
3'-UTR-mediated mRNA stabilization (GO:0070935)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
CRD-mediated mRNA stabilization (GO:0070934)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of thymocyte aggregation (GO:2000399)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of thymocyte aggregation (GO:2000398)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin-dependent endocytosis (GO:2000397)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquitin-dependent endocytosis (GO:2000395)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lamellipodium morphogenesis (GO:2000394)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
heme export from vacuole to cytoplasm (GO:0140357)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of lamellipodium morphogenesis (GO:2000393)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cumulus cell differentiation (GO:0001549)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil extravasation (GO:2000391)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
antral ovarian follicle growth (GO:0001547)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
preantral ovarian follicle growth (GO:0001546)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lipid export from cell (GO:0140353)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
primary ovarian follicle growth (GO:0001545)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
initiation of primordial ovarian follicle growth (GO:0001544)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ovarian follicle rupture (GO:0001543)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ovulation from ovarian follicle (GO:0001542)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
ovarian follicle development (GO:0001541)	75	0	1.25	-	 < 0.01	6.39E-01	1.00E00
regulation of ATP:ADP antiporter activity (GO:0070926)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RISC complex assembly (GO:0070922)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of siRNA processing (GO:0070921)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil extravasation (GO:2000389)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of antral ovarian follicle growth (GO:2000388)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antral ovarian follicle growth (GO:2000387)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ovarian follicle development (GO:2000386)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of ectoderm development (GO:2000384)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ectoderm development (GO:2000383)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesoderm development (GO:2000382)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesoderm development (GO:2000381)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of mesoderm development (GO:2000380)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulatory ncRNA processing (GO:0070918)	57	0	.95	-	 < 0.01	1.00E00	1.00E00
UV-damage excision repair (GO:0070914)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxygen metabolic process (GO:2000376)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of oxygen metabolic process (GO:2000374)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of clathrin-dependent endocytosis (GO:2000370)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
aminophospholipid translocation (GO:0140331)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
retinoid metabolic process (GO:0001523)	76	0	1.27	-	 < 0.01	6.40E-01	1.00E00
pseudouridine synthesis (GO:0001522)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA pseudouridine synthesis (GO:0070902)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA methylation (GO:0070901)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-13 production (GO:0032696)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA modification (GO:0070900)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-12 production (GO:0032695)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-10 production (GO:0032693)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-1 production (GO:0032692)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
positive regulation of acrosomal vesicle exocytosis (GO:2000368)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-1 beta production (GO:0032691)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
regulation of acrosomal vesicle exocytosis (GO:2000367)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-1 alpha production (GO:0032690)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
lysophospholipid translocation (GO:0140329)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of prostaglandin-E synthase activity (GO:2000363)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptide amidation (GO:0001519)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of prostaglandin-E synthase activity (GO:2000361)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of binding of sperm to zona pellucida (GO:2000360)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
selenocysteine incorporation (GO:0001514)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
RNA methylation (GO:0001510)	68	0	1.13	-	 < 0.01	6.32E-01	1.00E00
adhesion of symbiont to host cell (GO:0044650)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of interferon-beta production (GO:0032688)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of interferon-alpha production (GO:0032687)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatocyte growth factor production (GO:0032686)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of granulocyte macrophage colony-stimulating factor production (GO:0032685)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of connective tissue growth factor production (GO:0032683)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of binding of sperm to zona pellucida (GO:2000359)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of kidney smooth muscle cell differentiation (GO:2000358)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of lymphotoxin A production (GO:0032681)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of kidney smooth muscle cell differentiation (GO:2000357)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of kidney smooth muscle cell differentiation (GO:2000356)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ovarian follicle development (GO:2000355)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ovarian follicle development (GO:2000354)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell apoptotic process (GO:2000353)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD40 signaling pathway (GO:2000350)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neurotransmitter uptake (GO:0001504)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
cartilage condensation (GO:0001502)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of TRAIL production (GO:0032679)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-5 production (GO:0032674)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD40 signaling pathway (GO:2000349)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-3 production (GO:0032672)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of CD40 signaling pathway (GO:2000348)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatocyte proliferation (GO:2000347)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatocyte proliferation (GO:2000346)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of acrosome reaction (GO:2000344)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000342)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000340)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
serine import into mitochondrion (GO:0140300)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine (GO:0018395)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine acetylation (GO:0018394)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
internal peptidyl-lysine acetylation (GO:0018393)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-23 production (GO:0032667)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-21 production (GO:0032665)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000338)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-18 production (GO:0032661)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood microparticle formation (GO:2000334)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of blood microparticle formation (GO:2000332)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of terminal button organization (GO:2000331)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 17 cell lineage commitment (GO:2000330)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor apoptotic signaling pathway (GO:1902178)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902177)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
positive regulation of keratinocyte apoptotic process (GO:1902174)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of keratinocyte apoptotic process (GO:1902173)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of keratinocyte apoptotic process (GO:1902172)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to reactive nitrogen species (GO:1902170)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-16 production (GO:0032659)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-15 production (GO:0032658)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-13 production (GO:0032656)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 17 cell lineage commitment (GO:2000329)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 17 cell lineage commitment (GO:2000328)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-1 alpha production (GO:0032650)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucocorticoid receptor signaling pathway (GO:2000324)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of glucocorticoid receptor signaling pathway (GO:2000322)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 17 cell differentiation (GO:2000321)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 17 cell differentiation (GO:2000320)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
protein myristoylation (GO:0018377)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902167)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902164)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of cyclic nucleotide-gated ion channel activity (GO:1902161)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of interferon-alpha production (GO:0032647)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of hepatocyte growth factor production (GO:0032646)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of fractalkine production (GO:0032644)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of connective tissue growth factor production (GO:0032643)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 17 cell differentiation (GO:2000319)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 17 type immune response (GO:2000317)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000314)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000313)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of kainate selective glutamate receptor activity (GO:2000312)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of AMPA receptor activity (GO:2000311)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of NMDA receptor activity (GO:2000310)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of cyclic nucleotide-gated ion channel activity (GO:1902159)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamine methylation (GO:0018364)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to DNA damage checkpoint signaling (GO:1902153)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA metabolic process (GO:0006399)	188	0	3.13	-	 < 0.01	8.05E-02	9.32E-01
regulation of response to DNA integrity checkpoint signaling (GO:1902151)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
protein deadenylylation (GO:0044602)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein denucleotidylation (GO:0044601)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
interleukin-9 production (GO:0032638)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
termination of mitochondrial transcription (GO:0006393)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-8 production (GO:0032637)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transcription elongation by mitochondrial RNA polymerase (GO:0006392)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
interleukin-5 production (GO:0032634)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
interleukin-4 production (GO:0032633)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000309)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-3 production (GO:0032632)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000308)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000307)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of ceramide biosynthetic process (GO:2000304)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of ceramide biosynthetic process (GO:2000303)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle exocytosis (GO:2000302)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of response to cell cycle checkpoint signaling (GO:1902145)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein-pyridoxal-5-phosphate linkage (GO:0018352)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration (GO:0099703)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
response to inositol (GO:1902140)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to host defenses (GO:0052200)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
termination of RNA polymerase III transcription (GO:0006386)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transcription initiation at RNA polymerase III promoter (GO:0006384)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
adenosine to inosine editing (GO:0006382)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
interleukin-21 production (GO:0032625)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
interleukin-18 production (GO:0032621)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-17 production (GO:0032620)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
Lewis x epitope biosynthetic process (GO:0106402)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein geranylgeranylation (GO:0018344)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
protein farnesylation (GO:0018343)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein prenylation (GO:0018342)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
interleukin-15 production (GO:0032618)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
interleukin-13 production (GO:0032616)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-12 production (GO:0032615)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
7-methylguanosine mRNA capping (GO:0006370)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
interleukin-10 production (GO:0032613)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
interleukin-1 production (GO:0032612)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
interleukin-1 beta production (GO:0032611)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
interleukin-1 alpha production (GO:0032610)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to cholesterol (GO:0071397)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
cellular response to jasmonic acid stimulus (GO:0071395)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to testosterone stimulus (GO:0071394)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cellular response to progesterone stimulus (GO:0071393)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to estrogen stimulus (GO:0071391)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
termination of RNA polymerase II transcription (GO:0006369)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
type II interferon production (GO:0032609)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
interferon-beta production (GO:0032608)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
interferon-alpha production (GO:0032607)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
type I interferon production (GO:0032606)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
granulocyte macrophage colony-stimulating factor production (GO:0032604)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
chemokine production (GO:0032602)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
cellular response to mineralocorticoid stimulus (GO:0071389)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular response to cortisol stimulus (GO:0071387)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to corticosterone stimulus (GO:0071386)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription by RNA polymerase III (GO:0006359)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of transcription by RNA polymerase I (GO:0006356)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
intracellular transport of virus (GO:0075733)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
viral penetration into host nucleus (GO:0075732)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902109)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to corticotropin-releasing hormone stimulus (GO:0071376)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to parathyroid hormone stimulus (GO:0071374)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cellular response to luteinizing hormone stimulus (GO:0071373)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to follicle-stimulating hormone stimulus (GO:0071372)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
positive regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902104)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to gonadotropin stimulus (GO:0071371)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation of hair follicle development (GO:0051799)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of hair follicle development (GO:0051798)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
DNA methylation-dependent constitutive heterochromatin formation (GO:0006346)	39	0	.65	-	 < 0.01	1.00E00	1.00E00
regulation of hair follicle development (GO:0051797)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
protein depalmitoleylation (GO:1990697)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of timing of catagen (GO:0051796)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of timing of catagen (GO:0051795)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of timing of catagen (GO:0051794)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty acid catabolic process (GO:0051793)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty acid biosynthetic process (GO:0051792)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty acid metabolic process (GO:0051791)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid biosynthetic process (GO:0051790)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to epidermal growth factor stimulus (GO:0071364)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
cellular response to ether (GO:0071362)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
nucleosome disassembly (GO:0006337)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
DNA replication-dependent chromatin assembly (GO:0006335)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclear division (GO:0051785)	69	0	1.15	-	 < 0.01	6.33E-01	1.00E00
negative regulation of nuclear division (GO:0051784)	55	0	.92	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear division (GO:0051783)	157	0	2.62	-	 < 0.01	1.19E-01	1.00E00
DNA double-strand break attachment to nuclear envelope (GO:1990683)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell division (GO:0051782)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
behavioral response to nutrient (GO:0051780)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to melanocyte-stimulating hormone (GO:1990680)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of integrated proviral latency (GO:0075713)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to type III interferon (GO:0071358)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-18 (GO:0071351)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
response to redox state (GO:0051775)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-11 (GO:0071348)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
diphosphate metabolic process (GO:0071344)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
skeletal muscle acetylcholine-gated channel clustering (GO:0071340)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
DNA transposition (GO:0006313)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic recombination (GO:0006312)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
meiotic gene conversion (GO:0006311)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of hair follicle cell proliferation (GO:0071338)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of hair follicle cell proliferation (GO:0071336)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
hair follicle cell proliferation (GO:0071335)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to fructose stimulus (GO:0071332)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA alkylation repair (GO:0006307)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
homologous chromosome movement towards spindle pole in meiosis I anaphase (GO:0051758)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cannabinoid biosynthetic process (GO:1901696)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA modification (GO:0006304)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
meiotic sister chromatid cohesion, centromeric (GO:0051754)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
sebum secreting cell proliferation (GO:1990654)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
postreplication repair (GO:0006301)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
cellular response to sucrose stimulus (GO:0071329)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to disaccharide stimulus (GO:0071324)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to cGMP (GO:0071321)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
glutathione derivative biosynthetic process (GO:1901687)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
glutathione derivative metabolic process (GO:1901685)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to prolactin (GO:1990646)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
arsenate ion transmembrane transport (GO:1901684)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to iron ion starvation (GO:1990641)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to isoquinoline alkaloid (GO:0071317)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of viral genome replication (GO:0045071)	63	0	1.05	-	 < 0.01	6.29E-01	1.00E00
cellular response to morphine (GO:0071315)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral genome replication (GO:0045070)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
cellular response to cocaine (GO:0071314)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cellular response to caffeine (GO:0071313)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular response to alkaloid (GO:0071312)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
iron coordination entity transport (GO:1901678)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
response to prolactin (GO:1990637)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
reproductive senescence (GO:1990636)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic spindle assembly (GO:1901673)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of superoxide dismutase activity (GO:1901671)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of viral genome replication (GO:0045069)	92	0	1.53	-	 < 0.01	4.11E-01	1.00E00
regulatory T cell differentiation (GO:0045066)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cytotoxic T cell differentiation (GO:0045065)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T-helper 2 cell differentiation (GO:0045064)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
T-helper 1 cell differentiation (GO:0045063)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin K (GO:0071307)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
extrathymic T cell selection (GO:0045062)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin E (GO:0071306)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin D (GO:0071305)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative thymic T cell selection (GO:0045060)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin B1 (GO:0071301)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
germline cell cycle switching, mitotic to meiotic cell cycle (GO:0051729)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of superoxide dismutase activity (GO:1901668)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cell cycle switching, mitotic to meiotic cell cycle (GO:0051728)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of immature T cell proliferation in thymus (GO:0033092)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of NAD+ ADP-ribosyltransferase activity (GO:1901666)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial inner membrane fusion (GO:1990627)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of immature T cell proliferation (GO:0033091)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein de-ADP-ribosylation (GO:0051725)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of NAD+ ADP-ribosyltransferase activity (GO:1901664)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
quinone biosynthetic process (GO:1901663)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
quinone catabolic process (GO:1901662)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
quinone metabolic process (GO:1901661)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
calcium ion export (GO:1901660)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
transcytosis (GO:0045056)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
constitutive secretory pathway (GO:0045054)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein retention in Golgi apparatus (GO:0045053)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of immature T cell proliferation in thymus (GO:0033088)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of immature T cell proliferation (GO:0033087)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell differentiation in thymus (GO:0033085)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of immature T cell proliferation in thymus (GO:0033084)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
glycosyl compound catabolic process (GO:1901658)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of immature T cell proliferation (GO:0033083)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
regulation of extrathymic T cell differentiation (GO:0033082)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glycoside transport (GO:1901656)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
immature T cell proliferation in thymus (GO:0033080)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cytolysis in another organism (GO:0051715)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of killing of cells of another organism (GO:0051712)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translational initiation in response to stress (GO:1990611)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein insertion into ER membrane (GO:0045048)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
protein targeting to ER (GO:0045047)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome membrane (GO:0045046)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
dopamine uptake (GO:0090494)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
catecholamine uptake (GO:0090493)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
protein import into mitochondrial intermembrane space (GO:0045041)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial outer membrane (GO:0045040)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
immature T cell proliferation (GO:0033079)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
extrathymic T cell differentiation (GO:0033078)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
isoquinoline alkaloid metabolic process (GO:0033076)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of synoviocyte proliferation (GO:1901647)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of synoviocyte proliferation (GO:1901645)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleoside transmembrane transport (GO:1901642)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
dark adaptation (GO:1990603)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial inner membrane (GO:0045039)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
purine nucleotide-sugar transmembrane transport (GO:0090480)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of presynaptic membrane organization (GO:1901631)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
G0 to G1 transition (GO:0045023)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
early endosome to late endosome transport (GO:0045022)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
dibasic protein processing (GO:0090472)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular pigmentation (GO:0033059)	57	0	.95	-	 < 0.01	1.00E00	1.00E00
directional locomotion (GO:0033058)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA wobble uridine modification (GO:0070899)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA polymerase III preinitiation complex assembly (GO:0070898)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of presynaptic membrane organization (GO:1901629)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of postsynaptic membrane organization (GO:1901628)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of postsynaptic membrane organization (GO:1901627)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic membrane organization (GO:1901626)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to ergosterol (GO:1901625)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphocyte chemotaxis (GO:1901624)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of lymphocyte chemotaxis (GO:1901623)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901621)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901620)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitric oxide biosynthetic process (GO:0045019)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
mitochondrial magnesium ion transmembrane transport (GO:0045016)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic sister chromatid segregation (GO:0033048)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic sister chromatid segregation (GO:0033047)	61	0	1.02	-	 < 0.01	6.29E-01	1.00E00
platelet alpha granule organization (GO:0070889)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of sister chromatid segregation (GO:0033046)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
regulation of sister chromatid segregation (GO:0033045)	108	0	1.80	-	 < 0.01	2.69E-01	1.00E00
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcineurin-NFAT signaling cascade (GO:0070885)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of calcineurin-NFAT signaling cascade (GO:0070884)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
regulation of proline transport (GO:0070881)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of vesicle transport along microtubule (GO:1901610)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
intracellular aspartate homeostasis (GO:0090459)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA deamination (GO:0045006)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
DNA-templated DNA replication maintenance of fidelity (GO:0045005)	54	0	.90	-	 < 0.01	1.00E00	1.00E00
DNA replication proofreading (GO:0045004)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via synthesis-dependent strand annealing (GO:0045003)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via single-strand annealing (GO:0045002)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
polysaccharide localization (GO:0033037)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vesicle transport along microtubule (GO:1901609)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle transport along microtubule (GO:1901608)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycogen metabolic process (GO:0070875)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen metabolic process (GO:0070874)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
alpha-amino acid catabolic process (GO:1901606)	90	0	1.50	-	 < 0.01	4.09E-01	1.00E00
regulation of glycogen metabolic process (GO:0070873)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
endocytic iron import into cell (GO:0140298)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamate ADP-deribosylation (GO:0140291)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine ADP-deribosylation (GO:0140290)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myeloid cell apoptotic process (GO:0033028)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell apoptotic process (GO:0033027)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell apoptotic process (GO:0033026)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell apoptotic process (GO:0033025)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
mast cell apoptotic process (GO:0033024)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mast cell homeostasis (GO:0033023)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein exit from endoplasmic reticulum (GO:0070863)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein exit from endoplasmic reticulum (GO:0070862)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of protein exit from endoplasmic reticulum (GO:0070861)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
endosome fission (GO:0140285)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of bile acid biosynthetic process (GO:0070859)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of bile acid biosynthetic process (GO:0070858)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
tetrapyrrole catabolic process (GO:0033015)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of bile acid biosynthetic process (GO:0070857)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
tetrapyrrole biosynthetic process (GO:0033014)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
tetrapyrrole metabolic process (GO:0033013)	51	0	.85	-	 < 0.01	1.00E00	1.00E00
repair of kinetochore microtubule attachment defect (GO:0140274)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of meiosis (GO:0090427)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
repair of mitotic kinetochore microtubule attachment defect (GO:0140273)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
acinar cell differentiation (GO:0090425)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
hexose import across plasma membrane (GO:0140271)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell activation involved in immune response (GO:0033008)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell activation involved in immune response (GO:0033007)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to epidermal growth factor (GO:0070849)	53	0	.88	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell activation involved in immune response (GO:0033006)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell activation (GO:0033005)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
Hsp90 deacetylation (GO:0070846)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
polyubiquitinated misfolded protein transport (GO:0070845)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
polyubiquitinated protein transport (GO:0070844)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
misfolded protein transport (GO:0070843)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aggresome assembly (GO:0070842)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
inclusion body assembly (GO:0070841)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
doxorubicin metabolic process (GO:0044598)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
daunorubicin metabolic process (GO:0044597)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
malonate catabolic process (GO:0090410)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dehydroascorbic acid transport (GO:0070837)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
caveola assembly (GO:0070836)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
basement membrane assembly (GO:0070831)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
bicellular tight junction assembly (GO:0070830)	68	0	1.13	-	 < 0.01	6.32E-01	1.00E00
negative regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000299)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000298)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of synapse maturation (GO:2000297)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide catabolic process (GO:2000296)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide catabolic process (GO:2000295)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of defecation (GO:2000293)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of defecation (GO:2000292)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of myoblast proliferation (GO:2000291)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of myotome development (GO:2000290)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation protein catabolic process at presynapse (GO:0140251)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
oxidative stress-induced premature senescence (GO:0090403)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
stress-induced premature senescence (GO:0090400)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
heterochromatin organization (GO:0070828)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
butyryl-CoA catabolic process (GO:0044580)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of myoblast proliferation (GO:2000288)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of myotome development (GO:2000287)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein catabolic process at postsynapse (GO:0140249)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of amino acid biosynthetic process (GO:2000284)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein catabolic process at presynapse (GO:0140247)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of amino acid biosynthetic process (GO:2000283)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein catabolic process at synapse (GO:0140246)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of amino acid biosynthetic process (GO:2000282)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system neuron axonogenesis (GO:0048936)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
translation at postsynapse (GO:0140242)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
translation at synapse (GO:0140241)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
[4Fe-4S] cluster assembly (GO:0044572)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
[2Fe-2S] cluster assembly (GO:0044571)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
hydrogen sulfide biosynthetic process (GO:0070814)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
hydrogen sulfide metabolic process (GO:0070813)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA biosynthetic process (GO:2000279)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidative phosphorylation uncoupler activity (GO:2000277)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative phosphorylation uncoupler activity (GO:2000276)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
postsynaptic endocytosis (GO:0140239)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative phosphorylation uncoupler activity (GO:2000275)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dIMP salvage (GO:0106385)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dGMP salvage (GO:0106384)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of signaling receptor activity (GO:2000273)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
dAMP salvage (GO:0106383)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
translation at presynapse (GO:0140236)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
negative regulation of signaling receptor activity (GO:2000272)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
RNA polyadenylation at postsynapse (GO:0140235)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of fibroblast apoptotic process (GO:2000271)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleotide salvage (GO:0106381)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast apoptotic process (GO:2000270)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
lateral line system development (GO:0048925)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
purine ribonucleotide salvage (GO:0106380)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
posterior lateral line neuromast hair cell differentiation (GO:0048923)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
anterograde axonal transport of neurotransmitter receptor complex (GO:0140231)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dendritic cell proliferation (GO:0044565)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to defenses of other organism (GO:0052173)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of fibroblast apoptotic process (GO:2000269)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
posterior lateral line neuromast development (GO:0048919)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
serotonin-gated cation-selective signaling pathway (GO:0140227)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
posterior lateral line development (GO:0048916)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
posterior lateral line system development (GO:0048915)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
relaxation of smooth muscle (GO:0044557)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
secondary metabolite biosynthetic process (GO:0044550)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
ER-dependent peroxisome organization (GO:0032581)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein activation cascade (GO:2000257)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of male germ cell proliferation (GO:2000256)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of male germ cell proliferation (GO:2000255)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of male germ cell proliferation (GO:2000254)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of feeding behavior (GO:2000253)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of long-chain fatty acid import into cell (GO:0140214)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of long-chain fatty acid import into cell (GO:0140213)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of long-chain fatty acid import into cell (GO:0140212)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	95	0	1.58	-	 < 0.01	4.13E-01	1.00E00
NLRP3 inflammasome complex assembly (GO:0044546)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of flagellated sperm motility (GO:1902093)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
response to vitamin K (GO:0032571)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
response to progesterone (GO:0032570)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
apoptotic process in response to mitochondrial fragmentation (GO:0140208)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA surveillance (GO:0106354)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
tripeptide import across plasma membrane (GO:0140207)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of reproductive process (GO:2000243)	111	0	1.85	-	 < 0.01	2.69E-01	1.00E00
dipeptide import across plasma membrane (GO:0140206)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of reproductive process (GO:2000242)	86	0	1.43	-	 < 0.01	4.08E-01	1.00E00
oligopeptide import across plasma membrane (GO:0140205)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid import into cell (GO:0044539)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, plasma membrane to endosome (GO:0099646)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein-FAD linkage (GO:0018293)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of circulating fibrinogen levels (GO:0044537)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
retrograde axonal protein transport (GO:0099642)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion import into sarcoplasmic reticulum (GO:1902082)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion import into sarcoplasmic reticulum (GO:1902081)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion import into sarcoplasmic reticulum (GO:1902080)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
snRNA methylation (GO:0106349)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tRNA processing (GO:2000235)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of rRNA processing (GO:2000233)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
omega-hydroxyceramide biosynthetic process (GO:0106342)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of pancreatic stellate cell proliferation (GO:2000231)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of pancreatic stellate cell proliferation (GO:2000230)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
endosome to plasma membrane protein transport (GO:0099638)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of lateral motor column neuron migration (GO:1902078)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial mRNA stability (GO:0044528)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of lateral motor column neuron migration (GO:1902076)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
iron incorporation into metallo-sulfur cluster (GO:0018283)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to salt (GO:1902075)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
metal incorporation into metallo-sulfur cluster (GO:0018282)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to salt (GO:1902074)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902073)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein sulfhydration (GO:0044524)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902072)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902071)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
postsynaptic neurotransmitter receptor cycle (GO:0099630)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of sphingolipid mediated signaling pathway (GO:1902070)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic stellate cell proliferation (GO:2000229)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of pancreatic A cell differentiation (GO:2000227)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic A cell differentiation (GO:2000226)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of testosterone biosynthetic process (GO:2000225)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of testosterone biosynthetic process (GO:2000224)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
protein deamination (GO:0018277)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of sphingolipid mediated signaling pathway (GO:1902068)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor cycle (GO:0099627)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ventricular cardiac muscle cell membrane repolarization (GO:0099625)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
response to L-glutamate (GO:1902065)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine (GO:0018272)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell membrane repolarization (GO:0099624)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell membrane repolarization (GO:0099623)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell membrane repolarization (GO:0099622)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
mitochondrial translation (GO:0032543)	107	0	1.78	-	 < 0.01	4.29E-01	1.00E00
positive regulation of glutamate metabolic process (GO:2000213)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of glutamate metabolic process (GO:2000212)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate metabolic process (GO:2000211)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of anoikis (GO:2000210)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein localization to axon (GO:0099612)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of action potential firing threshold (GO:0099611)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mismatch repair (GO:0006298)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
symbiont-mediated disruption of host anatomical structure (GO:0052111)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA gap filling (GO:0006297)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, preincision complex assembly (GO:0006294)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell projection size (GO:0032536)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
pyrimidine dimer repair (GO:0006290)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of anoikis (GO:2000209)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of microvillus length (GO:0032532)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of ribosomal small subunit export from nucleus (GO:2000208)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ribosomal small subunit export from nucleus (GO:2000206)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ribosomal large subunit export from nucleus (GO:2000204)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ribosomal large subunit export from nucleus (GO:2000203)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of ribosomal subunit export from nucleus (GO:2000202)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ribosomal subunit export from nucleus (GO:2000201)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ribosomal subunit export from nucleus (GO:2000200)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of action potential firing pattern (GO:0099608)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lateral attachment of mitotic spindle microtubules to kinetochore (GO:0099607)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
polyamine transmembrane transport (GO:1902047)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
microtubule plus-end directed mitotic chromosome migration (GO:0099606)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of action potential firing rate (GO:0099605)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of Fas signaling pathway (GO:1902045)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Fas signaling pathway (GO:1902044)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)	50	0	.83	-	 < 0.01	1.00E00	1.00E00
base-excision repair, DNA ligation (GO:0006288)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
base-excision repair, gap-filling (GO:0006287)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
base-excision repair, AP site formation (GO:0006285)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein exit from endoplasmic reticulum (GO:0032527)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
somite rostral/caudal axis specification (GO:0032525)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
protein-DNA covalent cross-linking repair (GO:0106300)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of hematopoietic stem cell differentiation (GO:1902038)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of hematopoietic stem cell differentiation (GO:1902037)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic stem cell differentiation (GO:1902036)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of hematopoietic stem cell proliferation (GO:1902035)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of hematopoietic stem cell proliferation (GO:1902034)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic stem cell proliferation (GO:1902033)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
premeiotic DNA replication (GO:0006279)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of NADP metabolic process (GO:1902031)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
RNA-templated DNA biosynthetic process (GO:0006278)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
DNA replication termination (GO:0006274)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lagging strand elongation (GO:0006273)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
leading strand elongation (GO:0006272)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation involved in DNA replication (GO:0006271)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
DNA replication initiation (GO:0006270)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
cellular response to L-ascorbic acid (GO:0071298)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin (GO:0071295)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
cellular response to zinc ion (GO:0071294)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
rRNA 5'-end processing (GO:0000967)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nitrate import (GO:1902025)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
RNA 5'-end processing (GO:0000966)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
L-histidine transport (GO:1902024)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA 3'-end processing (GO:0000965)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA 5'-end processing (GO:0000964)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
L-lysine transport (GO:1902022)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA processing (GO:0000963)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial RNA catabolic process (GO:0000962)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA unwinding involved in DNA replication (GO:0006268)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of cilium-dependent cell motility (GO:1902020)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial RNA catabolic process (GO:0000961)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial RNA catabolic process (GO:0000960)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA topological change (GO:0006265)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
endosome transport via multivesicular body sorting pathway (GO:0032509)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
mitochondrial DNA replication (GO:0006264)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
cytokinetic process (GO:0032506)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
cellular response to mercury ion (GO:0071288)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to magnesium ion (GO:0071286)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to lithium ion (GO:0071285)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA catabolic process (GO:0000958)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to lead ion (GO:0071284)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA catabolic process (GO:0000957)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to iron(III) ion (GO:0071283)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to iron(II) ion (GO:0071282)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to iron ion (GO:0071281)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cellular response to copper ion (GO:0071280)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
UDP-alpha-D-glucose catabolic process (GO:0006258)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of translation in response to endoplasmic reticulum stress (GO:1902010)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
UDP catabolic process (GO:0006256)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
CTP catabolic process (GO:0006254)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dCTP catabolic process (GO:0006253)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to cobalt ion (GO:0071279)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-aspartic acid phosphorylation (GO:0018217)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine methylation (GO:0018216)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to cadmium ion (GO:0071276)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
cellular response to aluminum ion (GO:0071275)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dCMP catabolic process (GO:0006249)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
fatty acid transmembrane transport (GO:1902001)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
CMP catabolic process (GO:0006248)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
homogentisate catabolic process (GO:1902000)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein delipidation (GO:0051697)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide catabolic process (GO:0006244)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
actin filament uncapping (GO:0051695)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pointed-end actin filament capping (GO:0051694)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
actin filament capping (GO:0051693)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
CTP biosynthetic process (GO:0006241)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
protein K69-linked ufmylation (GO:1990592)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
dCDP biosynthetic process (GO:0006240)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-proline modification (GO:0018208)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
L-methionine salvage (GO:0071267)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
peptidyl-methionine modification (GO:0018206)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
'de novo' L-methionine biosynthetic process (GO:0071266)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-methionine biosynthetic process (GO:0071265)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation in response to starvation (GO:0071264)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-histidine modification (GO:0018202)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation in response to starvation (GO:0071262)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-glycine modification (GO:0018201)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
dTTP biosynthetic process (GO:0006235)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
establishment of ER localization (GO:0051686)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of ER location (GO:0051685)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dTDP biosynthetic process (GO:0006233)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of Golgi location (GO:0051684)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of Golgi localization (GO:0051683)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
dTMP biosynthetic process (GO:0006231)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to magnetism (GO:0071259)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to gravity (GO:0071258)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to electrical stimulus (GO:0071257)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
UTP biosynthetic process (GO:0006228)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine trans-autophosphorylation (GO:1990579)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dUDP biosynthetic process (GO:0006227)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
dUMP biosynthetic process (GO:0006226)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP biosynthetic process (GO:0006225)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial L-ornithine transmembrane transport (GO:1990575)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
localization of cell (GO:0051674)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
UMP biosynthetic process (GO:0006222)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
disruption of plasma membrane integrity in another organism (GO:0051673)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide biosynthetic process (GO:0006221)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide metabolic process (GO:0006220)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
GDP-mannose transmembrane transport (GO:1990570)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to chromate (GO:0071247)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to arsenic-containing substance (GO:0071243)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
actomyosin contractile ring assembly (GO:0000915)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to food (GO:0071240)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
uridine catabolic process (GO:0006218)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP-N-acetylglucosamine transmembrane transport (GO:1990569)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cytidine catabolic process (GO:0006216)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
actin cortical patch localization (GO:0051666)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
thymidine catabolic process (GO:0006214)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane raft localization (GO:0051665)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside metabolic process (GO:0006213)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
nuclear pore localization (GO:0051664)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein polyufmylation (GO:1990564)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
uracil catabolic process (GO:0006212)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
thymine catabolic process (GO:0006210)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of centrosome location (GO:0051661)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
establishment of centrosome localization (GO:0051660)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cellular response to antibiotic (GO:0071236)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to alcohol (GO:1905957)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial tube morphogenesis (GO:1905956)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to folic acid (GO:0071231)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase catabolic process (GO:0006208)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of mitochondrion location (GO:0051659)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial coenzyme A transmembrane transport (GO:1990559)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
maintenance of nucleus location (GO:0051658)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase metabolic process (GO:0006206)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
maintenance of organelle location (GO:0051657)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
IMP catabolic process (GO:0006204)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
response to capsazepine (GO:1901594)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dGTP catabolic process (GO:0006203)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of mitochondrion localization (GO:0051654)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
GMP catabolic process to guanine (GO:0006202)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial alpha-ketoglutarate transmembrane transport (GO:1990550)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to tumor cell (GO:0071228)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion import across plasma membrane (GO:1905949)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to molecule of fungal origin (GO:0071226)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to muramyl dipeptide (GO:0071225)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cellular response to peptidoglycan (GO:0071224)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of response to calcium ion (GO:1905945)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to bacterial lipopeptide (GO:0071221)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to bacterial lipoprotein (GO:0071220)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of gonad development (GO:1905941)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of gonad development (GO:1905940)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial NAD transmembrane transport (GO:1990549)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial FAD transmembrane transport (GO:1990548)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial phosphate ion transmembrane transport (GO:1990547)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrion localization (GO:0051646)	58	0	.97	-	 < 0.01	1.00E00	1.00E00
mitochondrial tricarboxylic acid transmembrane transport (GO:1990546)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Golgi localization (GO:0051645)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
mitochondrial ATP transmembrane transport (GO:1990544)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
mitochondrial S-adenosyl-L-methionine transmembrane transport (GO:1990543)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
centrosome localization (GO:0051642)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
mitochondrial transmembrane transport (GO:1990542)	102	0	1.70	-	 < 0.01	4.21E-01	1.00E00
mitochondrial manganese ion transmembrane transport (GO:1990540)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of gonad development (GO:1905939)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
cellular response to external biotic stimulus (GO:0071217)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of germ cell proliferation (GO:1905938)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of germ cell proliferation (GO:1905937)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of germ cell proliferation (GO:1905936)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell fate determination (GO:1905934)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell fate determination (GO:1905933)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein targeting to vacuole involved in autophagy (GO:0071211)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905932)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905931)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905930)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
fructose import across plasma membrane (GO:1990539)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
barbed-end actin filament uncapping (GO:0051638)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neuron projection maintenance (GO:1990535)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative transport (GO:1901571)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of acetylcholine uptake (GO:0051631)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative biosynthetic process (GO:1901570)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
acetylcholine uptake (GO:0051630)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to juxtaparanode region of axon (GO:0071206)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to juxtaparanode region of axon (GO:0071205)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of acetylcholine biosynthetic process (GO:1905923)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of acetylcholine biosynthetic process (GO:1905921)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative catabolic process (GO:1901569)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative metabolic process (GO:1901568)	53	0	.88	-	 < 0.01	1.00E00	1.00E00
epinephrine uptake (GO:0051625)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to camptothecin (GO:1901563)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
bone regeneration (GO:1990523)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of norepinephrine uptake (GO:0051622)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of norepinephrine uptake (GO:0051621)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
norepinephrine uptake (GO:0051620)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell differentiation involved in phenotypic switching (GO:1905917)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell differentiation involved in phenotypic switching (GO:1905916)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell differentiation involved in phenotypic switching (GO:1905915)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion export across plasma membrane (GO:1905913)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion export across plasma membrane (GO:1905912)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to metformin (GO:1901558)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide import into mitochondrion (GO:1990519)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to fenofibrate (GO:1901557)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
histamine uptake (GO:0051615)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell development (GO:1901552)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of serotonin uptake (GO:0051612)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelial cell development (GO:1901551)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of serotonin uptake (GO:0051611)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell development (GO:1901550)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
serotonin uptake (GO:0051610)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
replicative senescence (GO:0090399)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of amyloid fibril formation (GO:1905908)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid fibril formation (GO:1905907)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of amyloid fibril formation (GO:1905906)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
histamine transport (GO:0051608)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle lumen acidification (GO:1901546)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to raffinose (GO:1901545)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic DNA-templated DNA replication (GO:1990506)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication maintenance of fidelity (GO:1990505)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to electrical stimulus (GO:0051602)	53	0	.88	-	 < 0.01	1.00E00	1.00E00
dense core granule maturation (GO:1990502)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
exocyst localization (GO:0051601)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
phagosome-lysosome fusion involved in apoptotic cell clearance (GO:0090389)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phagolysosome assembly involved in apoptotic cell clearance (GO:0090387)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phagosome maturation involved in apoptotic cell clearance (GO:0090386)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phagosome-lysosome fusion (GO:0090385)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
phagosome-lysosome docking (GO:0090384)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phagosome acidification (GO:0090383)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
phagosome maturation (GO:0090382)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
positive regulation of hematopoietic progenitor cell differentiation (GO:1901534)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of hematopoietic progenitor cell differentiation (GO:1901533)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic progenitor cell differentiation (GO:1901532)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
oligopeptide export from mitochondrion (GO:0090374)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol efflux (GO:0090370)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of anion channel activity (GO:1901529)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitophagy (GO:1901526)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitophagy (GO:1901525)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of mitophagy (GO:1901524)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
icosanoid catabolic process (GO:1901523)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of ornithine metabolic process (GO:0090368)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA modification (GO:0090367)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA modification (GO:0090366)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA modification (GO:0090365)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of proteasome assembly (GO:0090364)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet-derived growth factor production (GO:0090362)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor production (GO:0090361)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine exposure on apoptotic cell surface (GO:0070782)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
response to biotin (GO:0070781)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
efferent axon development in a lateral line nerve (GO:0048894)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lateral line nerve development (GO:0048892)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-aspartate import across plasma membrane (GO:0070779)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
L-aspartate transmembrane transport (GO:0070778)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
D-aspartate transmembrane transport (GO:0070777)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial tube morphogenesis (GO:1901509)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of acylglycerol transport (GO:1901508)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of acylglycerol transport (GO:1901506)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ether biosynthetic process (GO:1901503)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
ether catabolic process (GO:1901502)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neuromast hair cell differentiation (GO:0048886)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neuromast development (GO:0048884)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
organofluorine metabolic process (GO:0090346)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
organohalogen metabolic process (GO:0090345)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
lateral line development (GO:0048882)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mechanosensory lateral line system development (GO:0048881)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of secretion of lysosomal enzymes (GO:0090341)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of secretion of lysosomal enzymes (GO:0090340)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
homeostasis of number of retina cells (GO:0048877)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
host-mediated regulation of intestinal microbiota composition (GO:0048874)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of brown fat cell differentiation (GO:0090336)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
homeostasis of number of cells within a tissue (GO:0048873)	53	0	.88	-	 < 0.01	1.00E00	1.00E00
regulation of brown fat cell differentiation (GO:0090335)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-templated DNA replication (GO:0090329)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
stem cell fate specification (GO:0048866)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
stem cell fate commitment (GO:0048865)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of locomotion involved in locomotory behavior (GO:0090327)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of locomotion involved in locomotory behavior (GO:0090326)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of locomotion involved in locomotory behavior (GO:0090325)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative phosphorylation (GO:0090324)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of chylomicron remnant clearance (GO:0090321)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of chylomicron remnant clearance (GO:0090320)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of chylomicron remodeling (GO:0090319)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of chylomicron remodeling (GO:0090318)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adenohypophysis morphogenesis (GO:0048855)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
brain morphogenesis (GO:0048854)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
forebrain morphogenesis (GO:0048853)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein targeting to membrane (GO:0090315)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
diencephalon morphogenesis (GO:0048852)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
hypophysis morphogenesis (GO:0048850)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein deacetylation (GO:0090312)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA methylation-dependent heterochromatin formation (GO:0090310)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cGMP transport (GO:0070731)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cAMP transport (GO:0070730)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ribonucleoprotein complex localization (GO:2000199)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ribonucleoprotein complex localization (GO:2000198)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ribonucleoprotein complex localization (GO:2000197)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of female gonad development (GO:2000196)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of female gonad development (GO:2000195)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of female gonad development (GO:2000194)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
ammonium import across plasma membrane (GO:0140157)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid transport (GO:2000192)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
venous blood vessel morphogenesis (GO:0048845)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
meiotic spindle assembly (GO:0090306)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of axon extension involved in axon guidance (GO:0048842)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
otolith development (GO:0048840)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of neural crest formation (GO:0090301)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor internalization (GO:0099590)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
response to cholesterol (GO:0070723)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphate transmembrane transport (GO:2000187)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of phosphate transmembrane transport (GO:2000185)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of progesterone biosynthetic process (GO:2000184)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of progesterone biosynthetic process (GO:2000182)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of androgen biosynthetic process (GO:2000180)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial potassium ion transmembrane transport (GO:0140141)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication (GO:0070716)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sodium-dependent organic cation transport (GO:0070715)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106289)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106288)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pro-T cell differentiation (GO:2000176)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of pro-T cell differentiation (GO:2000174)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of branching morphogenesis of a nerve (GO:2000173)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of branching morphogenesis of a nerve (GO:2000172)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendrite development (GO:2000171)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
formation of extrachromosomal circular DNA (GO:0001325)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphocyte chemotaxis (GO:0140131)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
enucleate erythrocyte development (GO:0048822)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of protein catabolic process at postsynapse, modulating synaptic transmission (GO:0099576)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of protein catabolic process at presynapse, modulating synaptic transmission (GO:0099575)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of peptidoglycan (GO:0032499)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of muramyl dipeptide (GO:0032498)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of lipopolysaccharide (GO:0032497)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to muramyl dipeptide (GO:0032495)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
response to peptidoglycan (GO:0032494)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
response to bacterial lipoprotein (GO:0032493)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of UDP-N-acetylglucosamine biosynthetic process (GO:0106279)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of molecule of fungal origin (GO:0032491)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of UDP-N-acetylglucosamine biosynthetic process (GO:0106278)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of hair follicle maturation (GO:0048819)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of hair follicle maturation (GO:0048818)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cytosol to ERGIC protein transport (GO:0106273)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of hair follicle maturation (GO:0048817)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to ERGIC (GO:0106272)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of Lewy body formation (GO:0140123)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of Lewy body formation (GO:0140122)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic cytosolic calcium ion concentration (GO:0099566)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of Cdc42 protein signal transduction (GO:0032489)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of Rap protein signal transduction (GO:0032487)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
Rap protein signal transduction (GO:0032486)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of Ral protein signal transduction (GO:0032485)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
Ral protein signal transduction (GO:0032484)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of Rab protein signal transduction (GO:0032483)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
Rab protein signal transduction (GO:0032482)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin-specific protease activity (GO:2000158)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ubiquitin-specific protease activity (GO:2000157)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of type I interferon production (GO:0032480)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde vesicle-mediated transport, Golgi to ER (GO:2000156)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cilium-dependent cell motility (GO:2000155)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
male genitalia morphogenesis (GO:0048808)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquitin-specific protease activity (GO:2000152)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
female genitalia morphogenesis (GO:0048807)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
extracellular vesicle biogenesis (GO:0140112)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission (GO:0099557)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0099555)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by soluble gas, modulating synaptic transmission (GO:0099554)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by endocannabinoid, modulating synaptic transmission (GO:0099553)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by lipid, modulating synaptic transmission (GO:0099552)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by neuropeptide, modulating synaptic transmission (GO:0099551)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling, modulating synaptic transmission (GO:0099550)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
otolith formation (GO:0032475)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
otolith morphogenesis (GO:0032474)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
Golgi calcium ion transport (GO:0032472)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of endoplasmic reticulum calcium ion concentration (GO:0032470)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA-templated transcription initiation (GO:2000143)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamine modification (GO:0018199)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-aspartic acid modification (GO:0018197)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by nitric oxide (GO:0099548)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine modification (GO:0018195)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
peptidyl-alanine modification (GO:0018194)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein catabolic process, modulating synaptic transmission (GO:0099546)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine octanoylation (GO:0018191)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by soluble gas (GO:0099543)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein octanoylation (GO:0018190)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by endocannabinoid (GO:0099542)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by lipid (GO:0099541)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by neuropeptide (GO:0099540)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum calcium ion homeostasis (GO:0032469)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
Golgi calcium ion homeostasis (GO:0032468)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytokinesis (GO:0032466)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein homooligomerization (GO:0032463)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in heart morphogenesis (GO:2000137)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein oligomerization (GO:0032460)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in heart morphogenesis (GO:2000136)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
synaptic signaling via neuropeptide (GO:0099538)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of presynaptic cytosolic calcium concentration (GO:0099533)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle endosomal processing (GO:0099532)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
slow endocytic recycling (GO:0032458)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of removal of superoxide radicals (GO:2000121)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium-dependent phosphate transport (GO:2000120)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein depropionylation (GO:0106230)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein nucleotidylation (GO:0018175)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
presynapse to nucleus signaling pathway (GO:0099526)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine oxidation (GO:0018171)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein urmylation (GO:0032447)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of sodium-dependent phosphate transport (GO:2000119)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of sodium-dependent phosphate transport (GO:2000118)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine glutarylation (GO:0106227)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage apoptotic process (GO:2000111)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage apoptotic process (GO:2000110)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle transport along microtubule (GO:0099517)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
actin filament-based transport (GO:0099515)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
adhesion of symbiont to host (GO:0044406)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle cytoskeletal transport (GO:0099514)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
melanosome organization (GO:0032438)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
ITP catabolic process (GO:0006193)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	78	0	1.30	-	 < 0.01	6.43E-01	1.00E00
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	128	0	2.13	-	 < 0.01	2.81E-01	1.00E00
regulation of macrophage apoptotic process (GO:2000109)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
activation of phospholipase A2 activity (GO:0032431)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
tRNA C3-cytosine methylation (GO:0106217)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA-templated DNA replication (GO:2000105)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA-templated DNA replication (GO:2000104)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of mammary stem cell proliferation (GO:2000103)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mammary stem cell proliferation (GO:2000101)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein oxidation (GO:0018158)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
symbiont-mediated disruption of host cellular anatomical structure (GO:0052008)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
'de novo' IMP biosynthetic process (GO:0006189)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
IMP biosynthetic process (GO:0006188)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
vesicle fusion to plasma membrane (GO:0099500)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
dGDP biosynthetic process (GO:0006185)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
polar body extrusion after meiotic divisions (GO:0040038)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
GTP biosynthetic process (GO:0006183)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
cGMP biosynthetic process (GO:0006182)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
dGMP biosynthetic process (GO:0006181)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mismatch repair (GO:0032425)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of development, heterochronic (GO:0040034)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
regulation of mismatch repair (GO:0032423)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
snRNA modification (GO:0040031)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
keratan sulfate biosynthetic process (GO:0018146)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
guanine salvage (GO:0006178)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GMP biosynthetic process (GO:0006177)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
dATP biosynthetic process (GO:0006175)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium:proton antiporter activity (GO:0032417)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
ADP biosynthetic process (GO:0006172)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of sodium:proton antiporter activity (GO:0032416)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of sodium:proton antiporter activity (GO:0032415)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
dAMP biosynthetic process (GO:0006170)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic nuclear division (GO:0040020)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
adenine salvage (GO:0006168)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
AMP biosynthetic process (GO:0006167)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside salvage (GO:0006166)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of multicellular organism growth (GO:0040018)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
deoxyguanosine catabolic process (GO:0006161)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
melanosome transport (GO:0032402)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
establishment of melanosome localization (GO:0032401)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of growth rate (GO:0040010)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
melanosome localization (GO:0032400)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
protein hydroxylation (GO:0018126)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
deoxyadenosine catabolic process (GO:0006157)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of growth rate (GO:0040009)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
adenosine catabolic process (GO:0006154)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
purine nucleoside catabolic process (GO:0006152)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine S-nitrosylation (GO:0018119)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle tissue development (GO:1905899)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein adenylylation (GO:0018117)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic spindle checkpoint signaling (GO:0071174)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
spindle assembly checkpoint signaling (GO:0071173)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
deoxyinosine catabolic process (GO:0006149)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to very-low-density lipoprotein particle stimulus (GO:1905890)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inosine catabolic process (GO:0006148)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to hydrostatic pressure (GO:0051599)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
guanine catabolic process (GO:0006147)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
meiotic recombination checkpoint signaling (GO:0051598)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translation in response to stress (GO:1990497)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
purine nucleobase catabolic process (GO:0006145)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
methylglyoxal catabolic process (GO:0051596)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
purine nucleobase metabolic process (GO:0006144)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
response to methylglyoxal (GO:0051595)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to folic acid (GO:0051593)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotransmitter transport (GO:0051590)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
viral translational termination-reinitiation (GO:0075525)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
viral translational frameshifting (GO:0075523)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
IRES-dependent viral translational initiation (GO:0075522)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to chromatin (GO:0071169)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
protein localization to chromatin (GO:0071168)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
ribonucleoprotein complex localization (GO:0071166)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride transport (GO:1905885)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA replication preinitiation complex assembly (GO:0071163)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride transport (GO:1905883)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopamine uptake involved in synaptic transmission (GO:0051586)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopamine uptake involved in synaptic transmission (GO:0051585)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of dopamine uptake involved in synaptic transmission (GO:0051584)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
dopamine uptake involved in synaptic transmission (GO:0051583)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotransmitter uptake (GO:0051582)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of neurotransmitter uptake (GO:0051581)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mRNA pseudouridine synthesis (GO:1990481)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
clathrin-dependent endocytosis of virus by host cell (GO:0075512)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of oogenesis (GO:1905879)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of postsynaptic density organization (GO:1905875)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic density organization (GO:1905874)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cell leading edge (GO:1905873)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cell leading edge (GO:1905872)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cell leading edge (GO:1905871)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of arginine metabolic process (GO:0000821)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glycerophosphate shuttle (GO:0006127)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to ultrasound (GO:1990478)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glutamine family amino acid metabolic process (GO:0000820)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid beta-oxidation (GO:0031999)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
endocytosis involved in viral entry into host cell (GO:0075509)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of fatty acid beta-oxidation (GO:0031998)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
entry of viral genome into host nucleus through nuclear pore complex via importin (GO:0075506)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mRNA export from nucleus in response to heat stress (GO:0031990)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of 3'-UTR-mediated mRNA stabilization (GO:1905869)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
epididymis development (GO:1905867)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
resolution of mitotic recombination intermediates (GO:0071140)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of heparan sulfate proteoglycan binding (GO:1905860)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acetaldehyde metabolic process (GO:0006117)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glycerol biosynthetic process (GO:0006114)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
fermentation (GO:0006113)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
smooth endoplasmic reticulum calcium ion homeostasis (GO:0051563)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of gluconeogenesis (GO:0006111)	66	0	1.10	-	 < 0.01	6.31E-01	1.00E00
positive regulation of mitochondrial calcium ion concentration (GO:0051561)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of cAMP-mediated signaling (GO:0043950)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
bombesin receptor signaling pathway (GO:0031989)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
locomotion involved in locomotory behavior (GO:0031987)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
resolution of DNA recombination intermediates (GO:0071139)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of heparan sulfate proteoglycan binding (GO:1905858)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of pentose-phosphate shunt (GO:1905857)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of pentose-phosphate shunt (GO:1905856)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
malate metabolic process (GO:0006108)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
oxaloacetate metabolic process (GO:0006107)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
response to diphenyl ether (GO:1901497)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fumarate metabolic process (GO:0006106)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
succinate metabolic process (GO:0006105)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
succinyl-CoA metabolic process (GO:0006104)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of cysteine metabolic process (GO:1901494)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
2-oxoglutarate metabolic process (GO:0006103)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
isocitrate metabolic process (GO:0006102)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphangiogenesis (GO:1901492)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
citrate metabolic process (GO:0006101)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
flavone metabolic process (GO:0051552)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of keratinocyte migration (GO:0051549)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of keratinocyte migration (GO:0051548)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of keratinocyte migration (GO:0051547)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
keratinocyte migration (GO:0051546)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of elastin biosynthetic process (GO:0051545)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of elastin biosynthetic process (GO:0051543)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
elastin biosynthetic process (GO:0051542)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to nitrosative stress (GO:1990442)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ossification involved in bone remodeling (GO:0043932)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ossification involved in bone maturation (GO:0043931)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric D-loop disassembly (GO:1905839)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric D-loop disassembly (GO:1905838)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to pyrimidine ribonucleotide (GO:1905835)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to pyrimidine ribonucleotide (GO:1905834)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule nucleation (GO:1905833)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of spindle assembly (GO:1905832)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
U6 2'-O-snRNA methylation (GO:1990438)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
snRNA 2'-O-methylation (GO:1990437)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pyruvate transmembrane transport (GO:1901475)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation by host of viral transcription (GO:0043923)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
siRNA 3'-end processing (GO:1990432)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation by host of viral transcription (GO:0043922)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
priRNA 3'-end processing (GO:1990431)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral transcription (GO:0043921)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear receptor-mediated mineralocorticoid signaling pathway (GO:0031959)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear receptor-mediated corticosteroid signaling pathway (GO:0031958)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein autophosphorylation (GO:0031954)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
superior temporal gyrus development (GO:0071109)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein K48-linked deubiquitination (GO:0071108)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
regulation of prostaglandin catabolic process (GO:1905828)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to interleukin-11 (GO:0071105)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromosome condensation (GO:1905821)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromosome separation (GO:1905820)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
miRNA transport (GO:1990428)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of tetrapyrrole biosynthetic process (GO:1901465)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic recombination-dependent replication fork processing (GO:1990426)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tetrapyrrole biosynthetic process (GO:1901463)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucocorticoid biosynthetic process (GO:0031948)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucocorticoid metabolic process (GO:0031945)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromosome separation (GO:1905819)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of chromosome separation (GO:1905818)	77	0	1.28	-	 < 0.01	6.42E-01	1.00E00
response to insulin-like growth factor stimulus (GO:1990418)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to brain-derived neurotrophic factor stimulus (GO:1990416)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
replication-born double-strand break repair via sister chromatid exchange (GO:1990414)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of unidimensional cell growth (GO:0051511)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of unidimensional cell growth (GO:0051510)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adrenomedullin receptor signaling pathway (GO:1990410)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of neural crest formation (GO:0090299)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial DNA replication (GO:0090298)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial DNA replication (GO:0090297)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondria-nucleus signaling pathway (GO:0031930)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial DNA replication (GO:0090296)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of synapse organization (GO:1905809)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of synapse pruning (GO:1905808)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear matrix anchoring at nuclear membrane (GO:0090292)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoclast proliferation (GO:0090291)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
excitatory synapse pruning (GO:1905805)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of osteoclast proliferation (GO:0090290)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
embryonic liver development (GO:1990402)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
embryonic lung development (GO:1990401)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
TOR signaling (GO:0031929)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
pyridoxine transport (GO:0031923)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of osteoclast proliferation (GO:0090289)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion import (GO:0090281)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
vitamin B6 transport (GO:0031919)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic plasticity (GO:0031915)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of somatostatin secretion (GO:0090275)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of somatostatin secretion (GO:0090274)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of somatostatin secretion (GO:0090273)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast growth factor production (GO:0090272)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of fibroblast growth factor production (GO:0090271)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of fibroblast growth factor production (GO:0090270)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
response to toluene (GO:1901424)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor production (GO:0090269)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of immune complex clearance by monocytes and macrophages (GO:0090265)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of immune complex clearance by monocytes and macrophages (GO:0090264)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of transcription-coupled nucleotide-excision repair (GO:0090262)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of inclusion body assembly (GO:0090261)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of response to alcohol (GO:1901419)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
seminal clot liquefaction (GO:0070684)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proteasome regulatory particle assembly (GO:0070682)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
glutaminyl-tRNAGln biosynthesis via transamidation (GO:0070681)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial fission (GO:0090258)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
pronephros development (GO:0048793)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
spontaneous exocytosis of neurotransmitter (GO:0048792)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of presynaptic active zone structure (GO:0048790)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
protein localization involved in establishment of planar polarity (GO:0090251)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
intralumenal vesicle formation (GO:0070676)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to interleukin-18 (GO:0070673)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of tetrapyrrole metabolic process (GO:1901403)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of tetrapyrrole metabolic process (GO:1901401)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cytoskeletal matrix organization at active zone (GO:0048789)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell migration involved in somitogenic axis elongation (GO:0090249)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in somitogenesis (GO:0090246)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axis elongation involved in somitogenesis (GO:0090245)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway involved in somitogenesis (GO:0090244)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell proliferation (GO:0070668)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell proliferation (GO:0070667)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell proliferation (GO:0070666)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
mast cell proliferation (GO:0070662)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of arachidonate secretion (GO:0090238)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of arachidonate secretion (GO:0090237)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
erythrophore differentiation (GO:0048773)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of metaphase plate congression (GO:0090235)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of kinetochore assembly (GO:0090234)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of spindle checkpoint (GO:0090233)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of spindle checkpoint (GO:0090232)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of spindle checkpoint (GO:0090231)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of centromere complex assembly (GO:0090230)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
sensory epithelium regeneration (GO:0070654)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nonfunctional rRNA decay (GO:0070651)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sarcomerogenesis (GO:0048769)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipoprotein transport (GO:0140077)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein transport (GO:0140075)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cardiac endothelial to mesenchymal transition (GO:0140074)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of spindle organization (GO:0090224)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
centrosome-templated microtubule nucleation (GO:0090222)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
chromosome localization to nuclear envelope involved in homologous chromosome segregation (GO:0090220)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
formin-nucleated actin cable assembly (GO:0070649)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vitamin D3 metabolic process (GO:0070640)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine butyrylation (GO:0140067)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine crotonylation (GO:0140066)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pigment granule maturation (GO:0048757)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid kinase activity (GO:0090218)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
branching morphogenesis of a nerve (GO:0048755)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pigment granule organization (GO:0048753)	39	0	.65	-	 < 0.01	1.00E00	1.00E00
semicircular canal morphogenesis (GO:0048752)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
spongiotrophoblast layer developmental growth (GO:0090214)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
axon arborization (GO:0140060)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of blood-brain barrier (GO:0090212)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of blood-brain barrier (GO:0090210)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
actin cortical patch organization (GO:0044396)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein targeting to vacuolar membrane (GO:0044395)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyridine nucleoside catabolic process (GO:0070638)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pyridine nucleoside metabolic process (GO:0070637)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
transepithelial ammonium transport (GO:0070634)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
transepithelial transport (GO:0070633)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell-matrix adhesion (GO:2000098)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle cell-matrix adhesion (GO:2000097)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
dendrite arborization (GO:0140059)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
neuron projection arborization (GO:0140058)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of triglyceride metabolic process (GO:0090209)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride metabolic process (GO:0090208)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol metabolic process (GO:0090206)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle fiber development (GO:0048743)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol metabolic process (GO:0090205)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of endocardial cushion to mesenchymal transition (GO:0140051)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle fiber development (GO:0048742)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
skeletal muscle fiber development (GO:0048741)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
negative regulation of release of cytochrome c from mitochondria (GO:0090201)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
glucose import in response to insulin stimulus (GO:0044381)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
zymogen granule exocytosis (GO:0070625)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to cytoskeleton (GO:0044380)	51	0	.85	-	 < 0.01	1.00E00	1.00E00
regulation of endocardial cushion to mesenchymal transition (GO:0140049)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
manganese ion export across plasma membrane (GO:0140048)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sebaceous gland development (GO:0048733)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of methylglyoxal (GO:0140041)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of peroxisome size (GO:0044375)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of type B pancreatic cell development (GO:2000077)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of centromeric sister chromatid cohesion (GO:0070602)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
centromeric sister chromatid cohesion (GO:0070601)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of cortisol biosynthetic process (GO:2000066)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of ureter smooth muscle cell differentiation (GO:2000063)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ureter smooth muscle cell differentiation (GO:2000062)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ureter smooth muscle cell differentiation (GO:2000061)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060)	99	0	1.65	-	 < 0.01	4.17E-01	1.00E00
negative regulation of oligodendrocyte differentiation (GO:0048715)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of oligodendrocyte differentiation (GO:0048714)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
mitochondrial ADP transmembrane transport (GO:0140021)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of astrocyte differentiation (GO:0048712)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of astrocyte differentiation (GO:0048711)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of astrocyte differentiation (GO:0048710)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of rRNA stability (GO:0044357)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
macropinocytosis (GO:0044351)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular cholesterol transport (GO:0032385)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular cholesterol transport (GO:0032384)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular cholesterol transport (GO:0032383)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059)	58	0	.97	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular sterol transport (GO:0032382)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	166	0	2.77	-	 < 0.01	1.21E-01	1.00E00
negative regulation of intracellular sterol transport (GO:0032381)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular sterol transport (GO:0032380)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translational fidelity (GO:0140018)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of non-canonical Wnt signaling pathway (GO:2000051)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
meiotic nuclear division (GO:0140013)	192	0	3.20	-	 < 0.01	8.16E-02	8.95E-01
embryonic viscerocranium morphogenesis (GO:0048703)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
embryonic neurocranium morphogenesis (GO:0048702)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
fibroblast apoptotic process (GO:0044346)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
stromal-epithelial cell signaling involved in prostate gland development (GO:0044345)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sodium-dependent phosphate transport (GO:0044341)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular lipid transport (GO:0032379)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular lipid transport (GO:0032378)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular lipid transport (GO:0032377)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol transport (GO:0032375)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of sterol transport (GO:0032372)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
L-aspartate import across plasma membrane (GO:0140009)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac cell fate specification (GO:2000043)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein polyglutamylation (GO:0018095)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
protein polyglycylation (GO:0018094)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation (GO:0044338)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in positive regulation of apoptotic process (GO:0044337)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion mediated by cadherin (GO:0044331)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid transport (GO:0032369)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
intracellular cholesterol transport (GO:0032367)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
intracellular sterol transport (GO:0032366)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
intracellular lipid transport (GO:0032365)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
intracellular oxygen homeostasis (GO:0032364)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
pyridoxal phosphate catabolic process (GO:0032361)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of stem cell division (GO:2000035)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
response to follicle-stimulating hormone (GO:0032354)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of hormone metabolic process (GO:0032352)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycine import across plasma membrane (GO:1900925)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycine import across plasma membrane (GO:1900924)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glycine import across plasma membrane (GO:1900923)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle cell contraction (GO:0106135)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle cell contraction (GO:0106134)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of male gonad development (GO:2000020)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-lysine acetylation (GO:0018076)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein K27-linked ubiquitination (GO:0044314)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
protein K6-linked deubiquitination (GO:0044313)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of aldosterone biosynthetic process (GO:0032349)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of aldosterone metabolic process (GO:0032346)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of male gonad development (GO:2000019)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
aldosterone biosynthetic process (GO:0032342)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of store-operated calcium entry (GO:0106129)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of male gonad development (GO:2000018)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
aldosterone metabolic process (GO:0032341)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of determination of dorsal identity (GO:2000017)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of determination of dorsal identity (GO:2000016)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of determination of dorsal identity (GO:2000015)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of adaxial/abaxial pattern formation (GO:2000011)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cobalamin metabolic process (GO:0106121)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of sterol biosynthetic process (GO:0106120)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
cytochrome c-heme linkage (GO:0018063)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid cycle (GO:0006099)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
pentose-phosphate shunt (GO:0006098)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
glyoxylate cycle (GO:0006097)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of sterol biosynthetic process (GO:0106119)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of chondrocyte differentiation (GO:0032331)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
regulation of sterol biosynthetic process (GO:0106118)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of metanephric comma-shaped body morphogenesis (GO:2000007)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric comma-shaped body morphogenesis (GO:2000006)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of metanephric S-shaped body morphogenesis (GO:2000005)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric S-shaped body morphogenesis (GO:2000004)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA damage checkpoint (GO:2000003)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA damage checkpoint (GO:2000002)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of DNA damage checkpoint (GO:2000001)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine oxidation (GO:0018057)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lactate metabolic process (GO:0006089)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA biosynthetic process from pyruvate (GO:0006086)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA biosynthetic process (GO:0006085)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
serine transport (GO:0032329)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA metabolic process (GO:0006084)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
acetate metabolic process (GO:0006083)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
molybdopterin cofactor biosynthetic process (GO:0032324)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cold-induced thermogenesis (GO:0106106)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate receptor clustering (GO:0106104)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
ER-dependent peroxisome localization (GO:0106101)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycerol metabolic process (GO:0006071)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
prostaglandin secretion (GO:0032310)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
ethanol catabolic process (GO:0006068)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
ethanol metabolic process (GO:0006067)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
UDP-glucuronate biosynthetic process (GO:0006065)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
icosanoid secretion (GO:0032309)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
glucuronate catabolic process (GO:0006064)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
uronic acid metabolic process (GO:0006063)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of prostaglandin secretion (GO:0032307)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
sorbitol catabolic process (GO:0006062)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sorbitol biosynthetic process (GO:0006061)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sorbitol metabolic process (GO:0006060)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of icosanoid secretion (GO:0032304)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine dimethylation (GO:0018027)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine monomethylation (GO:0018026)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine trimethylation (GO:0018023)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine methylation (GO:0018022)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
peptidyl-histidine methylation (GO:0018021)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hexitol metabolic process (GO:0006059)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mannoprotein catabolic process (GO:0006058)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mannoprotein metabolic process (GO:0006056)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
CMP-N-acetylneuraminate biosynthetic process (GO:0006055)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
N-acetylneuraminate metabolic process (GO:0006054)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
N-acetylmannosamine metabolic process (GO:0006051)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mannosamine metabolic process (GO:0006050)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of intraciliary retrograde transport (GO:1905799)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-proline dimethylation (GO:0018016)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA 3' uridylation (GO:0071076)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-glycine methylation (GO:0018013)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-alanine trimethylation (GO:0018012)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipid biosynthetic process (GO:0071072)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to pericentriolar material (GO:1905793)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-alanine methylation (GO:0018011)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
UDP-N-acetylglucosamine catabolic process (GO:0006049)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
UDP-N-acetylglucosamine biosynthetic process (GO:0006048)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
epithelium regeneration (GO:1990399)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
UDP-N-acetylglucosamine metabolic process (GO:0006047)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
N-acetylglucosamine catabolic process (GO:0006046)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
N-acetylglucosamine biosynthetic process (GO:0006045)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
N-acetylglucosamine metabolic process (GO:0006044)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
glucosamine catabolic process (GO:0006043)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glucosamine biosynthetic process (GO:0006042)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glucosamine metabolic process (GO:0006041)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
amino sugar metabolic process (GO:0006040)	50	0	.83	-	 < 0.01	1.00E00	1.00E00
AMPA selective glutamate receptor signaling pathway (GO:0098990)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of filopodium assembly (GO:0051490)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein K33-linked ubiquitination (GO:1990390)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-L-cysteine N-palmitoylation (GO:0018009)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-glycine N-myristoylation (GO:0018008)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of detection of mechanical stimulus involved in sensory perception of touch (GO:1905788)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of detection of mechanical stimulus involved in sensory perception of touch (GO:1905787)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine N6-acetylation (GO:0018003)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of anaphase-promoting complex-dependent catabolic process (GO:1905784)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-glutamic acid acetylation (GO:0018002)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidylserine exposure on apoptotic cell surface (GO:1905782)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylserine exposure on apoptotic cell surface (GO:1905780)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA strand displacement (GO:0000732)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA synthesis involved in DNA repair (GO:0000731)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
regulation of modification of synapse structure, modulating synaptic transmission (GO:0098987)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA recombinase assembly (GO:0000730)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mitotic cleavage furrow ingression (GO:1990386)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hyaloid vascular plexus regression (GO:1990384)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
chitin catabolic process (GO:0006032)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
chitin metabolic process (GO:0006030)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytosolic calcium ion concentration (GO:0051481)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
negative regulation of exonuclease activity (GO:1905778)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of exonuclease activity (GO:1905777)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA double-strand break processing (GO:0000729)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA helicase activity (GO:1905776)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via break-induced replication (GO:0000727)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of DNA helicase activity (GO:1905774)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
recombinational repair (GO:0000725)	118	0	1.97	-	 < 0.01	2.72E-01	1.00E00
poly(A)-dependent snoRNA 3'-end processing (GO:0071051)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesodermal cell differentiation (GO:1905772)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via homologous recombination (GO:0000724)	113	0	1.88	-	 < 0.01	2.69E-01	1.00E00
negative regulation of mesodermal cell differentiation (GO:1905771)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mesodermal cell differentiation (GO:1905770)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via recombination (GO:0000722)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
lipid transport across blood-brain barrier (GO:1990379)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine dimer repair by nucleotide-excision repair (GO:0000720)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glycosaminoglycan biosynthetic process (GO:0006024)	52	0	.87	-	 < 0.01	1.00E00	1.00E00
inositol biosynthetic process (GO:0006021)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
inositol metabolic process (GO:0006020)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
polyadenylation-dependent mRNA catabolic process (GO:0071047)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of double-stranded telomeric DNA binding (GO:1905768)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of double-stranded telomeric DNA binding (GO:1905767)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear histone mRNA catabolic process (GO:0071045)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histone mRNA catabolic process (GO:0071044)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of protection from non-homologous end joining at telomere (GO:1905765)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA duplex unwinding (GO:0000717)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CUT metabolic process (GO:0071043)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protection from non-homologous end joining at telomere (GO:1905764)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA damage recognition (GO:0000715)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antisense RNA transcript catabolic process (GO:0071041)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent antisense transcript catabolic process (GO:0071040)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
resolution of meiotic recombination intermediates (GO:0000712)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
vesicle fusion with vacuole (GO:0051469)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport postsynaptic membrane to endosome (GO:0098968)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
meiotic DNA repair synthesis (GO:0000711)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
exocytic insertion of neurotransmitter receptor to postsynaptic membrane (GO:0098967)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of corticotropin-releasing hormone secretion (GO:0051466)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
D-ribose metabolic process (GO:0006014)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
anterograde dendritic transport of messenger ribonucleoprotein complex (GO:0098964)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cortisol secretion (GO:0051464)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
dendritic transport of messenger ribonucleoprotein complex (GO:0098963)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
galactose metabolic process (GO:0006012)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of cortisol secretion (GO:0051463)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
UDP-alpha-D-glucose metabolic process (GO:0006011)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of cortisol secretion (GO:0051462)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of corticotropin secretion (GO:0051461)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of corticotropin secretion (GO:0051460)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent CUT catabolic process (GO:0071039)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
TRAMP-dependent tRNA surveillance pathway (GO:0071038)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic joint molecule formation (GO:0000709)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
meiotic strand invasion (GO:0000708)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CUT catabolic process (GO:0071034)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to cytoplasmic microtubule (GO:1905755)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic DNA recombinase assembly (GO:0000707)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic DNA double-strand break processing (GO:0000706)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of endosome to plasma membrane protein transport (GO:1905751)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of corticotropin secretion (GO:0051459)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
retrograde axonal transport of mitochondrion (GO:0098958)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
stress response to zinc ion (GO:1990359)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell fate specification (GO:0009996)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
corticotropin secretion (GO:0051458)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
anterograde axonal transport of mitochondrion (GO:0098957)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
oocyte differentiation (GO:0009994)	63	0	1.05	-	 < 0.01	6.29E-01	1.00E00
fucose metabolic process (GO:0006004)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
spindle attachment to meiosis I kinetochore (GO:0051455)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fructose 2,6-bisphosphate metabolic process (GO:0006003)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
intracellular water homeostasis (GO:0009992)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
intracellular pH elevation (GO:0051454)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
fructose 6-phosphate metabolic process (GO:0006002)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
fructose catabolic process (GO:0006001)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
intracellular pH reduction (GO:0051452)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
fructose metabolic process (GO:0006000)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
myoblast proliferation (GO:0051450)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
nuclear mRNA surveillance (GO:0071028)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of endosome to plasma membrane protein transport (GO:1905749)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
nuclear RNA surveillance (GO:0071027)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
hard palate morphogenesis (GO:1905748)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cytoplasmic RNA surveillance (GO:0071026)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of saliva secretion (GO:1905747)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA surveillance (GO:0071025)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA cis splicing, via spliceosome (GO:1905746)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA cis splicing, via spliceosome (GO:1905744)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
gap junction-mediated intercellular transport (GO:1990349)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated calcium channel activity (GO:1901387)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic cell cycle (GO:0051447)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic cell cycle (GO:0051446)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic cell cycle (GO:0051445)	65	0	1.08	-	 < 0.01	6.30E-01	1.00E00
negative regulation of ubiquitin-protein transferase activity (GO:0051444)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of chorionic trophoblast cell proliferation (GO:1901383)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin-protein transferase activity (GO:0051443)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of chorionic trophoblast cell proliferation (GO:1901382)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
telomeric 3' overhang formation (GO:0031860)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-proline import across plasma membrane (GO:1905737)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of L-proline import across plasma membrane (GO:1905735)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dendritic transport of mitochondrion (GO:0098939)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquitin-protein transferase activity (GO:0051438)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
organic heteropentacyclic compound catabolic process (GO:1901377)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
organic heteropentacyclic compound metabolic process (GO:1901376)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
retrograde dendritic transport (GO:0098934)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acetate ester transport (GO:1901374)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cytidine deamination (GO:0009972)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
lipid hydroperoxide transport (GO:1901373)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to glutathione (GO:1901370)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule end (GO:1905725)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
presynaptic signal transduction (GO:0098928)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated transport between endosomal compartments (GO:0098927)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
response to L-cysteine (GO:1901367)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0098925)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by nitric oxide (GO:0098924)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by soluble gas (GO:0098923)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by endocannabinoid (GO:0098921)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by lipid (GO:0098920)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protection from non-homologous end joining at telomere (GO:0031848)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
protein localization to perinuclear region of cytoplasm (GO:1905719)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of cornification (GO:1905716)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cornification (GO:1905715)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to phosphatidylethanolamine (GO:1905711)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane permeability (GO:1905710)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
epidermal cell fate specification (GO:0009957)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
radial pattern formation (GO:0009956)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
microtubule nucleation by microtubule organizing center (GO:0051418)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
proximal/distal pattern formation (GO:0009954)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
response to rapamycin (GO:1901355)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
microtubule nucleation by interphase microtubule organizing center (GO:0051415)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to cortisol (GO:0051414)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to insulin-like growth factor stimulus (GO:1990314)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
response to cortisone (GO:0051413)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during atrial cardiac muscle cell action potential (GO:0098912)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
dorsal/ventral axis specification (GO:0009950)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of ventricular cardiac muscle cell action potential (GO:0098911)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of atrial cardiac muscle cell action potential (GO:0098910)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
detoxification of nitrogen compound (GO:0051410)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane permeability (GO:1905709)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of glomerulus development (GO:0090194)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial ATP synthesis coupled proton transport (GO:1905707)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial ATP synthesis coupled proton transport (GO:1905706)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of branching involved in ureteric bud morphogenesis (GO:0090191)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of inhibitory synapse assembly (GO:1905704)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of inhibitory synapse assembly (GO:1905703)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of inhibitory synapse assembly (GO:1905702)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
polarity specification of anterior/posterior axis (GO:0009949)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
anterior/posterior axis specification (GO:0009948)	62	0	1.03	-	 < 0.01	6.29E-01	1.00E00
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to nitrosative stress (GO:0051409)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
proximal/distal axis specification (GO:0009946)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of SA node cell action potential (GO:0098907)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of Purkinje myocyte action potential (GO:0098906)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of vasculature development involved in avascular cornea development in camera-type eye (GO:1901346)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of bundle of His cell action potential (GO:0098905)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of AV node cell action potential (GO:0098904)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to leptomycin B (GO:1901344)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during action potential (GO:0098903)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of membrane depolarization during action potential (GO:0098902)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell action potential (GO:0098901)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of store-operated calcium channel activity (GO:1901341)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of store-operated calcium channel activity (GO:1901340)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of pancreatic juice secretion (GO:0090188)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of pancreatic juice secretion (GO:0090187)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic juice secretion (GO:0090186)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of kidney development (GO:0090185)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of secretion of lysosomal enzymes (GO:0090182)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol metabolic process (GO:0090181)	53	0	.88	-	 < 0.01	1.00E00	1.00E00
regulation of store-operated calcium channel activity (GO:1901339)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
thioester transport (GO:1901337)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lactone biosynthetic process (GO:1901336)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
lactone catabolic process (GO:1901335)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lactone metabolic process (GO:1901334)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
cell tip growth (GO:0009932)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of odontoblast differentiation (GO:1901331)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of odontoblast differentiation (GO:1901330)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of planar polarity involved in neural tube closure (GO:0090178)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of planar polarity involved in neural tube closure (GO:0090177)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
microtubule cytoskeleton organization involved in establishment of planar polarity (GO:0090176)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of planar polarity (GO:0090175)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
chondrocyte morphogenesis (GO:0090171)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi inheritance (GO:0090170)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of odontoblast differentiation (GO:1901329)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
response to cytochalasin B (GO:1901328)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to tacrolimus (GO:1901327)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dendrite self-avoidance (GO:0070593)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of spindle assembly (GO:0090169)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
Golgi reassembly (GO:0090168)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
Golgi disassembly (GO:0090166)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
asymmetric Golgi ribbon formation (GO:0090164)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of epithelial cell polarity (GO:0090162)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
Golgi ribbon formation (GO:0090161)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
Golgi to lysosome transport (GO:0090160)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of cell-cell adhesion involved in gastrulation (GO:0070587)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion involved in gastrulation (GO:0070586)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to mitochondrion (GO:0070585)	85	0	1.42	-	 < 0.01	4.08E-01	1.00E00
negative regulation of flagellated sperm motility (GO:1901318)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell fate commitment (GO:0009912)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of collateral sprouting in absence of injury (GO:0048698)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of collateral sprouting in absence of injury (GO:0048697)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of collateral sprouting in absence of injury (GO:0048696)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of collateral sprouting of injured axon (GO:0048694)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intracellular sphingolipid homeostasis (GO:0090156)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of collateral sprouting of injured axon (GO:0048693)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of sphingolipid biosynthetic process (GO:0090155)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II (GO:0001193)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of sphingolipid biosynthetic process (GO:0090154)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
maintenance of transcriptional fidelity during transcription elongation (GO:0001192)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of axon extension involved in regeneration (GO:0048691)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sphingolipid biosynthetic process (GO:0090153)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to mitochondrial membrane involved in mitochondrial fission (GO:0090152)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to mitochondrial membrane (GO:0090151)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
cadmium ion transmembrane transport (GO:0070574)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of spermidine biosynthetic process (GO:1901307)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuron projection regeneration (GO:0070572)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of spermidine biosynthetic process (GO:1901304)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cargo loading into COPII-coated vesicle (GO:1901303)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nitric-oxide synthase activity (GO:0050999)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of cargo loading into COPII-coated vesicle (GO:1901301)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide-mediated programmed cell death (GO:1901300)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
dimethylallyl diphosphate metabolic process (GO:0050993)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dimethylallyl diphosphate biosynthetic process (GO:0050992)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA polymerase I preinitiation complex assembly (GO:0001188)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of sprouting of injured axon (GO:0048687)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial membrane fission (GO:0090149)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane fission (GO:0090148)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
regulation of collateral sprouting of intact axon in response to injury (GO:0048683)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial nucleoid organization (GO:0090144)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleoid organization (GO:0090143)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of axon regeneration (GO:0048680)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial fission (GO:0090141)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial fission (GO:0090140)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
positive regulation of vitamin D receptor signaling pathway (GO:0070564)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of vitamin D receptor signaling pathway (GO:0070563)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vitamin D receptor signaling pathway (GO:0070562)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
vitamin D receptor signaling pathway (GO:0070561)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein secretion by platelet (GO:0070560)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of transcriptional start site selection at RNA polymerase II promoter (GO:0001178)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of actin cytoskeleton organization by cell-cell adhesion (GO:0090138)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transcriptional start site selection at RNA polymerase II promoter (GO:0001174)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
actin filament branching (GO:0090135)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcriptional start site selection (GO:0001173)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell migration involved in mesendoderm migration (GO:0090134)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA-templated transcription (GO:0001172)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of collateral sprouting (GO:0048671)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
mesendoderm migration (GO:0090133)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchyme migration (GO:0090131)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in sensory perception of touch (GO:0050976)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
sensory perception of touch (GO:0050975)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in equilibrioception (GO:0050973)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of synapse maturation (GO:0090129)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of synapse maturation (GO:0090128)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
neuron fate determination (GO:0048664)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
protein-containing complex assembly involved in synapse maturation (GO:0090126)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion involved in synapse maturation (GO:0090125)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell proliferation (GO:0048662)	75	0	1.25	-	 < 0.01	6.39E-01	1.00E00
response to linoleic acid (GO:0070543)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to platinum ion (GO:0070541)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of calcium ion (GO:0005513)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated cholesterol transport (GO:0090119)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
receptor-mediated endocytosis involved in cholesterol transport (GO:0090118)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
endosome to lysosome transport of low-density lipoprotein particle (GO:0090117)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
COPII-coated vesicle budding (GO:0090114)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
COPII-coated vesicle cargo loading (GO:0090110)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
protein K63-linked deubiquitination (GO:0070536)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
regulation of cell-substrate junction assembly (GO:0090109)	64	0	1.07	-	 < 0.01	6.30E-01	1.00E00
positive regulation of high-density lipoprotein particle assembly (GO:0090108)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
animal organ formation (GO:0048645)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
regulation of high-density lipoprotein particle assembly (GO:0090107)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle tissue development (GO:0048642)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pancreatic epsilon cell differentiation (GO:0090104)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
response to ceramide (GO:0106096)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of pigment cell differentiation (GO:0050942)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
glial cell projection elongation (GO:0106091)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle organ development (GO:0048635)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle tissue growth (GO:0048633)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle tissue growth (GO:0048632)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle tissue growth (GO:0048631)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
skeletal muscle tissue growth (GO:0048630)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell adhesion involved in sprouting angiogenesis (GO:0106089)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell adhesion involved in sprouting angiogenesis (GO:0106088)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pigment cell differentiation (GO:0050931)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
myoblast development (GO:0048627)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
myoblast fate specification (GO:0048626)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myoblast fate commitment (GO:0048625)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
post-embryonic digestive tract morphogenesis (GO:0048621)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycerol ether catabolic process (GO:0044269)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein-DNA complex remodeling (GO:0001120)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cholesterol import (GO:0070508)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA-templated DNA replication initiation (GO:0032298)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of positive chemotaxis (GO:0050928)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system axon ensheathment (GO:0032292)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system myelin formation (GO:0032290)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of negative chemotaxis (GO:0050925)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA modification (GO:1900864)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
embryonic hindgut morphogenesis (GO:0048619)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
aminoacyl-tRNA metabolism involved in translational fidelity (GO:0106074)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
embryonic foregut morphogenesis (GO:0048617)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106072)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
protein-DNA-RNA complex disassembly (GO:0001117)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106071)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
protein-DNA-RNA complex organization (GO:0001115)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
embryonic ectodermal digestive tract morphogenesis (GO:0048613)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcription open complex formation (GO:0001112)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
embryonic ectodermal digestive tract development (GO:0048611)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA polymerase II promoter clearance (GO:0001111)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
intestinal lipid catabolic process (GO:0044258)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system myelin maintenance (GO:0032287)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
central nervous system myelin maintenance (GO:0032286)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
sensory perception of sour taste (GO:0050915)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
sensory perception of salty taste (GO:0050914)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception of taste (GO:0050912)	52	0	.87	-	 < 0.01	1.00E00	1.00E00
regulation of cobalamin metabolic process (GO:0106064)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
promoter clearance during DNA-templated transcription (GO:0001109)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception of smell (GO:0050911)	347	0	5.78	-	 < 0.01	4.99E-03	2.36E-01
detection of mechanical stimulus involved in sensory perception of sound (GO:0050910)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of exit from mitosis (GO:0001100)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of gonadotropin secretion (GO:0032278)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of gonadotropin secretion (GO:0032277)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of gonadotropin secretion (GO:0032276)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
luteinizing hormone secretion (GO:0032275)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
gonadotropin secretion (GO:0032274)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcineurin-mediated signaling (GO:0106058)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcineurin-mediated signaling (GO:0106057)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
diapedesis (GO:0050904)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of calcineurin-mediated signaling (GO:0106056)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
leukocyte adhesive activation (GO:0050902)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leukocyte tethering or rolling (GO:0050901)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
lipid ubiquitination (GO:0120323)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipid modification by small protein conjugation (GO:0120322)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
IMP salvage (GO:0032264)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
GMP salvage (GO:0032263)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide salvage (GO:0032262)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
purine nucleotide salvage (GO:0032261)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
spermidine deacetylation (GO:0106048)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
polyamine deacetylation (GO:0106047)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
guanine deglycation, glyoxal removal (GO:0106046)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
guanine deglycation, methylglyoxal removal (GO:0106045)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
guanine deglycation (GO:0106044)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of GABA-A receptor activity (GO:0106040)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sperm mitochondrial sheath assembly (GO:0120317)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
establishment of secretory granule localization (GO:0032254)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900827)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900826)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900825)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein maturation by [4Fe-4S] cluster transfer (GO:0106035)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
protein maturation by [2Fe-2S] cluster transfer (GO:0106034)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
neuron projection fasciculation (GO:0106030)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
regulation of pigmentation (GO:0120305)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
background adaptation (GO:0120302)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
CTP salvage (GO:0044211)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
'de novo' CTP biosynthetic process (GO:0044210)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleoside transport (GO:0032244)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleoside transport (GO:0032243)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of nucleoside transport (GO:0032242)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleobase-containing compound transport (GO:0032241)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
neuron projection retraction (GO:0106028)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleobase-containing compound transport (GO:0032240)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
neuron projection organization (GO:0106027)	56	0	.93	-	 < 0.01	1.00E00	1.00E00
positive regulation of vesicle docking (GO:0106022)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
AMP salvage (GO:0044209)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
'de novo' AMP biosynthetic process (GO:0044208)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
UMP salvage (GO:0044206)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
'de novo' UMP biosynthetic process (GO:0044205)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of nucleobase-containing compound transport (GO:0032239)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
adenosine transport (GO:0032238)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
activation of store-operated calcium channel activity (GO:0032237)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic transmission, GABAergic (GO:0032229)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic transmission, dopaminergic (GO:0032227)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic transmission, cholinergic (GO:0032224)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic transmission, cholinergic (GO:0032223)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA 5'-cap (guanine-N7)-methylation (GO:0106005)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA (guanine-N7)-methylation (GO:0106004)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
intestinal hexose absorption (GO:0106001)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
riboflavin transport (GO:0032218)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance via telomerase (GO:0032211)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance via recombination (GO:0032208)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance via recombination (GO:0032207)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance (GO:0032205)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
telomere formation via telomerase (GO:0032203)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
telomere assembly (GO:0032202)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via semi-conservative replication (GO:0032201)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
symbiont-mediated disruption of host cell PML body (GO:0075342)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidic acid biosynthetic process (GO:1905695)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidic acid biosynthetic process (GO:1905693)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
renal amino acid absorption (GO:1990297)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of nerve growth factor receptor activity (GO:0051394)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA acetylation (GO:0051391)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of plasma membrane repair (GO:1905686)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of plasma membrane repair (GO:1905684)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotrophin TRK receptor signaling pathway (GO:0051388)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of neurotrophin TRK receptor signaling pathway (GO:0051387)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
modification of dendritic spine (GO:0098886)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neurotrophin TRK receptor signaling pathway (GO:0051386)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
postsynaptic neurotransmitter receptor internalization (GO:0098884)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
synapse pruning (GO:0098883)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
kinetochore organization (GO:0051383)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
kinetochore assembly (GO:0051382)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
RNA localization to chromatin (GO:1990280)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of adaptive immune memory response (GO:1905676)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of adaptive immune memory response (GO:1905675)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of adaptive immune memory response (GO:1905674)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of lysosome organization (GO:1905673)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of lysosome organization (GO:1905672)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of lysosome organization (GO:1905671)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
TORC2 complex disassembly (GO:1905670)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
action potential propagation (GO:0098870)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
TORC1 complex assembly (GO:1905669)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to endosome (GO:1905668)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to endosome (GO:1905667)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to endosome (GO:1905666)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
intramembranous bone growth (GO:0098867)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to gold nanoparticle (GO:1990268)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein decanoylation (GO:0051366)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to transition metal nanoparticle (GO:1990267)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to potassium ion starvation (GO:0051365)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
anti-Mullerian hormone receptor signaling pathway (GO:1990262)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pre-mRNA catabolic process (GO:1990261)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of artery morphogenesis (GO:1905653)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of artery morphogenesis (GO:1905652)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of artery morphogenesis (GO:1905651)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
signal clustering (GO:1990256)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidoreductase activity (GO:0051354)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of ligase activity (GO:0051351)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of double-strand break repair via single-strand annealing (GO:1901291)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of lyase activity (GO:0051350)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
succinyl-CoA biosynthetic process (GO:1901290)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proline import across plasma membrane (GO:1905647)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of cadmium ion (GO:0098849)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to acetaldehyde (GO:1905641)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
succinyl-CoA catabolic process (GO:1901289)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to acetaldehyde (GO:1905640)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051343)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of ligase activity (GO:0051340)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1905636)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to chromatin (GO:1905634)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cellular response to glyceraldehyde (GO:1905631)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
folate transmembrane transport (GO:0098838)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to glyceraldehyde (GO:1905630)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of serotonin biosynthetic process (GO:1905627)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic interphase (GO:0051329)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation of inhibitory postsynaptic potential (GO:0098828)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
meiotic M phase (GO:0051327)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
paranodal junction maintenance (GO:1990227)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
interphase (GO:0051325)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
prophase (GO:0051324)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
metaphase (GO:0051323)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA cap binding (GO:1905612)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
G2 phase (GO:0051319)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA cap binding (GO:1905610)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
G1 phase (GO:0051318)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage colony-stimulating factor production (GO:1901258)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage colony-stimulating factor production (GO:1901257)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
attachment of meiotic spindle microtubules to kinetochore (GO:0051316)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage colony-stimulating factor production (GO:1901256)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
spontaneous synaptic transmission (GO:0098814)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular transport of viral material (GO:1901253)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
auxin metabolic process (GO:0009850)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
meiotic metaphase chromosome alignment (GO:0051311)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
neurotransmitter reuptake (GO:0098810)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of lung goblet cell differentiation (GO:1901250)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephric cap mesenchymal cell proliferation (GO:0090096)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric cap mesenchymal cell proliferation (GO:0090095)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metanephric cap mesenchymal cell proliferation involved in metanephros development (GO:0090094)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle cell-matrix adhesion (GO:1905609)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of presynapse assembly (GO:1905608)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of presynapse assembly (GO:1905607)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of presynapse assembly (GO:1905606)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood-brain barrier permeability (GO:1905604)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905602)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905601)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
female meiosis chromosome separation (GO:0051309)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of lung goblet cell differentiation (GO:1901249)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905600)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
male meiosis chromosome separation (GO:0051308)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of lung ciliated cell differentiation (GO:1901248)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic chromosome separation (GO:0051307)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
mitotic sister chromatid separation (GO:0051306)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lung ciliated cell differentiation (GO:1901246)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
chromosome separation (GO:0051304)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of renal system process (GO:0098801)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
regulation of dipeptide transport (GO:0090089)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of oligopeptide transport (GO:0090088)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein deubiquitination (GO:0090086)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of protein deubiquitination (GO:0090085)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of inclusion body assembly (GO:0090084)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of inclusion body assembly (GO:0090083)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway (GO:0090080)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
abscission (GO:0009838)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
foam cell differentiation (GO:0090077)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
relaxation of skeletal muscle (GO:0090076)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
relaxation of muscle (GO:0090075)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein homodimerization activity (GO:0090074)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ribosome biogenesis (GO:0090071)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of ribosome biogenesis (GO:0090070)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
interleukin-1-mediated signaling pathway (GO:0070498)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of thrombin-activated receptor signaling pathway (GO:0070495)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
multidimensional cell growth (GO:0009825)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of thrombin-activated receptor signaling pathway (GO:0070494)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
alkaloid catabolic process (GO:0009822)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
alkaloid metabolic process (GO:0009820)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of ribosome biogenesis (GO:0090069)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of thalamus size (GO:0090067)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule nucleation (GO:0090063)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
T cell aggregation (GO:0070489)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neutrophil aggregation (GO:0070488)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of hypoxia (GO:0070483)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
flavonoid metabolic process (GO:0009812)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
stilbene metabolic process (GO:0009810)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac chamber formation (GO:1901211)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac chamber formation (GO:1901210)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oocyte development (GO:0048599)	59	0	.98	-	 < 0.01	6.29E-01	1.00E00
post-embryonic camera-type eye morphogenesis (GO:0048597)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
rRNA (guanine-N7)-methylation (GO:0070476)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
rRNA base methylation (GO:0070475)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart looping (GO:1901208)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of uterine smooth muscle contraction (GO:0070474)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of heart looping (GO:1901207)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
coumarin metabolic process (GO:0009804)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of uterine smooth muscle contraction (GO:0070473)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of uterine smooth muscle contraction (GO:0070472)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
uterine smooth muscle contraction (GO:0070471)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of extracellular matrix assembly (GO:1901203)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of extracellular matrix assembly (GO:1901202)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular matrix assembly (GO:1901201)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
determination of affect (GO:0050894)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sensory processing (GO:0050893)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
multicellular organismal-level water homeostasis (GO:0050891)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of cell migration involved in sprouting angiogenesis (GO:0090049)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
positive regulation of deacetylase activity (GO:0090045)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of tubulin deacetylation (GO:0090044)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tubulin deacetylation (GO:0090042)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
plus-end specific microtubule depolymerization (GO:0070462)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
thyroid-stimulating hormone secretion (GO:0070460)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
voluntary musculoskeletal movement (GO:0050882)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein kinase C signaling (GO:0090037)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of chaperone-mediated protein complex assembly (GO:0090035)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of chaperone-mediated protein complex assembly (GO:0090034)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
long-day photoperiodism (GO:0048571)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid hormone biosynthetic process (GO:0090031)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
prolactin secretion (GO:0070459)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of nitrogen compound (GO:0070458)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of heme biosynthetic process (GO:0070455)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of heme biosynthetic process (GO:0070453)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
brown fat cell differentiation (GO:0050873)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
white fat cell differentiation (GO:0050872)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
ectodermal digestive tract morphogenesis (GO:0048567)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of monocyte chemotaxis (GO:0090026)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
establishment of animal organ orientation (GO:0048561)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of anatomical structure orientation (GO:0048560)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of oligodendrocyte progenitor proliferation (GO:0070447)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of oligodendrocyte progenitor proliferation (GO:0070446)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of oligodendrocyte progenitor proliferation (GO:0070445)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte progenitor proliferation (GO:0070444)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell receptor signaling pathway (GO:0050861)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
embryonic digestive tract morphogenesis (GO:0048557)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of pinocytosis (GO:0048550)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070434)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070433)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070430)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell receptor signaling pathway (GO:0050859)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of B cell receptor signaling pathway (GO:0050855)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
B cell receptor signaling pathway (GO:0050853)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
positive regulation of pinocytosis (GO:0048549)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of pinocytosis (GO:0048548)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
primitive streak formation (GO:0090009)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of cerebral blood circulation (GO:0120277)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cerebral blood circulation (GO:0120276)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070429)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070428)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0070426)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0070425)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0070424)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
antibiotic metabolic process (GO:0016999)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium-mediated signaling (GO:0050849)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
progesterone receptor signaling pathway (GO:0050847)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
bone marrow development (GO:0048539)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
thymus development (GO:0048538)	60	0	1.00	-	 < 0.01	6.29E-01	1.00E00
anatomical structure arrangement (GO:0048532)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
defense response to fungus (GO:0050832)	56	0	.93	-	 < 0.01	1.00E00	1.00E00
olefinic compound catabolic process (GO:0120256)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
carbamoyl phosphate biosynthetic process (GO:0070409)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
olefinic compound biosynthetic process (GO:0120255)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
carbamoyl phosphate metabolic process (GO:0070408)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oxidation-dependent protein catabolic process (GO:0070407)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hydrocarbon catabolic process (GO:0120253)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
hydrocarbon metabolic process (GO:0120252)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
retrotransposition (GO:0032197)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
transposition (GO:0032196)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate (GO:0032194)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to freezing (GO:0050826)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptide antigen stabilization (GO:0050823)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptide stabilization (GO:0050822)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of coagulation (GO:0050820)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
septin cytoskeleton organization (GO:0032185)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
doxorubicin transport (GO:1900753)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of acyl-CoA biosynthetic process (GO:0050812)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of timing of cell differentiation (GO:0048505)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
protein deglycation, methylglyoxal removal (GO:0036530)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
(R)-carnitine transport (GO:1900749)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of p38MAPK cascade (GO:1900745)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
regulation of p38MAPK cascade (GO:1900744)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle, sleep (GO:0050802)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to motile cilium (GO:0120229)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein deglycation, glyoxal removal (GO:0036529)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine deglycation (GO:0036528)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine deglycation (GO:0036527)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine deglycation (GO:0036526)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein deglycation (GO:0036525)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
larynx development (GO:0120224)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
larynx morphogenesis (GO:0120223)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of blastocyst development (GO:0120222)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
maintenance of ciliary planar beating movement pattern (GO:0120221)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
astrocyte-dopaminergic neuron signaling (GO:0036520)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900738)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900737)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900736)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:1900731)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chemoattraction of serotonergic neuron axon (GO:0036517)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chemoattraction of dopaminergic neuron axon (GO:0036516)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
serotonergic neuron axon guidance (GO:0036515)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
proacrosomal vesicle fusion (GO:0120211)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
trimming of terminal mannose on C branch (GO:0036510)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:1900729)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation by symbiont of entry into host (GO:0075294)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of uterine smooth muscle relaxation (GO:1900721)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein alpha-1,2-demannosylation (GO:0036508)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein demannosylation (GO:0036507)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
maintenance of unfolded protein (GO:0036506)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
formation of structure involved in a symbiotic process (GO:0044111)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
activation of protein kinase B activity (GO:0032148)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
activation of protein kinase activity (GO:0032147)	72	0	1.20	-	 < 0.01	6.36E-01	1.00E00
protein desumoylation (GO:0016926)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of uterine smooth muscle relaxation (GO:1900719)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
sequestering of zinc ion (GO:0032119)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of carbohydrate phosphatase activity (GO:0032113)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to nutrient levels (GO:0032109)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to nutrient levels (GO:0032108)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
regulation of response to nutrient levels (GO:0032107)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
positive regulation of appetite (GO:0032100)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cell dedifferentiation (GO:0043697)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
dedifferentiation (GO:0043696)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
reverse cholesterol transport (GO:0043691)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of low-density lipoprotein receptor activity (GO:1905599)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of low-density lipoprotein receptor activity (GO:1905598)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of low-density lipoprotein particle receptor binding (GO:1905597)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of low-density lipoprotein particle receptor binding (GO:1905596)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of low-density lipoprotein particle receptor binding (GO:1905595)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of optical nerve axon regeneration (GO:1905592)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of optical nerve axon regeneration (GO:1905591)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
centrosome separation (GO:0051299)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
fibronectin fibril organization (GO:1905590)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of meiotic spindle orientation (GO:0051296)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
global gene silencing by mRNA cleavage (GO:0098795)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
co-translational protein modification (GO:0043686)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of meiotic spindle localization (GO:0051295)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
establishment of spindle orientation (GO:0051294)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
xenophagy (GO:0098792)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
nuclear pore complex assembly (GO:0051292)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
protein heterooligomerization (GO:0051291)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
protein heterotetramerization (GO:0051290)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
induction of programmed cell death (GO:0012502)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-arginine import across plasma membrane (GO:1905589)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of outer hair cell apoptotic process (GO:1905586)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of outer hair cell apoptotic process (GO:1905585)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
outer hair cell apoptotic process (GO:1905584)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of low-density lipoprotein particle clearance (GO:1905581)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of ERBB3 signaling pathway (GO:1905580)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
biofilm matrix disassembly (GO:0098786)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
biofilm matrix organization (GO:0098784)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
response to mitochondrial depolarisation (GO:0098780)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
exosomal secretion (GO:1990182)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA 3'-end processing (GO:1990180)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of ERBB3 signaling pathway (GO:1905578)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ganglioside GM1 transport to membrane (GO:1905572)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to nucleoplasm (GO:1990173)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor catabolic process (GO:1990172)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
stress response to cadmium ion (GO:1990170)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial cell proliferation (GO:1905563)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
lncRNA-mediated post-transcriptional gene silencing (GO:0000512)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
meiotic prometaphase I (GO:0098768)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
stress response to copper ion (GO:1990169)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein K33-linked deubiquitination (GO:1990168)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein K27-linked deubiquitination (GO:1990167)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
meiosis I cell cycle phase (GO:0098764)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
protein localization to site of double-strand break (GO:1990166)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
mitotic cell cycle phase (GO:0098763)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
recognition of apoptotic cell (GO:0043654)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
meiotic cell cycle phase (GO:0098762)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
mitochondrial fragmentation involved in apoptotic process (GO:0043653)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
engulfment of apoptotic cell (GO:0043652)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
protein depolymerization (GO:0051261)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
dicarboxylic acid biosynthetic process (GO:0043650)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood vessel branching (GO:1905555)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of blood vessel branching (GO:1905553)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to endoplasmic reticulum (GO:1905552)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-8 (GO:0098759)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to endoplasmic reticulum (GO:1905551)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to interleukin-8 (GO:0098758)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to endoplasmic reticulum (GO:1905550)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
dicarboxylic acid catabolic process (GO:0043649)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
meiotic spindle midzone assembly (GO:0051257)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cell cycle, embryonic (GO:0009794)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mitotic spindle midzone assembly (GO:0051256)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
spindle midzone assembly (GO:0051255)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of formation of translation preinitiation complex (GO:1901194)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of formation of translation preinitiation complex (GO:1901193)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
bone cell development (GO:0098751)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cellular response to nutrient (GO:0031670)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
cellular response to phenylpropanoid (GO:1905546)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of abscisic acid-activated signaling pathway (GO:0009789)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebellar neuron development (GO:0098749)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of L-arginine import across plasma membrane (GO:1905541)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of abscisic acid-activated signaling pathway (GO:0009787)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of ephrin receptor signaling pathway (GO:1901189)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of asymmetric cell division (GO:0009786)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
fast, calcium ion-dependent exocytosis of neurotransmitter (GO:0098746)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ephrin receptor signaling pathway (GO:1901187)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of ERBB signaling pathway (GO:1901186)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
cell aggregation (GO:0098743)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
maintenance of translational fidelity (GO:1990145)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
polyadenylation-dependent ncRNA catabolic process (GO:0043634)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to hypoxia (GO:1990144)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
polyadenylation-dependent RNA catabolic process (GO:0043633)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of postsynapse to nucleus signaling pathway (GO:1905539)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905537)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905535)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-leucine import across plasma membrane (GO:1905534)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of L-leucine import across plasma membrane (GO:1905533)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of L-leucine import across plasma membrane (GO:1905532)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
sequestering of metal ion (GO:0051238)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein insertion into plasma membrane (GO:0098737)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulatory ncRNA 3'-end processing (GO:0043628)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of the force of heart contraction (GO:0098736)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of the force of heart contraction (GO:0098735)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
lycopene catabolic process (GO:1901176)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
macromolecule depalmitoylation (GO:0098734)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
lycopene metabolic process (GO:1901175)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
macromolecule deacylation (GO:0098732)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
epithelial cell apoptotic process involved in palatal shelf morphogenesis (GO:1990134)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
meiotic spindle elongation (GO:0051232)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cortical microtubule organization (GO:0043622)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
spindle elongation (GO:0051231)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
spindle disassembly (GO:0051230)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
naphthalene catabolic process (GO:1901170)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of heat generation (GO:0031652)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of heat generation (GO:0031651)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of Golgi lumen acidification (GO:1905528)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi lumen acidification (GO:1905526)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein autoubiquitination (GO:1905524)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage migration (GO:1905523)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
germline stem cell asymmetric division (GO:0098728)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of presynaptic active zone assembly (GO:1905520)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic spindle disassembly (GO:0051228)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
symmetric cell division (GO:0098725)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neural crest cell migration involved in autonomic nervous system development (GO:1901166)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1990127)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of trophoblast cell migration (GO:1901165)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
astrocyte cell migration (GO:0043615)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of trophoblast cell migration (GO:1901164)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
asymmetric stem cell division (GO:0098722)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of trophoblast cell migration (GO:1901163)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
primary amino compound biosynthetic process (GO:1901162)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
primary amino compound catabolic process (GO:1901161)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of protein (GO:0051220)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
regulation of carbohydrate utilization (GO:0043610)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heat generation (GO:0031649)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
protein destabilization (GO:0031648)	59	0	.98	-	 < 0.01	6.29E-01	1.00E00
positive regulation of myelination (GO:0031643)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of myelination (GO:0031642)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of myelination (GO:0031641)	61	0	1.02	-	 < 0.01	6.29E-01	1.00E00
regulation of presynaptic active zone assembly (GO:1905518)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of fertilization (GO:1905516)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of short-term synaptic potentiation (GO:1905513)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of short-term synaptic potentiation (GO:1905512)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
carbohydrate utilization (GO:0009758)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hexose mediated signaling (GO:0009757)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
serine import across plasma membrane (GO:0098718)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
xylulose 5-phosphate biosynthetic process (GO:1901159)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
carbohydrate mediated signaling (GO:0009756)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of carbon utilization (GO:0043609)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
B cell receptor apoptotic signaling pathway (GO:1990117)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to jasmonic acid (GO:0009753)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
formamide metabolic process (GO:0043606)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
amide catabolic process (GO:0043605)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
RNA polymerase III assembly (GO:1990115)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to salicylic acid (GO:0009751)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
L-glutamate import across plasma membrane (GO:0098712)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
RNA polymerase II core complex assembly (GO:1990114)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to fructose (GO:0009750)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
iron ion import across plasma membrane (GO:0098711)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA polymerase I assembly (GO:1990113)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nitrate catabolic process (GO:0043602)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
plasminogen activation (GO:0031639)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:0031635)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule organizing center (GO:1905508)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of motile cilium assembly (GO:1905505)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of motile cilium assembly (GO:1905503)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
D-glucose import across plasma membrane (GO:0098708)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
sequestering of calcium ion (GO:0051208)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
gene expression involved in extracellular matrix organization (GO:1901148)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
iron ion import across cell outer membrane (GO:0098706)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein linear deubiquitination (GO:1990108)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to sucrose (GO:0009744)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
copper ion import across plasma membrane (GO:0098705)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein insertion into membrane (GO:0051205)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
carbohydrate import across plasma membrane (GO:0098704)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:1901145)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial membrane (GO:0051204)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
insulin catabolic process (GO:1901143)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
insulin metabolic process (GO:1901142)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
neurotransmitter loading into synaptic vesicle (GO:0098700)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
telomeric loop formation (GO:0031627)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of fever generation (GO:0031622)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
homologous chromosome orientation in meiotic metaphase I (GO:0031619)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of lipoteichoic acid (GO:0070392)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA-guanine transglycosylation (GO:0101030)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic nuclear membrane organization (GO:0101024)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
Harderian gland development (GO:0070384)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
vascular endothelial cell proliferation (GO:0101023)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA cytosine deamination (GO:0070383)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle membrane organization (GO:0048499)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
maintenance of animal organ identity (GO:0048496)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
anterograde synaptic vesicle transport (GO:0048490)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of ERK5 cascade (GO:0070378)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ERK5 cascade (GO:0070376)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
ERK5 cascade (GO:0070375)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ERK1 and ERK2 cascade (GO:0070371)	60	0	1.00	-	 < 0.01	6.29E-01	1.00E00
cellular heat acclimation (GO:0070370)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
activated T cell proliferation (GO:0050798)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
parasympathetic nervous system development (GO:0048486)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatocyte differentiation (GO:0070368)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatocyte differentiation (GO:0070367)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of hepatocyte differentiation (GO:0070366)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
hepatocyte differentiation (GO:0070365)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
detoxification of mercury ion (GO:0050787)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
oogenesis (GO:0048477)	118	0	1.97	-	 < 0.01	2.72E-01	1.00E00
actin polymerization-dependent cell motility (GO:0070358)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of white fat cell proliferation (GO:0070352)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of white fat cell proliferation (GO:0070351)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of white fat cell proliferation (GO:0070350)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
RNA destabilization (GO:0050779)	80	0	1.33	-	 < 0.01	6.46E-01	1.00E00
positive regulation of dendrite morphogenesis (GO:0050775)	65	0	1.08	-	 < 0.01	6.30E-01	1.00E00
PERK-mediated unfolded protein response (GO:0036499)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
IRE1-mediated unfolded protein response (GO:0036498)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of brown fat cell proliferation (GO:0070349)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of brown fat cell proliferation (GO:0070348)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036494)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of brown fat cell proliferation (GO:0070347)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tight junction organization (GO:0120193)	77	0	1.28	-	 < 0.01	6.42E-01	1.00E00
positive regulation of translation in response to endoplasmic reticulum stress (GO:0036493)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of fat cell proliferation (GO:0070346)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
tight junction assembly (GO:0120192)	74	0	1.23	-	 < 0.01	6.38E-01	1.00E00
eiF2alpha phosphorylation in response to endoplasmic reticulum stress (GO:0036492)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of fat cell proliferation (GO:0070345)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of termination of RNA polymerase II transcription (GO:0120191)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036491)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of fat cell proliferation (GO:0070344)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of bile acid secretion (GO:0120190)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of translation in response to endoplasmic reticulum stress (GO:0036490)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
white fat cell proliferation (GO:0070343)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
brown fat cell proliferation (GO:0070342)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
fat cell proliferation (GO:0070341)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
detection of bacterial lipopeptide (GO:0070340)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of bile acid secretion (GO:0120189)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of bile acid secretion (GO:0120188)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to chromatin (GO:0120187)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to chromatin (GO:0120186)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
ventral trunk neural crest cell migration (GO:0036486)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to bacterial lipopeptide (GO:0070339)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
trunk neural crest cell migration (GO:0036484)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of focal adhesion disassembly (GO:0120183)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0036483)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of focal adhesion disassembly (GO:0120182)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
focal adhesion disassembly (GO:0120181)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:0036481)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of vacuole organization (GO:0044090)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
cell-substrate junction disassembly (GO:0120180)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neuron intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0036480)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
adherens junction disassembly (GO:0120179)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vacuole organization (GO:0044088)	59	0	.98	-	 < 0.01	6.29E-01	1.00E00
steroid hormone biosynthetic process (GO:0120178)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
triglyceride homeostasis (GO:0070328)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
thyroid hormone transport (GO:0070327)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by BDNF (GO:0099191)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to glyoxal (GO:0036471)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein metabolic process (GO:0050748)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipoprotein metabolic process (GO:0050747)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein metabolic process (GO:0050746)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
presynaptic cytoskeleton organization (GO:0099187)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
detection of hot stimulus involved in thermoception (GO:0120168)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle recycling via endosome (GO:0036466)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by BDNF, modulating synaptic transmission (GO:0099183)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of G0 to G1 transition (GO:0070318)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of G0 to G1 transition (GO:0070317)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cold-induced thermogenesis (GO:0120163)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
regulation of G0 to G1 transition (GO:0070316)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
zinc ion import into synaptic vesicle (GO:0099180)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
TRAIL-activated apoptotic signaling pathway (GO:0036462)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
G1 to G0 transition involved in cell differentiation (GO:0070315)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
G1 to G0 transition (GO:0070314)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
olefin metabolic process (GO:1900673)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)	50	0	.83	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic membrane adhesion (GO:0099179)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde trans-synaptic signaling by endocanabinoid (GO:0099178)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of collagen catabolic process (GO:0120158)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of presynapse organization (GO:0099174)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
regulation of respiratory system process (GO:0044065)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
lens fiber cell morphogenesis (GO:0070309)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
lens fiber cell development (GO:0070307)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of excretion (GO:0044062)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
lens fiber cell differentiation (GO:0070306)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
response to cGMP (GO:0070305)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of appetite (GO:0032099)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of stress-activated protein kinase signaling cascade (GO:0070302)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to food (GO:0032097)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to food (GO:0032096)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
regulation of response to food (GO:0032095)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
response to food (GO:0032094)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein binding (GO:0032091)	80	0	1.33	-	 < 0.01	6.46E-01	1.00E00
regulation of digestive system process (GO:0044058)	53	0	.88	-	 < 0.01	1.00E00	1.00E00
myofibroblast differentiation (GO:0036446)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
synaptic signaling by nitric oxide (GO:0099163)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neuronal stem cell division (GO:0036445)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neurotransmitter loading into synaptic vesicle (GO:0099162)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
calcium import into the mitochondrion (GO:0036444)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of presynaptic dense core granule exocytosis (GO:0099161)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of recycling endosome localization within postsynapse (GO:0099158)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of lens transparency (GO:0036438)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0099152)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic density assembly (GO:0099151)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of endodeoxyribonuclease activity (GO:0032079)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of endodeoxyribonuclease activity (GO:0032078)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of deoxyribonuclease activity (GO:0032077)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of deoxyribonuclease activity (GO:0032076)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclease activity (GO:0032075)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclease activity (GO:0032074)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of restriction endodeoxyribonuclease activity (GO:0032072)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of endodeoxyribonuclease activity (GO:0032071)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of deoxyribonuclease activity (GO:0032070)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of exocytic insertion of neurotransmitter receptor to postsynaptic membrane (GO:0099145)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to zinc ion starvation (GO:0120127)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
presynaptic actin cytoskeleton organization (GO:0099140)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of nuclease activity (GO:0032069)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
positive regulation of gene expression via chromosomal CpG island demethylation (GO:0044029)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of gene expression via chromosomal CpG island methylation (GO:0044027)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
T cell meandering migration (GO:0120117)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA destabilization (GO:0036417)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA stabilization (GO:0036416)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of tRNA stability (GO:0036415)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation in response to stress (GO:0032058)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of translational initiation in response to stress (GO:0032057)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of translation in response to stress (GO:0032056)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of translation in response to stress (GO:0032055)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
acetate ester biosynthetic process (GO:1900620)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
somato-dendritic dopamine secretion (GO:0099123)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiolipin biosynthetic process (GO:0032049)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
acetate ester metabolic process (GO:1900619)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial DNA catabolic process (GO:0032043)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial DNA metabolic process (GO:0032042)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
tRNA 5'-end processing (GO:0099116)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
box H/ACA sno(s)RNA 3'-end processing (GO:0000495)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
box C/D sno(s)RNA 3'-end processing (GO:0000494)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
box H/ACA snoRNP assembly (GO:0000493)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
box C/D snoRNP assembly (GO:0000492)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
small nucleolar ribonucleoprotein complex assembly (GO:0000491)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
potassium channel activating, G protein-coupled receptor signaling pathway (GO:0099109)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maturation of 5S rRNA (GO:0000481)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to magnesium ion (GO:0032026)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
response to cobalt ion (GO:0032025)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
trypsinogen activation (GO:0032023)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ISG15-protein conjugation (GO:0032020)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
maturation of LSU-rRNA (GO:0000470)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of ARF protein signal transduction (GO:0032014)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ARF protein signal transduction (GO:0032013)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ARF protein signal transduction (GO:0032011)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000461)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maturation of 5.8S rRNA (GO:0000460)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolate interconversion (GO:0035999)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
detection of muscle stretch (GO:0035995)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
deltoid tuberosity development (GO:0035993)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
tendon formation (GO:0035992)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
tendon cell differentiation (GO:0035990)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of fatty acid beta-oxidation (GO:0032000)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
enzyme-directed rRNA pseudouridine synthesis (GO:0000455)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
snoRNA guided rRNA pseudouridine synthesis (GO:0000454)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
rRNA 2'-O-methylation (GO:0000451)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tendon development (GO:0035989)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
endodermal cell differentiation (GO:0035987)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
cellular response to trichostatin A (GO:0035984)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to trichostatin A (GO:0035983)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
endocytic hemoglobin import into cell (GO:0020028)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to host (GO:0075136)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hemoglobin metabolic process (GO:0020027)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of branching morphogenesis of a nerve (GO:1905492)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
skin morphogenesis (GO:0043589)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
tongue morphogenesis (GO:0043587)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tongue development (GO:0043586)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0098694)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aggrephagy (GO:0035973)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
calcium-dependent self proteolysis (GO:1990092)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
sodium-dependent self proteolysis (GO:1990091)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-histidine dephosphorylation (GO:0035971)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to nerve growth factor stimulus (GO:1990090)	60	0	1.00	-	 < 0.01	6.29E-01	1.00E00
peptidyl-threonine dephosphorylation (GO:0035970)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of motor neuron migration (GO:1905485)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
carbon catabolite activation of transcription from RNA polymerase II promoter (GO:0000436)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of motor neuron migration (GO:1905483)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter by glucose (GO:0000432)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
prosthetic group metabolic process (GO:0051189)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter by galactose (GO:0000431)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to nerve growth factor (GO:1990089)	62	0	1.03	-	 < 0.01	6.29E-01	1.00E00
regulation of transcription from RNA polymerase II promoter by glucose (GO:0000430)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
nuclear matrix organization (GO:0043578)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of respiratory gaseous exchange (GO:0043576)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
lens fiber cell apoptotic process (GO:1990086)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
peroxisomal transport (GO:0043574)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
COPI-coated vesicle budding (GO:0035964)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-13 (GO:0035963)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to interleukin-13 (GO:0035962)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
maintenance of DNA repeat elements (GO:0043570)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
pexophagy (GO:0000425)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
mitophagy (GO:0000423)	53	0	.88	-	 < 0.01	1.00E00	1.00E00
autophagy of mitochondrion (GO:0000422)	72	0	1.20	-	 < 0.01	6.36E-01	1.00E00
cartilage homeostasis (GO:1990079)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
meiotic sister chromatid cohesion (GO:0051177)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of sulfur metabolic process (GO:0051176)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
polyuridylation-dependent mRNA catabolic process (GO:1990074)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to nitrogen levels (GO:0043562)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
entry receptor-mediated virion attachment to host cell (GO:0098670)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
wybutosine biosynthetic process (GO:0031591)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
wybutosine metabolic process (GO:0031590)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA duplex unwinding (GO:1905464)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA duplex unwinding (GO:1905463)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA duplex unwinding (GO:1905462)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein peptidyl-prolyl isomerization (GO:0000413)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell apoptotic process (GO:1905460)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by galactose (GO:0000411)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation in response to stress (GO:0043558)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
xylulose 5-phosphate metabolic process (GO:0051167)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of translation in response to oxidative stress (GO:0043556)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA surveillance (GO:0035946)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of translation in response to stress (GO:0043555)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
xylitol metabolic process (GO:0051164)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial ncRNA surveillance (GO:0035945)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
perforin production (GO:0035944)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
xylitol catabolic process (GO:0051160)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031587)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031585)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
activation of phospholipase D activity (GO:0031584)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phospholipase D-activating G protein-coupled receptor signaling pathway (GO:0031583)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
hemidesmosome assembly (GO:0031581)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
membrane raft distribution (GO:0031580)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphoid progenitor cell differentiation (GO:1905458)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of transcription by galactose (GO:0000409)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphoid progenitor cell differentiation (GO:1905457)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of lymphoid progenitor cell differentiation (GO:1905456)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid progenitor cell differentiation (GO:1905455)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of myeloid progenitor cell differentiation (GO:1905454)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid progenitor cell differentiation (GO:1905453)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
phenylpropanoid metabolic process (GO:0009698)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905451)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inorganic anion import across plasma membrane (GO:0098658)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of signal transduction in absence of ligand (GO:1901099)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905450)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagosome maturation (GO:1901098)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of autophagosome maturation (GO:1901097)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
glucose 6-phosphate metabolic process (GO:0051156)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
regulation of autophagosome maturation (GO:1901096)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of striated muscle cell differentiation (GO:0051155)	60	0	1.00	-	 < 0.01	6.29E-01	1.00E00
molybdopterin cofactor metabolic process (GO:0043545)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle cell differentiation (GO:0051154)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
cytokinin biosynthetic process (GO:0009691)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of striated muscle cell differentiation (GO:0051153)	108	0	1.80	-	 < 0.01	2.69E-01	1.00E00
cytokinin metabolic process (GO:0009690)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
corticosterone secretion (GO:0035934)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle cell differentiation (GO:0051152)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
glucocorticoid secretion (GO:0035933)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell differentiation (GO:0051151)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
aldosterone secretion (GO:0035932)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle cell differentiation (GO:0051150)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
activation of protein kinase C activity (GO:1990051)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mineralocorticoid secretion (GO:0035931)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
corticosteroid hormone secretion (GO:0035930)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
spindle checkpoint signaling (GO:0031577)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
mitotic intra-S DNA damage checkpoint signaling (GO:0031573)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905448)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905447)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905446)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of clathrin coat assembly (GO:1905445)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle cell differentiation (GO:0051148)	71	0	1.18	-	 < 0.01	6.35E-01	1.00E00
retrograde neuronal dense core vesicle transport (GO:1990049)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
steroid hormone secretion (GO:0035929)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
anterograde neuronal dense core vesicle transport (GO:1990048)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
rRNA import into mitochondrion (GO:0035928)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
benzylpenicillin metabolic process (GO:1901086)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
indoleacetic acid metabolic process (GO:0009683)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA import into mitochondrion (GO:0035927)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell differentiation (GO:0051145)	54	0	.90	-	 < 0.01	1.00E00	1.00E00
stress-induced mitochondrial fusion (GO:1990046)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
induced systemic resistance (GO:0009682)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of NK T cell proliferation (GO:0051142)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of relaxation of smooth muscle (GO:1901082)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of NK T cell proliferation (GO:0051141)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of relaxation of smooth muscle (GO:1901081)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
foramen ovale closure (GO:0035922)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of NK T cell proliferation (GO:0051140)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of relaxation of smooth muscle (GO:1901080)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
desmosome disassembly (GO:0035921)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of relaxation of muscle (GO:1901079)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to glycine (GO:1905430)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of NK T cell differentiation (GO:0051138)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of relaxation of muscle (GO:1901078)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of relaxation of muscle (GO:1901077)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
regulation of NK T cell differentiation (GO:0051136)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of engulfment of apoptotic cell (GO:1901076)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of NK T cell activation (GO:0051135)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
calcium ion import into sarcoplasmic reticulum (GO:1990036)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of NK T cell activation (GO:0051134)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of engulfment of apoptotic cell (GO:1901074)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of NK T cell activation (GO:0051133)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
glucosamine-containing compound biosynthetic process (GO:1901073)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
calcium ion export across plasma membrane (GO:1990034)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
NK T cell activation (GO:0051132)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
glucosamine-containing compound catabolic process (GO:1901072)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated protein complex assembly (GO:0051131)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
glucosamine-containing compound metabolic process (GO:1901071)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
dorsal aorta morphogenesis (GO:0035912)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of termination of DNA-templated transcription (GO:0031554)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031550)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to glycine (GO:1905429)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
trans-Golgi network membrane organization (GO:0098629)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
guanosine-containing compound catabolic process (GO:1901069)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of myosin II filament organization (GO:0043519)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
guanosine-containing compound metabolic process (GO:1901068)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vasomotion (GO:1990029)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin nucleation (GO:0051127)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin nucleation (GO:0051126)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
dorsal aorta development (GO:0035907)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
descending aorta development (GO:0035906)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic assembly at neuromuscular junction (GO:0051124)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
hepoxilin biosynthetic process (GO:0051122)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
cellular response to immobilization stress (GO:0035903)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hepoxilin metabolic process (GO:0051121)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
response to immobilization stress (GO:0035902)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
negative regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031549)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to isolation stress (GO:0035900)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031548)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of JUN kinase activity (GO:0043508)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of JUN kinase activity (GO:0043507)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
regulation of JUN kinase activity (GO:0043506)	63	0	1.05	-	 < 0.01	6.29E-01	1.00E00
mitochondrial DNA repair (GO:0043504)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
sarcosine catabolic process (GO:1901053)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
skeletal muscle fiber adaptation (GO:0043503)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
sarcosine metabolic process (GO:1901052)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
skeletal muscle adaptation (GO:0043501)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
muscle adaptation (GO:0043500)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
positive regulation of exit from mitosis (GO:0031536)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of creatine transmembrane transporter activity (GO:1905408)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of creatine transmembrane transporter activity (GO:1905407)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905404)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905403)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
entrainment of circadian clock (GO:0009649)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905402)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
photoperiodism (GO:0009648)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
response to absence of light (GO:0009646)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
retinal cell apoptotic process (GO:1990009)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
response to low light intensity stimulus (GO:0009645)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA ligation (GO:0051106)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of DNA ligation (GO:0051105)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA ligation involved in DNA recombination (GO:0051102)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of binding (GO:0051100)	144	0	2.40	-	 < 0.01	1.82E-01	1.00E00
amyloid fibril formation (GO:1990000)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
response to red or far red light (GO:0009639)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to blue light (GO:0009637)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to herbicide (GO:0009635)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-glutamine import across plasma membrane (GO:1901036)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of L-glutamine import across plasma membrane (GO:1901034)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cold acclimation (GO:0009631)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to reactive oxygen species (GO:1901033)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to reactive oxygen species (GO:1901032)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of response to reactive oxygen species (GO:1901031)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
response to gravity (GO:0009629)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
sarcoplasmic reticulum calcium ion transport (GO:0070296)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
renal water absorption (GO:0070295)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
renal sodium ion absorption (GO:0070294)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
dextrin catabolic process (GO:1901027)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to nematode (GO:0009624)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
renal absorption (GO:0070293)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
ripoptosome assembly involved in necroptotic process (GO:1901026)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
N-acylphosphatidylethanolamine metabolic process (GO:0070292)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
N-acylethanolamine metabolic process (GO:0070291)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to fungus (GO:0009620)	69	0	1.15	-	 < 0.01	6.33E-01	1.00E00
positive regulation of calcium ion transmembrane transporter activity (GO:1901021)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
subtelomeric heterochromatin formation (GO:0031509)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
pericentric heterochromatin formation (GO:0031508)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
pigment cell development (GO:0070285)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion transmembrane transporter activity (GO:1901018)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
intermediate mesodermal cell differentiation (GO:0048392)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intermediate mesoderm formation (GO:0048391)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intermediate mesoderm morphogenesis (GO:0048390)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to symbiotic bacterium (GO:0009609)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
extracellular matrix constituent secretion (GO:0070278)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to symbiont (GO:0009608)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte adhesion to arterial endothelial cell (GO:1904999)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte adhesion to arterial endothelial cell (GO:1904998)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte adhesion to arterial endothelial cell (GO:1904997)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of fermentation (GO:1901003)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904992)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904990)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of response to salt stress (GO:1901000)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
intermediate mesoderm development (GO:0048389)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
endosomal lumen acidification (GO:0048388)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of retinoic acid receptor signaling pathway (GO:0048387)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of retinoic acid receptor signaling pathway (GO:0048386)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of retinoic acid receptor signaling pathway (GO:0048385)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
retinoic acid receptor signaling pathway (GO:0048384)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
pyroptotic inflammatory response (GO:0070269)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
necroptotic process (GO:0070266)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelial cell activation (GO:1904988)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell activation (GO:1904987)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of quinolinate biosynthetic process (GO:1904985)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine dephosphorylation (GO:0070262)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of quinolinate biosynthetic process (GO:1904984)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycine import into mitochondrion (GO:1904983)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of defense response to virus by host (GO:0050689)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of endosome organization (GO:1904980)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of defense response to virus (GO:0050687)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA processing (GO:0050685)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
regulation of lateral mesodermal cell fate specification (GO:0048378)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral mesodermal cell differentiation (GO:0048371)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral mesoderm formation (GO:0048370)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of endosome organization (GO:1904979)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mucus secretion (GO:0070256)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endosome organization (GO:1904978)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lymphatic endothelial cell migration (GO:1904977)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to bleomycin (GO:1904976)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
somatostatin secretion (GO:0070253)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to bleomycin (GO:1904975)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral translation (GO:1904973)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of viral translation (GO:1904971)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
brush border assembly (GO:1904970)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of urothelial cell proliferation (GO:0050677)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of urothelial cell proliferation (GO:0050675)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
urothelial cell proliferation (GO:0050674)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral mesoderm morphogenesis (GO:0048369)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral mesoderm development (GO:0048368)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
TCR signalosome assembly (GO:0036399)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-lysine crotonylation (GO:0120094)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
amylase secretion (GO:0036394)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell apoptotic process (GO:0070247)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-lysine crotonylation (GO:0120093)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of thymocyte apoptotic process (GO:0070245)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
thymocyte apoptotic process (GO:0070242)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytochrome-c oxidase activity (GO:1904960)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of homocysteine metabolic process (GO:0050668)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
homocysteine metabolic process (GO:0050667)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of homocysteine metabolic process (GO:0050666)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide biosynthetic process (GO:0050665)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
paraxial mesoderm structural organization (GO:0048352)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cytochrome-c oxidase activity (GO:1904959)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of activation-induced cell death of T cells (GO:0070236)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of midbrain dopaminergic neuron differentiation (GO:1904958)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of midbrain dopaminergic neuron differentiation (GO:1904956)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
T cell apoptotic process (GO:0070231)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050653)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dermatan sulfate proteoglycan biosynthetic process (GO:0050651)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
paraxial mesodermal cell fate commitment (GO:0048343)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
paraxial mesodermal cell differentiation (GO:0048342)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
paraxial mesoderm formation (GO:0048341)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
microtubule polymerization based movement (GO:0099098)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
paraxial mesoderm morphogenesis (GO:0048340)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
cell adhesion involved in sprouting angiogenesis (GO:0120078)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
calcitriol biosynthetic process from calciol (GO:0036378)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
angiogenic sprout fusion (GO:0120077)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
calcium export from the mitochondrion (GO:0099093)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of pyloric antrum smooth muscle contraction (GO:0120072)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of pyloric antrum smooth muscle contraction (GO:0120071)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
folate import into mitochondrion (GO:1904947)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to T-tubule (GO:0036371)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sulfide oxidation, using sulfide:quinone oxidoreductase (GO:0070221)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
paraxial mesoderm development (GO:0048339)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
mesoderm structural organization (GO:0048338)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesodermal cell fate specification (GO:0048337)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesodermal cell differentiation (GO:0048333)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
mesoderm morphogenesis (GO:0048332)	78	0	1.30	-	 < 0.01	6.43E-01	1.00E00
establishment of endoplasmic reticulum localization to postsynapse (GO:0099089)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axonal transport of messenger ribonucleoprotein complex (GO:0099088)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of stomach fundus smooth muscle contraction (GO:0120069)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of stomach fundus smooth muscle contraction (GO:0120068)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cone photoresponse recovery (GO:0036368)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
light adaption (GO:0036367)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of gastric emptying (GO:0120061)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sensory neuron migration (GO:1904937)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of gastric emptying (GO:0120060)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein auto-ADP-ribosylation (GO:0070213)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
protein poly-ADP-ribosylation (GO:0070212)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation in midbrain (GO:1904934)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axial mesodermal cell fate specification (GO:0048327)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axial mesodermal cell fate commitment (GO:0048322)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axial mesodermal cell differentiation (GO:0048321)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axial mesoderm formation (GO:0048320)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
renal potassium excretion (GO:0036359)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of small intestinal transit (GO:0120058)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrion-derived vesicle mediated transport (GO:0099075)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of small intestinal transit (GO:0120057)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrion to lysosome vesicle-mediated transport (GO:0099074)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein heterotrimerization (GO:0070208)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of protein localization to telomere (GO:0070203)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of protein localization to chromosome (GO:0070202)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
axial mesoderm morphogenesis (GO:0048319)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
axial mesoderm development (GO:0048318)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
Golgi inheritance (GO:0048313)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
intracellular distribution of mitochondria (GO:0048312)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
mitochondrion distribution (GO:0048311)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
snRNA (adenine-N6)-methylation (GO:0120049)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
stereocilium maintenance (GO:0120045)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
platelet maturation (GO:0036345)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
platelet morphogenesis (GO:0036344)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
psychomotor behavior (GO:0036343)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage proliferation (GO:0120042)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
post-anal tail morphogenesis (GO:0036342)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage proliferation (GO:0120041)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage proliferation (GO:0120040)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of RNA localization to telomere (GO:1904911)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of RNA localization to telomere (GO:1904910)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
organelle inheritance (GO:0048308)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of isotype switching to IgG isotypes (GO:0048304)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of isotype switching to IgG isotypes (GO:0048302)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
lymphocyte adhesion to endothelial cell of high endothelial venule (GO:0036339)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Fas signaling pathway (GO:0036337)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dendritic cell migration (GO:0036336)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
intestinal stem cell homeostasis (GO:0036335)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
epidermal stem cell homeostasis (GO:0036334)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
hepatocyte homeostasis (GO:0036333)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
vesicle scission (GO:0099050)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904908)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904907)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
avascular cornea development in camera-type eye (GO:0036331)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904906)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904905)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
ESCRT III complex disassembly (GO:1904903)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
clathrin coat assembly involved in endocytosis (GO:0099049)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vesicle tethering to endoplasmic reticulum (GO:0099044)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
vascular endothelial growth factor receptor-3 signaling pathway (GO:0036325)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
vesicle tethering to Golgi (GO:0099041)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
ceramide translocation (GO:0099040)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ghrelin secretion (GO:0036321)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
palmitic acid biosynthetic process (GO:1900535)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
palmitic acid metabolic process (GO:1900533)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sphingolipid translocation (GO:0099039)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
SREBP-SCAP complex retention in endoplasmic reticulum (GO:0036316)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to sterol (GO:0036315)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
response to sterol (GO:0036314)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
intermembrane sphingolipid transfer (GO:0120012)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to M-band (GO:0036309)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamatergic neuron differentiation (GO:0120008)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of glutamatergic neuron differentiation (GO:0120007)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glutamatergic neuron differentiation (GO:0120006)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube elongation (GO:0036306)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vesicle tethering (GO:0099022)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
umbilical cord morphogenesis (GO:0036304)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lymph vessel morphogenesis (GO:0036303)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
atrioventricular canal development (GO:0036302)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
maintenance of protein localization at cell tip (GO:0099017)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mRNA 5'-splice site recognition (GO:0000395)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
spliceosomal conformational changes to generate catalytic conformation (GO:0000393)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
spliceosomal complex disassembly (GO:0000390)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mRNA 3'-splice site recognition (GO:0000389)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) (GO:0000388)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA-type intron splice site recognition and cleavage (GO:0000379)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
parathyroid hormone secretion (GO:0035898)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
generation of catalytic spliceosome for second transesterification step (GO:0000350)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
aortic smooth muscle cell differentiation (GO:0035887)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein homodimerization activity (GO:0043496)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
vascular associated smooth muscle cell differentiation (GO:0035886)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
enteroendocrine cell differentiation (GO:0035883)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
amacrine cell differentiation (GO:0035881)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
malate-aspartate shuttle (GO:0043490)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
embryonic nail plate morphogenesis (GO:0035880)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
generation of catalytic spliceosome for first transesterification step (GO:0000349)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to flavonoid (GO:1905396)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to flavonoid (GO:1905395)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
plasma membrane lactate transport (GO:0035879)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of helicase activity (GO:0051097)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nail development (GO:0035878)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of helicase activity (GO:0051096)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of helicase activity (GO:0051095)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
endosome to pigment granule transport (GO:0043485)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
maintenance of meiotic sister chromatid cohesion, centromeric (GO:0035875)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lactate transmembrane transport (GO:0035873)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cellular pigment accumulation (GO:0043482)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
protein K11-linked deubiquitination (GO:0035871)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
pigment accumulation in tissues (GO:0043480)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein deneddylation (GO:0000338)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of snRNA transcription by RNA polymerase II (GO:1905382)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of snRNA transcription by RNA polymerase II (GO:1905381)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
constitutive protein ectodomain proteolysis (GO:0051089)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of snRNA transcription by RNA polymerase II (GO:1905380)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
chaperone mediated protein folding independent of cofactor (GO:0051086)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
pigment accumulation (GO:0043476)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
chaperone cofactor-dependent protein refolding (GO:0051085)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
'de novo' post-translational protein folding (GO:0051084)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
learned vocalization behavior (GO:0098583)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to potassium ion (GO:0035865)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
pigment metabolic process involved in pigmentation (GO:0043474)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
'de novo' cotranslational protein folding (GO:0051083)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to potassium ion (GO:0035864)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
dITP catabolic process (GO:0035863)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear membrane disassembly (GO:0051081)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
dITP metabolic process (GO:0035862)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to homocysteine (GO:1905375)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to homocysteine (GO:1905374)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ceramide phosphoethanolamine biosynthetic process (GO:1905373)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ceramide phosphoethanolamine catabolic process (GO:1905372)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ceramide phosphoethanolamine metabolic process (GO:1905371)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
re-entry into mitotic cell cycle (GO:0000320)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of fermentation (GO:0043465)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
megakaryocyte development (GO:0035855)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
eosinophil fate commitment (GO:0035854)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
chromosome passenger complex localization to spindle midzone (GO:0035853)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ATP-dependent activity (GO:0043462)	60	0	1.00	-	 < 0.01	6.29E-01	1.00E00
proton-transporting ATP synthase complex assembly (GO:0043461)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of intralumenal vesicle formation (GO:1905366)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of intralumenal vesicle formation (GO:1905365)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of endosomal vesicle fusion (GO:1905364)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dihydrolipoamide metabolic process (GO:0051068)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nephric duct elongation (GO:0035849)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cellular respiration (GO:0043457)	57	0	.95	-	 < 0.01	1.00E00	1.00E00
dihydrobiopterin metabolic process (GO:0051066)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
uterine epithelium development (GO:0035847)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of pentose-phosphate shunt (GO:0043456)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
oviduct epithelium development (GO:0035846)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of secondary metabolic process (GO:0043455)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell outer segment organization (GO:0035845)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
cloaca development (GO:0035844)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to meiotic spindle (GO:1905359)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spine apparatus assembly (GO:1905355)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to oxygen radical (GO:0000305)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
response to singlet oxygen (GO:0000304)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to superoxide (GO:0000303)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
pericyte cell migration (GO:1905351)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
retrograde transport, vesicle recycling within Golgi (GO:0000301)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
alkene metabolic process (GO:0043449)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of gravity (GO:0009590)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ciliary transition zone assembly (GO:1905349)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to cleavage furrow (GO:1905345)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
prostaglandin catabolic process (GO:1905344)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of UV (GO:0009589)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to kinetochore (GO:1905342)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-methionine acetylation (GO:0017196)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to kinetochore (GO:1905340)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
red, far-red light phototransduction (GO:0009585)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acetoacetic acid metabolic process (GO:0043438)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of visible light (GO:0009584)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-glutamine acetylation (GO:0017192)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane protein ectodomain proteolysis (GO:0051045)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
maintenance of protein complex location (GO:0098544)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to corticotropin-releasing hormone (GO:0043435)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane protein ectodomain proteolysis (GO:0051044)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
detection of other organism (GO:0098543)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-aspartic acid acetylation (GO:0017190)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
homologous recombination (GO:0035825)	64	0	1.07	-	 < 0.01	6.30E-01	1.00E00
negative regulation of calcium-independent cell-cell adhesion (GO:0051042)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium-independent cell-cell adhesion (GO:0051041)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
gene conversion (GO:0035822)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of calcium-independent cell-cell adhesion (GO:0051040)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear membrane reassembly (GO:0031468)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
glycine betaine transport (GO:0031460)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of aggrephagy (GO:1905337)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of aggrephagy (GO:1905336)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of aggrephagy (GO:1905335)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of gastric motility (GO:1905333)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of morphogenesis of an epithelium (GO:1905331)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine hydroxylation (GO:0017185)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
protein histidyl modification to diphthamide (GO:0017183)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of endosome size (GO:0051036)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of renal sodium excretion (GO:0035815)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of renal sodium excretion (GO:0035814)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of renal sodium excretion (GO:0035813)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
tRNA transport (GO:0051031)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of strand invasion (GO:0098530)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
renal sodium excretion (GO:0035812)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
snRNA transport (GO:0051030)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of urine volume (GO:0035811)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
anthranilate metabolic process (GO:0043420)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of urine volume (GO:0035810)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
glycine betaine biosynthetic process (GO:0031456)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glycine betaine metabolic process (GO:0031455)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of heterochromatin formation (GO:0031453)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of heterochromatin formation (GO:0031452)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
tracheoesophageal septum formation (GO:1905327)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiosis I spindle assembly checkpoint (GO:1905326)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of meiosis I spindle assembly checkpoint (GO:1905325)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
telomerase holoenzyme complex assembly (GO:1905323)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal stem cell migration (GO:1905322)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
neuromuscular junction development, skeletal muscle fiber (GO:0098529)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
rRNA transport (GO:0051029)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
skeletal muscle fiber differentiation (GO:0098528)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal stem cell migration (GO:1905320)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
homocysteine catabolic process (GO:0043418)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of urine volume (GO:0035809)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
chiasma assembly (GO:0051026)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle tissue regeneration (GO:0043417)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle tissue regeneration (GO:0043416)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle tissue regeneration (GO:0043415)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
egg coat formation (GO:0035803)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
adrenal cortex formation (GO:0035802)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
adrenal cortex development (GO:0035801)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of slow-twitch skeletal muscle fiber contraction (GO:0031449)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of fast-twitch skeletal muscle fiber contraction (GO:0031448)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of fast-twitch skeletal muscle fiber contraction (GO:0031446)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of heterochromatin formation (GO:0031445)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
slow-twitch skeletal muscle fiber contraction (GO:0031444)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fast-twitch skeletal muscle fiber contraction (GO:0031443)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA 3'-end processing (GO:0031442)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA 3'-end processing (GO:0031440)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
mesenchymal stem cell migration (GO:1905319)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inferior endocardial cushion morphogenesis (GO:1905317)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905312)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905310)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
barbed-end actin filament capping (GO:0051016)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of MAP kinase activity (GO:0043407)	52	0	.87	-	 < 0.01	1.00E00	1.00E00
actin filament severing (GO:0051014)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
microtubule severing (GO:0051013)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
microtubule sliding (GO:0051012)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glucocorticoid mediated signaling pathway (GO:0043402)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
steroid hormone receptor signaling pathway (GO:0043401)	62	0	1.03	-	 < 0.01	6.29E-01	1.00E00
negative regulation of cardiac myofibril assembly (GO:1905305)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac myofibril assembly (GO:1905304)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of macropinocytosis (GO:1905303)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of macropinocytosis (GO:1905302)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of macropinocytosis (GO:1905301)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
endothelial to hematopoietic transition (GO:0098508)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of intestinal epithelial cell development (GO:1905300)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipoprotein lipase activity (GO:0051006)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein lipase activity (GO:0051005)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein lipase activity (GO:0051004)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitric-oxide synthase activity (GO:0051001)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of nitric-oxide synthase activity (GO:0051000)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
response to methotrexate (GO:0031427)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
stem cell division (GO:0017145)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
insecticide metabolic process (GO:0017143)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic attachment of telomere to nuclear envelope (GO:0070197)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
synaptonemal complex disassembly (GO:0070194)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptonemal complex organization (GO:0070193)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
chromosome organization involved in meiotic cell cycle (GO:0070192)	76	0	1.27	-	 < 0.01	6.40E-01	1.00E00
kynurenine metabolic process (GO:0070189)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
nucleologenesis (GO:0017126)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial tyrosyl-tRNA aminoacylation (GO:0070184)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial tryptophanyl-tRNA aminoacylation (GO:0070183)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
plasma membrane phospholipid scrambling (GO:0017121)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of Golgi to plasma membrane protein transport (GO:0042998)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of transcription factor (GO:0042994)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of isotype switching to IgA isotypes (GO:0048298)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of isotype switching to IgA isotypes (GO:0048296)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of isotype switching to IgE isotypes (GO:0048295)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of isotype switching to IgE isotypes (GO:0048294)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of isotype switching to IgE isotypes (GO:0048293)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
isotype switching to IgG isotypes (GO:0048291)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
isotype switching to IgA isotypes (GO:0048290)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-serine biosynthetic process (GO:0070179)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-serine metabolic process (GO:0070178)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatic stellate cell proliferation (GO:1904898)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of enamel mineralization (GO:0070175)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
ESCRT complex disassembly (GO:1904896)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of enamel mineralization (GO:0070173)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of tooth mineralization (GO:0070172)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor signaling pathway via STAT (GO:1904893)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of tooth mineralization (GO:0070171)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tooth mineralization (GO:0070170)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of excitatory synapse assembly (GO:1904890)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
sequestering of actin monomers (GO:0042989)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of amyloid precursor protein biosynthetic process (GO:0042986)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of amyloid precursor protein biosynthetic process (GO:0042984)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
isotype switching to IgE isotypes (GO:0048289)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
amyloid precursor protein biosynthetic process (GO:0042983)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vesicle fusion with Golgi apparatus (GO:0048280)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of biomineral tissue development (GO:0070168)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of adiponectin secretion (GO:0070165)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
Wnt signalosome assembly (GO:1904887)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of adiponectin secretion (GO:0070164)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of adiponectin secretion (GO:0070163)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomerase catalytic core complex assembly (GO:1904884)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of telomerase catalytic core complex assembly (GO:1904882)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to hydrogen sulfide (GO:1904881)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to hydrogen sulfide (GO:1904880)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
activation of Janus kinase activity (GO:0042976)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
mitochondrial seryl-tRNA aminoacylation (GO:0070158)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904879)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA ligase activity (GO:1904877)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of DNA ligase activity (GO:1904875)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomerase RNA localization to Cajal body (GO:1904874)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of telomerase RNA localization to Cajal body (GO:1904872)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
mitochondrial glycyl-tRNA aminoacylation (GO:0070150)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to Cajal body (GO:1904871)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
determination of ventral identity (GO:0048264)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of centriole-centriole cohesion (GO:0030997)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
recombinational interstrand cross-link repair (GO:0036298)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
interstrand cross-link repair (GO:0036297)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to Cajal body (GO:1904869)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to Cajal body (GO:1904867)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial asparaginyl-tRNA aminoacylation (GO:0070145)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA rewinding (GO:0036292)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein trans-autophosphorylation (GO:0036290)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial alanyl-tRNA aminoacylation (GO:0070143)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle budding (GO:0070142)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of beta-catenin-TCF complex assembly (GO:1904864)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to UV-A (GO:0070141)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of beta-catenin-TCF complex assembly (GO:1904863)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
inhibitory synapse assembly (GO:1904862)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
DNA synthesis involved in mitotic DNA replication (GO:1904860)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipoprotein transport (GO:0042953)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
snoRNA localization (GO:0048254)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
lauric acid metabolic process (GO:0048252)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
elastic fiber assembly (GO:0048251)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
iron import into the mitochondrion (GO:0048250)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
SAGA complex assembly (GO:0036285)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial translation (GO:0070131)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial translation (GO:0070130)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of protein localization to telomere (GO:1904851)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of protein localization to telomere (GO:1904850)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glucoside transport (GO:0042946)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
D-serine transmembrane transport (GO:0042942)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lymphocyte chemotaxis (GO:0048247)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
D-alanine transmembrane transport (GO:0042941)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
macrophage chemotaxis (GO:0048246)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
D-amino acid transport (GO:0042940)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
norepinephrine secretion (GO:0048243)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
epinephrine secretion (GO:0048242)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
epinephrine transport (GO:0048241)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
sperm capacitation (GO:0048240)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
thiamine pyrophosphate transmembrane transport (GO:0030974)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial translation (GO:0070129)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
retrograde protein transport, ER to cytosol (GO:0030970)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
response to 5-fluorouracil (GO:0036275)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell chemotaxis to fibroblast growth factor (GO:1904849)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA aminoacylation for mitochondrial protein translation (GO:0070127)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
mitochondrial translational termination (GO:0070126)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to statin (GO:0036273)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell chemotaxis to fibroblast growth factor (GO:1904848)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell chemotaxis to fibroblast growth factor (GO:1904847)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
mitochondrial translational elongation (GO:0070125)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mitochondrial translational initiation (GO:0070124)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to methylphenidate (GO:0036271)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to diuretic (GO:0036270)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to L-glutamine (GO:1904845)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to L-glutamine (GO:1904844)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to nitroglycerin (GO:1904842)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tripeptide transport (GO:0042939)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
dipeptide transport (GO:0042938)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of protein targeting to vacuolar membrane (GO:1900483)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA recombination at telomere (GO:0048239)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of diacylglycerol biosynthetic process (GO:1900480)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
enterobactin transport (GO:0042930)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum unfolded protein response (GO:0030968)	57	0	.95	-	 < 0.01	1.00E00	1.00E00
swimming behavior (GO:0036269)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
swimming (GO:0036268)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine hydroxylation (GO:0030961)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA (guanine-N7)-methylation (GO:0036265)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
7-methylguanosine cap hypermethylation (GO:0036261)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA capping (GO:0036260)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
dorsal root ganglion morphogenesis (GO:1904835)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of aortic smooth muscle cell differentiation (GO:1904831)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma membrane to endosome transport (GO:0048227)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
nuclear receptor-mediated glucocorticoid signaling pathway (GO:0042921)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
astral microtubule nucleation (GO:0030954)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
multivesicular body assembly (GO:0036258)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of cytoskeleton polarity (GO:0030952)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
multivesicular body organization (GO:0036257)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of actin cytoskeleton polarity (GO:0030950)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to methylamine (GO:0036255)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of aortic smooth muscle cell differentiation (GO:1904829)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
interleukin-27-mediated signaling pathway (GO:0070106)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen sulfide biosynthetic process (GO:1904828)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-6-mediated signaling pathway (GO:0070105)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-6-mediated signaling pathway (GO:0070104)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen sulfide biosynthetic process (GO:1904826)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peroxisome transport along microtubule (GO:0036250)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-6-mediated signaling pathway (GO:0070103)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule plus-end (GO:1904825)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
purine nucleobase transmembrane transport (GO:1904823)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine-mediated signaling pathway (GO:0070101)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
inter-Golgi cisterna vesicle-mediated transport (GO:0048219)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle docking (GO:0048211)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle fusion to target membrane (GO:0048210)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to chromosome, telomeric region (GO:1904816)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to chromosome, telomeric region (GO:1904815)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to chromosome, telomeric region (GO:1904814)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of dense core granule transport (GO:1904811)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
9-cis-retinoic acid metabolic process (GO:0042905)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
9-cis-retinoic acid biosynthetic process (GO:0042904)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
COPII vesicle coating (GO:0048208)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate receptor signaling pathway (GO:1900451)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
vesicle targeting, rough ER to cis-Golgi (GO:0048207)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of glutamate receptor signaling pathway (GO:1900450)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
COPI coating of Golgi vesicle (GO:0048205)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
Golgi transport vesicle coating (GO:0048200)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
acyl deglucuronidation (GO:0036235)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of dense core granule transport (GO:1904809)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
deglucuronidation (GO:0036234)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein oxidation (GO:1904808)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein oxidation (GO:1904806)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of translation involved in cellular response to UV (GO:1904803)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate receptor signaling pathway (GO:1900449)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuron remodeling (GO:1904800)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to nuclear inner membrane (GO:0036228)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
otic vesicle formation (GO:0030916)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
olfactory placode formation (GO:0030910)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
contractile ring contraction (GO:0036213)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of defense response to bacterium (GO:1900425)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein splicing (GO:0030908)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
spermine transport (GO:0000296)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA fragment catabolic process (GO:0000292)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular response to oxidative stress (GO:1900409)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
M phase (GO:0000279)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
polysaccharide catabolic process (GO:0000272)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
polysaccharide biosynthetic process (GO:0000271)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
peptidoglycan metabolic process (GO:0000270)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
mitochondrial fission (GO:0000266)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial membrane permeability (GO:0035795)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial membrane permeability (GO:0035794)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:0035793)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
allantoin catabolic process (GO:0000256)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
allantoin metabolic process (GO:0000255)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
metanephric mesenchymal cell migration (GO:0035789)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of corticotropin-releasing hormone secretion (GO:0043397)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cell migration involved in metanephros development (GO:0035788)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell migration involved in kidney development (GO:0035787)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA binding (GO:0043392)	49	0	.82	-	 < 0.01	1.00E00	1.00E00
CD4-positive, alpha-beta T cell costimulation (GO:0035783)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mature natural killer cell chemotaxis (GO:0035782)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CD86 biosynthetic process (GO:0035781)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
CD80 biosynthetic process (GO:0035780)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal epithelial cell development (GO:1905298)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of CAMKK-AMPK signaling cascade (GO:1905291)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of CAMKK-AMPK signaling cascade (GO:1905290)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mycotoxin catabolic process (GO:0043387)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mycotoxin metabolic process (GO:0043385)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative T cell selection (GO:0043383)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of memory T cell differentiation (GO:0043382)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
insulin secretion involved in cellular response to glucose stimulus (GO:0035773)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
interleukin-13-mediated signaling pathway (GO:0035772)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of memory T cell differentiation (GO:0043381)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of memory T cell differentiation (GO:0043380)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of CAMKK-AMPK signaling cascade (GO:1905289)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
vascular associated smooth muscle cell apoptotic process (GO:1905288)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pachytene (GO:0000239)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
leptotene (GO:0000237)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
fibrous ring of heart morphogenesis (GO:1905285)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of retrograde transport, endosome to Golgi (GO:1905281)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of retrograde transport, endosome to Golgi (GO:1905280)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
memory T cell differentiation (GO:0043379)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
B cell chemotaxis across high endothelial venule (GO:0035769)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043377)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
endothelial cell chemotaxis to fibroblast growth factor (GO:0035768)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
endothelial cell chemotaxis (GO:0035767)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell lineage commitment (GO:0043375)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell chemotaxis to fibroblast growth factor (GO:0035766)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell differentiation (GO:0043374)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)	61	0	1.02	-	 < 0.01	6.29E-01	1.00E00
regulation of retrograde transport, endosome to Golgi (GO:1905279)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial tube formation (GO:1905278)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial tube formation (GO:1905276)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905273)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905271)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesangial cell-matrix adhesion (GO:0035759)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
beta selection (GO:0043366)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleate erythrocyte differentiation (GO:0043363)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
B cell chemotaxis (GO:0035754)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
lysosomal lumen pH elevation (GO:0035752)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of lysosomal lumen pH (GO:0035751)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
protein localization to myelin sheath abaxonal region (GO:0035750)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of prostaglandin biosynthetic process (GO:0031394)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of prostaglandin biosynthetic process (GO:0031393)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of prostaglandin biosynthetic process (GO:0031392)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromatin organization (GO:1905269)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromatin organization (GO:1905268)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
meiotic spindle organization (GO:0000212)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
natural killer cell chemotaxis (GO:0035747)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
granzyme A production (GO:0035746)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
enucleate erythrocyte maturation (GO:0043354)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
enucleate erythrocyte differentiation (GO:0043353)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
T-helper 1 cell cytokine production (GO:0035744)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell proliferation (GO:0035740)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905259)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905258)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
intraciliary transport involved in cilium assembly (GO:0035735)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
hepatic stellate cell activation (GO:0035733)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of aspartic-type peptidase activity (GO:1905246)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to 3,3',5-triiodo-L-thyronine (GO:1905243)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to 3,3',5-triiodo-L-thyronine (GO:1905242)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to hepatocyte growth factor stimulus (GO:0035729)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
response to hepatocyte growth factor (GO:0035728)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
protein unfolding (GO:0043335)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-12-mediated signaling pathway (GO:0035722)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
intraciliary retrograde transport (GO:0035721)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
intraciliary anterograde transport (GO:0035720)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
N-terminal protein amino acid modification (GO:0031365)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
response to cyclosporin A (GO:1905237)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to quercetin (GO:1905235)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to codeine (GO:1905233)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to L-glutamate (GO:1905232)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cellular response to borneol (GO:1905231)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to borneol (GO:1905230)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to insecticide (GO:0017085)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pigment metabolic process involved in developmental pigmentation (GO:0043324)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell degranulation (GO:0043323)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to nitrogen dioxide (GO:0035714)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to nitrogen dioxide (GO:0035713)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T-helper 2 cell activation (GO:0035712)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T-helper 1 cell activation (GO:0035711)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
natural killer cell degranulation (GO:0043320)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to thyrotropin-releasing hormone (GO:1905229)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to thyrotropin-releasing hormone (GO:1905225)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
epicardium morphogenesis (GO:1905223)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
atrioventricular canal morphogenesis (GO:1905222)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet formation (GO:1905221)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet formation (GO:1905220)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytotoxic T cell degranulation (GO:0043318)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
memory T cell activation (GO:0035709)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cytotoxic T cell degranulation (GO:0043317)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cytotoxic T cell degranulation (GO:0043316)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil degranulation (GO:0043315)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
T-helper 17 cell chemotaxis (GO:0035705)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
monocyte homeostasis (GO:0035702)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of eosinophil degranulation (GO:0043311)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of eosinophil degranulation (GO:0043310)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell migration (GO:0035701)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of platelet formation (GO:1905219)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to astaxanthin (GO:1905217)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA binding (GO:1905216)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA binding (GO:1905215)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of RNA binding (GO:1905214)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic chromosome condensation (GO:1905213)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of eosinophil degranulation (GO:0043309)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
eosinophil degranulation (GO:0043308)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
eosinophil activation (GO:0043307)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell degranulation (GO:0043306)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
respiratory chain complex III assembly (GO:0017062)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
7-methylguanosine RNA capping (GO:0009452)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
RNA modification (GO:0009451)	148	0	2.47	-	 < 0.01	1.84E-01	1.00E00
gamma-aminobutyric acid catabolic process (GO:0009450)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte degranulation (GO:0043302)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
positive regulation of sulfur amino acid metabolic process (GO:0031337)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiocyte differentiation (GO:1905209)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiocyte differentiation (GO:1905208)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of cardiocyte differentiation (GO:1905207)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of connective tissue replacement (GO:1905205)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of connective tissue replacement (GO:1905204)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of connective tissue replacement (GO:1905203)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid biosynthetic process (GO:0009449)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid metabolic process (GO:0009448)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
putrescine catabolic process (GO:0009447)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process (GO:0009446)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0017055)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
putrescine metabolic process (GO:0009445)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
pyridoxal 5'-phosphate salvage (GO:0009443)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycolate metabolic process (GO:0009441)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
methylglyoxal metabolic process (GO:0009438)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
carnitine metabolic process (GO:0009437)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
glyoxylate catabolic process (GO:0009436)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
NAD biosynthetic process (GO:0009435)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
chemokine-mediated signaling pathway (GO:0070098)	69	0	1.15	-	 < 0.01	6.33E-01	1.00E00
protein import (GO:0017038)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucagon secretion (GO:0070094)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucagon secretion (GO:0070093)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of glucagon secretion (GO:0070092)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
glucagon secretion (GO:0070091)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent endocytosis (GO:0070086)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
response to water (GO:0009415)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
response to water deprivation (GO:0009414)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle budding (GO:0048194)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of neuron remodeling (GO:1904799)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of core promoter binding (GO:1904798)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of core promoter binding (GO:1904797)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tear secretion (GO:0070075)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein nitrosylation (GO:0017014)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of core promoter binding (GO:1904796)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
clustering of voltage-gated calcium channels (GO:0070073)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
toxin biosynthetic process (GO:0009403)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proton-transporting two-sector ATPase complex assembly (GO:0070071)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
proton-transporting V-type ATPase complex assembly (GO:0070070)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of shelterin complex assembly (GO:1904792)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cysteine transport (GO:0042883)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein-tetrapyrrole linkage (GO:0017006)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cytochrome complex assembly (GO:0017004)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
protein-heme linkage (GO:0017003)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
NLRP1 inflammasome complex assembly (GO:1904784)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of NMDA glutamate receptor activity (GO:1904783)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
'de novo' actin filament nucleation (GO:0070060)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of NMDA glutamate receptor activity (GO:1904782)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to centrosome (GO:1904781)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to centrosome (GO:1904780)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
D-glucuronate transmembrane transport (GO:0042874)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
arachidonate secretion (GO:0050482)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
aldonate transmembrane transport (GO:0042873)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to centrosome (GO:1904779)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cell cortex (GO:1904778)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cell cortex (GO:1904777)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cell cortex (GO:1904776)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
mRNA splicing, via endonucleolytic cleavage and ligation (GO:0070054)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to tetrachloromethane (GO:1904772)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
antisense RNA metabolic process (GO:0042868)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyruvate catabolic process (GO:0042867)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
pyruvate biosynthetic process (GO:0042866)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
fused antrum stage (GO:0048165)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
multi-layer follicle stage (GO:0048162)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
primary follicle stage (GO:0048160)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated autophagy translocation complex disassembly (GO:1904764)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of myofibroblast differentiation (GO:1904762)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-alanine catabolic process (GO:0042853)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
L-alanine metabolic process (GO:0042851)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid dendritic cell activation (GO:0030887)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of myeloid dendritic cell activation (GO:0030886)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid dendritic cell activation (GO:0030885)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell migration (GO:1904753)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to nucleolus (GO:1904751)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to nucleolus (GO:1904750)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
behavioral response to ethanol (GO:0048149)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
D-xylose catabolic process (GO:0042843)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
behavioral response to cocaine (GO:0048148)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast proliferation (GO:0048147)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
D-glucuronate catabolic process (GO:0042840)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
astrocyte activation (GO:0048143)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
osteoclast maturation (GO:0036179)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to nucleolus (GO:1904749)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process involved in development (GO:1904748)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic process involved in development (GO:1904747)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process involved in development (GO:1904746)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomeric DNA binding (GO:1904744)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric DNA binding (GO:1904743)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric DNA binding (GO:1904742)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein arginylation (GO:0016598)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
D-glucuronate metabolic process (GO:0042839)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic plasticity by receptor localization to synapse (GO:1900383)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spermatocyte division (GO:0048137)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
male germ-line stem cell asymmetric division (GO:0048133)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cortical actin cytoskeleton organization (GO:0030866)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
female germ-line stem cell asymmetric division (GO:0048132)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cortical cytoskeleton organization (GO:0030865)	59	0	.98	-	 < 0.01	6.29E-01	1.00E00
positive regulation of polarized epithelial cell differentiation (GO:0030862)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of polarized epithelial cell differentiation (GO:0030860)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
phenotypic switching (GO:0036166)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vascular associated smooth muscle cell migration (GO:1904738)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:1904736)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:1904735)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of electron transfer activity (GO:1904734)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of electron transfer activity (GO:1904732)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of intestinal lipid absorption (GO:1904731)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of intestinal lipid absorption (GO:1904730)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of secondary metabolite biosynthetic process (GO:1900378)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of secondary metabolite biosynthetic process (GO:1900377)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of secondary metabolite biosynthetic process (GO:1900376)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
amyloid-beta metabolic process (GO:0050435)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral transcription (GO:0050434)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of purine nucleotide biosynthetic process (GO:1900372)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
catecholamine secretion (GO:0050432)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
pyridoxal phosphate biosynthetic process (GO:0042823)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pyridoxal phosphate metabolic process (GO:0042822)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
vitamin B6 catabolic process (GO:0042820)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
polarized epithelial cell differentiation (GO:0030859)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial cell differentiation (GO:0030857)	58	0	.97	-	 < 0.01	1.00E00	1.00E00
positive regulation of granulocyte differentiation (GO:0030854)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
inner dynein arm assembly (GO:0036159)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of granulocyte differentiation (GO:0030853)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of granulocyte differentiation (GO:0030852)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
granulocyte differentiation (GO:0030851)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
acylglycerol acyl-chain remodeling (GO:0036155)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal lipid absorption (GO:1904729)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
triglyceride acyl-chain remodeling (GO:0036153)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phosphatidylethanolamine acyl-chain remodeling (GO:0036152)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
phosphatidylcholine acyl-chain remodeling (GO:0036151)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine acyl-chain remodeling (GO:0036150)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904723)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
vitamin B6 biosynthetic process (GO:0042819)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
pyridoxamine metabolic process (GO:0042818)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pyridoxal metabolic process (GO:0042817)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vitamin B6 metabolic process (GO:0042816)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
phospholipase C-inhibiting G protein-coupled receptor signaling pathway (GO:0030845)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of intermediate filament depolymerization (GO:0030844)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of intermediate filament depolymerization (GO:0030842)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phosphatidylglycerol acyl-chain remodeling (GO:0036148)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to mycotoxin (GO:0036146)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dendritic cell homeostasis (GO:0036145)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of AMPA glutamate receptor clustering (GO:1904719)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of AMPA glutamate receptor clustering (GO:1904717)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of chaperone-mediated autophagy (GO:1904716)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of chaperone-mediated autophagy (GO:1904715)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chaperone-mediated autophagy (GO:1904714)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904711)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix, receptor recycling (GO:0016562)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix, translocation (GO:0016561)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix, docking (GO:0016560)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
establishment of body hair planar orientation (GO:0048105)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
establishment of body hair or bristle planar orientation (GO:0048104)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
somatic stem cell division (GO:0048103)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament depolymerization (GO:0030836)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
Schwann cell migration (GO:0036135)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of granulosa cell apoptotic process (GO:1904709)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to adherens junction (GO:1904704)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peroxisome fission (GO:0016559)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix (GO:0016558)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to adherens junction (GO:1904702)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
peroxisome membrane biogenesis (GO:0016557)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mRNA modification (GO:0016556)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
cytidine to uridine editing (GO:0016554)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
base conversion or substitution editing (GO:0016553)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac endothelial to mesenchymal transition (GO:0061999)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
long-chain fatty-acyl-CoA catabolic process (GO:0036116)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty-acyl-CoA catabolic process (GO:0036115)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty-acyl-CoA catabolic process (GO:0036114)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty-acyl-CoA catabolic process (GO:0036113)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty-acyl-CoA metabolic process (GO:0036112)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty-acyl-CoA metabolic process (GO:0036111)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
intein-mediated protein splicing (GO:0016539)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter by glucose (GO:0061987)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by glucose (GO:0061986)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
meiosis II cell cycle process (GO:0061983)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
meiosis I cell cycle process (GO:0061982)	135	0	2.25	-	 < 0.01	1.78E-01	1.00E00
negative regulation of nucleotide biosynthetic process (GO:0030809)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
leukotriene B4 metabolic process (GO:0036102)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
leukotriene B4 catabolic process (GO:0036101)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
leukotriene catabolic process (GO:0036100)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
mandibular condyle articular cartilage development (GO:0061978)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
temporomandibular joint articular cartilage development (GO:0061976)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
articular cartilage development (GO:0061975)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
perichondral bone morphogenesis (GO:0061974)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane bone morphogenesis (GO:0061973)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of left/right asymmetry (GO:0061966)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
rDNA heterochromatin formation (GO:0000183)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
penetration of cumulus oophorus (GO:0061956)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
midbody abscission (GO:0061952)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to plasma membrane (GO:0061951)	58	0	.97	-	 < 0.01	1.00E00	1.00E00
phosphorelay signal transduction system (GO:0000160)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell extravasation (GO:0035697)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
monocyte extravasation (GO:0035696)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mitophagy by internal vacuole formation (GO:0035695)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
c-di-GMP signaling (GO:0061939)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial protein catabolic process (GO:0035694)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein localization to somatodendritic compartment (GO:0061938)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
macrophage migration inhibitory factor signaling pathway (GO:0035691)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of erythrocyte enucleation (GO:0061931)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of erythrocyte enucleation (GO:0061930)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
rRNA modification (GO:0000154)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
chemokine (C-C motif) ligand 5 signaling pathway (GO:0035689)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
apical junction assembly (GO:0043297)	77	0	1.28	-	 < 0.01	6.42E-01	1.00E00
T-helper 1 cell diapedesis (GO:0035688)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T-helper 1 cell extravasation (GO:0035687)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
helper T cell diapedesis (GO:0035685)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
helper T cell extravasation (GO:0035684)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
memory T cell extravasation (GO:0035683)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine propionylation (GO:0061921)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
manchette disassembly (GO:1905199)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
manchette assembly (GO:1905198)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
actin cortical patch assembly (GO:0000147)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
posterior lateral line neuromast hair cell development (GO:0035677)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neuromast hair cell development (GO:0035675)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid transmembrane transport (GO:0035674)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
oligopeptide transmembrane transport (GO:0035672)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation of growth plate cartilage chondrocyte proliferation (GO:0061914)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
autophagosome-endosome fusion (GO:0061910)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of metaphase/anaphase transition of meiosis I (GO:1905188)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of metaphase/anaphase transition of meiosis I (GO:1905186)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of mitotic spindle orientation (GO:0000132)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
apoptotic cell clearance (GO:0043277)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
anoikis (GO:0043276)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
TRIF-dependent toll-like receptor signaling pathway (GO:0035666)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
autophagosome-lysosome fusion (GO:0061909)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
TIRAP-dependent toll-like receptor 4 signaling pathway (GO:0035665)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
TIRAP-dependent toll-like receptor signaling pathway (GO:0035664)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
MyD88-dependent toll-like receptor 4 signaling pathway (GO:0035660)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glial cell activation (GO:0061900)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle tissue regeneration (GO:1905179)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle tissue regeneration (GO:1905178)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905176)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905174)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
interleukin-18-mediated signaling pathway (GO:0035655)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
clathrin-coated vesicle cargo loading, AP-3-mediated (GO:0035654)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
clathrin-coated vesicle cargo loading (GO:0035652)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
replication fork processing (GO:0031297)	49	0	.82	-	 < 0.01	1.00E00	1.00E00
B cell costimulation (GO:0031296)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
membrane protein intracellular domain proteolysis (GO:0031293)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of lysosomal protein catabolic process (GO:1905167)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of lysosomal protein catabolic process (GO:1905166)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of lysosomal protein catabolic process (GO:1905165)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of phagosome maturation (GO:1905164)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to phagocytic vesicle (GO:1905161)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of carbohydrate biosynthetic process (GO:0043255)	124	0	2.07	-	 < 0.01	2.77E-01	1.00E00
endosome to melanosome transport (GO:0035646)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
enteric smooth muscle cell differentiation (GO:0035645)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phosphoanandamide dephosphorylation (GO:0035644)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sodium-independent organic anion transport (GO:0043252)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
sodium-dependent organic anion transport (GO:0043251)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of guanylate cyclase activity (GO:0031284)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of guanylate cyclase activity (GO:0031283)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of guanylate cyclase activity (GO:0031282)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cyclase activity (GO:0031280)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
L-histidine biosynthetic process (GO:0000105)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated sodium channel activity (GO:1905152)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
FMN biosynthetic process (GO:0009398)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sulfate assimilation (GO:0000103)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of voltage-gated sodium channel activity (GO:1905151)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
folic acid-containing compound catabolic process (GO:0009397)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of voltage-gated sodium channel activity (GO:1905150)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
folic acid-containing compound biosynthetic process (GO:0009396)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid transport (GO:0000101)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
proteasome assembly (GO:0043248)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
telomere maintenance in response to DNA damage (GO:0043247)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
2'-deoxyribonucleotide metabolic process (GO:0009394)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
bone mineralization involved in bone maturation (GO:0035630)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of pseudopodium assembly (GO:0031274)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of pseudopodium assembly (GO:0031272)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
pseudopodium retraction (GO:0031270)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lysosomal protein catabolic process (GO:1905146)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
eukaryotic translation initiation factor 2 complex assembly (GO:1905143)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
translational attenuation (GO:0009386)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ceramide transport (GO:0035627)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
receptor transactivation (GO:0035624)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
renal D-glucose absorption (GO:0035623)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
intrahepatic bile duct development (GO:0035622)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ER to Golgi ceramide transport (GO:0035621)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pseudopodium assembly (GO:0031269)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pseudopodium organization (GO:0031268)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
biotin import across plasma membrane (GO:1905135)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic chromosome separation (GO:1905134)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic chromosome separation (GO:1905133)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic chromosome separation (GO:1905132)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
stress granule disassembly (GO:0035617)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein branching point deglutamylation (GO:0035611)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein side chain deglutamylation (GO:0035610)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of axo-dendritic protein transport (GO:1905128)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of axo-dendritic protein transport (GO:1905126)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glucosylceramidase activity (GO:1905123)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
C-terminal protein deglutamylation (GO:0035609)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
myelin maintenance (GO:0043217)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
protein deglutamylation (GO:0035608)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine S-trans-nitrosylation (GO:0035606)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
daunorubicin transport (GO:0043215)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow (GO:0035604)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor signaling pathway involved in hemopoiesis (GO:0035603)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell (GO:0035602)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein deacylation (GO:0035601)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
tRNA methylthiolation (GO:0035600)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
actin rod assembly (GO:0031247)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore (GO:1905116)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of lateral attachment of mitotic spindle microtubules to kinetochore (GO:1905115)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
non-proteinogenic amino acid catabolic process (GO:0170044)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
non-proteinogenic amino acid biosynthetic process (GO:0170043)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
proteinogenic amino acid catabolic process (GO:0170040)	65	0	1.08	-	 < 0.01	6.30E-01	1.00E00
regulation of pulmonary blood vessel remodeling (GO:1905109)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
export from the mitochondrion (GO:0170037)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
import into the mitochondrion (GO:0170036)	50	0	.83	-	 < 0.01	1.00E00	1.00E00
L-amino acid catabolic process (GO:0170035)	70	0	1.17	-	 < 0.01	6.34E-01	1.00E00
post-translational protein targeting to membrane, translocation (GO:0031204)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
oligosaccharide biosynthetic process (GO:0009312)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
tRNA transcription by RNA polymerase III (GO:0042797)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
snRNA transcription by RNA polymerase III (GO:0042796)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
snRNA transcription by RNA polymerase II (GO:0042795)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
5S class rRNA transcription by RNA polymerase III (GO:0042791)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of acinar cell proliferation (GO:1904699)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of acinar cell proliferation (GO:1904698)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of acinar cell proliferation (GO:1904697)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
tRNA transcription (GO:0009304)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle contraction (GO:1904695)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle contraction (GO:1904694)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
midbrain morphogenesis (GO:1904693)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
snRNA transcription (GO:0009301)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of type B pancreatic cell proliferation (GO:1904692)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of type B pancreatic cell proliferation (GO:1904691)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic translational initiation (GO:1904690)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of developmental pigmentation (GO:0048087)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
tRNA 3'-end processing (GO:0042780)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of developmental pigmentation (GO:0048086)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytoplasmic translational initiation (GO:1904689)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translational initiation (GO:1904688)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of metalloendopeptidase activity (GO:1904684)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to 3-methylcholanthrene (GO:1904682)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to 3-methylcholanthrene (GO:1904681)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	71	0	1.18	-	 < 0.01	6.35E-01	1.00E00
plasma membrane ATP synthesis coupled electron transport (GO:0042774)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ATP synthesis coupled electron transport (GO:0042773)	73	0	1.22	-	 < 0.01	6.37E-01	1.00E00
DNA damage response, signal transduction resulting in transcription (GO:0042772)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of eye pigmentation (GO:0048074)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of eye pigmentation (GO:0048073)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of developmental pigmentation (GO:0048070)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of somatic stem cell division (GO:1904677)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of somatic stem cell division (GO:1904675)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of somatic stem cell population maintenance (GO:1904674)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of somatic stem cell population maintenance (GO:1904673)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of somatic stem cell population maintenance (GO:1904672)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
eye pigmentation (GO:0048069)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty acid biosynthetic process (GO:0042761)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty acid catabolic process (GO:0042760)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
male germ-line stem cell population maintenance (GO:0036098)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin protein ligase activity (GO:1904668)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
germ cell proliferation (GO:0036093)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of ubiquitin protein ligase activity (GO:1904667)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquitin protein ligase activity (GO:1904666)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
cleavage furrow ingression (GO:0036090)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid biosynthetic process (GO:0042759)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid catabolic process (GO:0042758)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian rhythm (GO:0042754)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
post-embryonic eye morphogenesis (GO:0048050)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cleavage furrow formation (GO:0036089)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
D-serine catabolic process (GO:0036088)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GDP-fucose import into Golgi lumen (GO:0036085)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-glucose transmembrane transport (GO:1904659)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of fat cell apoptotic process (GO:1904651)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle, non-REM sleep (GO:0042748)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle, REM sleep (GO:0042747)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle (GO:0042745)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide catabolic process (GO:0042744)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
mating behavior, sex discrimination (GO:0048047)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
focal adhesion assembly (GO:0048041)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
intratendonous ossification (GO:0036077)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ligamentous ossification (GO:0036076)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of fat cell apoptotic process (GO:1904649)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
direct ossification (GO:0036072)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
N-glycan fucosylation (GO:0036071)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to curcumin (GO:1904643)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to methionine (GO:1904640)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
D-xylose metabolic process (GO:0042732)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900281)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900280)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fibrinolysis (GO:0042730)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
heme O biosynthetic process (GO:0048034)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
heme O metabolic process (GO:0048033)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
protein O-linked fucosylation (GO:0036066)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
fucosylation (GO:0036065)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
cellular response to resveratrol (GO:1904639)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to ionomycin (GO:1904637)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to ionomycin (GO:1904636)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of podocyte apoptotic process (GO:1904635)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
slit diaphragm assembly (GO:0036060)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of podocyte apoptotic process (GO:1904633)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to glucoside (GO:1904632)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
farnesol catabolic process (GO:0016488)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to glucoside (GO:1904631)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
farnesol metabolic process (GO:0016487)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900279)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to diterpene (GO:1904630)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
flavin-containing compound catabolic process (GO:0042728)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
flavin-containing compound biosynthetic process (GO:0042727)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
flavin-containing compound metabolic process (GO:0042726)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by RNA polymerase III (GO:0016480)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
thiamine-containing compound biosynthetic process (GO:0042724)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
thiamine-containing compound metabolic process (GO:0042723)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of long-term synaptic potentiation (GO:1900272)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA splicing, via spliceosome (GO:0048026)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
positive regulation of melanin biosynthetic process (GO:0048023)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of melanin biosynthetic process (GO:0048022)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of melanin biosynthetic process (GO:0048021)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
filtration diaphragm assembly (GO:0036058)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to diterpene (GO:1904629)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to phorbol 13-acetate 12-myristate (GO:1904628)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
response to phorbol 13-acetate 12-myristate (GO:1904627)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by RNA polymerase I (GO:0016479)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of embryonic cell shape (GO:0016476)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA-directed DNA polymerase activity (GO:1900264)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-directed DNA polymerase activity (GO:1900262)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
sperm ejaculation (GO:0042713)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA-dependent RNA polymerase activity (GO:1900260)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Tie signaling pathway (GO:0048014)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine desuccinylation (GO:0036049)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein desuccinylation (GO:0036048)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine demalonylation (GO:0036047)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein demalonylation (GO:0036046)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to dimethyl sulfoxide (GO:1904619)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin binding (GO:1904618)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of actin binding (GO:1904616)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to biphenyl (GO:1904614)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904613)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904612)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of RNA-dependent RNA polymerase activity (GO:1900259)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
progesterone secretion (GO:0042701)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation, endogenous lipid antigen via MHC class Ib (GO:0048006)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
luteinizing hormone signaling pathway (GO:0042700)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell activation (GO:0036037)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
sequestering of triglyceride (GO:0030730)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
osteoclast development (GO:0036035)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
neural crest cell delamination (GO:0036032)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fat cell apoptotic process (GO:1904606)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic translational elongation (GO:1900249)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytoplasmic translational elongation (GO:1900248)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translational elongation (GO:1900247)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of RIG-I signaling pathway (GO:1900246)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of MDA-5 signaling pathway (GO:1900245)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle endocytosis (GO:1900244)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of phenotypic switching (GO:1900240)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ovulation (GO:0030728)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
embryonic skeletal limb joint morphogenesis (GO:0036023)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
limb joint morphogenesis (GO:0036022)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of phenotypic switching (GO:1900239)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:1900238)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of astrocyte activation (GO:0061890)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
P granule organization (GO:0030719)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
germ-line stem cell population maintenance (GO:0030718)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cellular response to erythropoietin (GO:0036018)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to erythropoietin (GO:0036017)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein localization to endosome (GO:0036010)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of astrocyte activation (GO:0061889)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of astrocyte activation (GO:0061888)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of single-species biofilm formation in or on host organism (GO:1900229)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of single-species biofilm formation in or on host organism (GO:1900228)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mini excitatory postsynaptic potential (GO:0061885)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of NLRP3 inflammasome complex assembly (GO:1900227)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of mini excitatory postsynaptic potential (GO:0061884)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of NLRP3 inflammasome complex assembly (GO:1900226)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of anterograde axonal transport of mitochondrion (GO:0061881)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of amyloid-beta clearance (GO:1900223)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of anterograde axonal transport of mitochondrion (GO:0061880)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid-beta clearance (GO:1900222)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of amyloid-beta clearance (GO:1900221)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
vitelline membrane formation (GO:0030704)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900218)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900217)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatic stellate cell contraction (GO:0061875)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatic stellate cell contraction (GO:0061874)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process involved in metanephric collecting duct development (GO:1900215)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hepatic stellate cell contraction (GO:0061873)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process involved in metanephric collecting duct development (GO:1900214)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatic stellate cell migration (GO:0061871)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatic stellate cell migration (GO:0061870)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900212)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900211)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiolipin metabolic process (GO:1900210)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid catabolic process (GO:0000098)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid biosynthetic process (GO:0000097)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid metabolic process (GO:0000096)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of hepatic stellate cell migration (GO:0061869)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cardiolipin metabolic process (GO:1900208)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
polarized secretion of basement membrane proteins in epithelium (GO:0061865)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
basement membrane constituent secretion (GO:0061864)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell apoptotic process involved in metanephros development (GO:1900200)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic metaphase (GO:0000089)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic M phase (GO:0000087)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
G2/M transition of mitotic cell cycle (GO:0000086)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
mitotic G2 phase (GO:0000085)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic G1 phase (GO:0000080)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuroblast migration (GO:0061855)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of neuroblast migration (GO:0061853)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
DNA replication checkpoint signaling (GO:0000076)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
response to cholecystokinin (GO:0061847)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	141	0	2.35	-	 < 0.01	1.80E-01	1.00E00
Sertoli cell barrier remodeling (GO:0061843)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
microtubule organizing center localization (GO:0061842)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
neuropeptide processing (GO:0061837)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to tricellular tight junction (GO:0061833)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
ribosomal small subunit export from nucleus (GO:0000056)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
ribosomal large subunit export from nucleus (GO:0000055)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
ribosomal subunit export from nucleus (GO:0000054)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
G protein-coupled purinergic nucleotide receptor signaling pathway (GO:0035589)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
G protein-coupled purinergic receptor signaling pathway (GO:0035588)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
sequestering of TGFbeta in extracellular matrix (GO:0035583)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cytosolic ciliogenesis (GO:0061824)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
telomeric D-loop disassembly (GO:0061820)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of guanyl-nucleotide exchange factor activity (GO:1905099)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of guanyl-nucleotide exchange factor activity (GO:1905098)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of guanyl-nucleotide exchange factor activity (GO:1905097)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
autophagosome assembly (GO:0000045)	91	0	1.52	-	 < 0.01	4.10E-01	1.00E00
positive regulation of type 2 mitophagy (GO:1905091)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of type 2 mitophagy (GO:1905090)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
telomeric DNA-containing double minutes formation (GO:0061819)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-serine trimethylation (GO:0035573)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vacuolar sequestering (GO:0043181)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-serine dimethylation (GO:0035572)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-serine methylation (GO:0035570)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
electron transport coupled proton transport (GO:0015990)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of type 2 mitophagy (GO:1905089)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty acid metabolic process (GO:0000038)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
rhythmic excitation (GO:0043179)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-proline methylation (GO:0035568)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of metanephros size (GO:0035566)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleoside salvage (GO:0043174)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of pronephros size (GO:0035565)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleotide salvage (GO:0043173)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
regulation of kidney size (GO:0035564)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromatin binding (GO:0035563)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromatin binding (GO:0035562)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of chromatin binding (GO:0035561)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
ribosomal small subunit assembly (GO:0000028)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of tight junction disassembly (GO:1905075)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
maltose catabolic process (GO:0000025)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of tight junction disassembly (GO:1905073)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac jelly development (GO:1905072)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
maltose metabolic process (GO:0000023)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic spindle elongation (GO:0000022)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
anterior visceral endoderm cell migration (GO:1905070)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-alanine catabolic process (GO:0055130)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell envelope organization (GO:0043163)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
L-proline biosynthetic process (GO:0055129)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
allantois development (GO:1905069)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
vibrational conductance of sound to the inner ear (GO:0055127)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
alpha-glucoside transport (GO:0000017)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of vascular associated smooth muscle cell differentiation (GO:1905063)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardioblast proliferation (GO:1905062)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
single strand break repair (GO:0000012)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
response to cation stress (GO:0043157)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
determination of left/right asymmetry in nervous system (GO:0035545)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
entrainment of circadian clock by photoperiod (GO:0043153)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
negative regulation of SNARE complex assembly (GO:0035544)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
induction of bacterial agglutination (GO:0043152)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of SNARE complex assembly (GO:0035543)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of SNARE complex assembly (GO:0035542)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
diadenosine tetraphosphate biosynthetic process (GO:0015966)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
diadenosine tetraphosphate metabolic process (GO:0015965)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
diadenosine triphosphate catabolic process (GO:0015964)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
diadenosine triphosphate metabolic process (GO:0015962)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
diadenosine polyphosphate catabolic process (GO:0015961)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
relaxation of cardiac muscle (GO:0055119)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
diadenosine polyphosphate biosynthetic process (GO:0015960)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle contraction (GO:0055118)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of base-excision repair (GO:1905053)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
epiboly involved in gastrulation with mouth forming second (GO:0055113)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of base-excision repair (GO:1905051)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
GDP-mannose biosynthetic process (GO:0009298)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
ingression involved in gastrulation with mouth forming second (GO:0055111)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial genome maintenance (GO:0000002)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
stress fiber assembly (GO:0043149)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
sno(s)RNA processing (GO:0043144)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of translation by machinery localization (GO:0043143)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptide modification (GO:0031179)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
diadenosine polyphosphate metabolic process (GO:0015959)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
otolith mineralization completed early in development (GO:0031173)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of metallopeptidase activity (GO:1905049)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
Golgi to transport vesicle transport (GO:0055108)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
Golgi to secretory granule transport (GO:0055107)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of Schwann cell proliferation involved in axon regeneration (GO:1905045)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell proliferation involved in axon regeneration (GO:1905044)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelium regeneration (GO:1905043)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelium regeneration (GO:1905042)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of epithelium regeneration (GO:1905041)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
otic placode development (GO:1905040)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA replication, removal of RNA primer (GO:0043137)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
retrograde transport, plasma membrane to Golgi (GO:0035526)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hindgut contraction (GO:0043134)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
NAD transport (GO:0043132)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein K29-linked deubiquitination (GO:0035523)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
erythrocyte enucleation (GO:0043131)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
monoubiquitinated protein deubiquitination (GO:0035520)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
rRNA methylation (GO:0031167)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
metallo-sulfur cluster assembly (GO:0031163)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
formate metabolic process (GO:0015942)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of membrane lipid metabolic process (GO:1905038)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
autophagosome organization (GO:1905037)	99	0	1.65	-	 < 0.01	4.17E-01	1.00E00
positive regulation of antifungal innate immune response (GO:1905036)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of antifungal innate immune response (GO:1905035)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antifungal innate immune response (GO:1905034)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905033)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905032)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905031)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein K29-linked ubiquitination (GO:0035519)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of canonical NF-kappaB signal transduction (GO:0043124)	65	0	1.08	-	 < 0.01	6.30E-01	1.00E00
oxidative RNA demethylation (GO:0035513)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pantothenate metabolic process (GO:0015939)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
coenzyme A catabolic process (GO:0015938)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905026)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905025)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905024)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
2'-deoxyribonucleotide biosynthetic process (GO:0009265)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleotide catabolic process (GO:0009264)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleotide biosynthetic process (GO:0009263)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleotide metabolic process (GO:0009262)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
positive regulation of myosin light chain kinase activity (GO:0035505)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of myosin light chain kinase activity (GO:0035504)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric part of ureteric bud development (GO:0035502)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
replication fork arrest (GO:0043111)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
anaphase-promoting complex-dependent catabolic process (GO:0031145)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
proteasome localization (GO:0031144)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
10-formyltetrahydrofolate catabolic process (GO:0009258)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
10-formyltetrahydrofolate biosynthetic process (GO:0009257)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-lysine import across plasma membrane (GO:1905010)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
10-formyltetrahydrofolate metabolic process (GO:0009256)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
peptidoglycan catabolic process (GO:0009253)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
glucan catabolic process (GO:0009251)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
glucan biosynthetic process (GO:0009250)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
hypoxanthine salvage (GO:0043103)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
amino acid salvage (GO:0043102)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
purine-containing compound salvage (GO:0043101)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
peroxisomal membrane transport (GO:0015919)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
aminophospholipid transport (GO:0015917)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
sister chromatid biorientation (GO:0031134)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
fatty-acyl-CoA transport (GO:0015916)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of axon diameter (GO:0031133)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid transmembrane transport (GO:0015913)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid transport (GO:0015912)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid import across plasma membrane (GO:0015911)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid import into peroxisome (GO:0015910)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of L-lysine import across plasma membrane (GO:1905008)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905006)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein lipoylation (GO:0009249)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during atrial cardiac muscle cell action potential (GO:1905000)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
isopentenyl diphosphate biosynthetic process (GO:0009240)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
inductive cell-cell signaling (GO:0031129)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid transport (GO:0015909)	54	0	.90	-	 < 0.01	1.00E00	1.00E00
sno(s)RNA 3'-end processing (GO:0031126)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
fatty acid transport (GO:0015908)	93	0	1.55	-	 < 0.01	4.11E-01	1.00E00
mRNA 3'-end processing (GO:0031124)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
snRNA pseudouridine synthesis (GO:0031120)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
siderophore metabolic process (GO:0009237)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cobalamin metabolic process (GO:0009235)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
menaquinone biosynthetic process (GO:0009234)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
menaquinone metabolic process (GO:0009233)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
riboflavin biosynthetic process (GO:0009231)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA pseudouridine synthesis (GO:0031119)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
rRNA pseudouridine synthesis (GO:0031118)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule polymerization (GO:0031116)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule polymerization (GO:0031115)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule polymerization (GO:0031113)	58	0	.97	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule polymerization or depolymerization (GO:0031111)	51	0	.85	-	 < 0.01	1.00E00	1.00E00
thiamine diphosphate biosynthetic process (GO:0009229)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleotide-sugar catabolic process (GO:0009227)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleotide-sugar biosynthetic process (GO:0009226)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
nucleotide-sugar metabolic process (GO:0009225)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
CMP biosynthetic process (GO:0009224)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleotide catabolic process (GO:0009223)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide catabolic process (GO:0009222)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide biosynthetic process (GO:0009220)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
microtubule polymerization or depolymerization (GO:0031109)	68	0	1.13	-	 < 0.01	6.32E-01	1.00E00
septin ring organization (GO:0031106)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dendrite regeneration (GO:0031104)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleotide metabolic process (GO:0009219)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide metabolic process (GO:0009218)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside triphosphate catabolic process (GO:0009217)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside triphosphate biosynthetic process (GO:0009216)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside triphosphate metabolic process (GO:0009215)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside triphosphate catabolic process (GO:0009210)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
follicle-stimulating hormone signaling pathway (GO:0042699)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
ovulation cycle (GO:0042698)	81	0	1.35	-	 < 0.01	6.48E-01	1.00E00
menopause (GO:0042697)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
thelarche (GO:0042695)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
muscle cell fate specification (GO:0042694)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
muscle cell fate commitment (GO:0042693)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside triphosphate catabolic process (GO:0009207)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904597)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904596)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside triphosphate catabolic process (GO:0009204)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of termination of RNA polymerase II transcription (GO:1904595)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of termination of RNA polymerase II transcription (GO:1904594)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
ribonucleoside triphosphate catabolic process (GO:0009203)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside triphosphate biosynthetic process (GO:0009202)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein refolding (GO:1904592)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside triphosphate metabolic process (GO:0009200)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein import (GO:1904591)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of protein import (GO:1904589)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to glycoprotein (GO:1904588)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to glycoprotein (GO:1904587)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to putrescine (GO:1904586)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to putrescine (GO:1904585)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to polyamine macromolecule (GO:1904584)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to polyamine macromolecule (GO:1904583)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular mRNA localization (GO:1904582)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular mRNA localization (GO:1904580)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
retinal cone cell differentiation (GO:0042670)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of selenocysteine incorporation (GO:1904571)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of selenocysteine incorporation (GO:1904570)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of inner ear auditory receptor cell fate specification (GO:0042669)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell fate determination (GO:0042668)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell fate specification (GO:0042667)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ectodermal cell fate specification (GO:0042666)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ectodermal cell fate specification (GO:0042665)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of endodermal cell fate specification (GO:0042664)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endodermal cell fate specification (GO:0042663)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesodermal cell fate specification (GO:0042662)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mesodermal cell fate specification (GO:0042661)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell fate specification (GO:0042660)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of selenocysteine incorporation (GO:1904569)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to wortmannin (GO:1904568)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to wortmannin (GO:1904567)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904566)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
platelet activating factor catabolic process (GO:0062234)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904565)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
prostanoid catabolic process (GO:0062232)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol 5-phosphate metabolic process (GO:1904562)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell fate specification (GO:0042659)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
symbiont-mediated perturbation of host defenses (GO:0030682)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-alanine transmembrane transport (GO:1904557)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
L-tryptophan transmembrane transport (GO:1904556)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-proline transmembrane transport (GO:1904555)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to arachidonate (GO:1904551)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to arachidonate (GO:1904550)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of oocyte maturation (GO:1900195)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of oocyte maturation (GO:1900194)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane bending (GO:0097753)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA stability (GO:0097752)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of oocyte maturation (GO:1900193)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
endosome membrane tubulation (GO:0097750)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of single-species biofilm formation (GO:1900191)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of single-species biofilm formation (GO:1900190)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
anagen (GO:0042640)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of free ubiquitin chain polymerization (GO:1904544)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of free ubiquitin chain polymerization (GO:1904542)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane tubulation (GO:0097749)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycolytic process through fructose-6-phosphate (GO:1904540)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA 5'-end processing (GO:0097745)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
renal urate salt excretion (GO:0097744)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hair cycle (GO:0042636)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
de novo centriole assembly (GO:0097742)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to nucleus (GO:1900181)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
cellular response to water deprivation (GO:0042631)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycolytic process through fructose-6-phosphate (GO:1904539)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of glycolytic process through fructose-6-phosphate (GO:1904538)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomeric loop disassembly (GO:1904535)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric loop disassembly (GO:1904534)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric loop disassembly (GO:1904533)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament binding (GO:1904531)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mating plug formation (GO:0042628)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
extracellular exosome biogenesis (GO:0097734)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucocorticoid mediated signaling pathway (GO:1900170)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vitamin metabolic process (GO:0030656)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
beta-lactam antibiotic metabolic process (GO:0030653)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament binding (GO:1904529)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule binding (GO:1904528)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule binding (GO:1904527)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule binding (GO:1904526)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of myofibroblast cell apoptotic process (GO:1904520)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glucocorticoid mediated signaling pathway (GO:1900169)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glial cell-derived neurotrophic factor production (GO:1900168)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glial cell-derived neurotrophic factor production (GO:1900166)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipid scramblase activity (GO:1900163)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
calcineurin-mediated signaling (GO:0097720)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid scramblase activity (GO:1900161)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aminoglycoside antibiotic metabolic process (GO:0030647)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
intracellular phosphate ion homeostasis (GO:0030643)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
protein localization to cytoplasmic microtubule plus-end (GO:1904518)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of TORC2 signaling (GO:1904515)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
neural tissue regeneration (GO:0097719)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to basolateral plasma membrane (GO:1904510)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of bone mineralization involved in bone maturation (GO:1900159)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of bone mineralization involved in bone maturation (GO:1900158)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of bone mineralization involved in bone maturation (GO:1900157)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of bone trabecula formation (GO:1900155)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of bone trabecula formation (GO:1900154)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900152)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
ciliary basal body-plasma membrane docking (GO:0097711)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
regulation of defense response to fungus (GO:1900150)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
polyketide metabolic process (GO:0030638)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to basolateral plasma membrane (GO:1904508)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomere maintenance in response to DNA damage (GO:1904507)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance in response to DNA damage (GO:1904506)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance in response to DNA damage (GO:1904505)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipophagy (GO:1904504)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lipophagy (GO:1904502)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
connective tissue replacement (GO:0097709)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of Schwann cell migration (GO:1900149)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of Schwann cell migration (GO:1900148)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
ferroptosis (GO:0097707)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell migration (GO:1900147)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of oligodendrocyte apoptotic process (GO:1900143)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of oligodendrocyte apoptotic process (GO:1900142)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of oligodendrocyte apoptotic process (GO:1900141)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of arachidonate secretion (GO:1900139)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase A2 activity (GO:1900138)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic chromosome movement towards spindle pole (GO:0016344)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of renin secretion into blood stream (GO:1900135)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of renin secretion into blood stream (GO:1900134)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of renin secretion into blood stream (GO:1900133)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
calcium-dependent cell-matrix adhesion (GO:0016340)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid binding (GO:1900131)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of lipid binding (GO:1900130)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
regulation of G-protein activated inward rectifier potassium channel activity (GO:1900128)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of polarity of follicular epithelium (GO:0016334)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of hyaluronan biosynthetic process (GO:1900127)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of hyaluronan biosynthetic process (GO:1900126)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
morphogenesis of follicular epithelium (GO:0016333)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of polarity of embryonic epithelium (GO:0016332)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of hyaluronan biosynthetic process (GO:1900125)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of nodal receptor complex assembly (GO:1900124)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of nodal receptor complex assembly (GO:1900123)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor binding (GO:1900122)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor binding (GO:1900121)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of receptor binding (GO:1900120)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of execution phase of apoptosis (GO:1900119)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of execution phase of apoptosis (GO:1900118)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of execution phase of apoptosis (GO:1900117)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
female meiosis chromosome segregation (GO:0016321)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
xenobiotic transport across blood-nerve barrier (GO:0061772)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to caloric restriction (GO:0061771)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum membrane fusion (GO:0016320)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrion transport along microtubule (GO:0047497)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of lung blood pressure (GO:0061767)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of nodal signaling pathway (GO:1900108)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of nodal signaling pathway (GO:1900107)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
late endosome to lysosome transport via multivesicular body sorting pathway (GO:0061764)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hyaluranon cable assembly (GO:1900106)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
multivesicular body-lysosome fusion (GO:0061763)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of hyaluranon cable assembly (GO:1900104)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
antifungal innate immune response (GO:0061760)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of endoplasmic reticulum unfolded protein response (GO:1900101)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
positive regulation of plasma cell differentiation (GO:1900100)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
low-density lipoprotein particle mediated signaling (GO:0055096)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
lipoprotein particle mediated signaling (GO:0055095)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to hyperoxia (GO:0055093)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
acylglycerol homeostasis (GO:0055090)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
leukocyte adhesion to arterial endothelial cell (GO:0061757)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leukocyte adhesion to vascular endothelial cell (GO:0061756)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of circulating fibrinogen levels (GO:0061755)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
substrate localization to autophagosome (GO:0061753)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction by action potential (GO:0100001)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
motor behavior (GO:0061744)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
motor learning (GO:0061743)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
protein targeting to lysosome involved in chaperone-mediated autophagy (GO:0061740)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
manganese ion homeostasis (GO:0055071)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
carnosine biosynthetic process (GO:0035499)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
carnosine metabolic process (GO:0035498)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein lipidation involved in autophagosome assembly (GO:0061739)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
late endosomal microautophagy (GO:0061738)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
SNARE complex disassembly (GO:0035494)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
SNARE complex assembly (GO:0035493)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
engulfment of target by autophagosome (GO:0061736)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukotriene production involved in inflammatory response (GO:0035491)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
type 2 mitophagy (GO:0061734)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of leukotriene production involved in inflammatory response (GO:0035490)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phosphate ion homeostasis (GO:0055062)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
purine nucleobase salvage (GO:0043096)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular metabolic compound salvage (GO:0043094)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
GDP-mannose biosynthetic process from fructose-6-phosphate (GO:0061729)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
GDP-mannose biosynthetic process from mannose (GO:0061728)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
methylglyoxal catabolic process to lactate (GO:0061727)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
gastric emptying (GO:0035483)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
gastric motility (GO:0035482)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cytosolic lipolysis (GO:0061725)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
amino acid import (GO:0043090)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lipophagy (GO:0061724)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
glycophagy (GO:0061723)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
asymmetric neuroblast division (GO:0055059)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
neuroblast division (GO:0055057)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
angioblast cell migration (GO:0035476)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
penile erection (GO:0043084)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
luteinizing hormone signaling pathway involved in ovarian follicle development (GO:0035471)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular wound healing (GO:0035470)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
anterior neural tube closure (GO:0061713)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
siderophore transport (GO:0015891)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
anastral spindle assembly (GO:0055048)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
determination of pancreatic left/right asymmetry (GO:0035469)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
reticulophagy (GO:0061709)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
cobalamin transport (GO:0015889)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
thiamine transport (GO:0015888)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
pantothenate transmembrane transport (GO:0015887)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heme transport (GO:0015886)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
folic acid transport (GO:0015884)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
FAD transport (GO:0015883)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
L-ascorbic acid transmembrane transport (GO:0015882)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
coenzyme A transport (GO:0015880)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vesicle cargo loading (GO:0035459)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
cellular response to interferon-alpha (GO:0035457)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
response to interferon-alpha (GO:0035455)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
intercellular bridge organization (GO:0043063)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic metaphase I homologous chromosome alignment (GO:0043060)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
carnitine transport (GO:0015879)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
biotin transport (GO:0015878)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA transport (GO:0015876)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
norepinephrine transport (GO:0015874)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
dopamine transport (GO:0015872)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
choline transport (GO:0015871)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
acetylcholine transport (GO:0015870)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle tissue development (GO:0055026)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle tissue development (GO:0055025)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle tissue development (GO:0055024)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle tissue growth (GO:0055023)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle fiber development (GO:0055020)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
forward locomotion (GO:0043056)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
borate transmembrane transport (GO:0035445)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nickel cation transmembrane transport (GO:0035444)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tripeptide transmembrane transport (GO:0035443)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
thermotaxis (GO:0043052)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dipeptide transmembrane transport (GO:0035442)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cell migration involved in vasculogenesis (GO:0035441)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
ADP transport (GO:0015866)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside transport (GO:0015864)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
uridine transmembrane transport (GO:0015862)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cytidine transport (GO:0015861)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
purine nucleoside transmembrane transport (GO:0015860)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle fiber development (GO:0055018)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell development (GO:0055014)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell differentiation (GO:0055011)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
dolichyl monophosphate biosynthetic process (GO:0043048)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside diphosphate catabolic process (GO:0009195)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside diphosphate biosynthetic process (GO:0009194)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
maintenance of protein localization in endoplasmic reticulum (GO:0035437)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside diphosphate metabolic process (GO:0009193)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside diphosphate catabolic process (GO:0009192)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptide biosynthetic process (GO:0043043)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
copper ion transmembrane transport (GO:0035434)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
amino acid activation for nonribosomal peptide biosynthetic process (GO:0043041)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
post-embryonic camera-type eye development (GO:0031077)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
nucleoside transport (GO:0015858)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
uracil transport (GO:0015857)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase transport (GO:0015855)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
guanine transport (GO:0015854)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
adenine transport (GO:0015853)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleobase transport (GO:0015851)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle tissue morphogenesis (GO:0055009)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
ventricular cardiac myofibril assembly (GO:0055005)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside diphosphate biosynthetic process (GO:0009189)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
ribonucleoside diphosphate biosynthetic process (GO:0009188)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
tRNA aminoacylation (GO:0043039)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside diphosphate metabolic process (GO:0009186)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
amino acid activation (GO:0043038)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
gluconate transmembrane transport (GO:0035429)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside diphosphate catabolic process (GO:0009184)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside diphosphate biosynthetic process (GO:0009183)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
extracellular matrix-cell signaling (GO:0035426)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside diphosphate metabolic process (GO:0009182)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
autocrine signaling (GO:0035425)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside diphosphate biosynthetic process (GO:0009180)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
spermidine transport (GO:0015848)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
putrescine transport (GO:0015847)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
polyamine transport (GO:0015846)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
monoamine transport (GO:0015844)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
methylammonium transport (GO:0015843)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
aminergic neurotransmitter loading into synaptic vesicle (GO:0015842)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
urea transport (GO:0015840)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside monophosphate catabolic process (GO:0009178)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside monophosphate catabolic process (GO:0009175)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside monophosphate catabolic process (GO:0009172)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside monophosphate biosynthetic process (GO:0009171)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside monophosphate metabolic process (GO:0009170)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine transport (GO:0015838)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
chromatin remodeling at centromere (GO:0031055)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
amine transport (GO:0015837)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
pre-miRNA processing (GO:0031054)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
primary miRNA processing (GO:0031053)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
peptidoglycan transport (GO:0015835)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside monophosphate biosynthetic process (GO:0009168)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
nucleoside catabolic process (GO:0009164)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside monophosphate metabolic process (GO:0009162)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
regulatory ncRNA-mediated heterochromatin formation (GO:0031048)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
valine transport (GO:0015829)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
tyrosine transport (GO:0015828)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
tryptophan transport (GO:0015827)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
threonine transport (GO:0015826)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-serine transport (GO:0015825)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
phenylalanine transport (GO:0015823)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
ornithine transport (GO:0015822)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
methionine transport (GO:0015821)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
L-leucine transport (GO:0015820)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside monophosphate catabolic process (GO:0009159)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside monophosphate biosynthetic process (GO:0009157)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
ribonucleoside monophosphate biosynthetic process (GO:0009156)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleotide catabolic process (GO:0009155)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
maintenance of rDNA (GO:0043007)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleotide biosynthetic process (GO:0009153)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleotide metabolic process (GO:0009151)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
Golgi to plasma membrane protein transport (GO:0043001)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
myosin II filament organization (GO:0031038)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lysine transport (GO:0015819)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
myosin II filament disassembly (GO:0031037)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
isoleucine transport (GO:0015818)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
histidine transport (GO:0015817)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
myosin filament disassembly (GO:0031035)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myosin filament assembly (GO:0031034)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
myosin filament organization (GO:0031033)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
L-glutamate transmembrane transport (GO:0015813)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
L-cystine transport (GO:0015811)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside triphosphate catabolic process (GO:0009149)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside triphosphate metabolic process (GO:0009147)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
purine nucleoside triphosphate catabolic process (GO:0009146)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of hemoglobin biosynthetic process (GO:0046986)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of hemoglobin biosynthetic process (GO:0046985)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleoside triphosphate catabolic process (GO:0009143)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of hemoglobin biosynthetic process (GO:0046984)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside diphosphate catabolic process (GO:0009140)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
S-adenosyl-L-methionine transport (GO:0015805)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear migration along microfilament (GO:0031022)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid transport (GO:0015803)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
basic amino acid transport (GO:0015802)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid transport (GO:0015801)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside diphosphate metabolic process (GO:0009138)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of lysosome size (GO:0062196)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
purine nucleoside diphosphate biosynthetic process (GO:0009136)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleoside diphosphate biosynthetic process (GO:0009133)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside monophosphate catabolic process (GO:0009131)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
exocrine pancreas development (GO:0031017)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside monophosphate metabolic process (GO:0009129)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
purine nucleoside monophosphate biosynthetic process (GO:0009127)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
peptide antigen transport (GO:0046968)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cytosol to endoplasmic reticulum transport (GO:0046967)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleoside monophosphate biosynthetic process (GO:0009124)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
3'-phosphoadenosine 5'-phosphosulfate transport (GO:0046963)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside metabolic process (GO:0009120)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
sensitization (GO:0046960)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
radial spoke assembly (GO:0062177)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
R-loop processing (GO:0062176)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
brexanolone catabolic process (GO:0062175)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
xanthine catabolic process (GO:0009115)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
hypoxanthine catabolic process (GO:0009114)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
brexanolone metabolic process (GO:0062173)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
purine nucleobase biosynthetic process (GO:0009113)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
nucleobase metabolic process (GO:0009112)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
lutein catabolic process (GO:0062172)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vitamin catabolic process (GO:0009111)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
ketone body catabolic process (GO:0046952)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
vitamin biosynthetic process (GO:0009110)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
lutein metabolic process (GO:0062170)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ketone body biosynthetic process (GO:0046951)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
behavioral response to starvation (GO:0042595)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor signaling pathway involved in heart process (GO:0086103)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine deacetylation (GO:0034983)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
mitochondrial protein processing (GO:0034982)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
endothelin receptor signaling pathway involved in heart process (GO:0086101)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
fatty-acyl-CoA biosynthetic process (GO:0046949)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
lipoate biosynthetic process (GO:0009107)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipoate metabolic process (GO:0009106)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
hydroxylysine biosynthetic process (GO:0046947)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of substance P secretion, neurotransmission (GO:1904496)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hydroxylysine metabolic process (GO:0046946)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lipopolysaccharide catabolic process (GO:0009104)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of substance P secretion, neurotransmission (GO:1904494)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to ciliary transition zone (GO:1904491)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
vascular endothelial cell response to fluid shear stress (GO:0097699)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via base-excision repair (GO:0097698)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleoside monophosphate phosphorylation (GO:0046940)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
establishment of protein-containing complex localization to telomere (GO:0097695)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of RNA localization to telomere (GO:0097694)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein folding in endoplasmic reticulum (GO:0034975)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to tetrahydrofolate (GO:1904482)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to tetrahydrofolate (GO:1904481)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glutamate receptor clustering (GO:0097688)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of intestinal absorption (GO:1904480)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
retinal metabolic process (GO:0042574)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via alternative nonhomologous end joining (GO:0097681)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
retinoic acid metabolic process (GO:0042573)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
box H/ACA sno(s)RNA processing (GO:0034964)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via classical nonhomologous end joining (GO:0097680)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
retinol metabolic process (GO:0042572)	50	0	.83	-	 < 0.01	1.00E00	1.00E00
box C/D sno(s)RNA processing (GO:0034963)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of transport across blood-brain barrier (GO:0150202)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of transport across blood-brain barrier (GO:0150201)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of transport across blood-brain barrier (GO:0150200)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of intestinal absorption (GO:1904479)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal absorption (GO:1904478)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelin production (GO:1904471)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endothelin maturation (GO:0034959)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pteridine-containing compound catabolic process (GO:0042560)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
DNA ADP-ribosylation (GO:0030592)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of matrix metallopeptidase secretion (GO:1904466)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of matrix metallopeptidase secretion (GO:1904465)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of matrix metallopeptidase secretion (GO:1904464)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of substance P secretion (GO:1904460)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pteridine-containing compound biosynthetic process (GO:0042559)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
pteridine-containing compound metabolic process (GO:0042558)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
symbiont intracellular protein transport in host (GO:0030581)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of substance P secretion (GO:1904458)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fatty acid primary amide metabolic process (GO:0062126)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuronal action potential (GO:1904457)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial gene expression (GO:0062125)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuronal action potential (GO:1904456)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of potassium:proton exchanging ATPase activity (GO:1904451)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolylpolyglutamate biosynthetic process (GO:0046901)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of plasma cell differentiation (GO:1900099)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of aspartate secretion (GO:1904450)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolylpolyglutamate metabolic process (GO:0046900)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of plasma cell differentiation (GO:1900098)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
hemoglobin biosynthetic process (GO:0042541)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
Cajal body organization (GO:0030576)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
bile acid catabolic process (GO:0030573)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of eIF2 alpha phosphorylation by heme (GO:0010999)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation by eIF2 alpha phosphorylation (GO:0010998)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of aspartate secretion (GO:1904448)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
folate import across plasma membrane (GO:1904447)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of Sertoli cell barrier (GO:1904446)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of Sertoli cell barrier (GO:1904445)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
free ubiquitin chain polymerization (GO:0010994)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of Sertoli cell barrier (GO:1904444)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
fatty acid primary amide biosynthetic process (GO:0062112)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
zinc ion import into organelle (GO:0062111)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
ubiquitin recycling (GO:0010992)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of thyroid gland epithelial cell proliferation (GO:1904442)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of thyroid gland epithelial cell proliferation (GO:1904441)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of inositol biosynthetic process (GO:1900089)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of iron ion import across plasma membrane (GO:1904440)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of inositol biosynthetic process (GO:1900088)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hypotonic salinity response (GO:0042539)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
amylin receptor signaling pathway (GO:0097647)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
hyperosmotic salinity response (GO:0042538)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
benzene-containing compound metabolic process (GO:0042537)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptidyl-tyrosine autophosphorylation (GO:1900086)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-tyrosine autophosphorylation (GO:1900085)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-tyrosine autophosphorylation (GO:1900084)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of arginine catabolic process (GO:1900082)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
L-ornithine import across plasma membrane (GO:0097640)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of arginine catabolic process (GO:1900081)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of iron ion import across plasma membrane (GO:1904439)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of low-density lipoprotein particle clearance (GO:0010989)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of low-density lipoprotein particle clearance (GO:0010988)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of iron ion import across plasma membrane (GO:1904438)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of transferrin receptor binding (GO:1904437)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of high-density lipoprotein particle clearance (GO:0010987)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipoprotein particle clearance (GO:0010986)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein particle clearance (GO:0010985)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of transferrin receptor binding (GO:1904435)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein particle clearance (GO:0010984)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of ferrous iron binding (GO:1904434)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of high-density lipoprotein particle clearance (GO:0010983)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of high-density lipoprotein particle clearance (GO:0010982)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of ferrous iron binding (GO:1904432)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of programmed necrotic cell death (GO:0062100)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
L-lysine import across plasma membrane (GO:0097639)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of t-circle formation (GO:1904431)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
L-arginine import across plasma membrane (GO:0097638)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of arginine biosynthetic process (GO:1900079)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of t-circle formation (GO:1904430)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of vitamin D 24-hydroxylase activity (GO:0010980)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuromuscular synaptic transmission (GO:1900075)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neuromuscular synaptic transmission (GO:1900073)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of t-circle formation (GO:1904429)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of vitamin D 24-hydroxylase activity (GO:0010979)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of GTP binding (GO:1904426)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of GTP binding (GO:1904425)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of GTP binding (GO:1904424)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	74	0	1.23	-	 < 0.01	6.38E-01	1.00E00
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of cellular hyperosmotic salinity response (GO:1900069)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
potassium ion export across plasma membrane (GO:0097623)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of peroxisome organization (GO:1900063)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of ceramide biosynthetic process (GO:1900060)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule nucleation (GO:0010968)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of xenophagy (GO:1904417)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of polyamine biosynthetic process (GO:0010967)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of phosphate transport (GO:0010966)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic sister chromatid separation (GO:0010965)	63	0	1.05	-	 < 0.01	6.29E-01	1.00E00
regulation of xenophagy (GO:1904415)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac ventricle development (GO:1904414)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glucan biosynthetic process (GO:0010962)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac ventricle development (GO:1904412)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
core 2 O-glycan biosynthetic process (GO:0016268)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
core 1 O-glycan biosynthetic process (GO:0016267)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of secretory granule organization (GO:1904411)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
intracellular magnesium ion homeostasis (GO:0010961)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
O-glycan processing (GO:0016266)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
magnesium ion homeostasis (GO:0010960)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound salvage (GO:0008655)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
gap junction assembly (GO:0016264)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
lipopolysaccharide metabolic process (GO:0008653)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of retinoic acid biosynthetic process (GO:1900054)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
selenocysteine catabolic process (GO:0016261)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
selenocysteine biosynthetic process (GO:0016260)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of retinoic acid biosynthetic process (GO:1900053)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of retinoic acid biosynthetic process (GO:1900052)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
serine phosphorylation of STAT protein (GO:0042501)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
male genitalia development (GO:0030539)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
embryonic genitalia morphogenesis (GO:0030538)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of secretory granule organization (GO:1904409)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of amino acid import across plasma membrane (GO:0010958)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of vitamin D biosynthetic process (GO:0010957)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitric oxide metabolic process (GO:1904406)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcidiol 1-monooxygenase activity (GO:0010956)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to formaldehyde (GO:1904404)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
selenocysteine metabolic process (GO:0016259)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to Thyroid stimulating hormone (GO:1904401)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to Thyroid stimulating hormone (GO:1904400)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
N-glycan processing to lysosome (GO:0016256)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
attachment of GPI anchor to protein (GO:0016255)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of hemostasis (GO:1900048)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
hexose transmembrane transport (GO:0008645)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein K63-linked ubiquitination (GO:1900045)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of protein K63-linked ubiquitination (GO:1900044)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
retina blood vessel maintenance (GO:0097601)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
androgen receptor signaling pathway (GO:0030521)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
estrogen receptor signaling pathway (GO:0030520)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of intestinal phytosterol absorption (GO:0010949)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by competitive promoter binding (GO:0010944)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
protein deglutarylation (GO:0061698)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular response to hypoxia (GO:1900039)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of autophagosome size (GO:0016243)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular response to heat (GO:1900036)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of macroautophagy (GO:0016242)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to heat (GO:1900034)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
autophagosome membrane docking (GO:0016240)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
nuclear receptor-mediated steroid hormone signaling pathway (GO:0030518)	52	0	.87	-	 < 0.01	1.00E00	1.00E00
positive regulation of BMP signaling pathway (GO:0030513)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
respiratory electron transport chain (GO:0022904)	107	0	1.78	-	 < 0.01	4.29E-01	1.00E00
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
electron transport chain (GO:0022900)	116	0	1.93	-	 < 0.01	2.71E-01	1.00E00
cytoplasmic microtubule depolymerization (GO:0010938)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage cytokine production (GO:0010936)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage cytokine production (GO:0010935)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
macrophage cytokine production (GO:0010934)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage tolerance induction (GO:0010933)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage tolerance induction (GO:0010932)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
microautophagy (GO:0016237)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
hormone-mediated apoptotic signaling pathway (GO:0008628)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
macroautophagy (GO:0016236)	220	0	3.67	-	 < 0.01	5.60E-02	7.62E-01
intrinsic apoptotic signaling pathway in response to osmotic stress (GO:0008627)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ruffle assembly (GO:1900028)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
granzyme-mediated apoptotic signaling pathway (GO:0008626)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated autophagy (GO:0061684)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
telomere capping (GO:0016233)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
seminal vesicle morphogenesis (GO:0061682)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein kinase C activity (GO:1900020)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway (GO:0030509)	88	0	1.47	-	 < 0.01	4.09E-01	1.00E00
inorganic diphosphate transport (GO:0030505)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of bone mineralization (GO:0030502)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010925)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010924)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatase activity (GO:0010923)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatase activity (GO:0010922)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatase activity (GO:0010921)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
iron-sulfur cluster assembly (GO:0016226)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of protein kinase C activity (GO:1900019)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of inositol phosphate biosynthetic process (GO:0010920)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
guanosine metabolic process (GO:0008617)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyridoxine biosynthetic process (GO:0008615)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytokine production involved in inflammatory response (GO:1900016)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
pyridoxine metabolic process (GO:0008614)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ether lipid biosynthetic process (GO:0008611)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
evoked neurotransmitter secretion (GO:0061670)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of corticotropin-releasing hormone receptor activity (GO:1900011)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of corticotropin-releasing hormone receptor activity (GO:1900010)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of inositol phosphate biosynthetic process (GO:0010919)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of very-low-density lipoprotein particle clearance (GO:0010916)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of very-low-density lipoprotein particle clearance (GO:0010915)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of isomerase activity (GO:0010912)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
spontaneous neurotransmitter secretion (GO:0061669)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
mitochondrial ribosome assembly (GO:0061668)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of isomerase activity (GO:0010911)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
attachment of spindle microtubules to kinetochore (GO:0008608)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
negative regulation of eating behavior (GO:1903999)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of eating behavior (GO:1903998)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903996)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of serine-type endopeptidase activity (GO:1900004)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of serine-type endopeptidase activity (GO:1900003)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010909)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010908)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of very-low-density lipoprotein particle remodeling (GO:0010903)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of very-low-density lipoprotein particle remodeling (GO:0010902)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of very-low-density lipoprotein particle remodeling (GO:0010901)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylcholine catabolic process (GO:0010900)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
iron ion export across plasma membrane (GO:1903988)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal D-glucose absorption (GO:1903985)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
muscle attachment (GO:0016203)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of TRAIL-activated apoptotic signaling pathway (GO:1903984)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of microglial cell activation (GO:1903980)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization (GO:0061646)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glial cell migration (GO:1903977)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of glial cell migration (GO:1903976)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
protein localization to CENP-A containing chromatin (GO:0061644)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glial cell migration (GO:1903975)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903974)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
chemoattraction of axon (GO:0061642)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903972)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to macrophage colony-stimulating factor (GO:1903971)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
helper T cell enhancement of adaptive immune response (GO:0035397)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemokine (C-X-C motif) ligand 9 production (GO:0035395)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-X-C motif) ligand 9 production (GO:0035394)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of response to macrophage colony-stimulating factor (GO:1903969)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
chemokine (C-X-C motif) ligand 9 production (GO:0035393)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein complex stability (GO:0061635)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
monounsaturated fatty acid biosynthetic process (GO:1903966)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
monounsaturated fatty acid metabolic process (GO:1903964)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
arachidonate transport (GO:1903963)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
positive regulation of anion transmembrane transport (GO:1903961)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of anion transmembrane transport (GO:1903960)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
thioester biosynthetic process (GO:0035384)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
regulation of monoatomic anion transmembrane transport (GO:1903959)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
thioester metabolic process (GO:0035383)	93	0	1.55	-	 < 0.01	4.11E-01	1.00E00
glycolytic process through fructose-1-phosphate (GO:0061625)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein targeting to mitochondrion (GO:1903955)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
glycolytic process from galactose (GO:0061623)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
glycolytic process through glucose-1-phosphate (GO:0061622)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
carbon dioxide transmembrane transport (GO:0035378)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
transepithelial water transport (GO:0035377)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
glycolytic process from mannose through fructose-6-phosphate (GO:0061619)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of atrial cardiac muscle cell action potential (GO:1903949)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule (GO:0035372)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of ventricular cardiac muscle cell action potential (GO:1903946)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatocyte apoptotic process (GO:1903945)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
miRNA transcription (GO:0061614)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
myo-inositol transport (GO:0015798)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of respiratory gaseous exchange (GO:1903942)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mannose to fructose-6-phosphate catabolic process (GO:0061611)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mannitol transmembrane transport (GO:0015797)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of respiratory gaseous exchange (GO:1903941)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of TORC2 signaling (GO:1903940)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
glycerol-3-phosphate transmembrane transport (GO:0015794)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycerol transmembrane transport (GO:0015793)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
polyol transmembrane transport (GO:0015791)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
UDP-xylose transmembrane transport (GO:0015790)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of TORC2 signaling (GO:1903939)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
thymine transport (GO:0035364)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to acrylamide (GO:1903937)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to sodium arsenite (GO:1903936)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to sodium arsenite (GO:1903935)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA primase activity (GO:1903934)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of DNA primase activity (GO:1903932)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
UDP-glucuronic acid transmembrane transport (GO:0015787)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
UDP-glucose transmembrane transport (GO:0015786)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
GDP-fucose transmembrane transport (GO:0015783)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CMP-N-acetylneuraminate transmembrane transport (GO:0015782)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleotide-sugar transmembrane transport (GO:0015780)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035359)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
intracellular triglyceride homeostasis (GO:0035356)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
primary palate development (GO:1903929)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
NAD transmembrane transport (GO:0035352)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to bisphenol A (GO:1903926)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
heme transmembrane transport (GO:0035351)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
FAD transmembrane transport (GO:0035350)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to bisphenol A (GO:1903925)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
glucuronoside transport (GO:0015779)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein processing in phagocytic vesicle (GO:1903923)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein processing in phagocytic vesicle (GO:1903921)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament severing (GO:1903920)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
polysaccharide transport (GO:0015774)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
viral budding via host ESCRT complex (GO:0039702)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
coenzyme A transmembrane transport (GO:0035349)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA transmembrane transport (GO:0035348)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hypoxanthine transport (GO:0035344)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin filament severing (GO:1903919)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament severing (GO:1903918)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
angiotensin-activated signaling pathway involved in heart process (GO:0086098)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
inosine transport (GO:0035340)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of fusion of virus membrane with host plasma membrane (GO:1903914)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of fusion of virus membrane with host plasma membrane (GO:1903913)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor clustering (GO:1903911)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of the force of heart contraction by cardiac conduction (GO:0086092)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor clustering (GO:1903910)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of heart rate by cardiac conduction (GO:0086091)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
mannose transmembrane transport (GO:0015761)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-valine biosynthetic process (GO:0009099)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
L-leucine biosynthetic process (GO:0009098)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
isoleucine biosynthetic process (GO:0009097)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family biosynthetic process, prephenate pathway (GO:0009095)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
fatty-acyl-CoA metabolic process (GO:0035337)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
cysteine catabolic process (GO:0009093)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
long-chain fatty-acyl-CoA metabolic process (GO:0035336)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
homoserine metabolic process (GO:0009092)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of receptor clustering (GO:1903909)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of hippo signaling (GO:0035332)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of plasma membrane raft polarization (GO:1903906)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of T cell polarity (GO:1903905)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of T cell polarity (GO:1903904)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of T cell polarity (GO:1903903)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
galactose transmembrane transport (GO:0015757)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
fucose transmembrane transport (GO:0015756)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fructose transmembrane transport (GO:0015755)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
methionine catabolic process (GO:0009087)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
methionine biosynthetic process (GO:0009086)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
hippo signaling (GO:0035329)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
lysine biosynthetic process (GO:0009085)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid catabolic process (GO:0009083)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid biosynthetic process (GO:0009082)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid metabolic process (GO:0009081)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
pyruvate family amino acid catabolic process (GO:0009080)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
monosaccharide transmembrane transport (GO:0015749)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
urate transport (GO:0015747)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
citrate transport (GO:0015746)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
AV node cell-bundle of His cell adhesion involved in cell communication (GO:0086072)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
SA node cell to atrial cardiac muscle cell communication (GO:0086070)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
succinate transport (GO:0015744)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
malate transport (GO:0015743)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
alpha-ketoglutarate transport (GO:0015742)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
fumarate transport (GO:0015741)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pyruvate family amino acid biosynthetic process (GO:0009079)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pyruvate family amino acid metabolic process (GO:0009078)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
non-replicative DNA transposition (GO:0098038)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family catabolic process (GO:0009074)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family biosynthetic process (GO:0009073)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid metabolic process (GO:0009072)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
serine family amino acid catabolic process (GO:0009071)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
serine family amino acid biosynthetic process (GO:0009070)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
wound healing, spreading of epidermal cells (GO:0035313)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
Purkinje myocyte to ventricular cardiac muscle cell communication (GO:0086068)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell to AV node cell communication (GO:0086066)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
sialic acid transport (GO:0015739)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell communication by electrical coupling involved in cardiac conduction (GO:0086064)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
glucuronate transmembrane transport (GO:0015738)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hexuronate transmembrane transport (GO:0015736)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
uronic acid transmembrane transport (GO:0015735)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
prostaglandin transport (GO:0015732)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
propanoate transmembrane transport (GO:0015730)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
serine family amino acid metabolic process (GO:0009069)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
aspartate family amino acid catabolic process (GO:0009068)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
aspartate family amino acid biosynthetic process (GO:0009067)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
glutamine family amino acid catabolic process (GO:0009065)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
amino acid catabolic process (GO:0009063)	103	0	1.72	-	 < 0.01	4.23E-01	1.00E00
positive regulation of dephosphorylation (GO:0035306)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
fatty acid catabolic process (GO:0009062)	89	0	1.48	-	 < 0.01	4.09E-01	1.00E00
negative regulation of dephosphorylation (GO:0035305)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of dephosphorylation (GO:0035303)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
oxaloacetate transport (GO:0015729)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
bundle of His cell to Purkinje myocyte communication by electrical coupling (GO:0086054)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lactate transport (GO:0015727)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
AV node cell to bundle of His cell communication by electrical coupling (GO:0086053)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane repolarization during SA node cell action potential (GO:0086052)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
formate transport (GO:0015724)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane repolarization during bundle of His cell action potential (GO:0086050)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
bilirubin transport (GO:0015723)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
canalicular bile acid transport (GO:0015722)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylserine metabolic process (GO:0150178)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
bile acid and bile salt transport (GO:0015721)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylethanolamine metabolic process (GO:0150175)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylcholine metabolic process (GO:0150174)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidylcholine metabolic process (GO:0150173)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to cycloheximide (GO:0046898)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pentose-phosphate shunt, non-oxidative branch (GO:0009052)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
pentose-phosphate shunt, oxidative branch (GO:0009051)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during bundle of His cell action potential (GO:0086048)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during Purkinje myocyte cell action potential (GO:0086047)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during SA node cell action potential (GO:0086046)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during AV node cell action potential (GO:0086045)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell to AV node cell communication by electrical coupling (GO:0086044)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
dosage compensation by inactivation of X chromosome (GO:0009048)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of hormone biosynthetic process (GO:0046886)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
follicle-stimulating hormone secretion (GO:0046884)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of follicle-stimulating hormone secretion (GO:0046882)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of follicle-stimulating hormone secretion (GO:0046881)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of follicle-stimulating hormone secretion (GO:0046880)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell membrane potential (GO:0086036)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
thiosulfate transport (GO:0015709)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nitrite transport (GO:0015707)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nitrate transmembrane transport (GO:0015706)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
iodide transport (GO:0015705)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation (GO:0086030)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
bicarbonate transport (GO:0015701)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
arsenite transport (GO:0015700)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-17A production (GO:0150153)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-17A production (GO:0150151)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of saliva secretion (GO:0046878)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of saliva secretion (GO:0046877)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
stomach development (GO:0062094)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
quinolinate metabolic process (GO:0046874)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
Purkinje myocyte to ventricular cardiac muscle cell signaling (GO:0086029)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell to AV node cell signaling (GO:0086026)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0086023)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell junction disassembly (GO:0150147)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell junction disassembly (GO:0150146)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD80 production (GO:0150145)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of CD80 production (GO:0150143)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD86 production (GO:0150142)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of CD86 production (GO:0150140)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vein smooth muscle contraction (GO:0062086)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
SA node cell to atrial cardiac muscle cell signaling (GO:0086018)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
Purkinje myocyte action potential (GO:0086017)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
SA node cell action potential (GO:0086015)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell action potential (GO:0086014)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
membrane repolarization during cardiac muscle cell action potential (GO:0086013)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during cardiac muscle cell action potential (GO:0086012)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
membrane repolarization during action potential (GO:0086011)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol dephosphorylation (GO:0046856)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of bone remodeling (GO:0046851)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
membrane repolarization (GO:0086009)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
detection of diacyl bacterial lipopeptide (GO:0042496)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of triacyl bacterial lipopeptide (GO:0042495)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell contraction (GO:0086004)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
detection of bacterial lipoprotein (GO:0042494)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
gamma-delta T cell differentiation (GO:0042492)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-33 production (GO:0150129)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-33 production (GO:0150127)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuromuscular junction development (GO:1904398)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuromuscular junction development (GO:1904397)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neuromuscular junction development (GO:1904396)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904395)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904394)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904393)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
cone retinal bipolar cell differentiation (GO:1904390)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of odontogenesis of dentin-containing tooth (GO:0042488)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of odontogenesis (GO:0042482)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-substrate junction organization (GO:0150118)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell-substrate junction organization (GO:0150117)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of cell-substrate junction organization (GO:0150116)	69	0	1.15	-	 < 0.01	6.33E-01	1.00E00
cell-substrate junction organization (GO:0150115)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
regulation of transepithelial transport (GO:0150111)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
rod bipolar cell differentiation (GO:1904389)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
phospholipid dephosphorylation (GO:0046839)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
cellular response to L-phenylalanine derivative (GO:1904387)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to L-phenylalanine derivative (GO:1904386)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
glycolipid transport (GO:0046836)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
carbohydrate phosphorylation (GO:0046835)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
cellular response to sodium phosphate (GO:1904384)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to sodium phosphate (GO:1904383)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA export from nucleus (GO:0046833)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA export from nucleus (GO:0046832)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of RNA export from nucleus (GO:0046831)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum mannose trimming (GO:1904380)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
middle ear morphogenesis (GO:0042474)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
lamellipodium organization (GO:0097581)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
outer ear morphogenesis (GO:0042473)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cell-cell junction (GO:0150107)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cell-cell junction (GO:0150106)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
transport across blood-brain barrier (GO:0150104)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
reactive gliosis (GO:0150103)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of monocyte activation (GO:0150102)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule anchoring at centrosome (GO:0150101)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac epithelial to mesenchymal transition (GO:0062044)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac epithelial to mesenchymal transition (GO:0062042)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
response to kainic acid (GO:1904373)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to actin cortical patch (GO:1904372)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to actin cortical patch (GO:1904370)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sequestering of iron ion (GO:0097577)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
vacuole fusion (GO:0097576)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
chemokinesis (GO:0042466)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
kinesis (GO:0042465)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
eye photoreceptor cell development (GO:0042462)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell development (GO:0042461)	64	0	1.07	-	 < 0.01	6.30E-01	1.00E00
fatty acid elongation (GO:0030497)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokinesis (GO:1904367)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sensory perception of hot stimulus (GO:0062036)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chemokinesis (GO:1904365)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic sister chromatid segregation (GO:0062033)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcitonin secretion (GO:1904364)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
coreceptor-mediated virion attachment to host cell (GO:0046814)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
receptor-mediated virion attachment to host cell (GO:0046813)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of calcitonin secretion (GO:1904362)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of stress granule assembly (GO:0062030)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ribonucleoside catabolic process (GO:0042454)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
deoxyguanosine metabolic process (GO:0042453)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
arginine biosynthetic process via ornithine (GO:0042450)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA methylation (GO:0030488)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of stress granule assembly (GO:0062029)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance via telomere lengthening (GO:1904357)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process (GO:0062026)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0062025)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere capping (GO:1904354)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein catabolic process in the vacuole (GO:1904352)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein catabolic process in the vacuole (GO:1904351)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of protein catabolic process in the vacuole (GO:1904350)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
progesterone metabolic process (GO:0042448)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
anterior/posterior axis specification, embryo (GO:0008595)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
hormone catabolic process (GO:0042447)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell morphogenesis (GO:0008594)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
mitochondrial double-strand break repair via homologous recombination (GO:0097552)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phenylethylamine metabolic process (GO:0042443)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial double-strand break repair (GO:0097551)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
eye pigment metabolic process (GO:0042441)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pigment metabolic process (GO:0042440)	58	0	.97	-	 < 0.01	1.00E00	1.00E00
nuclear migration along microtubule (GO:0030473)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylcholine catabolic process (GO:0010899)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of small intestine smooth muscle contraction (GO:1904349)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride catabolic process (GO:0010898)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of small intestine smooth muscle contraction (GO:1904348)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of small intestine smooth muscle contraction (GO:1904347)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of triglyceride catabolic process (GO:0010897)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride catabolic process (GO:0010896)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of gastric mucosal blood circulation (GO:1904346)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of gastric mucosal blood circulation (GO:1904344)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid biosynthetic process (GO:0010893)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
axon midline choice point recognition (GO:0016199)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of colon smooth muscle contraction (GO:1904343)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of smoothened signaling pathway (GO:0008589)	101	0	1.68	-	 < 0.01	4.20E-01	1.00E00
axon choice point recognition (GO:0016198)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of colon smooth muscle contraction (GO:1904341)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of sequestering of triglyceride (GO:0010890)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopaminergic neuron differentiation (GO:1904340)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
female gonad development (GO:0008585)	123	0	2.05	-	 < 0.01	2.76E-01	1.00E00
melanin biosynthetic process (GO:0042438)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
indole-containing compound catabolic process (GO:0042436)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
indole-containing compound biosynthetic process (GO:0042435)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle uncoating (GO:0016191)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic assembly at neuromuscular junction (GO:0008582)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopaminergic neuron differentiation (GO:1904339)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of dopaminergic neuron differentiation (GO:1904338)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol storage (GO:0010887)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol storage (GO:0010886)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of ductus arteriosus closure (GO:1904336)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol storage (GO:0010885)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
regulation of ductus arteriosus closure (GO:1904335)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid storage (GO:0010884)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062003)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle to endosome fusion (GO:0016189)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062002)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac endothelial to mesenchymal transition (GO:0062000)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
positive regulation of myofibroblast contraction (GO:1904330)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
thymus epithelium morphogenesis (GO:0097536)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
serotonin biosynthetic process (GO:0042427)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
lymphoid lineage cell migration into thymus (GO:0097535)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle coating (GO:0016183)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
choline catabolic process (GO:0042426)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lymphoid lineage cell migration (GO:0097534)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle budding from endosome (GO:0016182)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular stress response to acid chemical (GO:0097533)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
stress response to acid chemical (GO:0097532)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of complement activation, alternative pathway (GO:0030451)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cholesterol transport involved in cholesterol storage (GO:0010879)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cholesterol storage (GO:0010878)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of myofibroblast contraction (GO:1904328)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lipid transport involved in lipid storage (GO:0010877)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to cytosolic proteasome complex (GO:1904327)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian sleep/wake cycle, wakefulness (GO:1904326)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904325)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904323)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
execution phase of necroptosis (GO:0097528)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle contraction involved in micturition (GO:1904320)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
necroptotic signaling pathway (GO:0097527)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
epinephrine biosynthetic process (GO:0042418)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
epinephrine metabolic process (GO:0042414)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
carnitine catabolic process (GO:0042413)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of triglyceride biosynthetic process (GO:0010868)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle contraction involved in micturition (GO:1904318)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride biosynthetic process (GO:0010867)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (GO:1904317)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride biosynthetic process (GO:0010866)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (GO:1904316)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to methamphetamine hydrochloride (GO:1904313)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cristae formation (GO:0042407)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
thyroid hormone catabolic process (GO:0042404)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
base-excision repair, AP site formation via deaminated base removal (GO:0097510)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of gastro-intestinal system smooth muscle contraction (GO:1904306)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of gastro-intestinal system smooth muscle contraction (GO:1904305)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of gastro-intestinal system smooth muscle contraction (GO:1904304)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of maternal process involved in parturition (GO:1904303)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of maternal process involved in parturition (GO:1904301)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcytosis (GO:1904300)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
sialylation (GO:0097503)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
mannosylation (GO:0097502)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
stress response to metal ion (GO:0097501)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
receptor localization to non-motile cilium (GO:0097500)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
siRNA processing (GO:0030422)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
defecation (GO:0030421)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of proton-transporting ATPase activity, rotational mechanism (GO:0010849)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of reciprocal meiotic recombination (GO:0010845)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
retina layer formation (GO:0010842)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of circadian sleep/wake cycle, wakefulness (GO:0010841)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of circadian sleep/wake cycle, wakefulness (GO:0010840)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
respiratory chain complex IV assembly (GO:0008535)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
calcium activated galactosylceramide scrambling (GO:0061591)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
calcium activated phosphatidylcholine scrambling (GO:0061590)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of keratinocyte proliferation (GO:0010838)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein ADP-ribosylation (GO:0010836)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of protein ADP-ribosylation (GO:0010835)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
glycoside catabolic process (GO:0016139)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via telomere lengthening (GO:0010833)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of myotube differentiation (GO:0010832)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
calcium activated phosphatidylserine scrambling (GO:0061589)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glycoside metabolic process (GO:0016137)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
calcium activated phospholipid scrambling (GO:0061588)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of myotube differentiation (GO:0010831)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of myotube differentiation (GO:0010830)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
DNA-templated viral transcription (GO:0039695)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
viral RNA genome replication (GO:0039694)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
single stranded viral RNA replication via double stranded DNA intermediate (GO:0039692)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of centrosome duplication (GO:0010826)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of centrosome duplication (GO:0010825)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of centrosome duplication (GO:0010824)	49	0	.82	-	 < 0.01	1.00E00	1.00E00
sterol catabolic process (GO:0016127)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell chemotaxis (GO:0010820)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
calcium ion transmembrane transport via high voltage-gated calcium channel (GO:0061577)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
xanthophyll catabolic process (GO:0016124)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
xanthophyll biosynthetic process (GO:0016123)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
xanthophyll metabolic process (GO:0016122)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
carotene catabolic process (GO:0016121)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative stranded viral RNA replication (GO:0039689)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of T cell chemotaxis (GO:0010819)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
T cell chemotaxis (GO:0010818)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
calcitonin catabolic process (GO:0010816)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
bradykinin catabolic process (GO:0010815)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
substance P catabolic process (GO:0010814)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
neuropeptide catabolic process (GO:0010813)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
carotene metabolic process (GO:0016119)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
carotenoid catabolic process (GO:0016118)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
carotenoid biosynthetic process (GO:0016117)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of PERK-mediated unfolded protein response (GO:1903899)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
carotenoid metabolic process (GO:0016116)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of PERK-mediated unfolded protein response (GO:1903898)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
terpenoid catabolic process (GO:0016115)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of PERK-mediated unfolded protein response (GO:1903897)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
terpenoid biosynthetic process (GO:0016114)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of IRE1-mediated unfolded protein response (GO:1903896)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of IRE1-mediated unfolded protein response (GO:1903895)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of IRE1-mediated unfolded protein response (GO:1903894)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of ATF6-mediated unfolded protein response (GO:1903893)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATF6-mediated unfolded protein response (GO:1903892)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tetraterpenoid catabolic process (GO:0016110)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ATF6-mediated unfolded protein response (GO:1903891)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle priming (GO:0010808)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle priming (GO:0010807)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
tetraterpenoid biosynthetic process (GO:0016109)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)	51	0	.85	-	 < 0.01	1.00E00	1.00E00
tetraterpenoid metabolic process (GO:0016108)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-threonine phosphorylation (GO:0010801)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
sesquiterpenoid catabolic process (GO:0016107)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
triterpenoid biosynthetic process (GO:0016104)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine (C-C motif) ligand 20 production (GO:1903886)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
diterpenoid catabolic process (GO:0016103)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
diterpenoid biosynthetic process (GO:0016102)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-C motif) ligand 20 production (GO:1903884)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ganglion morphogenesis (GO:0061552)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
diterpenoid metabolic process (GO:0016101)	81	0	1.35	-	 < 0.01	6.48E-01	1.00E00
positive regulation of interleukin-17-mediated signaling pathway (GO:1903883)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trigeminal ganglion development (GO:0061551)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-17-mediated signaling pathway (GO:1903882)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cranial ganglion development (GO:0061550)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-17-mediated signaling pathway (GO:1903881)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane fusion involved in viral entry into host cell (GO:0039663)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
sympathetic ganglion development (GO:0061549)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
ganglion development (GO:0061548)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
glycine secretion, neurotransmission (GO:0061537)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycine secretion (GO:0061536)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
extraembryonic membrane development (GO:1903867)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
glutamate secretion, neurotransmission (GO:0061535)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
trunk segmentation (GO:0035290)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid secretion, neurotransmission (GO:0061534)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidative phosphorylation (GO:1903862)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendrite extension (GO:1903860)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
posterior head segmentation (GO:0035289)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
head segmentation (GO:0035287)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
brain segmentation (GO:0035284)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
central nervous system segmentation (GO:0035283)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
acetylcholine secretion (GO:0061526)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hindgut development (GO:0061525)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
pre-miRNA export from nucleus (GO:0035281)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cilium disassembly (GO:0061523)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of cristae formation (GO:1903852)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
Langerhans cell differentiation (GO:0061520)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of cristae formation (GO:1903850)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
miRNA-mediated gene silencing by mRNA destabilization (GO:0035279)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
miRNA-mediated gene silencing by inhibition of translation (GO:0035278)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
macrophage homeostasis (GO:0061519)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
microglial cell proliferation (GO:0061518)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of aorta morphogenesis (GO:1903849)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
macrophage proliferation (GO:0061517)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
exocrine system development (GO:0035272)	54	0	.90	-	 < 0.01	1.00E00	1.00E00
regulation of aorta morphogenesis (GO:1903847)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
monocyte proliferation (GO:0061516)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
interleukin-34-mediated signaling pathway (GO:0061514)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to arsenite ion (GO:1903843)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to arsenite ion (GO:1903842)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
centriole elongation (GO:0061511)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
quaternary ammonium group transport (GO:0015697)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
cellular response to arsenite(3-) (GO:1903841)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to arsenite(3-) (GO:1903840)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mercury ion transport (GO:0015694)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lead ion transport (GO:0015692)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cadmium ion transport (GO:0015691)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
protein O-linked mannosylation (GO:0035269)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
protein mannosylation (GO:0035268)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
gonad morphogenesis (GO:0035262)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
external genitalia morphogenesis (GO:0035261)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
internal genitalia morphogenesis (GO:0035260)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
early endosome to recycling endosome transport (GO:0061502)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
molybdate ion transport (GO:0015689)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein maturation by copper ion transfer (GO:0015680)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-arginine transmembrane transport (GO:1903826)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
plasma membrane copper ion transport (GO:0015679)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
copper ion import (GO:0015677)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
vanadium ion transport (GO:0015676)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nickel cation transport (GO:0015675)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
silver ion transport (GO:0015673)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oxygen transport (GO:0015671)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
carbon dioxide transport (GO:0015670)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine omega-N-methylation (GO:0035247)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine N-methylation (GO:0035246)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated potassium channel activity (GO:1903818)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of voltage-gated potassium channel activity (GO:1903817)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of collecting lymphatic vessel constriction (GO:1903816)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of collecting lymphatic vessel constriction (GO:1903815)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of collecting lymphatic vessel constriction (GO:1903814)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
gas transport (GO:0015669)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
L-serine import across plasma membrane (GO:1903812)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
L-asparagine import across plasma membrane (GO:1903811)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-histidine import across plasma membrane (GO:1903810)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ectopic germ cell programmed cell death (GO:0035234)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
glycine import across plasma membrane (GO:1903804)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
L-glutamine import across plasma membrane (GO:1903803)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
L-leucine import across plasma membrane (GO:1903801)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of miRNA processing (GO:1903800)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate-cysteine ligase activity (GO:0035229)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate-cysteine ligase activity (GO:0035227)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glial cell-neuron signaling (GO:0150098)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
amyloid-beta clearance by cellular catabolic process (GO:0150094)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
amyloid-beta clearance by transcytosis (GO:0150093)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic scaling (GO:0150092)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
multiple spine synapse organization, single dendrite (GO:0150090)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell competition in a multicellular organism (GO:0035212)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
multiple spine synapse organization (GO:0150089)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuroinflammatory response (GO:0150078)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
neuroinflammatory response (GO:0150076)	60	0	1.00	-	 < 0.01	6.29E-01	1.00E00
positive regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150074)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150073)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of arginase activity (GO:0150072)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of arginase activity (GO:0150070)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transport of virus (GO:0046794)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of deacetylase activity (GO:0150065)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vertebrate eye-specific patterning (GO:0150064)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
complement-mediated synapse pruning (GO:0150062)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
microtubule polymerization (GO:0046785)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
regulation of viral transcription (GO:0046782)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic neurotransmitter receptor diffusion trapping (GO:0150054)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic signaling by nitric oxide (GO:0150045)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
viral budding from plasma membrane (GO:0046761)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of calcium-dependent activation of synaptic vesicle fusion (GO:0150037)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of trans-synaptic signaling by endocannabinoid, modulating synaptic transmission (GO:0150036)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to lysosome (GO:0150033)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to lysosome (GO:0150032)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to lysosome (GO:0150031)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
viral budding (GO:0046755)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
viral exocytosis (GO:0046754)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
non-lytic viral release (GO:0046753)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
modified amino acid biosynthetic process (GO:0042398)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
phosphagen biosynthetic process (GO:0042396)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
oxidised low-density lipoprotein particle clearance (GO:0150024)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
apical dendrite arborization (GO:0150023)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
apical dendrite development (GO:0150022)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
apical dendrite morphogenesis (GO:0150021)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
basal dendrite arborization (GO:0150020)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of transcytosis (GO:1904298)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
viral capsid secondary envelopment (GO:0046745)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ERAD pathway (GO:1904293)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein localization to non-motile cilium (GO:0097499)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic DNA damage checkpoint (GO:1904291)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic DNA damage checkpoint (GO:1904290)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endothelial tube lumen extension (GO:0097498)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell delamination (GO:0097497)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle size (GO:0097494)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
hemocyte differentiation (GO:0042386)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glutathione transmembrane transport (GO:0034775)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
sympathetic neuron axon guidance (GO:0097492)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
sympathetic neuron projection guidance (GO:0097491)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
sympathetic neuron projection extension (GO:0097490)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
basal dendrite morphogenesis (GO:0150019)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
basal dendrite development (GO:0150018)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuron projection arborization (GO:0150013)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuron projection arborization (GO:0150012)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of neuron projection arborization (GO:0150011)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic DNA damage checkpoint (GO:1904289)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904283)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904282)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
basement membrane disassembly (GO:0034769)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vitamin K catabolic process (GO:0042377)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
phylloquinone catabolic process (GO:0042376)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
phylloquinone metabolic process (GO:0042374)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vitamin K biosynthetic process (GO:0042371)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of iron ion transmembrane transport (GO:0034761)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of iron ion transmembrane transport (GO:0034760)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
clathrin-dependent synaptic vesicle endocytosis (GO:0150007)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of spontaneous synaptic transmission (GO:0150003)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation by virus of viral protein levels in host cell (GO:0046726)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation by virus of viral protein levels in host cell (GO:0046725)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
tricellular tight junction assembly (GO:1904274)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
oxalic acid secretion (GO:0046724)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
L-alanine import across plasma membrane (GO:1904273)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
L-proline import across plasma membrane (GO:1904271)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lactic acid secretion (GO:0046722)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pyroptosome complex assembly (GO:1904270)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral motor column neuron migration (GO:0097477)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
citric acid secretion (GO:0046720)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vitamin D catabolic process (GO:0042369)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vitamin D biosynthetic process (GO:0042368)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of iron ion transmembrane transport (GO:0034759)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
spinal cord motor neuron migration (GO:0097476)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
motor neuron migration (GO:0097475)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of iron ion transport (GO:0034758)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of iron ion transport (GO:0034757)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cobalamin catabolic process (GO:0042366)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retinal cone cell apoptotic process (GO:0097474)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
water-soluble vitamin catabolic process (GO:0042365)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of iron ion transport (GO:0034756)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
retinal rod cell apoptotic process (GO:0097473)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
water-soluble vitamin biosynthetic process (GO:0042364)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
iron ion transmembrane transport (GO:0034755)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
fat-soluble vitamin catabolic process (GO:0042363)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
fat-soluble vitamin biosynthetic process (GO:0042362)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
menaquinone catabolic process (GO:0042361)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vitamin E metabolic process (GO:0042360)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
membrane disassembly (GO:0030397)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
fructosamine catabolic process (GO:0030392)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation by virus of viral protein levels in host cell (GO:0046719)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of Schwann cell chemotaxis (GO:1904268)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell chemotaxis (GO:1904266)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
borate transport (GO:0046713)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GDP catabolic process (GO:0046712)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
programmed cell death in response to reactive oxygen species (GO:0097468)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
GDP biosynthetic process (GO:0046711)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GDP metabolic process (GO:0046710)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
vitamin D metabolic process (GO:0042359)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
thiamine diphosphate metabolic process (GO:0042357)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
L-fucose metabolic process (GO:0042354)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GDP-L-fucose salvage (GO:0042352)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
'de novo' GDP-L-fucose biosynthetic process (GO:0042351)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
GDP-L-fucose biosynthetic process (GO:0042350)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
fructosamine metabolic process (GO:0030389)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
fructose 1,6-bisphosphate metabolic process (GO:0030388)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
sperm mitochondrion organization (GO:0030382)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
zinc ion import into Golgi lumen (GO:1904257)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
CDP biosynthetic process (GO:0046705)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
CDP metabolic process (GO:0046704)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of bile acid metabolic process (GO:1904253)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of bile acid metabolic process (GO:1904252)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
keratan sulfate catabolic process (GO:0042340)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of polynucleotide adenylyltransferase activity (GO:1904247)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of polynucleotide adenylyltransferase activity (GO:1904246)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquinone biosynthetic process (GO:0010795)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of polynucleotide adenylyltransferase activity (GO:1904245)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pancreatic trypsinogen secretion (GO:1904244)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA export from nucleus (GO:0010793)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
monoterpenoid metabolic process (GO:0016098)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic trypsinogen secretion (GO:1904242)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904240)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
keratan sulfate metabolic process (GO:0042339)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
piecemeal microautophagy of the nucleus (GO:0034727)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904239)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
meiotic sister chromatid cohesion involved in meiosis I (GO:0010789)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pericyte cell differentiation (GO:1904238)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of aconitate hydratase activity (GO:1904234)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of aconitate hydratase activity (GO:1904232)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of succinate dehydrogenase activity (GO:1904231)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
meiotic DNA double-strand break formation involved in reciprocal meiotic recombination (GO:0010780)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle targeting (GO:0016080)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
hippocampal pyramidal neuron differentiation (GO:0097432)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian sleep/wake cycle, non-REM sleep (GO:0042323)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian sleep/wake cycle, REM sleep (GO:0042322)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian sleep/wake cycle, sleep (GO:0042321)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of circadian sleep/wake cycle, REM sleep (GO:0042320)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of succinate dehydrogenase activity (GO:1904229)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904227)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904226)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
meiotic strand invasion involved in reciprocal meiotic recombination (GO:0010774)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA decay (GO:0016078)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
sno(s)RNA catabolic process (GO:0016077)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of serine C-palmitoyltransferase activity (GO:1904221)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell morphogenesis (GO:0010771)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein maturation by iron-sulfur cluster transfer (GO:0097428)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
snRNA catabolic process (GO:0016076)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell morphogenesis (GO:0010770)	67	0	1.12	-	 < 0.01	6.31E-01	1.00E00
regulation of serine C-palmitoyltransferase activity (GO:1904220)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
rRNA catabolic process (GO:0016075)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
sno(s)RNA metabolic process (GO:0016074)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
penicillin metabolic process (GO:0042316)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein kinase C deactivation (GO:0042313)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast migration (GO:0010764)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of iodide transmembrane transport (GO:1904213)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
type I hypersensitivity (GO:0016068)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of iodide transmembrane transport (GO:1904212)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fibroblast migration (GO:0010761)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol (GO:1904211)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage chemotaxis (GO:0010760)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
homoiothermy (GO:0042309)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein import into nucleus (GO:0042308)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
specification of segmental identity, mandibular segment (GO:0042305)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
hypoxia-inducible factor-1alpha signaling pathway (GO:0097411)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA damage response, signal transduction by p53 class mediator (GO:0030330)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage chemotaxis (GO:0010759)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage chemotaxis (GO:0010758)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
negative regulation of plasminogen activation (GO:0010757)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle hypertrophy (GO:1904206)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle hypertrophy (GO:1904205)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cGMP-mediated signaling (GO:0010754)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle hypertrophy (GO:1904204)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cGMP-mediated signaling (GO:0010753)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of cGMP-mediated signaling (GO:0010752)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of iodide transport (GO:1904202)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitric oxide mediated signal transduction (GO:0010751)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of iodide transport (GO:1904201)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of nitric oxide mediated signal transduction (GO:0010750)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
iodide transmembrane transport (GO:1904200)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
G protein-coupled opsin signaling pathway (GO:0016056)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to raffinose (GO:0097403)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
prenylcysteine metabolic process (GO:0030329)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
prenylcysteine catabolic process (GO:0030328)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
prenylated protein catabolic process (GO:0030327)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
stabilization of membrane potential (GO:0030322)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
transepithelial chloride transport (GO:0030321)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of nitric oxide mediated signal transduction (GO:0010749)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of long-chain fatty acid import across plasma membrane (GO:0010748)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of long-chain fatty acid import across plasma membrane (GO:0010747)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of long-chain fatty acid import across plasma membrane (GO:0010746)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage derived foam cell differentiation (GO:0010745)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
macrophage derived foam cell differentiation (GO:0010742)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
detection of fungus (GO:0016046)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of bacterium (GO:0016045)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
melanocyte differentiation (GO:0030318)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
osteoclast differentiation (GO:0030316)	67	0	1.12	-	 < 0.01	6.31E-01	1.00E00
positive regulation of protein kinase A signaling (GO:0010739)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of protein kinase A signaling (GO:0010738)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
protein kinase A signaling (GO:0010737)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein glutathionylation (GO:0010734)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein glutathionylation (GO:0010732)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
absorption of visible light (GO:0016038)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
light absorption (GO:0016037)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to phosphate starvation (GO:0016036)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
memory T cell proliferation (GO:0061485)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA import into mitochondrion (GO:0016031)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to TNF agonist (GO:0061481)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal cholesterol absorption (GO:0030300)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide biosynthetic process (GO:0010729)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide metabolic process (GO:0010726)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of primitive erythrocyte differentiation (GO:0010725)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of definitive erythrocyte differentiation (GO:0010724)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of ferrochelatase activity (GO:0010722)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T follicular helper cell differentiation (GO:0061470)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial to mesenchymal transition (GO:0010718)	56	0	.93	-	 < 0.01	1.00E00	1.00E00
negative regulation of extracellular matrix disassembly (GO:0010716)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of collagen metabolic process (GO:0010713)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of type B pancreatic cell proliferation (GO:0061469)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of collagen catabolic process (GO:0010711)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of collagen catabolic process (GO:0010710)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of inorganic anion transmembrane transport (GO:1903797)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of inorganic anion transmembrane transport (GO:1903796)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of inorganic anion transmembrane transport (GO:1903795)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein localization to lysosome (GO:0061462)	49	0	.82	-	 < 0.01	1.00E00	1.00E00
negative regulation of monoatomic anion transport (GO:1903792)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
uracil transmembrane transport (GO:1903791)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
glycolysis from storage polysaccharide through glucose-1-phosphate (GO:0093001)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
globoside biosynthetic process via lactosylceramide (GO:0010707)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
meiotic DNA double-strand break processing involved in reciprocal meiotic recombination (GO:0010705)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of amino acid transmembrane transport (GO:1903789)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of norepinephrine secretion (GO:0010701)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of norepinephrine secretion (GO:0010700)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutathione biosynthetic process (GO:1903788)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutathione biosynthetic process (GO:1903786)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
L-valine transmembrane transport (GO:1903785)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium ion import across plasma membrane (GO:1903784)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retrotrapezoid nucleus neuron differentiation (GO:0061452)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retrotrapezoid nucleus development (GO:0061451)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of sodium ion import across plasma membrane (GO:1903782)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trophoblast cell migration (GO:0061450)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac conduction (GO:1903781)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac conduction (GO:1903780)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
charged-tRNA amino acid modification (GO:0019988)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac conduction (GO:1903779)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
translesion synthesis (GO:0019985)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
protein localization to vacuolar membrane (GO:1903778)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
endocardial cushion cell fate commitment (GO:0061445)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endocardial cushion cell development (GO:0061444)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of DNA double-strand break processing (GO:1903775)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral budding via host ESCRT complex (GO:1903774)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
endocardial cushion cell differentiation (GO:0061443)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of viral budding via host ESCRT complex (GO:1903772)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
renal artery morphogenesis (GO:0061441)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney vasculature development (GO:0061440)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of beta-galactosidase activity (GO:1903771)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of beta-galactosidase activity (GO:1903770)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
miRNA processing (GO:0035196)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
kidney vasculature morphogenesis (GO:0061439)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation in bone marrow (GO:1903769)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
renal system vasculature morphogenesis (GO:0061438)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
renal system vasculature development (GO:0061437)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion export across plasma membrane (GO:1903766)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of potassium ion export across plasma membrane (GO:1903765)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of potassium ion export across plasma membrane (GO:1903764)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to caloric restriction (GO:0061433)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to methionine (GO:0061431)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903762)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
bone trabecula morphogenesis (GO:0061430)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903760)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
hatching (GO:0035188)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of SUMO transferase activity (GO:1903755)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of p38MAPK cascade (GO:1903753)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903751)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903750)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of RIG-I signaling pathway (GO:0039536)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of RIG-I signaling pathway (GO:0039535)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of MDA-5 signaling pathway (GO:0039534)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of MDA-5 signaling pathway (GO:0039533)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
MDA-5 signaling pathway (GO:0039530)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of protein localization to mitochondrion (GO:1903749)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of anterograde synaptic vesicle transport (GO:1903744)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of anterograde synaptic vesicle transport (GO:1903743)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of anterograde synaptic vesicle transport (GO:1903742)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
RIG-I signaling pathway (GO:0039529)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
embryonic hemopoiesis (GO:0035162)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
cGMP-mediated signaling (GO:0019934)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipid metabolic process (GO:1903726)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of centriole elongation (GO:1903724)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of centriole elongation (GO:1903723)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of centriole elongation (GO:1903722)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of I-kappaB phosphorylation (GO:1903721)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of I-kappaB phosphorylation (GO:1903719)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
guanine transmembrane transport (GO:1903716)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of aerobic respiration (GO:1903715)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
asparagine transmembrane transport (GO:1903713)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cysteine transmembrane transport (GO:1903712)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
spermidine transmembrane transport (GO:1903711)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
spermine transmembrane transport (GO:1903710)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine methylation, to symmetrical-dimethyl arginine (GO:0019918)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
uterine gland development (GO:1903709)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
enterocyte differentiation (GO:1903703)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
substantia propria of cornea development (GO:1903701)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
post-embryonic hindlimb morphogenesis (GO:0035129)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
post-embryonic forelimb morphogenesis (GO:0035128)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
post-embryonic limb morphogenesis (GO:0035127)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
post-embryonic appendage morphogenesis (GO:0035120)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
dendritic spine morphogenesis (GO:0060997)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
response to fungicide (GO:0060992)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
genitalia morphogenesis (GO:0035112)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
lipid tube assembly involved in organelle fusion (GO:0060989)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipid tube assembly (GO:0060988)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
endocrine hormone secretion (GO:0060986)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
epicardium-derived cardiac vascular smooth muscle cell differentiation (GO:0060983)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
coronary artery morphogenesis (GO:0060982)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cell migration involved in coronary angiogenesis (GO:0060981)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell migration involved in coronary vasculogenesis (GO:0060980)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
operant conditioning (GO:0035106)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
angiogenesis involved in coronary vascular morphogenesis (GO:0060978)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
coronary vasculature morphogenesis (GO:0060977)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
cardioblast migration to the midline involved in heart field formation (GO:0060975)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell migration involved in heart formation (GO:0060974)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell migration involved in heart development (GO:0060973)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
left/right pattern formation (GO:0060972)	143	0	2.38	-	 < 0.01	1.81E-01	1.00E00
embryonic heart tube left/right pattern formation (GO:0060971)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
response to mercury ion (GO:0046689)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
response to copper ion (GO:0046688)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
response to chromate (GO:0046687)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to cadmium ion (GO:0046686)	56	0	.93	-	 < 0.01	1.00E00	1.00E00
response to arsenic-containing substance (GO:0046685)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
response to pyrethroid (GO:0046684)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
endocardial cell fate commitment (GO:0060957)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endocardial cell differentiation (GO:0060956)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of retinal cell programmed cell death (GO:0046671)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of retinal cell programmed cell death (GO:0046670)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac vascular smooth muscle cell development (GO:0060948)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac vascular smooth muscle cell differentiation (GO:0060947)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
cardiac neuron differentiation (GO:0060945)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
epithelial to mesenchymal transition involved in cardiac fibroblast development (GO:0060940)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of retinal cell programmed cell death (GO:0046668)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
retinal cell programmed cell death (GO:0046666)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to luteinizing hormone (GO:0034699)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
response to prostaglandin F (GO:0034696)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
epicardium-derived cardiac fibroblast cell development (GO:0060939)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
epicardium-derived cardiac fibroblast cell differentiation (GO:0060938)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac fibroblast cell development (GO:0060936)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac fibroblast cell differentiation (GO:0060935)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
His-Purkinje system cell differentiation (GO:0060932)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
sinoatrial node cell development (GO:0060931)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
sinoatrial node cell fate commitment (GO:0060930)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
folic acid catabolic process (GO:0046657)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
folic acid metabolic process (GO:0046655)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolate biosynthetic process (GO:0046654)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolate metabolic process (GO:0046653)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
atrioventricular node cell fate commitment (GO:0060929)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
atrioventricular node cell development (GO:0060928)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cardiac pacemaker cell fate commitment (GO:0060927)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac pacemaker cell development (GO:0060926)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell fate commitment (GO:0060923)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
atrioventricular node cell differentiation (GO:0060922)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
sinoatrial node cell differentiation (GO:0060921)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cardiac pacemaker cell differentiation (GO:0060920)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization (GO:1904199)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of granulosa cell proliferation (GO:1904197)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of granulosa cell proliferation (GO:1904195)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholangiocyte apoptotic process (GO:1904193)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cholangiocyte apoptotic process (GO:1904192)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell proliferation involved in lung development (GO:0060916)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell differentiation involved in lung development (GO:0060915)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
heart formation (GO:0060914)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
chemotaxis to arachidonate (GO:0034670)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac cell fate determination (GO:0060913)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac cell fate specification (GO:0060912)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac cell fate commitment (GO:0060911)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of transformation of host cell by virus (GO:1904189)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of alpha-beta T cell differentiation (GO:0046639)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of pyruvate dehydrogenase activity (GO:1904182)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane depolarization (GO:1904181)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane depolarization (GO:1904180)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
gamma-delta T cell proliferation (GO:0046630)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
error-prone translesion synthesis (GO:0042276)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
error-free postreplication DNA repair (GO:0042275)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage cytokine production (GO:0060907)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
dorsal spinal cord interneuron anterior axon guidance (GO:0097380)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protection from natural killer cell mediated cytotoxicity (GO:0042270)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiosis I (GO:0060903)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of adipose tissue development (GO:1904179)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
gamma-delta T cell activation (GO:0046629)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation of adipose tissue development (GO:1904178)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of adipose tissue development (GO:1904177)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
positive regulation of bleb assembly (GO:1904172)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of organ growth (GO:0046622)	64	0	1.07	-	 < 0.01	6.30E-01	1.00E00
negative regulation of bleb assembly (GO:1904171)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of bleb assembly (GO:1904170)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
dorsal spinal cord interneuron axon guidance (GO:0097378)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spinal cord interneuron axon guidance (GO:0097377)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
interneuron axon guidance (GO:0097376)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cytolysis (GO:0042268)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
natural killer cell mediated cytotoxicity (GO:0042267)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
sensory neuron axon guidance (GO:0097374)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleobase-containing small molecule catabolic process (GO:0034656)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
peptidyl-aspartic acid hydroxylation (GO:0042264)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA protection (GO:0042262)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
retinoic acid catabolic process (GO:0034653)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein O-GlcNAcylation via threonine (GO:0097370)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cortisol biosynthetic process (GO:0034651)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cortisol metabolic process (GO:0034650)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
lens placode formation involved in camera-type eye formation (GO:0046619)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA synthesis involved in UV-damage excision repair (GO:1904161)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of Sertoli cell barrier (GO:0097368)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cytosolic ribosome assembly (GO:0042256)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
establishment of mitochondrion localization, microtubule-mediated (GO:0034643)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
mitochondrion migration along actin filament (GO:0034642)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of mitochondrion localization by microtubule attachment (GO:0034640)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axonemal central apparatus assembly (GO:1904158)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
DN4 thymocyte differentiation (GO:1904157)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
DN3 thymocyte differentiation (GO:1904156)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of centrosome cycle (GO:0046606)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
DN2 thymocyte differentiation (GO:1904155)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of centrosome cycle (GO:0046605)	58	0	.97	-	 < 0.01	1.00E00	1.00E00
positive regulation of retrograde protein transport, ER to cytosol (GO:1904154)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic centrosome separation (GO:0046604)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde protein transport, ER to cytosol (GO:1904152)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
UDP-glucosylation (GO:0097359)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic centrosome separation (GO:0046602)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of microglial cell mediated cytotoxicity (GO:1904151)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of centriole replication (GO:0046601)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of microglial cell mediated cytotoxicity (GO:1904150)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of planar polarity of embryonic epithelium (GO:0042249)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of centriole replication (GO:0046600)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
protein localization to heterochromatin (GO:0097355)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylcholine catabolic process (GO:0034638)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
establishment of planar polarity of follicular epithelium (GO:0042247)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
prenylation (GO:0097354)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
RNA repair (GO:0042245)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
autophagosome maturation (GO:0097352)	50	0	.83	-	 < 0.01	1.00E00	1.00E00
glutathione transport (GO:0034635)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
neutrophil clearance (GO:0097350)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of ossification (GO:0030279)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
regulation of microglial cell mediated cytotoxicity (GO:1904149)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to nonylphenol (GO:1904148)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to nonylphenol (GO:1904147)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic cell cycle process involved in oocyte maturation (GO:1904145)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of alkaline phosphatase activity (GO:0010694)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of alkaline phosphatase activity (GO:0010693)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of alkaline phosphatase activity (GO:0010692)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of microglial cell migration (GO:1904141)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of microglial cell migration (GO:1904140)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial outer membrane permeabilization (GO:0097345)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
'de novo' NAD biosynthetic process (GO:0034627)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
fatty acid elongation, polyunsaturated fatty acid (GO:0034626)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
ripoptosome assembly (GO:0097343)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty acid elongation, monounsaturated fatty acid (GO:0034625)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
zymogen inhibition (GO:0097341)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
inhibition of cysteine-type endopeptidase activity (GO:0097340)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to unfolded protein (GO:0034620)	70	0	1.17	-	 < 0.01	6.34E-01	1.00E00
nuclear fragmentation involved in apoptotic nuclear change (GO:0030264)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
apoptotic chromosome condensation (GO:0030263)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
chromosome condensation (GO:0030261)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
regulation of microglial cell migration (GO:1904139)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
response to antipsychotic drug (GO:0097332)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to cocaine (GO:0042220)	67	0	1.12	-	 < 0.01	6.31E-01	1.00E00
growth hormone secretion (GO:0030252)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
microglial cell migration (GO:1904124)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of otic vesicle morphogenesis (GO:1904120)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modified amino acid catabolic process (GO:0042219)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
response to antineoplastic agent (GO:0097327)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
melanocyte adhesion (GO:0097326)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
melanocyte proliferation (GO:0097325)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
melanocyte migration (GO:0097324)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
B cell adhesion (GO:0097323)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
terpene metabolic process (GO:0042214)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
autophagy of peroxisome (GO:0030242)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
skeletal muscle myosin thick filament assembly (GO:0030241)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
skeletal muscle thin filament assembly (GO:0030240)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
ectodermal cell differentiation (GO:0010668)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of otic vesicle morphogenesis (GO:1904118)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle cell apoptotic process (GO:0010667)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
cellular response to vasopressin (GO:1904117)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to vasopressin (GO:1904116)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle cell apoptotic process (GO:0010664)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle filament sliding (GO:1904113)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maternal determination of anterior/posterior axis, embryo (GO:0008358)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
L-histidine transmembrane transport (GO:0089709)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
asymmetric cell division (GO:0008356)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
L-histidine transmembrane export from vacuole (GO:0089708)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
germ cell migration (GO:0008354)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
apoptosome assembly (GO:0097314)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
female sex determination (GO:0030237)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell apoptotic process (GO:0010659)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol import (GO:1904109)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
striated muscle cell apoptotic process (GO:0010658)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
protein localization to ciliary inversin compartment (GO:1904108)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
muscle cell apoptotic process (GO:0010657)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
protein localization to microvillus (GO:1904106)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of convergent extension involved in gastrulation (GO:1904105)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of convergent extension involved in gastrulation (GO:1904103)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell communication by chemical coupling (GO:0010652)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell communication by electrical coupling (GO:0010651)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein O-linked glycosylation (GO:1904100)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell communication by electrical coupling (GO:0010650)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adult feeding behavior (GO:0008343)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
programmed necrotic cell death (GO:0097300)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
macrophage differentiation (GO:0030225)	50	0	.83	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation (GO:0022616)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
protein to membrane docking (GO:0022615)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane to membrane docking (GO:0022614)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
neutrophil differentiation (GO:0030223)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
eosinophil differentiation (GO:0030222)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
basophil differentiation (GO:0030221)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
platelet formation (GO:0030220)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of cell communication by electrical coupling (GO:0010649)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of cell communication by chemical coupling (GO:0010645)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell communication by electrical coupling (GO:0010644)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
cell communication by chemical coupling (GO:0010643)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet-derived growth factor receptor signaling pathway (GO:0010641)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
histone mRNA metabolic process (GO:0008334)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
megakaryocyte differentiation (GO:0030219)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
mammalian oogenesis stage (GO:0022605)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
hyaluronan biosynthetic process (GO:0030213)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
ovulation cycle process (GO:0022602)	57	0	.95	-	 < 0.01	1.00E00	1.00E00
heparin catabolic process (GO:0030211)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heparin biosynthetic process (GO:0030210)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial fusion (GO:0010637)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial fusion (GO:0010636)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial fusion (GO:0010635)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of transcription, start site selection (GO:0010630)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
closure of optic fissure (GO:0061386)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
heart trabecula morphogenesis (GO:0061384)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
trabecula morphogenesis (GO:0061383)	51	0	.85	-	 < 0.01	1.00E00	1.00E00
cell migration in diencephalon (GO:0061381)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dermatan sulfate biosynthetic process (GO:0030208)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate biosynthetic process (GO:0030206)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
heparin metabolic process (GO:0030202)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan catabolic process (GO:0030200)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of Schwann cell proliferation (GO:0010626)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of Schwann cell proliferation (GO:0010625)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell proliferation (GO:0010624)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
inferior colliculus development (GO:0061379)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
corpora quadrigemina development (GO:0061378)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by transcription factor localization (GO:0010621)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mammary gland lobule development (GO:0061377)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
G2/MI transition of meiotic cell cycle (GO:0008315)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mammillothalamic axonal tract development (GO:0061374)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mammillary axonal complex development (GO:0061373)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
determination of heart left/right asymmetry (GO:0061371)	70	0	1.17	-	 < 0.01	6.34E-01	1.00E00
testosterone biosynthetic process (GO:0061370)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle adaptation (GO:0010616)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle hypertrophy (GO:0010614)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
negative regulation of testicular blood vessel morphogenesis (GO:0061369)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tarsal gland development (GO:1903699)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA stability involved in response to stress (GO:0010610)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of microvillus assembly (GO:1903697)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride lipase activity (GO:0061365)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in luteolysis (GO:0061364)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of wound healing, spreading of epidermal cells (GO:1903691)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
optic chiasma development (GO:0061360)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of wound healing, spreading of epidermal cells (GO:1903690)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mRNA localization resulting in post-transcriptional regulation of gene expression (GO:0010609)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytoplasmic mRNA processing body assembly (GO:0010607)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic mRNA processing body assembly (GO:0010603)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
axonal transport of mitochondrion (GO:0019896)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of wound healing, spreading of epidermal cells (GO:1903689)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of Wnt protein secretion (GO:0061358)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of Wnt protein secretion (GO:0061357)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt protein secretion (GO:0061356)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
Wnt protein secretion (GO:0061355)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pteridine metabolic process (GO:0019889)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of cap-independent translational initiation (GO:1903679)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous antigen (GO:0019884)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
regulation of cap-independent translational initiation (GO:1903677)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous antigen (GO:0019883)	50	0	.83	-	 < 0.01	1.00E00	1.00E00
positive regulation of cap-dependent translational initiation (GO:1903676)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cell adhesion involved in heart morphogenesis (GO:0061344)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cell adhesion involved in heart morphogenesis (GO:0061343)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of cap-dependent translational initiation (GO:1903674)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic cleavage furrow formation (GO:1903673)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of sprouting angiogenesis (GO:1903671)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
lysine biosynthetic process via aminoadipic acid (GO:0019878)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of monopolar cell polarity (GO:0061339)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
behavioral response to nicotine (GO:0035095)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
sperm DNA condensation (GO:0035092)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
maintenance of apical/basal cell polarity (GO:0035090)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of complement-dependent cytotoxicity (GO:1903661)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of complement-dependent cytotoxicity (GO:1903660)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of apical/basal cell polarity (GO:0035089)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of apical/basal cell polarity (GO:0035088)	49	0	.82	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in outflow tract morphogenesis (GO:0061325)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in heart morphogenesis (GO:0061323)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
uracil metabolic process (GO:0019860)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
thymine metabolic process (GO:0019859)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cytosine metabolic process (GO:0019858)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase biosynthetic process (GO:0019856)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
L-ascorbic acid biosynthetic process (GO:0019853)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
Notch signaling involved in heart development (GO:0061314)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
L-ascorbic acid metabolic process (GO:0019852)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of chaperone-mediated protein folding (GO:1903645)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chaperone-mediated protein folding (GO:1903644)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cell surface receptor signaling pathway involved in heart development (GO:0061311)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of gastrin-induced gastric acid secretion (GO:1903640)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell development involved in outflow tract morphogenesis (GO:0061309)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell development involved in heart development (GO:0061308)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of gastrin-induced gastric acid secretion (GO:1903639)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein insertion into mitochondrial outer membrane (GO:1903638)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell differentiation involved in heart development (GO:0061307)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
nuclear speck organization (GO:0035063)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of protein insertion into mitochondrial outer membrane (GO:1903636)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retinal blood vessel morphogenesis (GO:0061304)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cornea development in camera-type eye (GO:0061303)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell-matrix adhesion (GO:0061302)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellum vasculature morphogenesis (GO:0061301)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebellum vasculature development (GO:0061300)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube anterior/posterior pattern specification (GO:0035054)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cytolysis (GO:0019835)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA catabolic process (GO:1903626)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube development (GO:0035050)	95	0	1.58	-	 < 0.01	4.13E-01	1.00E00
negative regulation of DNA catabolic process (GO:1903625)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of DNA catabolic process (GO:1903624)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
protein localization to photoreceptor connecting cilium (GO:1903621)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of transdifferentiation (GO:1903620)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of transdifferentiation (GO:1903618)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium-dependent ATPase activity (GO:1903612)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of calcium-dependent ATPase activity (GO:1903610)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
male pronucleus assembly (GO:0035039)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
female pronucleus assembly (GO:0035038)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
sperm entry (GO:0035037)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of inward rectifier potassium channel activity (GO:1903609)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to cytoplasmic stress granule (GO:1903608)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cytochrome c metabolic process (GO:1903606)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cytochrome metabolic process (GO:1903604)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leading edge cell differentiation (GO:0035026)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of Rho protein signal transduction (GO:0035024)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
quinolinate biosynthetic process (GO:0019805)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of Rac protein signal transduction (GO:0035021)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
adaptation of signaling pathway (GO:0023058)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
limb epidermis development (GO:0060887)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neuronal signal transduction (GO:0023041)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
semicircular canal fusion (GO:0060879)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
semicircular canal formation (GO:0060876)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral semicircular canal development (GO:0060875)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
anterior semicircular canal development (GO:0060873)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
semicircular canal development (GO:0060872)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
regulation of centriole replication (GO:0046599)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral entry into host cell (GO:0046598)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
termination of signal transduction (GO:0023021)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium-dependent cell-cell adhesion (GO:0046587)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of calcium-dependent cell-cell adhesion (GO:0046586)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of glial blood-brain barrier (GO:0060857)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of blood-brain barrier (GO:0060856)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
branching involved in lymph vessel morphogenesis (GO:0060854)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
Notch signaling pathway involved in arterial endothelial cell fate commitment (GO:0060853)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chondrocyte development involved in endochondral bone morphogenesis (GO:0003433)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte development (GO:0003431)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte growth (GO:0003430)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
endothelial cell fate specification (GO:0060847)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell fate commitment (GO:0060846)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
arterial endothelial cell fate commitment (GO:0060844)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
venous endothelial cell differentiation (GO:0060843)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
arterial endothelial cell differentiation (GO:0060842)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
venous blood vessel development (GO:0060841)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte morphogenesis (GO:0003429)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage morphogenesis (GO:0003422)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage axis specification (GO:0003421)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of growth plate cartilage chondrocyte proliferation (GO:0003420)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
endothelial cell fate commitment (GO:0060839)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
lymphatic endothelial cell fate commitment (GO:0060838)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell differentiation (GO:0060837)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
lymphatic endothelial cell differentiation (GO:0060836)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:0060831)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte proliferation (GO:0003419)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte differentiation (GO:0003418)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage development (GO:0003417)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
chondrocyte hypertrophy (GO:0003415)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
chondrocyte morphogenesis involved in endochondral bone morphogenesis (GO:0003414)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chondrocyte differentiation involved in endochondral bone morphogenesis (GO:0003413)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis (GO:0003412)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hydroxyproline transport (GO:0034589)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
halogenated hydrocarbon metabolic process (GO:0042197)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
chlorinated hydrocarbon metabolic process (GO:0042196)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
piRNA processing (GO:0034587)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
optic cup structural organization (GO:0003409)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
optic cup formation involved in camera-type eye development (GO:0003408)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retinal pigment epithelium development (GO:0003406)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
optic vesicle morphogenesis (GO:0003404)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
retinal cone cell development (GO:0046549)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
axis elongation (GO:0003401)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
regulation of protein O-linked glycosylation (GO:1904098)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
retinal rod cell development (GO:0046548)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of COPII vesicle coating (GO:0003400)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
development of primary female sexual characteristics (GO:0046545)	126	0	2.10	-	 < 0.01	2.79E-01	1.00E00
positive regulation of autophagic cell death (GO:1904094)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
development of secondary male sexual characteristics (GO:0046544)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of autophagic cell death (GO:1904093)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of autophagic cell death (GO:1904092)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of nucleus size (GO:0097298)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
saliva secretion (GO:0046541)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
'de novo' XMP biosynthetic process (GO:0097294)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
XMP biosynthetic process (GO:0097293)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
XMP metabolic process (GO:0097292)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
renal phosphate ion absorption (GO:0097291)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
inactivation of paternal X chromosome by genomic imprinting (GO:0060818)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ketone catabolic process (GO:0042182)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
random inactivation of X chromosome (GO:0060816)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
ketone biosynthetic process (GO:0042181)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
positive regulation of photoreceptor cell differentiation (GO:0046534)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase transmembrane transport (GO:1904082)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
xenobiotic catabolic process (GO:0042178)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein catabolic process (GO:0042177)	120	0	2.00	-	 < 0.01	2.73E-01	1.00E00
hepatocyte apoptotic process (GO:0097284)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
keratinocyte apoptotic process (GO:0097283)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesodermal to mesenchymal transition involved in gastrulation (GO:0060809)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
immune complex formation (GO:0097281)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histamine secretion mediated by immunoglobulin (GO:0097280)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell differentiation involved in embryonic placenta development (GO:0060806)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
epiblast cell-extraembryonic ectoderm cell signaling (GO:0060802)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell differentiation involved in embryonic placenta development (GO:0060800)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of trophectodermal cell proliferation (GO:1904075)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of trophectodermal cell proliferation (GO:1904073)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
presynaptic active zone assembly (GO:1904071)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
histamine secretion mediated by IgE immunoglobulin (GO:0097279)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
complement-dependent cytotoxicity (GO:0097278)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
sphingoid biosynthetic process (GO:0046520)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
heme metabolic process (GO:0042168)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
heme catabolic process (GO:0042167)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
ammonium homeostasis (GO:0097272)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex II assembly (GO:0034553)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
respiratory chain complex II assembly (GO:0034552)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
lipoprotein oxidation (GO:0042161)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex III assembly (GO:0034551)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
lipoprotein modification (GO:0042160)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood coagulation (GO:0030194)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
sphingoid metabolic process (GO:0046519)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
ceramide catabolic process (GO:0046514)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
sphingosine biosynthetic process (GO:0046512)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of locomotor rhythm (GO:1904060)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sphinganine biosynthetic process (GO:0046511)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
omega-hydroxylase P450 pathway (GO:0097267)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
lipoprotein catabolic process (GO:0042159)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
melatonin biosynthetic process (GO:0030187)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
melatonin metabolic process (GO:0030186)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nitric oxide transport (GO:0030185)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of sensory perception of pain (GO:1904058)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of sensory perception of pain (GO:1904057)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholangiocyte proliferation (GO:1904056)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholangiocyte proliferation (GO:1904055)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cholangiocyte proliferation (GO:1904054)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
glycerol ether biosynthetic process (GO:0046504)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
intracellular mRNA localization (GO:0008298)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
uroporphyrinogen III metabolic process (GO:0046502)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of spontaneous neurotransmitter secretion (GO:1904050)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protoporphyrinogen IX metabolic process (GO:0046501)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethionine metabolic process (GO:0046500)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
DNA strand invasion (GO:0042148)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
spermidine biosynthetic process (GO:0008295)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
renal tubular secretion (GO:0097254)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
acetylcholine biosynthetic process (GO:0008292)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
acetylcholine metabolic process (GO:0008291)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte apoptotic process (GO:0097252)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vacuole fusion, non-autophagic (GO:0042144)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
late meiotic recombination nodule assembly (GO:0042140)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-templated DNA replication initiation (GO:0030174)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of spontaneous neurotransmitter secretion (GO:1904049)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of spontaneous neurotransmitter secretion (GO:1904048)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial growth factor production (GO:1904046)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to aldosterone (GO:1904045)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
response to aldosterone (GO:1904044)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation of cystathionine beta-synthase activity (GO:1904042)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cystathionine beta-synthase activity (GO:1904041)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of iron export across plasma membrane (GO:1904040)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
meiotic DNA double-strand break formation (GO:0042138)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
sequestering of neurotransmitter (GO:0042137)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
amyloid-beta clearance (GO:0097242)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell migration to bone marrow (GO:0097241)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
chromosome attachment to the nuclear envelope (GO:0097240)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
proteoglycan catabolic process (GO:0030167)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of iron export across plasma membrane (GO:1904039)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of iron export across plasma membrane (GO:1904038)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
miRNA catabolic process (GO:0010587)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
miRNA metabolic process (GO:0010586)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
glutamine secretion (GO:0010585)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of t-SNARE clustering (GO:1904034)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of t-SNARE clustering (GO:1904032)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cyclin-dependent protein kinase activity (GO:1904031)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of cyclin-dependent protein kinase activity (GO:1904030)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
cellular response to methylglyoxal (GO:0097238)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nitrate metabolic process (GO:0042126)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
ribophagy (GO:0034517)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to vitamin B6 (GO:0034516)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial unfolded protein response (GO:0034514)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
pancreatic juice secretion (GO:0030157)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein import into mitochondrial matrix (GO:0030150)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of cyclin-dependent protein kinase activity (GO:1904029)	49	0	.82	-	 < 0.01	1.00E00	1.00E00
positive regulation of collagen fibril organization (GO:1904028)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of collagen fibril organization (GO:1904027)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of collagen fibril organization (GO:1904026)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucose catabolic process to lactate via pyruvate (GO:1904025)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucose catabolic process to lactate via pyruvate (GO:1904024)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glucose catabolic process to lactate via pyruvate (GO:1904023)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet activation (GO:0010572)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of G protein-coupled receptor internalization (GO:1904022)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclear cell cycle DNA replication (GO:0010571)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of G protein-coupled receptor internalization (GO:1904021)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of G protein-coupled receptor internalization (GO:1904020)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
endothelial cell activation (GO:0042118)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
monocyte activation (GO:0042117)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
centromere complex assembly (GO:0034508)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA polyadenylation (GO:0097222)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to kinetochore (GO:0034501)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
sphingolipid catabolic process (GO:0030149)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
epithelial cell apoptotic process (GO:1904019)	61	0	1.02	-	 < 0.01	6.29E-01	1.00E00
cellular response to Thyroglobulin triiodothyronine (GO:1904017)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to Thyroglobulin triiodothyronine (GO:1904016)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to serotonin (GO:1904015)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to serotonin (GO:1904014)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycoprotein biosynthetic process (GO:0010561)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycoprotein biosynthetic process (GO:0010560)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
response to Aroclor 1254 (GO:1904010)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lysosomal membrane permeability (GO:0097214)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lysosomal membrane permeability (GO:0097213)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lysosomal membrane organization (GO:0097212)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of lung blood pressure (GO:0014916)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of glycoprotein biosynthetic process (GO:0010559)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
tRNA threonylcarbamoyladenosine modification (GO:0002949)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
tRNA C5-cytosine methylation (GO:0002946)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of sebum secreting cell proliferation (GO:1904003)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA dihydrouridine synthesis (GO:0002943)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of sebum secreting cell proliferation (GO:1904002)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of eating behavior (GO:1904000)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
tRNA N2-guanine methylation (GO:0002940)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
myotube cell development involved in skeletal muscle regeneration (GO:0014906)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myotube cell development (GO:0014904)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
muscle hyperplasia (GO:0014900)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA N1-guanine methylation (GO:0002939)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
bradykinin biosynthetic process (GO:0002936)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
retina vasculature morphogenesis in camera-type eye (GO:0061299)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
lipid hydroxylation (GO:0002933)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
retina vasculature development in camera-type eye (GO:0061298)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
tendon sheath development (GO:0002932)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061296)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trabecular meshwork development (GO:0002930)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061295)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation (GO:0002926)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002925)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of humoral immune response (GO:0002922)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
vasopressin secretion (GO:0030103)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
transposable element silencing (GO:0010526)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion transport into cytosol (GO:0010523)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphocyte anergy (GO:0002913)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphocyte anergy (GO:0002912)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of lymphocyte anergy (GO:0002911)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of reciprocal meiotic recombination (GO:0010520)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
spermidine metabolic process (GO:0008216)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
spermine metabolic process (GO:0008215)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein dealkylation (GO:0008214)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mineralocorticoid metabolic process (GO:0008212)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
glucocorticoid metabolic process (GO:0008211)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
estrogen metabolic process (GO:0008210)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase activity (GO:0010519)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidylinositol biosynthetic process (GO:0010513)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
androgen metabolic process (GO:0008209)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylinositol biosynthetic process (GO:0010512)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagy of mitochondrion (GO:1903599)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylinositol biosynthetic process (GO:0010511)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
C21-steroid hormone catabolic process (GO:0008208)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
C21-steroid hormone metabolic process (GO:0008207)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
positive regulation of gap junction assembly (GO:1903598)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
mature B cell apoptotic process (GO:0002901)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
bile acid metabolic process (GO:0008206)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of gap junction assembly (GO:1903597)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of gap junction assembly (GO:1903596)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of histamine secretion by mast cell (GO:1903595)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of histamine secretion by mast cell (GO:1903593)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
RNA secondary structure unwinding (GO:0010501)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to L-arginine (GO:1903577)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of bipolar cell polarity (GO:0061245)	49	0	.82	-	 < 0.01	1.00E00	1.00E00
response to L-arginine (GO:1903576)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cornified envelope assembly (GO:1903575)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to endoplasmic reticulum stress (GO:1903573)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to ciliary membrane (GO:1903569)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to ciliary membrane (GO:1903568)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to ciliary membrane (GO:1903567)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cilium (GO:1903566)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cilium (GO:1903565)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cilium (GO:1903564)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
pattern specification involved in mesonephros development (GO:0061227)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of extracellular exosome assembly (GO:1903553)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular exosome assembly (GO:1903551)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesonephros development (GO:0061218)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
one-carbon compound transport (GO:0019755)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of mesonephros development (GO:0061217)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of growth hormone activity (GO:1903547)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to photoreceptor outer segment (GO:1903546)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to butyrate (GO:1903545)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to butyrate (GO:1903544)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of exosomal secretion (GO:1903543)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of exosomal secretion (GO:1903542)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of exosomal secretion (GO:1903541)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to postsynaptic membrane (GO:1903540)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of isoprenoid metabolic process (GO:0019747)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in mesonephros development (GO:0061209)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic cell cycle process involved in oocyte maturation (GO:1903538)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
meiotic cell cycle process involved in oocyte maturation (GO:1903537)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
pentacyclic triterpenoid metabolic process (GO:0019742)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nitrogen utilization (GO:0019740)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane tubulation (GO:1903526)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
antifungal humoral response (GO:0019732)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
antibacterial humoral response (GO:0019731)	110	0	1.83	-	 < 0.01	2.69E-01	1.00E00
positive regulation of blood circulation (GO:1903524)	49	0	.82	-	 < 0.01	1.00E00	1.00E00
antimicrobial humoral response (GO:0019730)	187	0	3.12	-	 < 0.01	8.03E-02	9.30E-01
negative regulation of blood circulation (GO:1903523)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of single strand break repair (GO:1903518)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of single strand break repair (GO:1903516)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
calcium ion transport from cytosol to endoplasmic reticulum (GO:1903515)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
Mo-molybdopterin cofactor metabolic process (GO:0019720)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum to cytosol transport (GO:1903513)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
phytanic acid metabolic process (GO:1903512)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic spindle checkpoint (GO:1903504)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
apical constriction (GO:0003383)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
epithelial cell morphogenesis (GO:0003382)	50	0	.83	-	 < 0.01	1.00E00	1.00E00
cell fate commitment involved in formation of primary germ layer (GO:0060795)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
sweat gland development (GO:0060792)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sphingosine-1-phosphate receptor signaling pathway (GO:0003376)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
cellular response to camptothecin (GO:0072757)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to glutathione (GO:0072753)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to rapamycin (GO:0072752)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to leptomycin B (GO:0072750)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of apoptosis involved in tissue homeostasis (GO:0060785)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in tissue homeostasis (GO:0060784)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesenchymal smoothened signaling pathway involved in prostate gland development (GO:0060783)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell proliferation involved in prostate gland development (GO:0060782)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell-matrix adhesion involved in ameboidal cell migration (GO:0003366)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of cell polarity involved in ameboidal cell migration (GO:0003365)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
brainstem development (GO:0003360)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to cytochalasin B (GO:0072749)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to cell division site (GO:0072741)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to anisomycin (GO:0072740)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial cell proliferation involved in prostate gland development (GO:0060770)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
noradrenergic neuron fate commitment (GO:0003359)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cilium beat frequency (GO:0003356)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of cilium movement (GO:0003354)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of cilium movement (GO:0003353)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethioninamine metabolic process (GO:0046499)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
S-adenosylhomocysteine metabolic process (GO:0046498)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pulmonary myocardium development (GO:0003350)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
response to anisomycin (GO:0072739)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
nicotinamide riboside metabolic process (GO:0046495)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to diamide (GO:0072738)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to diamide (GO:0072737)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
heme B metabolic process (GO:0046492)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to tert-butyl hydroperoxide (GO:0072736)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-methylmalonyl-CoA metabolic process (GO:0046491)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to tert-butyl hydroperoxide (GO:0072735)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to staurosporine (GO:0072734)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
isopentenyl diphosphate metabolic process (GO:0046490)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to staurosporine (GO:0072733)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to calcium ion starvation (GO:0072732)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell proliferation involved in prostate gland development (GO:0060769)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in prostate gland development (GO:0060767)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of androgen receptor signaling pathway (GO:0060766)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of androgen receptor signaling pathway (GO:0060765)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in mammary gland development (GO:0060764)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in mammary gland duct morphogenesis (GO:0060762)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
epicardium-derived cardiac endothelial cell differentiation (GO:0003349)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac endothelial cell differentiation (GO:0003348)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
epicardial cell to mesenchymal cell transition (GO:0003347)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
proepicardium cell migration involved in pericardium morphogenesis (GO:0003345)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pericardium morphogenesis (GO:0003344)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
septum transversum development (GO:0003343)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
proepicardium development (GO:0003342)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003340)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glyoxylate metabolic process (GO:0046487)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
ether lipid metabolic process (GO:0046485)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
response to amitrole (GO:0072722)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to dithiothreitol (GO:0072721)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to dithiothreitol (GO:0072720)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell chemotaxis (GO:0060755)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell chemotaxis (GO:0060754)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell chemotaxis (GO:0060753)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
branch elongation involved in mammary gland duct branching (GO:0060751)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in mammary gland duct elongation (GO:0060750)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
corneocyte desquamation (GO:0003336)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
corneocyte development (GO:0003335)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
keratinocyte development (GO:0003334)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
negative regulation of extracellular matrix constituent secretion (GO:0003332)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glycosphingolipid catabolic process (GO:0046479)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of extracellular matrix constituent secretion (GO:0003331)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
lactosylceramide metabolic process (GO:0046478)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular matrix constituent secretion (GO:0003330)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
glycosylceramide catabolic process (GO:0046477)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
glycosylceramide biosynthetic process (GO:0046476)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to cisplatin (GO:0072719)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to cisplatin (GO:0072718)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to actinomycin D (GO:0072717)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to actinomycin D (GO:0072716)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to hydroxyurea (GO:0072711)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
response to hydroxyurea (GO:0072710)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
mammary gland alveolus development (GO:0060749)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
tertiary branching involved in mammary gland duct morphogenesis (GO:0060748)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mammary gland branching involved in pregnancy (GO:0060745)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
mammary gland branching involved in thelarche (GO:0060744)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
epithelial cell maturation involved in prostate gland development (GO:0060743)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
epithelial cell differentiation involved in prostate gland development (GO:0060742)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
prostate gland stromal morphogenesis (GO:0060741)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pancreatic PP cell fate commitment (GO:0003329)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell fate commitment (GO:0003327)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pancreatic A cell fate commitment (GO:0003326)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell development (GO:0003323)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
pancreatic A cell development (GO:0003322)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
platelet activating factor metabolic process (GO:0046469)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood pressure by epinephrine-norepinephrine (GO:0003321)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
membrane lipid catabolic process (GO:0046466)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
cellular response to sorbitol (GO:0072709)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
dolichyl diphosphate metabolic process (GO:0046465)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to sorbitol (GO:0072708)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
acylglycerol catabolic process (GO:0046464)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
acylglycerol biosynthetic process (GO:0046463)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
monoacylglycerol metabolic process (GO:0046462)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
neutral lipid catabolic process (GO:0046461)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
cellular response to mercaptoethanol (GO:0072705)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neutral lipid biosynthetic process (GO:0046460)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
response to mercaptoethanol (GO:0072704)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
late endosome to Golgi transport (GO:0034499)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to methyl methanesulfonate (GO:0072703)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
early endosome to Golgi transport (GO:0034498)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
response to methyl methanesulfonate (GO:0072702)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to phagophore assembly site (GO:0034497)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
mesenchymal-epithelial cell signaling involved in prostate gland development (GO:0060739)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
epithelial-mesenchymal signaling involved in prostate gland development (GO:0060738)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
prostate gland morphogenetic growth (GO:0060737)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
prostate gland growth (GO:0060736)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of eIF2 alpha phosphorylation by dsRNA (GO:0060735)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:0060734)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of inositol phosphate biosynthetic process (GO:0060732)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of intestinal epithelial structure maintenance (GO:0060731)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal epithelial structure maintenance (GO:0060730)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cell migration to the midline involved in heart development (GO:0003318)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pancreatic PP cell differentiation (GO:0003312)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid metabolic process (GO:0046459)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
pancreatic D cell differentiation (GO:0003311)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
hexadecanal metabolic process (GO:0046458)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pancreatic A cell differentiation (GO:0003310)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
dihydrofolate metabolic process (GO:0046452)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
vacuolar transmembrane transport (GO:0034486)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
intestinal epithelial structure maintenance (GO:0060729)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in embryonic placenta development (GO:0060723)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in embryonic placenta development (GO:0060722)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of spongiotrophoblast cell proliferation (GO:0060721)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell differentiation (GO:0003309)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
spongiotrophoblast cell proliferation (GO:0060720)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of Wnt signaling pathway involved in heart development (GO:0003308)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt signaling pathway involved in heart development (GO:0003307)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
physiological cardiac muscle hypertrophy (GO:0003301)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
cardiac muscle hypertrophy (GO:0003300)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
FMN metabolic process (GO:0046444)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
FAD metabolic process (GO:0046443)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-lysine metabolic process (GO:0046440)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
pilomotor reflex (GO:0097195)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylglycerol catabolic process (GO:0034478)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
U6 snRNA 3'-end processing (GO:0034477)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
U5 snRNA 3'-end processing (GO:0034476)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
U4 snRNA 3'-end processing (GO:0034475)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
chorionic trophoblast cell development (GO:0060719)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chorionic trophoblast cell differentiation (GO:0060718)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
U2 snRNA 3'-end processing (GO:0034474)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
U1 snRNA 3'-end processing (GO:0034473)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
chorion development (GO:0060717)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
syncytiotrophoblast cell differentiation involved in labyrinthine layer development (GO:0060715)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
labyrinthine layer morphogenesis (GO:0060713)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
spongiotrophoblast layer development (GO:0060712)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
cardiac muscle hypertrophy in response to stress (GO:0014898)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
striated muscle hypertrophy (GO:0014897)	48	0	.80	-	 < 0.01	1.00E00	1.00E00
chorio-allantoic fusion (GO:0060710)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
muscle hypertrophy (GO:0014896)	50	0	.83	-	 < 0.01	1.00E00	1.00E00
smooth muscle hypertrophy (GO:0014895)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to denervation involved in regulation of muscle adaptation (GO:0014894)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
striated muscle atrophy (GO:0014891)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
L-cysteine metabolic process (GO:0046439)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
D-amino acid biosynthetic process (GO:0046437)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-alanine metabolic process (GO:0046436)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dentin mineralization (GO:0097188)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dentinogenesis (GO:0097187)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
germ-line stem cell division (GO:0042078)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cell migration involved in gastrulation (GO:0042074)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
response to carbon monoxide (GO:0034465)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glycogen cell differentiation involved in embryonic placenta development (GO:0060709)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spongiotrophoblast differentiation (GO:0060708)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
trophoblast giant cell differentiation (GO:0060707)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
90S preribosome assembly (GO:0034463)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell differentiation involved in embryonic placenta development (GO:0060706)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
small-subunit processome assembly (GO:0034462)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
muscle atrophy (GO:0014889)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoribonuclease activity (GO:0060702)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
striated muscle adaptation (GO:0014888)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
negative regulation of ribonuclease activity (GO:0060701)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ribonuclease activity (GO:0060700)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
cardiac muscle adaptation (GO:0014887)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
transition between slow and fast fiber (GO:0014886)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transition between fast and slow fiber (GO:0014883)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
ruffle assembly (GO:0097178)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
epoxide metabolic process (GO:0097176)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
microtubule anchoring at centrosome (GO:0034454)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
microtubule anchoring (GO:0034453)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
response to electrical stimulus involved in regulation of muscle adaptation (GO:0014878)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to muscle inactivity involved in regulation of muscle adaptation (GO:0014877)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
response to injury involved in regulation of muscle adaptation (GO:0014876)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to stimulus involved in regulation of muscle adaptation (GO:0014874)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
protein repair (GO:0030091)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to muscle activity involved in regulation of muscle adaptation (GO:0014873)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to muscle inactivity (GO:0014870)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
D-amino acid metabolic process (GO:0046416)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
urate metabolic process (GO:0046415)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
mesenchymal stem cell proliferation (GO:0097168)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
circadian regulation of translation (GO:0097167)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	66	0	1.10	-	 < 0.01	6.31E-01	1.00E00
very-low-density lipoprotein particle clearance (GO:0034447)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of plasma lipoprotein oxidation (GO:0034445)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of plasma lipoprotein oxidation (GO:0034444)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein oxidation (GO:0034443)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein oxidation (GO:0034442)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle oxidation (GO:0034441)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipid oxidation (GO:0034440)	89	0	1.48	-	 < 0.01	4.09E-01	1.00E00
skeletal myofibril assembly (GO:0014866)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction by chemo-mechanical energy conversion (GO:0014862)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction via regulation of action potential (GO:0014861)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neurotransmitter secretion involved in regulation of skeletal muscle contraction (GO:0014860)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of central B cell tolerance induction (GO:0002897)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of central B cell tolerance induction (GO:0002895)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of type II hypersensitivity (GO:0002894)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of type II hypersensitivity (GO:0002892)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of immunoglobulin mediated immune response (GO:0002891)	53	0	.88	-	 < 0.01	1.00E00	1.00E00
negative regulation of immunoglobulin mediated immune response (GO:0002890)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
fasciculation of motor neuron axon (GO:0097156)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lipoprotein lipid oxidation (GO:0034439)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fasciculation of sensory neuron axon (GO:0097155)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
epithelial fluid transport (GO:0042045)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
glycoprotein transport (GO:0034436)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
fluid transport (GO:0042044)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell apoptotic process (GO:0097152)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of inhibitory postsynaptic potential (GO:0097151)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
neuronal stem cell population maintenance (GO:0097150)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle cell proliferation (GO:0014859)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
skeletal muscle cell proliferation (GO:0014856)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
response to inactivity (GO:0014854)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic metaphase/anaphase transition (GO:0030071)	92	0	1.53	-	 < 0.01	4.11E-01	1.00E00
regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction (GO:0014853)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
insulin processing (GO:0030070)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction (GO:0014852)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
proteasomal ubiquitin-independent protein catabolic process (GO:0010499)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid leukocyte mediated immunity (GO:0002888)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
intercellular transport (GO:0010496)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of hypersensitivity (GO:0002885)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of hypersensitivity (GO:0002884)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of hypersensitivity (GO:0002883)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002882)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002881)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002880)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
post-translational protein acetylation (GO:0034421)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ureter smooth muscle contraction (GO:0014849)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
growth factor dependent regulation of skeletal muscle satellite cell proliferation (GO:0014843)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell proliferation (GO:0014841)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of acute inflammatory response to non-antigenic stimulus (GO:0002879)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of acute inflammatory response to non-antigenic stimulus (GO:0002878)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of acute inflammatory response to non-antigenic stimulus (GO:0002877)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of chronic inflammatory response to antigenic stimulus (GO:0002876)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of chronic inflammatory response to antigenic stimulus (GO:0002875)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of chronic inflammatory response to antigenic stimulus (GO:0002874)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of epidermal cell division (GO:0010482)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
epidermal cell division (GO:0010481)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T cell anergy (GO:0002870)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
urate biosynthetic process (GO:0034418)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein refolding (GO:0042026)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
DNA endoreduplication (GO:0042023)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myoblast migration involved in skeletal muscle regeneration (GO:0014839)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
myoblast differentiation involved in skeletal muscle regeneration (GO:0014835)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration (GO:0014834)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
vesicle transport along actin filament (GO:0030050)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of acute inflammatory response to antigenic stimulus (GO:0002866)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of acute inflammatory response to antigenic stimulus (GO:0002865)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of acute inflammatory response to antigenic stimulus (GO:0002864)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of inflammatory response to antigenic stimulus (GO:0002862)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of gastrulation (GO:0010470)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
muscle filament sliding (GO:0030049)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
actin modification (GO:0030047)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
vascular associated smooth muscle contraction (GO:0014829)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
parallel actin filament bundle assembly (GO:0030046)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
vein smooth muscle contraction (GO:0014826)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
actin filament fragmentation (GO:0030043)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
actin filament depolymerization (GO:0030042)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
artery smooth muscle contraction (GO:0014824)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
detection of wounding (GO:0014822)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tonic smooth muscle contraction (GO:0014820)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002859)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell mediated immune response to tumor cell (GO:0002856)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell proliferation (GO:0010464)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell mediated immune response to tumor cell (GO:0002855)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell proliferation (GO:0010463)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002854)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002853)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002852)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart rate (GO:0010460)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of peripheral T cell tolerance induction (GO:0002851)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
guanylate kinase-associated protein clustering (GO:0097117)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neurexin clustering involved in presynaptic membrane assembly (GO:0097115)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
AMPA glutamate receptor clustering (GO:0097113)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation by iron (GO:0045994)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid receptor clustering (GO:0097112)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum-Golgi intermediate compartment organization (GO:0097111)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of embryonic development (GO:0045992)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
carbon catabolite activation of transcription (GO:0045991)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
carbon catabolite regulation of transcription (GO:0045990)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
contractile actin filament bundle assembly (GO:0030038)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction (GO:0014819)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
microspike assembly (GO:0030035)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
microvillar actin bundle assembly (GO:0030034)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lamellipodium assembly (GO:0030032)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell commitment (GO:0014813)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart rate (GO:0010459)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
exit from mitosis (GO:0010458)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
regulation of peripheral T cell tolerance induction (GO:0002849)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
centriole-centriole cohesion (GO:0010457)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell fate commitment (GO:0010455)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of striated muscle contraction (GO:0045989)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell mediated immune response to tumor cell (GO:0002841)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle contraction (GO:0045988)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle contraction (GO:0045986)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
presynaptic membrane assembly (GO:0097105)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
endothelial tip cell fate specification (GO:0097102)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell fate specification (GO:0097101)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014809)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein maturation by protein folding (GO:0022417)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
intracellular manganese ion homeostasis (GO:0030026)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of somitogenesis (GO:0014807)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
smooth muscle hyperplasia (GO:0014806)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
smooth muscle adaptation (GO:0014805)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle process (GO:0022410)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of immune response to tumor cell (GO:0002838)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to tumor cell (GO:0002835)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
fungiform papilla formation (GO:0061198)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
fungiform papilla morphogenesis (GO:0061197)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of type 2 immune response (GO:0002830)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
fungiform papilla development (GO:0061196)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cell cycle, embryonic (GO:0045977)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic cell cycle, embryonic (GO:0045976)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
taste bud development (GO:0061193)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sclerotome development (GO:0061190)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell cycle phase (GO:0022403)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
maintenance of cell polarity (GO:0030011)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
negative adaptation of signaling pathway (GO:0022401)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of opsin-mediated signaling pathway (GO:0022400)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of type 2 immune response (GO:0002829)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of type 2 immune response (GO:0002828)	34	0	.57	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 1 type immune response (GO:0002827)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 1 type immune response (GO:0002826)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 1 type immune response (GO:0002825)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002823)	60	0	1.00	-	 < 0.01	6.29E-01	1.00E00
positive regulation of sclerotome development (GO:0061189)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of rDNA heterochromatin formation (GO:0061188)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of rDNA heterochromatin formation (GO:0061187)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty acid omega-oxidation (GO:0010430)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of adaptive immune response (GO:0002820)	65	0	1.08	-	 < 0.01	6.30E-01	1.00E00
negative regulation of dermatome development (GO:0061185)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of growth rate (GO:0045967)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of dermatome development (GO:0061184)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of dermatome development (GO:0061183)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopamine metabolic process (GO:0045964)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of chondrocyte development (GO:0061182)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of chondrocyte development (GO:0061181)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopamine metabolic process (GO:0045963)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of complement activation, classical pathway (GO:0045960)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0002816)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0002815)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide-mediated programmed cell death (GO:0010421)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
biosynthetic process of antibacterial peptides active against Gram-negative bacteria (GO:0002812)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of complement activation, classical pathway (GO:0045959)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of complement activation, alternative pathway (GO:0045957)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of bipolar cell polarity (GO:0061172)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of bipolar cell polarity (GO:0061171)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hair follicle placode formation (GO:0061170)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic recombination (GO:0045950)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to methanol (GO:0033986)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of antibacterial peptide biosynthetic process (GO:0002808)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of antimicrobial peptide biosynthetic process (GO:0002807)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of antimicrobial peptide biosynthetic process (GO:0002805)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of antibacterial peptide production (GO:0002803)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of hair follicle placode formation (GO:0061168)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation (GO:0045948)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
response to 11-deoxycorticosterone (GO:1903496)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to dehydroepiandrosterone (GO:1903495)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to dehydroepiandrosterone (GO:1903494)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by RNA polymerase III (GO:0045945)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
establishment of monopolar cell polarity (GO:0061162)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by RNA polymerase I (GO:0045943)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cytokinesis (GO:1903490)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid metabolic process (GO:0045940)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
box H/ACA sno(s)RNA metabolic process (GO:0033979)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of bipolar cell polarity involved in cell morphogenesis (GO:0061159)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lactation (GO:1903489)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
3'-UTR-mediated mRNA destabilization (GO:0061158)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
mRNA destabilization (GO:0061157)	75	0	1.25	-	 < 0.01	6.39E-01	1.00E00
choline metabolic process (GO:0019695)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of lactation (GO:1903487)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
endothelial tube morphogenesis (GO:0061154)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
deoxyribose phosphate metabolic process (GO:0019692)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
trachea gland development (GO:0061153)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
trachea submucosa development (GO:0061152)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle contraction (GO:0045932)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
box C/D sno(s)RNA metabolic process (GO:0033967)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
P-body assembly (GO:0033962)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
neural plate mediolateral regionalization (GO:0021998)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neural plate axis specification (GO:0021997)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neuropore closure (GO:0021995)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
initiation of neural tube closure (GO:0021993)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neural plate formation (GO:0021990)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic actomyosin contractile ring assembly actin filament organization (GO:1903479)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lung smooth muscle development (GO:0061145)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic actomyosin contractile ring assembly (GO:1903475)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
alveolar secondary septum development (GO:0061144)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of female receptivity (GO:0045925)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of female receptivity (GO:0045924)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
lung ciliated cell differentiation (GO:0061141)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
olfactory cortex development (GO:0021989)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neurohypophysis development (GO:0021985)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
adenohypophysis development (GO:0021984)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
propionate metabolic process, methylmalonyl pathway (GO:0019678)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ammonia assimilation cycle (GO:0019676)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
GDP-mannose metabolic process (GO:0019673)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
positive regulation of complement activation (GO:0045917)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cell cycle DNA replication (GO:1903465)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of catecholamine metabolic process (GO:0045915)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cell cycle DNA replication (GO:1903463)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
anaerobic glutamate catabolic process (GO:0019670)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of catecholamine metabolic process (GO:0045914)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
Okazaki fragment processing involved in mitotic DNA replication (GO:1903461)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hypothalamus cell differentiation (GO:0021979)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
nitrogenous compound fermentation (GO:0019666)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
anaerobic amino acid catabolic process (GO:0019665)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lactate catabolic process (GO:1903457)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of vasoconstriction (GO:0045906)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
glucose catabolic process to lactate via pyruvate (GO:0019661)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
glycolytic fermentation (GO:0019660)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of G1 to G0 transition (GO:1903452)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational fidelity (GO:0045903)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of G1 to G0 transition (GO:1903451)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of G1 to G0 transition (GO:1903450)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of translational elongation (GO:0045900)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
spinal cord ventral commissure morphogenesis (GO:0021965)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
glucose catabolic process to lactate (GO:0019659)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
androst-4-ene-3,17-dione biosynthetic process (GO:1903449)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lung proximal/distal axis specification (GO:0061115)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein transport from ciliary membrane to plasma membrane (GO:1903445)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
branching involved in pancreas morphogenesis (GO:0061114)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of brown fat cell differentiation (GO:1903444)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
pancreas morphogenesis (GO:0061113)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
response to lipoic acid (GO:1903442)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to ciliary membrane (GO:1903441)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
dense core granule biogenesis (GO:0061110)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
central nervous system interneuron axonogenesis (GO:0021956)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aerobic electron transport chain (GO:0019646)	63	0	1.05	-	 < 0.01	6.29E-01	1.00E00
seminal vesicle epithelium development (GO:0061108)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cytokinetic process (GO:1903438)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
seminal vesicle development (GO:0061107)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of stomach neuroendocrine cell differentiation (GO:0061106)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cytokinetic process (GO:1903436)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of stomach neuroendocrine cell differentiation (GO:0061105)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of constitutive secretory pathway (GO:1903435)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adrenal chromaffin cell differentiation (GO:0061104)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of constitutive secretory pathway (GO:1903434)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
carotid body glomus cell differentiation (GO:0061103)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-glucuronate catabolic process to D-xylulose 5-phosphate (GO:0019640)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of constitutive secretory pathway (GO:1903433)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
stomach neuroendocrine cell differentiation (GO:0061102)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neuroendocrine cell differentiation (GO:0061101)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
lung neuroendocrine cell differentiation (GO:0061100)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell maturation (GO:1903430)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration (GO:0021944)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
formation of radial glial scaffolds (GO:0021943)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
radial glia guided migration of Purkinje cell (GO:0021942)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule cytoskeleton (GO:0072698)	43	0	.72	-	 < 0.01	1.00E00	1.00E00
negative regulation of cerebellar granule cell precursor proliferation (GO:0021941)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cerebellar granule cell precursor proliferation (GO:0021940)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to cell cortex (GO:0072697)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of reactive oxygen species biosynthetic process (GO:1903428)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
regulation of DNA recombination at telomere (GO:0072695)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
organic phosphonate metabolic process (GO:0019634)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fluoride transmembrane transport (GO:1903424)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle recycling (GO:1903423)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
protein localization to endoplasmic reticulum tubular network (GO:1903420)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell-granule cell precursor cell signaling (GO:0021937)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cerebellar granule cell precursor proliferation (GO:0021936)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cerebellar granule cell precursor tangential migration (GO:0021935)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
hindbrain tangential cell migration (GO:0021934)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
radial glia guided migration of cerebellar granule cell (GO:0021933)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
hindbrain radial glia guided cell migration (GO:0021932)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
urate catabolic process (GO:0019628)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebellar granule cell precursor proliferation (GO:0021930)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid catabolic process (GO:0019626)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
response to glycoside (GO:1903416)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
T cell extravasation (GO:0072683)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to bile acid (GO:1903413)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
response to bile acid (GO:1903412)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
muscle hypertrophy in response to stress (GO:0003299)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
physiological muscle hypertrophy (GO:0003298)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
atrial ventricular junction remodeling (GO:0003294)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac septum cell differentiation (GO:0003292)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
atrial septum secundum morphogenesis (GO:0003290)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell proliferation in external granule layer (GO:0021924)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
thymocyte migration (GO:0072679)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
T cell migration (GO:0072678)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
reactive oxygen species biosynthetic process (GO:1903409)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
positive regulation of P-type sodium:potassium-exchanging transporter activity (GO:1903408)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
osteoclast fusion (GO:0072675)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
multinuclear osteoclast differentiation (GO:0072674)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of P-type sodium:potassium-exchanging transporter activity (GO:1903407)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of P-type sodium:potassium-exchanging transporter activity (GO:1903406)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
lamellipodium morphogenesis (GO:0072673)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein localization to nuclear body (GO:1903405)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neutrophil extravasation (GO:0072672)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of renal phosphate excretion (GO:1903403)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of renal phosphate excretion (GO:1903402)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
L-lysine transmembrane transport (GO:1903401)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
septum secundum development (GO:0003285)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
phenylethylamine catabolic process (GO:0019607)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021910)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to vacuole (GO:0072666)	58	0	.97	-	 < 0.01	1.00E00	1.00E00
2-oxobutyrate catabolic process (GO:0019606)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to vacuole (GO:0072665)	74	0	1.23	-	 < 0.01	6.38E-01	1.00E00
butyrate metabolic process (GO:0019605)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to peroxisome (GO:0072663)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
protein localization to peroxisome (GO:0072662)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in plasma membrane (GO:0072660)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of endoribonuclease activity (GO:0060699)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipid catabolic process (GO:0060697)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid catabolic process (GO:0060696)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol transporter activity (GO:0060695)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
optokinetic behavior (GO:0007634)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol transporter activity (GO:0060694)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in salivary gland morphogenesis (GO:0060693)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
epithelial cell maturation involved in salivary gland development (GO:0060691)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
epithelial cell differentiation involved in salivary gland development (GO:0060690)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
jump response (GO:0007630)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in heart morphogenesis (GO:0003278)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in outflow tract morphogenesis (GO:0003275)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
endocardial cushion fusion (GO:0003274)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cell migration involved in endocardial cushion formation (GO:0003273)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
endocardial cushion formation (GO:0003272)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003271)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
forebrain-midbrain boundary formation (GO:0021905)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
commitment of neuronal cell to specific neuron type in forebrain (GO:0021902)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in membrane (GO:0072658)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in mitochondrion (GO:0072656)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to mitochondrion (GO:0072655)	74	0	1.23	-	 < 0.01	6.38E-01	1.00E00
cell differentiation involved in salivary gland development (GO:0060689)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in prostate gland morphogenesis (GO:0060687)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of prostatic bud formation (GO:0060686)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
grooming behavior (GO:0007625)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of prostatic bud formation (GO:0060685)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
ultradian rhythm (GO:0007624)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial-mesenchymal cell signaling (GO:0060684)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling (GO:0060683)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
primary ureteric bud growth (GO:0060682)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of female receptivity (GO:0007621)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
branch elongation involved in ureteric bud branching (GO:0060681)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
copulation (GO:0007620)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of secondary heart field cardioblast proliferation (GO:0003266)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of cardioblast proliferation (GO:0003264)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
cardioblast migration (GO:0003260)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
courtship behavior (GO:0007619)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
mating (GO:0007618)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
dichotomous subdivision of terminal units involved in ureteric bud branching (GO:0060678)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ureteric bud formation (GO:0060676)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
short-term memory (GO:0007614)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
epithelial cell morphogenesis involved in placental branching (GO:0060672)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
epithelial cell differentiation involved in embryonic placenta development (GO:0060671)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
branching involved in labyrinthine layer morphogenesis (GO:0060670)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
cardioblast anterior-lateral migration (GO:0003259)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in heart valve morphogenesis (GO:0003252)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell proliferation involved in heart valve morphogenesis (GO:0003251)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in heart valve morphogenesis (GO:0003250)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
UDP-glucuronate metabolic process (GO:0046398)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-33 production (GO:0072639)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
5-phosphoribose 1-diphosphate metabolic process (GO:0046391)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
embryonic placenta morphogenesis (GO:0060669)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling (GO:0060668)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipid efflux (GO:1902999)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
branch elongation involved in salivary gland morphogenesis (GO:0060667)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurofibrillary tangle assembly (GO:1902998)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dichotomous subdivision of terminal units involved in salivary gland branching (GO:0060666)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of neurofibrillary tangle assembly (GO:1902997)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling (GO:0060665)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of neurofibrillary tangle assembly (GO:1902996)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in salivary gland morphogenesis (GO:0060664)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
phototransduction, UV (GO:0007604)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phototransduction, visible light (GO:0007603)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
salivary gland cavitation (GO:0060662)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid precursor protein catabolic process (GO:1902992)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
submandibular salivary gland formation (GO:0060661)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic telomere maintenance via semi-conservative replication (GO:1902990)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
post-embryonic cardiac muscle cell growth involved in heart morphogenesis (GO:0003247)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac muscle tissue growth involved in heart morphogenesis (GO:0003245)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
circumferential growth involved in left ventricle morphogenesis (GO:0003243)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac chamber ballooning (GO:0003242)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
growth involved in heart morphogenesis (GO:0003241)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
deoxyribose phosphate catabolic process (GO:0046386)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
deoxyribose phosphate biosynthetic process (GO:0046385)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
CMP-N-acetylneuraminate metabolic process (GO:0046381)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
N-acetylneuraminate biosynthetic process (GO:0046380)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nipple sheath formation (GO:0060659)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nipple morphogenesis (GO:0060658)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
neurofibrillary tangle assembly (GO:1902988)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation involved in mitotic DNA replication (GO:1902983)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sinus venosus morphogenesis (GO:0003236)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sinus venosus development (GO:0003235)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-arabinose metabolic process (GO:0046373)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
fructose biosynthetic process (GO:0046370)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mammary gland bud elongation (GO:0060649)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication termination (GO:1902979)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mammary gland bud morphogenesis (GO:0060648)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication preinitiation complex assembly (GO:1902977)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication initiation (GO:1902975)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
mammary gland epithelial cell differentiation (GO:0060644)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle tissue development (GO:0003228)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
right ventricular compact myocardium morphogenesis (GO:0003226)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ventricular trabecula myocardium morphogenesis (GO:0003222)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
right ventricular cardiac muscle tissue morphogenesis (GO:0003221)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
GDP-L-fucose metabolic process (GO:0046368)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
left ventricular cardiac muscle tissue morphogenesis (GO:0003220)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
2-oxobutyrate metabolic process (GO:0046361)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
2-oxobutyrate biosynthetic process (GO:0046360)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
telomere tethering at nuclear periphery (GO:0034398)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
telomere localization (GO:0034397)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication (GO:1902969)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
protein localization to cell surface (GO:0034394)	37	0	.62	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle cell apoptotic process (GO:0034393)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to early endosome (GO:1902966)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to early endosome (GO:1902965)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell apoptotic process (GO:0034390)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription initiation by RNA polymerase II (GO:0060633)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
regulation of meiosis I (GO:0060631)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cardiac right ventricle formation (GO:0003219)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cardiac left ventricle formation (GO:0003218)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902960)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac right atrium morphogenesis (GO:0003213)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
butyrate catabolic process (GO:0046359)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac ventricle formation (GO:0003211)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cardiac atrium formation (GO:0003210)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA catabolic process (GO:0046356)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
disaccharide catabolic process (GO:0046352)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
disaccharide biosynthetic process (GO:0046351)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of homologous chromosome segregation (GO:0060629)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of ER to Golgi vesicle-mediated transport (GO:0060628)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
high-density lipoprotein particle clearance (GO:0034384)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
low-density lipoprotein particle clearance (GO:0034383)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
chylomicron remnant clearance (GO:0034382)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902957)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle clearance (GO:0034381)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902956)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of early endosome to recycling endosome transport (GO:1902955)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
high-density lipoprotein particle assembly (GO:0034380)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of early endosome to recycling endosome transport (GO:1902954)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of chromosome condensation (GO:0060623)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of ER to Golgi vesicle-mediated transport (GO:1902953)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic spine maintenance (GO:1902952)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol import (GO:0060621)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol import (GO:0060620)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic spine maintenance (GO:1902951)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic spine maintenance (GO:1902950)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
cardiac chamber formation (GO:0003207)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
endocardial cushion morphogenesis (GO:0003203)	38	0	.63	-	 < 0.01	1.00E00	1.00E00
amino sugar biosynthetic process (GO:0046349)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
amino sugar catabolic process (GO:0046348)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
diacylglycerol catabolic process (GO:0046340)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
very-low-density lipoprotein particle assembly (GO:0034379)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
chylomicron assembly (GO:0034378)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
craniofacial suture morphogenesis (GO:0097094)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle assembly (GO:0034377)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
high-density lipoprotein particle remodeling (GO:0034375)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle clustering (GO:0097091)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
low-density lipoprotein particle remodeling (GO:0034374)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
nipple development (GO:0060618)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of tau-protein kinase activity (GO:1902949)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
presynaptic membrane organization (GO:0097090)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of tau-protein kinase activity (GO:1902948)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
very-low-density lipoprotein particle remodeling (GO:0034372)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of tau-protein kinase activity (GO:1902947)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to early endosome (GO:1902946)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
mammary gland bud formation (GO:0060615)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
chylomicron remodeling (GO:0034371)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
triglyceride-rich lipoprotein particle remodeling (GO:0034370)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
fat pad development (GO:0060613)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated chloride channel activity (GO:1902943)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mammary gland fat development (GO:0060611)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of voltage-gated chloride channel activity (GO:1902941)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phosphatidylethanolamine catabolic process (GO:0046338)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
phosphatidylethanolamine metabolic process (GO:0046337)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
methyl-branched fatty acid metabolic process (GO:0097089)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
lateral inhibition (GO:0046331)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle remodeling (GO:0034369)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
protein-lipid complex remodeling (GO:0034368)	28	0	.47	-	 < 0.01	1.00E00	1.00E00
vascular associated smooth muscle cell development (GO:0097084)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
protein-containing complex remodeling (GO:0034367)	30	0	.50	-	 < 0.01	1.00E00	1.00E00
plasma membrane selenite transport (GO:0097080)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tube lumen cavitation (GO:0060605)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
branch elongation of an epithelium (GO:0060602)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of alcohol biosynthetic process (GO:1902932)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
lateral sprouting from an epithelium (GO:0060601)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
dichotomous subdivision of an epithelial terminal unit (GO:0060600)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of JNK cascade (GO:0046329)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
glycerol biosynthetic process from pyruvate (GO:0046327)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
D-glucose import (GO:0046323)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of fatty acid oxidation (GO:0046321)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
NAD salvage (GO:0034355)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
'de novo' NAD biosynthetic process from tryptophan (GO:0034354)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of glial cell apoptotic process (GO:0034352)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
phosphocreatine biosynthetic process (GO:0046314)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cellular response to thyroxine stimulus (GO:0097069)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to thyroxine (GO:0097068)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
glial cell apoptotic process (GO:0034349)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of type III interferon production (GO:0034346)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dendritic spine maintenance (GO:0097062)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of type III interferon production (GO:0034345)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dendritic spine organization (GO:0097061)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
regulation of type III interferon production (GO:0034344)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
type III interferon production (GO:0034343)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to type III interferon (GO:0034342)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein polyubiquitination (GO:1902916)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuroepithelial cell differentiation (GO:1902913)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of melanosome transport (GO:1902910)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA folding (GO:0034337)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
L-kynurenine catabolic process (GO:0097053)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
L-kynurenine metabolic process (GO:0097052)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to endoplasmic reticulum membrane (GO:0097051)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
retrograde axonal transport (GO:0008090)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell apoptotic process (GO:0097050)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
adherens junction assembly (GO:0034333)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of melanosome transport (GO:1902908)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of autophagosome assembly (GO:1902902)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of antibacterial peptide production (GO:0002786)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of antimicrobial peptide production (GO:0002784)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
motor neuron apoptotic process (GO:0097049)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
dendritic cell apoptotic process (GO:0097048)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
antibacterial peptide biosynthetic process (GO:0002780)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine exposure on blood platelet (GO:0097045)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle adaptation (GO:0014745)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle hypertrophy (GO:0014741)	40	0	.67	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle hyperplasia (GO:0014740)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
antibacterial peptide secretion (GO:0002779)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
COP9 signalosome assembly (GO:0010387)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
antibacterial peptide production (GO:0002778)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
antimicrobial peptide biosynthetic process (GO:0002777)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
antimicrobial peptide secretion (GO:0002776)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antimicrobial peptide production (GO:0002775)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
Fc receptor mediated inhibitory signaling pathway (GO:0002774)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein linear polyubiquitination (GO:0097039)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
mesodermal cell migration (GO:0008078)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
heme export (GO:0097037)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of plasma membrane sterol distribution (GO:0097036)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
diol biosynthetic process (GO:0034312)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
diol metabolic process (GO:0034311)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
primary alcohol catabolic process (GO:0034310)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle hyperplasia (GO:0014739)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of muscle hyperplasia (GO:0014738)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle atrophy (GO:0014737)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle atrophy (GO:0014736)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of muscle atrophy (GO:0014735)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
skeletal muscle hypertrophy (GO:0014734)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle adaptation (GO:0014733)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
skeletal muscle atrophy (GO:0014732)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
natural killer cell inhibitory signaling pathway (GO:0002769)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
immune response-inhibiting cell surface receptor signaling pathway (GO:0002767)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
immune response-inhibiting signal transduction (GO:0002765)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
mature conventional dendritic cell differentiation (GO:0097029)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of myeloid leukocyte differentiation (GO:0002762)	60	0	1.00	-	 < 0.01	6.29E-01	1.00E00
positive regulation of antimicrobial humoral response (GO:0002760)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
primary alcohol biosynthetic process (GO:0034309)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
establishment of blood-nerve barrier (GO:0008065)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
dendritic cell dendrite assembly (GO:0097026)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
primary alcohol metabolic process (GO:0034308)	98	0	1.63	-	 < 0.01	4.16E-01	1.00E00
Toll signaling pathway (GO:0008063)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
lymphocyte migration into lymph node (GO:0097022)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of the force of skeletal muscle contraction (GO:0014728)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of twitch skeletal muscle contraction (GO:0014724)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction by modulation of calcium ion sensitivity of myofibril (GO:0014723)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction by calcium ion signaling (GO:0014722)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
twitch skeletal muscle contraction (GO:0014721)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antimicrobial humoral response (GO:0002759)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
MyD88-dependent toll-like receptor signaling pathway (GO:0002755)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of anion channel activity (GO:0010360)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
renal albumin absorption (GO:0097018)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
eye pigment granule organization (GO:0008057)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
renal protein absorption (GO:0097017)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
mitochondrial fusion (GO:0008053)	27	0	.45	-	 < 0.01	1.00E00	1.00E00
sensory organ boundary specification (GO:0008052)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to granulocyte macrophage colony-stimulating factor (GO:0097012)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
female courtship behavior (GO:0008050)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
eukaryotic translation initiation factor 4F complex assembly (GO:0097010)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014718)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014717)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of anion channel activity (GO:0010359)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation following phagocytosis (GO:0002747)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
male courtship behavior (GO:0008049)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lithium ion transport (GO:0010351)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of plasma lipoprotein particle levels (GO:0097006)	56	0	.93	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic assembly at neuromuscular junction (GO:0045887)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic assembly at neuromuscular junction (GO:0045886)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of smoothened signaling pathway (GO:0045880)	44	0	.73	-	 < 0.01	1.00E00	1.00E00
branchiomeric skeletal muscle development (GO:0014707)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of plasmacytoid dendritic cell cytokine production (GO:0002737)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of plasmacytoid dendritic cell cytokine production (GO:0002736)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid dendritic cell cytokine production (GO:0002735)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein tyrosine kinase activity (GO:0061099)	22	0	.37	-	 < 0.01	1.00E00	1.00E00
synaptic target recognition (GO:0008039)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid dendritic cell cytokine production (GO:0002733)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
neuron recognition (GO:0008038)	53	0	.88	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell cytokine production (GO:0002732)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of smoothened signaling pathway (GO:0045879)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic cell cytokine production (GO:0002731)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell cytokine production (GO:0002730)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
positive regulation of sister chromatid cohesion (GO:0045876)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of sister chromatid cohesion (GO:0045875)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
tRNA processing (GO:0008033)	127	0	2.12	-	 < 0.01	2.80E-01	1.00E00
positive regulation of phospholipid translocation (GO:0061092)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid translocation (GO:0061091)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
extracellular matrix assembly (GO:0085029)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045870)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
protein K6-linked ubiquitination (GO:0085020)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell cytokine production (GO:0002729)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell cytokine production (GO:0002728)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell cytokine production (GO:0002727)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
response to non-ionic osmotic stress (GO:0010335)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell cytokine production (GO:0002725)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein refolding (GO:0061084)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein refolding (GO:0061083)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081)	41	0	.68	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell mediated immunity (GO:0002714)	53	0	.88	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell mediated immunity (GO:0002713)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of prostaglandin secretion involved in immune response (GO:0061078)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated protein folding (GO:0061077)	68	0	1.13	-	 < 0.01	6.32E-01	1.00E00
negative regulation of T cell mediated immunity (GO:0002710)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
regulation of neural retina development (GO:0061074)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
iris morphogenesis (GO:0061072)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
pH elevation (GO:0045852)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pH reduction (GO:0045851)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
detoxification of zinc ion (GO:0010312)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of nitrogen utilization (GO:0045848)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to kinetochore involved in kinetochore assembly (GO:1903394)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of adherens junction organization (GO:1903393)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of adherens junction organization (GO:1903392)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle tissue development (GO:0045843)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
regulation of adherens junction organization (GO:1903391)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic metaphase/anaphase transition (GO:0045842)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	36	0	.60	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic nuclear division (GO:0045840)	49	0	.82	-	 < 0.01	1.00E00	1.00E00
ribonucleoside bisphosphate metabolic process (GO:0033875)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic nuclear division (GO:0045839)	46	0	.77	-	 < 0.01	1.00E00	1.00E00
positive regulation of homophilic cell adhesion (GO:1903387)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
sclerotome development (GO:0061056)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
myotome development (GO:0061055)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of homophilic cell adhesion (GO:1903385)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic nuclear division (GO:0045836)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic nuclear division (GO:0045835)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell growth involved in cardiac muscle cell development (GO:0061052)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903383)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell growth involved in cardiac muscle cell development (GO:0061051)	18	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903382)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell growth involved in cardiac muscle cell development (GO:0061050)	35	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903381)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of isotype switching (GO:0045830)	31	0	.52	-	 < 0.01	1.00E00	1.00E00
nucleoside bisphosphate biosynthetic process (GO:0033866)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleoside bisphosphate metabolic process (GO:0033865)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of NAD(P)H oxidase activity (GO:0033864)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of NAD(P)H oxidase activity (GO:0033861)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of NAD(P)H oxidase activity (GO:0033860)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment (GO:0021899)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
commitment of multipotent stem cells to neuronal lineage in forebrain (GO:0021898)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
forebrain astrocyte development (GO:0021897)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
forebrain astrocyte differentiation (GO:0021896)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebral cortex GABAergic interneuron development (GO:0021894)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
cerebral cortex GABAergic interneuron fate commitment (GO:0021893)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell growth involved in cardiac muscle cell development (GO:0061049)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic chromosome condensation (GO:1903379)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of branching involved in lung morphogenesis (GO:0061048)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903378)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
glucuronate metabolic process (GO:0019585)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of isotype switching (GO:0045829)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of branching involved in lung morphogenesis (GO:0061047)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of isoprenoid metabolic process (GO:0045828)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of isoprenoid metabolic process (GO:0045827)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
facioacoustic ganglion development (GO:1903375)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular wound healing (GO:0061044)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of vascular wound healing (GO:0061043)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of endoplasmic reticulum tubular network organization (GO:1903373)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
vascular wound healing (GO:0061042)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart contraction (GO:0045823)	45	0	.75	-	 < 0.01	1.00E00	1.00E00
regulation of endoplasmic reticulum tubular network organization (GO:1903371)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart contraction (GO:0045822)	26	0	.43	-	 < 0.01	1.00E00	1.00E00
female gonad morphogenesis (GO:0061040)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hypothalamus gonadotrophin-releasing hormone neuron development (GO:0021888)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
hypothalamus gonadotrophin-releasing hormone neuron differentiation (GO:0021886)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of cartilage development (GO:0061037)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycogen catabolic process (GO:0045819)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of fear response (GO:1903367)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen catabolic process (GO:0045818)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
negative regulation of fear response (GO:1903366)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
olfactory bulb mitral cell layer development (GO:0061034)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of fear response (GO:1903365)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
transcription initiation-coupled chromatin remodeling (GO:0045815)	54	0	.90	-	 < 0.01	1.00E00	1.00E00
secretion by lung epithelial cell involved in lung growth (GO:0061033)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
visceral serous pericardium development (GO:0061032)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
endodermal digestive tract morphogenesis (GO:0061031)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
epithelial cell differentiation involved in mammary gland alveolus development (GO:0061030)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
protein localization to basolateral plasma membrane (GO:1903361)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway involved in forebrain neuroblast division (GO:0021874)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
forebrain neuroblast division (GO:0021873)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
Cajal-Retzius cell differentiation (GO:0021870)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
arabinose metabolic process (GO:0019566)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi organization (GO:1903358)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
umbilical cord development (GO:0061027)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac muscle tissue regeneration (GO:0061026)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
glycerol catabolic process (GO:0019563)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of nucleus organization (GO:1903353)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-ornithine transmembrane transport (GO:1903352)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
blood coagulation, intrinsic pathway (GO:0007597)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
lactation (GO:0007595)	42	0	.70	-	 < 0.01	1.00E00	1.00E00
forebrain ventricular zone progenitor cell division (GO:0021869)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
forebrain radial glial cell differentiation (GO:0021861)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
L-histidine catabolic process to glutamate and formate (GO:0019557)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
L-histidine catabolic process to glutamate and formamide (GO:0019556)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
hepatoblast differentiation (GO:0061017)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
positive regulation of bicellular tight junction assembly (GO:1903348)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of bicellular tight junction assembly (GO:1903347)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
snRNA import into nucleus (GO:0061015)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA catabolic process (GO:0061014)	88	0	1.47	-	 < 0.01	4.09E-01	1.00E00
glutamate catabolic process via 2-hydroxyglutarate (GO:0019552)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glutamate catabolic process to aspartate (GO:0019550)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic DNA double-strand break formation (GO:1903343)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hepatic duct development (GO:0061011)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
gallbladder development (GO:0061010)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic DNA double-strand break formation (GO:1903341)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GABAergic neuron differentiation in basal ganglia (GO:0021858)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hypothalamic tangential migration using cell-axon interactions (GO:0021856)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
hypothalamus cell migration (GO:0021855)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
cerebral cortex GABAergic interneuron migration (GO:0021853)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pyramidal neuron migration to cerebral cortex (GO:0021852)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
common bile duct development (GO:0061009)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process to ornithine (GO:0019547)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vacuolar transport (GO:1903337)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process to glutamate (GO:0019544)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in kidney morphogenesis (GO:0061006)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
propionate catabolic process (GO:0019543)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vacuolar transport (GO:1903336)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vacuolar transport (GO:1903335)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
pattern specification involved in kidney development (GO:0061004)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
propionate biosynthetic process (GO:0019542)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein folding (GO:1903334)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic spine morphogenesis (GO:0061003)	32	0	.53	-	 < 0.01	1.00E00	1.00E00
propionate metabolic process (GO:0019541)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein folding (GO:1903333)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein folding (GO:1903332)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of iron-sulfur cluster assembly (GO:1903331)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neuroblast division in subventricular zone (GO:0021849)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
ventricular zone neuroblast division (GO:0021847)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
cell proliferation in forebrain (GO:0021846)	39	0	.65	-	 < 0.01	1.00E00	1.00E00
substrate-independent telencephalic tangential interneuron migration (GO:0021843)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to endoplasmic reticulum (GO:0072599)	47	0	.78	-	 < 0.01	1.00E00	1.00E00
chemorepulsion involved in interneuron migration from the subpallium to the cortex (GO:0021842)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
directional guidance of interneurons involved in migration from the subpallium to the cortex (GO:0021840)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of iron-sulfur cluster assembly (GO:1903329)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of tRNA metabolic process (GO:1903328)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of tRNA metabolic process (GO:1903327)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of tRNA metabolic process (GO:1903326)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
oxalate transport (GO:0019532)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
oxygen metabolic process (GO:0072592)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
parturition (GO:0007567)	14	0	.23	-	 < 0.01	1.00E00	1.00E00
embryonic olfactory bulb interneuron precursor migration (GO:0021831)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
interneuron migration from the subpallium to the cortex (GO:0021830)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
pentitol catabolic process (GO:0019527)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
caveolin-mediated endocytosis (GO:0072584)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
clathrin-dependent endocytosis (GO:0072583)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
D-gluconate metabolic process (GO:0019521)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nitrogen cycle metabolic process (GO:1903314)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA metabolic process (GO:1903313)	133	0	2.22	-	 < 0.01	1.78E-01	1.00E00
aldonic acid metabolic process (GO:0019520)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
endocardial cushion development (GO:0003197)	51	0	.85	-	 < 0.01	1.00E00	1.00E00
tricuspid valve formation (GO:0003195)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
gonadotrophin-releasing hormone neuronal migration to the hypothalamus (GO:0021828)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
pulmonary valve formation (GO:0003193)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mitral valve formation (GO:0003192)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
substrate-independent telencephalic tangential migration (GO:0021826)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
atrioventricular valve formation (GO:0003190)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell motility involved in cerebral cortex radial glia guided migration (GO:0021822)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pentitol metabolic process (GO:0019519)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
glycine receptor clustering (GO:0072579)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-threonine catabolic process to glycine (GO:0019518)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
endothelial cell apoptotic process (GO:0072577)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
liver morphogenesis (GO:0072576)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
response to phenylpropanoid (GO:0080184)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in liver morphogenesis (GO:0072575)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
hepatocyte proliferation (GO:0072574)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
tolerance induction to lipopolysaccharide (GO:0072573)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-proline hydroxylation (GO:0019511)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
S-adenosylhomocysteine catabolic process (GO:0019510)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of pyruvate kinase activity (GO:1903302)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sex-chromosome dosage compensation (GO:0007549)	25	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of hexokinase activity (GO:1903301)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of hexokinase activity (GO:1903300)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
primary sex determination, germ-line (GO:0007542)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
aortic valve formation (GO:0003189)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tricuspid valve morphogenesis (GO:0003186)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
sinoatrial valve morphogenesis (GO:0003185)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration (GO:0021817)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
coronary sinus valve morphogenesis (GO:0003182)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration (GO:0021816)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration (GO:0021815)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
cell motility involved in cerebral cortex radial glia guided migration (GO:0021814)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration (GO:0021813)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-methionine salvage from methylthioadenosine (GO:0019509)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
neuronal-glial interaction involved in cerebral cortex radial glia guided migration (GO:0021812)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide transmembrane transport (GO:0080170)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell maturation (GO:0072560)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
lateral sprouting involved in mammary gland duct morphogenesis (GO:0060599)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
primary sex determination (GO:0007538)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis (GO:0060598)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mammary placode formation (GO:0060596)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor signaling pathway involved in mammary gland specification (GO:0060595)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
mammary gland specification (GO:0060594)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
mammary gland formation (GO:0060592)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
chondroblast differentiation (GO:0060591)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
coronary sinus valve development (GO:0003178)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tricuspid valve development (GO:0003175)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
sinoatrial valve development (GO:0003172)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
blood vessel lumenization (GO:0072554)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
terminal button organization (GO:0072553)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of synaptic specificity at neuromuscular junction (GO:0007529)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein lipid oxidation (GO:0060588)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein lipid oxidation (GO:0060587)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
adult somatic muscle development (GO:0007527)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
multicellular organismal-level iron ion homeostasis (GO:0060586)	33	0	.55	-	 < 0.01	1.00E00	1.00E00
somatic muscle development (GO:0007525)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of prostaglandin-endoperoxide synthase activity (GO:0060585)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of prostaglandin-endoperoxide synthase activity (GO:0060584)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
cell fate determination involved in pattern specification (GO:0060582)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
visceral muscle development (GO:0007522)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell fate commitment involved in pattern specification (GO:0060581)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
muscle cell fate determination (GO:0007521)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
coronary vein morphogenesis (GO:0003169)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
ventral spinal cord interneuron fate determination (GO:0060580)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Purkinje myocyte differentiation (GO:0003168)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
atrioventricular bundle cell differentiation (GO:0003167)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
bundle of His development (GO:0003166)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
Purkinje myocyte development (GO:0003165)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
His-Purkinje system development (GO:0003164)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
sinoatrial node development (GO:0003163)	9	0	.15	-	 < 0.01	1.00E00	1.00E00
atrioventricular node development (GO:0003162)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cardiac conduction system development (GO:0003161)	20	0	.33	-	 < 0.01	1.00E00	1.00E00
endocardium morphogenesis (GO:0003160)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of fertilization (GO:0080154)	19	0	.32	-	 < 0.01	1.00E00	1.00E00
ventral spinal cord interneuron fate commitment (GO:0060579)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
myoblast fate determination (GO:0007518)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
superior vena cava morphogenesis (GO:0060578)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pulmonary vein morphogenesis (GO:0060577)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
intestinal epithelial cell maturation (GO:0060574)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
cell fate specification involved in pattern specification (GO:0060573)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
morphogenesis of an epithelial bud (GO:0060572)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
morphogenesis of an epithelial fold (GO:0060571)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
morphogenesis of an endothelium (GO:0003159)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
endocardium development (GO:0003157)	13	0	.22	-	 < 0.01	1.00E00	1.00E00
muscular septum morphogenesis (GO:0003150)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
glycolate catabolic process (GO:0046296)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycolate biosynthetic process (GO:0046295)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
formaldehyde catabolic process (GO:0046294)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
fibroblast activation (GO:0072537)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
formaldehyde biosynthetic process (GO:0046293)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
formaldehyde metabolic process (GO:0046292)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound transmembrane transport (GO:0072531)	17	0	.28	-	 < 0.01	1.00E00	1.00E00
mesoderm migration involved in gastrulation (GO:0007509)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of termination of DNA-templated transcription (GO:0060567)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic density protein 95 clustering (GO:1902897)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of termination of DNA-templated transcription (GO:0060566)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
gonadal mesoderm development (GO:0007506)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
terminal web assembly (GO:1902896)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of miRNA transcription (GO:1902894)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
digestive tract mesoderm development (GO:0007502)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in morphogenesis (GO:0060561)	24	0	.40	-	 < 0.01	1.00E00	1.00E00
mesodermal cell fate specification (GO:0007501)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
membranous septum morphogenesis (GO:0003149)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
mesodermal cell fate determination (GO:0007500)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
outflow tract septum morphogenesis (GO:0003148)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
neural crest cell migration involved in heart formation (GO:0003147)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube formation (GO:0003144)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube morphogenesis (GO:0003143)	71	0	1.18	-	 < 0.01	6.35E-01	1.00E00
cardiogenic plate morphogenesis (GO:0003142)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
determination of left/right asymmetry in lateral mesoderm (GO:0003140)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound catabolic process (GO:0072529)	21	0	.35	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound biosynthetic process (GO:0072528)	39	0	.65	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound metabolic process (GO:0072527)	62	0	1.03	-	 < 0.01	6.29E-01	1.00E00
pyridine-containing compound biosynthetic process (GO:0072525)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcidiol 1-monooxygenase activity (GO:0060559)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to spindle microtubule (GO:1902889)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of calcidiol 1-monooxygenase activity (GO:0060558)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
protein localization to astral microtubule (GO:1902888)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of vitamin D biosynthetic process (GO:0060557)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vitamin D biosynthetic process (GO:0060556)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to oxidative stress (GO:1902884)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of fructose 1,6-bisphosphate metabolic process (GO:0060552)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of fructose 1,6-bisphosphate metabolic process (GO:0060551)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
secondary heart field specification (GO:0003139)	11	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060550)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
primary heart field specification (GO:0003138)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
endodermal-mesodermal cell signaling (GO:0003133)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesodermal-endodermal cell signaling (GO:0003131)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proteasome core complex assembly (GO:0080129)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
flavonoid catabolic process (GO:0046275)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
stilbene catabolic process (GO:0046272)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phenylpropanoid catabolic process (GO:0046271)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of secondary heart field cardioblast proliferation (GO:0072513)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
AMP transport (GO:0080121)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
CAAX-box protein maturation (GO:0080120)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060549)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of necroptotic process (GO:0060545)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of strand invasion (GO:0060542)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of amacrine cell differentiation (GO:1902871)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
heart induction (GO:0003129)	8	0	.13	-	 < 0.01	1.00E00	1.00E00
diaphragm morphogenesis (GO:0060540)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heart field specification (GO:0003128)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
detection of nodal flow (GO:0003127)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of retina development in camera-type eye (GO:1902866)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
bronchus cartilage development (GO:0060532)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
propionyl-CoA biosynthetic process (GO:1902860)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vasoconstriction by circulating norepinephrine (GO:0003117)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vasoconstriction by norepinephrine (GO:0003116)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
squamous basal epithelial stem cell differentiation involved in prostate gland acinus development (GO:0060529)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
response to disaccharide (GO:0034285)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
propionyl-CoA catabolic process (GO:1902859)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
propionyl-CoA metabolic process (GO:1902858)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:0060527)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of non-motile cilium assembly (GO:1902857)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
prostate glandular acinus morphogenesis (GO:0060526)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
prostate glandular acinus development (GO:0060525)	12	0	.20	-	 < 0.01	1.00E00	1.00E00
negative regulation of non-motile cilium assembly (GO:1902856)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of non-motile cilium assembly (GO:1902855)	15	0	.25	-	 < 0.01	1.00E00	1.00E00
prostate epithelial cord elongation (GO:0060523)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of the force of heart contraction by chemical signal (GO:0003108)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of glomerular filtration by angiotensin (GO:0003106)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of glomerular filtration (GO:0003105)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of glomerular filtration (GO:0003104)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by endothelin (GO:0003100)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
terpene catabolic process (GO:0046247)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
kynurenic acid biosynthetic process (GO:0034276)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
kynurenic acid metabolic process (GO:0034275)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in prostatic bud elongation (GO:0060517)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
primary prostatic bud elongation (GO:0060516)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neuronal signal transduction (GO:1902847)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic spindle elongation (GO:1902846)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
prostate induction (GO:0060514)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
prostatic bud formation (GO:0060513)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
type I pneumocyte differentiation (GO:0060509)	10	0	.17	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagy in response to ER overload (GO:0034263)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear migration along microtubule (GO:1902838)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in lung development (GO:0060506)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of proline import across plasma membrane (GO:1902836)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of proline import across plasma membrane (GO:1902834)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
bud dilation involved in lung branching (GO:0060503)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in lung morphogenesis (GO:0060502)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell proliferation involved in lung morphogenesis (GO:0060501)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
coumarin catabolic process (GO:0046226)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
aflatoxin catabolic process (GO:0046223)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
aflatoxin metabolic process (GO:0046222)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
regulation of urea metabolic process (GO:0034255)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of late endosome to lysosome transport (GO:1902824)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of late endosome to lysosome transport (GO:1902823)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of late endosome to lysosome transport (GO:1902822)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
nitric oxide catabolic process (GO:0046210)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of amide metabolic process (GO:0034249)	23	0	.38	-	 < 0.01	1.00E00	1.00E00
snoRNA splicing (GO:0034247)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription elongation by RNA polymerase II (GO:0034244)	16	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to microtubule (GO:1902817)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of syncytium formation by plasma membrane fusion (GO:0034242)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to microtubule (GO:1902816)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage fusion (GO:0034241)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage fusion (GO:0034240)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle fiber differentiation (GO:1902811)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nitric oxide metabolic process (GO:0046209)	29	0	.48	-	 < 0.01	1.00E00	1.00E00
spermine catabolic process (GO:0046208)	3	0	.05	-	 < 0.01	1.00E00	1.00E00
nor-spermidine metabolic process (GO:0046204)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spermidine catabolic process (GO:0046203)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage fusion (GO:0034239)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle fiber differentiation (GO:1902809)	7	0	.12	-	 < 0.01	1.00E00	1.00E00
islet amyloid polypeptide processing (GO:0034231)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle transport (GO:1902805)	2	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic vesicle transport (GO:1902804)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle transport (GO:1902803)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
somatic recombination of T cell receptor gene segments (GO:0002681)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
ethanolamine transport (GO:0034229)	4	0	.07	-	 < 0.01	1.00E00	1.00E00
tRNA thio-modification (GO:0034227)	5	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to zinc ion starvation (GO:0034224)	6	0	.10	-	 < 0.01	1.00E00	1.00E00
